{"text_format":"1","workbook":"xlsx","n_sheets":221,"sheets":["Index","Sheet1","A0001","A0002","A0003","A0004","A0005","A0006","A0007","A0009","A0010","A0011","A0013","A0012","A0014","A0016","A0017","A0018","A0020","A0021","A0023","A0024","A0025","A0026","A0027","A0029","A0030","A0031","A0032","A0033","A0034","A0036","A0040","A0041","A0042","A0043","A0044","A0046","A0049","A0052","A0054","A0055","A0057","A0058","A0061","A0063","A0067","A0069","A0070","A0071","A0072","A0073","A0074","A0075","A0076","A0077","A0078","A0079","A0080","A0081","A0082","A0083","A0084","A0085","A0086","A0088","A0089","A0900","A0901","A0902","A0903","A0904","A0905","A0906","A0907","A0908","A0909","A0910","A0911","A0912","A0913","A0914","A0915","A0916","A0917","A0918","A0919","A0920","A0921","A0922","A0923","A0924","A0925","A0926","A0927","A0928","A0929","A0930","A0931","A0932","A0933","A0934","A0935","A0936","A0937","A0938","A0939","A0940","A0941","A0942","A0943","A0944","A0945","A0946","A0947","A0948","A0949","A0950","A0951","A0952","A0953","A0954","A0955","A0956","A0957","A0958","A0959","A0960","A0961","A0962","A0963","A0964","A0965","A0966","A0967","A0968","A0969","A0970","A0971","A0972","A0973","A0974","A0975","A0976","A0977","A0978","A0979","A0980","A0981","A0982","A0983","A0984","A0985","A0986","A0987","A0988","A0989","A0990","A0991","A0992","A0993","A0994","A0995","A0996","A0997","A0998","A0999","A1000","A1001","A1002","A1003","A1004","A1005","A1006","A1007","A1008","A1009","A1010","A1011","A1012","A1013","A1014","A1015","A1016","A1017","A1018","A1019","A1020","A1021","A1022","A1023","A1024","A1025","A1026","A1027","A1028","A1029","A1030","A1031","A1032","A1033","A1034","A1035","A1036","A1037","A1038","A1039","A1040","A1041","A1042","A1043","A1044","A1045","A1046","A1047","A1048","A1049","A1050","A1051","A1052","TEMPLATE"],"not_rendered":{"charts":0,"images":0,"macros":1,"external_links":1,"defined_names":2,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900"}

{"sheet":"Index","index":0,"n_rows":219,"n_cols":8,"rows_kept":219,"cut":false,"hidden":false,"merged":[]}
["App No.","Reference","Application Title","Status","Next Review","Notes","Contact","Organisation"]
["0001",{"$f":"INDIRECT(\"A\"&A2&\"!B4\")","v":"CAG 1-06(FT1)/2013"},{"$f":"INDIRECT(\"A\"&$A2&\"!B6\")","v":"Hounslow and Richmond Community Healthcare NHS Trust – Community Nursing Survey"},{"$f":"INDIRECT(\"A\"&$A2&\"!B32\")","v":"Expired"},{"$f":"INDIRECT(\"A\"&$A2&\"!B34\")","v":"2014-02-14"},"2014-02-14",{"$f":"(INDIRECT(\"A\"&$A2&\"!B9\"))","v":"David Lee"},{"$f":"(INDIRECT(\"A\"&$A2&\"!B8\"))","v":"Hounslow and Richmond Community Healthcare NHS Trust"}]
["0002","CAG 1-06(FT2)/2013","HES Cancer Extract",{"$f":"INDIRECT(\"A\"&$A3&\"!B32\")","v":"Supported"},"2020-02-13","2020-02-13","Helen Forbes","National Cancer Services Analysis Team"]
["0003","CAG 2-03(a)/2013","Application for transfer of data from the Health and Social Care Information Centre (HSCIC) to commissioning organisation Accredited Safe Havens (ASH)\n",{"$f":"INDIRECT(\"A\"&$A4&\"!B32\")","v":"Supported"},"00:00:00","00:00:00","Ming Tang","NHS England"]
["0004","CAG 2-06(a)/2013","Maternity Information System Data Linkage Pilot",{"$f":"INDIRECT(\"A\"&$A5&\"!B32\")","v":"Expired"},"N/A","N/A","Hannah Knight","Royal College of Obstetricians and Gynaecologists"]
["0005","CAG 3-03(PR2)/2013","Wales Cancer Patients’ Experience Survey 2013: Acute and specialist hospital survey of inpatients and day cases",{"$f":"INDIRECT(\"A\"&$A6&\"!B32\")","v":"Expired"},"N/A","N/A","Chris Dawson","Welsh Government"]
["0006","CAG 4-08(a)/2013","2013 Ambulance Survey of Callers to Clinical Support Desks","Expired","N/A","N/A","Ian Seccombe","Care Quality Commission"]
["0007","CAG 4-08(b)/2013","Fragility Fracture Secondary Prevention Audit",{"$f":"INDIRECT(\"A\"&$A8&\"!B32\")","v":"Expired"},"N/A","N/A","Emma Adams","Health and Social Care Information Centre"]
["0009","CAG 4-08(d)/2013","Multi-Centre Home Tracheostomy Ventilation Service Evaluation","Supported","2015-01-14","2015-01-14","Dr Michael Davies","Papworth Hospital NHS Foundation Trust"]
["0010","CAG 5-03(PR4)/2013","Cardiff and the Vale University Health Board (Wales) inpatients and day cases survey contributing to an assessment of health status contribution to Quality of Life Years","Expired","N/A","N/A","Dr Reg Race","Quality Health"]
["0011","CAG 5-07(a)/2013","National COPD Audit ","Supported","2014-09-25","2014-09-25","Emma Skipper","Royal College of Physicians of London"]
["0012","CAG 5-07(b)/2013","National audit of management of Hepatitis B in pregnancy","Expired","2016-12-11","2016-12-11","Dr Claire Thorne","University College London"]
["0013","CAG 5-07(c)/2013","UK Transcatheter Aortic Valve Implantation (TAVI) Registry, UK Renal Denervation Registry (UKRDNR), and National Neuromodulation Registry (NNR)","Expired","N/A","N/A","Julie Sanders","University College London"]
["0014","CAG 5-07(d)/2013","National Emergency Laparotomy Audit",{"$f":"INDIRECT(\"A\"&$A14&\"!B33\")","v":"Supported"},"00:00:00","00:00:00","Sharon Drake","Royal College of Anaesthetists"]
["0016","CAG 5-07(f)/2013","National Vascular Registry",{"$f":"INDIRECT(\"A\"&$A15&\"!B33\")","v":"Supported"},"00:00:00","00:00:00","Dr David Cromwell","Royal College of Surgeons of England"]
["0017","CAG 6-03(PR5)/2013","CQC 2013 Inpatients Survey","Expired","N/A","N/A","Ian Seccombe","Care Quality Commission"]
["0018","CAG 6-07(a)/2013","Enhanced quality assurance process of the provision of NHS-funded care for people with a learning disability or autistic spectrum disorder","Expired","N/A","N/A","Ray Avery","NHS England"]
["0020","CAG 6-07(c)/2013","HQIP NCA 099 National Clinical Audit & Quality Improvement Programme for Chronic Kidney Disease in Primary Care\n","Supported","2015-12-10","2015-12-10","Andy Syme, HQIP CKD Audit Project Manager","Informatica Systems Limited (Data processor on behalf of HQIP)"]
["0021","CAG 6-07(d)/2013","Inflammatory Bowel Disease Registry","Expired","N/A","N/A","Richard Gardner","British Society of Gastroenterology"]
["0023","CAG 6-07(f)/2013","CRIS – Lambeth DataNet linkage","Expired","N/A","N/A","Dr Max Henderson","South London and Maudsley NHS Foundation Trust"]
["0024","CAG 7-04(a)/2013","Disclosure of commissioning data sets and GP data for risk stratification purposes to data processors working on behalf of GPs","Supported","2022-09-30","2022-09-30","Ming Tang","NHS England"]
["0025","CAG 7-07(a)/2013","Application for transfer of data from the HSCIC to commissioning organisation accredited safe heavens: inclusion of invoice validation as a purpose within CAG 2-03 (a)/2013","Supported",{"$f":"INDIRECT(\"A\"&$A22&\"!B34\")","v":"2022-09-30"},"2022-09-30","Ming Tang","NHS England"]
["0026","CAG 7-07(b)/2013","Invoice validation within Clinical Commissioning Groups (CCGs) controlled \nenvironment for Finance ","Supported","2022-09-30","2022-09-30","Ming Tang","NHS England"]
["0027","CAG 7-07(c)/2013 ","Invoice validation within NHS England within the Commissioning Support Units controlled environment (for Finance) on behalf of Clinical Commissioning Groups","Supported","2022-09-30","2022-09-30","Ming Tang","NHS England"]
["0029","CAG 8-03(PR1)/2013","Prospective evaluation of the diagnostic efficacy of the 2010 United Kingdom National Institute for Clinical Excellence Guidelines on Chronic Heart Failure\n","Expired","2018-07-04","2018-07-04","Dr Klaus Witte","Leeds Teaching Hospitals NHS Trust"]
["0030","CAG 8-03(PR2)/2013","UK Register of Fatal anaphylactic reactions","Supported","2023-01-10","2023-01-10","Dr Vibha Sharma","Central Manchester University Hospitals NHS Foundation Trust"]
["0031","CAG 8-03(PR6)/2013","IOSwean","Supported","2015-01-28","2015-01-28","Dr Andrew Jones","Guy’s and St Thomas’s NHS Foundation Trust"]
["0032","CAG 8-03(PR7)/2013","Analysis of Routine Outcomes Relating to TAVI through Computational Algorithms (AORTA)\n","Expired","00:00:00","00:00:00","Samuel Urwin","Newcastle upon Tyne Hospitals NHS Foundation Trust"]
["0033","CAG 8-03(PR9)/2013","National Prostate Cancer Audit: analysis of existing datasets","Supported","2023-10-24","2023-10-24","Emma Skipper","Royal College of Surgeons of England"]
["0034","CAG 8-03(PR11)/2013","Hip Fracture Audit",{"$f":"INDIRECT(\"A\"&$A30&\"!B33\")","v":"Supported"},"00:00:00","00:00:00","Jessica Butler, NHFD Project Manager","Healthcare Quality Improvement Partnership (HQIP) and NHS England"]
["0036","CAG 8-06(b)/2013","National Chronic Obstructive Pulmonary Disease (COPD) Audit Programme - Secondary Care Clinical Audit","Supported","2023-12-12","2023-12-12","Lara Amusan, Programme Manager, National Asthma and COPD Audit Programme (NACAP) ","The Royal College of Physicians (Audit and Accreditation, Care Quality Improvement Department) "]
["0040","CAG 9-07(b)/2013","2014 Community Mental Health Survey","Expired","N/A","N/A","Ian Seccombe\n","Care Quality Commission"]
["0041","CAG 10-03(PR2)/2014","National Cancer Patients’ Experience Survey 2014: Acute and specialist trust surveys of inpatients and day cases","Expired","N/A","N/A","Dr Reg Race","Quality Health"]
["0042",{"$f":"INDIRECT(\"A\"&A34&\"!B4\")","v":"CAG 10-03(PR3)/2014"},{"$f":"INDIRECT(\"A\"&$A34&\"!B6\")","v":"Piloting new approaches 2014"},"Expired","N/A","N/A",{"$f":"(INDIRECT(\"A\"&$A34&\"!B9\"))","v":"Ian Seccombe"},{"$f":"(INDIRECT(\"A\"&$A34&\"!B8\"))","v":"Care Quality Commission"}]
["0043","CAG 10-03(PR4)/2014","Parents’ Experiences of Neonatal Care","Expired","2015-01-28","2015-01-28","Chris Graham","Picker Institute Europe\n"]
["0044","CAG 10-03(PR5)/2014","2014 Accident and Emergency Department (A&E) Survey","Expired","N/A","N/A","Ian Seccombe","Care Quality Commission"]
["0046","CAG 10-07(b)/2014","NICOR registries/audits","Expired","N/A","N/A","Dr Julie Sanders","University College London"]
["0049","CAG 1-05(a)/2014","2014 Child Inpatient and Day Case Survey","Supported","2015-09-28","2015-09-28","Karen Hallt","Care Quality Commission"]
["0052","CAG 1-06(c)/2014","Case Register for Rampton Hospital ","Supported","2015-09-11","2015-09-11","Dr Birgit Völlm","Nottinghamshire Healthcare NHS Trust "]
["0054","CAG 2-03(PR2)/2014","Mental Disorder & Cancer care: a data linkage study in south London II",{"$f":"INDIRECT(\"A\"&$A40&\"!B32\")","v":"Expired"},"N/A","N/A","Professor Robert Stewart","Kings College London"]
["0055","CAG 2-03(PR3)/2014","National Chronic Obstructive Pulmonary Disease (COPD) Audit Programme\n- Pulmonary Rehabilitation Clinical Audit Pilot\n","Expired","N/A","N/A","Ms Emma Skipper","Royal College of Physicians "]
["0057","CAG 4-03(PR1)/2014","Cost-effectiveness of models of care for young people with eating disorders","Supported",{"$f":"INDIRECT(\"A\"&$A42&\"!B34\")","v":"2017-08-26"},"2017-08-26","Professor Sarah Byford","King's College London"]
["0058","CAG 4-05(a)/2014","Community wide requirements to reduce mortality rate in North Lincolnshire","Supported","2015-08-22","2015-08-22","Dr Robert Jaggs-Fowler","North Lincolnshire Clinical Commissioning Group"]
["0061","CAG 4-05(d)/2014","Enhanced quality assurance process of the provision of NHS- funded care for people with a learning disability or autistic spectrum disorder","Supported","2016-03-09","2016-03-09","Kath Murphy","NHS England "]
["0063","CAG 5(PS2) 2014","Why do people with autism fare so differently in adult life?","Supported","2015-07-18","2015-07-18","Professor Emily Simonoff","Kings College London"]
["0067","CAG 6 (PS1) /2014","Towards an earlier diagnosis of Neuroendocrine Tumours (NETS): \nDoes faecal occult blood (FOB) testing identifiy Iieo-colonic NET in the \nNHS Bowel Cancer Screening Programme (BCSP)","Supported","2015-10-28","2015-10-28","Dr John Ramage","Hampshire Hospitals NHS Foundation Trust "]
["0069","CAG 6 (PS3)/2014","Survey of the experience of patients with Neuroendocrine cancers in active treatment in specialist hospital centres in England ","Expired","2015-08-26","2015-08-26","Dr Reg Race","NET Patient Foundation and Quality Health"]
["0070","CAG 7(PS1)/2014","An evaluation of 12-month all cause mortality in patients with hip fracture","Supported","2015-08-19","2015-08-19","Dr. Ruth Richardson","Royal National Orthopaedic Hospital"]
["0071","CAG 7(PS2)/2014","2014 Inpatients Survey","Supported","2015-08-26","2015-08-26","Paul Williamson","Care Quality Commission"]
["0072","CAG 8-02(a)/2014","Assuring Transformation: Data collection by Clinical Commissioning Groups to populate patient registers and reporting","Supported","2022-12-10","2022-12-10","Clare McConnell, Senior Analytical Lead","NHS England on behalf of Clinical Commissioning Groups"]
["0073","CAG 8-02(b)/2014","Data collection by NHS England Area Teams responsible for commissioning secure mental health and child and adolescent mental health services to populate patient register and reporting.","Supported","2022-12-10","2022-12-10","Clare McConnell, Senior Analytical Lead","NHS England on behalf of Clinical Commissioning Groups "]
["0074","CAG 8-02(c)/2014","Assuring Transformation: Enhanced Quality Assurance Process Data flow (Disclosure by HSCIC to NHS England)","Supported","2022-12-10","2022-12-10","Clare McConnell, Senior Analytical Lead","NHS England"]
["0075","CAG 9(PS1)/2014","2015 Community Mental Health Survey","Supported","2015-11-20","2015-11-20","Paul Williamson","Care Quality Commission (CQC)"]
["0076","CAG 10(PS1)/2015","2015 Maternity Survey","Supported","2016-04-08","2016-04-08","Paul Williamson","Care Quality Commission"]
["0077","CAG 9(PS2)/2014","PHE Congenital Anomaly and Rare Disease Registration Service ","Expired","N/A","N/A","Sarah Stevens, Public Health Consultant, National Disease Registration","Public Health England"]
["0078","CAG 10-02(d)/2015","Public Health England National Congenital Anomaly and Rare Disease Registration Service","Expired","2022-04-01","2022-04-01","Dr Jem Rashbass","Public Health England"]
["0079","15/CAG/0112","Human pituitary growth hormone recipients","Expired","2020-05-01","2020-05-01","Dr Peter Adlard, Co-ordinator. Senior Research Associate and Honorary Consultant Paediatrician","Pituitary Growth Hormone Follow-up Study, based at UCL Institute of Child Health and Great Ormond Street Hospital for Children Foundation Trust"]
["0080","15/CAG/0119","MBRRACE-UK – Delivering the Maternal, Newborn and Infant Clinical Outcome Review Programme (MNI-CORP)",{"$f":"INDIRECT(\"A\"&$A58&\"!B33\")","v":"Supported"},"00:00:00","00:00:00","Professor Jennifer J Kurinczuk","National Perinatal Epidemiology Unit (NPEU), University of Oxford on behalf of the MBRRACE-UK collaboration"]
["0081","CAG 5-05(a)/2014","Southend-on-Sea integrated care pioneer","Supported","2015-10-22","2015-10-22","Melanie Craig, Accountable Officer Southend CCG and Simon Leftley, Southend on Sea Borough Council","Southend CCG and Southend Borough Council"]
["0082","CAG 10-02(b)/2015","2015 Inpatients Survey","Supported","2016-05-28","2016-05-28","Paul Williamson","Care Quality Commission"]
["0083","15/CAG/0148","Improving Care in the NHS","Supported","2023-06-26","2023-06-26","Mr David Cromwell","The Royal College of Surgeons of England"]
["0084","15/CAG/0005","Research to identify measures of quality and safety of healthcare","Supported",{"$f":"INDIRECT(\"A\"&$A62&\"!B34\")","v":"2021-07-30"},"2021-07-30","Professor Paul Aylin","Imperial College London"]
["0085","15/CAG/0107","Improving Cardiac Arrest Recognition and Effectiveness (ICARE)","Supported","2016-08-03","2016-08-03","Professor Caroline Watkins","University of Central Lancashire"]
["0086","15/CAG/0173","Quality Health and NHS England: National Cancer Patient Survey","Expired","2016-08-19","2016-08-19","Mr Daniel Ratchford","Quality Health"]
["0088","15/CAG/0170","Holding patient identifiable data within the National Head and Neck Cancer Audit (HANA)","Expired","2017-09-25","2017-09-25","Neal McCann",{"$f":"(INDIRECT(\"A\"&$A65&\"!B8\"))","v":"Dendrite Clinical Systems"}]
["0089",{"$f":"INDIRECT(\"A\"&A66&\"!B4\")","v":"15/CAG/0158"},{"$f":"INDIRECT(\"A\"&$A66&\"!B6\")","v":"The fracture liaison service database"},"Supported","2023-10-15","2023-10-15",{"$f":"(INDIRECT(\"A\"&$A66&\"!B9\"))","v":"Laura Thomas, Project manager (Fracture Liaison Service Database)"},"Healthcare Quality Improvement Partnership (HQIP)"]
["0900","15/CAG/0144","Getting It Right First Time Programme","Supported","2015-10-14","2015-10-14","Mr John Machin","The Royal National Orthopaedic Hospital NHS Trust (RNOH)"]
["0901","15/CAG/0200","2016 Community Mental Health Survey","Supported","2016-12-16","2016-12-16","Mr Paul Williamson","Care Quality Commission"]
["0902","15/CAG/0210","Child Health Clinical Outcome Review Programme","Expired","00:00:00","00:00:00","Dr Marisa Mason","National Confidential Enquiry into Patient Outcome and Death (NCEPOD)"]
["0903","15/CAG/0178","Investigating the epidemiology of Female Genital Mutilation (FGM) in children under the age of 16 in the United Kingdom and the Republic of Ireland using surveillance methodology.","Expired","2017-10-16","2017-10-16","Dr Deborah Hodes","Central and North West London NHS FT"]
["0904","16/CAG/0009","Risk of Malignancy after Gamma Knife Stereotactic Radiosurgery, Ten Years On","Expired\n","2018-03-22","2018-03-22","Ms Alison Grainger","The National Centre for Stereotactic Radiosurgery, Sheffield Teaching Hospitals NHS Foundation Trust"]
["0905","16/CAG/0010","Wales Cancer Patients’ Experience Survey 2016",{"$f":"INDIRECT(\"A\"&$A72&\"!B32\")","v":"Supported"},"2017-03-22","2017-03-22","Dr Reg Race","Wales Government (sponsor) and Quality Health (implementation provider). Macmillan Cancer Support provides logistical and financial support to the survey."]
["0906","16/CAG/0018","Evaluation of Bowel Cancer Screening Helper Kit","Supported","2017-02-22","2017-02-22","Nicola Stephens","Head of Intelligence & IMT Public Health, Office of the Director of Public Health"]
["0907","15/CAG/0185","Antibiotics Post Surgery in Endocarditis 2004 – 2013 ","Supported","2017-04-22","2017-04-22","Dr John Klein","Guys & St Thomas NHS Foundation Trust"]
["0908","16/CAG/0041","2016 Adult Inpatient Survey","Supported","2017-05-04","2017-05-04","Chris Graham","Picker Institute Europe"]
["0909","16/CAG/0056","Learning Disabilities Mortality Review Programme","Expired","00:00:00","00:00:00","Dr Pauline Heslop","University of Bristol"]
["0910","16/CAG/0068","Cancer Research UK (CRUK) bowel cancer screening","Expired","N/A","N/A","Kathryn Weir","Cancer Research UK"]
["0911","16/CAG/0030","HES data on sepsis for Christie Chemotherapy patients","Supported","2017-07-11","2017-07-11","Tom Liptrot","The Christie NHS Foundation Trust"]
["0912","16/CAG/0006","UK National Flap Registry (UKNFR)","Supported","2023-07-11","2023-07-11","Mr Peter Kalu, UKNFR Audit Lead ","British Association of Plastic and Aesthetic Surgeons"]
["0913","16/CAG/0071","Benchmarking clinical quality healthcare measures","Supported","2023-08-04","2023-08-04","Michelle Lockett, Principle Clinical Informatician","University Hospitals Birmingham Foundation Trust (UHB)"]
["0914","16/CAG/0028","Use of administrative data for the evaluation of gynaecological cancer care services in England","Supported","2018-08-02","2018-08-02","Dr Ipek Gurol-Urganci","The Royal College of Surgeons of England"]
["0915","16/CAG/0116","National Cancer Patient experience survey 2016","Expired",{"$f":"INDIRECT(\"A\"&$A82&\"!B34\")","v":"2017-08-26"},"2017-08-26","Ruth Hudson","NHS England "]
["0916","15/CAG/0143","National Prostate Cancer Audit – PROMS/PREMS","Supported","2022-09-10","2022-09-10","Emma Skipper, Associate director","HQIP"]
["0917","16/CAG/0079","National clinical audit of breast cancer in older patients","Supported","2023-09-02","2023-09-02","Prof David Cromwell, Director of Clinical Effectiveness Unit","The Royal College of Surgeons of England"]
["0918","16/CAG/0097","Pathways of Care for young people in secure institutions (national service evaluation)","Supported","2017-09-15","2017-09-15","Dr Heidi Hales","St George’s Medical School"]
["0919","16/CAG/0111","The role of hospital organisation, surgical factors and their enhanced recovery pathway on patient outcomes and NHS costs following primary hip and knee replacement surgery","Expired","00:00:00","00:00:00","Andrew Judge","University of Oxford"]
["0920","16/CAG/0153",{"$f":"INDIRECT(\"A\"&$A87&\"!B6\")","v":"UK Renal Registry"},"Supported","2023-12-16","2023-12-16","Dr Retha Steenkamp, Head of Operations for the UK Renal Registry ","Southmead Hospital, UK Renal Registry"]
["0921","16/CAG/0077","2016 Accident and Emergency Survey","Supported","2017-06-13","2017-06-13","Chris Graham","Picker Institute Europe"]
["0922","16/CAG/0058","National Maternity and Perinatal Audit","Supported","2022-06-15","2022-06-15","George Dunn, NMPA Lead","Royal College of Obstetricians and Gynaecologists"]
["0923","17/CAG/0014","Hospital readmission and myocardial infarction after aortic surgery: A service evaluation","Supported","2018-02-13","2018-02-13","Dr Bijan Modarai","St Thomas’ Hospital"]
["0924","16/CAG/0050","ECG Diabetic Foot Ulcer (DFU) Pilot","Supported","2023-03-13","2023-03-13","Tom Newbound, Programme Director","NHS England"]
["0925","17/CAG/0017","Enhancing the Safety of Midwifery-Led Births enquiry (ESMiE)","Expired","00:00:00","00:00:00","Professor Jenny Kurinczuk","University of Oxford"]
["0926","16/CAG/0157","2017 Community Mental Health Survey","Supported","2017-12-22","2017-12-22","Chris Graham","Picker Institute Europe"]
["0927","CAG 6-06(a)/2014","Welsh Cancer Intelligence and Surveillance Unit (WCISU)","Supported","2023-01-10","2023-01-10","John Lawson","Public Health Wales NHS Trust"]
["0928","16/CAG/0108","National Clinical Audit for Specialist Rehabilitation following major Injury (NCASRI: Data linkage within the Major Trauma pathway.","Expired","2019-01-10","2019-01-10","Professor Lynne Turner-Stokes","Northwick Park Hospital"]
["0929","15/CAG/0197","Holding patient identifiable data within the National Head and Neck Cancer Audit (HANA)(prospective elements)","Supported","2017-12-11","2017-12-11","Mr Neal McCann","Dendrite Clinical Systems"]
["0930","17/CAG/0006","An evaluation of the level of clinician's adherence to the NICE hypertension in pregnancy guidance across maternity units in England","Supported","2019-03-16","2019-03-16","Dr Diane Farrar",{"$f":"(INDIRECT(\"A\"&$A97&\"!B8\"))","v":"Bradford Teaching Hospitals"}]
["0931",{"$f":"INDIRECT(\"A\"&A98&\"!B4\")","v":"17/CAG/0045"},"Hospital-Led Innovations for End of Life Care","Expired","2018-03-29","2018-03-29",{"$f":"(INDIRECT(\"A\"&$A98&\"!B9\"))","v":"Mr Giles Colclough"},"McKinsey and Company "]
["0932","16/CAG/0140","The British Association of Urological Surgeons (BAUS) Audits","Expired","2021-03-30","2021-03-30","Ms Patricia Hagan","The British Association of Urological Surgeons"]
["0933","17/CAG/0085","Audit of the Comprehensive Health Assessment Tool (CHAT)","Expired","2018-06-15","2018-06-15","Dr Charlotte Lennox","University of Manchester"]
["0934","17/CAG/0070","2017 Adult Inpatient Survey","Supported","2018-06-26","2018-06-26","Carolina Casanas i Comabella","Picker Institute Europe"]
["0935","17/CAG/0125","All-cause mortality within 12 months following Hip Fracture","Supported",{"$f":"INDIRECT(\"A\"&$A102&\"!B34\")","v":"2022-08-15"},"2022-08-15","Professor Andrew Judge","Big Health Data Group (BHDG), Nuffield Department of Orthopaedics"]
["0936","16/CAG/0105","Post surgical predictors of chronic pain after total knee replacement","Expired","00:00:00","00:00:00","Professor Andrew Judge","Big Health Data Group (BHDG), University of Oxford"]
["0937","17/CAG/0121","Cancer Patient Experience Survey 2017",{"$f":"INDIRECT(\"A\"&$A104&\"!B32\")","v":"Expired"},"2018-08-29","2018-08-29","Mr Daniel Ratchford","Quality Health"]
["0938","17/CAG/0115","ECG Diabetic Foot Ulcer (DFU) Pilot","Supported","2018-08-31","2018-08-31","Mr Nicholas Collins\n","NHS England"]
["0939","17/CAG/0152","Barts Health (NICOR) UK Transcatheter Aortic Valve Implantation (TAVI)","Expired","00:00:00","00:00:00","Mr James Chal, NICOR Chief Operating Officer","Barts Health NHS Trust"]
["0940","17/CAG/0153","NICOR Commissioning through Evaluation (CtE) Registries/Audits","Expired","00:00:00","00:00:00","James Chal, NICOR Chief Operating Officer","Barts Health NHS Trust"]
["0941","CAG 6-06(b)/2014","Congenital Anomaly Register and Information Service for Wales (CARIS)","Supported","2023-09-12","2023-09-12","David Tucker – CARIS Manager","Public Health Wales"]
["0942","CAG 6-06(c)/2014","Wales Abdominal Aortic Aneurysm Screening Programme (WAAASP)","Supported","2022-09-12","2022-09-12","Dr Rosemary Fox","Wales Abdominal Aortic Aneurysm Screening Programme"]
["0943","15/CAG/0207","NHS Cancer Screening Programmes: National Coordination and Quality Assurance","Expired","00:00:00","00:00:00","Anne Mackie, Director of Screening - PHE","Public Health England"]
["0944","17/CAG/0157","The delivery of major trauma care in England - impact and effectiveness following a whole system reorganisation",{"$f":"INDIRECT(\"A\"&$A111&\"!B32\")","v":"Expired"},"00:00:00","00:00:00","Professor Andrew Judge","Big Health Data Group (BHDG)"]
["0945","17/CAG/0150","National Perinatal Mortality Review Tool (PMRT)",{"$f":"INDIRECT(\"A\"&$A112&\"!B33\")","v":"Supported"},"00:00:00","00:00:00","Professor Jennifer J Kurinczuk","University of Oxford"]
["0946","17/CAG/0174","UTMoST Study","Expired","2022-11-07","2022-11-07","Professor Prieto Alhambra","Big Health Data Group (BHDG)"]
["0947","15/CAG/0190","National Study of HIV in Pregnancy and Childhood","Expired","2018-12-03","2018-12-03","Claire Thorne","UCL Great Ormond Street Institute of Child Health"]
["0948",{"$f":"INDIRECT(\"A\"&A115&\"!B4\")","v":"17/CAG/0071"},"Barts Health (NICOR) National Cardiac Audit Programme (NCAP)","Expired","00:00:00","00:00:00","James Chal, NICOR Chief Operating Officer","Barts Health (NICOR) National Cardiac Audit Programme (NCAP)"]
["0949","17/CAG/0193","UKRETS (United Kingdom Registry of Endocrine and Thyroid Surgery)","Expired","2019-02-21","2019-02-21","Dr Sebastian Aspinall","British Association of Endocrine and Thyroid Surgeons"]
["0950","17/CAG/0184","UK collaborative clinical audit of health care for children and young people with suspected epileptic seizures (Epilepsy12)",0,"00:00:00","00:00:00","Helen Stacey","Royal College of Paediatrics and Child Health"]
["0951","17/CAG/0030","UKSAFE","Expired","2022-02-24","2022-02-24","Dr Andrew Judge","Big Health Data Group at Oxford University"]
["0952","18/CAG/0042",{"$f":"INDIRECT(\"A\"&$A119&\"!B6\")","v":"2018 Maternity Survey"},"Supported","2019-03-29","2019-03-29","Ms Jenny King","Picker Institute Europe, CQC and NHS England"]
["0953","18/CAG/0018","Pre-Hospital Emergency Medicine (PHEM) Feedback","Supported","2022-04-16","2022-04-16","Dr Matthew Snowsill, PHEM Feedback Project Founder and Lead","Princess Alexandra Hospital NHS Trust"]
["0954","18/CAG/0063","National Clinical Audit of Rheumatoid and Early Inflammatory Arthritis Clinical Audit",{"$f":"INDIRECT(\"A\"&$A121&\"!B33\")","v":"Supported"},"00:00:00","00:00:00","Neena Garnavos","British Society for Rheumatology (commissioned by HQIP)"]
["0955","18/CAG/0057","Hospice-led innovations for end of life care","Supported",{"$f":"INDIRECT(\"A\"&$A122&\"!B34\")","v":"2019-04-20"},"2019-04-20","Mr Giles Colclough","NHS England and Hospice UK"]
["0956","18/CAG/0064","National Bone and Joint Infection Registry","Supported","2023-05-10","2023-05-10","Mr. Mike Reed","Northumbria Healthcare NHS Trust"]
["0957","17/CAG/0185","2018 Community Mental Health Survey","Supported","2018-11-23","2018-11-23","Ms Jenny King","Picker"]
["0958","17/CAG/0100","London Borough of Tower Hamlets Whole Systems Data\nIntegration Project","Supported","2020-07-26","2020-07-26","Dr Somen Banerjee","London Borough of Tower Hamlets"]
["0959","18/CAG/0072","NHS Improvement Getting It Right First Time (GIRFT) Program","Supported","2023-06-18","2023-06-18","John Machin","NHS Improvement"]
["0960","18/CAG/0076","Audit: evaluation of availability of patient contact details for use in the NHS Patient Survey Programme","Expired","00:00:00","00:00:00","Ms Jenny King","Picker Institute, on behalf of the Care Quality Commission"]
["0961","18/CAG/0098","2018 NHS Adult Inpatient Survey","Expired","N/A","N/A","Ms Jenny King","Picker Institute Europe, CQC and NHS England"]
["0962","18/CAG/0146","National Joint Registry (NJR)",{"$f":"INDIRECT(\"A\"&$A129&\"!B33\")","v":"Supported"},"00:00:00","00:00:00","Chris Boulton, NJR Deputy Director of Operations",{"$f":"(INDIRECT(\"A\"&$A129&\"!B8\"))","v":"Healthcare Quality Improvement Partnership"}]
["0963",{"$f":"INDIRECT(\"A\"&A130&\"!B4\")","v":"18/CAG/0110"},"2018 Urgent and Emergency Care Survey","Expired","2020-08-28","2020-08-28",{"$f":"(INDIRECT(\"A\"&$A130&\"!B9\"))","v":"Ms Jenny King"},"Picker Institute Europe"]
["0964","18/CAG/0107","National Cancer Patient Experience Survey 2018 (CPES)","Expired","2020-08-29","2020-08-29","Ms Charlotte Houston","NHS England"]
["0965","18/CAG/0131","Inflammatory Bowel Disease Registry","Supported","2023-05-14","2023-05-14","Ms Liz Dobson","IBD Registry Limited\n3 St Andrews Place\nRegent's Park\nLondon\nNW1 4LB"]
["0966","18/CAG/0143","Associations between frailty and outcomes after knee replacement","Expired","2020-09-24","2020-09-24","Rob Middleton","Big Health Data Group at the University of Oxford"]
["0967","18/CAG/0144","Reconstructive strategy and implant design in knee replacement","Expired","00:00:00","00:00:00","Rob Middleton","Big Health Data Group at the University of Oxford"]
["0968","17/CAG/0124","National Diabetes Audit (Adults) - Wales","Expired","00:00:00","00:00:00","Chris Dew (Analysis Lead Manager)","NHS Digital (on behalf of HQIP and NHS England)"]
["0969","CAG 7-04(b)/2014","UK National Screening Committee Hepatitis B in Pregnancy",{"$f":"INDIRECT(\"A\"&$A136&\"!B32\")","v":"Expired"},"00:00:00","00:00:00","Dr Claire Thorne","University College London and the Immunisation, Hepatitis and Blood Safety Department at Public Health England (PHE)"]
["0970","18/CAG/0127","Child Health Clinical Outcome Review Programme – Long-Term Ventilation","Expired","00:00:00","00:00:00","Marisa Mason","Healthcare Quality Improvement Partnership (HQIP) commissioned application from the National Confidential Enquiry into Patient Outcome and Death (NCEPOD)"]
["0971","18/CAG/0147","National Adult Community Acquired Pneumonia Audit 2018-19","Expired","2021-10-22","2021-10-22","Ms Sally Welham","British Thoracic Society"]
["0972","17/CAG/0196","Understanding local Heart Failure Pathways of Care","Expired","00:00:00","00:00:00","Mr Trevor Morris","Blackpool Teaching Hospitals NHS Foundation Trust"]
["0973","18/CAG/0150","2018 Children and Young People’s Patient Experience Survey","Expired","2020-11-09","2020-11-09","Ms Jenny King","Picker Institute Europe"]
["0974","18/CAG/0166","National Clinical Audit for Specialist Rehabilitation following major Injury (NCASRI) – Transfer of Controllership Arrangements","Supported","2023-11-16","2023-11-16","Ms Antoinette Edwards","Trauma Audit and Research Network (TARN)"]
["0975","18/CAG/0183","2019 Community Mental Health Survey","Expired",{"$f":"INDIRECT(\"A\"&$A142&\"!B34\")","v":"2020-11-16"},"2020-11-16","Ms Jenny King","Picker Institute Europe"]
["0976","18/CAG/0149","National Ophthalmology Database (NOD) Audit","Expired","2019-11-21","2019-11-21","Professor John Sparrow","Royal College of Ophthalmologists"]
["0977","15/CAG/0166","UK Shunt Registry (UKSR)","Supported","2023-06-09","2023-06-09","Prof. J D Pickard, Honorary Clinical Director, NIHR Brain Injury MedTech and In-Vitro Diagnostic Co-operative (MIC)  ","University of Cambridge"]
["0978","15/CAG/0209","2016 Child Inpatient and Day Case Survey","Supported","2017-07-01","2017-07-01","Mr Paul Williamson","Care Quality Commission (CQC)"]
["0979","CAG 2-06(a)/2014","Evaluation of the Nottingham City Alcohol Intensive Case Management Service","Supported","2016-02-02","2016-02-02","Dr Jean Robinson","Nottingham City Council"]
["0980","17/CAG/0023","National Bariatric Surgery Registry (NBSR)","Supported","2023-04-06","2023-04-06","Kerri Smith, BOMSS Secretariat ","National Bariatric Surgery Register\nName of controller for application: Mr Kamal Mahawar, Consultant Surgeon, Chairman of NBSR "]
["0981","17/CAG/0027","CQC Maternity Survey","Supported","2018-02-06","2018-02-06","Mr Chris Graham","Picker Institute Europe, CQC and NHS England"]
["0982","17/CAG/0073","Application to hold patient identifiable data within the National Head and Neck Cancer Audit (HANA)","Supported","2021-04-28","2021-04-28","Professor Iain Hutchinson","Saving Faces and Dendrite"]
["0983","17/CAG/0130","Colonoscopic surveillance for familial risk of colorectal cancer","Expired","2022-09-08","2022-09-08","Professor Huw Thomas","London North West Healthcare NHS Trust"]
["0984","19/CAG/0001",{"$f":"INDIRECT(\"A\"&$A151&\"!B6\")","v":"National Asthma and COPD Audit Programme (NACAP): Paediatric Asthma Clinical Audit"},"Supported","2023-03-20","2023-03-20","Lara Amusan, NACAP Programme Manager / Rachael Andrews, Deputy NACAP Programme Manager / Eloya Imoedemhe, Asthma Project Manager","The Royal College of Physicians of London (on behalf of HQIP)"]
["0985","19/CAG/0005","Outcomes of patients undergoing lower limb vascular procedures in the National Vascular Registry","Supported","2020-04-12","2020-04-12","Dr Richard Armstrong","North Bristol NHS Trust"]
["0986","19/CAG/0055","Triage-HF Plus: Cardiac Implantable Electronic Device Remote Monitoring Combined with Telephone Triage to Identify and Manage Worsening Heart Failure","Supported","2023-05-24","2023-05-24","Dr. Fozia Z Ahmed","Manchester University NHS Foundation Trust"]
["0987","19/CAG/0051","Piloting a new questionnaire to understand patient experiences of liver transplant services","Expired","2019-05-24","2019-05-24","Dr Jenny King","Picker Institute Europe"]
["0988","18/CAG/0092","Prostate brachytherapy survival outcomes supported by death certificate information from NHS Digital","Expired","2020-06-14","2020-06-14","Ms Jennifer Uribe","Royal Surrey County Hospital NHS Foundation Trust "]
["0989","19/CAG/0097","2019 NHS Adult Inpatient Survey","Supported","2021-08-12","2021-08-12","Ms Tamatha Webster","Care Quality Commission"]
["0990","19/CAG/0102","2019 NHS Adult Inpatient Survey – Mixed Methods Standalone Pilot","Expired","2021-08-21","2021-08-21","Ms Laura Thomas, Research Director","Care Quality Commission"]
["0991","19/CAG/0083 ","National Clinical Audit of Psychosis","Expired","2019-08-20","2019-08-20","Ms Beatrice Tooke, Programme Manager ","Healthcare Quality Improvements Partnership"]
["0992","19/CAG/0137","National Cancer Patient Experience Survey 2019","Expired","2022-09-10","2022-09-10","Jenny King - Chief Research Officer","NHS England"]
["0993","19/CAG/0176","All Wales Perinatal Survey (Historic data - 1993 to 2012)","Supported","2023-11-01","2023-11-01","Ms. Rosalind Reilly, Consultant in Public Health","Public Health Wales"]
["0994","19/CAG/0180","CQC 2019/20 Children and Young People’s Patient Experience Survey – Mixed Method Standalone Pilot","Expired","2021-11-18","2021-11-18","Ms Laura Thomas, Research Director",{"$f":"(INDIRECT(\"A\"&$A161&\"!B8\"))","v":"Ipsos MORI on behalf of the Care Quality Commission"}]
["0995",{"$f":"INDIRECT(\"A\"&A162&\"!B4\")","v":"19/CAG/0181"},"CQC 2019/20 Maternity Survey – Mixed Methods Standalone Pilot","Expired",{"$f":"INDIRECT(\"A\"&$A162&\"!B34\")","v":"2020-11-18"},"2020-11-18",{"$f":"(INDIRECT(\"A\"&$A162&\"!B9\"))","v":"Ms Laura Thomas, Research Director"},"Ipsos MORI on behalf of the Care Quality Commission"]
["0996",{"$f":"INDIRECT(\"A\"&A163&\"!B4\")","v":"19/CAG/0206"},"2020 Community Mental Health Survey","Expired","00:00:00","00:00:00","Ms Jenny King, Chief Research Officer","Picker, CQC and NHS England "]
["0997","19/CAG/0145","Transfusion Medicine Epidemiology Review","Supported","2024-01-17","2024-01-17","Miss Jan Mackenzie\nNational CJD Research and Surveillance Unit, Bryan Matthews\nWestern General Hospital\nEdinburgh","University of Edinburgh"]
["0998","19/CAG/0021","Maternity Survey 2019","Expired","2021-03-15","2021-03-15","Ms Jenny King","Picker Institute Europe"]
["0999","20/CAG/0016","2020 Maternity Survey","Expired","00:00:00","00:00:00","Tamatha Webster","Care Quality Commission"]
["1000","20/CAG/0067 (previously 16/CAG/0056)","Learning Disability Mortality Review (LeDeR) programme","Supported","2023-05-12","2023-05-12","Tom Cahill, National Director, Learning Disability and Autism, NHS England","NHS England and NHS Improvement"]
["1001","20/CAG/0011","An exploratory descriptive analysis of the 5-year survivorship of total ankle replacements compared with equivalent rates in administrative datasets with further adjusting for co-varieties",{"$f":"INDIRECT(\"A\"&$A168&\"!B32\")","v":"Expired"},"00:00:00","00:00:00","Dr Toby Jennison","Royal Devon and Exeter NHS Foundation Trust "]
["1002","20/CAG/0043",{"$f":"INDIRECT(\"A\"&$A169&\"!B6\")","v":"Adult social care free text analysis"},"Supported","2022-07-12","2022-07-12","Mahnaz Shaukat","London Borough of Islington"]
["1003","20/CAG/0025","SUPER (Southampton cardiac surgery Unit Performance Evaluation and Review Project)","Supported","2022-08-03","2022-08-03","Dr Suvitesh Luthra FRCS(CTh), Consultant Cardiac Surgeon","University Hospital Southampton NHS Foundation Trust"]
["1004","20/CAG/0093","2020 Urgent and Emergency Care Survey","Supported","2022-08-28","2022-08-28","Ms Jenny King","Care Quality Commission"]
["1005","20/CAG/0105","National Clinical Audit of Psychosis","Supported","2023-08-20","2023-08-20","Aimee Morris, Programme Manager            ","Healthcare Quality Improvement Partnership (HQIP) and NHS England "]
["1006","20/CAG/0085","2020 NHS Adult Inpatient Main Stage Survey – Mixed Methods","Expired","2022-09-22","2022-09-22","Laura Thomas","Ipsos MORI"]
["1007","20/CAG/0102","National Haemophilia Database (NHD)","Supported","2023-09-30","2023-09-30","Professor Charles Hay","United Kingdom Haemophilia Doctors Organisation"]
["1008","20/CAG/0139","2021 NHS Maternity Survey – Mixed Methods","Expired",null,"2022-11-24","Stacey Smith","Care Quality Commission"]
["1009","20/CAG/0111","Under 16 Cancer Patient Experience Survey 2020-2023","Supported",null,"2023-11-20","Peter Williamson, Insight and Feedback Manager","NHS England and NHS Improvement & Picker Institute Europe"]
["1010","20/CAG/0155","Community Mental Health Survey 2021","Supported",null,"2022-11-30","Tamatha Webster, CQC Survey Manager","Picker Institute & Care Quality Commission"]
["1011","20/CAG/0145","2020 Children and Young People’s Patient Experience Survey","Supported",null,{"$f":"INDIRECT(\"A\"&$A178&\"!B34\")","v":"2022-12-04"},"Tamatha Webster","Picker Institute Europe & Care Quality Commission"]
["1012","21/CAG/0007",{"$f":"INDIRECT(\"A\"&$A179&\"!B6\")","v":"National Neonatal Audit Programme (NNAP) data flow"},0,null,"00:00:00","Rachel Winch, National Neonatal Audit Programme Manager","Royal College of Paediatrics and Child Health"]
["1013","21/CAG/0028","Motor Neuron Disease Register for England, Wales and Northern Ireland","Supported",null,"2022-04-14","Professor Ammar Al-Chalabi, Consultant Neurologist and Head of Basic and Clinical Neuroscience","Kings College London (KCL)"]
["1014","20/CAG/0130","Yorkshire and Humber Care Record (YHCR) Population Health Management (PHM) for non-research purposes","Supported",null,"2022-04-12","Johnny Chagger","Humber Teaching NHS Foundation Trust"]
["1015","21/CAG/0047","Neonatal Intensive Care Data to be provided to the National Pregnancy in Diabetes Audit (part of the National Diabetes Audit NDA","Supported",null,"2023-05-07","Carla Howgate","NHS Digital"]
["1016",{"$f":"INDIRECT(\"A\"&A183&\"!B4\")","v":"21/CAG/0032"},"Non-statutory Medical Examiner System – second phase","Supported",null,"2022-05-10","Mr Nick Day, Policy and Programme Lead","NHS England and NHS Improvement"]
["1017","21/CAG/0084","National Cancer Patient experience survey 2021 (NCPES)","Supported",null,"2023-06-17","Nikki Gambles, Insight & Feedback Manager","Picker Institute Europe (on behalf of NHS England & NHS Improvement)"]
["1018",{"$f":"INDIRECT(\"A\"&A185&\"!B4\")","v":"20/CAG/0151"},"NHS Digital and BAD: Dermatology Intervention Service and Clinical Registries","Supported",null,"2023-06-21","Ms Tania von Hospenthal","British Association of Dermatologists"]
["1019",{"$f":"INDIRECT(\"A\"&A186&\"!B4\")","v":"21/CAG/0085"},"The Child Health Clinical Outcome Review Programme (CH-CORP)","Supported",null,"2023-07-13","Dr Marisa Mason","National Confidential Enquiry into Patient Outcome and Death (NCEPOD) "]
["1020",{"$f":"INDIRECT(\"A\"&A187&\"!B4\")","v":"21/CAG/0074"},"CQC 2021 Community Mental Health Survey - Mixed Methods stand alone pilot","Supported",null,"2023-08-10","Laura Thomas","Ipsos MORI"]
["1021",{"$f":"INDIRECT(\"A\"&A188&\"!B4\")","v":"21/CAG/0090"},"Paediatric Intensive Care Audit Network (Non research application)",{"$f":"INDIRECT(\"A\"&$A188&\"!B33\")","v":"Supported"},null,"00:00:00","Professor Richard Feltbower, ","University of Leeds"]
["1022","21/CAG/0105","Adherence to oral anticoagulants and statins","Supported",null,"2022-09-06","Dr Emmanouela Kampouraki","Leeds Teaching Hospitals NHS Trust,"]
["1023","21/CAG/0107","Wales Cancer Network – hosted by Public Health Wales NHS Trust","Supported",null,"2022-09-06","Emma Moore","Quality Health"]
["1024","21/CAG/0116","United Kingdom COVID and Gynaecological Cancers Study (UKCOGS)","Supported",null,"2022-09-06","Professor Ranjit Manchanda","Queen Mary University London and Barts Health NHS Trust\nJoint Research Office"]
["1025","19/CAG/0134","Welsh residents treated in England – use of Secondary Uses Services (SUS) Dataset for Wales Health Boards and Trusts","Expired",null,"00:00:00","Darren Lloyd","NHS Wales Informatics Services"]
["1026","CAG 8-02(d)/2014","Patient Episode Database Wales","Expired",null,"00:00:00","Darren Lloyd ","Health Solution Wales "]
["1027","21/CAG/0136","National Drug & Alcohol Treatment Monitoring System (NDTMS) & Criminal Justice Intervention Teams (CJIT)  [replacing and extending National Drug Treatment Monitoring System collection ECC 5-05(e)/2012]",{"$f":"INDIRECT(\"A\"&$A194&\"!B33\")","v":"Supported"},null,"00:00:00","Rosanna O’Connor - Director, Addictions & Inclusion","The Office of Health Improvement and Disparities, Department of Health and Social Care"]
["1028","21/CAG/0153 ","NHS Cancer Screening Programmes: National Coordination and Quality Assurance","Supported",null,"2023-07-06","Ming Tang","NHS England"]
["1029","21/CAG/0154 ","NHS Abdominal Aortic Aneurysm Screening Programme (NAAASP)","Supported",null,"2023-11-15","Ming Tang","NHS England"]
["1030","19/CAG/0177","The Child Death Review Programme","Supported",null,"2023-10-05","Rosalind Reilly","Public Health Wales "]
["1031","21/CAG/0147","2021 NHS Adult Inpatient Main Stage Survey – Mixed Methods","Supported",null,"2023-11-08","Laura Thomas, Research Director ","Ipsos MORI on behalf of the Care Quality Commission"]
["1032","21/CAG/0174","CQC 2022 Urgent and Emergency Care Survey – Mixed Methods Standalone Pilot","Supported",null,"2022-12-14","Laura Thomas","Care Quality Commission"]
["1033","21/CAG/0181","Community Mental Health 2022 Survey","Supported",null,"2023-12-20","Jenny King,  Chief research officer ","Care Quality Commission"]
["1034","22/CAG/0016","2022 NHS Maternity Survey - Mixed Methods","Supported",null,"2022-02-07","Ms Laura Thomas, Research Director","Ipsos MORI on behalf of the Care Quality Commission"]
["1035","20/CAG/0116","Quality and Outcomes in Oral and Maxillofacial Surgery (QOMS)","Supported",null,"2023-12-03","Mr Fabien Puglia","Saving Faces"]
["1036","22/CAG/0014","The Trauma Audit & Research Network (TARN)","Supported",null,"2023-02-21","Antoinette Edwards, Executive Director ","Trauma Audit and Research Network (TARN)"]
["1037","21/CAG/0150","Biliary Atresia Registry (England and Wales)",{"$f":"INDIRECT(\"A\"&$A204&\"!B33\")","v":"Supported"},null,"00:00:00","Professor Mark Davenport, Consultant Paediatric Surgery and National Lead for Biliary Atresia ","Kings College Hospital NHS Foundation Trust (KCH)"]
["1038","22/CAG/0015","REDCap registry for the UK highly specialised national service for Bardet-Biedl syndrome","Supported",null,"2023-02-25","Dr Elizabeth Forsythe","University College London"]
["1039",{"$f":"INDIRECT(\"A\"&A206&\"!B4\")","v":"22/CAG/0007"},"Prison healthcare, focusing on natural and other non-natural deaths","Supported",null,"2023-03-22","Dr Neil Smith","NCEPOD"]
[1040,{"$f":"INDIRECT(\"A\"&A207&\"!B4\")","v":"21/CAG/0094"},"Time limited access for NHS Digital to undertake record linkage of East Anglian Air Ambulance patients to HES and ECDS","Supported",null,null,"Kate Lachowycz, Research & Development Lead","East Anglian Air Ambulance (EAAA)"]
[1041,{"$f":"INDIRECT(\"A\"&A208&\"!B4\")","v":"22/CAG/0087"},"Epidemiology and Outcome from Out of Hospital Cardiac Arrest (Non-research application)",{"$f":"INDIRECT(\"A\"&$A208&\"!B33\")","v":"Supported"},null,null,"Professor Gavin Perkins, Director Warwick Clinical Trials Unit","University of Warwick"]
[1042,"22/CAG/0100",{"$f":"INDIRECT(\"A\"&$A209&\"!B6\")","v":"National Cancer Patient Experience Survey 2022-2024 "},"Supported",null,null,"Ms Nikki Gambles ","NHS England and Picker Institute Europe"]
[1043,"22/CAG/0114",{"$f":"INDIRECT(\"A\"&$A210&\"!B6\")","v":"NHS England (NICOR) National Cardiac Audit Programme (NCAP)"},{"$f":"INDIRECT(\"A\"&$A210&\"!B33\")","v":"Supported"},null,null,"Professor Nick Linker","NHS England & NHS Improvement"]
[1044,"22/CAG/0116 ",{"$f":"INDIRECT(\"A\"&$A211&\"!B6\")","v":"NHS England (NICOR): UK Transcatheter Aortic Valve Implantation (TAVI)"},{"$f":"INDIRECT(\"A\"&$A211&\"!B33\")","v":"Supported"},null,null,"Professor Nick Linker","NHS England & NHS Improvement"]
[1045,"22/CAG/0117",{"$f":"INDIRECT(\"A\"&$A212&\"!B6\")","v":"NICOR Commissioning through Evaluation Registries/Audits: \n• Percutaneous Mitral Valve Repair,\n• Left Atrial Appendage Occlusion and \n• Patent Foramen Ovale Closure in Adults\n"},"Supported",null,null,"Professor Nick Linker","NHS England & NHS Improvement"]
[1046,"22/CAG/0107",{"$f":"INDIRECT(\"A\"&$A213&\"!B6\")","v":"The 2022 Urgent and Emergency Care Survey"},"Supported",null,null,"Tamantha Webster","Picker Institute Europe"]
[1047,"22/CAG/0084",{"$f":"INDIRECT(\"A\"&$A214&\"!B6\")","v":"Warrington Health and Wellbeing Survey 2022"},"Supported",null,null,"Ms Frances Mann","Warrington Borough Council"]
[1048,"22/CAG/0128","Stroke Patient Reported Experience Measures (PREMS) ","Supported",null,null,"Juliet Bouverie,OBE","Stroke Association"]
[1049,"22/CAG/0115","Evaluation of ocular and systemic outcomes after treatment of ocular melanoma and other ocular tumours","Supported",null,null,"Professor Heinrich Heimann","Liverpool University Hospitals NHS Foundation Trust"]
[1050,"22/CAG/0152","2022 NHS Adult Inpatient Main Stage Survey –Mixed Methods","Supported",null,null,"Laura Thomas","Care Quality Commission"]
[1051,"22/CAG/0101",{"$f":"INDIRECT(\"A\"&$A218&\"!B6\")","v":"Nottingham and Nottinghamshire ICB S251 non-research purposes "},"Supported",null,null,"Maria Principe","Nottingham and Nottinghamshire Integrated Care Board (ICB)"]
[1052,"22/CAG/0102",{"$f":"INDIRECT(\"A\"&$A219&\"!B6\")","v":"West Yorkshire ICB S251 non-research purposes"},"Supported",null,null,"Mrs Natalie Tolson ","West Yorkshire Integrated Care Board (ICB)"]

{"sheet":"Sheet1","index":1,"n_rows":0,"n_cols":0,"rows_kept":0,"cut":false,"hidden":false,"merged":[]}

{"sheet":"A0001","index":2,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[19,2,19,4],[20,2,20,4],[18,2,18,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","0001"]
["Reference","CAG 1-06(FT1)/2013"]
["Other Refs"]
["Application Title","Hounslow and Richmond Community Healthcare NHS Trust – Community Nursing Survey"]
["Application Summary","This service evaluation application from Hounslow and Richmond Community Healthcare NHS Trust detailed sending a survey to patients that had been seen by the community nursing survey between 1 October and 31 December 2012. The application detailed that the size of this cohort was not likely to exceed 1,000 patients.  The application detailed that name and address details would be sent to NHS Quality Health in order to send surveys to patients. Date of birth and NHS number were requested in order to carry out mortality checks using DBS. No clinical information apart from the fact that the patient has received treatment from community nursing would be submitted to Quality Health.\n"]
["Applicant Organisation Name","Hounslow and Richmond Community Healthcare NHS Trust"]
["Contact Name","David Lee"]
["Address","Thames House"]
[null,"180 High Street"]
[null,"Teddington, Middlesex"]
["Postcode","TW11 8HU"]
["Telephone","01246 856263"]
["Email","reg.race@quality-health.co.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"Y","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"□","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Patients seen by community nursing service between 01/10/2012 and 31/12/2012.  Total cohort size 1000."]
["Description of confidential patient information used","Patient personal details:  Surname, Forename, \nHome address, Post code, Date of birth, NHS number\nGender, Ethnicity\nPatient administrative data: Date last contacted, Team/area\n"]
["S251 Class(es)","□","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Hounslow and Richmond Community Healthcare NHS Trust"]
["Status","Expired"]
[]
["Next Review Date","2014-02-14"]
["Notes","Application considered at CAG meeting on 18/04/2013.\nQuality Health approved to receive mortality data from DBS.  Support not required for Quality Health to access contact details to send out surveys as Quality Health are acting as data processor on behalf of data controller."]

{"sheet":"A0002","index":3,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[19,2,19,4],[20,2,20,4],[18,2,18,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","0002"]
["Reference","CAG 1-06(FT2)/2013"]
["Other Refs","PIAG 1-08(l)/2003; PIAG 4-09(e)/2003; PIAG 1-07(p)/2004"]
["Application Title","HES Cancer Extract"]
["Application Summary","This application from the National Cancer Services Analysis Team requested support to hold a database of hospital episodes and cancer registration records related to cancer services in England, to link databases together and to share processed HES data, and linked data with the Cancer Registries in England. The data would be used to support cancer policy development, cancer service reconfiguration, and to support the National Cancer Program, both centrally and in the form of Cancer Networks, NHS service providers and commissioners of cancer services.  This application consolidated the following 3 applications:\n1. 1-08(l)/2003, Data analysis of existing data sources to demonstrate variation in cancer service provision in England\n2. 4-09(e)/2003, Inter-comparison of data collected by ONS on cancer registration, and held as part of the HES database of hospital admissions by ONS\n3. 1-07(p)/2004, Collaboration with cancer registries to share work carried out by the NatCanSAT using HES and NSTS data, with Cancer Registration Data\nA combined application had been requested as all three applications referred to the same data extract, however they had been submitted separately over a number of meetings. As it had been indicated that funding was likely to move to the NHS Commissioning Board from April 2013 it was agreed that one resubmission should be made to cover all three applications to ensure clarity in future."]
["Applicant Organisation Name","National Cancer Services Analysis Team"]
["Contact Name","Helen Forbes"]
["Address","Clatterbridge Centre for Oncology NHS Trust"]
[null,"Clatterbridge Road"]
[null,"Bebington, Wirral"]
["Postcode","CH63 4JY"]
["Telephone","0151 482 7739"]
["Email","helen.c.forbes@nhs.net"]
["Medical Purposes","□","preventative medicine"]
[null,"Y","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"□","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Cancer patients in England"]
["Description of confidential patient information used","date of birth, NHS number, postcode"]
["S251 Class(es)","□","Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"Y","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"□","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"□","Class VI - granting of access to data for purposes I-V"]
["Sponsor","NHS England"]
["Status","Supported"]
[]
["Next Review Date","2020-02-13"]
["Notes","Application considered at CAG meeting on 18/04/2013\nConditions of support:\n1. The specified patient identifiable information is only used for the purpose(s) set out in the application.\n\n2. Confidentiality is preserved and that there is no disclosure of information in aggregate or patient level form that may inferentially identify a person, nor will any attempt be made to identify individuals, households or organisations in the data.\n\n3. Requirements of the Statistics and Registration Services Act 2007 are adhered to regarding publication when relevant.\n\n4. All staff with access to patient identifiable information have contractual obligations of confidentiality, enforceable through disciplinary procedures.\n\n5. All staff with access to patient identifiable information have received appropriate ongoing training to ensure they are aware of their responsibilities.\n\n6. Activities are consistent with the Data Protection Act 1998.\n\n7. Audit of data processing by a designated agent of the Secretary of State is facilitated and supported.\n\n8. The wishes of patients who have withheld or withdrawn their consent are respected.\n\n9. The NIGB Office is notified of any significant changes (purpose, data flows, security arrangements) to the application.\n\n10. An annual report is provided no later than 12 months from the date of your final confirmation letter. Details are available on the NIGB website. \n11. Any breaches of security around this particular flow of data should be reported to the NIGB within 10 working days, along with remedial actions taken.\n"]

{"sheet":"A0003","index":4,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[7,1,7,4],[19,2,19,4],[20,2,20,4],[8,1,8,4],[27,2,27,4],[13,1,13,4],[14,1,14,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[31,1,31,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[33,1,33,4],[28,2,28,4],[29,2,29,4],[30,1,30,4]]}
[]
[]
["Application Number","0003"]
["Reference","CAG 2-03(a)/2013"]
["Other Refs"]
["Application Title","Application for transfer of data from the Health and Social Care Information Centre (HSCIC) to commissioning organisation Accredited Safe Havens (ASH)\n"]
["Application Summary","The purpose of this non-research application was to enable the flow of data, required to support commissioning purposes, from the HSCIC to Accredited Safe Havens (ASHs). It was mutually agreed that the consideration would be restricted to the existing outbound commissioning data sets, flowing from the HSCIC to ASHs."]
["Applicant Organisation Name","NHS England"]
["Contact Name","Ming Tang"]
["Address","Director of Data and Information Systems"]
[null,"Quarry House"]
[null,"Leeds"]
["Postcode","LS2 7UE"]
["Telephone"," "]
["Email","ming.tang@nhs.net"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","All citizens for whom care is commissioned or might be commissioned"]
["Description of confidential patient information used","Contents of the full range of Commissioning Data Sets, that is:\n• Admitted Patient Care\n• Accident & Emergency\n• Waiting List\n• Critical Care\n• Augmented Care Periods\n• Mental Health\n• Care Activity and Future care Activity (the latter cover outpatient and diagnostic attendances and the associated future attendances and replace the previous outpatient CDS.\n"]
["S251 Class(es)","□","Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Department of Health"]
["Status","Supported"]
[]
["Next Review Date"]
["Notes","CAG currently considering an amendment to this application; the Register will be updated once a decision is taken however its status remains active.\n\nAmendment scope 19/07/2016\nThe amendment confirmed the scope to cover the HSCIC to make the data sets specified\nabove available to DSCROs for de-identification and linkage to other commissioning data\nsets, and make this available to Commissioners (CCGs and NHS England) as part of\nreference CAG 2-03 (a)/2013. The update paper specified that the data sets are nationally\ndefined and provide the minimum level of detail necessary to support service activity and\nquality monitoring for individuals that access the service.                                                        The Secretary of State for Health, having considered the advice from the Confidentiality\nAdvisory Group as set out below, has determined the following:\n1. The following datasets are included within the existing scope of CAG 2-03 (a)/2013\n Improving Access to Psychological Therapies (IAPT)\n Diagnostic Imaging Datasets (DIDS)\n Children and Young People’s Health Services Dataset (CYPHS)                                              Following meeting on 17 March 2016, the CAG recommended that support be extended to 31 March 2017. This recommendation was subject to the following specific conditions of support:\n\nFrom 27 April 2016, the following datasets are now included: Mental Health Minimum Data set (MHMDS), Mental Health Learning Disabilities Data set (MHLDDS), Mental Health Service Data set (MHSDS) (once available) and the Maternity Services Data Set (MSDS).\n\n1. An executive summary to be provided to the June 2016 meeting, in accordance with published timescales, setting out the applicant understanding as to what support covered, purposes data could be used and to whom it applied, against each of the following individual references, so as to confirm mutual understanding: \n\na. CAG 2-03 (a)/2013 \nb. CAG 7-04 (a)/2013 \nc. CAG 7-07 (a)/2013 \nd. CAG 7-07 (b)/2013 \ne. CAG 7-07 (c)/2013 \n\n2. An update/presentation to be provided to the June 2016 meeting of the current status of the programme relevant to the exit strategy, including a clear articulation of what identifiers would be utilised within the definition of ‘anonymisation in context’. \n\n3. Further reports to be provided, against all five references, to the September 2016 and December 2016 meetings providing updates against the timescales presented to CAG; to include: \na.         Status report showing the progress against the timelines described to CAG in February and March 2016 \nb.         Consideration on how the future solution is impacted by emerging issues \nc.         In light of the dependencies described, and as these become clearer, how the plan has to evolve, and any impact on the solution. \n\nApplication considered at CAG meeting on 19/04/2013\n\nThe following was approved following the update report considered in February 2015.\n\nBased upon the current early stages and positive approach being taken to move towards the revised ‘end state’, it was agreed that continuing support should initially be provided for a 12 month period (from 30 April 2015) with an interim report on progression at 6 months. In light of the available information considered and discussions, members agreed that this extension should be subject to key information being provided back to CAG as discussed at the meeting. Current support expires on 30 April 2015 therefore members advised that the following list information be provided prior to this date to enable continuing support to come into effect post 30 April 2015. \n\nInformation to be provided prior to 30 April 2015\n\n1. Updated project plan/documentation with detail on timescales for key milestones and phases\n2. Tangible evidence of patient notification material (posters, guidance etc) \n3. Statement on how patient objection in relation to this support is currently being handled and timescale/delivery plan of effective processing and respect of objections under this support, including what has/would need to happen and when.\n4. Published information on websites (NHS England and HSCIC) to be reviewed for inaccuracies and updated in relation to all activities taking place under Regulation 5. \n\nUpdate report to be provided to August 2014 meeting on fair processing, data sources and responses to clarifications.\n\nMembers recommended that support should be provided for a period of six months until end October 2013. This would enable sufficient time for the applicants to further define and establish progress towards the ‘end state’. A detailed report for consideration should be provided to the CAG October meeting to clearly identify the requirements for continuing and/or amended support, with an interim report, including a roadmap of future plans, to be provided to the CAG June meeting."]

{"sheet":"A0004","index":5,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","0004"]
["Reference","CAG 2-06(a)/2013"]
["Other Refs"]
["Application Title","Maternity Information System Data Linkage Pilot"]
["Application Summary","This application from the Royal College of Obstetricians and Gynaecologists (RCOG) detailed a pilot project to collect patient information from electronic maternity information systems (MIS) and Hospital Episode Statistics (HES) data in order to create a database to enable the development of robust and clinically meaningful performance indicators for maternity care. The database would be used to develop new indicators for evaluating maternity services, including maternal and neonatal outcome.  Support was requested to allow access to identifiable data from 15 maternity services over a 12 month period and link to HES inpatient and maternity data already held by the Royal College of Surgeons (RCS).  In order to link to HES data identifiable data would be submitted from MIS and provided to the HSCIC. A look up table with identifiable data and HESID would be sent to the applicant. The HESID would then be used to link MIS and HES datasets.  It was confirmed RCS would process the data on behalf of the RCOG.\n"]
["Applicant Organisation Name","Royal College of Obstetricians and Gynaecologists"]
["Contact Name","Hannah Knight"]
["Address","27 Sussex Place"]
[null,"Regent's Park"]
[null,"London"]
["Postcode","NW1 4RG"]
["Telephone","02077726385"]
["Email","hknight@rcog.org.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"Y","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"□","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Women delivering in selected UK hospitals over a 12 month period."]
["Description of confidential patient information used","Baby date of birth, baby time of birth, postcode, mother's NHS number, mother's date of birth"]
["S251 Class(es)","□","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"Y","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Royal College of Obstetricians and Gynaecologists"]
["Status","Expired"]
[]
["Next Review Date","N/A"]
["Notes","Application considered at CAG meeting on 19/04/2013.\n\nSpecific conditions of support\n1. Confirmation of suitable security arrangements via IG Toolkit submission, Confirmed 12 July 2013\n2. Please ensure that the Data Protection registration for RCOG is updated to include relevant purposes and data and notify the Confidentiality Advice Team once this is completed.  Confirmed.\n3. Please ensure that reasonable efforts are made to inform the cohort of the processing and ensure that these include details of how patients can opt out at a local level.  Confirmed 16 July 2013.\n"]

{"sheet":"A0005","index":6,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","0005"]
["Reference","CAG 3-03(PR2)/2013"]
["Other Refs"]
["Application Title","Wales Cancer Patients’ Experience Survey 2013: Acute and specialist hospital survey of inpatients and day cases"]
["Application Summary","This application from the Welsh Government detailed the Wales Cancer Patients’ Experience Survey 2013. The application used an identical survey method to that of the National Cancer Patients’ Experience Survey 2012: Acute and specialist trust surveys of inpatients and day cases (ECC 5-03(FT4)/2012), as well as other Cancer Patient Experience Surveys.  The survey would involve NHS Quality Health sending questionnaires to all adult inpatients and day case patients with a primary diagnosis of cancer who had been admitted to an acute or specialist NHS Hospital in Wales during June 2012- March 2013 inclusive. Identifiable data including name, address and NHS number would be disclosed from NHS trusts to NHS Quality Health. In addition; sex, ethnicity, year of birth, admission and discharge dates, ICD10 code and speciality code were requested.\n\n"]
["Applicant Organisation Name","Welsh Government"]
["Contact Name","Chris Dawson"]
["Address","Healthcare Quality Division, Department for Health, Social Services and Children"]
[null,"Cathays Park"]
[null,"Cardiff"]
["Postcode","CF10 3NQ"]
["Telephone","01246 856623"]
["Email","reg.race@quality-health.co.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"Y","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"□","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Adult inpatients and day case patients with a primary diagnosis of cancer who have been admitted to an acute or specialist NHS Hospital in Wales during June 2012- March 2013  inclusive. It is anticipated that a figure of c. 11,000 patients will be available from a 6 month period, but a slightly longer time period has been chosen to give scope for deduplication of records across and within LHBs given that this is the first occasion on which a dataset of this kind has been drawn."]
["Description of confidential patient information used","Name, address, sex, ethnic group, year of birth, ICD10 code, admission and discharge dates, speciality code, treating Board, admission type (in-patient or day case), NHS Number"]
["S251 Class(es)","□","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Wales Government"]
["Status","Expired"]
[]
["Next Review Date","N/A"]
["Notes","Application considered at CAG meeting on 14/06/2013"]

{"sheet":"A0006","index":7,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0006"]
["Reference","CAG 4-08(a)/2013"]
["Other Refs"]
["Application Title","2013 Ambulance Survey of Callers to Clinical Support Desks"]
["Application Summary","This service evaluation application from the Care Quality Commission detailed a telephone survey to be undertaken as part of the NHS national patient survey programme. The aim of the survey was to build a national picture of people’s experience of using ‘hear and treat’ services in order to lead to improvements in overall patient experience.  Support was requested in order for the co-ordination centre and fieldwork agencies to access identifiable data from ambulance trusts. A census would be sent from ambulance trusts to the co-ordination centre where a random sample would be selected and patient details would then be sent to fieldwork agencies to carry out calls. Access was requested to contact details including caller name and telephone number.\n"]
["Applicant Organisation Name","Care Quality Commission"]
["Contact Name","Ian Seccombe"]
["Address","Finsbury Tower"]
[null,"103-105 Bunhill Row"]
[null,"London"]
["Postcode","EC1Y 8TG"]
["Telephone","07855 464 479"]
["Email","ian.seccombe@cqc.org.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Callers who received clinical advice or triage over the telephone by a telephone advisor or member of the Clinical Support Desk referred to a Clinical Advisor working at a Clinical Support desk during November 2013. The size of the end sample will be 1000 service users for all but one trust, who will use a sample size of 500, and this will require a sample to be drawn from a census of callers compiled by the trust. The caller may be the patient or may be a person calling on behalf of a patient."]
["Description of confidential patient information used","name, phone number, gender, date of call, time of call"]
["S251 Class(es)","□","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"□","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","NHS England"]
["Status","Expired"]
[]
["Next Review Date","N/A"]
["Notes","Application considered at CAG meeting on 14/06/2013"]

{"sheet":"A0007","index":8,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","0007"]
["Reference","CAG 4-08(b)/2013"]
["Other Refs"]
["Application Title","Fragility Fracture Secondary Prevention Audit"]
["Application Summary","This audit application from the Health and Social Care Information Centre detailed an audit which aimed to evaluate standards of care in the prevention of secondary fracture following a non-hip fragility fracture. The audit aligned with the priorities described in the Department of Health’s Prevention Package for Older people and aimed to raise standards of care and improve the patient pathway in conjunction with the Quality Outcomes Framework being implemented in primary care.  The application covered a pilot activity commissioned by the Healthcare Quality Improvement Partnership (HQIP) for 18 months initially to assess the feasibility of collecting and linking data from primary and secondary sources, with the possibility of extension.  Support was requested in order to access data from Fracture Liaison Services (FLS) and General Practices for patients over 50 years old or above with a fragility fracture from April 2011.  Identifiable data would be used to validate NHS number in the first instance and then to link the two datasets using NHS number.\n"]
["Applicant Organisation Name","Health and Social Care Information Centre"]
["Contact Name","Emma Adams"]
["Address","1 Trevelyan Square"]
[null,"Boar Lane"]
[null,"Leeds"]
["Postcode","LS1 6AE"]
["Telephone","0113 254 7230"]
["Email","emma.adams@hscic.gov.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"Y","the provision of care and treatment"]
[null,"□","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","People with a fragility fracture"]
["Description of confidential patient information used","name, date of birth, NHS number, postcode, sex, organisation code (GP code or Trust code)"]
["S251 Class(es)","□","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"Y","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Healthcare Quality Improvement Partnership"]
["Status","Expired"]
[]
["Next Review Date","N/A"]
["Notes","\nApplication considered at CAG meeting on 14/06/2013\nApproval excludes automated extraction from GP practices where opt out is in place.\n\nConditions of support\n1. The terms and conditions of the use of the Apollo system should be amended before new automated extractions take place and there should be a clear agreement which specifies whether GP practices agree to the extraction of data from their systems without explicit consent.\n2. As a minimum, two forms of direct communication with GP practices should be provided prior to a new extraction taking place.\n\nOther conditions were specified and met in relation to the other aspect of the application and detailed within the outcome letter 21 August 2013.\n"]

{"sheet":"A0009","index":9,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","0009"]
["Reference","CAG 4-08(d)/2013"]
["Other Refs"]
["Application Title","Multi-Centre Home Tracheostomy Ventilation Service Evaluation"]
["Application Summary","This application from Papworth Hospital NHS Foundation Trust detailed a multi-service evaluation survey of patients supported via invasive ventilation at home. The survey aimed to review underlying diagnoses, clinical management during hospital admission, home care arrangements, long-term follow-up arrangements and patient outcomes including survival.\nA recommendation for class 1, 3, 4, 5 and 6 support was requested to allow identifiable data to be sent from a number of centres to Papworth Hospital in order to provide an understanding of the number of patients treated and how their care provision, treatment and outcomes may differ on a regional basis. Identifiable data including date of birth, NHS number and postcode would be submitted in relation to patients treated within the last 5 years. Mortality data would be accessed using the NHS Spine at Papworth Hospital.  Access was requested to NHS number, date of birth and postcode.\n"]
["Applicant Organisation Name","Papworth Hospital NHS Foundation Trust"]
["Contact Name","Dr Michael Davies"]
["Address","Respiratory Support and Sleep Centre"]
[null,"Cambridge"]
[null," "]
["Postcode","CB23 3RE"]
["Telephone","01480 830 541"]
["Email","michael.davies@papworth.nhs.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"Y","the provision of care and treatment"]
[null,"□","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Patients residing in England and Wales receiving domiciliary ventilatory support via tracheostomy."]
["Description of confidential patient information used","NHS number, postcode, date of birth, date of death"]
["S251 Class(es)","□","Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"Y","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Papworth Hospital NHS Foundation Trust"]
["Status","Supported"]
[]
["Next Review Date","2015-01-14"]
["Notes","Application considered at CAG meeting on 14/06/2013.\nSpecific conditions of support\n\n1. Confirmation of suitable security arrangements via IG Toolkit submission. Confirmed 31 May 2013.\n\n2. Ensure that reasonable efforts are made to inform the cohort and their carers in relation to this specific activity; including production of an activity specific patient information leaflets for distribution which should include details of how to opt out. A patient information leaflet was submitted which included details regarding how a patient could object to the use of their data. It was confirmed that the leaflet would be given to patients/carers when attending routine appointments at participating hospitals.\n\n3. Please consider how the patient and carer cohort could be engaged with directly and provide more details of the patient group consultation and result of this to date. A questionnaire and information about the evaluation was sent to patients in order to seek their views, all patients indicated that they were supportive of the application. The application was discussed with representatives of the Muscular Dystrophy Campaign who were supportive of the study. It was confirmed that one carer would act as a lay representative for the study.\n"]

{"sheet":"A0010","index":10,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0010"]
["Reference","CAG 5-03(PR4)/2013"]
["Other Refs"]
["Application Title","Cardiff and the Vale University Health Board (Wales) inpatients and day cases survey contributing to an assessment of health status contribution to Quality of Life Years"]
["Application Summary","This service evaluation application from Quality Health set out the purpose of a survey of\npatients treated in Cardiff and the Vale University Health Board or Velindre NHS Trust\nhospitals, in order to inform the planning of future services and investigate the impact of health\nstatus on overall wellbeing. A recommendation for class 4, 5 and 6 support was requested to\ncover access to patient contact details to enable survey questionnaires to be sent out.\nAccess was requested to name, address, NHS number and date of discharge."]
["Applicant Organisation Name","Quality Health"]
["Contact Name","Dr Reg Race"]
["Address","Unit 1, Holmewood Business Park"]
[null,"Chesterfield Road, Holmewood"]
[null,"Chesterfield, Derbyshire"]
["Postcode","S42 5US"]
["Telephone","01246 856623"]
["Email","reg.race@quality-health.co.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Adult inpatients and day case patients, predicted to be c. 20,000, discharged from any of the named hospitals within the Health Board area during a 6 month period This cohort has been chosen to enable sufficient numbers of patients to be included for the purposes of the study"]
["Description of confidential patient information used","name, address, NHS number, gender, discharge date"]
["S251 Class(es)","□","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Cardiff and the Vale University Health Board"]
["Status","Expired"]
[]
["Next Review Date","N/A"]
["Notes","Application considered at CAG meeting on 08/08/2013"]

{"sheet":"A0011","index":11,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0011"]
["Reference","CAG 5-07(a)/2013"]
["Other Refs"]
["Application Title","National COPD Audit "]
["Application Summary","This audit application from the Royal College of Physicians (RCP) set out the purpose of a pilot activity to test the submission of secondary care clinical audit dataset to inform the National COPD Audit. The application provided details of future plans in order to put the current pilot request into context.  The initial pilot phase would identify any necessary amendments to the dataset and data collection systems. The British Thoracic Society (BTS) would collect identifiable data and anonymised data only would be passed to the RCP.  A recommendation for class 1, 5 and 6 support was requested to cover access to identifiable data items for the pilot phase to test collection of information, including patient identifiable items, for the purpose of reviewing appropriateness, feasibility and reliability of the secondary care clinical audit dataset.  Access was requested to NHS number, date of birth, date of death and postcode."]
["Applicant Organisation Name","Royal College of Physicians of London"]
["Contact Name","Emma Skipper"]
["Address","Clinical Effectiveness & Evaluation Unit"]
[null,"11 St Andrews Place"]
[null,"London"]
["Postcode","NW1 4LE"]
["Telephone","0203 075 1502"]
["Email","emma.skipper@rcplondon.ac.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","125 adult patients with COPD, comprising a pilot dataset of 5 patients per site across 25 sites"]
["Description of confidential patient information used","NHS number, date of birth, date of death, postcode"]
["S251 Class(es)","□","Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"□","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Healthcare Quality Improvement Partnership (HQIP)"]
["Status","Supported"]
[]
["Next Review Date","2014-09-25"]
["Notes","Application considered at CAG meeting on 08/08/2013.\nConfidentiality Advisory Group advice \n\nIn line with the considerations above, the CAG agreed that the minimum criteria under the Regulations appeared to have been met, and therefore advised recommending conditional support to the Secretary of State for Health, subject to compliance with the specific and standard conditions of support as set out below. \n\nSpecific conditions of support\n\n1. This support applies to the pilot activity only.\n\n2. Please provide a copy of the patient information leaflet referenced within the patient poster. Submitted.\n\n3. Please consider whether a consent based approach can be tested when carrying out data collection for the pilot activity. Withdrawn, please see comments below.\n\n4. Confirmation of suitable security arrangements via IG Toolkit submission.\n"]

{"sheet":"A0013","index":12,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0013"]
["Reference","CAG 5-07(c)/2013"]
["Other Refs","(replaced with 17/CAG/0152)"]
["Application Title","UK Transcatheter Aortic Valve Implantation (TAVI) Registry, UK Renal Denervation Registry (UKRDNR), and National Neuromodulation Registry (NNR)"]
["Application Summary","This audit application from University College London described three national audit datasets:\n1) TAVI – a record of all TAVI procedures performed in the UK since the introduction of the technique in 2007. The dataset included demographic data, indications, procedural details and outcomes up to hospital discharge.  Follow up data would be collected at 1 and 3 years.\n2) UKRDNR – a UK registry of patients undergoing renal denervation for hypertension.\n3) NNR – a database including all patients undergoing neuromodulation.\nThe datasets would be analysed with the aim to drive improvements in the quality of care.  Findings would be shared with participating Trusts and aggregate analysis reports published.  A recommendation for class 4, 5 and 6 support was requested to cover access by NICOR to identifiable data on patients undergoing the relevant procedures, to track patients across NHS organisations and to link to national datasets such as Hospital Episode Statistics (HES) and ONS mortality data.  Access was requested to name, NHS number, date of birth, date of death and postcode.\n"]
["Applicant Organisation Name","University College London"]
["Contact Name","Julie Sanders"]
["Address","NICOR"]
[null,"170 Tottenham Court Road"]
[null,"London"]
["Postcode","W1T 7HA"]
["Telephone","0203 108 3929"]
["Email","j.sanders@ucl.ac.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"Y","the provision of care and treatment"]
[null,"□","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","All NHS patients undergoing transcatheter aortic valve implantation, renal denervation or neuromodulation"]
["Description of confidential patient information used","name, NHS number, date of birth, date of death, postcode"]
["S251 Class(es)","□","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","NHS England"]
["Status","Expired"]
[]
["Next Review Date","N/A"]
["Notes","Superceeded by 17/CAG/0152 on 08/09/2017\n\nApplication considered at CAG meeting on 08/08/2013.\n\nThe applicant had stated that the issue of obtaining patient consent is under review. Work is also ongoing with MRIS to investigate the possibility of de-identifying the dataset. A full update on these should be provided in the next annual review with details of any discussions and together with the actions arising from them.\n\nIt was noted that the open day cited by the applicant had taken place in 2014. More specific detail pertaining to the patient and user feedback and involvement and any resultant outcomes should be included in the next annual review.\n\nSpecific conditions of support\n1. Confirmation of suitable security arrangements via IG Toolkit submission. Confirmed 23 December 2013.\n2. Please provide a letter of support from the Caldicott Guardian or equivalent.  Received 11 October 2013.\n3. Postcode should be reduced to Census Lower Level Super Output Area at the earliest opportunity.  Confirmed 11 October 2013.\n4. Please amend the patient information leaflet to ensure that this reflects the approval from the Secretary of State of Health and remove references to the National Information Governance Board. Please also ensure that all audits are listed within the information leaflet.  Revised patient information leaflet submitted. \n\n5. Please confirm that confidentiality clauses are included within staff contracts for staff involved in the specified activities.  Confirmed 27/01/2014 that disciplinary procedures were in place for the intentional misuse of confidential information and that this would constitute gross misconduct and may result in dismissal at first offence.\n\n"]

{"sheet":"A0012","index":13,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0012"]
["Reference","CAG 5-07(b)/2013"]
["Other Refs"]
["Application Title","National audit of management of Hepatitis B in pregnancy"]
["Application Summary","This audit application from University College London set out a national clinical audit of the management of pregnant women with hepatitis B and their babies over a 12 month period. The audit would measure current practice against the NHS Infectious Diseases in Pregnancy Screening Programme standards with respect to referral of all women screening positive for hepatitis B or with a prior diagnosis, and evaluate specialist and perinatal management of hepatitis B positive women and their infants.  A recommendation for class 4, 5 and 6 support was requested to cover access to data from maternity services on around 3000 pregnant women screening positive for hepatitis B or with a prior diagnosis of hepatitis B.  NHS number would be requested in order to carry out data linkages. Month and year of birth of mother would be used to help de-duplication. Date of birth of infant would be used to establish timing of interventions in relation to delivery.  Access was requested to NHS number, date of birth of infant, month and year of birth of mother."]
["Applicant Organisation Name","University College London"]
["Contact Name","Dr Claire Thorne"]
["Address","Institute of Child Health"]
[null,"30 Guilford Street"]
[null,"London"]
["Postcode","WC1N 1EH"]
["Telephone","0207 905 2105"]
["Email","claire.thorne@ucl.ac.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"Y","the provision of care and treatment"]
[null,"□","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","3000 pregnant women screening positive for hepatitis B in England"]
["Description of confidential patient information used","Date of birth of infant, month and year of birth of mother, NHS number"]
["S251 Class(es)","□","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","University College London"]
["Status","Expired"]
[]
["Next Review Date","2016-12-11"]
["Notes","May 2022 - Support Expired:\nApplicant confirmed in May 2022 that all confidential patient information had been deleted from the dataset, and ‘s251’; support was no longer required.\n\nIn terms of the public benefit of the Hepatitis B in Pregnancy Audit, the findings were used to inform the updated (Jan 2021) guidance on the hepatitis B antenatal screening and selective neonatal immunisation pathway in England. You can find the Audit’s contribution and main findings mentioned here: https://www.gov.uk/government/publications/hepatitis-b-antenatal-screening-and-selective-neonatal-immunisation-pathway/guidance-on-the-hepatitis-b-antenatal-screening-and-selective-neonatal-immunisation-pathway--2 There is also a manuscript in draft writing up some of the audit findings – specifically to characterise the population of pregnant women living with HBV infection in England (as this has not been done before on a national basis).\n\nAmendment Request (Approved 12/10/2018)\nThe amendment seeks an extension to the duration of support under the Regulations to the end of January 2019, to enable the completion of transfer of confidential patient information collated during the audit to Public Health England.\n\nApplication considered at CAG meeting on 08/08/2013.\nSpecific conditions of support\n1. Confirmation of suitable security arrangements via IG Toolkit submission Confirmed 08/07/2013\n2. Please confirm that date shifting will be used in order to de-identify data for the purposes of analysis.  Confirmed 31/10/2013\n3. Please confirm that those staff with access to confidential patient information should be asked to sign confidentiality agreements.  Confirmed 31/10/2013\n4. Please provide a copy of the audit specific information leaflet.  Provided 31/10/2013\n5. Please provide further information in relation to the outcomes of patient consultations.  Provided 31/10/2013.  It was confirmed that a patient representative (a mother with chronic hepatitis B) had been identified for the audit advisory group and would contribute to ongoing discussions regarding patient engagement.  Consultation with recently delivered women with hepatitis B with respect to using data for this audit had concluded with no concerns being raised.  It was confirmed that patient opt-out rates would be monitored on an ongoing basis to further assess the acceptability of the proposed approach for this application.\n"]

{"sheet":"A0014","index":14,"n_rows":36,"n_cols":3,"rows_kept":36,"cut":false,"hidden":false,"merged":[[31,1,31,4],[32,1,32,4],[34,1,34,4],[35,1,35,4],[21,1,21,4],[22,1,22,4],[23,1,23,4],[24,0,30,0],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,2,30,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0014"]
["Reference","CAG 5-07(d)/2013"]
["Other Refs"]
["Application Title","National Emergency Laparotomy Audit"]
["Application Summary","This audit application from the Royal College of Anaesthetists set out a study aiming to identify and disseminate best practice in the delivery of care to patients undergoing emergency laparotomy in order to reduce associated morbidity and mortality. A recommendation for class 4, 5 and 6 support was requested to cover access to identifiable data on patients aged 18 and over undergoing emergency laparotomy in England and Wales between 1 December 2013 and 30 November 2015, and to link this data to Hospital Episode Statistics (HES), ONS mortality data and Intensive Care National Audit and Research Centre (ICNARC) data.  Linkages would be carried out by the Health and Social Care Information Centre’s Data Linkage Service.  Access was requested to NHS number, hospital number, date of birth, date of death and postcode."]
["Applicant Organisation Name","Royal College of Anaesthetists"]
["Contact Name","Sharon Drake"]
["Address","Churchill House"]
[null,"35 Red Lion Square"]
[null,"London"]
["Postcode","WC1R 4SG"]
["Telephone","0207 092 1676"]
["Email","sdrake@rcoa.ac.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"Y","the provision of care and treatment"]
[null,"□","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Adult patients undergoing emergency laparotomy in England and Wales from 01/12/13-30/11/15; estimated cohort 40,000 annually across 192 sites"]
["Description of confidential patient information used","NHS number, hospital number, date of birth, date of death, postcode"]
["National Data Opt \nOut Status","The Secretary of State for Health and Social Care decision maker, on advice from the CAG, has supported a request to defer the National Data Opt Out. As such, the National Data Opt Out does not need to be applied for this activity"]
["S251 Class(es)","□","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Healthcare Quality Improvement Partnership"]
["Status","Supported"]
[]
["Next Review Date","2023-11-15"]
["Notes","Amendment supported 15 July to defer applying the National Data Opt-Out in relation to CAG 5-07(d)/2013\n\nSpecific conditions of support \n\n1.\tPatient and public involvement needs to be undertaken specifically around the non-application of the National Data Opt-Out. Feedback from this activity needs to be provided to the CAG. Condition met 20 October 2022. Condition met 20 October 2022.\n\n2.\tThe patient notification materials need to be revised and a layered approach adopted, including posters and leaflets, as well as online information. Condition met 20 October 2022.\n\n3.\tThe National Data Opt-Out is not to be applied to patients included in the activities specified in ref. CAG 5-07(d)/2013. \n\n4.\tA local patient objection mechanism must continue to be used in relation to CAG 5-07(d)/2013.\n\n5.\tFurther, more accessible, forms of patient notification are to be explored and fed back on at annual review.\n\n6.\tPatient and public involvement needs to be conducted throughout the lifetime of the application.\n\n\n20 July 2022 – amendment supported to allow the Royal College of Anaesthetists to use a cloud-based method of storing back up data, instead of a tape-based system. \n\n23 June 2020 – Amendment supported to include additional questions in the National Emergency Laparotomy Audit (NELA) dataset, for the purpose of collecting information on the impact of Covid-19 on emergency laparotomies.\n\n07 October 2019: Amendment supported to include the addition of linkage to the HES Critical Care data to be undertaken by NHS Digital, Royal College of Anaethetistics as a procesor of pseudonymised audit data for anlaysis purposes and to enable wider clinical data collected during the audit linkage to be shared back with Trusts who had originally provided patient care. \n\nAmendment update 23/08/2016:                                                                                                                                                                                                          The initial application requested approval to send the NHS number to HSCIC for linkage. However the applicant has been informed that the minimum required for \npurposes is the NHS number and the Date of Birth. The request is therefore for 1 additional data item (DOB) to be sent to HSCIC.\n\nAmendment request \nRequested received and approved January 2014 for a change in purpose to enable anonymised audit data to be disclosed for further research or audit purposes. The amendment was specifically in relation to the used of anonymised data in the EPOCH Trial, Enhanced Peri-Operative Care for High-risk patients.\n\nApplication considered at CAG meeting on 08/08/2013\nSpecific conditions of support\n1. Confirmation of suitable security arrangements via IG Toolkit submission Confirmed 30/07/2013\n2. Please provide a letter of support from the Caldicott Guardian or equivalent.\n3. Please provide the audit specific patient information leaflet and confirm how this will be made available to patients.                  "]

{"sheet":"A0016","index":15,"n_rows":36,"n_cols":3,"rows_kept":36,"cut":false,"hidden":false,"merged":[[31,1,31,4],[32,1,32,4],[34,1,34,4],[35,1,35,4],[21,1,21,4],[22,1,22,4],[23,1,23,4],[24,0,30,0],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,2,30,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0016"]
["Reference","CAG 5-07(f)/2013"]
["Other Refs"]
["Application Title","National Vascular Registry"]
["Application Summary","This audit application from the Royal College of Surgeons of England set out a project aiming to establish a National Vascular Registry; a collaboration between the Vascular Society of Great Britain and Ireland and the Clinical Effectiveness Unit of the Royal College of Surgeons of England. The registry would investigate the standard of care for patients undergoing abdominal aortic aneurysm (AAA) repair, carotid endarterectomy and interventions for peripheral arterial disease.  This Registry was an evolution of two existing national projects: the National Vascular Database and the Carotid Interventions Audit.  A recommendation for class 4, 5 and 6 support was requested in order to collect data from patients undergoing emergency procedures, from whom consent could not be sought.  Consent would be sought from patients undergoing elective procedures.  Data in relation to patients undergoing AAA repair would be linked to National AAA Screening Programme data, data in relation to patients undergoing surgery for peripheral arterial disease would be linked to data from the National Diabetes Audit and data in relation to patients with carotid arterial disease with National Stroke Audit data.  Access was requested to NHS number, date of birth and postcode.\n\n"]
["Applicant Organisation Name","Royal College of Surgeons of England"]
["Contact Name","Dr David Cromwell"]
["Address","Clinical Efffectiveness Unit"]
[null,"35-43 Lincoln's Inn Fields"]
[null,"London"]
["Postcode","WC2A 3PE"]
["Telephone","0207 869 6608"]
["Email","dcromwell@rcseng.ac.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"Y","the provision of care and treatment"]
[null,"□","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Adult patients undergoing index vascular interventions in NHS acute hospital settings in England and Wales (emergency procedures only; consent to be sought from patients undergoing elective procedures)"]
["Description of confidential patient information used","NHS number, date of birth, postcode"]
["National Data Opt \nOut Status","The Secretary of State for Health and Social Care decision maker, on advice from the CAG, has supported a request to defer the National Data Opt Out. As such, the National Data Opt Out does not need to be applied for this activity"]
["S251 Class(es)","□","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Healthcare Quality Improvement Partnership"]
["Status","Supported"]
[]
["Next Review Date","2023-12-06"]
["Notes","Amendment supported 23 June 2022 to defer applying the National Data Opt-Out in relation to CAG 5-07(f)/2013\n\nSpecific conditions of support\n\n1.\tThe patient notification materials needed to be revised to provide clearer information on how patients can register project-specific dissent.\n\n2.\tMembers noted that the Privacy Notice contained the following passage, “If you give consent and then change your mind, please send an nvr@rcseng.ac.uk and put “Request to opt-out” in the subject line.” The word “email” needs to be added before the email address.\n\n3.\tPatient and public involvement and engagement need to be undertaken, specifically around the non-application of the National Data Opt-Out. Feedback from this is to be provided within 3 months of the issue of this outcome letter. \n\n4.\tThe National Data Opt-Out is not to be applied to patients included in the activities specified in CAG 5-07(f)/2013.\n\n5.\tA local patient objection mechanism must continue to be used in relation to CAG 5-07(f)/2013.\n\n\n24 January 2022 - Amendment supported:\nAmendment supported 24 January 2022 to allow NVR to collect additional clinical data via the REDCap system, for the purposes of a quality improvement initiative.\n\n14 January 2020 – Amendment supported to allow the National Vascular Registry (NVR) to augment the collection of data on the clinical and short-term outcome information on patients undergoing arterial vascular procedures with data on implanted medical devices, in order to report on monitor and report on the long-term outcomes of implanted vascular devices.\n\nApplication considered at CAG meeting on 08/08/2013.\nSpecific conditions of support\n1. Confirmation of suitable security arrangements via IG Toolkit submission Confirmed 30/07/2013\n2. Please provide a data flow diagram, which includes confirmation in relation to when data is pseudonymised. Received 05/11/2013\n3. Please submit final patient information leaflets, consent forms and details of consent processes.  Received 05/11/2013. Please ensure that the patient information leaflets include details of how to opt out via the local care team. \n\n23 April 2020 – amendment supported to include additional questions in the patient datasets for abdominal aortic aneurysm repair procedures and for peripheral arterial disease procedures, to aid the applicants in assessing whether access to elective and urgent vascular operations within the UK has been affected by the Covid-19 pandemic\n"]

{"sheet":"A0017","index":16,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","0017"]
["Reference","CAG 6-03(PR5)/2013"]
["Other Refs"]
["Application Title","CQC 2013 Inpatients Survey"]
["Application Summary","This service evaluation application set out details of the transfer of patient identifiable data from acute and specialist trusts to defined survey contractors for the purpose of mailing out questionnaires for the 2013 acute inpatient survey.  The cohort would relate to inpatients aged 16 years or over who were discharged from acute and specialist NHS hospitals in June, July or August 2012 (earlier for smaller trusts), who had had one overnight stay in hospital. Inpatients treated for obstetrics/maternity or psychiatric reasons, private patients, current inpatients, those without a full UK postal address, and those who are found to be deceased prior to the start of the mailings would not be included in the cohort. Such checks would be carried out locally by the Trusts.  A recommendation of support was requested to cover the transfer of patient identifiable information (as listed within the application) from trusts and the subsequent processing of this information by specified contractors. It was indicated that that NHS trusts would be advised to employ the service of one of the specified ‘approved contractors’ to reduce the cost, burden and risk in the provision of survey data.  The applicant confirmed that the methodology and sampling frame were identical to those used for the 2012 acute inpatient survey. It was noted that ICD10 code would be included within the data submitted from trusts for the 2013 survey in the sample file, that anonymised data would be shared with NHS England and the Department of Health for specific purposes and that the completion of the questionnaire on-line would be piloted.  It was confirmed that Patient Perspective, Quality Health, Picker and Capita Surveys and Research would be the specific contractors used to administer surveys."]
["Applicant Organisation Name","Care Quality Commission"]
["Contact Name","Ian Seccombe"]
["Address","Finsbury Tower"]
[null,"103-105 Bunhill Row"]
[null,"London"]
["Postcode","EC1Y 8TG"]
["Telephone","07855 464 479"]
["Email","ian.seccombe@cqc.org.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"Y","the provision of care and treatment"]
[null,"□","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Living patients aged 16 years old or over who were discharged from acute and specialist NHS hospitals in June, July or August 2013 (and earlier for smaller trusts), having had one overnight stay in hospital.  Excluded psychiatry, obstetrics/maternity and day cases."]
["Description of confidential patient information used","name, address, postcode"]
["S251 Class(es)","□","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"□","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"□","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","NHS England"]
["Status","Expired"]
[]
["Next Review Date","N/A"]
["Notes","Application considered at CAG meeting on 03/10/2013"]

{"sheet":"A0018","index":17,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0018"]
["Reference","CAG 6-07(a)/2013"]
["Other Refs"]
["Application Title","Enhanced quality assurance process of the provision of NHS-funded care for people with a learning disability or autistic spectrum disorder"]
["Application Summary","This service evaluation application from NHS England set out the purpose of two distinct activities which formed part of the actions arising from the national review of events at Winterbourne View Hospital, as published in ‘Transforming care: A national response to Winterbourne’ (Department of Health, December 2012), and its supporting concordat. A recommendation for class 1, 4, 5 and 6 support was requested, firstly to support triangulation of data on NHS funded care for patients with a learning disability or autistic spectrum disorder, and secondly to carry out a review of a random sample of care reviews carried out by local health and care commissioners to ensure that these reviews were properly conducted."]
["Applicant Organisation Name","NHS England"]
["Contact Name","Ray Avery"]
["Address","Partnership Manager"]
[null,"Quarry House"]
[null,"Leeds"]
["Postcode","LS2 7UE"]
["Telephone"," "]
["Email","ray.avery@nhs.net"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"Y","the provision of care and treatment"]
[null,"□","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","people with a learning disability or autistic spectrum disorder who are in receipt of NHS-funded care (and/or local authority funded care, for quality assurance element)"]
["Description of confidential patient information used","name, NHS number, date of admission, reason for admission, diagnosis, date of last review"]
["S251 Class(es)","□","Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","NHS England"]
["Status","Expired"]
[]
["Next Review Date","N/A"]
["Notes","Application considered at CAG meeting on 03/10/2013\n\nAs from 26 March 2015 support is no longer required under Regulation 5 of the Health Service (Control of Patient Information) Regulations 2002 as the applicant has confirmed there is an alternative legal basis in place.\nExpired on 26/03/2015.\nAn amendment has been approved (20 October 2014) to enable NHS England to undertake the December 2014 ‘Assuring Transformation’ data collection and process this data until 27 February 2015. This data will subsequently be retained for a period of 12 months. \nContingency support is in place to allow NHS England to undertake the March 2015 data collection however this aspect is not currently in effect and remains dormant until NHS England confirm by end January 2015 whether support is required as the expectation is that the HSCIC will undertake this data collection if suitable Directions are in place so that support under Regulation 5 would not be required. The Register will be updated if this latter aspect is required. \n\nAmendment approved to enable NHS England to carry out data collection for September 2014.\n\nSpecific conditions of support:\n1. The support relates to the materials submitted (28 November and 16 December 2013) on the basis that they are final versions.\n2. Support is provided to the amendment to enable quarterly data collection for the triangulation activity to August 2014 only. \n3. Support is provided to enable access to the additional identifiable data items listed in the document reviewed by the CAG titled ‘WVR Assuring Transformation data collection – pilot’\n4. Any future changes, if necessary, should clearly set out these changes and be on the basis of final, organisationally approved documents prior to submission to CAG. Changes to security arrangements must be agreed with the HSCIC IG delivery team and CAG to receive such confirmation directly from the HSCIC along with copies of relevant documents. This was considered important in light of the bespoke arrangements. \n5. Documented confirmation from the HSCIC IG Delivery team that following their review in the New Year, the assurance arrangements in place are suitable to manage the confidentiality and security of the information to be processed."]

{"sheet":"A0020","index":18,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0020"]
["Reference","CAG 6-07(c)/2013"]
["Other Refs"]
["Application Title","HQIP NCA 099 National Clinical Audit & Quality Improvement Programme for Chronic Kidney Disease in Primary Care\n"]
["Application Summary","This audit application from Informatica Systems Limited set out the purpose of a national primary care CKD audit covering all GP practices in England and Wales and the interfaces between primary and specialist secondary care. This activity aims to improve the diagnosis and recording of chronic kidney disease (CKD) in primary care, to audit primary care management against NICE quality standards and understand and map the variation of patient care in this setting.  A recommendation for class 1, 4 and 5 support was requested to enable patient information regarding all patients with relevant Read codes to be extracted from participating GP practices using a tool developed by the applicant and linked to Hospital Episode Statistics (HES) and Office for National Statistics (ONS) data."]
["Applicant Organisation Name","Informatica Systems Limited (Data processor on behalf of HQIP)"]
["Contact Name","Andy Syme, HQIP CKD Audit Project Manager"]
["Address","BMA House"]
[null,"Tavistock Square"]
[null,"London"]
["Postcode","WC1H 9JR"]
["Telephone","20 7874 0770"]
["Email","ASyme@bmj.com"]
["Medical Purposes","□","preventative medicine"]
[null,"Y","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"Y","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Patients aged over 18 with or at risk of chronic kidney disease"]
["Description of confidential patient information used","NHS number, date of birth, postcode"]
["S251 Class(es)","□","Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"□","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Healthcare Quality Improvement Partnership (HQIP)"]
["Status","Supported"]
[]
["Next Review Date","2015-12-10"]
["Notes","Amendment Request 27/02/2017\nIt was stated in the original application that the National CKD Audit was commissioned for three years with an option to extend a further two years. Due to delays with NHS Digital processing of the HES data applications the linked data was not made available in time to be reported in December 2016. This amendment requests an extension to the end date of the project, to cover up to 19 December 2017, in line with the extension that had been granted by HQIP.                          Application considered at CAG meeting on 03/10/2013.\nSpecific conditions of support\n\n1. Confirmation of suitable security arrangements via IG Toolkit submission. Confirmed 11/11/2013\n\n2. Please provide a copy of the privacy impact assessment once complete.  Received 30/10/2013.\n\n3. Please ensure that the patient information leaflet accurately reflects the data to be extracted and submit an updated version.  It was confirmed 30/10/2013 that the leaflet would be updated and submitted prior to any data collection.\n"]

{"sheet":"A0021","index":19,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0021"]
["Reference","CAG 6-07(d)/2013"]
["Other Refs","Activity now covered under 18/CAG/0131"]
["Application Title","Inflammatory Bowel Disease Registry"]
["Application Summary","This audit application from the British Society of Gastroenterology set out the purpose of establishing a national IBD Registry which would feed into national service development planning and fulfil national audit, IBD standards and quality improvement benchmarks.  The application also detailed using the registry to allow patients to be identified for research purposes and for the Health and Social Care Information Centre (HSCIC) to write to patients on behalf of the applicant.  A recommendation for class 4, 5 and 6 support was requested in order to access data, including NHS number, date of birth and postcode in relation to all patients in the UK who had been diagnosed with IBD. Data sources included HES, ONS, Bowel Cancer audit, cancer registries, IBD Registry patient management system and data collected via a web portal system.  Data would be collected by the HSCIC and only pseudonymised data would be disclosed to the British Society of Gastroenterology for analysis purposes."]
["Applicant Organisation Name","British Society of Gastroenterology"]
["Contact Name","Richard Gardner"]
["Address","3 St Andrew's Place"]
[null,"Regent's Park"]
[null,"London"]
["Postcode","NW1 4LB"]
["Telephone",2079353150]
["Email","r.gardner@bsg.org.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","All patients in the UK with diagnosis of inflammatory bowel disease"]
["Description of confidential patient information used","NHS number, date of birth, postcode"]
["S251 Class(es)","□","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","British Society of Gastroenterology"]
["Status","Expired"]
[]
["Next Review Date","N/A"]
["Notes","14 May 2018 - Please note this application's support has expired as of 14/05/2018, and is now covered under reference 18/CAG/0131.\n\nAmendment (Approved - 14/9/2017)\nThe applicant submitted the following two amendments to the original application:\n1. Extension to support – the applicants requested an extension to the duration of support under the Regulations while further work is undertaken to improve the approach adopted to gain patient’s consent for their data being linked, pseudonymised and processed by the Registry.\n2. Additional purpose – the applicants requested an extension of the purposes for which the pseudonymised data held in the IBD Registry can be used. The request is that the Registry be allowed to provide anonymised, aggregate reports to companies that have or are developing healthcare products (e.g. drugs or medical devices) for use in Inflammatory Bowel Disease\nSpecific Conditions of Support\n1. Support is extended for a further 12 months from the data of this outcome letter.\n2. The applicants are required to provide an update on progress towards the fully consented model within the next annual review.\n3. If it becomes apparent that a further extension to the duration of support is required beyond the period covered within this amendment, the applicants are advised that the amendment request should be submitted in advance of the expiration of support. A strong rationale would be required to justify the further duration extension.\n4. Patient and public notification materials should be updated to include clear information around the additional purpose for supply of anonymised aggregated data to commercial companies and provide a mechanism to raise objection to the use of data in this way. An interim report, together with submission of the revised notification materials is required within six months of this date of this outcome.\n5. Patient consent materials should be updated to include a specific consent point in relation to the additional purpose for supply of anonymised aggregated data to commercial companies.\nPatients should be able to withhold consent for this purpose, whilst agreeing to inclusion in the Registry. An interim report, together with submission of the revised notification materials is required within six months of this date of this outcome.\n6. Confirmation of suitable security arrangements via IG Toolkit submission of University of Liverpool and Chameleon Information Management Services Ltd. (Confirmed - British Society of Gastroenterology, Version 14, 2016-17, satisfactory at 63% with an improvement plan in place).\n\nApplication considered at CAG meeting on 03/10/2013\nApplicant must work towards seeking consent and adopt a consent based approach within 18 months from initial approval.\nSpecific conditions of support\n1. Confirmation of suitable security arrangements via IG Toolkit submission. It was confirmed that all information would be processed by the HSCIC and a satisfactory toolkit submission was noted. \n2. Please provide the following further information:\na) Details of the consent process\nb) Timescales and milestones for movement towards a fully consented approach\nc) Patient information materials\nd) Confirmation that patients who registered objections would not have their data included on the Registry\n3. As part of the annual review, please provide details of the number of patients who have been approached for consent.\n4. Support will be provided for a limited time period only whilst progress is made towards utilising a fully consented approach. \n"]

{"sheet":"A0023","index":20,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0023"]
["Reference","CAG 6-07(f)/2013"]
["Other Refs"]
["Application Title","CRIS – Lambeth DataNet linkage"]
["Application Summary","This service evaluation application from South London and Maudsley NHS Foundation Trust set out the purpose of a study aiming to utilise linked datasets in three projects investigating healthcare services provided to patients and identifying social characteristics associated with severe mental illness in the Lambeth GP patient population.  A recommendation for class 4 and 6 support was requested in order to link the SLaM Biomedical Research Centre Clinical Record Interactive Search (CRIS) dataset, a pseudonymised case record system, and LDN - a local primary care database containing information from GPs in one of South London and Maudsley’s four catchment boroughs. Data collected from LDN included a problem list summary of each consultation, each long term condition, all medication prescribed and all clinical values (blood test results and other investigations)."]
["Applicant Organisation Name","South London and Maudsley NHS Foundation Trust"]
["Contact Name","Dr Max Henderson"]
["Address","Institute of Psychiatry, Kings College London"]
[null,"Weston Education Centre, Cutcombe Road"]
[null,"London"]
["Postcode","SE5 9RJ"]
["Telephone","0203 228 8564"]
["Email","max.j.henderson@kcl.ac.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"Y","the provision of care and treatment"]
[null,"□","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Patients of GPs in Lambeth"]
["Description of confidential patient information used","Name, NHS number, date of birth, date of death, postcode, gender, ethnicity, occupation"]
["S251 Class(es)","□","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"□","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","South London and Maudsley NHS Foundation Trust"]
["Status","Expired"]
[]
["Next Review Date","N/A"]
["Notes","Application Closed on 21/8/2017 - applicants established an exit strategy from support.\n\nApplication considered at CAG meeting on 03/10/2013.\nSpecific conditions of support\n\n1. Confirmation of suitable security arrangements via IG Toolkit submission. Confirmed 08 October 2013.\n\n2. Please submit updated patient information leaflets to ensure that the details of the specific data flows in relation to this project are included. Information in relation to amended patient information material submitted 17 December 2013, REC approval for patient information materials provided 25 February 2014.\n\n3. Support applies to the specified projects only; any additional use of the dataset will be subject to an additional application. Confirmed.\n"]

{"sheet":"A0024","index":21,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0024"]
["Reference","CAG 7-04(a)/2013"]
["Other Refs"]
["Application Title","Disclosure of commissioning data sets and GP data for risk stratification purposes to data processors working on behalf of GPs"]
["Application Summary","This application from NHS England sought support for the activity of risk stratification to be used by clinical commissioners to target vulnerable patient groups and offer them appropriate services. The aim of risk stratification is to reduce hospital readmissions and target clinical interventions to high risk patients.  A recommendation for class 1, 4, 5 and 6 support was requested to support the disclosure of commissioning data sets (ref CAG 2-03 (a)/2013) from the Health and Social Care Information Centre (HSCIC) and GP data from GP systems to data processors working under the instruction of GPs as data controllers; to support disclosure of patient confidential data to enable the indirect care element of risk stratification, namely for the preliminary processing to combine and process primary care and secondary care data and select target populations; and to provide protection to the HSCIC to legitimise the onward transfer.  Access was requested to commissioning data sets approved under CAG 2-03(a)/2013 including NHS number, local hospital number, date of birth, postcode, gender and ethnicity, and to GP data including patient data, event data, referral data, prescriptions, conditions / diagnosis groups, health groups, interventions group, exclusions group, and practice data (practice ID and registered patient list).\nAmendment request-23/07/2015-An amendment request was submitted to the July 2015 CAG meeting which outlined a number of changes that had arisen following the initial outcome. The following changes were specified:\n1. Administrative changes that had originated from the consolidation of Commissioning Support Units (CSUs)\n2. Transfer of in-house risk stratification services from 5 Clinical Commissioning Groups (CCGs) to Nottinghamshire Health Informatics Service. Nottinghamshire Health Informatics Service was a new risk stratification service supplier.\n3. Transfer of in-house management from 3 CCGs to an approved risk stratification supplier –NHS South Central and West CSU.\n4. Inclusion of Wirral CCG as a new in-house risk stratification service supplier.\n5. Confirmation of new CCGs waiting to undertake risk stratification using established risk stratification service suppliers."]
["Applicant Organisation Name","NHS England"]
["Contact Name","Ming Tang"]
["Address","Director of Data and Information Systems"]
[null,"Quarry House"]
[null,"Leeds"]
["Postcode","LS2 7UE"]
["Telephone"," "]
["Email","ming.tang@nhs.net"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population"]
["Description of confidential patient information used","commissioning data sets approved under CAG 2-03(a)/2013 including NHS number, local hospital number, date of birth, postcode, gender and ethnicity, and to GP data including patient data, event data, referral data, prescriptions, conditions / diagnosis groups, health groups, interventions group, exclusions group, and practice data (practice ID and registered patient list)"]
["S251 Class(es)","□","Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Department of Health"]
["Status","Supported"]
[]
["Next Review Date","2022-09-30"]
["Notes","Amendment supported 29 September 2022\n\nTo extend the duration for 12 months to 30 September 2023. \n\nThe following sets out the specific conditions of support. \n\n1.\tSupport is extended until 30 September 2023\n\n2.\tA new framework application is submitted prior to this date to ensure support is continued post 30 September 2023\n\n3.\tBimonthly meetings are held with CAG during this period to review progress towards a new application\n\n4.\tAll other conditions applied as part of the annual review outcome letter (letter dated 19 May 2022) remain. \n\n\n28 June 2022 - Amendment supported  to amend the data controllers from the CCGs listed in the application to ICBs from 01 July 2022. \n\nNHS England will continue to manage the application on behalf of the ICBs/GP’s. \n\nSpecific conditions of support \n\n1.\tThis amendment comes into effect from 01 July 2022.\n\n2.\tThe CAG agreed that conditions applied as part of the annual review outcome letter (letter dated 19 May 2022) remain. These conditions are provided below as confirmation. \n\n3.\tAny request to extend support post 30 September 2022 should be done as part of a revised submission to be considered at a full CAG meeting. The applicants are advised to check the CAG meeting dates and apply in sufficient time to allow an outcome to be issued prior to 30 September 2022, by 31 August 2022 at the latest.\n\nThe new application should address the following:\n\na)\tClarity on the scope of support requested, both in terms of dataflows and purposes\n\nb)\tClear communication strategy with examples of patent notification materials\n\nc)\tDetail on how local patient objection mechanisms will be managed, and clarity that the National Data Opt Out will be applied.\n\nd)\tEvidence that risk stratification suppliers have had DSPT submissions verified by NHS Digital.\n\ne)\tA comprehensive monitoring plan to ensure local activities remain within the scope of support\n\nf)\tDetail, with anticipated timescales, of a clear exit strategy from Regulation 5 support\n\ng)\tDemonstrable evidence of the improved outcomes and benefits that risk stratification has had to date.\n\nh)\tConsideration whether change in legal entities from CCGs to ICBs impacts risk stratification and how.\n\n19 May 2022 - Annual Review Supported\n\nNew conditions of support added:\nNew application to be submitted prior to next annual review date, taking into account the following:\n\n1. Clarity on the scope of support requested, both in terms of dataflows and purposes\n\n2. Clear communication strategy with examples of patent notification materials\n\n3. Detail on how local patient objection mechanisms will be managed, and clarity that the National Data Opt Out will be applied.\n\n4. Evidence that risk stratification suppliers have had DSPT submissions verified by NHS Digital.\n\n5. A comprehensive monitoring plan to ensure local activities remain within the scope of support\n\n6. Detail, with anticipated timescales, of a clear exit strategy from Regulation 5 support\n\n7. Demonstrable evidence of the improved outcomes and benefits that risk stratification has had to date.\n\n8. Consideration whether change in legal entities from CCGs to ICBs impacts risk stratification and how.\n\nApplication has been extended for a further 24 months.\nFollowing meeting on 17 March 2016, the CAG recommended that support be extended to 31 March 2017. This recommendation was subject to the following specific conditions of support:\n\n1. An executive summary to be provided to the June 2016 meeting, in accordance with published timescales, setting out the applicant understanding as to what support covered, purposes data could be used and to whom it applied, against each of the following individual references, so as to confirm mutual understanding: \n\na. CAG 2-03 (a)/2013 \nb. CAG 7-04 (a)/2013 \nc. CAG 7-07 (a)/2013 \nd. CAG 7-07 (b)/2013 \ne. CAG 7-07 (c)/2013 \n\n2. An update/presentation to be provided to the June 2016 meeting of the current status of the programme relevant to the exit strategy, including a clear articulation of what identifiers would be utilised within the definition of ‘anonymisation in context’. \n\n3. Further reports to be provided, against all five references, to the September 2016 and December 2016 meetings providing updates against the timescales presented to CAG; to include: \na.         Status report showing the progress against the timelines described to CAG in February and March 2016 \nb.         Consideration on how the future solution is impacted by emerging issues \nc.         In light of the dependencies described, and as these become clearer, how the plan has to evolve, and any impact on the solution. \n\nThe following was approved following the update report considered in February 2015.\n\nBased upon the current early stages and positive approach being taken to move towards the revised ‘end state’, it was agreed that continuing support should initially be provided for a 12 month period (from 30 April 2015) with an interim report on progression at 6 months. In light of the available information considered and discussions, members agreed that this extension should be subject to key information being provided back to CAG as discussed at the meeting. Current support expires on 30 April 2015 therefore members advised that the following list information be provided prior to this date to enable continuing support to come into effect post 30 April 2015. \n\nInformation to be provided prior to 30 April 2015\n\n1. Updated project plan/documentation with detail on timescales for key milestones and phases\n2. Tangible evidence of patient notification material (posters, guidance etc) \n3. Statement on how patient objection in relation to this support is currently being handled and timescale/delivery plan of effective processing and respect of objections under this support, including what has/would need to happen and when.\n4. Published information on websites (NHS England and HSCIC) to be reviewed for inaccuracies and updated in relation to all activities taking place under Regulation 5. \n\nReport to be provided to August 2014 meeting providing update on fair processing, data sources and responses to clarification (see 15 May 2014 meeting minutes).\n\nSpecific Conditions Set:\n\na. Compliance with the Data Protection Act 1998, particularly clarification of data controller and fair processing responsibilities to be established in conjunction with the ICO, with final position to be provided to CAG as soon as agreed. Support does not come into effect until the ICO has confirmed compliance with the Data Protection Act 1998. \n1) Confirmation was received on 23 January 2014 from the Information Commissioners Office that subject to the agreed actions, they were generally satisfied with what had been agreed. \n2) NHS England confirmed that the data controllers for GP data would be GPs and this data will only be released by agreement of the GP. When this data is linked with Secondary Uses Service (SUS) data it is understood that GPs will be data controllers in common with the HSCIC. \n3) NHS England confirmed that CCGs, CSUs and any relevant commercial third parties will be acting as data processors on behalf of and as directed by the GP. \n\nb. Risk stratification suppliers to meet the necessary security and assurance standards in place for all applications approved under Regulation 5, and to achieve compliance with all conditions established by the HSCIC (or relevant bodies) before information under this application can flow. Such approaches and conditions to be agreed with the relevant parties. \n\nc. Support applies only to named and existing risk stratification suppliers and existing contracts; new suppliers should have in place the to be agreed final option(s) as this is in line with the overarching approval provided to NHS England [CAG 2-03 (a)/2013] \n\nd. A list of named risk stratification suppliers operating under this current support and the data flows to be published by NHS England / HSCIC. \n\ne. Support is only provided to named and existing providers which operate the following: \n1) Data is received “de identified for local access” (NHS number) or is pseudonymised on landing \n2) Processing is within a “closed box” with strict role based access \n3) Re-identification is solely for the purpose of direct care and is available only to those with a direct clinical care relationship with the patient. \n\nf. Review of supplier specifications to be assessed by the applicant against these conditions and progression towards exit strategy. \n\ng. Position over clarification of retention period of data to be held by existing risk stratification suppliers to be included with consideration of potentially different retention periods for the small percentage who go onto receive interventions from the large numbers of low risk patients who do not need further care. \n\nh. Detail on how right of patient objection will be managed. \n\ni. The proposed list of conditions to be excluded from the full patient GP record was acknowledged to be incomplete. The current iteration allows highly sensitive information (i.e. rape, incest, domestic violence or drug treatment for sensitive conditions) to be collected. This list should be updated and finalised with the relevant exclusions removed to avoid the risk of inadvertently transferring inappropriate information. \n\nj. Documented engagement with the HSCIC to maintain and enhance the development of the appropriate exit strategies, in particular pseudonymisation prior to landing or reliance on HSCIC for the linkage for the entire risk stratification process. \n\nk. Due to time taken from provisional to final support, this condition is amended to require a report on progress to be provided to the CAG meeting in May 2014 (submission deadline 17 April 2014 – precise report date subject to discussion 27/01/2014) to confirm: \n• the risk stratification standards \n• the exit strategy. \n• Provision of other information in line with the comments above. It is advised that contact is made with the Confidentiality Advice Team to clarify these requirements as necessary. "]

{"sheet":"A0025","index":22,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0025"]
["Reference","CAG 7-07(a)/2013"]
["Other Refs"]
["Application Title","Application for transfer of data from the HSCIC to commissioning organisation accredited safe heavens: inclusion of invoice validation as a purpose within CAG 2-03 (a)/2013"]
["Application Summary","This non-research application from NHS England sought support to enable the correct commissioner to be identified to enable payment for treatment. This was requested as an interim measure and would form a part of NHS England’s managed change process."]
["Applicant Organisation Name","NHS England"]
["Contact Name","Ming Tang"]
["Address","Director of Data and Information Systems"]
[null,"Quarry House"]
[null,"Leeds"]
["Postcode","LS2 7UE"]
["Telephone"," "]
["Email","ming.tang@nhs.net"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Population receiving health care treatment across the NHS"]
["Description of confidential patient information used","Invoice Number, NHS Number, Unique Patient Event identifier, Unique Patient Identifier, Geographical Locator (identifying location), Provider Details, Point of Delivery, Relevant date of treatment, Relevant GP’s ODS Code (identifying the relevant and unique GP practice), Description of service (for example, oncology or radiology which may indicate the patient’s condition), Description of treatment (Clinical Code, written description), Description of Prescribed Drug "]
["S251 Class(es)","□","Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Department of Health"]
["Status","Supported"]
[]
["Next Review Date","2022-09-30"]
["Notes","Amendment supported 29 September 2022 \n\nTo extend the duration for 12 months to 30 September 2023. \n\nThe following sets out the specific conditions of support. \n\n1.\tProvide confirmation of NHS Digital DSPT assurances for NHS South, Central and West CSU and NHS Midlands and Lancashire CSU within one month.\n\n2.\tAgree timescale with CAG for a resubmission of the invoice validation application   \n\n28 June 2022 - amendment supported to amend the data controllers from the CCGs listed in the application to ICBs from 01 July 2022. \n\nNHS England will continue to manage the application on behalf of the ICBs.\n\nSpecific conditions of support \n\n1.\tThis amendment comes into effect from 01 July 2022.\n\n2.\tThe CAG agreed that conditions applied as part of the annual review outcome letter (letter dated 24 May 2022) remain. These conditions are provided below as confirmation. \n\n3.\tProvide assurance that the organisations listed in the annual review letter dated 24 May 2022 have had their DSPT submissions assured by NHS Digital.\n\n4.\tGive an anticipated timeframe for when clarity will be gained on how the change from CCGs to ICBs will impact the invoice validation application\n\n17 December 2021 - Amendment supported\n\nAmendment supported to add the date of birth as a data item that is transferred by providers to NHS Digital\n\nCondition of support added; \n\n1. Report to be provided in 3 months providing clear update status on entities that have not yet achieved satisfactory security assurances, with expectation the majority will have achieved the standards.  \n\n29 September 2020 - Amendment supported to extend the duration of the study until 30 September 2022.\n\nNew condition of support: \nReport to be provided in 3 months providing clear update status on entities that have not yet achieved satisfactory security assurances, with expectation the majority will have achieved the standards. \n\n17 March 2016 - Application has been extended for a further 24 months\n\nFollowing a successful amendment, the need to respect patient objections has been waived for this reference, for the purpose of invoice validation. \n\nAmendment - Following meeting on 17 March 2016, the CAG recommended that support be extended to 31 March 2017. This recommendation was subject to the following specific conditions of support:\n\n1. An executive summary to be provided to the June 2016 meeting, in accordance with published timescales, setting out the applicant understanding as to what support covered, purposes data could be used and to whom it applied, against each of the following individual references, so as to confirm mutual understanding: \n\na. CAG 2-03 (a)/2013 \nb. CAG 7-04 (a)/2013 \nc. CAG 7-07 (a)/2013 \nd. CAG 7-07 (b)/2013 \ne. CAG 7-07 (c)/2013 \n\n2. An update/presentation to be provided to the June 2016 meeting of the current status of the programme relevant to the exit strategy, including a clear articulation of what identifiers would be utilised within the definition of ‘anonymisation in context’. \n\n3. Further reports to be provided, against all five references, to the September 2016 and December 2016 meetings providing updates against the timescales presented to CAG; to include: \na.         Status report showing the progress against the timelines described to CAG in February and March 2016 \nb.         Consideration on how the future solution is impacted by emerging issues \nc.         In light of the dependencies described, and as these become clearer, how the plan has to evolve, and any impact on the solution. \n\nThe following was approved following the update report considered in February 2015.\n\nBased upon the current early stages and positive approach being taken to move towards the revised ‘end state’, it was agreed that continuing support should initially be provided for a 12 month period (from 30 April 2015) with an interim report on progression at 6 months. In light of the available information considered and discussions, members agreed that this extension should be subject to key information being provided back to CAG as discussed at the meeting. Current support expires on 30 April 2015 therefore members advised that the following list information be provided prior to this date to enable continuing support to come into effect post 30 April 2015. \n\nInformation to be provided prior to 30 April 2015\n\n1. Updated project plan/documentation with detail on timescales for key milestones and phases\n2. Tangible evidence of patient notification material (posters, guidance etc) \n3. Statement on how patient objection in relation to this support is currently being handled and timescale/delivery plan of effective processing and respect of objections under this support, including what has/would need to happen and when.\n4. Published information on websites (NHS England and HSCIC) to be reviewed for inaccuracies and updated in relation to all activities taking place under Regulation 5. \n\nUpdate report to be provided to August 2014 meeting providing update on retention period.\n\nConditions of Support:\n1. Revision of the application forms to reflect the accurate position as indicated above, to be provided no later than 19 December 2013  \n2. 6 monthly reports on progress toward exit/ final state. To include: milestones/ progress on progress implementing CAG 7-07 (a)/2013; report on service user engagement; any data breaches; outcome of audit (covering points 3 & 4 below, also see point 6)  \n3. Separation of staff/ processes with acce+B15ss to PDS etc. for invoice validation from others with access to other data for different purposes; there should be a separate controlled environment in which this work will be undertaken and specific statements regarding confidentiality clauses in employment contracts of those processing PCD  \n4. The same security assurance requirements as previously applied to the overarching application that must be approved by the HSCIC prior to any disclosure. This requirement applies to NHS E as it does to other organisations  \n5. Clarity to be provided on how NHS England and relevant parties will demonstrate compliance for applications CAG 707 a-c/2013 respectively.  \n6. External audit of IG (and compliance with at least 3 &4) at least once within 12 month period \n7. Actions specified by the Information Commissioner’s Office (privacy impact assessment submission direct to ICO and review of retention and data items in CAG update report) to be provided in line with agreed timescales.  \n8. Any future issues around Data Protection compliance to be proactively raised with the Information Commissioner’s Office and must be satisfactorily resolved to enable the support to remain valid.  \n9. PCD is not shared with NHS Shared Business Services for the purposes of invoice validation for NHS patients.  \n10. Any disclosure for purposes of financial audit should be subject to a separate application. \n11. An up to date backing dataset and supporting information flows/justification should be reported against at time of first report.  \n12. This is a complex programme of change, therefore NHS England should work with DH colleagues and other relevant stakeholders to best identify how the different organisations with responsibility in this field should be expected to contribute collaboratively.  "]

{"sheet":"A0026","index":23,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0026"]
["Reference","CAG 7-07(b)/2013"]
["Other Refs"]
["Application Title","Invoice validation within Clinical Commissioning Groups (CCGs) controlled \nenvironment for Finance "]
["Application Summary","This non-research application from NHS England sought support to enable the correct commissioner to be identified to enable payment for treatment. This was requested as an interim measure and would form a part of NHS England’s managed change process."]
["Applicant Organisation Name","NHS England"]
["Contact Name","Ming Tang"]
["Address","Director of Data and Information Systems"]
[null,"Quarry House"]
[null,"Leeds"]
["Postcode","LS2 7UE"]
["Telephone"]
["Email","ming.tang@nhs.net"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Population receiving health care treatment across the NHS"]
["Description of confidential patient information used","Invoice Number, NHS Number, Unique Patient Event identifier, Unique Patient Identifier, Geographical Locator (identifying location), Provider Details, Point of Delivery, Relevant date of treatment, Relevant GP’s ODS Code (identifying the relevant and unique GP practice), Description of service (for example, oncology or radiology which may indicate the patient’s condition), Description of treatment (Clinical Code, written description), Description of Prescribed Drug"]
["S251 Class(es)","□","Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Department of Health"]
["Status","Supported"]
[]
["Next Review Date","2022-09-30"]
["Notes","Amendment supported 29 September 2022 \n\nTo extend the duration for 12 months to 30 September 2023. \n\nThe following sets out the specific conditions of support. \n\n1.\tProvide confirmation of NHS Digital DSPT assurances for NHS South, Central and West CSU and NHS Midlands and Lancashire CSU within one month.\n\n2.\tAgree timescale with CAG for a resubmission of the invoice validation application   \n\n28 June 2022 - amendment supported to amend the data controllers from the CCGs listed in the application to ICBs from 01 July 2022. \n\nNHS England will continue to manage the application on behalf of the ICBs.\n\nSpecific conditions of support \n\n1.\tThis amendment comes into effect from 01 July 2022.\n\n2.\tThe CAG agreed that conditions applied as part of the annual review outcome letter (letter dated 24 May 2022) remain. These conditions are provided below as confirmation. \n\n3.\tProvide assurance that the organisations listed in the annual review letter dated 24 May 2022 have had their DSPT submissions assured by NHS Digital.\n\n4.\tGive an anticipated timeframe for when clarity will be gained on how the change from CCGs to ICBs will impact the invoice validation application\n\n17 December 2021 - Amendment supported\nAmendment supported to add the date of birth as a data item that is transferred by providers to NHS Digital\n\nCondition of support added; \n1. Report to be provided in 3 months providing clear update status on entities that have not yet achieved satisfactory security assurances, with expectation the majority will have achieved the standards.  \n\n29 September 2020 - Amendment supported to extend the duration of the study until 30 September 2022.\n\nNew condition of support: \nReport to be provided in 3 months providing clear update status on entities that have not yet achieved satisfactory security assurances, with expectation the majority will have achieved the standards. \n\n17 March 2016 - Application has been extended for a further 24 months\n\nFollowing a successful amendment, the need to respect patient objections has been waived for this reference, for the purpose of invoice validation. \n\nAmendment (Approved - 10/10/2017)\n1. To remove the requirement to respect patient objections from the flow of information to Controlled Environments for Finance (CEfE) which are required to support invoice validation. This request extended to include NHS England’s demographic data which is shared with CCGs to enable their CEfF to undertake the processing of data to accurately verify the CCGs patients in line with their requirements under the Data Protection Act 1998 by ensuring that commissioners have the most up-to-date and accurate information.\n2. To extend the duration of support in place for the application for a further 18 months, up to 30 September 2018.\n\nSpecific Conditions of Support\n1. The requirement to apply to type 2 objections to the flow of confidential patient information from NHS Digital to support invoice validation of specialist commissioning services has been removed.\n2. Support extends to the flow of NHS England’s demographic data to the Controlled Environment for Finance for CCGs.\n3. Support applies to prospective data flows only from the date of this outcome letter.\n4. Support is extended up to 30 September 2018 only.\n5. Patient Notifications – a report is required to the CAG within three months of the date of this outcome letter, to provide an update in relation to the following points:\na. Consider how information will be made available to the sub-group of patients, who had previously registered type 2 objections, which would no longer be respected in this specific circumstance. Provide an overview of how communications would be managed for this sub-group, providing copies of any documentation where appropriate.\nb. Consult with patients and the public around the communications strategy which is devised for this sub-group of patients, to test the acceptability of the methods proposed and the suitability of any materials which are written to serve this purpose.\n\nFollowing meeting on 17 March 2016, the CAG recommended that support be extended to 31 March 2017. This recommendation was subject to the following specific conditions of support:\n\n1. An executive summary to be provided to the June 2016 meeting, in accordance with published timescales, setting out the applicant understanding as to what support covered, purposes data could be used and to whom it applied, against each of the following individual references, so as to confirm mutual understanding: \n\na. CAG 2-03 (a)/2013 \nb. CAG 7-04 (a)/2013 \nc. CAG 7-07 (a)/2013 \nd. CAG 7-07 (b)/2013 \ne. CAG 7-07 (c)/2013 \n\n2. An update/presentation to be provided to the June 2016 meeting of the current status of the programme relevant to the exit strategy, including a clear articulation of what identifiers would be utilised within the definition of ‘anonymisation in context’. \n\n3. Further reports to be provided, against all five references, to the September 2016 and December 2016 meetings providing updates against the timescales presented to CAG; to include: \na.         Status report showing the progress against the timelines described to CAG in February and March 2016 \nb.         Consideration on how the future solution is impacted by emerging issues \nc.         In light of the dependencies described, and as these become clearer, how the plan has to evolve, and any impact on the solution. \n\nThe following was approved following the update report considered in February 2015.\n\nBased upon the current early stages and positive approach being taken to move towards the revised ‘end state’, it was agreed that continuing support should initially be provided for a 12 month period (from 30 April 2015) with an interim report on progression at 6 months. In light of the available information considered and discussions, members agreed that this extension should be subject to key information being provided back to CAG as discussed at the meeting. Current support expires on 30 April 2015 therefore members advised that the following list information be provided prior to this date to enable continuing support to come into effect post 30 April 2015. \n\nInformation to be provided prior to 30 April 2015\n\n1. Updated project plan/documentation with detail on timescales for key milestones and phases\n2. Tangible evidence of patient notification material (posters, guidance etc) \n3. Statement on how patient objection in relation to this support is currently being handled and timescale/delivery plan of effective processing and respect of objections under this support, including what has/would need to happen and when.\n4. Published information on websites (NHS England and HSCIC) to be reviewed for inaccuracies and updated in relation to all activities taking place under Regulation 5. \n\nUpdate report to be provided to August 2014 meeting providing update on retention period.\nConditions of Support:\n1. Revision of the application forms to reflect the accurate position as indicated above, to be provided no later than 19 December 2013  \n2. 6 monthly reports on progress toward exit/ final state. To include: milestones/ progress on progress implementing CAG 7-07 (a)/2013; report on service user engagement; any data breaches; outcome of audit (covering points 3 & 4 below, also see point 6)  \n3. Separation of staff/ processes with access to PDS etc. for invoice validation from others with access to other data for different purposes; there should be a separate controlled environment in which this work will be undertaken and specific statements regarding confidentiality clauses in employment contracts of those processing PCD  \n4. The same security assurance requirements as previously applied to the overarching application that must be approved by the HSCIC prior to any disclosure. This requirement applies to NHS E as it does to other organisations  \n5. Clarity to be provided on how NHS England and relevant parties will demonstrate compliance for applications CAG 707 a-c/2013 respectively.  \n6. External audit of IG (and compliance with at least 3 &4) at least once within 12 month period \n7. Actions specified by the Information Commissioner’s Office (privacy impact assessment submission direct to ICO and review of retention and data items in CAG update report) to be provided in line with agreed timescales.  \n8. Any future issues around Data Protection compliance to be proactively raised with the Information Commissioner’s Office and must be satisfactorily resolved to enable the support to remain valid.  \n9. PCD is not shared with NHS Shared Business Services for the purposes of invoice validation for NHS patients.  \n10. Any disclosure for purposes of financial audit should be subject to a separate application. \n11. An up to date backing dataset and supporting information flows/justification should be reported against at time of first report.  \n12. This is a complex programme of change, therefore NHS England should work with DH colleagues and other relevant stakeholders to best identify how the different organisations with responsibility in this field should be expected to contribute collaboratively.  \n"]

{"sheet":"A0027","index":24,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0027"]
["Reference","CAG 7-07(c)/2013 "]
["Other Refs"]
["Application Title","Invoice validation within NHS England within the Commissioning Support Units controlled environment (for Finance) on behalf of Clinical Commissioning Groups"]
["Application Summary","This non-research application from NHS England sought support to enable the correct commissioner to be identified to enable payment for treatment. This was requested as an interim measure and would form a part of NHS England’s managed change process."]
["Applicant Organisation Name","NHS England"]
["Contact Name","Ming Tang"]
["Address","Director of Data and Information Systems"]
[null,"Quarry House"]
[null,"Leeds"]
["Postcode","LS2 7UE"]
["Telephone"]
["Email","ming.tang@nhs.net"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Population receiving health care treatment across the NHS"]
["Description of confidential patient information used","Invoice Number, NHS Number, Unique Patient Event identifier, Unique Patient Identifier, Geographical Locator (identifying location), Provider Details, Point of Delivery, Relevant date of treatment, Relevant GP’s ODS Code (identifying the relevant and unique GP practice), Description of service (for example, oncology or radiology which may indicate the patient’s condition), Description of treatment (Clinical Code, written description), Description of Prescribed Drug"]
["S251 Class(es)","□","Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Department of Health"]
["Status","Supported"]
[]
["Next Review Date","2022-09-30"]
["Notes","Amendment supported 29 September 2022\n\nTo extend the duration for 12 months to 30 September 2023. \n\nThe following sets out the specific conditions of support. \n\n1.\tProvide confirmation of NHS Digital DSPT assurances for NHS South, Central and West CSU and NHS Midlands and Lancashire CSU within one month.\n\n2.\tAgree timescale with CAG for a resubmission of the invoice validation application   \n\n28 June 2022 - amendment supported to amend the data controllers from the CCGs listed in the application to ICBs from 01 July 2022. \n\nNHS England will continue to manage the application on behalf of the ICBs.\n\nSpecific conditions of support \n\n1.\tThis amendment comes into effect from 01 July 2022.\n\n2.\tThe CAG agreed that conditions applied as part of the annual review outcome letter (letter dated 24 May 2022) remain. These conditions are provided below as confirmation. \n\n3.\tProvide assurance that the organisations listed in the annual review letter dated 24 May 2022 have had their DSPT submissions assured by NHS Digital.\n\n4.\tGive an anticipated timeframe for when clarity will be gained on how the change from CCGs to ICBs will impact the invoice validation application\n\n17 December 2021 - Amendment supported\nAmendment supported to add the date of birth as a data item that is transferred by providers to NHS Digital\n\nCondition of support added; \n1. Report to be provided in 3 months providing clear update status on entities that have not yet achieved satisfactory security assurances, with expectation the majority will have achieved the standards.  \n\n29 September 2020 - Amendment supported to extend the duration of the study until 30 September 2022.\n\nNew condition of support: \nReport to be provided in 3 months providing clear update status on entities that have not yet achieved satisfactory security assurances, with expectation the majority will have achieved the standards. \n\n17 March 2016 - Application has been extended for a further 24 months\n\nFollowing a successful amendment, the need to respect patient objections has been waived for this reference, for the purpose of invoice validation. \n\nAmendment (Approved - 10/10/2017)\n1. To remove the requirement to respect patient objections from the flow of information to Controlled Environments for Finance (CEfE) which are required to support invoice validation. This request extended to include NHS England’s demographic data which is shared with CCGs to enable their CEfF to undertake the processing of data to accurately verify the CCGs patients in line with their requirements under the Data Protection Act 1998 by ensuring that commissioners have the most up-to-date and accurate information.\n2. To extend the duration of support in place for the application for a further 18 months, up to 30 September 2018.\n\nSpecific Conditions of Support\n1. The requirement to apply to type 2 objections to the flow of confidential patient information from NHS Digital to support invoice validation of specialist commissioning services has been removed.\n2. Support extends to the flow of NHS England’s demographic data to the Controlled Environment for Finance for CCGs.\n3. Support applies to prospective data flows only from the date of this outcome letter.\n4. Support is extended up to 30 September 2018 only.\n5. Patient Notifications – a report is required to the CAG within three months of the date of this outcome letter, to provide an update in relation to the following points:\na. Consider how information will be made available to the sub-group of patients, who had previously registered type 2 objections, which would no longer be respected in this specific circumstance. Provide an overview of how communications would be managed for this sub-group, providing copies of any documentation where appropriate.\nb. Consult with patients and the public around the communications strategy which is devised for this sub-group of patients, to test the acceptability of the methods proposed and the suitability of any materials which are written to serve this purpose.\n\nFollowing meeting on 17 March 2016, the CAG recommended that support be extended to 31 March 2017. This recommendation was subject to the following specific conditions of support:\n\n1. An executive summary to be provided to the June 2016 meeting, in accordance with published timescales, setting out the applicant understanding as to what support covered, purposes data could be used and to whom it applied, against each of the following individual references, so as to confirm mutual understanding: \n\na. CAG 2-03 (a)/2013 \nb. CAG 7-04 (a)/2013 \nc. CAG 7-07 (a)/2013 \nd. CAG 7-07 (b)/2013 \ne. CAG 7-07 (c)/2013 \n\n2. An update/presentation to be provided to the June 2016 meeting of the current status of the programme relevant to the exit strategy, including a clear articulation of what identifiers would be utilised within the definition of ‘anonymisation in context’. \n\n3. Further reports to be provided, against all five references, to the September 2016 and December 2016 meetings providing updates against the timescales presented to CAG; to include: \na.         Status report showing the progress against the timelines described to CAG in February and March 2016 \nb.         Consideration on how the future solution is impacted by emerging issues \nc.         In light of the dependencies described, and as these become clearer, how the plan has to evolve, and any impact on the solution. \n\nThe following was approved following the update report considered in February 2015.\n\nBased upon the current early stages and positive approach being taken to move towards the revised ‘end state’, it was agreed that continuing support should initially be provided for a 12 month period (from 30 April 2015) with an interim report on progression at 6 months. In light of the available information considered and discussions, members agreed that this extension should be subject to key information being provided back to CAG as discussed at the meeting. Current support expires on 30 April 2015 therefore members advised that the following list information be provided prior to this date to enable continuing support to come into effect post 30 April 2015. \n\nInformation to be provided prior to 30 April 2015\n\n1. Updated project plan/documentation with detail on timescales for key milestones and phases\n2. Tangible evidence of patient notification material (posters, guidance etc) \n3. Statement on how patient objection in relation to this support is currently being handled and timescale/delivery plan of effective processing and respect of objections under this support, including what has/would need to happen and when.\n4. Published information on websites (NHS England and HSCIC) to be reviewed for inaccuracies and updated in relation to all activities taking place under Regulation 5. \n\nUpdate report to be provided to August 2014 meeting providing update on retention period.\nConditions of Support:\n1. Revision of the application forms to reflect the accurate position as indicated above, to be provided no later than 19 December 2013  \n2. 6 monthly reports on progress toward exit/ final state. To include: milestones/ progress on progress implementing CAG 7-07 (a)/2013; report on service user engagement; any data breaches; outcome of audit (covering points 3 & 4 below, also see point 6)  \n3. Separation of staff/ processes with access to PDS etc. for invoice validation from others with access to other data for different purposes; there should be a separate controlled environment in which this work will be undertaken and specific statements regarding confidentiality clauses in employment contracts of those processing PCD  \n4. The same security assurance requirements as previously applied to the overarching application that must be approved by the HSCIC prior to any disclosure. This requirement applies to NHS E as it does to other organisations  \n5. Clarity to be provided on how NHS England and relevant parties will demonstrate compliance for applications CAG 707 a-c/2013 respectively.  \n6. External audit of IG (and compliance with at least 3 &4) at least once within 12 month period \n7. Actions specified by the Information Commissioner’s Office (privacy impact assessment submission direct to ICO and review of retention and data items in CAG update report) to be provided in line with agreed timescales.  \n8. Any future issues around Data Protection compliance to be proactively raised with the Information Commissioner’s Office and must be satisfactorily resolved to enable the support to remain valid.  \n9. PCD is not shared with NHS Shared Business Services for the purposes of invoice validation for NHS patients.  \n10. Any disclosure for purposes of financial audit should be subject to a separate application. \n11. An up to date backing dataset and supporting information flows/justification should be reported against at time of first report.  \n12. This is a complex programme of change, therefore NHS England should work with DH colleagues and other relevant stakeholders to best identify how the different organisations with responsibility in this field should be expected to contribute collaboratively.  \n"]

{"sheet":"A0029","index":25,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0029"]
["Reference","CAG 8-03(PR1)/2013"]
["Other Refs"]
["Application Title","Prospective evaluation of the diagnostic efficacy of the 2010 United Kingdom National Institute for Clinical Excellence Guidelines on Chronic Heart Failure\n"]
["Application Summary","This audit application from Leeds Teaching Hospitals NHS Trust set out the purpose of a follow-up study on an existing cohort of 3,691 patients in the Leeds area who had received a N-terminal pro-B-type natriuretic peptide (NTproBNP) blood test in the period between 1 May 2012 and 1 May 2013 and were subsequently admitted to hospital.  A recommendation for class 6 support was requested to cover access to Hospital Episode Statistics data on hospitalisation and Office for National Statistics data on mortality, both held by the Health and Social Care Information Centre, in order to assess patient outcomes following the blood test, the usefulness of the blood test as a predictor of subsequent outcomes, and the overall effectiveness of the national heart failure pathway."]
["Applicant Organisation Name","Leeds Teaching Hospitals NHS Trust"]
["Contact Name","Dr Klaus Witte"]
["Address","Cardiology Department"]
[null,"Leeds General Infirmary"]
[null,"Leeds"]
["Postcode","LS1 3EX"]
["Telephone"," "]
["Email","k.k.witte@leeds.ac.uk "]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"Y","the provision of care and treatment"]
[null,"□","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","3,691 patients in the Leeds area who had received a N-terminal pro-B-type natriuretic peptide (NTproBNP) blood test in the period between 1 May 2012 and 1 May 2013 and were subsequently admitted to hospital"]
["Description of confidential patient information used","date of admission, date of diagnosis and date of death"]
["S251 Class(es)","□","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"□","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"□","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Leeds Teaching Hospitals NHS Trust"]
["Status","Expired"]
[]
["Next Review Date","2018-07-04"]
["Notes","All identfiiers have been deleted in line with the protocol.\n\nWe have published a highly cited paper using these data and confirmed the utility of primary care biomarker testing for heart failure: Gierula J, Cubbon RM, Paton MF, Byrom R, Lowry JE, Winsor SF, McGinlay M, Sunley E, Pickles E, Kearney LC, Koshy A, Slater TA, Chumun HK, Jamil HA, Bailey KM, Barth JH, Kearney MT, Witte KK. Prospective evaluation and long-term follow-up of patients referred to secondary care based upon natriuretic peptide levels in primary care. Eur Heart J Qual Care Clin Outcomes 2019;5:218-224. doi: 10.1093/ehjqcco/qcy053\n\nThis manuscript has been a springboard for further work in this field.\n\n\nApplication considered at CAG meeting on 28/11/2013.\n\nSpecific conditions of support\n\n1. Confirmation of suitable security arrangements via IG Toolkit submission  Confirmed 31/05/2013\n2. Confirmation that data will be pseudonymised following linkages. Confirmed\n3. Confirmation that reasonable efforts will be made to inform the cohort about the processing and that any objection will be respected. Confirmed\n\n"]

{"sheet":"A0030","index":26,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0030"]
["Reference","CAG 8-03(PR2)/2013"]
["Other Refs"]
["Application Title","UK Register of Fatal anaphylactic reactions"]
["Application Summary","This service evaluation application from Central Manchester University Hospitals NHS Foundation Trust set out the purpose of a study to review deaths from anaphylactic reactions, evaluating whether treatment was given, if so what treatment and why it was ineffective.  A recommendation for class 2, 4 and 6 support was requested to cover linking data on an existing locally held database of deceased patients with data held by coroners."]
["Applicant Organisation Name","Central Manchester University Hospitals NHS Foundation Trust"]
["Contact Name","Dr Vibha Sharma"]
["Address","Consultant in Paediatric Allergy"]
[null,"Oxford Road"]
[null,"Manchester"]
["Postcode","M13 9WL"]
["Telephone"]
["Email","vibha.sharma@nhs.net"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"Y","the provision of care and treatment"]
[null,"□","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","existing local dataset of deceased patients who died from anaphylactic reactions and corresponding data held by coroners"]
["Description of confidential patient information used","date of birth, date of death, cause of death"]
["S251 Class(es)","□","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"Y","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"□","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Central Manchester University Hospitals NHS Foundation Trust"]
["Status","Supported"]
[]
["Next Review Date","2023-01-10"]
["Notes","Amendment supported 18 October 2022 \n\nTo clarify that ‘s251’ support is in place for the applicant to receive data of deceased individuals from anaphylactic reactions, from the following organisations as data sources;\n\n•\tPICANet - Paediatric Intensive Care Audit Network (via Universities of Leeds & Leicester)\n•\tICNARC – Intensive Care National Audit and Research Centre \n•\tNCEPOD - National Confidential Enquiry into Patient Outcome and Death\n•\tNHS Digital (Hospital Episode Statistics)\n•\tNational Reporting and Learning (“NRLS”) and the Learning from Patient Safety Events (LFPSE) Systems\n•\tOffice of National Statistics for Wales (in addition to the existing Office of National statistics in England)\n\n\n28 July 2020 - Annual Review:\nThe following sets out the updated specific conditions of support applied against this application reference.\n\n1. All staff at Manchester University NHS Foundation Trust (R0A) that are involved in processing information under this application reference should have successfully completed local security awareness training before processing any information under support.\n\nApplication considered at CAG meeting on 28/11/2013.\nSpecific conditions of support\n\n1. Confirmation of suitable security arrangements via IG Toolkit submission. Confirmed 10/01/2014.\n\n2. This recommendation of support is in relation to data disclosed to the applicant prospectively from the date of this approval, including data concerning events pre-dating the approval. The approval does not include any data previously disclosed and held by the applicant.\n\n3. Please continue to review the requirement for retention of identifiable data and separate and ensure that clinical data is separated from identifiable data at the earliest possible stage.\n\n"]

{"sheet":"A0031","index":27,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0031"]
["Reference","CAG 8-03(PR6)/2013"]
["Other Refs"]
["Application Title","IOSwean"]
["Application Summary","This service evaluation application from Guy’s and St Thomas’s NHS Foundation Trust set out the purpose of an international observational study of critically ill patients who were ventilated in an intensive care unit for more than 24 hours during a specified two week period, to assess variations in the process of weaning patients off ventilation and any impact on the patient outcome.  The study included 25 sites in the UK with ten patients per site.  A recommendation for class 1 and 5 support was requested to cover access to patient data. "]
["Applicant Organisation Name","Guy’s and St Thomas’s NHS Foundation Trust"]
["Contact Name","Dr Andrew Jones"]
["Address","Department of Intensive Care Medicine, St Thomas's Hospital"]
[null,"Westminster Bridge Road"]
[null,"London"]
["Postcode","SE1 7EH"]
["Telephone","02071883039"]
["Email","andrew.jones@gstt.nhs.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"Y","the provision of care and treatment"]
[null,"□","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","250 patients across 25 UK sites who were ventilated in an intensive care unit for more than 24 hours during a specified two week period"]
["Description of confidential patient information used","month and year of birth, date of death, gender"]
["S251 Class(es)","□","Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"□","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"□","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Guy’s and St Thomas’s NHS Foundation Trust"]
["Status","Supported"]
[]
["Next Review Date","2015-01-28"]
["Notes","Application considered at CAG meeting on 28/11/2013\n\n2. Please ensure that Caldicott Guardian permission is provided from each site and that any access for these purposes will be managed in line with the Trust’s Information Governance toolkit return prior to accessing data at that site.\n3. Transfer of confidential patient data outside of the European Economic Area is not included within the approval. It is the applicant’s responsibility to ensure that there is an appropriate security measures and legal basis in place for this.\nSpecific conditions of support\n\n1. Confirmation of satisfactory IG toolkit submission for the applicant’s organisation. Confirmed 27/01/2014. \n\n2. Please ensure that Caldicott Guardian permission is provided from each site and that any access for these purposes will be managed in line with the Trust’s Information Governance toolkit return prior to accessing data at that site.\n\n3. Transfer of confidential patient data outside of the European Economic Area is not included within the approval. It is the applicant’s responsibility to ensure that there is an appropriate security measures and legal basis in place for this. \n"]

{"sheet":"A0032","index":28,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0032"]
["Reference","CAG 8-03(PR7)/2013"]
["Other Refs"]
["Application Title","Analysis of Routine Outcomes Relating to TAVI through Computational Algorithms (AORTA)\n"]
["Application Summary","This service evaluation application from Newcastle upon Tyne Hospitals NHS Foundation Trust set out the purpose of a project to compare and validate data held locally on patients who had undergone transcatheter aortic valve implantation or surgical aortic valve replacement procedures against data on the same held by the Hospital Episode Statistics (HES) and National Institute for Cardiovascular Outcomes Research (NICOR) databases.  A recommendation for class 1, 3, 5 and 6 support was requested to cover access by a researcher to 500 patient records at Newcastle upon Tyne Hospitals NHS Foundation Trust in order to extract pseudonymised data for linking with the already pseudonymised HES and NICOR datasets.  "]
["Applicant Organisation Name","Newcastle upon Tyne Hospitals NHS Foundation Trust"]
["Contact Name","Samuel Urwin"]
["Address","Regional Medical Physics Department"]
[null,"Freeman Hospital"]
[null,"High Heaton"]
["Postcode","NE7 7DN"]
["Telephone","01912 336161 x38624"]
["Email","samuel.urwin@nuth.nhs.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"Y","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","500 local records of patients who underwent transcatheter aortic valve implantation  (TAVI) or surgical aortic valve replacement (SAVR)."]
["Description of confidential patient information used","partial postcode, sex, age, ethnicity"]
["S251 Class(es)","□","Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"Y","Class III - to identify and contact patients to obtain consent"]
[null,"□","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Newcastle upon Tyne Hospitals NHS Foundation Trust"]
["Status","Expired"]
[]
["Next Review Date"]
["Notes","This service evaluation has ceased collecting data and as the data controller has confirmed that section 251 support for this study can be expired. \n\nApplication considered at CAG meeting on 28/11/2013.\nSpecific conditions of support\n\n1. Confirmation of suitable security arrangements via IG Toolkit submission, please see security review requirement section here; http://www.hra.nhs.uk/resources/confidentiality-advisory-group/confidentiality-advisory-group-cag-application-advice/ and contact Exeter.helpdesk@nhs.net with any queries.  Confirmed 04/07/2013\n\n"]

{"sheet":"A0033","index":29,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0033"]
["Reference","CAG 8-03(PR9)/2013"]
["Other Refs"]
["Application Title","National Prostate Cancer Audit: analysis of existing datasets"]
["Application Summary","This application refers to a collaborative prostate cancer audit which is part of the Healthcare Quality Improvement Partnership programme looking at treatment and outcomes for all patients. The application detailed the linkage of the HES dataset already held by the Royal College of Surgeons (PIAG 2-07(i)/2004 Audit of outcomes after surgical procedures using linked HES data and ONS mortality data) to cancer registry data held by Public Health England using the Health and Social Care Information Centre’s date linkage service."]
["Applicant Organisation Name","Royal College of Surgeons of England"]
["Contact Name","Emma Skipper"]
["Address","27A Harley Place"]
[null,"London"]
[]
["Postcode","W1G 8LZ"]
["Telephone","07398 693285"]
["Email","emma.skipper@hqip.org.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"Y","the provision of care and treatment"]
[null,"□","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","All men with an ICD-10 diagnostic code of C61 (malignant neoplasm of the prostate) in England and Wales from 2008-2011"]
["Description of confidential patient information used","NHS number, date of birth, postcode, sex"]
["S251 Class(es)","□","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Healthcare Quality Improvement Partnership"]
["Status","Supported"]
[]
["Next Review Date","2023-10-24"]
["Notes","20 October 2020 – Confirmation that support is expired for English data only given confirmation that PHE that date of death is not considered identifiable. Support continues to be in place for processing of Welsh data.\n\nAmendment Request (Approved 09/08/2018)\nThe amendment sought support for an extension to the duration of support which was in place for the Prostate Cancer Audit. The audit will collect data on a continual basis from 01/07/2018. The audit is delivered under contract to Healthcare Quality Improvement Partnership (HQIP). Support is requested on an ongoing basis and the data will be retained for the duration of time that a contract remains in place and where there is no change in data controller or data processors. The Royal College of Surgeons was successful in recent retendering process to continue to provide the audit as commissioned by HQIP.\n\nApplication considered at CAG meeting on 28/11/2013.\nSpecific conditions of support\n1. Confirmation of suitable security arrangements via IG Toolkit submission. Confirmed 31 July 2013\n\n"]

{"sheet":"A0034","index":30,"n_rows":36,"n_cols":3,"rows_kept":36,"cut":false,"hidden":false,"merged":[[31,1,31,4],[32,1,32,4],[34,1,34,4],[35,1,35,4],[21,1,21,4],[22,1,22,4],[23,1,23,4],[24,0,30,0],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,2,30,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0034"]
["Reference","CAG 8-03(PR11)/2013"]
["Other Refs","ECC 3-04(s)/2011"]
["Application Title","Hip Fracture Audit"]
["Application Summary","This audit application was originally submitted by the Health and Social Care Information Centre and received approval by the Secretary of State for Health on 11 April 2011.  The application set out aims to use case-mix, process and outcome data together with quality standards to improve the quality of care.  A recommendation for class 1, 3, 4, 5 and 6 was requested to cover linkage with Hospital Episode Statistics (HES) data.  Access was requested to NHS number, date of birth, date of death and postcode.   \n\nAmendment requested 11 July 2016\n\nThis amendment is to add ‘commissioning support’ to the list of approved purposes for\nsecondary use of the data (in an anonymised format).                                                                                    "]
["Applicant Organisation Name","Healthcare Quality Improvement Partnership (HQIP) and NHS England"]
["Contact Name","Jessica Butler, NHFD Project Manager"]
["Address","National Hip Fracture Database"]
[null,"11 St Andrews Place, Regent’s Park"]
[null,"London"]
["Postcode","NW1 4LE"]
["Telephone","020 3075 1561"]
["Email","jessica.butler@rcp.ac.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"Y","the provision of care and treatment"]
[null,"□","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Patients diagnosed with fragility hip fracture"]
["Description of confidential patient information used","NHS number, postcode, date of birth, date of death"]
["National Data Opt \nOut Status","The Secretary of State for Health and Social Care decision maker, on advice from the CAG, has supported a request to defer the National Data Opt Out. As such, the National Data Opt Out does not need to be applied for this activity"]
["S251 Class(es)","□","Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"Y","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Healthcare Quality Improvement Partnership"]
["Status","Supported"]
[]
["Next Review Date","2023-10-13"]
["Notes","Amendment supported 22 December 2022 \nTo revise the questions used for data collection in the National Audit of Inpatient Falls\n\nNew condition of support:\n\n1.\tThe applicant is to split out the NAIF application from the hip fracture audit via new separate application to CAG. \n\nAmendment supported 22 July 2022 to defer applying the National Data Opt-Out in relation to CAG 8-03(PR11)/2013\n\nSpecific conditions of support \n\n1.\tThis outcome confirms a change to the original conditions of support. The National Data Opt-Out is not to be applied to patients included in the activities specified in CAG 8-03(PR11)/2013.\n\nUpdate to NDO exemption conditions:\n\n2.\tA local patient objection mechanism must continue to be used in relation to CAG 8-03(PR11)/2013. Applicant is requested to confirm this is the case, within one month from the date of this letter.\n\nCondition met 29 September 2022\n\n3.\tPlease provide all associated patient notification materials, which should be made clearer than the current draft. It should be made clear on these notifications how patients are able to apply a local opt out to the NHFD. These should have been reviewed by a patient and public involvement group, and provided within one month from the date of this letter.\n\nCondition met 29 September 2022\n\n4.\tPlease provide evidence of discussions with patients and the public, surrounding the non-application of the National Data Opt-Out, within 3 months from the date of this letter.\n\nCondition met 29 September 2022\n\n03 December 2021 - Amendment supported:\nAmendment supported to clarify that collection of first name, surname and sex into the National Hip Fracture Database (NHFD) are included in support, and to include and clarify additional data items collected in the main and theatre datasets, is supported, subject to compliance with the standard conditions of support.\n\n03 December 2021 - Amendment supported:\nAmendment supported to revise the questions used for data collection in the National Audit of Inpatient Falls, is supported, subject to compliance with the standard conditions of support.\n\n27 November 2020 – Amendment supported to revise the questions used for data collection in the National Audit of Inpatient Falls.\n\nNotified 12 May 2020 that an additional question will be added to the dataset that  will ask about the COVID-status of patients submitted to the database. The relevant cohort of patients will not change. \n\n25 November 2019: Amendment supported to expand the patient cohort within the scope of the audit to include those who suffer femoral fractures. Wider changes were made to the supporting clinical dataset collected within the audit, which did not impact of the items of confidential patient information being processed were also supported\n\n18 November 2019 - An Amendment was supported to expand the dataset collected for the second phase of the National Audit of Inpatient Falls to include information on the management of patients before the fracture-causing fall occurred and the immediate post-fall management. The dataset will also be amended to included data on femoral fractures in addition to hip fractures. \n\nAmendment Request (Approved 14/12/2018)\nThe amendment seeks to bring in an additional audit, the National Audit of Inpatient Falls, under the overarching application. This is a sub-cohort of patients included within the National Hip Fracture Audit. It was confirmed that the items of confidential patient information, data flows and processors remained unchanged in the amendment. The amendment did seek to extend the scope of the audit to include submissions from Community Trusts or Health Boards and Mental Health Trusts in England and Wales. A letter of support for the amendment had been provided by the Health Quality Improvement Partnership, as controller for the audit activity.\n\nAmendment Request (Approved 27/07/2018)\nThe amendment proposed set out a proposed linkage between the National Hip Fracture Database and the National Joint Registry in order to explore the use of total hip replacement. It was explained that the Royal College of Physicians had been commissioned to carry out linkage between the National Hip Fracture Database (data controller HQIP; data processors: RCP, Crown informatics) and the National Joint Registry (data controller HQIP, data processor Northgate Public Services), in order to explore the use of the ‘total hip replacement’ for hip fracture.\nThis will involve the transfer of confidential patient information from the National Hip Fracture Database (NHFD), held by from Crown Informatics to Northgate Public Services. The following data items would be transferred to facilitate linkage:\n NHS number;  Forename;  Surname;  DOB;  Postcode.\nThis will be supplemented with the following additional clinical data items:\n Date and time of admission;  admitting hospital;  date and time of operation;  procedure type.\nThe patient cohort to be included would patients with a record of total hip replacement within the database since 2011.\nNorthgate would subsequently link the NHFD data to the National Joint Registry (NJR) data for the same period and provide an assessment of the extent to which the two databases describe the same cohort of patients. The proposed data linkage would be undertaken on a one-off basis.\n\nAmendment update 16 September 2016:                                                                            The current amendment was submitted in response to a request from NHS Digital to clarify the specific datasets for which support has been given.\nThe applicant clarified that the linkages would be performed by HSCIC/NHS Digital to NHS Digital held datasets (including, but not limited to HES, SUS, ONS and PEDW for Wales) for general commissioning purposes and potential onward flagging to commissioning organisations, as opposed to specific linkage with HES data only.\n\nApplication considered at CAG meeting on 28/11/2013.\nOriginally an amendment request from application ECC 3-04(s)/2011; new reference number issued due to change of data controller, but annual review date remains 21 June based on anniversary of original approval in 2011.\nSpecific conditions of support\n1. Confirmation of suitable security arrangements via IG Toolkit submission.  Confirmed 25/10/2013\n2. Please provide a report on the steps taken to improve this completion rate and move away from the need for other identifiers for linkage or validation of NHS number at annual review stage.\n\nAmendment update 18 November 2019:\nAn amendment was supported to expand the dataset collected for the second phase of the National Audit of Inpatient Falls to include information on the management of patients before the fracture-causing fall occurred and the immediate post-fall management. The dataset will also be amended to included data on femoral fractures in addition to hip fractures. \n"]

{"sheet":"A0036","index":31,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0036"]
["Reference","CAG 8-06(b)/2013"]
["Other Refs"]
["Application Title","National Chronic Obstructive Pulmonary Disease (COPD) Audit Programme - Secondary Care Clinical Audit"]
["Application Summary","This audit application from the Royal College of Physicians of London (RCP) followed a successful secondary care audit feasibility pilot (CAG 5-07(a)/2013) and sought support for the full secondary care audit element of the programme.  A recommendation for class 1, 4, 5 and 6 support was requested to collect data via a web-based audit tool from every eligible organisation in relation to consecutive cases identified prospectively from February 2014 to May 2014, comprising approximately 200 NHS Trusts.  Access was requested to NHS number, postcode, date of birth and date of death. Amendment approved October 2014 - primary care clinical audit dataset to inform the National COPD Audit. This was an amendment to the main audit application which included collection of secondary care clinical audit data. Applicant confirmed August 2015 that Welsh primary care data only would be included within the data collection.\n"]
["Applicant Organisation Name","The Royal College of Physicians (Audit and Accreditation, Care Quality Improvement Department) "]
["Contact Name","Lara Amusan, Programme Manager, National Asthma and COPD Audit Programme (NACAP) "]
["Address","National Asthma and COPD Audit Programme (NACAP), Audit and Accreditation, "]
[null,"The Royal College of Physicians"]
[null,"London: 11 St Andrew’s Place, "]
["Postcode","NW1 4LE "]
["Telephone","020 3075 1526 (London) / 0151 3181916 (Liverpool)"]
["Email","Lara.amusan@rcp.ac.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"Y","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Patient admissions to hospital with COPD exacerbations (in England and Wales). Consecutive cases identified prospectively by every eligible unit (hospital/Trust/Health Board) over a three month period.  Audit data collection:  Feb-May 2014 (approx. 200 Trusts). "]
["Description of confidential patient information used","NHS number, postcode, date of birth, date of death, Cause of death (text and coded),\n Gender, Ethnicity, Hospital Unit Identifier, Date of admission, Date and time of discharge\n"]
["S251 Class(es)","□","Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Healthcare Quality Improvement Partnership"]
["Status","Supported"]
[]
["Next Review Date","2023-12-12"]
["Notes","19 March 2021 - Amendment supported\nThe amendment, to include an additional exclusion criteria to the COPD audit, and to include additional ICD-10 codes in the inclusion criteria for the COPD audit, is supported, subject to compliance with the standard conditions of support.\n\n17 August 2020 – Amendment supported to revise the secondary care data flows in the National Children and Young People’s Asthma Audit so that data will be sent in pseudonymised, patient-level format from NHS Digital and NWIS to Imperial College London directly, removing the need for Crown Informatics to receive the returned, linked data from NHS Digital and NWIS. \n\n17 August 2020 - Amendment supported to include additional data items in the dataset for the adult asthma secondary care audit and to remove other items from the same dataset.\n\n04 February 2020 – Amendment supported to revise the data flow so that NHS Digital and NWIS will now send the anonymised, patient-level data directly to Imperial College London, instead of via Crown Informatics\n\nAmendment Request (Approved: 25/05/2018)\nThis amendment sought support to extend the scope of support to include the collection of data to facilitate the adult asthma audit programme. The name of the audit programme had been updated and was now the National Asthma and COPD Audit. It was confirmed that the inclusion of the asthma data collection within the existing application would not require any additional items of confidential patient information. Support was also requested to extend to the collection of secondary care information for both asthma and COPD patients.\n\nAmendment request 30/01/2017\nThe primary care approval covered the annual extraction of patient identifiable audit data from routinely collected general practice data. Data collection was managed under contract by NHS Digital (formerly the HSCIC).\nAs a condition of the original approval, CAG had requested that the applicant continue to explore the feasibility of using a pseudonymised approach to data collection for primary care. Consequently, for the 2016-2018 rounds of primary care audit (which would only take place in Wales) it was proposed that NHS Wales Informatics Service (NWIS) would manage the extraction of patient-level data (for all patients aged 35 and over with a recorded diagnosis of COPD on primary care registers) from general practice clinical systems.\nPseudonymisation of identifiable fields would be undertaken at source: NHS number would be replaced by a study ID, postcode would be transformed to LSOA and WIMD index, date of birth would be transformed to patient age and date of death (if recorded) would be transformed to age at death.The pseudonymised data would be transferred securely to the NWIS ‘safe haven’ central repository, from where it would be securely transferred to the RCP for cleaning, analysis and reporting.                                                                                                                           In line with the conditions of support, the change in data flows and data processor provided an exit strategy from the S251 approval for the primary care audit, as patient identifiable data would no longer be transferred out of participating GP practices.\nThe secondary care audit procedures would remain the same. Data would continue to be held by NHS Digital from the first round of the audit as per the original approval.\n\nA+B19mendment request 16th September 2016:                                                                                 The amendment proposed a change in data processing methodology, and data processor. The new data processor – Crown Informatics - could enable data to be collected continuously, replacing the current system of snapshot audits at set time periods. Crown Informatics would enter the data into a bespoke web based audit tool, and transfer it to HSCIC, DARS and NWIS. The data would be linked and returned to Crown Informatics, still in identifiable form.\nCrown Informatics requested support to combine and pseudonymise the data (this function was previously carried out by HSCIC). Support was also requested for Crown Informatics to share the data with other bodies including researchers, and to provide identifiable data on the behalf of researchers or auditors for linkage.\nA change in data items was also proposed. The following items would be removed: cause of death, ethnicity, Hospital Unit Identifier, and time of discharge. The following additional items would be collected: gender, date and time of admission, date and time of arrival and date of discharge. Other data items to be collected remained the same as in the original application. Application considered at CAG meeting on 28/11/2013\nCAG 8-06(b)/2013 – audit data will be linked to HES, PEDW, ONS and MRIS data.\nSpecific conditions of support\n1. Confirmation of suitable security arrangements via IG Toolkit submission Confirmed 03/07/2013"]

{"sheet":"A0040","index":32,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","0040"]
["Reference","CAG 9-07(b)/2013"]
["Other Refs"]
["Application Title","2014 Community Mental Health Survey"]
["Application Summary","This application from the Care Quality Commission (CQC) set out the purpose of carrying out the community mental health survey, one of the surveys within the NHS national patient survey programme. The survey data would be used by NHS trusts and Clinical Commissioning Groups (CCG’s) in local improvement activities. CQC would use data as part of its regulatory and surveillance activities and other relevant functions and data would also be shared with NHS England and the Department of Health.\nA recommendation for class 5 and 6 support was requested to cover access to confidential patient data from mental health trusts providing mental health services to one of four ‘approved’ contractors and to the central coordinator (Picker Europe), to enable contractors to send out questionnaires."]
["Applicant Organisation Name","Care Quality Commission"]
["Contact Name","Ian Seccombe\n"]
["Address","Care Quality Commission\n"]
[null,"Finsbury Tower\n"]
[null,"103-105 Bunhill Row, London\n\n"]
["Postcode","EC1Y 8TG"]
["Telephone"]
["Email","ian.seccombe@cqc.org.uk'"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","People aged 18 and over who had been in contact with NHS mental health services in the three month period, 1 September 2013 to 30 November 2013"]
["Description of confidential patient information used","name, address, year of birth, gender, ethnicity, date of last contact, CPA status and GP practice code."]
["S251 Class(es)","□","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"□","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","NHS England"]
["Status","Expired"]
[]
["Next Review Date","N/A"]
["Notes","Application considered at CAG meeting on 09/01/2014"]

{"sheet":"A0041","index":33,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0041"]
["Reference","CAG 10-03(PR2)/2014"]
["Other Refs"]
["Application Title","National Cancer Patients’ Experience Survey 2014: Acute and specialist trust surveys of inpatients and day cases"]
["Application Summary","This application from Quality Health set out the purpose of carrying out a survey of adult inpatients and day case patients with a primary diagnosis of cancer who have been admitted to an acute or specialist NHS Trust during September, October and November 2013. A recommendation for class 2, 4 and 6 support was requested to allow access to patient contact details in order to send out the National Cancer Patients’ Experience Survey 2014. Access was requested to name, address, sex, ethnic group, ICD10 code, admission and discharge dates, speciality code, referring CCG, admission type, NHS number, date of birth."]
["Applicant Organisation Name","Quality Health"]
["Contact Name","Dr Reg Race"]
["Address","Unit 1, Holmewood Business Park"]
[null,"Chesterfield Road, Holmewood,"]
[null,"Chesterfield"]
["Postcode","S42 5US"]
["Telephone","01246 856623"]
["Email","reg.race@quality-health.co.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"Y","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Adult inpatients and day case patients with a primary diagnosis of cancer who have been admitted to an acute or specialist NHS Trust during September, October and November 2013  "]
["Description of confidential patient information used","Name, address, sex, ethnic group, date of birth, ICD10 code, admission and discharge dates, speciality code, referring CCG, admission type, NHS Number"]
["S251 Class(es)","□","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"Y","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"□","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","NHS England"]
["Status","Expired"]
[]
["Next Review Date","N/A"]
["Notes","Application considered at CAG meeting on 06/03/2014\nApplication has now ended and a formal closure letter has been sent to the applicant."]

{"sheet":"A0042","index":34,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0042"]
["Reference","CAG 10-03(PR3)/2014"]
["Other Refs"]
["Application Title","Piloting new approaches 2014"]
["Application Summary","This application from the Care Quality Commission (CQC) set out the purpose of trialling new approaches to the National Inpatient Survey to increase the frequency and granularity of the survey. It is anticipated that the survey will be run up to four times a year. The increased frequency of this survey should provide more accurate survey data for the data packs used in CQC inspections. Increased granularity provides a benefit to obtaining performance data for sub-units within trusts and enable greater precision in targeting poor performance."]
["Applicant Organisation Name","Care Quality Commission"]
["Contact Name","Ian Seccombe"]
["Address","Finsbury Tower"]
[null,"103-105 Bunhill Row"]
[null,"LONDON"]
["Postcode","EC1Y 8TG"]
["Telephone"]
["Email","ian.seccombe@cqc.org.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Inpatients aged 16 years old or over who were discharged from acute and specialist NHS hospitals in either December 2013 or February 2014 (and earlier for smaller trusts), having had one overnight stay in hospital. The guidance instructs trust to exclude:\n• deceased patients \n• children or young persons aged under 16 years at the time of sampling \n• obstetrics/maternity service users, including spontaneous miscarriages  \n• patients admitted for planned termination of pregnancy \n• psychiatry patients  \n• day cases \n• private patients (non-NHS) \n• any patients who are known to be current inpatients patients without a UK postal address\n• Any patient known to have requested their details are not used for any purpose other than their clinical care"]
["Description of confidential patient information used","Unique identifier code, title, first name, surname, address fields, postcode (where available), admission/discharge dates, main specialty on discharge, whether admission from Treatment Centre, route of admission, NHS Site code on admission and discharge, ethnicity, gender, year of birth."]
["S251 Class(es)","□","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"□","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"□","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Care Quality Commission"]
["Status","Expired"]
[]
["Next Review Date","N/A"]
["Notes","Application considered at CAG meeting on 06/03/2014"]

{"sheet":"A0043","index":35,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0043"]
["Reference","CAG 10-03(PR4)/2014"]
["Other Refs"]
["Application Title","Parents’ Experiences of Neonatal Care"]
["Application Summary","This application from the Picker Institute set out a survey of parent experience of neonatal care services in hospitals in England and Wales in 2014, to assess any improvements made since the 2011 survey. A recommendation for class 5 support was requested to cover access to name and contact information for 200 babies discharged from 125 hospitals, in order for questionnaires to be sent to parents."]
["Applicant Organisation Name","Picker Institute Europe\n"]
["Contact Name","Chris Graham"]
["Address","Picker Institute Europe\n"]
[null,"Buxton Court\n"]
[null,"3 West Way\n\n"]
["Postcode","OX2 0JB"]
["Telephone"]
["Email","chris.graham@pickereurope.ac.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Mothers (18 years and over) of babies discharged from 125 hospitals (approx 200 per hospital)."]
["Description of confidential patient information used","mothers name, address, postcode, date of delivery mother’s ethnicity and hospital site."]
["S251 Class(es)","□","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"□","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Picker Institute Europe\n"]
["Status","Expired"]
[]
["Next Review Date","2015-01-28"]
["Notes","Application considered at CAG meeting on 06/03/2014.\nSpecific conditions of support\n\n1. Confirmation of suitable security arrangements via IG Toolkit submission. Confirmed 02/09/2011\n\n2. If research, confirmation of favourable Research Ethics Committee opinion. Applicant confirmed activity not research 13/01/2014.\n\nThe applicant confirmed that support can be expired as of 27 July 2022. \n\nThe public benefit of the application was use of the findings from the survey to drive improvements in overall experiences of neonatal care. at a local level.\n\n"]

{"sheet":"A0044","index":36,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","0044"]
["Reference","CAG 10-03(PR5)/2014"]
["Other Refs"]
["Application Title","2014 Accident and Emergency Department (A&E) Survey"]
["Application Summary","This application is for a recommendation of support for the transfer of patient identifiable data from acute and specialist trusts, to an approved survey contractor (Picker, Quality Health, Patient Perspective or CAPITA Surveys & Research) for the purpose of mailing out questionnaires for the 2014 A&E survey.  The 2014 A&E survey will be the fifth carried out to date. All 147 eligible trusts will be asked to conduct the survey with preparations expected to begin in March 2014 and fieldwork is expected to start from May 2014."]
["Applicant Organisation Name","Care Quality Commission"]
["Contact Name","Ian Seccombe"]
["Address","Finsbury Tower"]
[null,"103-105 Bunhill Row"]
[null,"London"]
["Postcode","EC1Y 8TG"]
["Telephone"]
["Email","ian.seccombe@cqc.org.uk "]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","People aged 16 and over who visited an A&E department in the sampling month chosen by Trusts (January, February or March 2014). The survey guidance instructs trusts to exclude: \n- deceased patients \n- children or young persons aged under 16 years at the date of their attendance at the A&E Department (approval for involvement of 16 and 17 year olds was included in the last A&E survey section 251 application)\n- any attendances at Minor Injuries Units or Walk-in Centres \n- any patients who were admitted to hospital via Medical or Surgical Admissions Units and therefore have not visited the A&E Department,\n- any patients who are known to be current inpatients \n- planned attendances at outpatient clinics which are run within the Emergency Department (such as fracture clinics)\n- patients without a UK postal address\n- patients attending primarily to obtain contraception (e.g. the morning after pill), patients who suffered a miscarriage or another form of abortive pregnancy outcome whilst at the hospital, and patients with a concealed pregnancy \n- any patient known to have requested their details are not used for any purpose other than their clinical care"]
["Description of confidential patient information used","Title, first name, surname, address, postcode, unique identifier code, date and time of attendance, NHS Site code, ethnicity, gender, year of birth and GP Practice Code (GPPC)"]
["S251 Class(es)","□","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"□","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"□","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Care Quality Commission"]
["Status","Expired"]
[]
["Next Review Date","N/A"]
["Notes","Please see the minutes of 6 March 2014 CAG meeting for further information."]

{"sheet":"A0046","index":37,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","0046"]
["Reference","CAG 10-07(b)/2014"]
["Other Refs","CAG 10-07(b)/2013"]
["Application Title","NICOR registries/audits"]
["Application Summary","This application from the University College London set out the purpose of carrying out three new audits in relation to the following procedures: \n\n1. Percutaneous Mitral Valve Repair: a catheter-based device which is used to repair heart valves, providing an alternative to open heart for those patients who are clinically appropriate \n2. Left Atrial Appendage Occlusion: a device used to prevent stroke in patients with atrial fibrillation (irregular and rapid heartbeat) \n3. Patent Foramen Ovale Closure in Adults: a procedure to close a hole, or potential hole, between the upper chambers of the heart, to prevent stroke \n"]
["Applicant Organisation Name","University College London"]
["Contact Name","Dr Julie Sanders"]
["Address","The National Institute for Cardiovascular Outcomes"]
[null,"Research (NICOR), University College London, 3rd Floor, "]
[null,"170 Tottenham Court Road, London"]
["Postcode","W1T 7HA"]
["Telephone","020 3108 3934"]
["Email","j.sanders@ucl.ac.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Each of the three registries will collect data on all NHS patients undergoing the above stated procedures"]
["Description of confidential patient information used","NHS England have introduced Commissioning through Evaluation as research evidence, and supporting clinical trials, are less likely to be available for more specialised treatments where patient numbers may be too small to support research data requirements, treatment costs may be very costly, or there may be particular ethical considerations involved in exposing patients to an experimental treatment rather than one which is more routinely considered.\nIt is anticipated that Commissioning through Evaluation will lead to a bank of high quality information which will help to form either future commissioning policies or NICE appraisal, which will result in more patients gaining access to promising treatments.\nServices and/or treatments which form part of the Commissioning through Evaluation programme have all been identified by clinicians and patient representatives as showing significant ‘promise’ as potential treatment options for the future.\nThe purpose is to record all NHS patients receiving these new treatments, and to create the necessary data linkages with HES and ONS data that will enable the technologies to be evaluated by calculating patients’ survival outcomes and pathways (readmissions, etc.). \n"]
["S251 Class(es)","□","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","University College London"]
["Status","Expired"]
[]
["Next Review Date","N/A"]
["Notes","Superceeded by 17/CAG/0153 on 08/08/2017\n\nApplication considered at CAG meeting on 06/03/2014.\n\nThe applicant had stated that the issue of obtaining patient consent is under review. Work is also ongoing with MRIS to investigate the possibility of de-identifying the dataset. A full update on these should be provided in the next annual review with details of any discussions and together with the actions arising from them.\n\nIt was noted that the open day cited by the applicant had taken place in 2014. More specific detail pertaining to the patient and user feedback and involvement and any resultant outcomes should be included in the next annual review.\n\nSpecific conditions of support\n1. Confirmation of suitable security arrangements via IG Toolkit submission. Confirmed \n2. Please forward an amended version of the patient information leaflet in line with the comments above. Amended version submitted.\n3. Please submit a letter of support from the sponsor organisation. Submitted.\n4. Please confirm what data items are included within the audit dataset. Datasets submitted.\n"]

{"sheet":"A0049","index":38,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[9,0,11,0],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,1,9,4],[10,1,10,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[34,1,34,4],[11,1,11,4],[12,1,12,4],[28,2,28,4],[29,2,29,4],[22,1,22,4],[13,1,13,4],[14,1,14,4],[19,2,19,4],[20,2,20,4],[21,1,21,4],[33,1,33,4],[30,1,30,4],[31,1,31,4]]}
[]
[]
["Application Number","0049"]
["Reference","CAG 1-05(a)/2014"]
["Other Refs"]
["Application Title","2014 Child Inpatient and Day Case Survey"]
["Application Summary","A recommendation of support for the transfer of patient identifiable data from acute and specialist trusts, to an approved survey contractor for the purpose of mailing out questionnaires for the 2014 children’s survey"]
["Applicant Organisation Name","Care Quality Commission"]
["Contact Name","Karen Hallt"]
["Address","Care Quality Commission"]
[null,"Finsbury Tower, 103-105 Bunhill Row"]
[null,"London"]
["Postcode","EC1Y 8TG"]
["Telephone","07789 875498"]
["Email","Karen.hallt@cqc.org.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Children aged 0-17 who have been admitted as an inpatient or received treatment as a day case patient in June 2014. The survey guidance to be issued to trusts will ask them exclude the following patients: \nTrusts will be asked to exclude the following patients when compiling their sample lists:\n• Deceased patients\n• Patients aged 18 years or older at time of their discharge\n• Obstetrics/maternity patients, including spontaneous miscarriages\n• Newborn babies where the mother is the primary patient (i.e. well babies, specialty code 424)\n• Patients who were only admitted to a Neonatal Intensive Care Unit (NICU), Local Neonatal Unit (LNU) or a SCBU (Special Care Baby Unit) i.e. specialty code 422.\n• Patients admitted for planned termination of pregnancy\n• Psychiatry patients, including CAMHS\n• Private patients (nonNHS)\n• Current inpatients\n• Patients without a UK postal address\n• Any patient known to have requested their details are not used for any purpose other than their clinical care (if this information is collected by the trust they should ensure that they remove these patients from their sample list at this stage, in addition trusts will be asked to maintain a log of all opt-outs resulting from the pre-survey publicity, and should cross reference that log during the sampling).   "]
["Description of confidential patient information used","Name and address of patient and the patient’s parent/carer"]
["S251 Class(es)","□","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"□","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Care Quality Commission"]
["Status","Supported"]
[]
["Next Review Date","2015-09-28"]
["Notes","Specific conditions of support\n1. Confirmation of suitable security arrangements via IG Toolkit submission, please see security review requirement section here; http://www.hra.nhs.uk/resources/confidentiality-advisory-group/confidentiality-advisory-group-cag-application-advice/ and contact exeter.helpdesk@nhs.net with any queries. Please provide information in relation to any improvement plans submitted.\n2. Support is provided to access contact details for parents/carers of patients aged 0-12 and for patients aged 13-17.\n3. Support is provided for a period of 12 months and the representativeness checking process using anonymised data outlined above should be utilised with those Trusts undertaking the dissemination of surveys themselves to determine whether this did present a feasible alternative. Strong evidence would be required that there was no practicable alternative if a further application for a future survey was submitted.\n4. Please provide further information in relation to the disclosure of data to the Department of Health and NHS England, in particular the requirement for respondent level data.\n5. Please submit the patient information materials in relation to the survey.\n6. Please confirm that patient objections can be processed both at Trust level and by the survey contractor and that there will be a consistent approach to managing objections by survey contractors and details of this approach.\n\n"]

{"sheet":"A0052","index":39,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","0052"]
["Reference","CAG 1-06(c)/2014"]
["Other Refs"]
["Application Title","Case Register for Rampton Hospital "]
["Application Summary","This application from Nottinghamshire Healthcare NHS Trust set out the purpose of establishing a register of patients at Rampton Hospital (for patients admitted from 01 January 2013) to identify whether interventions are effective in preventing re-offending once a patient returns to the community. Linkages to mortality data from the HSCIC and Ministry of Justice database (to identify post discharge offending) would take place via the Applied Information Department within Rampton and identifiers would be removed from the dataset prior to anonymised disclosure."]
["Applicant Organisation Name","Nottinghamshire Healthcare NHS Trust "]
["Contact Name","Dr Birgit Völlm"]
["Address","Clinical Associate Professor and Reader in Forensic Psychiatry  Head of Section Forensic Mental Health \n \n"]
[null,"Institute of Mental Health  University of Nottingham Innovation Park"]
[null,"Triumph Rd Nottingham"]
["Postcode"," NG7 2TU"]
["Telephone"]
["Email","Birgit.Vollm@nottingham.ac.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","All patients in Rampton Hospital admitted from the 1st of January 2013. The current population is about 340 adult patients and the median length of stay is eight years. The Hospital hosts the National High Secure Service for Women, the National High Secure Service for Learning Disability, the National High Secure Service for Deaf Patients and units for male patients with mental illness and personality disorders. "]
["Description of confidential patient information used","Unique case register number, admission number, admission unit, year of birth, year of admission, gender, ethnicity and nationality, marital status on admission, primary ICD10 diagnosis and up to three additional ICD10 diagnoses, preadmission criminal history, index offence, year of discharge, year of death, primary cause of death plus three other contributory causes of death, post discharge offending, first and last HCR20 scores, HoNOS forensic scores."]
["S251 Class(es)","□","Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Nottinghamshire Healthcare NHS Trust"]
["Status","Supported"]
[]
["Next Review Date","2015-09-11"]
["Notes","Application considered at CAG meeting on 10/04/2014.\nSpecific conditions of support\n1. Outputs are to be used solely for the purposes of service evaluation. Processing and use of the data outputs for any research purpose are currently excluded from the scope of this approval. Should there be a future intention to supply anonymised data for research purposes an amendment should be requested via the Confidentiality Advisory Group and a favourable ethical opinion obtained from a relevant research ethics committee.\n2. Onward disclosure of identifiable data is excluded from the scope of this approval\n3. Maintenance of a satisfactory Information Governance Toolkit submission for the approval duration."]

{"sheet":"A0054","index":40,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","0054"]
["Reference","CAG 2-03(PR2)/2014"]
["Other Refs"]
["Application Title","Mental Disorder & Cancer care: a data linkage study in south London II"]
["Application Summary","To link cancer registry data held with data held by SLAM, HES and mortality data which were all linked via existing approvals. The resulting pseudonymised database would be used to investigate whether people who have had a mental disorder have delayed presentation of cancer, trajectories of their cancer treatments and other incidental conditions compared to those who do not have a mental disorder."]
["Applicant Organisation Name","Kings College London"]
["Contact Name","Professor Robert Stewart"]
["Address","Institute of Psychiatry, King's College London"]
[null,"PO Box 63, De Crespigny Park"]
[null,"Denmark Hill, LONDON"]
["Postcode","SE5 8AF"]
["Telephone",2032288563]
["Email","robert.stewart@kcl.ac.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"Y","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"□","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population"]
["Description of confidential patient information used","NHS number, date of birth, Postcode (most recent home postcode) and patient first and last name"]
["S251 Class(es)","□","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"□","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Kings College London"]
["Status","Expired"]
[]
["Next Review Date","N/A"]
["Notes","Applicant confirmed study can be expired from ‘s251’ support on 18 November 2022 as the data has been pseudonymised. If further linkages/refresh are planned, applicants intend to submit a new application accordingly.\n\nWith regards to public benefit, the applicants confirmed that this unique linkage between mental healthcare and cancer care data has allowed several studies to be carried out on cancer as experienced by people with mental disorders. Applicants therefore hope to put together a clearer picture of how mental health may impact on quality of care which they will endeavour to flag to policy makers.\n\n\nUpdate: 3/8/2017\n\nThis application is not Non-Research. A copy of this form has been made on the CAG Research Register, all further updates are to be made there.\n\nApplication considered at CAG meeting on 10/04/2014.\nSpecific conditions of support\n\n1. Favourable opinion from a Research Ethics Committee. Received 09/07/2014\n\n2. Support is for the specified linkage only and additional applications should be made for support for further linkages. Confirmed\n\n3. Confirmation of satisfactory security arrangements via confirmation of a satisfactory IG toolkit submission. Confirmed v11 -  91%.\n"]

{"sheet":"A0055","index":41,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0055"]
["Reference","CAG 2-03(PR3)/2014"]
["Other Refs"]
["Application Title","National Chronic Obstructive Pulmonary Disease (COPD) Audit Programme\n- Pulmonary Rehabilitation Clinical Audit Pilot\n"]
["Application Summary","This application from the Royal College of Physicians set out the purpose of a pilot for the pulmonary rehabilitation audit, commissioned by the Healthcare Quality Improvement Partnership, which would provide a snapshot audit of service delivery and quality. The audit aimed to enable providers of pulmonary rehabilitation for COPD to improve the quality of care provided in these settings, through the provision of high quality time–limited data collections."]
["Applicant Organisation Name","Royal College of Physicians "]
["Contact Name","Ms Emma Skipper"]
["Address","Chronic Obstructive Pulmonary Disease (COPD) Audit Programme"]
[null,"The Royal College of Physicians of London"]
[null,"11 St Andrews Place, London"]
["Postcode","NW1 4LE"]
["Telephone"]
["Email","emma.skipper@rcplondon.ac.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Data will be collected on patients with a primary diagnosis of COPD attending a discharge assessment appointment for a pulmonary rehabilitation programme in England and Wales (in approx. 20 programme provider organisations) over a two month period.  Up to 20 consecutive cases per participating organisation.  "]
["Description of confidential patient information used","NHS number, Home Postcode, Date of Birth; Gender; Ethnicity, \nUnique Unit of Identifier, Date of Assessment, Date of discharge"]
["S251 Class(es)","□","Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"□","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Royal College of Physicians "]
["Status","Expired"]
[]
["Next Review Date","N/A"]
["Notes","Applicant confirmed using consent based methodology September 2014"]

{"sheet":"A0057","index":42,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0057"]
["Reference","CAG 4-03(PR1)/2014"]
["Other Refs"]
["Application Title","Cost-effectiveness of models of care for young people with eating disorders"]
["Application Summary","This application from King’s College London will identify all new cases of anorexia nervosa in young people in the British Isles over a 12 month period, using the Child and Adolescent Psychiatric Surveillance System (CAPSS). At six and 12 months after each young person has been identified, the Applicant will gather follow-up information about the services each young person received and his/her health outcomes. This data will be used to estimate the cost-effectiveness of the different models of care provided to each young person and help us to explore whether increasing the provision of specialist services would benefit young people and their families and would be good value for money.\n\nA recommendation for class 1, 2, 5 and 6 support is being requested to use patient identifiable data for case verification/matching of baseline and follow-up data, removal of duplicate notifications and the calculation of Body Mass Index (BMI). Geographical information will be used to describe the population presenting with anorexia nervosa to identify geographical difference between models of care."]
["Applicant Organisation Name","King's College London"]
["Contact Name","Professor Sarah Byford"]
["Address","Institute of Psychiatry at King’s College London"]
[null,"The David Goldberg Centre, De Crespigny Park"]
[null,"Box P024, London"]
["Postcode","SE5 8AF"]
["Telephone","0207 848 0043"]
["Email","s.byford@kcl.ac.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","This study will include children and adolescents aged 8 to 18 years, in contact with community-based mental health services, who meet the diagnostic criteria for anorexia nervosa as follows:\nONE bullet point criterion of EACH GROUP below should be fulfilled. Detailed diagnostic criteria are presented below:\nGroup A\n• Restriction of food, low body weight, or\n• Weight less than expected for age\nGroup B\n• Fear of gaining weight, or\n• Fear of becoming fat, or\n• Behaviour that interferes with weigh gain, for example excessive exercising, self-induced vomiting, use of laxatives and diuretics\nGroup C\n• Body image disturbance\n• Persistent lack of recognition of the seriousness of the current low body weight."]
["Description of confidential patient information used","NHS Number, hospital number, date of birth, sex, town of residence and first half of postcode."]
["S251 Class(es)","□","Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,"Y","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"□","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","King's College London"]
["Status","Supported"]
[]
["Next Review Date","2017-08-26"]
["Notes","Application considered at CAG meeting on 02 May 2014.\nSpecific conditions of support\n\n1. The Information Leaflet should reference how patients can opt-out of their information being included in the study. The Applicant clarified on 11/07/2014 that the information leaflet is shared with the general public and not specifically with patients. It was confirmed that the leaflet is to be used on the CAPSS web page as general information on the CostED study.\n2. Confirmation of suitable security arrangements via IG Toolkit submission. Confirmed 10/07/2014.\n\n"]

{"sheet":"A0058","index":43,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","0058"]
["Reference","CAG 4-05(a)/2014"]
["Other Refs"]
["Application Title","Community wide requirements to reduce mortality rate in North Lincolnshire"]
["Application Summary","This application from North Lincolnshire Clinical Commissioning Group set out the purpose of obtaining details of deceased patients in order to review primary care medical files and identify root causes. The overall aim was to improve service provisions and reduce mortality rates."]
["Applicant Organisation Name","North Lincolnshire Clinical Commissioning Group"]
["Contact Name","Dr Robert Jaggs-Fowler"]
["Address","North Lincolnshire Clinical Commissioning Group"]
[null,"Health Place, Wrawby Road"]
[null,"Brigg, North Lincolnshire"]
["Postcode","DN20 8GS"]
["Telephone","01652 636600"]
["Email","robert.jaggs-fowler@nhs.net "]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Deceased patients in the North Lincolnshire area between April 2013 and March 2014"]
["Description of confidential patient information used","Deceased patients in the North Lincolnshire area between April 2013 and March 2014"]
["S251 Class(es)","□","Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"□","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","North Lincolnshire Clinical Commissioning Group "]
["Status","Supported"]
[]
["Next Review Date","2015-08-22"]
["Notes","Application considered at CAG meeting on 19/06/2014.\nSpecific conditions of support\n\n1. Confirmation of suitable security arrangements via IG Toolkit submission. Approved 15 August 2014.\n2. Please ensure that efforts are made to inform the public that the review is taking place, for example by displaying posters within GP practices.\n"]

{"sheet":"A0061","index":44,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","0061"]
["Reference","CAG 4-05(d)/2014"]
["Other Refs"]
["Application Title","Enhanced quality assurance process of the provision of NHS- funded care for people with a learning disability or autistic spectrum disorder"]
["Application Summary","The application set out a proposal for NHS England to effectively case manage the care of patients, who require secure mental health care or child and adolescent mental health services. This would involve access by the case management team to the Secure Mental Health System currently hosted by Cheshire and Merseyside CSU and extracts from the child and adolescent mental health data set as described in section (i) of the application."]
["Applicant Organisation Name","NHS England "]
["Contact Name","Kath Murphy"]
["Address","Assistant Head of Specialised Services, Specialised Services"]
[null,"Quarry House "]
[null,"Leeds "]
["Postcode","LS2 7UE"]
["Telephone"]
["Email","England.igqueries@nhs.net "]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","All patients who are referred to and in receipt of specialised mental health care services commissioned by NHS England and with case management processes in place. This covers:\n• Secure services for people detained under the powers of the Mental Health Act 1983 and subsequent amendments; and\n• Child and Adolescent Mental Health in-patient services.\n"]
["Description of confidential patient information used","Access by the case management team to the Secure Mental Health System currently hosted by Cheshire and Merseyside CSU and extracts from the child and adolescent mental health data set as described in section (i) of the application. This includes NHS number, full name, gender, date of birth\n"]
["S251 Class(es)","□","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"□","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"□","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","NHS England "]
["Status","Supported"]
[]
["Next Review Date","2016-03-09"]
["Notes","Specific conditions of support\n\n1. The support specifically excludes activities related to the direct care or treatment of an individual as this falls outside the scope of the Health Service (Control of Patient Information) Regulations 2002.  The function of the case manager appears to go beyond that of direct care and it is for this ‘grey area’ that support is provided. \n\n2. The support covers only those named parties within the application, specifically the case manager, the administrator supporting that case manager and CSU analyst (with the analyst based in the Cheshire and Merseyside CSU). \n\n3. Confirmation to received directly from the HSCIC that NHS England have a satisfactory IG toolkit standard, and copy of improvement plan if in place. It was noted that some information had previously been supplied in relation to CAG 8-02 (a-c) and this was pending further applicant clarity on progression. \n\n4. Support is provided for a period of 12 months from date of final approval. \n\n5. Applicants to ensure that any changes to the exit strategy or approach must be closely aligned with CAG 8-02 (a-c)/2014 and to report accordingly at key points. \n\n6. Where patient objection is expressed, any subsequent processing of that patient data in the face of that objection cannot be legitimised under this support (Regulation 5) and another legal basis will need to be established. Any pre-existing patient objection cannot be overridden through this support. \n\n7. Access to family, carer or any third party details is not information of the patient and access to this information is therefore excluded under this support; another legal basis will need to be established to process third party information.  \n"]

{"sheet":"A0063","index":45,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","0063"]
["Reference","CAG 5(PS2) 2014"]
["Other Refs"]
["Application Title","Why do people with autism fare so differently in adult life?"]
["Application Summary","This application from Kings College London set out the purpose of obtaining up to date address from the Health and Social Care Information Centre (HSCIC) by providing HSCIC with personal identifiers held with consent. The address information would then be used to write to the cohort to invite them to participate in further stages of the study.\n\n\n\n"]
["Applicant Organisation Name","Kings College London"]
["Contact Name","Professor Emily Simonoff"]
["Address","Department of Child and Adolescent Psychiatry"]
[null,"Institute of Psychiatry"]
[null,"Kings College London"]
["Postcode","SE5 8AF"]
["Telephone"]
["Email","Emily.simonoff@kcl.ac.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Male and female participants aged 21-25 years"]
["Description of confidential patient information used","Name, date of birth, date of death and address, NHS number"]
["S251 Class(es)","□","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"Y","Class III - to identify and contact patients to obtain consent"]
[null,"□","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"□","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Kings College London"]
["Status","Supported"]
[]
["Next Review Date","2015-07-18"]
["Notes","Application considered at CAG meeting on May 2014\n\n\nSpecific conditions of support\n1. Confirmation that assurance that a script is in place for the researcher to use which ensures that the telephone call would not apply pressure on the participant to consent. Confirmed.\n2. Confirmation of a favourable Research Ethics Committee opinion. Confirmed\n3. Confirmation of suitable security arrangements via IG Toolkit submission. Confirmed. \n4. Please provide a signed copy of the IRAS form. Received\n"]

{"sheet":"A0067","index":46,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0067"]
["Reference","CAG 6 (PS1) /2014"]
["Other Refs"]
["Application Title","Towards an earlier diagnosis of Neuroendocrine Tumours (NETS): \nDoes faecal occult blood (FOB) testing identifiy Iieo-colonic NET in the \nNHS Bowel Cancer Screening Programme (BCSP)"]
["Application Summary","This application from Hampshire Hospitals NHS Foundation Trust set out the purpose of a service evaluation project which aimed to analyse and assess patients diagnosed with colorectal (and terminal illeal) NETs identified through the NHS Bowel Cancer Screening Programme (NHS BCSP). The application was defined as service evaluation by the applicants using the HRA decision tool.\nAmendment request-24/09/2015-An amendment was requested for an extension to the study duration for a further six months to March 2016. It was noted that without an extension to the duration the study would not be able to fulfil its aims, to assist in establishing incidence and current practice in England that will help inform the updating of national UKINETS guidelines for this patient population."]
["Applicant Organisation Name","Hampshire Hospitals NHS Foundation Trust "]
["Contact Name","Dr John Ramage"]
["Address","Clinical Centre of Excellence for Neuroendocrine Tumours"]
[null,"Kings Health Partners, Kings College Hospital"]
[null,"Westminster Bridge Road, London"]
["Postcode","SE1 7EH"]
["Telephone"]
["Email","John.ramage@hhft.nhs.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Coloretal Carcinilds or Neuroendocrine Tumours (CR NETs) identified from the \nnational BCSP"]
["Description of confidential patient information used"," Name, NHS number, postcode and date of birth to \nallow linkages to take place. Date of death would be retained for analysis purposes"]
["S251 Class(es)","□","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"□","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Hampshire Hospitals NHS Foundation Trust "]
["Status","Supported"]
[]
["Next Review Date","2015-10-28"]
["Notes","Application considered at CAG meeting on 28/08/2014.\nSpecific conditions of support\n\n1. Confirmation of suitable security arrangements via IG Toolkit submission. Confirmed \n2. Please confirm what arrangements are in place to ensure the security of the transfer of confidential patient information. Details of arrangements provided.\n3. Please confirm how many individuals will have access to identifiable data. Confirmed as three named individuals.\n4. Please confirm whether mortality data would be of benefit to the study and whether additional identifiers would be required to obtain this from the HSCIC or Trusts. Confirmed (see further information section above)\n5. Please ensure that all individuals with access to the dataset have completed mandatory NHS information governance training requirements.\n6. Please ensure that date of death is reduced to month and year as soon as possible.\n"]

{"sheet":"A0069","index":47,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0069"]
["Reference","CAG 6 (PS3)/2014"]
["Other Refs"]
["Application Title","Survey of the experience of patients with Neuroendocrine cancers in active treatment in specialist hospital centres in England "]
["Application Summary","This application from Quality Health set out the purpose of identifying patients how have undergone Neuroendocrine tumour (NET)  cancer treatment to request they complete a  patient survey regarding their experiences. The patient survey is designed to examine the care and treatment received by patients with a known diagnosis of neuroendocrine cancer, who are in active treatment at a specialist centre within the NHS for this purpose. The patient experience survey is designed to identify barriers to effective diagnosis and treatment that may exist and to measure the patients perceptions of quality of care. These issues are of particular importance for NET patients as informal evidence indicates that some patients have to present many times before their condition is diagnosed accurately and treatment started."]
["Applicant Organisation Name","NET Patient Foundation and Quality Health"]
["Contact Name","Dr Reg Race"]
["Address","Unit 1, Holmewood Business Park"]
[null,"Chesterfield Road, Holmewood"]
[null,"Chesterfield, Derbyshire"]
["Postcode","S42 5US"]
["Telephone","01246 856623"]
["Email","reg.race@quality-health.co.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Adult patients aged 16 and over with an identified  primary diagnosis of neuroendocrine cancer who have attended one of 8 specialist NHS Hospitals in England for active treatment. \n\nThe cohort will consist of up to 5,000 patients in active treatment as in-patients or day case patients (national codes 1,2 and 3 and excluding 4, outpatients), who have attended a specialist centre during the period July 2013 – July 2014 inclusive. Records will be de-duplicated."]
["Description of confidential patient information used","Name, Address, Postcode, NHS Number, Sex, Ethnic Group, Year of Birth, Admission and Discharge Dates, Admission Type, Referring CCG and ICD10 code."]
["S251 Class(es)","□","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","The NET Patient Foundation"]
["Status","Expired"]
[]
["Next Review Date","2015-08-26"]
["Notes","Support can be expired as of 17 August 2022.\n\nAll data files for the Cohort have been deleted and relevant database fields for all patients have been overwritten with null values and are no longer accessible to any staff.\n\nApplication considered at CAG meeting on 28/08/2014.\nSpecific conditions of support\n\n1. An overview of the appropriate methods for meeting the fair processing requirements to inform patients of the survey was requested. Confirmed 21/08/2014.\n2. The questionnaire should be amended to move references to completion of the questionnaire being voluntary up to a more prominent position on the front page. Confirmed 12/08/2014.\n3. Confirmation of suitable security arrangements via IG Toolkit submission. Confirmed 07/07/2014.\n"]

{"sheet":"A0070","index":48,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0070"]
["Reference","CAG 7(PS1)/2014"]
["Other Refs"]
["Application Title","An evaluation of 12-month all cause mortality in patients with hip fracture"]
["Application Summary","This application from the Royal National Orthopaedic Hospital, London set out the purpose of using date of death to identify those patients entered onto the National Hip Fracture Database who subsequently died in the 12-months following their injury. Once the identified which patients died within 12-months of their fracture an analysis of the cause of death on their death certificate will be completed to identify trends in cause of death. Linking cause of death to date of death would enable a determination as to whether there is a time-linked distribution in the mortality of patients following hip fracture."]
["Applicant Organisation Name","Royal National Orthopaedic Hospital"]
["Contact Name","Dr. Ruth Richardson"]
["Address","Institute of Orthopaedics, Royal National Orthopaedic Hospital"]
[null,"Brockley Hill"]
[null,"Stanmore, London"]
["Postcode","HA7 4LP"]
["Telephone","07971243359"]
["Email","rsfrichardson@doctors.org.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Deceased patients who suffered a hip fracture in the year prior to death"]
["Description of confidential patient information used","Date of death"]
["S251 Class(es)","□","Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"□","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Royal National Orthopaedic Hospital"]
["Status","Supported"]
[]
["Next Review Date","2015-08-19"]
["Notes","Application considered at CAG meeting on 02/10/2014.\nSpecific conditions of support\n\n1. Confirmation of what arrangements are in place to raise awareness of this project as part the fair processing under the Data Protection Act 1998. Confirmed on 26/08/2014 that general posters will be used raise awareness of this study.\n2. Confirmation of which patient groups will be contacted based on the findings of this evaluation. Confirmed 26/08/2014.\n3. Confirmation of suitable security arrangements via IG Toolkit submission. Confirmed 23/09/2014 by the HSCIC External Information Governance Delivery team.\n"]

{"sheet":"A0071","index":49,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","0071"]
["Reference","CAG 7(PS2)/2014"]
["Other Refs"]
["Application Title","2014 Inpatients Survey"]
["Application Summary","This application from the Care Quality Commission set out the transfer of patient identifiable data from acute and specialist Trusts, to an approved survey  contractor for the purpose of mailing out questionnaires for the 2014 inpatient survey."]
["Applicant Organisation Name","Care Quality Commission"]
["Contact Name","Paul Williamson"]
["Address","Finsbury Tower"]
[null,"103-105 Bunhill Row"]
[null,"LONDON"]
["Postcode","EC1Y 8TG"]
["Telephone","020 7448 9046"]
["Email","paul.williamson@cqc.org.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Inpatients aged 16 years old or over who were discharged from acute and specialist NHS hospitals in June, July or August 2014 (and earlier for smaller trusts), having had one overnight stay in hospital. The guidance instructs trust to exclude:\n• deceased patients \n• children or young persons aged under 16 years at the time of sampling \n• obstetrics/maternity service users, including spontaneous miscarriages  \n• patients admitted for planned termination of pregnancy \n• psychiatry patients  \n• day cases \n• private patients (non-NHS) \n• any patients who are known to be current inpatients patients without a UK postal address\n• Any patient known to have requested their details are not used for any purpose other than their clinical care "]
["Description of confidential patient information used","Title, initial, full name, full address, postcode, ethnicity, year of birth, gender, date and time of attendance."]
["S251 Class(es)","□","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"□","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Care Quality Commission"]
["Status","Supported"]
[]
["Next Review Date","2015-08-26"]
["Notes","Application considered at CAG meeting on 02/10/2014.\nSpecific conditions of support\n\n1. Confirmation that the 2014 guidance manual does not contain any changes since the 2013 version, which was submitted in this application.\n2. Confirmation of suitable security arrangements via IG Toolkit submission. Confirmed 15/08/2014.\n"]

{"sheet":"A0072","index":50,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0072"]
["Reference","CAG 8-02(a)/2014"]
["Other Refs","CAG 8-02(b)/2014 and CAG 8-02(c)/2014"]
["Application Title","Assuring Transformation: Data collection by Clinical Commissioning Groups to populate patient registers and reporting"]
["Application Summary","This is the first of a set of three linked applications. The purpose of this application is to establish a legal basis for Clinical Commissioning Groups (CCGs) to collect data from providers of specialist in-patient services for people with a learning disability and/or autism. The data will be used to populate the registers required by Transforming Care. The purposes of the registers are to: \ni. ensure that all patients in NHS funded care for specialist in-patient services for people with a learning disability and/or autism spectrum disorder are known to the responsible NHS commissioner and that reviews of their care have or will take place in line with principles of Transforming Care: to support the Assuring Transformation cycle of Enhanced Quality Assurance. \nii. support reporting to assure the public that effective action is being taken to address the wider failings identified by the review of the events at Winterbourne View Hospital; \niii. meet the safeguarding requirements suggested by patients, their families and advocates \niv. ensure that remedial action is taken to address areas of continued concern is taken.\n\nIn response to the review of events at Winterbourne View Hospital, a set of requirements was set out for commissioners of services for patients with learning difficulties and/or autism spectrum disorders. These requirements covered the auditing, monitoring and analysing of the provision made by the health service for patient care and treatment and were included in Transforming care: A national response to Winterbourne View and a supporting Concordat (December 2012).1 The requirements are intended to reduce the risk of a repeat of the events at Winterbourne View for patients in similar circumstances. These requirements create a robust monitoring and assurance regime. This requires the commissioners of NHS funded services for patients, which met the criteria, to receive personal confidential data to fulfil this assurance function.\n"]
["Applicant Organisation Name","NHS England on behalf of Clinical Commissioning Groups"]
["Contact Name","Clare McConnell, Senior Analytical Lead"]
["Address","5E09, Quarry House"]
[null,"Quarry Hill"]
[null,"Leeds"]
["Postcode","LS2 7UE "]
["Telephone","07730 381 082"]
["Email","clare.mcconnell1@nhs.net"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","People in in-patient beds for mental and/or behavioural healthcare who have either learning disabilities and/or an autistic spectrum disorder (including Asperger’s syndrome). This includes any age, any level of security (general/low/medium/high) and any status under the Mental Health Act (informal or detained)"]
["Description of confidential patient information used","NHS Number, date of birth, gender, ethnicity, full postcode, admission information and reason, patient care plan"]
["S251 Class(es)","□","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","NHS England"]
["Status","Supported"]
[]
["Next Review Date","2022-12-10"]
["Notes","25 February 2022 – Annual review supported, and new condition applied \n1. Support is extended on condition that the applicant provides a progress report, and a plan for achieving workable solutions at the next annual review (December 2022), including estimated times to complete targets. Support is initially extended until this time, at which point consideration will be made for continued support.\n\n10 August 2021 - Amendment supported to enable the flow of confidential patient information from providers to commissioners where patients have been identified as inpatients in-scope of Transforming Care (TC) through the Mental Health Services Data Set (MHSDS)  but are not being recorded in Assuring Transformation (AT)\n\n10 December 2020 - Amendment supported\nThe amendment, to extend the duration of support required, is conditionally supported, subject to compliance with the standard and specific conditions of support.\n\nSpecific conditions of support:\n\n1. Support is extended on condition that the applicant provides a progress report, and a plan for achieving workable solutions at the next annual review, including estimated times to complete targets. Support is initially extended until this time, at which point consideration will be made for continued support. Condition met February 2022 (as part of Dec 2021 annual review). New condition applied.\n\n2. Confirmation of suitable security arrangements via IG Toolkit submission. \n• The NHS Digital 2018/19 DSPT review for NHS England were confirmed as ‘Standards Met’ on the NHS Digital DSPT Tracker (checked 1 December 2020), the 2019/20 DSPT is currently under review\n\nFebruary 2019 – Amendment supported to extend the duration of support to 31 March 2021. Support also extended to the ongoing retention of a pseudonymised analysis dataset for five years following data collection.\n\nAmendment approved 06 October 2015 to cover the addition of new questions; specifically patient home postcode. This was primarily for the HSCIC to be assured that the NHS number, CCG and postcode would be consistent for each patient in the annual Learning Disabilities Census dataset; this would therefore require full postcode to support the need for reconciliation to prevent duplication with the Assuring Transformation dataset.\n\nApplication considered at CAG meeting on 06/11/2014.\nThe application is approved from 10 December 2014 to 31 March 2016 and is subject to compliance with the standard and updated specific conditions of approval. This is also subject to satisfactory reports provided for consideration in February 2015 (Information Governance Toolkit update), a comprehensive update on outstanding actions in June 2015, and an annual review submitted to the November 2015 meeting.\n\nConditions of support\n1. Where a patient seeks to object to the data processing, any intent not to respect the objection must be legitimised under a different legal basis; support under the 2002 Regulations cannot be relied upon in those instances. \n\n2. Legacy data collected prior to the date of final approval in this letter is excluded from the scope of support and an alternative legal basis will need to be established to continue processing this data. Data related to third parties, not considered to be that of the patient, is also excluded from the scope of support. \n\n3. Written update report to be provided in six months (submit to deadline of 13 May 2015 for consideration at 04 June 2015 meeting), to include \n\na. Practical application of patient objection – guidance, process, experience, handling and outcomes \nb. Updated patient and carer leaflet \nc. Progression towards exit strategy – update, plan, any potential issues. \nd. Information Governance Toolkit submission – status update on actions, impacting on the application, required to attain a satisfactory standard \n\n4. In light of the improvement plan actions required to bring NHS England Area Teams to a satisfactory level, a report to be provided end February 2015 confirming all Information Governance Toolkit aspects, impacting on the application data flows, scheduled for completion by this time have been satisfactorily completed. \n"]

{"sheet":"A0073","index":51,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","0073"]
["Reference","CAG 8-02(b)/2014"]
["Other Refs","CAG 8-02(a)/2014 and CAG 8-02(c)/2014 "]
["Application Title","Data collection by NHS England Area Teams responsible for commissioning secure mental health and child and adolescent mental health services to populate patient register and reporting."]
["Application Summary","This is the second of a set of three linked applications. This application outlines the requirements for case management carried out by NHS England’s Area Teams, and the Enhanced Quality Assurance function which is undertaken by NHS England. The latter is enabled by the dataset currently submitted directly by CCGs, and which in the future will be collected and disseminated by the Health and Social Care Information Centre (HSCIC). This flow of data allows NHS England to oversee the case management activities undertaken by commissioners and ensures that the standards of patient care outlined in Transforming Care are met and maintained. \n\nThe purpose of this application is to establish a legal basis for NHS England Specialist Commissioning Teams based in Area Teams (ATs) to collect data from providers of specialist in-patient services for people with a learning disability and/or autism. The data will be used to populate the registers required by Transforming Care. The purposes of the registers are to: \ni. ensure that all patients in NHS funded care for specialist in-patient services for people with a learning disability and/or autism spectrum disorder are known to the responsible NHS commissioner and that reviews of their care have or will take place in line with principles of Transforming Care: to support the Assuring Transformation cycle of Enhanced Quality Assurance. \nii. support reporting to assure the public that effective action is being taken to address the wider failings identified by the review of the events at Winterbourne View Hospital; \niii. meet the safeguarding requirements suggested by patients, their families and advocates \niv. ensure that remedial action is taken to address areas of continued concern is taken. \n\nAssuring Transformation is a programme of work being co-ordinated by NHS England, using data collected in both Clinical Commissioning Groups (CCGs) and NHS England’s Area Team (AT) registers. \n"]
["Applicant Organisation Name","NHS England on behalf of Clinical Commissioning Groups "]
["Contact Name","Clare McConnell, Senior Analytical Lead"]
["Address","5E09, Quarry House"]
[null,"Quarry Hill"]
[null,"Leeds"]
["Postcode","LS2 7UE "]
["Telephone","07730 381 082"]
["Email","clare.mcconnell1@nhs.net"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","People in in-patient beds for mental and/or behavioural healthcare who have either learning disabilities and/or an autistic spectrum disorder (including Asperger’s syndrome). This includes any age, any level of security (general/low/medium/high) and any status under the Mental Health Act (informal or detained)"]
["Description of confidential patient information used","NHS Number, date of birth, gender, ethnicity, full postcode, admission information and reason, patient care plan "]
["S251 Class(es)","□","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","NHS England"]
["Status","Supported"]
[]
["Next Review Date","2022-12-10"]
["Notes","25 February 2022 – Annual review supported, and new condition applied \n1. Support is extended on condition that the applicant provides a progress report, and a plan for achieving workable solutions at the next annual review (December 2022), including estimated times to complete targets. Support is initially extended until this time, at which point consideration will be made for continued support.\n\n10 August 2021 - Amendment supported to enable the flow of confidential patient information from providers to commissioners where patients have been identified as inpatients in-scope of Transforming Care (TC) through the Mental Health Services Data Set (MHSDS)  but are not being recorded in Assuring Transformation (AT)\n\n10 December 2020 - Amendment supported\nThe amendment, to extend the duration of support required, is conditionally supported, subject to compliance with the standard and specific conditions of support.\n\nSpecific conditions of support:\n\n1. Support is extended on condition that the applicant provides a progress report, and a plan for achieving workable solutions at the next annual review, including estimated times to complete targets. Support is initially extended until this time, at which point consideration will be made for continued support. Condition met February 2022 (as part of Dec 2021 annual review). New condition applied.\n\n2. Confirmation of suitable security arrangements via IG Toolkit submission. \n• The NHS Digital 2018/19 DSPT review for NHS England were confirmed as ‘Standards Met’ on the NHS Digital DSPT Tracker (checked 1 December 2020), the 2019/20 DSPT is currently under review\n\n01 July 2020 – amendment supported to include NHS Lead Providers of Provider Collaboratives as data processors, collect data from providers of specialist inpatient services for people with a learning disability and/or autism on behalf of NHS England\n\nFebruary 2019 – Amendment supported to extend the duration of support to 31 March 2021. Support also extended to the ongoing retention of a pseudonymised analysis dataset for five years following data collection. \n\nAmendment approved 06 October 2015 to cover the addition of new questions; specifically patient home postcode. This was primarily for the HSCIC to be assured that the NHS number, CCG and postcode would be consistent for each patient in the annual Learning Disabilities Census dataset; this would therefore require full postcode to support the need for reconciliation to prevent duplication with the Assuring Transformation dataset.\n\nApplication considered at CAG meeting on 06/11/2014.\nThe application is approved from 10 December 2014 to 31 March 2016 and is subject to compliance with the standard and updated specific conditions of approval. This is also subject to satisfactory reports provided for consideration in February 2015 (Information Governance Toolkit update), a comprehensive update on outstanding actions in June 2015, and an annual review submitted to the November 2015 meeting. \n\nConditions of support\n\n1. Where a patient seeks to object to the data processing, any intent not to respect the objection must be legitimised under a different legal basis; support under the 2002 Regulations cannot be relied upon in those instances. \n\n2. Legacy data collected prior to the date of final approval in this letter is excluded from the scope of support and an alternative legal basis will need to be established to continue processing this data. Data related to third parties, not considered to be that of the patient, is also excluded from the scope of support. \n\n3. Written update report to be provided in six months (submit to deadline of 13 May 2015 for consideration at 04 June 2015 meeting), to include \n\na. Practical application of patient objection – guidance, process, experience, handling and outcomes \nb. Updated patient and carer leaflet \nc. Progression towards exit strategy – update, plan, any potential issues. \nd. Information Governance Toolkit submission – status update on actions, impacting on the application, required to attain a satisfactory standard \n\n4. In light of the improvement plan actions required to bring NHS England Area Teams to a satisfactory level, a report to be provided end February 2015 confirming all Information Governance Toolkit aspects, impacting on the application data flows, scheduled for completion by this time have been satisfactorily completed. \n"]

{"sheet":"A0074","index":52,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","0074"]
["Reference","CAG 8-02(c)/2014"]
["Other Refs","CAG 8-02(a)/2014 and CAG 8-02(b)/2014 "]
["Application Title","Assuring Transformation: Enhanced Quality Assurance Process Data flow (Disclosure by HSCIC to NHS England)"]
["Application Summary","Application considered at CAG meeting on 06/11/2014.\nThis is the third of a set of three linked applications. This application establishes a legal basis for NHS England to receive data from the Health and Social Care Information Centre (HSCIC) about specialist in-patient services for people with a learning disability and/or an autism spectrum disorder. This data flow from the HSCIC to NHS England will be used to monitor the performance of commissioners in managing the care received by the patients they are responsible for. The overall objectives are to: \ni. ensure that all patients in NHS funded care for specialist in-patient services for people with a learning disability and/or autism spectrum disorder are known to the responsible NHS commissioner and that reviews of their care have or will take place in line with principles of Transforming Care; \nii. support reporting to assure the public that effective action is being taken to address the wider failings identified by the review of the events at Winterbourne View Hospital; \niii. meet the safeguarding requirements suggested by patients, their families and advocates \niv. ensure that remedial action is taken to address areas of continued concern is taken. \n\nThis application additionally enables the fifth part of the Transforming care objectives \nv. complete the Assuring Transformation cycle of Enhanced Reporting enabling NHS England to oversee the work done by commissioners in ensuring patients care is managed and regularly reviewed. The data flow and data set within this application is a dataset which will allow NHS England to seek assurance from commissioners about patients. This includes prompting commissioners to review patient care and monitoring the number of patients that met the criteria. \n"]
["Applicant Organisation Name","NHS England"]
["Contact Name","Clare McConnell, Senior Analytical Lead"]
["Address","5E09, Quarry House"]
[null,"Quarry Hill"]
[null,"Leeds"]
["Postcode","LS2 7UE "]
["Telephone","07730 381 082"]
["Email","clare.mcconnell1@nhs.net"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","People in in-patient beds for mental and/or behavioural healthcare who have either learning disabilities and/or an autistic spectrum disorder (including Asperger’s syndrome). This includes any age, any level of security (general/low/medium/high) and any status under the Mental Health Act (informal or detained)"]
["Description of confidential patient information used","NHS Number, date of birth, gender, ethnicity, full postcode, admission information and reason, patient care plan "]
["S251 Class(es)","□","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","NHS England"]
["Status","Supported"]
[]
["Next Review Date","2022-12-10"]
["Notes","25 February 2022 – Annual review supported, and new condition applied \n1. Support is extended on condition that the applicant provides a progress report, and a plan for achieving workable solutions at the next annual review (December 2022), including estimated times to complete targets. Support is initially extended until this time, at which point consideration will be made for continued support.\n\n10 August 2021 - Amendment supported to enable the flow of confidential patient information from providers to commissioners where patients have been identified as inpatients in-scope of Transforming Care (TC) through the Mental Health Services Data Set (MHSDS)  but are not being recorded in Assuring Transformation (AT)\n\n10 December 2020 - Amendment supported\nThe amendment, to extend the duration of support required, is conditionally supported, subject to compliance with the standard and specific conditions of support.\n\nSpecific conditions of support:\n\n1. Support is extended on condition that the applicant provides a progress report, and a plan for achieving workable solutions at the next annual review, including estimated times to complete targets. Support is initially extended until this time, at which point consideration will be made for continued support. Condition met February 2022 (as part of Dec 2021 annual review). New condition applied.\n\n2. Confirmation of suitable security arrangements via IG Toolkit submission. \n• The NHS Digital 2018/19 DSPT review for NHS England were confirmed as ‘Standards Met’ on the NHS Digital DSPT Tracker (checked 1 December 2020), the 2019/20 DSPT is currently under review\n\nFebruary 2019 – Amendment supported to extend the duration of support to 31 March 2021. Support also extended to the ongoing retention of a pseudonymised analysis dataset for five years following data collection. \n\nAmendment approved 06 October 2015 to cover the addition of new questions; specifically patient home postcode. This was primarily for the HSCIC to be assured that the NHS number, CCG and postcode would be consistent for each patient in the annual Learning Disabilities Census dataset; this would therefore require full postcode to support the need for reconciliation to prevent duplication with the Assuring Transformation dataset.\n\nThe application is approved from 10 December 2014 to 31 March 2016 and is subject to compliance with the standard and updated specific conditions of approval. This is also subject to satisfactory reports provided for consideration in February 2015 (Information Governance Toolkit update), a comprehensive update on outstanding actions in June 2015, and an annual review submitted to the November 2015 meeting. \n\nConditions of support\n\n1. Where a patient seeks to object to the data processing, any intent not to respect the objection must be legitimised under a different legal basis; support under the 2002 Regulations cannot be relied upon in those instances. \n\n2. Legacy data collected prior to the date of final approval in this letter is excluded from the scope of support and an alternative legal basis will need to be established to continue processing this data. Data related to third parties, not considered to be that of the patient, is also excluded from the scope of support. \n\n3. Written update report to be provided in six months (submit to deadline of 13 May 2015 for consideration at 04 June 2015 meeting), to include \n\na. Practical application of patient objection – guidance, process, experience, handling and outcomes \nb. Updated patient and carer leaflet \nc. Progression towards exit strategy – update, plan, any potential issues. \nd. Information Governance Toolkit submission – status update on actions, impacting on the application, required to attain a satisfactory standard \n\n4. In light of the improvement plan actions required to bring NHS England Area Teams to a satisfactory level, a report to be provided end February 2015 confirming all Information Governance Toolkit aspects, impacting on the application data flows, scheduled for completion by this time have been satisfactorily completed. \n"]

{"sheet":"A0075","index":53,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0075"]
["Reference","CAG 9(PS1)/2014"]
["Other Refs"]
["Application Title","2015 Community Mental Health Survey"]
["Application Summary","This application from the Care Quality Commission (CQC) set out the purpose of carrying out the community mental health survey, one of the surveys within the NHS national patient survey programme. The survey data would be used by NHS trusts and Clinical Commissioning Groups (CCG’s) in local improvement activities. CQC would use data as part of its regulatory and surveillance activities and other relevant functions and data would also be shared with NHS England and the Department of Health."]
["Applicant Organisation Name","Care Quality Commission (CQC)"]
["Contact Name","Paul Williamson"]
["Address","User Voice Development Manager"]
[null,"Care Quality Commission, Finsbury Tower"]
[null,"103-105 Bunhill Row, London"]
["Postcode","EC1Y 8TG"]
["Telephone"]
["Email","Paul.williamson@cqc.org.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","People aged 18 and over "]
["Description of confidential patient information used","Name, address, year of birth, gender, ethnicity, date of last contact, CPA status, GP practice code and mental health care cluster code from NHS trusts, 1 September 2014 to 30 November 2014."]
["S251 Class(es)","□","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"□","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Care Quality Commission (CQC)"]
["Status","Supported"]
[]
["Next Review Date","2015-11-20"]
["Notes","Application considered at CAG meeting on 24/11/2015\n\nSpecific conditions of support\n\n1. Confirmation of suitable security arrangements via Information Governance Toolkit (IGT) submission. Confirmed"]

{"sheet":"A0076","index":54,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","0076"]
["Reference","CAG 10(PS1)/2015"]
["Other Refs"]
["Application Title","2015 Maternity Survey"]
["Application Summary","This application from Care Quality Commission set out the purpose of identifying and\ntransferring patient identifiable information from Trusts to approved survey contractors for\nthe purpose of mailing out questionnaires and reminders for the 2015 maternity survey.\nThe 2015 maternity survey will be the fourth carried out to date. All eligible trusts will be\nasked to conduct the survey with preparations expected to begin in March 2015 and\nfieldwork expected to start from May.\nA recommendation for class 5 and 6 support was requested to cover access for auditing,\nmonitoring and analysing patient care and treatment and to allow access to an authorised\nuser for this purpose."]
["Applicant Organisation Name","Care Quality Commission"]
["Contact Name","Paul Williamson"]
["Address","Care Quality Commission\n\n\n"]
[null,"Finsbury Tower"]
[null,"London\n103-105 Bunhill Row"]
["Postcode","EC1Y 8TG"]
["Telephone"]
["Email","Karen.Hallt@cqc.org.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Women who gave birth in January or February 2015 and were aged 16 years or over at the time of the delivery. The sample size will be a minimum of 300 women at each trust, with the larger trusts reaching a sample size of 850 (dependent on the size of the sample available over January and February 2015). "]
["Description of confidential patient information used","Access was requested to title, first name, surname, address and postcode, mother’s year\nof birth, mother’s ethnic group, day of delivery, month of delivery, year of delivery, actual\ndelivery place, place of birth: NHS site code, CCG code, postcode sector and trust-held\nprovider information."]
["S251 Class(es)","□","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"□","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","NHS England "]
["Status","Supported"]
[]
["Next Review Date","2016-04-08"]
["Notes","Application considered at CAG meeting on 16/01/2015\n\nSpecific conditions of support\n1. Provision of the final versions of the leaflet for 16 and 17 year olds, poster, questionnaire and guidance on attributing antenatal and postnatal care, when available. Submitted 20th March 2015.\n2. Favourable opinion from a Research Ethics Committee. Received 3rd March 2015\n3. Confirmation from the IGT Team at the Health and Social Care Information Centre (HSCIC) of suitable security arrangements via Information Governance Toolkit (IGT) submission for Picker Institute Europe, Quality Health, Patient Perspective or Capita. HSCIC have confirmed satisfactory compliance on 18th/19th March 2015.\n"]

{"sheet":"A0077","index":55,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","0077"]
["Reference","CAG 9(PS2)/2014"]
["Other Refs"]
["Application Title","PHE Congenital Anomaly and Rare Disease Registration Service "]
["Application Summary","To provide continuous epidemiological monitoring of the frequency, nature, cause and outcomes of congenital anomalies for the populations of the North East of England and the West Midlands by means of two regional registers of congenital anomalies, the West Midlands Congenital Anomaly Register (WMCAR) and the Northern Congenital Abnormality Survey (NorCAS).  \n\nTo provide essential epidemiological information to the British Isles Network Of Congenital Anomalies Registers (BINOCAR) Hub and European Surveillance of Congenital Anomalies (EUROCAT)  to enable epidemiological monitoring of the frequency, nature, cause and outcomes of congenital anomalies for the population of the UK and Europe respectively.\n"]
["Applicant Organisation Name","Public Health England"]
["Contact Name","Sarah Stevens, Public Health Consultant, National Disease Registration"]
["Address","Public Health England"]
[null,"5th Floor North, Wellington House"]
[null,"133-155 Waterloo Road"]
["Postcode","SE1 8UG"]
["Telephone","07468 473744"]
["Email","sarah.stevens@phe.gov.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","All deliveries in the geographical regions specified. For NorCAS the Strategic Clinical Network area of North East and North Cumbria. For WMCAR the former West Midlands health region or current WM ONS Statistical Region"]
["Description of confidential patient information used","Mother’s full name\nAddress at delivery\nPostcode\nHospital number mother\nNHS number mother\nMother’s Date of birth\nBaby’s name\nBaby's gender\nAddress\nPostcode\nHospital number baby\nNHS number baby\nDate of booking\nDate of birth\nDate of death\nAddress at conception and booking\nPlace of booking and birth\nBaby’s address and postcode if different from mother\nFather’s name \n"]
["S251 Class(es)","□","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"□","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Department of Health"]
["Status","Expired"]
[]
["Next Review Date","N/A"]
["Notes","."]

{"sheet":"A0078","index":56,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","0078"]
["Reference","CAG 10-02(d)/2015"]
["Other Refs"]
["Application Title","Public Health England National Congenital Anomaly and Rare Disease Registration Service"]
["Application Summary","To address the national requirements for high quality public health disease surveillance identified by the Chief Medical Officer, Public Health England (PHE) has committed to the expansion of congenital anomaly and rare disease registration in England from the current 49% of births to cover the whole population of England. The creation of the National Congenital Anomaly and Rare Disease Registration Service (NCARDRS) also supports the request from patients, identified through public consultation, for rare disease registration and is integral to the Department of Health 2020 Vision on Rare Diseases set out in the UK Rare Disease Strategy.\nThe purpose of NCARDRS is to provide continuous epidemiological monitoring of the frequency, nature, cause and outcomes of congenital anomalies and rare diseases for the population of England. This will act as a much-needed resource to support individual patients, their families, clinicians, research, service delivery, commissioning and public health.\nThis national service incorporates the seven existing regional registers in England (CAROBB, SWCAR, WANDA, NorCAS, WMCAR, EMSYCAR and YHCAR1), the National Downs Syndrome and Cytogenetic Register (NDSCR) and the BINOCAR hub. In those parts of the country where there is currently no data collection, new regional teams will be established. From the 1st April 2015 all these components will come together as one, single comprehensive national registration service for England, managed and provided by PHE. NCARDRS will provide essential data for clinicians, public health, service delivery and will report to the European Surveillance of Congenital Anomalies (EUROCAT) to enable epidemiological monitoring of the frequency, nature, cause and outcomes of congenital anomalies and rare diseases for the population Europe.\nSupport for the legacy data collected since 1 April 2013 from BINOCAR register (PIAG 2-08(e)/2002) is included.\n\nAmendment request-15/06/2015\n\nAmendment to process all legacy data from BINOCAR registers.\n\nAmendment request - 29/6/15\nAs part of the ongoing development of NCARDRS, additional national data sources have been\nidentified to help with the core registration functions of case ascertainment and completion.\nThese are as follows:\n  Mothers and Babies: Reducing Risk through Audits and Confidential Enquiries across the\n UK (MBRRACE-UK)\n  Newborn Blood Spot Screening programme\n  National Hearing Screening Programme\n  National Infant Physical Examination\n  ONS births and deaths data\n  Badger neonatal\n  National Institute for Cardiovascular Outcomes Research (NICOR)\n  Private healthcare providers of antenatal screening services\n  Private maternity care services\n  Private healthcare providers treating individuals with congenital anomalies and rare diseases\n\nNational data feeds would reduce the data collection burden on frontline clinical staff, who\ncurrently provide the majority of data to NCARDRS.\nAdditional data items were also requested:\n\n  Consultant - obstetric, paediatric, neonatal\n  GP name\n  GP practice address\n  Details of post mortem - type, results, location\n  Cause of death\n  Procedures - prenatal and postnatal & dates\n  Mother's country of birth\n  Place of death\n  Referral hospital\n  Date of admission/discharge\n  Ethnicity of baby\n  Rare diseases\n  Prescription drugs\n  Father’s DOB\n  Father’s address, including postcode\n  Father’s NHS number\n  Morbidities\n  Family history of congenital anomaly/rare disease\n\nNCARDRS has reached an agreement with all of the new feeds, with the exception of Badger\nneonatal (work ongoing) and private services."]
["Applicant Organisation Name","Public Health England"]
["Contact Name","Dr Jem Rashbass"]
["Address","Public Health England"]
[null,"5th Floor North"]
[null,"Wellington House, 133-155 Waterloo Road"]
["Postcode","SE1 8UG"]
["Telephone"]
["Email","Jem.Rashbass@phe.gov.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","A congenital anomaly is defined as any defect present at delivery, probably originating before birth, and\nincludes structural, chromosomal, genetic and biochemical defects and malformations."]
["Description of confidential patient information used","Access was requested to a variety of sources including cytogenetic laboratories, post mortem laboratories, ultrasound departments, delivery suites, computerised obstetric notes, ONS data, Personal Demographics Service and other outcome datasets. Name, postcode, NHS number and data of death were requested in order to carry out linkages, collect follow up data and to ensure the correct individual was identified. Legacy data from BINOCAR registers was also requested."]
["S251 Class(es)","□","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"□","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Department of Health (PHE is an executive agency of the Department of Health)"]
["Status","Expired"]
[]
["Next Review Date","2022-04-01"]
["Notes","01 October 2021 - Support Expired:\nApplicant confirmed support expired 01 October 2021\n\nThe applicant has confirmed support is no longer required as ‘s251’ support is being superseded by NHS Directions. The dataset is now controlled by NHS Digital.\n\n26 May 2021 - Condition of support added upon annual review\n\nSpecific conditions of support:\nResponses to the below conditions are to be provided within six months of the issuing of this outcome letter:\n\n1. The document review is to be undertaken and feedback provided to the CAG.\n\n2. An update on the timeline for the creation of the registration portal needs to be provided. \n\nThe response would be considered at the next available full CAG meeting. \n\n\nThe below is to be provided at the next annual review:\n\n1. Further justification on why all the items of confidential patient information currently stored need to be retained long-term and an explanation on why data minimisation cannot be applied.\n\n\nApplication considered at CAG meeting on 19/02/2015\n\nThe outcome letter was issued on the 13/4/16; this is superseded by the outcome letter issued on the 26/4/16.\n\nSpecific conditions of support to be met or agreed to prior to final support\n1. Confirmation from the IGT Team at the Health and Social Care Information Centre of suitable security arrangements via Information Governance Toolkit (IGT) submission. V12 confirmed 01 April 2015\n2. Submission of a final draft of the patient information leaflet. Provided by applicant 26 March 2015\n3. Confirmation of how patient information would be disseminated to parents/patients. Provided by applicant 26 March 2015\n4. Support extends only to the cohort specified within the application, suspected and diagnosed cases of congenital anomaly and rare diseases in England as defined within the application. Provided by application 26 March 2015\n\nAmendment approved February 2017                                                                                     As part of the ongoing development of the National Congenital Anomaly and Rare Disease Registration Service (NCARDRS), and the expansion into rare diseases, additional national data sources have been identified to help with the core registration functions of case ascertainment and completion. \n\nThese new data sources were:\n• Sickle Cell and Thalassaemia (SCT) legacy data\n• Hospital Episode Statistics (HES)\n• ONS births and deaths data\nThese additional sources were approved.B8"]

{"sheet":"A0079","index":57,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0079"]
["Reference","15/CAG/0112"]
["Other Refs"]
["Application Title","Human pituitary growth hormone recipients"]
["Application Summary","The 1883 individuals in the UK treated with pituitary derived growth hormone are at risk of developing Creutzfeldt-Jakob Disease.  We know the names and dates of birth , and for public health reasons relating to transmissibility, we are responsible for knowing  their life status and cause of death.  Anonymised information  is shared with Public Health  England and the Department of Health. We also report  on issues relating to epidemiology and causation, and for this we need to know the dates and causes of death for this finite cohort."]
["Applicant Organisation Name","Pituitary Growth Hormone Follow-up Study, based at UCL Institute of Child Health and Great Ormond Street Hospital for Children Foundation Trust"]
["Contact Name","Dr Peter Adlard, Co-ordinator. Senior Research Associate and Honorary Consultant Paediatrician"]
["Address","Room LG16, UCL Institute of Child Health"]
[null,"30 Guilford Street"]
[null,"London"]
["Postcode","WC1N 1EH"]
["Telephone","07774 494218"]
["Email","P.Adlard@ucl.ac.uk;Peter.Adlard@nhs.net\n"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","All known individuals treated with pituitary derived human growth hormone (hGH) in the UK between 1959 and 1985.  This was 1883 individuals, of  whom 1503 are still alive."]
["Description of confidential patient information used","Already known: name and demographics, NHS numbers, original diagnosis hGH treatment data.\nRequested: Cancer registrations, dates and causes of death, local health registration location\n"]
["S251 Class(es)","□","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"□","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"□","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Great Ormond Street Hospital for Children Foundation Trust"]
["Status","Expired"]
[]
["Next Review Date","2020-05-01"]
["Notes","06 January 2022 - Support expired\nApplicant confirmed on 6tth January 2022 that ‘s251’ Regulation 5 support from CAG can be expired as the database and associated linkage now has an alternate legal basis under ‘s251’ Regulation 3. The dataset will be transferred to UKHSA under the control of Katy Sinka.\n\nIn terms of public benefits, the storage and management of this historical data is important for public health protection purposes. The dataset provides a complete or near complete record of those treated with a pituitary derived hGH in the UK before the risk of iCJD acquisition was recognised. It provides a unique source of evidence about the risks of iatrogenic transmission of prion diseases from this specific healthcare exposure and more generally. In particular, the dataset provides a source of information about the length of incubation period between exposure and disease. This evidence continues to inform public health risks from other healthcare exposures to prions -particularly those associated with surgery, such as the historic use of human derived dural grafts and possible transfer via surgical instruments.\n\n\nApplication considered at CAG meeting on 13 March 2015. \n\nSpecific conditions of support \n1. Confirmation from the IGT Team at the Health and Social Care Information Centre of suitable security arrangements via Information Governance Toolkit (IGT) submission. Confirmed \n\n\n\n"]

{"sheet":"A0080","index":58,"n_rows":36,"n_cols":3,"rows_kept":36,"cut":false,"hidden":false,"merged":[[31,1,31,4],[32,1,32,4],[34,1,34,4],[35,1,35,4],[21,1,21,4],[22,1,22,4],[23,1,23,4],[24,0,30,0],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,2,30,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0080"]
["Reference","15/CAG/0119"]
["Other Refs","ECC 5-05(f)/2012"]
["Application Title","MBRRACE-UK – Delivering the Maternal, Newborn and Infant Clinical Outcome Review Programme (MNI-CORP)"]
["Application Summary","Overarching context: The Maternal, Newborn and Infant Clinical Outcome Review Programme (MNI-CORP) is a national programme which aims to assess quality and stimulate improvement in safety and effectiveness in maternal, newborn and infant healthcare by systematically enabling clinicians, managers and policy makers to learn from adverse events. The purpose of the Programme is to monitor, through population surveillance, the frequency of deaths and review clinical practice in relation to maternal, perinatal and infant mortality and morbidity and identify risks that can be attributed to suboptimal clinical care as well as example of good practice.\nReports on the findings of this work will be disseminated to regulators, policy makers, commissioners, service providers, practitioners and patient groups with the aim of supporting changes that improve the quality and safety of maternal, newborn and infant health care.\nThe aim and objectives of the MNI-CORP programme\nThe aim of the MNI-CORP programme is: To learn lessons from adverse events and to produce recommendations for improvements to care to ensure that care provided for future mothers, babies and families is safe, of high quality, and patient and family-centred.\nThe objectives are to:\nDeliver national surveillance and confidential enquiries which will:\n• Assess quality and safety of maternity and infant services;\n• Support improvements in service quality through national learning;\n• Produce evidence-based recommendations and good practice points;\n• Influence clinical practice, service provision, health policy and clinical education.\nTo achieve the aims and objectives of the MNI-CORP programme the MBBRACE-UK collaboration have been commissioned to conduct national mortality surveillance and confidential enquiries to investigate the care provided for: \n• all women who die during pregnancy or up to 12 months after the end of their pregnancy regardless of how their pregnancy ends (mortality surveillance and confidential enquiries);\n• a sample of women who experience particular, very serious, illness in pregnancy or related to pregnancy who survive; some of these conditions are maternal 'near-miss' events (topic-specific morbidity confidential enquiries);\n• all women whose pregnancy ends as a late fetal loss (late miscarriage), that is, the baby is delivered between 22+0 and 23+6 weeks of pregnancy showing no signs of life (mortality surveillance);\n• all women whose pregnancy ends as a termination of pregnancy resulting in an outcome from 22+0 weeks of gestation onwards (mortality surveillance);\n• all women whose pregnancy results in a stillbirth (24+0 weeks gestation onwards) (mortality surveillance and topic-specific confidential enquiries);\n• all women and their babies where the baby dies in the first 28 days after birth or without ever having been discharged from hospital (mortality surveillance and topic-specific confidential enquiries);\n• a sample of infants who experience particular, very serious, illness in the first few weeks after birth who may or may not survive; this involves reviewing the care provided to a sample of women during pregnancy and their infant after birth (topic-specific mortality and morbidity confidential enquiries).\n\nThe purpose of this application is to enable the following activities which involve the collection and use of personal identifiable data collected without consent in relation to data collected 1st January 2009 to 31st March 2017 and to enable comparison with historical data:\n1. Analysis and reporting of national late fetal loses, stillbirth and neonatal mortality rates for deaths 1st January 2010 to 31st March 2017\n2. Analysis and reporting of national maternal mortality rates for maternal deaths 1st January 2009 to 31st March 2017\n3. Collection of detailed clinical information and copies of case notes to enable confidential enquiries of all maternal deaths which occurred from 1st January 2009 to 31st March 2017.\n4. Collection of detailed clinical information and copies of case notes to enable confidential enquiries of a rolling programme of topic-specific serious maternal morbidity involving retrospective identification of cases from 2009 onwards.\n5. Collection of detailed clinical information and copies of a sample of case notes to enable confidential enquiries of a rolling programme of topic-specific perinatal mortality and serious infant morbidity involving retrospective identification of cases from 2009 onwards.\n6. To share non-identifiable data derived from the NHS numbers for babies system (NN4B) with the National Neonatal Audit Programme, also commissioned by HQIP\nIn order to calculate rates we also receive and process identifiable denominator data for stillbirths, infant deaths, live births and maternal deaths from the Office for National Statistics for England and Wales 1st January 2009 onwards. We also receive and process identifiable data from the NN4B system for stillbirths and live births 1st January 2013 to 31st December 2014 and from the system replacing NN4B from 1st January 2015.\nData are currently processed under NIGB/CAG approval: ECC 5-05 (f)/2012\nAmendment request-22/06/2015: The amendment request detailed accessing confidential patient information from the National Confidential Enquiry into Suicide and Homicide (NCISH) at the University of Manchester, rather than directly from Mental Health Trusts, due a number of difficulties accessing the required information from Trusts. It was noted that there was now limited time for the inclusion of the cases in the confidential enquiries which were currently underway and for which the applicant was reaching the reporting stage. Whilst NCISH could provide questionnaires only, rather than case notes, the applicant confirmed that receiving copies of the questionnaires relating to these specific cases would allow the case assessors access to at some information about the perinatal mental health care of the patients to review and ensure that any additional lessons for improvements in care were not missed.\nAmendment request - 11/07/2016:  The amendment request was to limit the extent of the redaction which is carried out for the perinatal confidential enquiries. Redaction will be solely limited to the complete removal of the mother and baby identifiers, and project team will not redact the hospital and clinician details.\n\nThere are two reasons for this proposal. The first reason is that the redaction of the details of the clinician and hospital results in the loss of important information about who is delivering care and what level of care is available in that Unit to be provided. Redaction of the clinician details in particular leads to loss of information about the seniority of the clinicians providing care and importantly making key clinical decisions and redaction of the hospital details leads to loss of information about the level of services which are provided. This has important implications in terms of assessing the quality of care in terms of deciding what services are available and what can care can thus reasonably be expected to be delivered, who is making critical decisions, whether any inappropriate decisions were inappropriate simply because the staff member was too junior to be making critical decisions, that a more senior member of staff should have been called or whether decisions were inappropriate despite senior staff being on hand.\n\nThe second reason is that going forward the MBRRACE-UK budget will be cut by 15% and it is therefore necessary to find practical ways of making savings whilst still being able to deliver the whole national Maternal, Newborn and Infant Clinical Outcome Review Programme. This proposal will reduce by more than half the time taken to redact each set of case notes."]
["Applicant Organisation Name","National Perinatal Epidemiology Unit (NPEU), University of Oxford on behalf of the MBRRACE-UK collaboration"]
["Contact Name","Professor Jennifer J Kurinczuk"]
["Address","Professor of Perinatal Epidemiology"]
[null,"University of Oxford"]
[null,"Old Road Campus, Headington, Oxford"]
["Postcode","OX3 7LF"]
["Telephone","01865 289717"]
["Email","Jenny.kurinczuk@npeu.ox.ac.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","• Maternal deaths: all women who die during pregnancy or up to 12 months after the end of their pregnancy regardless of how their pregnancy ends (mortality surveillance and confidential enquiries);\n• Maternal morbidity: a sample of women who experience particular, very serious, illness in pregnancy or related to pregnancy who survive; some of these conditions are maternal 'near-miss' events (topic-specific morbidity confidential enquiries);\n• Late fetal losses: all women whose pregnancy ends as a late fetal loss (late miscarriage), that is, the baby is delivered between 22+0 and 23+6 weeks of pregnancy showing no signs of life (mortality surveillance);\n• Late terminations of pregnancy: all women whose pregnancy ends as a termination of pregnancy resulting in an outcome from 22+0 weeks of gestation onwards (mortality surveillance);\n• Stillbirths: all women whose pregnancy results in a stillbirth (24+0 weeks gestation onwards) (mortality surveillance and topic-specific confidential enquiries);\n• Neonatal deaths: all women and their babies where the baby dies in the first 28 days after birth or without ever having been discharged from hospital (mortality surveillance and topic specific confidential enquiries);\n• Perinatal morbidity and mortality: a sample of babies who experience particular, very serious, illness in the first few weeks after birth who may or may not survive; this involves reviewing the care provided to a sample of women during pregnancy and their babies after birth (topic-specific mortality and morbidity confidential enquiries).\nWe use the term ‘perinatal’ to generally distinguish the ‘baby’ work from the maternal work. \n\n"]
["Description of confidential patient information used","Access was requested to name, postcode, NHS number, date of birth and date of\ndeath in relation to maternal deaths, maternal morbidity, late fetal losses, late\nterminations of pregnancy, stillbirths, neonatal deaths and perinatal morbidity and\nmortality. Data sources include NHS Trusts, Health and Social Care Information Centre (HES), Office of National Statistics (death, birth and stillbirth certificate information) and NHS numbers for Babies (NN4B)"]
["National Data Opt \nOut Status","The Secretary of State for Health and Social Care decision maker, on advice from the CAG, has supported a request to defer the National Data Opt Out. As such, the National Data Opt Out does not need to be applied for this activity"]
["S251 Class(es)","□","Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","The Commissioner and Funder of this research is the Healthcare Quality Improvement Partnership (The full protocol for the programme is given as Attachment A; the funding confirmation letter is attached as Appendix B of the protocol).\n\nThe NPEU Information Guardian is the Director of the Unit, Prof Jennifer Kurinczuk (letter given as Attachment B)\n"]
["Status","Supported"]
[]
["Next Review Date","2023-05-01"]
["Notes","Amendment supported 12 August \n\nTo extend the duration of ‘s251’ support, in order to include patients treated between 1 January 2009 and 30 September 2025\n\nAmendment supported 21 April 2022 to defer applying the National Data Opt-Out in relation to 15/CAG/0119\n\nSpecific conditions of support\n\n1.\tProvide updated posters and website text within one month of this outcome letter.\n\nCondition met June 2022\n\n2.\tProvide an update to the inclusion of information in maternity notes/app, to use of charities and the Royal College of Midwives, as well as consideration of the use of social media within six months of this outcome letter. Condition met 01 November 2022 \n\n3.\tThis outcome confirms a change to the original conditions of support. The National Data Opt-Out is not to be applied to patients included in the activities specified in 15/CAG/0119. \n\n4.\tA local patient objection mechanism must continue to be used\n\n\n10 August 2021 - Amendment supported to extend the duration of support to enable MBRRACE-UK to include patients treated between 1 January 2009 and 30 September 2022, for MBRRACE-UK to continue to hold the identifiable data about all women who died as a maternal death from 1 January 2009 onwards until 30 September 2022, to disclose confidential patient information to NHS Digital in order for them to link with Hospital Episode Statistics (HES) and for NHS Digital to provide the applicant with a dataset regarding women who have died and all the women who have survived, and to obtain an additional data item from the Personal Demographic Service (PDS) data held by NHS Digital\n\n11 December 2020 - Amendment supported\nThe amendment, to enable MBRRACE-UK to continue to hold the identifiable data about all women who died as a maternal death from 1st January 2009 onwards until a trusted third party arrangement can be identified or until 30 September 2021 (whichever is earlier), is conditionally supported, subject to compliance with the standard and specific conditions of support.\n\n1. Please provide an update regarding the progress of finding a trusted third party to retain the dataset in six months from the date of this letter. Condition met as part of 2021 annual review, confirmed by email 06 August 2021\n\n2. Confirmation of suitable security arrangements via IG Toolkit submission. \n\nConfirmed – Nuffield Department of Population Health, University of Oxford (EE133863-MSD-NDOPH-NDPH) has a confirmed ‘Standards Met’ grade on DSPT submission 2019/20 and University of Leicester - College of Life Sciences (EE133832-CMBSP) has a confirmed ‘Standards Met’ grade on DSPT submission 2018/19 (Confirmed by check of the DSPT tracker 09 December 2020). \n\nAmendment (Approved 19/07/2018)\n- Background\nThe Confidentiality Advice Team undertook an assessment of the 2018 annual review for the application, which was received in April 2018. A query was raised around the retention of an administrative data set which held confidential patient information in relation to all reported maternal deaths since 01/01/2009, as it was unclear whether the existing support extended to retention of this data.\nIt was clarified that the original application had specified that this information would be retained; however, it was explained that a trusted third party, NHS Digital, would be approached for this retention. This retention arrangement had not yet been secured with NHS Digital which prompted the applicant to submit the proposed amendment to extend the scope of support so that the MBRRACE-UK collaboration could retain this data set on a long-term basis.\nAmendment Request\nThis amendment application sought support to enable the MBRRACE-UK collaboration to retain the administrative database which holds confidential patient information in relation to all maternal deaths which have been recorded since 01/01/2009.\nThe applicant proposed ongoing retention on a long-term basis, but is currently seeking support up to 30 September 2021 in line with the current funding of the overarching MBRRACE-UK programme.\nSpecific Conditions of Support\n1. Support is recommended for the ongoing retention, by the University of Oxford (on behalf of HQIP), of the maternal deaths dataset for a period of one year from date of this letter. During this time HQIP and the applicant are required to explore and establish a more appropriate arrangement/organisational location for the ongoing retention of this data. A report is required by the time of next annual review, at the latest, on the substantive progress which has been made to achieve this.\n2. Confirmation from the IGT Team at NHS Digital of suitable security arrangements via Information Governance Toolkit (IGT) submission (Confirmed – University of Oxford – National Perinatal Epidemiology Unit shows a satisfactory reviewed reported grade, V14.1, 2017/18).\n\nAmendment Request (Approved 23/11/2016)\nThe amendment was submitted to clarify the purposes of the application as it had become apparent to the applicant, that the aims, whilst fully detailed in the protocol, were not completely detailed in the CAG application form.\nThe primary purposes for the application are non-research, surveillance and quality improvement purposes with the goal of reducing maternal and perinatal deaths. The applicant had detailed in the protocol the capacity for the secondary use of the data collected for research purposes.\nThe amendment application is to rectify this oversight and to explicitly include the secondary use of the data collected by MBRRACE-UK for other purposes, including research, within the application.                                                                                                                                       Specific conditions of support 23/11/2016\n1. Confirmation that the MBRRACE-UK website has been updated with the secondary use purposes of the collected dataset\n                                                                                                                        \nAmendment as of 22/06/2015:\nThe amendment request detailed accessing confidential patient information from the National Confidential Enquiry into Suicide and Homicide (NCISH) at the University of Manchester, rather than directly from Mental Health Trusts, due a number of difficulties accessing the required information from Trusts. It was noted that there was now limited time for the inclusion of the cases in the confidential enquiries which were currently underway and for which the applicant was reaching the reporting stage. Whilst NCISH could provide questionnaires only, rather than case notes, the applicant confirmed that receiving copies of the questionnaires relating to these specific cases would allow the case assessors access to at some information about the perinatal mental health care of the patients to review and ensure that any additional lessons for improvements in care were not missed.\n                                                                                                                         Application considered at CAG meeting on 26/03/2015\nSpecific conditions of support \n1. Confirmation from the IGT Team at the Health and Social Care Information Centre of suitable security arrangements via Information Governance Toolkit (IGT) submission. Confirmed \nUpdate: 15/08/2016 - An amendment to limit the extent of the redaction which is carried out for the perinatal confidential enquiries was approved. Redaction will be solely limited to the complete removal of the mother and baby identifiers, and project team will not redact the hospital and clinician details."]

{"sheet":"A0081","index":59,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0081"]
["Reference","CAG 5-05(a)/2014"]
["Other Refs"]
["Application Title","Southend-on-Sea integrated care pioneer"]
["Application Summary","Support has been provided for a period of twelve months (from 13/04/2015) for the following six purposes and to allow for processing of data via a data processor (currently PI Benchmark) on behalf of the applicants. \n1. Analysing the health of a population (“risk stratification for commissioning”)\n2. Targeting additional preventive care interventions, [for example the support of a community matron], to high-risk patients (“risk stratification for case finding”).\nPurpose 1 and 2 above are subject to the conditions set out in CAG 7-04 (a)/2013\n3. Identify high cost individuals whose care may need to be reviewed by the multidisciplinary team with whom they have a legitimate relationship\n4. Identify those with abnormal or perceived abnormal outcomes (for example emergency admissions) for alternative interventions\n5. Commission new services in an affordable manner by identifying populations of clients with certain constellations of features\n6. Assess whether new services are having the desired effects\n"]
["Applicant Organisation Name","Southend CCG and Southend Borough Council"]
["Contact Name","Melanie Craig, Accountable Officer Southend CCG and Simon Leftley, Southend on Sea Borough Council"]
["Address","NHS Southend Clinical Commissioning Group"]
[null,"5-15 Harcourt House, Harcourt Avenue"]
[null,"Southend on Sea, Essex"]
["Postcode","SS2 6HE "]
["Telephone","01702 313787"]
["Email","samantha.shepherd3@nhs.net"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","The adult population of Southend-on-Sea (previous 3 years medical history only)"]
["Description of confidential patient information used","The primary care and commissioning data extracts approved in the S251 support for risk stratification purposes - CAG 7-04(a)/2013 plus GP data set with agreed exclusions (The extract will include such data items as NHS number, age, postcode, date of death, gender, ethnicity, coded main conditions, prescribing and referral data and known allergies, but not all GP data will be included and there is a list of nationally agreed Read Codes covering the most sensitive conditions that will be excluded. Free text will also be excluded.) Admitted patient care, Elective admission list, Outpatients, Future out patients, Accident and emergency."]
["S251 Class(es)","□","Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Department of Health"]
["Status","Supported"]
[]
["Next Review Date","2015-10-22"]
["Notes","Application considered at CAG meeting on 24/07/2014\n\nSpecific conditions of support:\n1. The six purposes listed in the ‘application summary’ section are approved. All other purposes are removed from scope.\n \n2. Approval for the purpose of risk stratification will be subject to the existing conditions set out in relation to the risk stratification application CAG 7-04 (a)/2013. \n\n3. Effective design, harmonisation and implementation of handling and respecting patient objections to be in place prior to any data flows taking place. \n\n4. Following final approval, a report to be provided to CAG at a six-month interval on progress, issues, patient objections and communications\n\n5. Removal of any text from all documentation (now and future) stating that approval or agreement has derived from the HRA Confidentiality Advisory Group. Correct approval/agreement must reflect the approver (the Secretary of State for Health).\n\n6. The applicants to make available to any person who requests it the full application documentation (subject to any other existing legal constraints) \n\n7. Age to be used for the purposes of analysis instead of full date of birth\n8. Any purposes relating to innovation should be submitted as an individual application on a case by case basis as these develop as currently the scope is unknown and it would be unclear what could be supported.\n9. Evaluation of benefits realised through new approach to be provided at annual review stage (no later than 12 months following date of final approval) \n10. Any new contract should contain provision to ensure separation of the pseudonymisation key from the data processor\n11. The communication plan as specified to be implemented.  \n12. GP letter to be revised in line with advice from Dr Calland and the CAG.\n13. Confirmation from the HSCIC IG Delivery team that those processing data have achieved a satisfactory IG toolkit level. \n"]

{"sheet":"A0082","index":60,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0082"]
["Reference","CAG 10-02(b)/2015"]
["Other Refs"]
["Application Title","2015 Inpatients Survey"]
["Application Summary","This application from Care Quality Commission set out the purpose of the 2015 Inpatient Survey. The inpatient survey would include all 154 eligible trusts who would be asked to conduct the survey with preparations expected to begin in August 2015. Approximately 1,250 patients would be included at each trust.\nAmendment request-07/08/2015-The applicant confirmed that within the original application only one mailing file containing confidential patient data were requested from NHS trusts. During the time the application was completed and prior to the conclusion of the NHS trusts briefings, it was assumed that NHS trusts would be able to submit ICD10 (International Classification of Diseases) chapter codes in one mailing file according to the proposed timetable.\nFollowing the Co-ordination Centre’s NHS trust briefing they received feedback from some NHS trusts that they would be unable to meet the proposed timetable due to the request for ICD10 chapter codes. The Co-ordination Centre estimate at least 30% of trusts (this is a very conservative estimate and we expect it to be even higher) will be unable to meet the sample deadline. Three out of four of the CQC’s approved contractors that conduct the Inpatient survey on behalf of NHS trusts, have told the Co-ordination Centre that they would be unable to compile the sample in the timeline proposed as they do not complete coding of discharged patients until two or three weeks post-discharge.\nThe applicant submitted an amendment request in order to resolve this issue, whereby a request would be submitted to the trusts who were unable to supply ICD-10 codes with their original sample file provide the Co-ordination Centre with a second mailing file that would contain only two variables: the patient record number (anonymised, unique identifier) and the ICD10 chapter code. The applicant would request that trusts provide the second sample file after their original sample has been approved and securely transferred to the Co-ordination Centre.\nThe applicant also included within the request that all NHS trusts that decide to send the ICD10 chapter codes with the second mailing need to submit the codes to the Co-ordination Centre. These include NHS trusts that operated the survey in-house, as well as those that used CQC approved contractors. All second mailing files would be submitted directly to the Co-ordination Centre and will not be seen by approved contractors."]
["Applicant Organisation Name","Care Quality Commission"]
["Contact Name","Paul Williamson"]
["Address","Care Quality Commission"]
[null,"Finsbury Tower"]
[null,"103-105 Bunhill Row"]
["Postcode","EC1Y 8TG"]
["Telephone","020 7448 9046"]
["Email","Karen.Hallt@cqc.org.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Inpatients aged 16 years old or over who were discharged from acute and specialist NHS hospitals in July* 2015 (and earlier for smaller trusts), having had one overnight stay in hospital. The guidance instructs trust to exclude:\n• deceased patients \n• children or young persons aged under 16 years at the time of sampling \n• obstetrics/maternity service users, including spontaneous miscarriages  \n• patients admitted for planned termination of pregnancy \n• psychiatry patients  \n• day cases \n• private patients (non-NHS) \n• any patients who are known to be current inpatients patients without a UK postal address\n• Any patient known to have requested their details are not used for any purpose other than their clinical care, including those responding to posters displayed on hospital wards referring to the survey (the guidance manual requests that all responses to posters are logged and used for this purpose). \n* Please note, the 2015 survey will involve patients sampled from just one month, standard across all trusts. An explanation for this change is given in section M."]
["Description of confidential patient information used","Administration of the Inpatient survey requires NHS trusts to share two distinct sets of information with their approved contractor:\n\nThe mailing file is used to address questionnaires to the appropriate person. It contains:\n\n A standardised unique identifier code, to be constructed as survey identifier, trust code followed by a whole number (consecutive across the sample of 1,250 patients from each trust), e.g. IP15XXXnnnn where XXX is the trusts 3 digit trust code and nnnn is the 4 digit serial number relating to sampled patients, e.g., 0001-0850. \n Title (Mr, Mrs, Ms, etc.) \n First name \n Surname \n Address Fields \n Postcode (where available)\n NHS Site code on discharge\n"]
["S251 Class(es)","□","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"□","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","NHS England (Having taken over the responsibility for the national survey programme from the Department of Health on 1st April 2013)."]
["Status","Supported"]
[]
["Next Review Date","2016-05-28"]
["Notes","Application considered at CAG meeting on 15 January 2015.\nSpecific conditions of support\n\n1. Information in surveys and patient letters should be provided which informs patient about the right to object to future and current surveys and that their information will be shared with other organisations such as NHS England and Department of Health. It was confirmed that the following text would be included within the covering letter “The data will also be shared with the Health and Social Care Information Centre, or other organisations, working on behalf of Department of Health or NHS England for the purpose of generating these indicators.”\n\n2. Confirmation from the IGT Team at the Health and Social Care Information Centre of suitable security arrangements via Information Governance Toolkit (IGT) submission. IGTK confirmed for Picker, Capita Business Services Ltd, Quality Health and Patient Perspective.\n"]

{"sheet":"A0083","index":61,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","0083"]
["Reference","15/CAG/0148"]
["Other Refs"]
["Application Title","Improving Care in the NHS"]
["Application Summary","We request the patient level Hospital Episode Statistics (HES) data to support our programme of national clinical audits and service evaluations that examine the quality of care delivered by the English NHS.  We will use HES data and linked HES-ONS mortality data to produce information on clinical practice patterns and patient outcomes for English NHS organisations, using HES as either a standalone source of national healthcare data or in combination with data from national clinical audits.  The information will be produced at an appropriate aggregate level to support quality assurance activities within these organisations (such as benchmarking), as well as at a national and regional level to support policy makers and commissioners.\nWe will use HES data to identify patient groups of interest, and then describe trends and variation in the number of patients treated, their case-mix, the treatments given and outcomes of care. Patient groups will be defined either in terms of their clinical characteristics (specified diagnoses and/or procedures) or in terms of clinical outcomes/events such as death, birth, or a treatment complication (e.g. postoperative bleeding).  We will also use HES in combination with data collected by national clinical audits.  HES data will be used to estimate the number of patients eligible for inclusion in the audits, which enables levels of participation to be monitored, and we will use HES to validate important data items collected by the audits (e.g. type of procedures, and reporting of outcomes).\nThe use of HES-ONS linked mortality data will allow the inclusion of information about deaths which occur after discharge from hospital (and which would otherwise not be available from HES data alone).  This will produce a more complete picture of health care outcomes for organisations and patients.\nWe plan to link the HES data and the HES-ONS linked mortality data to patient data collected by the national clinical audits.  Linked HES-audit data will provide additional details on comorbidity, complications and further treatments, and will enable more accurate information to be produced on the quality of NHS care than would be possible from the separate datasets.  (Any such applications for s251 support for data linkage will be made on an individual project basis separately from this application.)  \n"]
["Applicant Organisation Name","The Royal College of Surgeons of England"]
["Contact Name","Mr David Cromwell"]
["Address","The Royal College of Surgeons of England"]
[null,"Clinical Effectiveness Unit"]
[null,"35-43 Lincoln’s Inn Fields"]
["Postcode","WC2A 3PE"]
["Telephone","020 7869 6609"]
["Email","lcopley@rcseng.ac.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"Y","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"Y","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Patient groups will be defined either in terms of their clinical characteristics (specified diagnoses and/or procedures) or in terms of clinical outcomes/events such as death, birth, or a treatment complication (e.g. postoperative bleeding).  "]
["Description of confidential patient information used","Access was requested to:\n• Demographic data: HES generated unique identifier, age at admission, month and year of birth, postcode district of residence, sex, ethnicity, measures of socio-economic deprivation, dates of admission, and discharge, elective/urgent admission, discharge destination including in-hospital death).\n• Diagnostic Data: diagnostic codes based on the ICD-10 classification\n• Procedure Data: procedure codes and corresponding dates\n• Geographical Data: NHS Trust, NHS region and current electoral ward\n• Critical Care Data: dates of start and end of high dependency/ITU care, type of care\n• Maternity data: baby’s date of birth, birth weight, and gestational age, baby’s sex, place of delivery, number of previous pregnancies. \n• HES data and ONS Morality data linkage: event and date of death after discharge from hospital, cause of death based on ICD-10 classification\n"]
["S251 Class(es)","□","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","The Royal College of Surgeons of England"]
["Status","Supported"]
[]
["Next Review Date","2023-06-26"]
["Notes","Application considered at CAG meeting on 05 June 2015.\nSpecific conditions of support \n1. Update on security audits and full report to be included within annual review submission. \n2. Confirmation from the IGT Team at the Health and Social Care Information Centre of suitable security arrangements via Information Governance Toolkit (IGT) submission. Confirmed 27th April 2015. \n\n"]

{"sheet":"A0084","index":62,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0084"]
["Reference","15/CAG/0005"]
["Other Refs"]
["Application Title","Research to identify measures of quality and safety of healthcare"]
["Application Summary","This application from Imperial College London set out the purpose of the establishment of two databases. The first database would include a monthly and annual pseudonymised extract of Hospital Episode Statistics (HES) from the Health and Social Care Information Centre (HSCIC) on English NHS hospitals for the purpose of research. Data from this database would be provided to the Dr Foster Unit at Imperial College in a pseudonymised format.\nThe second database would hold a limited set of identifiable fields including NHS number and local patient ID to allow acute provider trusts to identify their own patients contributing to mortality alerts or other quality and safety alerts for the purpose of case note audits and mortality reviews.\nA recommendation for class 4 and 6 support was requested to cover disclosure of confidential patient information from the Health and Social Care Information Centre (HSCIC) to Imperial College London."]
["Applicant Organisation Name","Imperial College London"]
["Contact Name","Professor Paul Aylin"]
["Address","Dr Foster Unit"]
[null,"School of Public Health"]
[null,"Imperial College London, 3 Dorset Rise"]
["Postcode","EC4Y 8EN"]
["Telephone",2075943334]
["Email","p.aylin@imperial.ac.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population"]
["Description of confidential patient information used","Access was requested to monthly and annual extracts of HES, including Hospital Consultant Code, General Practitioner Code and Referring Practitioner Code and NHS number, Local Patient ID (LOPATID) and date of death (these three data items would be included on the second database only)"]
["S251 Class(es)","□","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"□","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Imperial College London"]
["Status","Supported"]
[]
["Next Review Date","2021-07-30"]
["Notes","29/07/2019: Amendment supported to change the location of the server equipment which hosted the project database to a new Imperial College facility located at the Virtus data centre. This is covered by the Imperial College London, Faculty of Medicine, School of Public Health (Primary Care and Public Health, Dr Foster Unit) DSPT submission. NHS Digital confirmed the Standards Met had been via email 07 June 2019. \n\nThis application was first considered at the CAG meeting held on 15 January 2015, subsequently at a CAG meeting on 26 March 2015 and via sub-group discussion. \n1. An amended version of appendix G should be provided.\n2. The research database must be used for medical research purposes only.\n3. It should be ensured that historical data processed under PIAG 2-07(d)/2007 is irreversibly pseudonymised in line with this application. This should be carried out as soon as possible, please confirm when this is complete. New identifiable data processed under CAG [15/CAG/0005] should be retained for a maximum of three years after which it should be destroyed or irreversibly pseudonymised on a rolling basis.\n4. It should be ensured that all patient information is as coherent as possible with clear instructions to allow patient objection.\n5. Confirmation from the IGT Team at the Health and Social Care Information Centre of suitable security arrangements via Information Governance Toolkit (IGT) submission. Confirmed 22 April 2015.\n6. Confirmation of a favourable research ethics committee opinion. Confirmed"]

{"sheet":"A0085","index":63,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","0085"]
["Reference","15/CAG/0107"]
["Other Refs"]
["Application Title","Improving Cardiac Arrest Recognition and Effectiveness (ICARE)"]
["Application Summary","This application from University of Central Lancashire set out the purpose of exploring whether the recognition of, and response to, out of hospital cardiac arrest by English ambulance services can be improved.\n1) Identifying the tape recorded call handler conversations that resulted in a particular range of ambulance service response categories for suspected out of hospital cardiac arrest.\n2) Identifying the tape recorded call handler conversations that resulted in a particular range of ambulance service response categories not related to out of hospital cardiac arrest.\n3) Listening to conversations and identify the key “indicator” words from the person who made the call that were highly indicative of out of hospital cardiac arrest.\n4) Listening to conversations and identify the key “indicator” words from the person who made the call to explore if similar key “indicator” words are used for both out of hospital"]
["Applicant Organisation Name","University of Central Lancashire"]
["Contact Name","Professor Caroline Watkins"]
["Address","University of Central Lancashire"]
[null,"Clinical Practice Research Unit"]
[null,"Preston"]
["Postcode","PR1 2HE"]
["Telephone","01772 893646"]
["Email","clwatkins@uclan.ac.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"Y","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"□","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","There are two groups of patients for which access to their 999 calls is required in order to calculate estimates of sensitivity and specificity of call handler diagnosis of out of hospital cardiac arrest: \n\ni) 999 calls made regarding patients who contacted (or someone contacted the emergency services (North West Ambulance Service) on their behalf for out of hospital cardiac arrest, during a 12 month period (1/07/2013 to 30/06/2014). \nii) 999 calls made regarding patients who contacted (or someone contacted the emergency services (North West Ambulance Service) on their behalf for a non-cardiac arrest related condition as defined below.  \n\nIt is proposed that all cases of OHCA from hospital records will be identified. These cases will be matched with their ambulance records and these records will be searched to find those cases where the call handler has not recognised an OHCA. All the codes used for these cases (false negatives) will be identified and listed. All the cases where any of these false negative codes have been used will be identified. These cases will be matched with their hospital records to identify the final diagnosis. These cases will include the correct recognition of a non-OHCA by call handlers (true negatives).\n"]
["Description of confidential patient information used","Access was requested to recordings of 999 calls from the North West Ambulance Service."]
["S251 Class(es)","□","Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"□","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","The name of the Sponsor and Caldicott Guardian for North West Ambulance Service is Professor Kevin Mackway-Jones.\nThe name of the Sponsor for the University of Central Lancashire is Mrs Denise Forshaw.\n"]
["Status","Supported"]
[]
["Next Review Date","2016-08-03"]
["Notes","This application was considered at the CAG meeting held on 19 February 2015.\n1. Please confirm how the application was defined as non-research. It was confirmed that the activity was now considered to be research and that an application to a Research Ethics Committee was made. A favourable opinion for the study was received on 7 July 2015.\n2. Please ensure that information in relation to the processing is displayed on relevant websites and this includes details of how to object. Details of the information to be provided were submitted.\n3. Please confirm the scope of the application and cohort size in line with the above. The applicant confirmed that the matching of the non-telephone call data would be carried out by an individual who was employed by the NHS Trust at which the matching was undertaken and that these individuals would have permission to access the data through their normal working role. Therefore, the applicant confirmed that they were not seeking support for this aspect of the study.\n4. Confirmation from the IGT Team at the Health and Social Care Information Centre of suitable security arrangements via Information Governance Toolkit (IGT) submission. Confirmed."]

{"sheet":"A0086","index":64,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0086"]
["Reference","15/CAG/0173"]
["Other Refs"]
["Application Title","Quality Health and NHS England: National Cancer Patient Survey"]
["Application Summary","This non-research application from NHS England and Quality Health sets out the purpose of conducting a survey in order to collect and analyse data to secure continuous improvement for provider performance, assess local improvements and provide an overview in cancer patient experience, improve provider quality and to enable patients to make informed choices on where to go for cancer treatment. The applicant is seeking section 251 support in order for NHS Acute Trusts to disclose confidential patient information to Quality Health and for Quality Health to liaise with Trusts in order for patient questionnaires to be sent to patients under cover of appropriate Trust letter headed paper."]
["Applicant Organisation Name","Quality Health"]
["Contact Name","Mr Daniel Ratchford"]
["Address","Unit 1, Holmewood Business Park"]
[null,"Chesterfield Road, Holmewood"]
[null,"Chesterfield, Derbyshire"]
["Postcode","S42 5US"]
["Telephone","01246 856263"]
["Email","daniel.ratchford@quality-health.co.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Adult inpatients and day case patients with a primary diagnosis of cancer who have been admitted to an acute or specialist NHS Trust during April, May and June 2015."]
["Description of confidential patient information used"," Access was requested to name and address including full postcode, NHS number, gender and ethnicity. Access is also requested to year of birth, admission and discharge dates, admission type, ICD10 code, speciality code and referring CCG.\n"]
["S251 Class(es)","□","Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","NHS England"]
["Status","Expired"]
[]
["Next Review Date","2016-08-19"]
["Notes","Old applications for the National Cancer Patient’s Experience survey: Acute and Specialist trust surveys of inpatients and day cases.\n\nThe currently supported reference is 21/CAG/0084\n\nSupport can be expired as of 17 August 2022.\n\nAll data files for the Cohort have been deleted and relevant database fields for all patients have been overwritten with null values and are no longer accessible to any staff.\n\nThis application was considered at the precedent set CAG meeting held on 31 July 2015.\n\nSpecific conditions of support \n1. Confirmation from the IGT Team at the Health and Social Care Information Centre of suitable security arrangements via Information Governance Toolkit (IGT) submission. Confirmed [18/03/2015]"]

{"sheet":"A0088","index":65,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","0088"]
["Reference","15/CAG/0170"]
["Other Refs","16/CAG/0003 / 15/CAG0197"]
["Application Title","Holding patient identifiable data within the National Head and Neck Cancer Audit (HANA)"]
["Application Summary","This application from Saving Faces, the Facial Surgery Research Foundation sets out the purpose of conducting a commissioned audit on behalf of the Healthcare Quality Improvement Partnership (HQIP). The HANA database was to assess and improve the quality of services and the outcomes achieved by head and neck cancer treatments across the NHS. The data would provide comparative information to patients, commissioners and regulators of healthcare professionals. HANA will collect data on pre-operative health status and co-morbidity, details of the treatments provided and the principle healthcare professionals responsible, and also the development of any recognised complications following surgical and non-surgical treatments delivered within NHS hospitals. \nThe applicant was seeking s251 support in order for confidential patient information to be disclosed to Dendrite Clinical Systems Ltd for the purpose of data linkage, retaining the linked datasets (includes identifiers) as part of a database for audit purposes, and to anonymise the data for Saving Faces to analyse. \nThe applicant was seeking s251 support in order to disclose NHS numbers to the Health and Social Care Information Centre (HSCIC) for the purpose of checking mortality data to determine whether the patient was deceased and the associated cause of death. \nThe applicant was also seeking s251 support in order for HSCIC to disclose the DHANO historical data set, which includes confidential patient information, to Dendrite Clinical Systems Ltd, for the purpose of data linkage and retaining the data within the database.\nA recommendation for class 1, 4, 6 support was requested to allow access to an authorised user for the purpose of extracting and anonymising and linking patient identifiable information obtained from one or more source. \n"]
["Applicant Organisation Name","Dendrite Clinical Systems"]
["Contact Name","Neal McCann"]
["Address","Information Governance Manager"]
[null,"Station Road"]
[null,"Henley on Thames, Oxfordshire"]
["Postcode","RG9 1AY"]
["Telephone","44 1491 411 288"]
["Email","nmccann@e-dendrite.com"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Patients with a diagnosis head and neck cancer in England and Wales"]
["Description of confidential patient information used","First name, last name, NHS number, date of birth, postcode, date of treatment, date of death"]
["S251 Class(es)","□","Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"□","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Healthcare quality Improvement Partnership (HQIP)"]
["Status","Expired"]
[]
["Next Review Date","2017-09-25"]
["Notes","June 2022 - Support Expired\nSuperseded by 17/CAG/0073.\n\nSecretary of State decision\n2. See Application 15/CAG/0197 for the prospective elements.\n\nSpecific conditions of support \n1.  The prospective elements of the study have been deferred for consideration at the next meeting.\n2. Confirmation from the IGT Team at the Health and Social Care Information Centre of suitable security arrangements via Information Governance Toolkit (IGT) submission. Confirmed 15/07/2015.\n\nThis application was considered at the CAG meeting held on 06 August 2015.\n\n\n"]

{"sheet":"A0089","index":66,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0089"]
["Reference","15/CAG/0158"]
["Other Refs"]
["Application Title","The fracture liaison service database"]
["Application Summary","This application describes a database, commissioned by the Health Care Quality Improvement Partnership (HQIP), to support the implementation of the Department of Health’s Prevention Package for Older People by collecting high quality data to raise the standard of care and improve the patient pathway consistently with the Quality Outcomes Framework in primary care.\nA recommendation for class 1,4 & 6 support was requested to cover access to data from The Fracture Liaison Service (FLS) and Office of National Statistics (ONS) and Hospital Episodes Statistics (HES) data from the Health and Social Care Information Centre in relation to men and women aged 50 years and over with a fragility fracture."]
["Applicant Organisation Name","Healthcare Quality Improvement Partnership (HQIP)"]
["Contact Name","Laura Thomas, Project manager (Fracture Liaison Service Database)"]
["Address","The Spine"]
[null,"2 Paddington Village"]
[null,"Liverpool"]
["Postcode","L7 3FA"]
["Telephone","+44 (0)203 075 1511"]
["Email","laura.thomas@rcp.ac.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Men and women aged 50 years and over with a fragility fracture"]
["Description of confidential patient information used","Access was requested to name, postcode, NHS number, date of birth and date of death. Name would be used to verify NHS number only and would then be deleted."]
["S251 Class(es)","□","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"□","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","HQIP"]
["Status","Supported"]
[]
["Next Review Date","2023-10-15"]
["Notes","Amendment supported 28 October 2022 \nTo change a data item collected within the dataset for the Fracture Liaison Service Database from gender to sex\n\n10 December 2021 - Amendment supported to clarify clinical data items collected within the dataset for the Fracture Liaison Service Database.\n\n25 November 2019: Amendment supported to revise the clinical dataset collected for patients included within the database. This would include details of whether the patient died prior to assessment, abbreviated mental test scores and wider information on bone therapies. Data on periprosthetic and ‘other’ fractures would no longer be collected. The amendment did change the items of confidential patient informaiton being processed or the supported data flows. \n\nApplication considered at CAG meeting on 09 July 2015.\nConditions of support\n1. Applicant to include a report on the retention period at time of next annual review.\n2. The applicant should report on the completeness of valid NHS number at annual review stage to ensure that this additional step and collection of name was necessary.\n3. An updated patient information sheet to be provided, with a change from “other health organisations” to “NHS health care organisations”.\n4. Confirmation from the IGT Team at the Health and Social Care Information Centre of suitable security"]

{"sheet":"A0900","index":67,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","0900"]
["Reference","15/CAG/0144"]
["Other Refs"]
["Application Title","Getting It Right First Time Programme"]
["Application Summary","This application from Royal National Orthopaedic Hospital NHS Trust set out the purpose of a service evaluation project to determine the specific causes of medical negligence claims as surgical specialities through detailed case analysis from law firm data from the NHS Litigation Authority (NHSLA) panel firms. The project aims to improve the provision of patient care and the management of health services in the surgical specialities. The project aims to identify poor practice and influence national guidelines to address this poor practice.\n\nA recommendation for classes 5 and 6 support was requested to cover access to data from NHSLA panel law firms in relation to patients who have made a claim against an NHS Trust in relation to surgical care since 2003.\n"]
["Applicant Organisation Name","The Royal National Orthopaedic Hospital NHS Trust (RNOH)"]
["Contact Name","Mr John Machin"]
["Address","C/O Rosemary Radband,"]
[null,"The Royal National Orthopaedic Hospital,"]
[null,"Brockley Hill, Stanmore,"]
["Postcode","HA7 4LP"]
["Telephone"]
["Email","John.t.machin@gmail.com"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Patients who have made a claim against an NHS trust in relation to surgical care which has been registered with the NHSLA since 2003."]
["Description of confidential patient information used","Patient age, NHSLA claim ID number, description of medical negligence claim including dates of incident, dates of case creation and outcome of case, damages paid and case costs. This is all data we already possess but now require it to cross reference new data."]
["S251 Class(es)","□","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"□","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"□","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","The Royal National Orthopaedic Hospital, Stanmore"]
["Status","Supported"]
[]
["Next Review Date","2015-10-14"]
["Notes","This application was considered at the CAG meeting held on 04 June 2015. \nSpecific conditions of support \n\n1. Please ensure that information in relation to the project, with details about how to object, are available on the NHSLA website. \n2. Please confirm the individuals that will have access to the requested data and confirm the duty of confidentiality owed by these individuals, the information governance training that they had undertaken and the governance arrangements in place to ensure accountability to the Information Custodian. \n3. Confirmation from the IGT Team at the Health and Social Care Information Centre of suitable security arrangements via Information Governance Toolkit (IGT) submission. Please see security review requirement section of the HRA website: http://www.hra.nhs.uk/resources/confidentiality-advisory-group/confidentiality-advisory-group-cag-application-advice/ and contact Exeter.helpdesk@nhs.net with any queries. \n"]

{"sheet":"A0901","index":68,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0901"]
["Reference","15/CAG/0200"]
["Other Refs"]
["Application Title","2016 Community Mental Health Survey"]
["Application Summary","This application from the Care Quality Commission (CQC) set out the purpose of carrying out the 2016 mental health survey, one of the surveys within the NHS national patient survey programme. The survey data would be used by NHS trusts and Clinical Commissioning Groups (CCG’s) in local improvement activities. CQC would use data as part of its regulatory and surveillance activities and other relevant functions and data would also be shared with NHS England and the Department of Health. \nA recommendation for class 5 and 6 support was requested to cover access to confidential patient data from mental health trusts providing mental health services to one of four ‘approved’ contractors, to enable contractors to send out questionnaires. \nPlease note that this study achieved most recent approval under the reference CAG 9 (PS1) 2014 – 2015 Mental health survey. Changes to the application since last year have been highlighted within the application form. Substantive changes may be referred to a full review at a CAG meeting. \nThe fundamentals did not appear to deviate significantly from what had been approved previously other than the review of the “approved contractor status” which was currently underway. The applicant confirmed that the contractor for the Co-ordination Centre for 2015 will be confirmed in November 2015 and relevant updates will be sent to the committee at that time.  \n\n"]
["Applicant Organisation Name","Care Quality Commission"]
["Contact Name","Mr Paul Williamson"]
["Address","Finsbury Tower"]
[null,"103-105 Bunhill Row"]
[null,"London"]
["Postcode","EC1Y 8TG"]
["Telephone"]
["Email","Paul.williamson@cqc.org.uk "]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","People aged 18 and over who had been in contact with NHS mental health services in the three month period, 1 September 2015 to 30 November 2015, and who were receiving specialist care or treatment for a mental health condition, including those who receive care under the Care Programme Approach (CPA). \nThe survey guidance instructs trusts to exclude:\n• Anyone seen only once for an assessment (For example, those who were seen by a duty worker or a psychiatrist for a single assessment.) \n• Anyone primarily receiving drug & alcohol services \n• Anyone primarily receiving Learning Disability services \n• Anyone receiving specialist forensic services \n• Anyone receiving psychological treatments from IAPT services \n• Anyone primarily receiving Chronic Fatigue/ME services \n• Anyone primarily receiving Psychosexual Medicine (sexual dysfunction) services \n• Anyone receiving Gender Identity services \n• Anyone seen for assessment only through a liaison service, even if they were seen more than once\n• Any service users who are under 18 years of age on the date the sample is drawn \n• Any service users who are known to be current inpatients at the time of drawing the sample \n• Any service user known to have requested their details are not used for any purpose other than their clinical care \n\n"]
["Description of confidential patient information used","Administration of the community mental health survey requires NHS trusts to share two distinct sets of information with their approved contractor:\n\nThe mailing file is used to address questionnaires to the appropriate person. It contains:\n\n Trustcode\n A standardised unique identifier code, to be constructed as survey identifier, trust code followed by a whole number (consecutive across the sample of 850 service users from each trust), e.g. MH16XXXnnnn where XXX is the trusts 3 digit trust code and nnnn is the 4 digit serial number relating to sampled service users, e.g., 0001-0850. \n Title (Mr, Mrs, Ms, etc.) \n First name \n Surname \n Address Fields \n Postcode \n\nThe sample data file is used to link demographic data to the survey responses, to aid analysis and to enable checks to be carried out for any errors in how the sample was drawn. This file contains:\n Trustcode\n The unique identifier code (as above)\n Year of birth \n Gender \n Ethnic category \n Day of last contact \n Month of last contact \n Year of last contact \n CPA status \n CCG code\n Mental Health Care Cluster Code\n\nThe survey guidance instructs the separation of these two files before they are submitted to the approved contractor (guidance section 4.3 and 9.8).\n\nThis latter sample file is also shared with the Co-ordination Centre to enable centralised checks on the appropriateness of samples drawn, as described under section (k).  For clarity, please note that the Co-ordination Centre do not receive any names or addresses.\n\nMental Health Care Cluster data will be submitted by trusts directly to the Co-ordination Centre and will not be shared with approved contractors. Trusts will be instructed in the updated version of the guidance, and reminded via ebulletins and a letter from CQC, to send this to the Co-ordination Centre at the same time as they send their sample to their approved contractor. The sampling checklist and declaration will include a commitment that the trust has removed care cluster from the data shared with their approved contractor. The Approved Contractor will not open data from the trust without reviewing the sampling checklist and declaration to ensure trusts have followed processes, and this will be communicated to approved contractors via an e-bulletin and at the planned briefing event (see section k). \n\nThe same method of transfer will be used as in 2015 and is detailed below:\n\nTrusts submitting data to the Co-ordination Centre\nMental Health Care Cluster information will be sent by trusts directly to the Co-ordination Centre. The file provided by trusts will contain only the unique ID, the Trust code and the care cluster code for all service users in the original survey sample. The Co-ordination Centre will link this to the final data set using the unique ID. This final data set will include the sample file information for respondents and non-respondents, and response data for respondents. \n\nTrusts will be provided with clear instructions on how to safely transfer the data which will be done using a secure FTP server:\n• Each trust will be issued their own username and password unique to them (normally restricted to one contact at the trust who prepared the file). Passwords will be provided over the telephone. \n• Files placed on the FTP will also be password protected and trust contacts will be asked to provide the password to the Co-ordination Centre over the phone.\n\nStoring the data at the Co-ordination Centre:\nStoring the full respondent level dataset (sample information and response data):\nonly nominated staff at the Co-ordination Centre will have access to the folder on the FTP server containing the cluster code data. Files will be removed from the FTP site and saved securely on the network for which access is restricted to the Research and Policy team.\n\nThe Co-ordination Centre does not have access to any mailing data (names and addresses) so there is no risk of linkage between cluster code data and personal information.\n\nTransferring the data to CQC:\nData will be transferred to CQC using the secure FTP server. A designated contact at CQC will have their own username and password unique to them. This password will be provided over the telephone. Files placed on the FTP will also be password protected and the password will be provided to CQC over the telephone.\n\nStoring the data at CQC:\nThe surveys team at the CQC will hold the full respondent level dataset sent by the Co-ordination Centre, containing sample file information for the full sample and response data where submitted. This will be sent securely to CQC and stored on the CQC network in a folder restricted only to members of the survey team and the statistician team.\n\nData containing the care cluster code will not be shared internally within CQC. Should we receive any requests for analysis, this would be processed by CQC statisticians, and only anonymous results aggregated to trust level shared. \n\nSharing the data\nData will be shared with NHS England who will use the results to understand patients’ experiences of NHS services and to drive improvements. We have received written confirmation from NHS England that they do not require cluster code and this will therefore be removed from the data set shared with them. \n"]
["S251 Class(es)","□","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"□","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","NHS England (Having taken over the responsibility for the national survey programme from the Department of Health on 1st April 2013).\n"]
["Status","Supported"]
[]
["Next Review Date","2016-12-16"]
["Notes","This application was considered at precedent set CAG meeting held on 23 October 2015. The application was considered via the Precedent Set process under criteria 11 – repeat projects.\n1. Confirmation from the IGT Team at the Health and Social Care Information Centre of suitable security arrangements via Information Governance Toolkit (IGT) submission. Confirmed 27/08/2015.\nAs the above conditions have been accepted and/or met, this letter provides confirmation of final approval. I will arrange for the register of approved applications on the HRA website to be updated with this information.\n"]

{"sheet":"A0902","index":69,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","0902"]
["Reference","15/CAG/0210"]
["Other Refs"]
["Application Title","Child Health Clinical Outcome Review Programme"]
["Application Summary","The aim of the Child Health Clinical Outcome Review Programme is to review the organisation of care and clinical practice to identify potentially remediable factors in the care provided for children and young people. The programme will look at the quality of the delivery of care.\nThe programme comprises two studies; one focusing on adolescent and young peoples’ mental health and one on chronic neurodisability. A report of the findings will be published and widely disseminated. The commentary and recommendations made in the report will be based on peer review of the data submitted.\nSupport under the Regulations is requested to be able to extract and collect identifiable data on a large sample of cases from which the applicant will take random samples for in-depth case note review, and to be able to request data from different care providers such as secondary care and GPs, to build a picture of the quality of care being provided."]
["Applicant Organisation Name","National Confidential Enquiry into Patient Outcome and Death (NCEPOD)"]
["Contact Name","Dr Marisa Mason"]
["Address","Ground Floor"]
[null,"Abbey House"]
[null,"74-76 St John Street"]
["Postcode","EC1M 4DZ"]
["Telephone","020 7251 9060"]
["Email","mmason@ncepod.org.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","For each study a separate sample of patients will be selected for inclusion for retrospective review.\nMental Health:  young people aged between 11 to 25 years who have self-harmed or have an eating disorder, depression and/or anxiety.\nChronic neurodisability: children and young people up to the age of 25 years old with cerebral palsy.\n"]
["Description of confidential patient information used","Access was requested to patient case notes in order to extract patient identifiable information.\nInformation to be extracted is;\nNHS number, hospital number, date of birth, gender, date of admission, source of admission, name of admitting clinician/operating clinician, date of discharge/death,\ndate of procedure, type of procedure (OPCS code), diagnosis (ICD10 code), name and postcode."]
["S251 Class(es)","□","Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","The work is commissioned on behalf of NHS England, Welsh Government, DHSSPS Northern Ireland, Scottish Government and public hospitals in Jersey, Guernsey and the Isle of Man"]
["Status","Expired"]
[]
["Next Review Date"]
["Notes","Support expired 08 July 2021\n\nThis application was considered by a sub-committee meeting via correspondence following cancellation of the CAG meeting scheduled on 10th December 2015.                                     1. Clarification about the difference in approach between the data collection taking\nplace in Northern Ireland and that in England and Wales, including justification for using identifiable information in England and Wales. Justification for the approach in England and Wales provided 01/02/2016\n2. Clarification on the scope of support requested;\na. When will the data collection be taking place? Response 01/02/2016. Collection to start March 2016 support is restricted to collection covering a 6 week period and not 6 months as outlined in the response letter, an amendment will be required if this is for a 6 month period.\nb. Collection of case notes – is this from the site where patients were treated and any others expected to provide care in the pathway or are details of the whole random sample to be sent to all organisations delivering care? Response 01/02/2016. Case notes will be available to treating sites only and not across sites.\nc. Previous notes – please provide justification for this and clarify how it will affect the current care which is under investigation. Response 01/02/2016. Updated application received to cover this request.\nPage 3 of 6\nSupport is restricted to case notes covering a 3 year period and not 5 years as had originally been outlined in the protocol.\nd. Pilot study – is support required for this? Response 01/02/2016, support is not required for the pilot\n3. Attachment B_ STUDY TYPES UNDERTAKEN BY NCEPOD – please advise\nwhich are relevant to this application? Response 01/02/2016. Updated document provided\n4. Confirmation that the organisations involved will be reminded of their\nresponsibilities, as Data Controller, under the DPA Fair processing to notify patients about the use of their personal information. Confirmed 01/02/2016"]

{"sheet":"A0903","index":70,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0903"]
["Reference","15/CAG/0178"]
["Other Refs"]
["Application Title","Investigating the epidemiology of Female Genital Mutilation (FGM) in children under the age of 16 in the United Kingdom and the Republic of Ireland using surveillance methodology."]
["Application Summary","This application from Central and North West London NHS FT / Royal College of Paediatrics and Child Health (RCPCH) set out the primary aims to identify the number of new cases of childhood FGM presenting to doctors; to identify the circumstances of FGM, including where it is being done and by whom, and to identify the reasons for referral and so inform referral guidelines and identify groups that may be missed. The information generated will be used to plan health services, educate professional and produce guidelines. The study will run over a 13 month period.\n\nA recommendation for class 1, 3, 5 and 6 support was requested to cover disclosure of confidential patient information from NHS Trusts to the Royal College of Paediatrics and Child Health and Document Capture Company in their capacity as data processors."]
["Applicant Organisation Name","Central and North West London NHS FT"]
["Contact Name","Dr Deborah Hodes"]
["Address","University College Hospital"]
[null,"6th Floor, 250 Euston Road"]
[null,"London"]
["Postcode","NW1 2PG"]
["Telephone","0203 4475241"]
["Email","deborah.hodes@nhs.net"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"Y","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"□","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Any child aged under 16 years not already known to have FGM who was: \na) Seen because of suspected FGM \nb) Seen for another conditions and FGM is suspected following assessment\nc) Has a genital piercing or\nd) Has had a female cosmetic genital surgery including labiopolasty\n\nThe total estimated cohort size is 150."]
["Description of confidential patient information used","Date of birth, NHS number, Hospital ID and sector level postcode were requested."]
["S251 Class(es)","□","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"Y","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"□","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"□","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Royal College of Paediatrics and CHild Health\n"]
["Status","Expired"]
[]
["Next Review Date","2017-10-16"]
["Notes","This study followed a standard BPSU methodology and was published in 2020.\n\nThis epidemiological surveillance study identified a very low number of children with FGM in the UK, and these numbers\nare consistent with other sources of data. Most children in this study had had FGM performed prior to arrival in the UK, with\nonly a few cases in British children. Where FGM was identified the majority was classified as WHO type 1 or 2 or 4, which\ncan be difficult for doctors, even specialists, to identify, and was associated with few complications. There was only one criminal prosecution in the 2-year\nstudy period. These results are consistent with very little FGM happening in the UK, but do not exclude the possibility that paediatric FGM maybe continuing on a hidden level.\n\nAmendment Request 24/02/2017\nThe original application outlined the data collection period to commence for 13 months in order to identify children with Female Genital Mutilation, the incidence of the condition and the clinical management. However, the lower end of the expected number of cases has been reported.\nThe applicants requested an extension for a further 12 months, plus 12 month follow up which would take the total surveillance period up to 24 months. The applicants had justified the extension to confirm the incidence of FGM in comparison to the number of cases seen in the first year. Confirmation of this through a second year of surveillance, plus the additional follow up period will strengthen the view that the level of incidence is truly lower than expected.\nThe data collection and reporting methodology would remain unchanged.                              Specific Conditions of Support 24/02/2017\n1. Correct information on the project website around the nature of the CAG recommendation of approval under the Regulations to clarify that this is not an ethical review.\n2. Confirmation of suitable security arrangements via IG Toolkit submission. (Confirmed - Royal College of Paediatrics & Child Health, Version 13 2015-16, reviewed satisfactory grade at 71%).                                      This application was considered at the CAG meeting held on 17 September 2015."]

{"sheet":"A0904","index":71,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0904"]
["Reference","16/CAG/0009"]
["Other Refs"]
["Application Title","Risk of Malignancy after Gamma Knife Stereotactic Radiosurgery, Ten Years On"]
["Application Summary","This application from the National Centre for Stereotactic surgery at Sheffield teaching hospital NHS Trust set out the purpose to evaluate the risk of malignant transformation by matching their treated patient population with national cancer register statistics and evaluating survival data. An earlier study was completed by in 2005 and assessed the risks in the initial 5014 UK patients, with 30,000 years of follow-up. The applicant now wishes to re-run this study to strengthen the data by including further follow-up for the original 5014 patients and all UK patients treated by them in the last ten years. This will now total around 12,000 patients and approximately 75,000 years of patient follow-up. Due to the large sample size and the fact that some patients will have died and others will have moved so that up to date contact information will not be held the researchers feel it impractical to contact all of them to gain consent.\n\nThe study will enable a more thorough understanding of the long-term risks associated with stereotactic radiosurgery treatment and therefore the ability to give the patients more robust statistical risk of malignant changes possible in the long-term post treatment.\n\nS251 support was requested to allow the disclosure of NHS numbers to ONS for case matching. Dates and cause of death, will be requested to establish overall survival data and evaluate whether the cause of death was attributable to a treatment-related malignancy. Cancer registrations of these treated patients will also be requested so that a comparison can be made with the exact location and dose of treatment to establish if they could be caused by the high-dose, single fraction radiation delivered to treat their (usually benign) condition. The applicant has confirmed with the HSCIC that the previous application accessed data under the NHS central register application.\n\nA recommendation for class 1, 4, 5, and 6 support was requested to cover access to an authorised user for the process of extracting and anonymising the information, for linking patient identifiable information obtained from more than one source, and for auditing, monitoring and analysing patient care and treatment."]
["Applicant Organisation Name","The National Centre for Stereotactic Radiosurgery, Sheffield Teaching Hospitals NHS Foundation Trust"]
["Contact Name","Ms Alison Grainger"]
["Address","The National Centre for Stereotactic Radiosurgery"]
[null,"The Royal Hallamshire Hospital, C Floor"]
[null,"Glossop Road, Sheffield, South Yorkshire"]
["Postcode","S10 2JF"]
["Telephone","0114 271 3576"]
["Email","Alison.grainger@sth.nhs.uk / Alison.grainger@nhs.net"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"Y","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","All UK patients treated by their department up until 31/12/2015"]
["Description of confidential patient information used","Access was requested to NHS numbers, dates and cause of death, cancer registrations"]
["S251 Class(es)","□","Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,"Y","Class II - present or past geographical locations of patients "]
[null,"Y","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Sheffield Teaching Hospitals NHS Foundation Trust"]
["Status","Expired\n"]
[]
["Next Review Date","2018-03-22"]
["Notes","Expired\n\nApplicant has confirmed in September 2022 that ‘s251’ support no longer required as all confidential patient information has been deleted since 2017. \n\nThe benefits for the public from being able to accurately evaluate the real risk of this malignant development after Gamma Knife Stereotactic Radiosurgery (GKSRS), will aid accurate patient counselling and consent. This should improve patient care both in the UK and internationally as patients worldwide will benefit from strengthened and updated information on the real risk of malignant induction or transformation after radiation treatment for mainly benign disease.\n\n\nThis application was considered at the precedent set CAG meeting held on 15 January 2016.\n\n1. The applicant was requested to provide further information on what they are doing and continue to do to engage with patients in the delivery of and informing them about this study - this could be through website, relevant patient groups and charities. Confirmed 03/03/2016\n2. The applicant was requested to give a precise date of when the data will be deleted following the end of the study. Confirmed 03/03/2016\n3. The applicant was requested to provide further information on how patients will be informed about or be allowed to opt out. Confirmed 03/03/2016\n4. It is mentioned that work would be undertaken in a busy office although data will be kept securely. The applicant was requested to confirm how data would be kept securely whilst people are working on this within the busy office, please provide further information. Confirmed 03/03/2016\n5. The applicant was requested to provide detail of the other classes of support that were required. Confirmed 03/03/2016\n6. Confirmation from the IGT Team at the Health and Social Care Information Centre of suitable security arrangements via Information Governance Toolkit (IGT) submission. Confirmed 04/03/2016"]

{"sheet":"A0905","index":72,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0905"]
["Reference","16/CAG/0010"]
["Other Refs"]
["Application Title","Wales Cancer Patients’ Experience Survey 2016"]
["Application Summary","This application from the Welsh Government detailed the Wales Cancer Patients’ Experience Survey 2016. The application used an identical survey method to that of the Welsh Cancer Patients Experience survey 2013: Acute and specialist hospital survey of inpatients and day cases (ECC 3-03(PR2)/2013), as well as other Cancer Patient Experience Surveys.\n\nThe survey would involve Picker Institute Europe sending questionnaires to all adult inpatients and day-case patients with a primary diagnosis of cancer who had been admitted to an acute or specialist NHS Hospital in Wales during March 2015- March 2016 inclusive. Identifiable data including name, address and NHS number would be disclosed from NHS trusts to Picker Institute Europe. In addition; sex, ethnicity, year of birth, admission and discharge dates, ICD10 code and speciality code were requested. Also: treating board, board of residence or commissioning board and admission type (inpatient or day case).  \n\nA recommendation for class 2, 4, and 6 support was requested to select and contact patients to gain their consent to link patient identifiable information obtained from more than one source and to allow access to an authorised user for one or more of the above purposes."]
["Applicant Organisation Name","Wales Government (sponsor) and Quality Health (implementation provider). Macmillan Cancer Support provides logistical and financial support to the survey."]
["Contact Name","Dr Reg Race"]
["Address","Quality Health, Unit 1, Holmewood Business Park"]
[null,"Chesterfield Road, Holmewood"]
[null,"Chesterfield, Derbyshire"]
["Postcode"," S42 5US"]
["Telephone","01246 856623"]
["Email","reg.race@quality-health.co.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"Y","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"Y","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Adult inpatients and day case patients with a primary diagnosis of cancer who have been admitted to an acute or specialist NHS Hospital in Wales during June 2012- March 2013 inclusive"]
["Description of confidential patient information used","Access was requested to name, address, NHS number, sex, ethnicity, year of birth, admission and discharge dates, IC10 code, speciality code, treating board, board of residence or commissioning board and admission type"]
["S251 Class(es)","□","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"Y","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"□","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Wales Government"]
["Status","Supported"]
[]
["Next Review Date","2017-03-22"]
["Notes","This application was considered at the precedent set CAG meeting held on 15 January 2016. The application was considered via the Precedent Set process under criteria 11 – repeat projects.\n\n1. Please provide further details on where the key for the pseudonymised data is to be kept and who can access. Confirmed 2/03/2016\n2. Please provide further details on what will be done to effectively anonymise the data. Confirmed 2/03/2016\n3. Confirmation from the IGT Team at the Health and Social Care Information Centre of suitable security arrangements via Information Governance Toolkit (IGT) submission. Confirmed 26/02/2016\n\nThe applicant confirmed that support can be expired as of 4 August 2022."]

{"sheet":"A0906","index":73,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0906"]
["Reference","16/CAG/0018"]
["Other Refs"]
["Application Title","Evaluation of Bowel Cancer Screening Helper Kit"]
["Application Summary","This application from Leeds City Council set out the purpose to evaluate whether posting a bowel cancer screening helper kit to every individual invited to take part in the bowel cancer screening programme (approximately 12,500 patients over a three month period) alongside their normal invitation to Bowel cancer screening will increase uptake of bowel cancer screening across Leeds. This project is based on the successful Cancer Research UK (CRUK) pilot in London that took place earlier this year. The findings of the London pilot indicate a potential increase in uptake of between 2-6%, although it is important to note that, in the London pilot, the increase in uptake varied depending on the characteristics of the sample (for example whether they have been screened before).\n\nCurrently patients are invited to participate in the national screening programme (if they are aged 60 – 74 years) via an invitation letter, mailed to the patients registered UK address, with a screening test card distributed to the same address (approximately 2 weeks after initial invite). The North East Bowel Screening hubs (who are responsible for the invitation process using the North East Hub dashboard in OBIEE) has insufficient capacity to conduct the helper kit mailing process so is it proposed that Leeds City Council receive details of patients invited via secure Filezilla file transfer daily from the North East hub. Leeds City Council will then process the data and produce mail merge excel document to enable mailing of the helper kit direct to patients. This application proposes the improvement of the existing bowel screening product by introducing a more user friendly kit, provided to individual patients by Leeds City Council through the post. Patients will receive the kit approximately 5 days after they receive their initial invitation to take part in the screening programme and prior to them receiving their screening test card.\n\nThis application was booked on to the previous meeting under reference 15/CAG/0187 but withdrawn due to agreements with the anticipated third party contractor for the mail out not being agreed. It had been decided by the applicant that Leeds City Council would conduct the mail out rather than a third party.\n\nA recommendation for class 6 support was requested to allow access to an authorised user for one or more of the above purposes."]
["Applicant Organisation Name","Head of Intelligence & IMT Public Health, Office of the Director of Public Health"]
["Contact Name","Nicola Stephens"]
["Address","Leeds City Council"]
[null,"2nd Floor West"]
[null,"Civic Hall, Leeds"]
["Postcode","LS1 lUR"]
["Telephone","0191 445 5680"]
["Email","marie.oallowav@ohnt.nhs.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"Y","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","All adults aged 60-74yrs who are invited to Bowel screening during a three month period.\nNo randomisation is being applied to this project."]
["Description of confidential patient information used","Name, address & full postcode of the cohort\nDate screening invitation letter sent out"]
["S251 Class(es)","□","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"□","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Public Health England"]
["Status","Supported"]
[]
["Next Review Date","2017-02-22"]
["Notes","This application was considered at the CAG meeting held on 11 February 2016.\n\n1. Letter of recommendation from the Caldicott Guardian (or equivalent). Confirmed 22/02/2016\n2. Confirmation from the IGT Team at the Health and Social Care Information Centre of suitable security arrangements via Information Governance Toolkit (IGT) submission. Confirmed 22/02/2016"]

{"sheet":"A0907","index":74,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0907"]
["Reference","15/CAG/0185"]
["Other Refs"]
["Application Title","Antibiotics Post Surgery in Endocarditis 2004 – 2013 "]
["Application Summary","This application from Guys & St Thomas NHS Foundation Trust set out the purpose to establish the relapse rate of infective endocarditis within one year in patients treated with heart valve surgery at the centre over a 10 year period. The hospital statistics provided will fill in data gaps for deceased patients and patients with unknown history within one year after treatment.\n\nSupport under the Health Service (Control of Patient Information) Regulations 2002 was requested to allow the disclosure of confidential patient information from Guys and St Thomas’ to the Health and Social Care Information Centre (HSCIC) in order for the HSCIC to link to the Hospital Episode Statistics (HES) database and provide a linked file containing identifiable patient information back to the applicant. This application was considered at the CAG meeting held on 26 November 2015."]
["Applicant Organisation Name","Guys & St Thomas NHS Foundation Trust"]
["Contact Name","Dr John Klein"]
["Address","Department of Infection"]
[null,"5th Floor North Wing, St Thomas’ Hospital"]
[null,"London"]
["Postcode","SE1 7EH"]
["Telephone","020 7188 3109"]
["Email","John.klein@gstt.nhs.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","To ensure accurate individual patient identification of 46 patients."]
["Description of confidential patient information used","NHS number, gender, postcode and date of birth"]
["S251 Class(es)","Y","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Guys & St Thomas NHS Foundation Trust"]
["Status","Supported"]
[]
["Next Review Date","2017-04-22"]
["Notes","This application was considered at the Confidentiality Advisory Group meeting 26 November 2015.\n\n1. Appropriate summary information to be made available on the website so relevant patients can register a concern. Confirmed 08/02/2016\nMembers noted that the language used on the website was not particularly clear or patient focused. Please amend the information made available to patients using lay language this should not be overly medically focussed. Please provide an update and amended copy at the 1st annual review.\n\n2. Confirmation from the IGT Team at the Health and Social Care Information Centre of suitable security arrangements via Information Governance Toolkit (IGT) submission. Confirmed 25/03/2016"]

{"sheet":"A0908","index":75,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","0908"]
["Reference","16/CAG/0041"]
["Other Refs"]
["Application Title","2016 Adult Inpatient Survey"]
["Application Summary","This application from Care Quality Commission set out the purpose of the 2016\nInpatient Survey. The inpatient survey would include all eligible trusts who would be\nasked to conduct the survey with preparations expected to begin in August 2016. All\ntrusts will draw a sample of patients according to set criteria, and follow\nstandardised materials and procedures for all stages of the survey. Administration\nof the Inpatient survey requires NHS trusts to share two distinct sets of information\nwith their approved contractor; a mailing fila and a sample data file.\nThe end product from this survey will be a set of aggregate statistical data that does\nnot contain patient identifiable information. This statistical dataset is used for a wide\nvariety of purposes to support ongoing improvement in overall patient experience:\nThe survey data is used extensively by NHS trusts and Clinical Commissioning\nGroups (CCG’s) in local improvement.\n\nApproximately 1,250 patients would be included at each trust. These are inpatients\naged 16 years old or over who were discharged from acute and specialist NHS\nhospitals in July 2016 (and earlier for smaller trusts), having had one overnight stay\nin hospital."]
["Applicant Organisation Name","Picker Institute Europe"]
["Contact Name","Chris Graham"]
["Address","Buxton Court"]
[null,"3 West Way"]
[null,"Oxford"]
["Postcode","OX2 0JB"]
["Telephone","01865 208118"]
["Email","nick.pothecary@PickerEurope.ac.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Approximately 1,250 patients would be included at each trust. These are inpatients\naged 16 years old or over who were discharged from acute and specialist NHS\nhospitals in July 2016 (and earlier for smaller trusts), having had one overnight stay\nin hospital."]
["Description of confidential patient information used","Name address and postcode, ethnicity, year of birth, date and time of attendance, CCG code, ICD10 code, NHS site code on admission or discharge, main specialty on discharge, whether admission from Treatment Centre, route of admission."]
["S251 Class(es)","□","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"□","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","NHS England "]
["Status","Supported"]
[]
["Next Review Date","2017-05-04"]
["Notes","This application was considered at the Confidentiality Advisory Group sub-committee meeting 11 March 2016.\n\n1. Recommendation from the Caldicott Guardian (or equivalent). Confirmed 7/04/2016\n\n2. Confirmation from the IGT Team at the Health and Social Care Information\nCentre of suitable security arrangements via Information Governance Toolkit\n(IGT) submission. Confirmed 12/04/2016       \n                                                                                                                               Amendment 15 July 2016\n\nAn amendment was requested for access to additional data items with a change to the\nsampling methodology for the study. Access was requested to treatment function code.\nThis item of data will allow trusts to more accurately identify patients who are ineligible,\nparticularly patients who have been treated for planned termination of pregnancy. In\nprevious surveys, trusts had used “main specialty” to identify these patients, but there are\nproblems with the accuracy of these codes in terms of the actual treatment received in\ncertain cases. After trialling the collection of ‘treatment function’ code in 2016, the\napplicant would stop collecting ‘main specialty’ in 2017 onwards.\n\nThe “treatment function” data would also allow more accurate sub-group analysis of\nresults than “main specialty.” “Main specialty” is the specialty under which a consultant is\nregistered at the trust. So he or she may work in different specialties (obstetrics and\ngynaecology is a common example) but will be registered against one or the other – not\nboth.                                                                                                                                An amendment was received for a change to the data flows with a change to the sampling\nmethodology. Currently NHS trusts split patient name and address details out into a\n‘mailing file’ which is kept separate from their demographic information held in a ‘sample\nfile’. This process was introduced in 2014. During the 2015 Inpatient Survey however a\nserious error occurred, which would have been prevented had the contractor been able to\naccess one combined file. The error was reviewed alongside other evidence provided by\nthe approved contractors and for 2016, the separation of the sampling and mailing files\nwas recommended after they are submitted to the approved contractor. This change will\nmaintain the integrity of the resulting dataset, by reducing the chance of sampling and\nmailing files becoming desynchronised due to changes inadvertently made to one file and\nnot the other.\nThe amendment request also covered the implementation of this process across the 2016\nA&E survey as well as other patient surveys.                                                       "]

{"sheet":"A0909","index":76,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","0909"]
["Reference","16/CAG/0056"]
["Other Refs","(re-submission of 16/CAG/0005)"]
["Application Title","Learning Disabilities Mortality Review Programme"]
["Application Summary","This application from University of Bristol set out the purpose of the Learning Disability Mortality Review (LeDeR) Programme as a service improvement initiative. It was commissioned by the Healthcare Quality Improvement Partnership (HQIP) on behalf of NHS England.\n\nThe aim of the programme was to drive improvement in the quality of service delivery for people with learning disabilities (LD) and help to reduce premature mortality and health inequalities in this population. The remit of the LeDeR Programme was primarily to support local agencies to review deaths of people with learning disabilities and to use the learning gained to make improvements in the delivery of care. The LeDeR programme will develop and roll out a standardised process for reviews to support this local delivery, and provide strategic support for its implementation. In doing so, it will be building on the well-established practice in health and social care of conducting mortality reviews as a means of improving patient care.\n\nThe anonymised mortality case reviews will be collated and evaluated by the programme team to ensure that learning is being embedded in practice. This will be reported on annually. Reports on the findings of this work will be disseminated to regulators, policy makers, commissioners, service providers, practitioners and patient and family groups with the aim of supporting changes that improve the quality and safety of care for people with learning disabilities.\n\nThis application was a re-submission of 16/CAG/0005 previously reviewed at the 14th January 2016 CAG meeting."]
["Applicant Organisation Name","University of Bristol"]
["Contact Name","Dr Pauline Heslop"]
["Address","Norah Fry Research Centre"]
[null,"School for Policy Studies, University of Bristol"]
[null,"8 Priory Road, Bristol "]
["Postcode","BS8 1TZ"]
["Telephone","0117 3310973"]
["Email","Pauline.Heslop@bristol.ac.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","People with learning disabilities who have died"]
["Description of confidential patient information used"," Relating to people with learning disabilities: name of deceased person, date of birth, date of death, gender, NHS number, first 2 digits of postcode, ethnicity, gender, information about the circumstances leading to the death of the individual, including the person's medical history, details of diagnoses and treatments, contacts with services, the care and support that they have received prior to death, and their cause of death.\n Relating to the person’s next of kin/family: name of relative/next of kin, address, and relationship to the deceased."]
["S251 Class(es)","Y","Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","University of Bristol"]
["Status","Expired"]
[]
["Next Review Date"]
["Notes","Application expired on 31/05/2020 as HQIP is no longer the controller. New application established under reference 20/CAG/0067. \n\n11 October 2019: The applicant sought support to include the North East Commissioning Support Unit (NECSU) as a data processer and to amend the data flows to include the flow of confidential information to NECSU. The amendment was fully supported, subject to compliance with the standard conditions of support.\n\nAn amendment to extend the duration of support until 31 May 2020 was supported.\n\nAmendement Request (Approved 8/2/2018)\nThe amendment requests support for the following two changes:\n1. Redacted, rather than pseudonymised, information to be sent to Steering Groups – which would involve the sharing the initials and NHS number of the patient where necessary, plus the name of relevant professionals, agencies, organisations and care providers sufficient to enable recommendations to be addressed.\n2. The Learning Disability Mortality Review team to be able to store the data in this redacted form for the 10 year period.\n\nAmendment Request 03/01/2017\nThe amendment requested the following two changes to the existing supported project:\n1. Change to Data Flow – previously the applicants had shared NHS Numbers with the Office of National Statistics (ONS) in order to obtain the ICD-10 code for each person’s death. However, due to changes in ONS data flows, the applicants are now required to share data with NHS Digital in order to obtain the coding of death causes.\n2. Extension of Data Items and Retention – the current application provided support for the applicants to collect the first two digits of a deceased person’s postcode in order to identify any service improvements related to area based population. However, since undertaking the pilot stage of the programme, the applicants had found that the full postcode was required in order to use UK Data Service GeoConvert programme. The applicants indicated that once postcodes had been used to identify the area-based deprivation indices, the postcode would only be retained at district level, which the amendment was also requested to support.    \n\nSpecific conditions of support 03/01/2017\n1. Explore the potential for deprivation scoring to be undertaken by NHS Digital on the applicant’s behalf and the relevant information provided as part of the data download. Provide an update at the next annual review around the progress which has been made with this condition.\n2. Confirmation of suitable security arrangements via IG Toolkit submission - (Confirmed - Version 13 (2015-16) reported a reviewed satisfactory score at 91%).                                                                                                                                                                                           This application was considered at the CAG meeting held on 21 April 2016.\n1. Receipt of revised patient information. Clarification received 26/05/2016 and reviewed by the Chair\n2. Confirmation from the IGT Team at the Health and Social Care Information Centre of suitable security arrangements via Information Governance Toolkit (IGT) submission. Please see security review requirement section of the HRA website: http://www.hra.nhs.uk/resources/confidentiality-advisory-group/confidentiality-advisory-group-cag-application-advice/ and contact Exeter.helpdesk@nhs.net with any queries. Confirmed"]

{"sheet":"A0910","index":77,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0910"]
["Reference","16/CAG/0068"]
["Other Refs","(prev 16/CAG/0014)"]
["Application Title","Cancer Research UK (CRUK) bowel cancer screening\nendorsement mailing"]
["Application Summary","This application from Cancer Research UK set out the purpose of this request to facilitate\ntwo mailings of a targeted CRUK and NHS branded personalised bowel cancer screening\nendorsement direct mailings.\nThe overarching aim of the project was to increase participation of the Guaiac Faecal\nOccult Blood Test (gFOBT) i.e. the bowel cancer screening programme by raising\nawareness of the Bowel Cancer Screening Programme (BCSP) amongst the eligible\npopulation and reduce barriers to participation.\nThis project sets out to test the effectiveness of introducing an additional step in the\nbowel cancer screening programme call process (when combined with a supporting\nadvertising campaign) on increasing participation in the BCSP.\nThe project was informed by 2 previous pilots in London and Wales. These found that\nadvertising combined with direct mail (London pilot) and a highly targeted and\npersonalised version of direct mail (Wales pilot), were effective methods of improving\nuptake. This project will apply learning from both previous pilot projects, and has the\npotential to increase uptake beyond 9% in some groups. Each of the four participating\nbowel cancer screening hubs has confirmed their support for the project.\nA recommendation for class 4 and 6 support was requested to allow the disclosure\nof confidential patient information from 4 NHS Bowel Cancer Screening programme\nhubs to a third party data processor, Real Digital International, on a daily basis\n(week days only) between Monday 21 March 2016 to Friday 22 April (25 days)."]
["Applicant Organisation Name","Cancer Research UK"]
["Contact Name","Kathryn Weir"]
["Address","Health Campaigns and Marketing Team"]
[null,"Angel Building"]
[null,"407 St John Street. London"]
["Postcode","EC1V 4AD"]
["Telephone","02034695380"]
["Email","Kathryn.Weir@cancer.org.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Men and Women aged 60-74 yrs who are eligible for gFOBT (guaiac faecal occult blood test) screening during the project dates of Monday 21st March to Friday 22nd April 2016, are classified as either 'First Timers' or 'Non-Responders' and are living in one of the 27 target CCG areas."]
["Description of confidential patient information used","Name/ address, including postcode/NHS number"]
["S251 Class(es)",null,"Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,null,"Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Public Health England"]
["Status","Expired"]
[]
["Next Review Date","N/A"]
["Notes","Application Closed on 21/8/2017 \n\nThis application was considered at the Confidentiality Advisory Group meeting 26 May 2016.\n\n1. Confirmation from the IGT Team at the Health and Social Care Information Centre of\nsuitable security arrangements via Information Governance Toolkit (IGT) submission.\nPlease see security review requirement section of the HRA website:\nhttp://www.hra.nhs.uk/resources/confidentiality-advisory-group/confidentialityadvisory-\ngroup-cag-application-advice/ and contact Exeter.helpdesk@nhs.net with\nany queries. Provided\n\nAs the above conditions have been accepted and/or met, this letter provides\nconfirmation of final approval. I will arrange for the register of approved applications\non the HRA website to be updated with this information.                                                                                                                                                          Amendment update:                                                                                                                                                                                             A number of changes were proposed:\nThe launch of the original mail-out was delayed, so an extension to the time limit was requested to allow it to be completed. Only 1 Bowel Screening Cancer hub would participate, rather than 4 as originally suggested.\nBased on evidence that males were less likely to participate in the bowel screening programme than females, and that males may respond better to literature targeted specifically to them, new gender-specific letters had been produced.\nIn light of a recent directive from the Secretary of State, the Health and Social Care Information Centre (HSCIC) is required to establish and operate a system to process and uphold Type 2 Objections, and in accordance with the principles outlined. In light of this, the applicant was required to make an adjustment to the way in which data was extracted from the bowel screening programme, to ensure that Type 2 objections were upheld and that nobody who had registered an objection would receive a mail out. This would involve a small change to the data flow."]

{"sheet":"A0911","index":78,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0911"]
["Reference","16/CAG/0030"]
["Other Refs"]
["Application Title","HES data on sepsis for Christie Chemotherapy patients"]
["Application Summary","This application from The Christie NHS Foundation Trust set out the purpose to\nidentify risk factors for neutropenic sepsis amongst people receiving chemotherapy\nat the Christie Hospital.\n\nPatient’s undergoing chemotherapy that have a fever are encouraged to contact\nThe Christie patient hotline and any cases of suspected neutropenic sepsis are\nreferred to their nearest A&E. Around 2/3 of patients are referred to other hospitals.\nBecause The Christie does not have routine access to these hospital’s data, The\napplicant does not have a good understanding of what happens to those patients\nand require access to HES data to get this information.\n\nNHS numbers of the cohort will be sent to HSCIC and HES data will be sent back.\nThese data will be combined with data on patients admitted to the Christie with\ndiagnosis of febrile neutropenia or sepsis together with other data related to risk of\nsepsis for all Christie patients, all these datasets are already held by Christie. The\ncombined Christie held data and HES data will only be used to build and validate a\nmodel and decision making tool for predicting emergency admissions due to febrile\nneutropenia or sepsis amongst chemotherapy patients being treated at the Christie\nHospital. The use of this model in clinical practice to identify high risk patient will\nallow several interventions to take place amongst those patient.\n\nA recommendation for class 4, 5 and 6 support was requested to link patient\nidentifiable information form more than one source, for auditing monitoring and\nanalysing patient care and treatment and to cover access to an authorised user for\none or more of the above purposes."]
["Applicant Organisation Name","The Christie NHS Foundation Trust"]
["Contact Name","Tom Liptrot"]
["Address","Wilmslow Road"]
[null,"Manchester "]
[]
["Postcode","M20 4BX"]
["Telephone","0161 918 2060"]
["Email","tom.liptrot@christie.nhs.uk "]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","All patients treated with chemotherapy at the Christie between 2013 and 2015. This is around 13,000 patients."]
["Description of confidential patient information used","NHS Number, date of treatment, ICD-10 code, hospital of treatment from the following HES datasets:\n• Accident and emergency\n• Inpatient\n• Critical Care\n"]
["S251 Class(es)",null,"Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","The Christie NHS Foundation Trust"]
["Status","Supported"]
[]
["Next Review Date","2017-07-11"]
["Notes","This application was considered by the Confidentiality Advisory Group meeting 17 March 2016.\n\n1. Please provide further detail on who will analyse the data on receipt from HSCIC – will\nthis be a member of the care team? If someone outside the care team then only\npseudonymised data should be received from HSCIC to prevent disclosure.\nConfirmed 1/07/2016\n2. The privacy notice should be updated on the website to avoid reference to NIGB and\nthe method of opt-out for potential participants should be provided. Progress on this\nelement should be reported to CAG within 3 months’ time.\n3. Fair processing notices should be displayed at the relevant hospital. Confirmed\n1/07/2016\n4. Confirmation from the IGT Team at the Health and Social Care Information\nCentre of suitable security arrangements via Information Governance Toolkit\n(IGT) submission. Confirmed 14/03/2016"]

{"sheet":"A0912","index":79,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0912"]
["Reference","16/CAG/0006"]
["Other Refs"]
["Application Title","UK National Flap Registry (UKNFR)"]
["Application Summary","This application from the British Association of Plastic, Reconstructive and Aesthetic\nSurgeons sets out the purpose of setting up the UK National Flap Registry (UKNFR).\nCurrently, there are no figures on the numbers of flap reconstructive procedures that are\ncarried out in the UK for reconstruction of the head and neck, breast, trunk, upper and\nlower limb, perineal and after sarcoma resection. It is estimated that approximately 7000\nsuch procedures are carried out in the UK. These reconstructions are necessary for a\nvariety of indications such as tumour excision, after trauma, burns, or infection. The aim\nof the UK National Flap Registry Database is to collect information about all major flaps\nand assess the quality of care provided for these patients.\nThis audit would also allow for comparison of clinical performance with national and\ninternational standards, and provide useful data on changing trends in reconstruction.\nThe Registry s cross-speciality with input from plastic, maxillofacial and breast surgeons\nand is collaboration between 5 National Surgical associations: British Association of\nPlastic Reconstructive and aesthetic Surgeons (BAPRAS), British Association of Oral\nMaxillofacial Surgeons (BAOMS), British Association of Head and Neck Oncologists\n(BAHNO), Association of Breast Surgery (ABS) and British Society of Surgery of the\nHand (BSSH).\nIn line with Consultant outcome publication by HQIP, the long-term goal is to publish\nsurgeon specific outcomes for flap reconstruction procedures in England."]
["Applicant Organisation Name","British Association of Plastic and Aesthetic Surgeons"]
["Contact Name","Mr Peter Kalu, UKNFR Audit Lead "]
["Address","BAPRAS, Royal College of Surgeons of England"]
[null,"35-43 Lincoln’s Inn Fields"]
[null,"London"]
["Postcode","WC2A 3PE"]
["Telephone","020 7831 5161"]
["Email","secretariat@bapras.org.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","All patients undergoing reconstructive flap procedures (principally surgery for defects after cancer resection, trauma, infection and burns) in England and Wales."]
["Description of confidential patient information used","All patients undergoing reconstructive flap procedures (principally surgery for defects after cancer resection, trauma, infection and burns) in England and Wales."]
["S251 Class(es)",null,"Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,null,"Class VI - granting of access to data for purposes I-V"]
["Sponsor","British Association of Plastic, Reconstructive and Aesthetic Surgeons (BAPRAS) "]
["Status","Supported"]
[]
["Next Review Date","2023-07-11"]
["Notes","This application was considered by the Confidentiality Advisory Group meeting 14 January 2016.                                                                                                                                              1. Support would be for 12 months from the date of the final approval letter. Response\nreceived and accepted 19 March 2016\n2. In order for support to continue after the 12 months a clear exit strategy must be\nprovided at the first annual review for this application. This should detail;\na. What decision has been taken about moving to a consent model or for the\ninformation to be anonymised, pseudonymisation or combination of these\napproaches and when or if this is to be implemented?\nb. Provide details of the anonymisation or pseudonymisation standard and\nprocess for consent, copies of the consent materials should also be provided if\napplicable.\nc. Confirmation of exactly when support will no longer be required or\nprovide clear justification why support continues to be required. Response\nreceived and confirmed 19 March 2016\n3. Provide details of the process for managing access to the UKNFR for researchers and\nprovide details of what and how data will be made available for example, disclosure\nPage 3 of 5\nand access policies and assurance that there will be no further onward disclosure of\nidentifiable information. Received 19 March 2016.\n4. Provide a revised version of the patient information literature in clear lay language\nremoving clinical terms. Received 19 March 2016\n5. Provide details of how patients will be informed about this project Received 19 March\n2016\n6. Provide details of how patient objections will be managed, and how patients will be\ninformed about this process Received\n7. Confirmation from the IGT Team at the Health and Social Care Information Centre of\nsuitable security arrangements via Information Governance Toolkit (IGT) submission\nfor Dendrite Clinical Solutions. Please see security review requirement section of the\nHRA website: http://www.hra.nhs.uk/resources/confidentiality-advisorygroup/\nconfidentiality-advisory-group-cag-application-advice/ and contact\nExeter.helpdesk@nhs.net with any queries. Received 22 April 2016\nOn reviewing the responses, members felt that the responses did not fully cover their\nconcerns with regards to the patient information literature and patient notification.\nSpecifically;\n Patient information literature - members would like a poster to be provided\nwhich will inform patients about the registry and what will happen to their\ninformation, and about how they could opt out should they wish to do so. Poster\nprovided 4 May 2016\n How will patient be informed about the project – members were concerned\nthat it was not appropriate for the surgeon to inform patient at this point, as they\nare likely to be distressed and unreceptive. Members requested that you consider\nhow this can be managed more appropriately and advise how you will do this.\nClarification received 4 May 2016\n How to opt out – members were unclear when this was to happen and were\nconcerned that it was not appropriate before the surgery, as some patients will\nfeel unable to upset the doctor at this time. Also it was not clear how patients\ncould opt out. Members requested that patients are provided with contact details\nin order for them to be able to request to opt out. Contact should be possible by\nphone, email or in writing. Details of how patients can opt out should be provided.\nUpdated process provided 4 May 2016"]

{"sheet":"A0913","index":80,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","0913"]
["Reference","16/CAG/0071"]
["Other Refs","previously 16/CAG/0052"]
["Application Title","Benchmarking clinical quality healthcare measures"]
["Application Summary","This application from University Hospitals Birmingham Foundation Trust (UHB) set out the purpose of receiving monthly and annual extract of Hospital Episode Statistics (HES) and HES linked ONS (Office National Statistics) Mortality datasets from the Health and Social Care Information Centre (HSCIC). This will cover all English hospital activity.\nThe objective of this work is to support both University Hospitals Birmingham and other NHS Trusts and commissioners in the ongoing monitoring of clinical quality and organisational effectiveness. This purpose is fulfilled either:\n directly, i.e. the NHS Trust holds a subscription to use the HED system, or\n indirectly i.e. analytics are provided via a non-NHS organisation who holds a subscription to use aggregate small number suppressed data within the HED system. The applicant has reviewed the NHS standard (ISB 1523) relating to anonymisation and confirmed the system was compliant with this. This has also been corroborated by a recent audit from the HSCIC particularly in relation to small numbers suppression.\n through clinically-led bespoke reports based on retrospective, pseudonymised data which if requested are published in peer review journals with small numbers suppressed.\nThe level of data that can be viewed within the online analytical system depends on the access level of the named individual user and which organisation they are working for. Any modules within the system that use ONS data are not accessible to non-NHS users.\nIn summary, the types of users/data requestors and access controls in place are as follows:\n Non-NHS User: Access to aggregate level small number supressed analytics only formed using HES APC, OP or A&E data (but NOT ONS data).\n NHS but non-Hospital User: Access to aggregate level small number supressed analytics only formed using HES APC, OP, A&E and/or ONS linked data.\n NHS Hospital User: Access to aggregate level small number supressed analytics only formed using HES APC, OP, A&E or ONS linked data unless Caldicott authorisation is in place to allow access to low level details and/or sensitive items for their own organisation only.\nPatient information is only available to organisations who deliver the care and only if Caldicott Guardian approval has been received from that same organisation. In such instances a summary (but not all fields present in the raw HES or ONS data) will be provided at spell or patient level.\nA recommendation for class 4, 5, and 6 support was requested to cover access to identifiable patient information in order to conduct root cause analyses, both for internal governance and also to provide assurance to external regulatory authorities across a range of key indicators (ie. HSMR, SHMI)."]
["Applicant Organisation Name","University Hospitals Birmingham Foundation Trust (UHB)"]
["Contact Name","Michelle Lockett, Principle Clinical Informatician"]
["Address","University Hospitals Birmingham"]
[null,"Queen Elizabeth Hospital Birmingham, Mindelsohn Way"]
[null,"Edgebaston, Birmingham"]
["Postcode","B15 2GW"]
["Telephone","0121 371 2427"]
["Email","Michelle.lockett@uhb.nhs.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","All patients accessing acute hospital care"]
["Description of confidential patient information used","Confidential patient information will only be shared at episode/spell level with the organisation in which the patient received that care:\n• HES-ONS: Date of death\n• HES-ONS: Cause of death\n• HES-ONS: Place of death\n• HES: Consultant GMC code\n• HES: Local patient ID\n• HES: GP Practice Code"]
["S251 Class(es)",null,"Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","University Hospitals Birmingham NHS Foundation Trust."]
["Status","Supported"]
[]
["Next Review Date","2023-08-04"]
["Notes","Conditionally Supported - 07 August 2020\nNew conditions in letter sent. The following sets out the updated specific conditions of support applied against this application reference.\n\n1. University Hospitals Birmingham NHS Foundation Trust should achieve the security assurance action plan as agreed with NHS Digital.  All staff involved in processing information under this application reference should be aware of the precise scope of support and its boundaries and have successfully completed local security awareness training before processing any information under support.\n\nThis application was considered by the Confidentiality Advisory Group meeting 20 July 2016.\nSpecific Confiditons of Support                                                                                                                                1. Confirmation that identifiable data will not be held for over three years, or justification as to why de-identification in this time period is not reasonably practicable or is undesirable. Confirmed, 23/6/16\n2. Confirmation that identifiable data will only be processed for subscribers to the service. Confirmed, 23/6/16\n3. Provision of satisfactory patient notification materials, including a project specific patient objection mechanism. Provided, 23/6/16\n4. Provision of a patient and public involvement plan. This is to be reported against at the first annual review. Provided, 23/6/16\n5. Confirmation from the IGT Team at the Health and Social Care Information Centre of suitable security arrangements via Information Governance Toolkit (IGT) submission. Confirmed, version 13, 24/6/16."]

{"sheet":"A0914","index":81,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0914"]
["Reference","16/CAG/0028"]
["Other Refs"]
["Application Title","Use of administrative data for the evaluation of gynaecological cancer care services in England"]
["Application Summary","This application from Clinical Effectiveness Unit set out the purpose of this service evaluation to develop valid, clinically relevant, methodologically rigorous and technically robust performance indicators to access the quality of gynaecological cancer care in England.\nThe applicant wished to examine the potential of using linked Cancer Registry (CR), Hospital Episode Statistics (HES) and Office for National Statistics (ONS) data to describe the pattern of care on women diagnosed with gynaecological cancer in England, including the treatments they receive and their outcomes in terms of complications, readmissions and mortality. With this linked dataset the applicant will be able to determine how successfully these performance indicators could be used to compare quality between different levels of care including;\n Regional level/Cancer networks\n Hospital provider\n Individual consultant (e.g. surgeon level)\nA recommendation for class 4, 5 and 6 support was requested to cover access to an extract of linked patient level cancer data from the Public Health England (PHE) Office of Data Release (ODR)."]
["Applicant Organisation Name","The Royal College of Surgeons of England"]
["Contact Name","Dr Ipek Gurol-Urganci"]
["Address","Clinical Effectiveness Unit"]
[null,"The Royal College of Surgeons of England"]
[null,"35-43 Lincoln’s In Fields"]
["Postcode","WC2A 3PE"]
["Telephone","02079272152"]
["Email","ipek.gurol@lshlm.ac.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Approximately 10,000 cases of gynaecological cancers were diagnosed per year between 2000 and 2010. The anticipated size of the cohort is 160,000 (2000-2015)."]
["Description of confidential patient information used","Data from the ODR  in relation to date of death to LSHTM."]
["S251 Class(es)",null,"Specific Support"]
[null,"□","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","LSHTM"]
["Status","Supported"]
[]
["Next Review Date","2018-08-02"]
["Notes","Amendment Request (Approved 09/08/18)\nThis amendment was submitted to seek an extension to the duration of support under the Regulations through to 31 December 2020. Due to delays experienced during data extraction and processing, the data sets required for analysis were not received until January 2018.\n\nThis application was considered by the Confidentiality Advisory Group meeting 17 March 2016.                                                                                                                                          The consultants will be made aware of the project through their professional organisations, which we closely collaborate with.\n- Royal College of Obstetricians and Gynaecologists: The project will be described (including background, aims / objectives, methods and outputs) on the RCOG's Lindsay Stewart Centre for https://www.rcog.org.uk/en/guidelines-research-services/audit-quality-improvement/\n- British Gynaecological Cancer Society (BGCS): Prof Jan van der Meulen introduced the project to the British Surgical Gynaecological Oncology Group during the BGCS 2016 Scientific Conference on May 12, 2016. We aim to further publicise the project on the BGCS website and though the newsletter that is sent to all membership."]

{"sheet":"A0915","index":82,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0915"]
["Reference","16/CAG/0116"]
["Other Refs"]
["Application Title","National Cancer Patient experience survey 2016"]
["Application Summary","This non-research application from NHS England and Quality Health set out the purpose of conducting a survey in order to collect and analyse data to secure continuous improvement for provider performance, assess local improvements and provide an overview in cancer patient experience, improve provider quality and to enable patients to make informed choices on where to go for cancer treatment. The applicant is seeking s251 support in order for NHS Acute Trusts to disclose confidential patient information to Quality Health and for Quality Health to liaise with Trusts in order for patient questionnaires to be sent to patients under cover of appropriate Trust letter headed paper.\nA recommendation for class 1, 4, 5 and 6 support was requested for the purpose of extracting and anonymising the information, to link patient identifiable information from more than one source, for auditing, monitoring and analysing patient care and treatment and to allow access to an authorised user for one or more of the above purposes."]
["Applicant Organisation Name","NHS England "]
["Contact Name","Ruth Hudson"]
["Address","Patients and Information Directorate"]
[null,"NHS England"]
[null,"Quarry House, Leeds "]
["Postcode","LS2 7UE"]
["Telephone"]
["Email","Ruth.hudson4@nhs.net "]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Adult inpatients and day case patients with a primary diagnosis of cancer who have been admitted to an acute or specialist NHS Trust during April, May and June 2016.  "]
["Description of confidential patient information used","Name, address, sex, ethnic group, year of birth, ICD10 code, admission and discharge dates, speciality code, referring CCG, admission type, NHS Number"]
["S251 Class(es)",null,"Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","NHS England"]
["Status","Expired"]
[]
["Next Review Date","2017-08-26"]
["Notes","Old applications for the National Cancer Patient’s Experience survey: Acute and Specialist trust surveys of inpatients and day cases.\n\nThe currently supported reference is 21/CAG/0084\n\nThis application was considered by the Confidentiality Advisory Group meeting 12 August 2016.                                                                                                                                             1. The CAG set out the following recommendations, which would improve any future applications:\n(a) The contract of employment for staff of Quality Health should contain reference to the staff members' duty of confidence regarding patient data. The contract is clear on matters \"regarding the activities and interests of the Company\" but does not mention confidential patient data.\n(b) It was acknowledged that every effort is made by Quality Health to avoid letters being sent to the wrong patient or to patients already deceased. Future applications should report on any such incidents to ensure that any system issues were avoided.\nThese recommendations were not intended to delay the recommendation of support for this survey, but were matters to be considered in future applications.\n2. Confirmation from the IGT Team at the Health and Social Care Information Centre of suitable security arrangements via Information Governance Toolkit (IGT) submission. Confirmed via ICO website 26 August 2016"]

{"sheet":"A0916","index":83,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0916"]
["Reference","15/CAG/0143"]
["Other Refs"]
["Application Title","National Prostate Cancer Audit – PROMS/PREMS"]
["Application Summary","This application from Royal College of Surgeons, sponsored by the Healthcare Quality Improvement Partnership, set out the purpose of collecting Patient Reported Outcomes Measures (PROMS) and Patient Reported Experience Measures (PREMS) data in response to patients who underwent radical treatment between 1 April 2014 and 31 March 2015 and candidates for radical treatment between 1 April 2015 and 31 March 2016 for whom the National Prostate Cancer Audit (NPCA) has complete data for.\nA recommendation for class 4 and 6 support was requested to cover access by Quality Health (on behalf of the Royal College of Surgeons) to patient name and address from the National Cancer Registration Service (NCRS) in order to send out surveys and NHS number and date of birth are requested to ensure that patient sample and survey response data are accurately matched.\nQuality Health would send out postal questionnaires to patients and carry out mortality checks using DBS."]
["Applicant Organisation Name","HQIP"]
["Contact Name","Emma Skipper, Associate director"]
["Address","27A Harley Place, \n\n"]
[null,"London"]
[]
["Postcode","W1G 8LZ"]
["Telephone","07398 693285"]
["Email","emma.skipper@hqip.org.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","All men with newly diagnosed prostate cancer (ICD-10 diagnostic code of C61 - malignant neoplasms of the prostate) in England Wales are included in the NPCA. From the NPCA patient population, the following cohorts of men in England will be identified for the NPCA PROMs/PREMs:\n\nMen diagnosed with localised (non-metastatic) prostate cancer between\n\n1) 1 April 2015 and 31 March 2016 who underwent radical treatment (n = 15,000), and\n2) 1 April 2016 and 31 March 2017 who are candidates for radical treatment (irrespective of treatment) for whom the NPCA has complete staging data (n = 25,000)\n\nThese data are submitted by NHS Trusts to the National Cancer Registration Service (NCRS), the NPCA data collection partner, as part of the NPCA prospective audit on a monthly basis.\n"]
["Description of confidential patient information used","Name (first name and surname), NHS number, address, postcode, and date of birth"]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,null,"Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Health Quality Improvement Partnership (HQIP)."]
["Status","Supported"]
[]
["Next Review Date","2022-09-10"]
["Notes","25 November 2019: Amendment supported to change to the supported data flows to enable registered patient opt-outs to be checked by Quality Health Ltd. using the Secure Message Exchange for Social care and Health (MESH) service. NHS Numbes would be entered directly into the MESH portal by Quality Health to enable all known opt-outs to be applied. Quality Health would no longer disclose confidential patient information to the list cleaning service at NHS Digital to confirm known dissents. \n\n17 September 2019: Amendment supported to extend the scope of the patient cohort to be invited to participate in the prostate cancer audit patient reported outcomes survey to include those individuals who had received a diagnosis from 01/04/2018 onwards for an initial six-month period\n\nAmendment updated 31 August 2016:                                                                                   This application was for approval for the transfer of minimal patient data (collected as part of the National Prostate Cancer Audit) from the Wales Cancer Network (NPCA data collection partner in Wales) to Quality Health (NPCA survey provider). The CEU would not receive the patient identifiers required for administration of the PROMs/PREMs postal surveys (Name and address, NHS number, Date of Birth, Postcode) as these would be securely passed directly from the WCN only to Quality Health.\nThe applicant proposed to extend the approach already approved by CAG to carry out the study in England, to Wales. They stated that this involved a change in data flows and data sources. They would collect PROMs and PREMs data via a third party.\n\nThis application was considered by the Confidentiality Advisory Group meeting 04 June 2015. \n1. In line with other national surveys, cover letters on NHS Trust headed paper should be included with the survey sent to patients. The applicant raised concerns about how this would be implemented, given the limited Trust involvement and the potential burden in requesting that these letters were approved within each Trust. The applicant asked members to reconsider this condition and members agreed that the condition should be amended to reflect that the letters would be sent from the audit clinical leads on NHS England headed paper. The letter should provide a full explanation regarding the use of confidential patient information and how and why contact details had been released.\n2. Please ensure that Caldicott Guardians at NHS Trusts are informed about the survey. It was confirmed that a letter would be sent to the Caldicott Guardian at each participating Trust informing then about the NPCA PROMs/PREMs survey.\n3. Confirmation from the IGT Team at the Health and Social Care Information Centre of suitable security arrangements via Information Governance Toolkit (IGT) submission. Confirmed for Quality Health.                                                                                                                                                                                                                                                                                   "]

{"sheet":"A0917","index":84,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","0917"]
["Reference","16/CAG/0079"]
["Other Refs"]
["Application Title","National clinical audit of breast cancer in older patients"]
["Application Summary","This application from the Clinical Effectiveness Unit (CEU) at The Royal College of\nSurgeons in collaboration with the Association of Breast Surgery set out the\npurpose to evaluate the process of care and outcomes for women aged over 70\nyears with a histological diagnosis of breast cancer and who are treated within\nEngland and Wales. The data controller for this study is the Healthcare Quality\nImprovement Partnership (HQIP), the applicant is the data processor.\nAbout 45,000 new cases of breast cancer are diagnosed each year in England and\nWales. National clinical guidelines provide health services with evidence about the\nbest care for breast cancer, and these emphasize that treatment should be based\non clinical need and fitness for treatment rather than age. However, various\npublications have revealed that UK services have a non-standard approach to\nmanaging breast cancer in older patients, and this might be one reason for why the\nsurvival of women aged 75 years and older was particularly low in the UK and\nIreland compared to other European countries.\nThe patterns of care observed for women in this later age group will be compared\nwith those among women diagnosed with breast cancer aged 50-70 years. All\nwomen aged 50 years and over, with a diagnosis of breast cancer (ICD-10 codes\nC50 and D05), accessing secondary care services in England and Wales from April\n2016 to March 2019 will be included in the cohort. The Audit will cover the care\npathway from referral for diagnosis to the end of the primary therapy, and provide\ninformation on the comparative performance of Breast Cancer Units. An important\npart of the audit will be to take account of how planned and actual treatments are\nmodified for women who differ in their ability to tolerate specific therapies because\nthey are frail or have comorbidities.\nThe Audit will use existing sources of patient data collected by national\norganisations. The main source will be the national cancer registration datasets in\nEngland and Wales. These datasets provide information about the type of cancer\nthat women have (eg, invasive, non-invasive) and the process of diagnosis. The\nRegistry data will be linked to routine hospital datasets (Hospital Episode Statistics\nfor England and Patient Episode Data for Wales) to provide information about\nsurgical treatments, and with other national cancer datasets for radiotherapy and\nchemotherapy.\nTo comply with information governance requirements in relation to patient\nidentifiable data, the linkage of databases will be managed by the Cancer Registries\nin England and Wales, for data on English patients this will be the National Cancer\nRegistration and Analysis Service and the Health and Social Care Information\nCentre. The Health and Social Care Information Centre will be responsible for\nlinking the patient records from the COSD dataset to HES and the ONS Death\nRegister. The National Cancer Registration and Analysis Service is responsible for\nlinking the patient records from the COSD dataset to the radiotherapy (RTDS) and\nchemotherapy (SACT) datasets, as it is the data controller for these data\ncollections. The National Cancer Registration and Analysis Service / Public Health\nEngland has already obtained Section 251 approval for the linkage of the English\ndatasets. Patient survival will be determined from information in the Office for\nNational Statistics (ONS) Death Registry. These linkages will be repeated annually.\nThe CEU will not receive these patient identifiers in the datasets supplied for\nanalysis, instead, the CEU will receive a dataset in which patient records have been\nassigned a unique"]
["Applicant Organisation Name","The Royal College of Surgeons of England"]
["Contact Name","Prof David Cromwell, Director of Clinical Effectiveness Unit"]
["Address","Clinical Effectiveness Unit"]
[null,"The Royal College of Surgeons of England"]
[null,"35-43 Lincoln’s In Fields"]
["Postcode","WC2A 3PE"]
["Telephone","0207 869 6608"]
["Email","dcromwell@rcseng.ac.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","All women aged 50 years and over, with a diagnosis of breast cancer (ICD-10 codes C50 and D05), accessing secondary care services in England and Wales from April 2016 to March 2019.\n\nIt will cover emergency and elective procedures and treatments for this group, as well as their outcomes in terms of complications, re-admissions and survival.\n"]
["Description of confidential patient information used","For all patients included in the study, the following identifiers will be used for linkage:\n1. NHS number\n2. Date of Birth\n3. Postcode\n4. Sex.\n\nThe linkage process for data on English patients will be managed by the National Cancer Registration and Analysis Service and the Health and Social Care Information Centre. The CEU will not receive these patient identifiers in the datasets supplied for analysis. Instead, the CEU will receive a dataset in which patient records have been assigned a unique pseudonymised identifier that will allow their records to be linked across different anonymised datasets\n\nIn addition, the CEU will receive the following data items: \n1. Age at diagnosis (years).\n2. Geographical identifiers for both patient residence and site of treatment, such as Lower Layer Super Output Areas (LSOA).\n3. Dates of all episodes of care (including diagnosis) / Dates of admissions and discharge for relevant procedures\n4. Date of death, cause of death, and location of death"]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Healthcare Quality Improvement Partnership"]
["Status","Supported"]
[]
["Next Review Date","2023-09-02"]
["Notes","21 October 2020 - Confirmation that support is expired for English data only given confirmation that PHE that date of death is not considered identifiable. Support continues to be in place for processing of Welsh data\n\n11 October 2019: The applicant sought support to change the definition of the cohort, so that all patients aged 50 and over, with a diagnosis of breast cancer and who accessed secondary care, are included in the audit, until the commissioning contract between the Royal College of Surgeons and Healthcare Quality Improvement Partnership has ended. The amendment was fully supported, subject to compliance with the standard conditions of support.\n\nAmendment Request 22/11/2016\nThe amendment request was submitted to revise the definition of the patient cohort. In the original CAG application, the patient cohort was defined as “All women aged 50 years and over, with a diagnosis of breast cancer (ICD-10 codes C50 and D05), accessing secondary care services in England and Wales from April 2016 to March 2019.” The amendment requested revision of this patient cohort definition to: “All women aged 50 years and over, with a diagnosis of breast cancer (ICD-10 codes C50 and D05), accessing secondary care services in England and Wales from January 2014 to December 2017.                                     Specific conditions of support\n1. Confirmation of suitable security arrangements via IG Toolkit submission"]

{"sheet":"A0918","index":85,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0918"]
["Reference","16/CAG/0097"]
["Other Refs"]
["Application Title","Pathways of Care for young people in secure institutions (national service evaluation)"]
["Application Summary","This application from Central and North West London NHS Foundation Trust set out the overarching purpose of undertaking a NHS England funded service evaluation linked to CAMHS Transformation.\nThe aim was to scope the secure institutions which currently make up the secure estate for young people, to clarify how many young people are currently detained in secure institutions in England and to identify the level of need, characteristics and pathways of care for these young people. This indicated to be important in beginning to address the gap in knowledge in this area where service provision has grown organically without prior service evaluation, to inform commissioning needs for the Clinical Reference Group and Commissioners, consider the implications of service delivery in terms of the different legislative and funding bodies and enable discussion about whether pathways into the different secure institutions are appropriate for the young people. This service evaluation of the pathways into and needs of young people within the entire secure estate is intended to enable the overall secure service providers to consider what intervention package would be appropriate into the different secure institutions.\nA recommendation for class 1, 5 and 6 support was requested to achieve the purposes set out in the application."]
["Applicant Organisation Name","St George’s Medical School"]
["Contact Name","Dr Heidi Hales"]
["Address","HMYOI Cookham Wood"]
[null,"Sir Evelyn Road"]
[null,"Rochester"]
["Postcode","ME1 3LU"]
["Telephone"]
["Email","Heidi.hales@nhs.net"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","All young people in secure institutions (hospitals, secure children’s homes, secure training centres, young offender institutes) on a specific date (date tbc)"]
["Description of confidential patient information used","Age on census date, gender, ethnicity, country of origin, area in England of origin, mental health diagnoses or needs, length of detention, legal status, planned discharge information\nAll will be pseudonymised on site by staff with contracts with the local institution\n"]
["S251 Class(es)",null,"Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,null,"Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","CNWL NHS Foundation Trust & NHS England\n"]
["Status","Supported"]
[]
["Next Review Date","2017-09-15"]
["Notes","This application was considered at the Confidentiality Advisory Group meeting 04 August 2016.                                                                                                                                          The clarifications should be read in the context of the CAG advice above. The following clarifications were provided during a teleconference between Professor Bartlett and a sub-committee of members, and in a summary letter from the applicant dated 26 August 2016.\n1. Members were unclear as to the precise scope of support that was requested and requested clarification on the following:\na. It was indicated that a small number of sites may not be able to provide resource; please clarify which sites are not able to provide resource.\nIt was clarified that 2 out of 54 sites had so far stated they would require the research assistant to assist with data collection. Others could follow, but the applicant indicated that this would be a minority. Further correspondence dated 06 September detailed that Werrington YOI and potentially Ardenleigh secure unit had also asked that relevant data be collected from their sites.\nb. How many researchers are seeking support, for example, is support requested for the assistant psychologist only, or a research assistant?\nIt was explained that the terms assistance psychologist and research assistant had been used interchangeably, and referred to only one person.\nc. Clarification as to the methodology of the data extraction\nThe applicant stated that the research assistant would have login details for SystmOne at Cookham Wood, and this would be extended to work on other sites via an honorary contract at the relevant sites.\n2. Clarification as to the relevant population; it was noted that there may be young people in a secure unit due to criminal activity with no mental health issues, therefore members questioned whether the cohort would be confined solely to those with mental health issues only, or whether it would be broader. At present, members were supportive of extracting medical information relevant to mental health only.\nIt was explained that there were 3 questions in the census relating to physical health conditions, which were to capture complexity in the young people in these secure environments. They would only collect data relevant to the main focus of the project, which would be any diagnosis of a physical disability, long-term health"]

{"sheet":"A0919","index":86,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","0919"]
["Reference","16/CAG/0111"]
["Other Refs"]
["Application Title","The role of hospital organisation, surgical factors and their enhanced recovery pathway on patient outcomes and NHS costs following primary hip and knee replacement surgery"]
["Application Summary","This application from Big Health Data Group, Oxford University set out the purpose of using data from the National Joint Registry (NJR) linked to Health and Social Care Information Centre (HSCIC) Health Episode Statistics (HES)-Patient Reported Outcome Measures (PROMs) data to: (1) Identify determinants of geographical variation in patient outcomes and NHS costs; (2) Determine the clinical and cost-effectiveness of the enhanced recovery pathway.\nIdentifiable data from the NJR, which has been collected with consent from patients, will be transferred to the HSCIC. The HSCIC will use the identifiers (NHS number, date of birth, gender and postcode as well as a unique NJR patient identifier) to link the data with the HES-PROMS dataset. The data will be pseudonymised by the HSCIC before being transferred to the University of Oxford for analysis.\nA recommendation for class 1, 4 and 6 support was requested for the process of extracting and anonymising the information, to link patient identifiable information obtained from more than one source, to allow access to an authorised user for the above purposes."]
["Applicant Organisation Name","University of Oxford"]
["Contact Name","Andrew Judge"]
["Address","Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Science (NDORMS),"]
[null,"Windmill Road,"]
[null,"Oxford"]
["Postcode","OX3 7LD"]
["Telephone","01865 737837"]
["Email","andrew.judge@ndorms.ox.ac.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"□","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Linked NJR and HES-PROMS data"]
["Description of confidential patient information used","Identifiable NJR data will be provided to the HSCIC for data linkage. NJR will send NHS number, date of birth, gender and postcode as well as a unique NJR patient identifier (pseudonymised) for linkage. The HSCIC data to be linked for this project is HES admitted patient care and linked PROMS data."]
["S251 Class(es)",null,"Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,null,"Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","University of Oxford"]
["Status","Expired"]
[]
["Next Review Date"]
["Notes","All identifiers have been deleted.\n\nOver 150,000 hip and knee replacement operations take place each year in the NHS and this number is expected to increase.\n\nIn the NHS patients can choose which hospital they want to have their surgery in. Information on the outcomes of surgery between different hospitals would help patients in making their decision. Outcomes of surgery will vary across different\nhospitals and areas of the country. This may be explained by a hospital treating more complex and sicker patients, and this must be accounted for. However, differences in patient outcomes could also be explained by how hospitals organised their services, such as bed availability, numbers of operating theatres and specialist surgeons, using new surgical techniques, or centralising care into specialist high volume hospitals. Knowledge of this would help NHS managers to change the way services are organised and reduce variation in outcomes between hospitals.\n\nA new patient pathway for hip and knee replacement called enhanced recovery has been introduced in NHS and private hospitals. It is hoped this will benefit patients, through patient education before and after surgery, that includes making changes around the home, exercises to strengthen the joint and changes to diet, to help reduce the risk of complications and speed up a patient’s recovery time. For patients in whom it is suitable, they will further benefit by being able to return home earlier to continue their recuperation at home with appropriate support. This in turn will benefit the hospital by freeing up space for other patients on the waiting list. However, hospitals organise enhanced recovery services in different ways and it is unclear which way is best.\nObjectives\n\n1.            Identification of hospital organisation, surgical factors, and the enhanced recovery pathway as determinants of geographical variation in patient outcomes and NHS costs\n\n2.            Natural experiment to determine the clinical and cost-effectiveness of the ERP\nKey findings – Objective 1\n\nStatistical analysis of national linked data from the National Joint Registry (NJR), Hospital Episode Statistics (HES) and Patient Reported Outcomes Measures (PROMs) databases between 2014 to 2016.\n\nGeographical variation - 210,725 primary TKR were identified nested in 31,715 census areas and 207 CCG areas (173,107 primary THR, 30,850 census areas, and 207 CCG). ≈60% of patients were women; the average age was ≈69 years. Whilst we identified a number of factors that predicted outcomes of surgery (e.g. age, gender, co-morbidity, deprivation, baseline hip/knee function, surgical volume, numbers of orthopaedic surgeons, beds, operating theatres), these factors did not explain observed geographical variation in outcomes of surgery across CCGs. The absolute change in OKS varied from 11.2 to 19.1 points (OHS 17.5 to 24.9), 6-month complication rate of TKR from 1.5% to 8.4% (THR 2.0% to 8.6%), mean length of stay TKR 2.7 to 6.6 days (THR 2.5 to 6.2), hospitalisation cost £4564 to £8901 (THR £4322 to £8566).\nKey findings – Objective 2\nWe used the national NJR-HES-PROMs linked datasets from April 2008 to December 2016. \nNatural experiment (Interrupted time series) – 438,921 primary THR and 525,088 primary TKR were identified. For THR, overall LOS decreased from 5.6 days in April 2008 to 3.6 in December 2016 (TKR 5.7 to 3.6). Although older patients had a longer LOS, the decreasing trend in LOS was seen across all age groups (e.g. 4.7 days to 3.0 days in those age< 60 and 8.1 days to 5.3 days in age 85+). A trend in decreasing LOS was seen in patients with and without pre-existing co-morbidity. For THR, hospital admission costs decreased from £7573 in April 2008 to £5239 in December 2016 (TKR £7461 to £5158). Over the study period there was an improvement in PROMs, with an improvement in change in OHS 6 months after surgery of 17.7 points in April 2008, with this change increasing to 22.9 points in December 2016 (TKR OKS 15.0 to 17.1). The overall proportion of complications was low and decreased from 4.1% in April 2008 to 1.7% March 2016. For THR 5-year revision rates declined from 5.9 per 1000 implant years (95% CI: 4.8 to 7.2) at risk in April 2008 to 2.9 (95% CI: 2.2 to 3.9) in December 2011 (TKR/UKR 6.6/1000 to 5.4/1000). Trends in LOS, bed costs, PROMs, complications, and revision surgery were consistent with a continuation of a pre-existing secular trend and were not temporally related to implementation of the national ERAS programme.\n\nHealth economics (costs) – We identified 854,866 individuals undergoing TKR/THR in NJR-HES. The mean censor-adjusted 1-year hospitalisation costs for THR and TKR were £7,827 (95%CI £7,813 to £7,842) and £7,805 (95%CI £7,790 to £7,818), respectively. The censor-adjusted 2-year costs were £9,258 (95%CI £9,233 to £9,280) and £9,452 (95%CI £9,430 to £9,475) for THR and TKR respectively. Complications, revisions and death were the major predictors of 1-year hospitalisation costs.\n\nConclusion\n\nOur data show that outcomes of TKR/THR have been gradually improving over time, with a decrease in length of stay, reduction in inpatient bed day cost, improvement in patient reported outcomes of pain and function, decrease in complications, and reduction in 5-year revision risk. These trends of improving outcomes were seen across all age groups, and in those with and without co-morbidity. However, trends of improving outcomes had begun prior to the introduction of the formal NHS ERAS role out, and therefore not temporally associated with the national ERAS programme. These findings are positive, in highlighting that reductions in LOS have been achieved without adversely impacting on patient outcomes.\n\nEven though patient outcomes have been improving over time, analysis of the most recent years of data identified potentially unwarranted variations in patient outcomes of TKR/THR. This variation cannot be explained by differences in patients case mix, surgical factors, or hospital organisational factors. This information is informative to commissioners in monitoring variations in outcomes of surgery.\nStudy Outputs\nPresented at conference:\n•             Garriga, C., et al. (2019) “Geographical variation in patient outcomes of primary knee replacement across clinical commissioning groups: Study from the National Joint Registry of England, Wales, Ireland and the Isle of Man.” Annual European Congress of Rheumatology (EULAR 2019), Madrid, Spain, 12-15 June 2019. Oral. Abstract number OP0306.\n•             Garriga, C., et al. (2019) “Geographical variation in outcomes of primary hip replacement: Study from the National Joint Registry of England and Wales.” World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases – Paris, France 4 – 7 April 2019. Poster Presentation: P376 \n•             Garriga, C., et al. (2018) “Impact of a National Enhanced Recovery Programme on Patient Outcomes of Primary hip replacement: An Interrupted Time Series Analysis from England.” 19th European Federation of National Associations of Orthopaedics and Traumatology (EFORT) Congress - Barcelona, Spain. 30 May - 01 June 2018. Oral. Abstract number: 1614.\n•             Garriga, C., et al. (2018) “Impact of a National Enhanced Recovery Programme on Patient Outcomes of Primary total and unicompartmental knee replacement: 2008-2016 England trends.” Osteoarthritis Research Society International (OARSI). Liverpool, UK. 26-29 April 2018. Abstract number: 387. Poster. https://doi.org/10.1016/j.joca.2018.02.426\n•             Garriga, C., et al. (2018) “Repercussion of a national intervention on patient outcomes of primary knee arthroplasty to enhance the recovery pathway: 2008-2016 England trends.” World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO). Kraków, Poland. 19-22 April 2018. Poster number: P674..\nAccepted Publications:\n•             Garriga, C. Murphy, J. Leal, J. Price, A. Prieto-Alhambra, D. Carr, A. Arden. NK. Rangan, A. Cooper, C. Peat, G. Fitzpatrick, R. Barker, K. Judge, A. Impact of a national enhanced recovery after surgery programme on patient outcomes of primary total knee replacement: an interrupted time series analysis from \"The National Joint Registry of England, Wales, Northern Ireland and the Isle of Man\". Osteoarthritis Cartilage. 2019 May 10. pii: S1063-4584(19)30976-8. doi: 10.1016/j.joca.2019.05.001\n•             Leal J, Murphy J, Garriga C, Delmestri A, Rangan A, Price A, Carr A, Prieto-Alhambra D, Judge A. Costs of Joint Replacement in Osteoarthritis: A Study Using the National Joint Registry and Clinical Practice Research Datalink Data Sets. Arthritis Care Res (Hoboken). 2022 Mar;74(3):392-402. doi: 10.1002/acr.24470. Epub 2022 Jan 13.\n•             Judge A, Carr A, Price A, Garriga C, Cooper C, Prieto-Alhambra D, Old F, Peat G, Murphy J, Leal J, Barker K, Underdown L, Arden N, Gooberman-Hill R, Fitzpatrick R, Drew S, Pritchard MG. The impact of the enhanced recovery pathway and other factors on outcomes and costs following hip and knee replacement: routine data study. Southampton (UK): NIHR Journals Library; 2020 Jan.\n•             Garriga C, Murphy J, Leal J, Arden NK, Price AJ, Prieto-Alhambra D, Carr AJ, Rangan A, Cooper C, Peat G, Fitzpatrick R, Barker KL, Judge A. Assessment on patient outcomes of primary hip replacement: an interrupted time series analysis from 'The National Joint Registry of England and Wales'. BMJ Open. 2019 Nov 21;9(11):e031599. doi: 10.1136/bmjopen-2019-031599.\n•             Garriga C, Leal J, Sánchez-Santos MT, Arden N, Price A, Prieto-Alhambra D, Carr A, Rangan A, Cooper C, Peat G, Fitzpatrick R, Barker K, Judge A. Geographical Variation in Outcomes of Primary Hip and Knee Replacement. JAMA Netw Open. 2019 Oct 2;2(10):e1914325. doi: 10.1001/jamanetworkopen.2019.14325.\n\n\nThis application was considered by the Confidentiality Advisory Group sub-committee meeting 12 August 2016.                                                                                                                            1. Patient information sheets should be updated to inform those who consent to inclusion on the National Joint Registry that their information may be linked to databases at NHS Digital/The Health and Social Care Information Centre. The updated information sheets should be provided to the Committee for review when available. Confirmation should also be provided that the website has been amended. Rescinded 15 September 2016\nThis condition was queried by the applicant in emails sent on 25 August 2016:\n‘The NJR patient information sheets available online, (http://www.njrcentre.org.uk/njrcentre/Portals/0/Documents/England/Patient%20consent/NJR%20Patient%20Information%20Leaflet%20English%20March%202015.pdf) state that if patients consent to inclusion on the National Joint Registry that their information may be linked to other databases. “Operation and patient information in the NJR is used to link to other healthcare information.”\nThe information sheet also explains what the data is used for “Operation and patient information in the NJR may be used for medical research. The purpose of this research is to improve our understanding and treatment of joint problems. The majority of our research uses only anonymised information that means it is impossible to identify individuals”. University Oxford as a separate organisation does not have any dominion over the information that the NJR puts online or in patient information sheets. Although I can understand why the members would like to see more specific information, I also understand that the NJR links with many different databases and keeping documents updated and more importantly accurate would be near impossible (and I would imagine a list of all the different names of databases would be overwhelming for the patients).\nI would like to explain again that the information we are applying for access to from the HSCIC (HES and PROMs) and NJR is all completely anonymous, national, large data that has been previously collected. Researchers working on the data will not be able to identify patients.’\nA query was also received from HQIP on behalf of the National Joint Registry, clarifying that the University of Oxford could not address this point on behalf of the NJR and expressing concern that NJR had not been approached directly regarding the change to their patient information leaflets.\nThe Sub-Committee considered this information and took into account the fact that the NJR patient information leaflets had been developed and approved in conjunction with the Confidentiality Advisory Group, under a separate application. Members commented that overall the public involvement work completed by the University of Oxford was commendable, and the public facing website was of a high standard.\nThe Sub-Committee therefore agreed to rescind this condition of support. There would not be a requirement to update the patient information leaflets.\n2. Confirmation from the IGT Team at the Health and Social Care Information Centre of suitable security arrangements via Information Governance Toolkit (IGT) submission. Confirmed 9 August 2016."]

{"sheet":"A0920","index":87,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","0920"]
["Reference","16/CAG/0153"]
["Other Refs","16/CAG/0153 (previously 16/CAG/0107)"]
["Application Title","UK Renal Registry"]
["Application Summary","The UK Renal Registry (UKRR) collects, analyses and reports on patients with Chronic kidney disease, including those receiving renal replacement therapy, and Acute kidney injury. It receives data from renal units and laboratories in the UK.\nThis application is to consolidate a number of amendments, updates and extension to the original application in 2004 (PIAG 1-07(c)/2004). It seeks to adopt the same patient identifiers for all patients involved and provides updated information on dataflow and information governance."]
["Applicant Organisation Name","Southmead Hospital, UK Renal Registry"]
["Contact Name","Dr Retha Steenkamp, Head of Operations for the UK Renal Registry "]
["Address","The UK Renal Registry"]
[null,"Brandon House, Building 20a1, Southmead Road"]
[null,"Bristol, "]
["Postcode","BS34 7RR "]
["Telephone","0117-4148155 "]
["Email","Retha.Steenkamp@renalregistry.nhs.uk "]
["Medical Purposes","□","preventative medicine"]
[null,"Y","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","The population of England and Wales with: Chronic kidney disease stages 2 to 5 or\nAcute kidney injury or patients using Renal replacement and related extracorporeal therapy (including peritoneal dialysis, haemodialysis, haemodiafiltration, haemofiltration, plasmapheresis, plasma exchange and renal transplantation)"]
["Description of confidential patient information used","Forename and Surname, Address, Postcode, Date of birth, Ethnicity, Gender, Occupation, GP registration, NHS number, Hospital name and code and Hospital patient number, Date and cause of death."]
["S251 Class(es)",null,"Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","The Renal Association"]
["Status","Supported"]
[]
["Next Review Date","2023-12-16"]
["Notes","03 August 2021 - amendment supported to allow the disclosure of confidential patient information from the UK Renal Registry (UKRR) to NHS Digital in order to link to data from National Institute for Cardiac Outcomes Research (NICOR), in order to establish a centrally held cardiorenal audit and research database\n\n04 May 2020 – amendment supported to expand the data flows required for the UK Renal Registry to include patients diagnosed with stage 1 Chronic Kidney Disease, to increase the frequency of data linkages between the UK Renal Registry and Public Health England and to establish a data linkage with the Intensive Care National Audit and Research Centre (ICNARC).\n\n12/04/2019: Amendment detailing the following changes to the application activity supported: \n1. Patient identifiers to facilitate linkage with Public Health England reduced to: NHS Number, Date of birth and Gender only (with UKRR ID), removing the following items: Hospital Number and full name (forename/initial/surname).\n2. Additional data flow to NHS England – monthly transfer of Renal Replacement Therapy (RRT) and Acute Kidney Injury data (AKI) which will include NHS Number, date of birth, postcode and gender,\n3. Additional data flow to NHS Wales Informatics Service – to facilitate linkage with the PEDW dataset to mirror follow-up which is in place via NHS Digital for English patients. This data flow would involve the disclosure of the following items of confidential patient information: UKRR ID number, NHS Number, date of birth, gender and postcode.\n\nSpecific conditions of support\n1. Provision, at the time of next annual review, of report providing evidence of progression towards unnecessary use of identifiers, specifically in relation to data flows involving NHS Digital, and steps to investigate the provision of study ID instead of confidential patient information.\n\n04 May 2020 – amendment supported to expand the data flows required for the UK Renal Registry to include patients diagnosed with stage 1 Chronic Kidney Disease, to increase the frequency of data linkages between the UK Renal Registry and Public Health England and to establish a data linkage with the Intensive Care National Audit and Research Centre (ICNARC)."]

{"sheet":"A0921","index":88,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0921"]
["Reference","16/CAG/0077"]
["Other Refs"]
["Application Title","2016 Accident and Emergency Survey"]
["Application Summary","This application from the Picker Institute Europe set out the purpose of carrying out the 2016 Accident and Emergency Survey sponsored by the Care Quality Commission. This was specifically to enable the transfer of identifiable data from acute trusts, to an approved survey contractor for the purpose of mailing out questionnaires for the 2016 accident and emergency survey. It was expect from past experience that the vast majority trusts involved will opt to use an approved survey contractor, either: Picker Institute Europe, Quality Health, Patient Perspective, CAPITA Surveys & Research or the new approved contractor, Membership Engagement Services Ltd. (MES).\nThe 2016 A&E survey will be the sixth carried out to date. It was expected that 147 trusts will be eligible for the survey (dependent on the outcome of the development work and chosen sampling strategy). Trusts will be asked to conduct the survey with preparations expected to begin in July 2016 and fieldwork expected to start from November 2016. All trusts will draw a sample of patients according to set criteria, and follow standardised materials and procedures for all stages of the survey. An overview of the survey methodology was provided with this application."]
["Applicant Organisation Name","Picker Institute Europe"]
["Contact Name","Chris Graham"]
["Address","Buxton Court"]
[null,"3 West Way"]
[null,"Oxford"]
["Postcode","OX2 0JB"]
["Telephone","01865 208118"]
["Email"]
["Medical Purposes","□","preventative medicine"]
[null,null,"medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"□","the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","People aged 16 and over who visited an A&E department in the specified sampling month (likely to be August or September 2016). \n"]
["Description of confidential patient information used","Title (Mr, Mrs, Ms, etc.), First name, Surname,  Address Fields,  Postcode, Date and time of attendance,  NHS Site code (hospital where treated),  Department type,  Ethnicity,  Gender,  Year of birth."]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,null,"Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Care Quality Commission"]
["Status","Supported"]
[]
["Next Review Date","2017-06-13"]
["Notes","Specific conditions of support\n1. Confirmation from the IGT Team at the Health and Social Care Information Centre of suitable security arrangements via Information Governance Toolkit (IGT) submission. Confirmed 13/05/2016."]

{"sheet":"A0922","index":89,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","0922"]
["Reference","16/CAG/0058"]
["Other Refs"]
["Application Title","National Maternity and Perinatal Audit"]
["Application Summary","This application from the Royal College of Obstetricians and Gynaecologists set out the\npurpose of delivering a new Healthcare Quality Improvement Partnership (HQIP)-\ncommissioned national, prospective, clinical audit of maternity services in England, Scotland and Wales, in order to improve the quality of services and the outcomes\nachieved for mothers and newborns.\nThe commissioned audit programme consists of three phases of work:\n1. An ‘organisational survey’ to collect provider-level information on service delivery and\nthe organisation of maternity care, which will contribute to a better understanding of\nthe care provided to pregnant women.\n2. A continuous prospective clinical audit that produces information for maternity units\nto monitor patterns of care and maternal and perinatal outcomes.\n3. A series of in-depth topic-specific, time-limited audits (‘sprint audits’), predominantly\nfocusing on specific types of maternal and neonatal outcomes.                                                       Most maternity units in the UK already use electronic maternity information systems\n(MIS) to capture demographic and clinical information related to each pregnancy and\ndelivery under their care. These databases cover antenatal booking through to postnatal\ncare. Although each MIS collects slightly different information, there is sufficient similarity\nbetween MISs to allow a minimum dataset to be developed.  "]
["Applicant Organisation Name","Royal College of Obstetricians and Gynaecologists"]
["Contact Name","George Dunn, NMPA Lead"]
["Address","Royal College of Obstetricians and Gynaecologists"]
[null,"10-18 Union Street"]
[null,"London Bridge"]
["Postcode","SE1 1SZ"]
["Telephone","020 7045 6798"]
["Email","gdunn@rcog.org.uk"]
["Medical Purposes","□","preventative medicine"]
[null,"Y","medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,"Y","the provision of care and treatment"]
[null,null,"the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Over a 48 month period (April 2014 to April 2018), from English & Welsh NHS trusts to the Royal College of Obstetricians and Gynaecologists"]
["Description of confidential patient information used","Baby’s date of birth, Baby’s time of birth, Mother’s postcode, Mother’s date of birth, Mother’s NHS number, Baby’s NHS number, Mother’s Ethnicity, Mother’s socioeconomic status."]
["S251 Class(es)",null,"Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2022-06-15"]
["Notes","03 August 2021 - Amendment supported to extend the duration of support until 31 December 2022\n\n03 August 2020 – Amendment supported to clarify that NHS Digital will conduct the linkage of the English ONS register of live births and stillbirths with the ONS mortality register, Personal Demographics Service (PDS) birth notification dataset, Maternity Services Data Set (MSDS), Maternity Information System (MIS), National Neonatal Research Database (NNRD), HES and English mental health datasets is supported, and provide the NMPA team with pseudonymised data. The applicant also clarified that the MSDS will provide maternity data to the NMPA.\n\n11 October 2019: Amendment supported to extend the duration of support to 30 June 2021 and to enable access to confidenital patient information by five additional audit staff members for analysis purposes. The sources of the Welsh data were clarfiied as Maternity Indicators Data Set (MIds) and the National Community Child Health Database (NCCHD) following local changes to how information is collected following the closure of the Welsh Maternity Indicators dataset.\n\nAmendment Request (Approved 04/06/2018)\nThe amendment includes two requests as follows:\n1. In original application stated that “[ONS birth register] data will provide validated birth details and validated date of death for mothers and newborns in England and Wales.” However, in discussion with NHS Digital, it has been confirmed that the ONS birth register cannot provide all of this information. The applicants have requested that linkage with PDS birth notification data is also supported, in order to calculate case ascertainment for mothers.\n2. The applicants are seeking additional linkage with Mental Health Minimum Data Set (MHMDS), Mental Health and Learning Disabilities Data Set (MHLDDS), Mental Health Services Data Set (MHSDS) and Improving Access to Psychological Therapies (IAPT) dataset. The amendment request is for ongoing linkage of the NMPA dataset with the mental health datasets described. Since the NMPA is commissioned until June 2019 in the first instance, the applicants will initially link the NMPA dataset between 1 April 2014 and 31 March 2017, and then propose to link the NMPA dataset between 1 April 2017 and 31 March 2018 during 2019.\n\nSpecific conditions of support                                                                                                        1. Provision, in first annual review, of an update on the mechanisms for opting-out of\nthe study which have been adopted as a result of patient and public engagement, as\nabove.\n2. Confirmation from the IGT Team at the Health and Social Care Information Centre of\nsuitable security arrangements via Information Governance Toolkit (IGT) submission.\nConfirmed (version 13) 01 June 16"]

{"sheet":"A0923","index":90,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0923"]
["Reference","17/CAG/0014"]
["Other Refs"]
["Application Title","Hospital readmission and myocardial infarction after aortic surgery: A service evaluation"]
["Application Summary","Current survival data suggested that a large proportion of patients did not survive to two years after their operation. Diseases of the aorta were common, especially in older men. Endovascular repairs were increasingly offered to older and more unwell patients. Evidence from the United States suggested that patients who had endovascular repairs often had short life expectancy due to disease other than their aneurysm.\nSt Thomas’ was a national leader in treating aortic disease and providing complex endovascular repairs. The site held details of 1800 patients who had been treated by the vascular surgical team. The service evaluation aimed to describe:\n The rate of hospital admission in the five years following surgery and the reasons for these admissions\n The rate of myocardial infarction in the five years following surgery\nAs St Thomas’ was a tertiary referral centre, these patients were treated from across the country therefore in order to obtain this information there was a need to link to national datasets."]
["Applicant Organisation Name","St Thomas’ Hospital"]
["Contact Name","Dr Bijan Modarai"]
["Address","Academic Department of Vascular Surgery"]
[null,"Westminster Bridge Road"]
[null,"London"]
["Postcode","SE1 7EH"]
["Telephone","0207 188 0216"]
["Email","Bijan.Modarai@kcl.ac.uk"]
["Medical Purposes","□","preventative medicine"]
[null,null,"medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Data from Guys and St Thomas’ NHS Foundation Trust in relation to patients who have undergone aortic surgery at St Thomas’ Hospital between 2006-2016.                                            The database contains 1800 patients who have had around 2200 procedures."]
["Description of confidential patient information used","Name, Date of birth, NHS number, and Date of surgery"]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,null,"Class VI - granting of access to data for purposes I-V"]
["Sponsor","Guys and St Thomas’ NHS Foundation Trust"]
["Status","Supported"]
[]
["Next Review Date","2018-02-13"]
["Notes","Specific conditions of support\n1. Revised patient notification materials to be provided for review. These should be shorter and easier to understand. It is recommended that the materials are reviewed by patients or members of the public.\nRevised patient materials were provided by email on 6 February 2017. The revised notifications were written in lay friendly language. The applicant stated that they had been reviewed by clinical nurse specialists, a number of nursing staff, two patients who have had aortic repair and one patient awaiting surgery. This condition is confirmed as met by the CAT on 13 February 2017.\n2. Confirmation from the IGT Team at the Health and Social Care Information Centre of suitable security arrangements via Information Governance Toolkit (IGT) submission Published on website, review grade Satisfactory – confirmed 13 January 2017"]

{"sheet":"A0924","index":91,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0924"]
["Reference","16/CAG/0050"]
["Other Refs"]
["Application Title","ECG Diabetic Foot Ulcer (DFU) Pilot"]
["Application Summary","Currently each year in England approximately 60,000 people with diabetes present with foot ulceration.  The 5-year mortality rate for these patients is around 50% and significant proportion of mortality associated with cardiac events. \nDespite this, nationally there was no routine process within Diabetic Foot Ulcer (DFU) pathways to identify cardiac issues and to initiate further clinical action where necessary. NHS Improving Quality (now part of NHS England) set up a pilot to addresses this. \n\nThe pilot embeds into routine care, the provision of a 12 lead ECG for all new DFU patients attending a Diabetic Foot Clinic. The ECG is provided to the patient during their first appointment. The results are reviewed prompting further clinical action where necessary. This work marks a more holistic approach with Diabetic Foot Clinics focusing beyond the foot.\n\nOf the patients who receive an ECG as part of routine care a significant proportion had consented to the National Diabetes Footcare Audit (NDFA).  The pilot wishes to use NHS Numbers to cross reference this NDFA data with national mortality data to identify whether patients who received an ECG as part of routine care at the pilot sites had significantly differing 1-5 year mortality rates compared to patients within the NDFA who receiving care at other sites. \nThe results have the potential to bring about a change in clinical practice across England and significantly reduce the numbers of people who die within 5 years of developing a DFU.\n"]
["Applicant Organisation Name","NHS England"]
["Contact Name","Tom Newbound, Programme Director"]
["Address","NHS Diabetes Programme, NHS England"]
[null,"Quarry House, Quarry Hill "]
[null,"Leeds "]
["Postcode","LS2 7UE"]
["Telephone","07795 391 649"]
["Email","Tom.Newbound@nhs.net"]
["Medical Purposes","□","preventative medicine"]
[null,null,"medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","People receiving care for DFU’s. "]
["Description of confidential patient information used","NHS number NDFA status and ECG status."]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,null,"Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","NHS England "]
["Status","Supported"]
[]
["Next Review Date","2023-03-13"]
["Notes","Specific conditions of support                                                                                                                         1. The applicant should confirm that they will consider patient notification and opt-out through the website and that they would provide an update on the progress of this at next annual review stage.\n2. Confirmation from the IGT Team at the Health and Social Care Information Centre of suitable security arrangements via Information Governance Toolkit (IGT) submission. Confirmed via email, October 2016.\n3. Recommendation from Caldicott Guardian provided on 13 March 2017."]

{"sheet":"A0925","index":92,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","0925"]
["Reference","17/CAG/0017"]
["Other Refs"]
["Application Title","Enhancing the Safety of Midwifery-Led Births enquiry (ESMiE)"]
["Application Summary","Purpose of application\nThis application from National Perinatal Epidemiology Unit, University of Oxford set out the purpose of a confidential enquiry of intrapartum stillbirths and intrapartum-related neonatal deaths occurring in births planned in midwifery–led settings (AMUs, FMUs and home) in England, Wales and Scotland between 2013 and 2016. This application concerns an ‘add-on’ confidential enquiry which is designed to complement the current MBRRACE-UK 2016 confidential enquiry into term intrapartum stillbirths and intrapartum related neonatal deaths.   A UK-wide confidential enquiry into term intrapartum related stillbirths and neonatal deaths (collectively referred to as perinatal deaths) is currently being conducted as part of the MBRRACE-UK run UK-wide Maternal, Newborn and Infant Clinical Outcome Review Programme (MNI-CORP). The majority of births and thus perinatal deaths in England (87% of births in 2013) occur in consultant-led obstetric units. The findings of the MBRRACE-UK enquiry will therefore predominantly relate to care provided in obstetric units, and only a small proportion of the cases investigated are likely to have occurred in planned home births or in planned births in freestanding (FMU) and alongside midwifery units (AMU). Deaths in births planned in these midwifery-led settings are an equally important group to investigate because the proportion of births in these settings is increasing and the nature of suboptimal care may be different, particularly in out-of-hospital settings (FMUs and home).                                                The primary purpose of the ESMiE confidential enquiry is to review the quality of care during pregnancy and birth received by women and babies in births planned in midwifery units, freestanding maternity units and at home which end in intrapartum-related perinatal death. The overall aim of the enquiry is to increase understanding of the potentially avoidable or remediable factors involved in intrapartum stillbirths and intrapartum-related neonatal deaths in births planned in midwifery-led settings and to identify areas where care might be improved to avoid future similar deaths. Reports of the findings and recommendations of this work will be disseminated to policy makers, commissioners, service providers, practitioners and patient groups with the aim of supporting changes that improve the quality and safety of maternal and newborn health care.                                                                                         Support was requested to enable the following activities:\n To use identifiable patient data held in the MBRRACE-UK perinatal death surveillance system (held in the MBRRACE-UK data hub at the University of Oxford) to identify a sample of intrapartum stillbirths and intrapartum-related neonatal deaths that occurred in births planned to occur in AMUs, FMUs and at home between 1 January 2013 and 31 December 2016.\n To collect and process patient identifiable information from case notes for the purposes of conducting a confidential enquiry of intrapartum stillbirths and intrapartum-related neonatal deaths."]
["Applicant Organisation Name","University of Oxford"]
["Contact Name","Professor Jenny Kurinczuk"]
["Address","National Perinatal Epidemiology Unit"]
[null,"Old Road Campus"]
[null,"Headington, Oxford"]
["Postcode","OX3 7LF"]
["Telephone"]
["Email","jenny.kurinczuk@npeu.ox.ac.uk"]
["Medical Purposes","□","preventative medicine"]
[null,null,"medical diagnosis"]
[null,"□","medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,"□","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","The cohort will include intrapartum stillbirths and intrapartum-related neonatal deaths occurring in births planned in alongside midwifery units (AMU), freestanding midwifery units (FMU) and at home. There will be 50 cases identified per planned place of birth setting. The list of sampled cases will be identified using the MBRRACE-UK perinatal surveillance database."]
["Description of confidential patient information used","Maternal details\n Full name,\n Date of birth,\n Hospital/NHS number,\n Ethnicity\n Country of birth\n Home address including postcode,\n Full clinical information relevant to the pregnancy, baby death and postnatal and bereavement care of the woman.\nBaby details\n Full name,\n Date of birth,\n Hospital/NHS number,\n MBRRACE-UK ID,\n Ethnicity,\n Planned and actual place of birth (Trust/Health Board),\n Birthweight,\n Gestation at delivery,\n Sex,\n Home address including postcode,\n Place and cause of death,"]
["S251 Class(es)",null,"Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,"□","Class II - present or past geographical locations of patients "]
[null,"□","Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Department of Health"]
["Status","Expired"]
[]
["Next Review Date"]
["Notes","All identifiers have been deleted.\n\nEvery year in the UK around 100 intrapartum-related perinatal deaths occur in births where the woman received labour care in a midwifery unit or at home. These babies, who were alive at the start of labour, died during labour or in the first month after birth from problems that occurred during labour or birth. The aim of the confidential enquiry carried out under Regulation 5 support was to identify ways in which care during labour and birth might be improved to prevent similar deaths in the future. Overall the purpose of the enquiry was for the wider public benefit of ensuring policy and practice leads to improved patient outcomes. Findings from the enquiry were widely disseminated. This included a publication in a peer reviewed journal https://obgyn.onlinelibrary.wiley.com/doi/full/10.1111/1471-0528.16327, a presentation at an MBRRACE-UK event attended by over 200 maternity care health professionals, and a meeting for national policy and practice stakeholders from across the UK. Findings of the enquiry prompted two further research projects, including a national survey about preparedness for the management of emergencies in midwifery units, which led to the setting up of a NHS England working group to address some of the issues identified.\n\nSpecific Conditions of Support\n1. Support is extended to cover England and Wales only.\n2. Support is extended to cover up to 100 samples across the three specified birth settings – once the sample size has been achieved within each cohort, up to the total cohort of 100 patients, no further records can be screened for eligibility.\n3. Patient Notification Materials – review draft information for the website and revise language used to make this more accessible for a broader audience. Provide an update at the time of first annual review around the revisions which have been made.\n4. Confirmation from the IGT Team at NHS Digital of suitable security arrangements via Information Governance Toolkit (IGT) submission. (Confirmed in place as follows:\nUniversity of Leicester – The Infant Morbidity and Mortality Studies (TIMMS): EE133832/ECC0013 (hosted second use team/project), Version 13 (2015-16) reviewed satisfactory grade at 79% (with an improvement plan in place).\nUniversity of Oxford – National Perinatal Epidemiology Unit: EE133863-8J017-NPEU (hosted secondary use team/project), Version 13 (2015-16) reviewed satisfactory grade at 100%.)"]

{"sheet":"A0926","index":93,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0926"]
["Reference","16/CAG/0157"]
["Other Refs"]
["Application Title","2017 Community Mental Health Survey"]
["Application Summary","This application from Picker Institute Europe set out the purpose of understanding patients’ experiences of NHS services and to drive improvements to the services.                                        The application was for a recommendation of support for the transfer of patient identifiable data from mental health providers, to an approved survey contractor for the purpose of mailing out questionnaires for the 2017 community mental health survey.\nAlongside this the applicant also wished to pilot four new interventions to increase response rate and make the survey more representative. These were: pre approach mailer, in a sealed envelope, redesigned covering letter, redesigned questionnaire (layout and colour) and redesigned flyer (targeted at 18 – 35 age group). Patients would be randomised to receive different combinations of these ‘interventions’.\nThe methodology used for this survey was approved by CAG in 2015 for the 2016 Community Mental Health Survey. There had been one change to this methodology, which was approved as an amendment to the National Patient Survey Programme in August 2016. This amendment was to enable Trusts to submit one file containing both mailing and sample to the contractor, as opposed to two separate files.                                                                                                 Some NHS Trusts could opt to undertake the mailing of questionnaires themselves, but most would use contractors. The application concerned the use of contractors only."]
["Applicant Organisation Name","Picker Institute Europe"]
["Contact Name","Chris Graham"]
["Address","Buxton Court"]
[null,"3 West Way"]
[null,"Oxford"]
["Postcode","OX2 0JB"]
["Telephone","01865 208118"]
["Email","Chris.graham@pickereurope.ac.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Data from Mental Health Trusts in relation to people aged 18 and over who had been in contact with NHS mental health services in the three month period, 1 September 2016 to 30 November 2016, and who were receiving specialist care or treatment for a mental health condition, including those who receive care under the Care Programme Approach (CPA). "]
["Description of confidential patient information used","Name and full Address including Postcode"]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,null,"Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Care Quality Commission"]
["Status","Supported"]
[]
["Next Review Date","2017-12-22"]
["Notes","Specific conditions of support                                                                                                                     1. The Sub-Committee suggests using the online patient panel to seek patient views on access to names and addresses by contractors. Please note that this is a suggestion only and support is not conditional on this point.\n2. The Sub-Committee suggests that the possibility of opting out of the survey is mentioned within the main text of the letter, for example adding the text ‘if you have any questions including what to do if you do not wish to take part…’ in the final paragraph. Please note that this is a suggestion only and support is not conditional on this point."]

{"sheet":"A0927","index":94,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","0927"]
["Reference","CAG 6-06(a)/2014"]
["Other Refs"]
["Application Title","Welsh Cancer Intelligence and Surveillance Unit (WCISU)"]
["Application Summary","This application from Public Health Wales set out the purpose of a population-based national cancer register for Wales.\nWCISU’s role was to provide cancer-specific health intelligence for public health and population health action related to:\n• Root causes of poor health and health inequalities.                                                                           • Population health improvement\n• Disease prevention\n• Population health needs assessment\n• Health care service planning\n• Evaluation, research and development."]
["Applicant Organisation Name","Public Health Wales NHS Trust"]
["Contact Name","John Lawson"]
["Address","No 2 Capital Quarter"]
[null,"Tyndall Street"]
[null,"Cardiff"]
["Postcode","CF10 4BZ"]
["Telephone","029 2010 4307"]
["Email","John.Lawson@wales.nhs.uk "]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Patients within the resident population of Wales diagnosed with a registerable disease i.e. cancer."]
["Description of confidential patient information used","Forename, Surname, Date of birth, Address, Postcode, NHS number, Hospital case record number, Treating hospital(s), Treating clinician(s), Date of diagnosis, Details of examinations and treatments carried out i.e. colonoscopy, CT, barium enema, diagnostic biopsies, surgery, Full pathology details of registered diseases, Multiple Disciplinary Team (MDT) findings, Stage of tumour, Treatments, Death date, Causes of death."]
["S251 Class(es)",null,"Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Public Health Wales NHS Trust"]
["Status","Supported"]
[]
["Next Review Date","2023-01-10"]
["Notes","Amendment Request dated 30/01/17\nThe amendment requested the following changes to the existing supported project:\n1. Notify of a change of organisation address – as of September 2016\n2. Inform of a change of IT support to Public Health Wales informatics – which simplifies and strengthens all security arrangements and brings IT support and security for WCISU within the same legal authority\n3. Implementation of Public Health Wales ENCORE – this is a migration of the Welsh system onto Public Health Englands system\n4. A request for additional data sources with new data items;\na. SACT (systemic anticancer treatment)\nb. Private hospitals\nc. Primary care\nd. Wales cancer patient experience survey (WCPES)\ne. National Audit Data\nf. Prescribing data\ng. Patient related outcome surveys\nh. National imaging results                                                                                                                       Specific conditions of support dated 30/01/17                                                                                     1. If the applicant wishes to extract data from primary care a further amendment would need to be submitted to CAG for review which would require a targeted patient notification with specific instructions on how individuals could opt out/object\n2. Security assurance arrangements\na. The expectation is for the assessment to reach 91% within one year from final approval to avoid jeopardising the state of future approval. It is understood that the report confirms that a report to the WIGB on the progress made against the outstanding actions against the CPIP assessment will be required in the October 2017 meeting.\nb. There should be full compliance with regards to a mechanism to respect patient objection. The CAG will look specifically at this aspect at time of annual review.\nc. A detailed report at time of annual review showing compliance with all outstanding actions. If there is any possibility that at time of annual review that all aspects have not been achieved, or that an improvement plan exists, this must be flagged in advance with the Advice Team following the report to WIGB in October 2017.\nd. As the Head of IG is named as the lead for the outstanding aspects, to consider that this role be present at time of next consideration"]

{"sheet":"A0928","index":95,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0928"]
["Reference","16/CAG/0108"]
["Other Refs"]
["Application Title","National Clinical Audit for Specialist Rehabilitation following major Injury (NCASRI: Data linkage within the Major Trauma pathway."]
["Application Summary","This application was submitted by London North West Healthcare NHS Trust on behalf of the Healthcare Quality Improvement Programme (HQIP). The National Clinical Audit of Specialist Rehabilitation following Major Injury (NCASRI) was commissioned by the HQIP on behalf of NHS England to examine current provision of services for patients who have suffered severe injuries. A key component of the NCASRI programme is to link the TARN and UKROC datasets in order to be able to track individual patients discharged from major trauma centres to identify those that subsequently received specialist rehabilitation.\nThis will provide the facility to relate outcomes to presentation characteristics and process information, such as early implementation of the rehabilitation prescription, prompt referral and transfer times, and appropriate levels of specialist input. The audit will drive (a) improved and equitable access to specialist rehabilitation services for eligible patients, (b) improved physical and psychological recovery and (c) the reduction of long-term disability and costs of on-going care, to the individual and their families and to society.                                                                It is anticipated that this will lead to overall findings that improve the quality of care offered to the wider population of patients, especially for the population of severely injured patients requiring specialist rehabilitation following major trauma."]
["Applicant Organisation Name","Northwick Park Hospital"]
["Contact Name","Professor Lynne Turner-Stokes"]
["Address","The UK Rehabilitation Outcomes Collaborative (UKROC), London North West Healthcare Trust"]
[null,"Watford Road"]
[null,"Harrow, Middlesex"]
["Postcode","HA1 3UJ"]
["Telephone","(0) 208-869-2800"]
["Email","lynne.turner-stokes@doctors.org.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","All adult patients (16 years or over) admitted to a Major Trauma Centre (MTC) from 1/7/2016 who are identified as having complex rehabilitation needs and require specialist rehabilitation in a UKROC-registered specialist rehabilitation service for the duration of the audit. All conditions are eligible, including musculoskeletal, vascular, neurological and other non-neurological conditions, including amputation."]
["Description of confidential patient information used","• Age,                                                                                                                                             • Gender\n• Ethnicity\n• GP, CCG and funding source details\n• Postcode (1st part only)\n Date of birth,  NHS number,  Date of death "]
["S251 Class(es)",null,"Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","London North West Healthcare NHS Trust"]
["Status","Expired"]
[]
["Next Review Date","2019-01-10"]
["Notes","14 December 2020 - Support expired\nConfirmed by email from HQIP. Dataset transferred to new support under CAG reference 18/CAG/0166.\n\nSpecific Conditions of Support\n1. Support extends to relevant information generated in England and Wales only.\n2. Support extends only to processing information for the purposes of the activities specified in the application. Processing of information, under this reference, for research purposes is excluded from the scope of the support.\n3. Confirmation from the IG External Delivery Team at NHS Digital of suitable security arrangements via Information Governance Toolkit (IGT) submission. Published v13 score reviewed grade specified as ‘Satisfactory’."]

{"sheet":"A0929","index":96,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0929"]
["Reference","15/CAG/0197"]
["Other Refs","15/CAG/0170"]
["Application Title","Holding patient identifiable data within the National Head and Neck Cancer Audit (HANA)(prospective elements)"]
["Application Summary","This application from Saving Faces, the Facial Surgery Research Foundation, set out the purpose of conducting a commissioned audit on behalf of the Healthcare Quality Improvement Partnership (HQIP). The HANA database aims to assess and improve the quality of services and the outcomes achieved by head and neck cancer treatments across the NHS. The data will provide comparative information to patients, commissioners and regulators of healthcare professionals. HANA will collect data on pre-operative health status and co-morbidity, details of the treatments provided and the principle healthcare professionals responsible, and also the development of any recognised complications following surgical and non-surgical treatments delivered within NHS hospitals.\nThe applicant was seeking ‘s251 support’ in order for confidential patient information to be disclosed to Dendrite Clinical Systems Ltd for the purpose of data linkage, retaining the linked datasets (includes identifiers) as part of a database for audit purposes, and to anonymise the data prior to transfer to Saving Faces for the purpose of analysis.                                                                The applicant was also seeking s251 support in order to disclose NHS Number to the Health and Social Care Information Centre (HSCIC) for the purpose of checking mortality data to determine whether the patient was deceased and the associated cause of death.                The original application, which had been reviewed at the August 2015 CAG meeting had also sought ‘s251 support’ in order for HSCIC to disclose the DHANO historical data set, which included confidential patient information, to Dendrite Clinical Systems Ltd, for the purpose of data linkage and retaining the data within the database. These retrospective elements (the transfer of DAHNO data from HSCIC to Dendrite) had received final approval for 12 months on 25 September 2015 under reference 15/CAG/0170. Therefore this application was for the prospective elements of the study only.\nSupport was requested for the following purposes;\n• Hospital performance – facilities and their timely availability, pastoral aspects of care\n• Clinician performance - surgical skills of surgeons measured BHANO standards and the current surgeon-level reporting fields; and for the first time oncologist performance in terms of disease control and complications\n• Long-term treatment outcomes – complications of treatment, disease control and survival"]
["Applicant Organisation Name","Dendrite Clinical Systems"]
["Contact Name","Mr Neal McCann"]
["Address","Information Governance Manager"]
[null,"Henley on Thames"]
[null,"Oxfordshire"]
["Postcode","RG9 1AY"]
["Telephone","44 1491 411 288"]
["Email","nmccann@e-dendrite.com"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Patients with a diagnosis head and neck cancer in England and Wales"]
["Description of confidential patient information used","First name, last name, NHS number, date of birth, postcode, date of treatment, date of death"]
["S251 Class(es)",null,"Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,null,"Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Healthcare quality Improvement Partnership (HQIP)"]
["Status","Supported"]
[]
["Next Review Date","2017-12-11"]
["Notes","June 2022 - Support Expired\nSuperseded by 17/CAG/0073.\n\nSpecific conditions of support\n1. Feedback on the discussed pilot on consent to be provided to the CAG when available or at time of annual review\n2. Update on progress with moving towards an exit strategy in line with other HQIP audits should be provided at next annual review stage.\n3. Exploration of, and move to, ensuring relevant identifiers are should be provided that the identifiers including the name would be destroyed when no longer need for example in the case of death.\n4. Patient facing materials should be revised to be written in clear English, be specific about the identifiers being used and why and should refer explicitly to the mechanism for patients to register an objection.\n5. The processing of information for the purpose of direct care is excluded from the scope of this support.\n6. Any processing of data to support research purposes is excluded from the terms of this support. A new IRAS application would be required if intending to process data for the purposes of research.\n7. Confirmation from the IGT Team at the Health and Social Care Information Centre of suitable security arrangements via Information Governance Toolkit (IGT) submission. Please see security review requirement section of the HRA website: http://www.hra.nhs.uk/resources/confidentiality-advisory-group/confidentiality-advisory-group-cag-application-advice/ and contact Exeter.helpdesk@nhs.net with any queries. CONFIRMED 15/07/2015"]

{"sheet":"A0930","index":97,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0930"]
["Reference","17/CAG/0006"]
["Other Refs"]
["Application Title","An evaluation of the level of clinician's adherence to the NICE hypertension in pregnancy guidance across maternity units in England"]
["Application Summary","This application from Bradford Teaching Hospitals set out the purpose which will gather information related to indicators of adherence to the UK National Institute for Health and Clinical Excellence's Hypertension in Pregnancy guideline. Information including: aspirin prescription for high risk women, measurement of blood pressure and proteinuria at each antenatal visit and recognition of deviations from normal with referral to specialist services and enhanced monitoring will be obtained.\nResearch teams working within each maternity unit taking part in this study will obtain the medical records of women who had given birth at their unit either before or after the publication of the most recent NICE hypertension in pregnancy guideline. The information will allow the applicants to see if there had been changes to the consistency and quality of care following the publication of the national guideline and if this varied across maternity units. This will also allow assessment of how well doctors and midwives follow care recommendations and this will then be used to inform education programmes to improve adherence to guidance and in doing so improve the consistency and quality of care for all future pregnant women."]
["Applicant Organisation Name","Bradford Teaching Hospitals"]
["Contact Name","Dr Diane Farrar"]
["Address","Bradford Institute for Health Research"]
[null,"Bradford Royal Infirmary"]
[null,"Bradford"]
["Postcode","BD9 6RJ"]
["Telephone","01274383416"]
["Email","diane.farrar@bthft.nhs.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","The patient cohort is defined as women delivering in the study maternity units, after 24 weeks gestation, during the years 2009-2010 and 2012-2013, to provide contemporary data but excluding the year the revised NICE guidance was released. The infant’s date of birth is being utilised to calculate a random sample of patient records of woman delivering children to be included within the study. The applicants requested support to collate information in relation to 8000 patients across 10 maternity units within the England."]
["Description of confidential patient information used","Mother's date of birth, Hospital number, Infant's date of birth                                                              Only infant’s date of birth will be held for analysis as this will determine whether the child was born pre or post NICE guidance issue."]
["S251 Class(es)",null,"Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Bradford Teaching Hospitals"]
["Status","Supported"]
[]
["Next Review Date","2019-03-16"]
["Notes","Specific Conditions of Support                                                                                                         1. The Committee recommended that the child’s date of birth was extracted in month and year of birth. Provide agreement to this term, or if this is not appropriate for the project, provide a stronger rationale to support the extraction and retention of the date of birth in the complete form.  \n2. Clarify the focus years for the study, before and after the NICE guidance.                            3. Confirm the items of confidential patient information which will be recorded on the research forms within the Trusts.                                                                                                                   4. Patient notification and objection – posters should be drafted for display in baby clinics, together with an advert to be displayed on the Institution website to provide details of the project and opt-out arrangements. Submit copies of the documentation for consideration together with an explanation of how the opt-out system will be managed.                                                5. Provide clarification of the security arrangements for study linkage data which will be stored at the relevant Trust sites, including details of how and where it will be stored and who will be able to access this information.                                                \n6. Patient Notification and Objections – posters and advertisements, as detailed above, need to be displayed in the appropriate areas to facilitate notification and allow patient dissent. An update can be included at first annual review around this.\n7. Provide an update on the progress made securing CRN funding for the project – this should be included at first annual review.\n8. Confirmation from the IGT Team at NHS Digital of suitable security arrangements via Information Governance Toolkit (IGT) submission. (Confirmed - Bradford Teaching Hospitals NHS Foundation Trust, Version 13 2015-16, states a self-assessed satisfactory score – reviewed grade confirmed by email 09/03/2017)."]

{"sheet":"A0931","index":98,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0931"]
["Reference","17/CAG/0045"]
["Other Refs"]
["Application Title","Hospital-Led Innovations for End of Life Care"]
["Application Summary","This application from McKinsey and Company on behalf of Hospice UK and NHS England set out the purpose of evaluating the effectiveness of innovations in end of life care. \n\nResearch had shown that 80% of patients preferred to die at home, and only 5% in hospital, however the reality was that end of life care was more likely to take place in a hospital setting, which was costly as well as unwelcome for patients. Care models had been introduced at 24 hospices, aimed at reducing hospital-based end-of-life care. These models of care would be evaluated using both quantitative and qualitative methodology; the end result would be a report and set of recommendations for NHS England and end of life care commissioners, and advice for hospices on how to implement the most effective new models. \n\nThis application specifically related to the use of identifiable information to link patient datasets for quantitative analysis, in order to examine whether rates of hospital-based end-of-life care decreased where the new care models were used.\n\nThe Hospices involved would transfer identifiable information to NHS Digital, who would link these to the HES database, and provide PHE with the pseudonymous HES IDs.  Support under Section 251 was requested to cover this activity only. \n\nFurther linkage would take place at PHE under an alternative legal basis. The applicant would be provided with aggregated, de-personalised data for analysis. \n"]
["Applicant Organisation Name","McKinsey and Company "]
["Contact Name","Mr Giles Colclough"]
["Address","1 Jermyn Street"]
[null,"London "]
[]
["Postcode","SW1Y 4UH"]
["Telephone","0207 839 8040"]
["Email","giles_colclough@mckinsey.com"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Adult patients who have benefited from selected hospice-led innovations in end of life care, who lived and died in England between 2010 and 2017. "]
["Description of confidential patient information used","NHS number, date of birth, gender, postcode. "]
["S251 Class(es)",null,"Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","NHS England "]
["Status","Expired"]
[]
["Next Review Date","2018-03-29"]
["Notes","18 August 2020 - Expiry of study support: study confirmed that support is no longer needed as all data is pseudonymised.\n\nSpecific conditions of support\n1. Public involvement work to be carried out with a hospice user group, or similar, to test the acceptability of accessing identifiable patient data without consent (outside the direct care team) for this purpose. This should be reported back at annual review. \n2. Confirmation from the IGT Team at NHS Digital of suitable security arrangements via Information Governance Toolkit (IGT) submission. (IG toolkit confirmed published and reviewed as satisfactory - McKinsey and Company, Version 13, 2015-16). \n"]

{"sheet":"A0932","index":99,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","0932"]
["Reference","16/CAG/0140"]
["Other Refs"]
["Application Title","The British Association of Urological Surgeons (BAUS) Audits"]
["Application Summary","This application from the British Association of Urological Surgeons set out the purpose of non-research audits into the following urological surgical procedures:\nNephrectomy, Radical Prostatectomy, Cystectomy, Percutaneous Nephrolithotomy (PCNL) – stone surgery, Female Stress Urinary Incontinence, Urethroplasty, Retroperitoneal Lymph Node Dissection (RPLND), Ureteroscopic Stone Surgery, Upper Tract Transitional Cell Carcinoma.\nThe application requests support to collect follow-up information on patients whose data had formed part of the historic audit publications and also requests support for the prospective collection of information about patients who will be undergoing these procedures.\nThe purpose of these audits is to ascertain which surgeons are undertaking these particular procedures, where the surgery is being carried out and how well it is being done with the aim of monitoring performance and improving patient care. The audits will be used to monitor which surgeons are undertaking these specific procedures and to monitor their performance. The audit information will be used to inform commissioning and NICE guidance.\nThe BAUS audit programme had historically received support for a cancer audit programme with a smaller focus. This application was originally considered under PIAG in 2004. Following notification of a change in process by the BAUS team in 2011, it was determined by NIGB that support was no longer required as confidential identifiable patient data was no longer leaving the clinical care team.\nThe application identified that the BAUS system had subsequently changed, since the suspension of the previous PIAG/NIGB support, in May 2015, from which time, confidential patient identifiable data had been processed through the arrangement with Dendrite. It appeared that there was no lawful basis for the data processing from May 2015 onwards."]
["Applicant Organisation Name","The British Association of Urological Surgeons"]
["Contact Name","Ms Patricia Hagan"]
["Address","35-43 Lincoln’s Inn Fields"]
[null,"London"]
[]
["Postcode","WC2A 3PE"]
["Telephone","0207 6869 6952"]
["Email","phagan@baus.org.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","The application covers two intended cohorts. The first cohort is intended to cover patients who formed part of historic audit publications and requests support to collect follow-up information on these individuals. The second cohort is prospective and is intended to cover those patients who will be undergoing the above identified urological surgical procedures moving forward."]
["Description of confidential patient information used","Forename, Surname, Date of birth, Date of operation, Date of discharge/death, Cause of death, Sex."]
["S251 Class(es)",null,"Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","The British Association of Urological Surgeons"]
["Status","Expired"]
[]
["Next Review Date","2021-03-30"]
["Notes","12 May 2021 - Support expired\nAll data held was destroyed on that date.  \n\nA list of publications arising from the BAUS registries is available on our website: https://www.baus.org.uk/_userfiles/pages/files/publications/audit/BAUS%20Data%20and%20Audit%20project%20publications%20-%20April%202021.pdf\n \nAnnual reports from the audits are also available on the site: https://www.baus.org.uk/professionals/baus_business/data_audit.aspx\n \nFor patients and the wider public surgeon and unit specific data has been available on our site for a number of years, this data will be removed at the end of this year but the summary data provided for each audit will remain available. https://www.baus.org.uk/patients/surgical_outcomes/default.aspx\n\nSpecific Conditions of Support (Updated)\n1. Support does not apply retrospectively to any data processing that has taken place prior to final support coming into effect.\n2. Provide an interim report on actions undertaken in relation to patient notification and how this has moved forward, providing detail of any actual activity which has taken place or an overview of activity which has been scheduled for the future. This report is required three months after final support for the application has been issued.                                                                  3. Provide an interim report on the actions which have been undertaken and progress made around taking prospective consent from patients for the inclusion of their data within the audits. This report should be provided nine months after final support for the application has been issued and will be considered ahead of the annual review.\n4. At first annual review, provide an update on the projects were being undertaken around data linkage together with detail around the data items required to enable future linkage.\n5. At first annual review, provide an update on progress in discussions with NHS Digital and other government organisations, around the possibility of moving to a different data collection system which makes greater use of HES and moves away from the requirement to retain patient identifiable data to enable the audits to be carried out.\n6. Confirmation from the IGT Team at the NHS Digital of suitable security arrangements via Information Governance Toolkit (IGT) submission. (Confirmed - Dendrite on Version 13 2015-16 shows a reviewed grade of satisfactory, published 21/04/2016)"]

{"sheet":"A0933","index":100,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number",933]
["Reference","17/CAG/0085"]
["Other Refs"]
["Application Title","Audit of the Comprehensive Health Assessment Tool (CHAT)"]
["Application Summary","The University of Manchester has been commissioned by NHS England to undertake a clinical audit of the Comprehensive Health Assessment Tool (CHAT) within the Children and Young People’s Secure Estate.  Since 2004, the Department of Health and more recently NHS England have commissioned the University of Manchester to develop the Comprehensive Health Assessment Tool (CHAT) for the Children and Young People’s Secure Estate, aged 10-18 years old. The CHAT consists of a first night risk assessment, to identify urgent and immediate health needs; followed by a more comprehensive assessment of physical health (to be completed within 3 days of admission), mental health (to be completed within 3 days of admission), substance misuse (to be completed within 5 days of admission) and neurodisability (to be completed within 10 days of admission). The CHAT also consists of care plans which follow a young person from admission to discharge, with the aim of ensuring health needs are met, or plans are in place once they transition out of the Secure Estate into community services e.g. Youth Offending Teams.\n\nThe University of Manchester was further funded to provide training to all healthcare staff within the Secure Estate on how to use the CHAT and to support the implementation of the CHAT in each establishment. As of January 2016, the CHAT is in routine use within each of the 21 establishments which form the Children and Young People’s Secure Estate. The Secure Estate consists of four Young Offender Insitutions, three Secure Training Centres and 12 Secure Children’s Homes. \nIn 2016, NHS England commissioned the University of Manchester to undertake an audit of CHAT. The aim is to undertake a process-based clinical audit of the implementation and quality of CHAT assessments and subsequent care planning, for example auditing if there are clear care pathways for onward referral once health needs are identified by the CHAT.  \n\nThe audit will result in one overall report to NHS England which will contain overarching themes and recommendations for improvements to practice.  Each site will also be provided with an individual report containing a tailored action plan and recommendations.            \n\nThe application defines a medical purpose through the audit of CHAT assessment tool. On 24th February 2017, The Youth Custody Improvement Board (YCIB) reported specially that ‘A review of the use of the Comprehensive Health Assessment Tool (CHAT) should be undertaken to ensure it is effectively collecting and communicating the information about individual young people that is needed.  This audit would fulfil this ministerial requirement.  The applicants state that improvements in health care provision as a result of this audit are firmly in the public interest. \n"]
["Applicant Organisation Name","University of Manchester"]
["Contact Name","Dr Charlotte Lennox"]
["Address","2.315 Jean McFarlane Building"]
[null,"University of Manchester"]
[null,"Oxford Road, Manchester"]
["Postcode","M22 4ER"]
["Telephone"]
["Email","Charlotte.lennox@manchester.ac.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","The cohort covers young people within the Secure Estate across England who had undergone a CHAT within a retrospective six month audit period. This process-based audit will sample approximately 30 CHAT assessments at each establishment of young people admitted over a retrospective six month period. For smaller sites with less than 30 admissions over six months, all CHAT assessments will be included."]
["Description of confidential patient information used","Access was requested to the individual health care records, to include mental health data, for all patients included within the audit, to allow review of the CHAT assessment and associated care plans. The applicants will extract anonymised information which will focus on the completion and quality of the CHAT assessment only."]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","University of Manchester"]
["Status","Expired"]
[]
["Next Review Date","2018-06-15"]
["Notes","Access to source data (SystmOne clinical care records) is now complete.  No patient identifiable information was extracted for the audit.\n\nThere were no public benefits to this audit.  There are however benefits for the Children and Young People within the Secure Estate.  The audit produced a series of recommendations for NHS England to act on to improve the quality and reporting in relation to the CHAT assessment.  This has direct patient benefit.\n\nSpecific Conditions of Support\n1. Patient Notification and Dissent:\na. Further consideration should be given to the improvement of patient notification and dissent opportunities for patients within the Secure Estate, to enable any individuals still residence to be informed of the audit and allowed opportunity to dissent, should they wish,\nb. An information poster should be produced and submitted for consideration together with any additional materials which are devised,\nc. An overview report of additional activity, together with any relevant supporting documentation should be submitted for consideration within three months of the date of this letter.\n2. Confirmation from the IGT Team NHS Digital of suitable security arrangements via Information Governance Toolkit (IGT) submission. (Confirmed - University of Manchester - Offender Health Research Network shows a published reported score of 83% on Version 13 2015/16).\nRecommendation\n1. It was recommended that the consenting process for the overall CHAT assessment be revised to include specific consent for audit activity. With prospective consent in place, there would be no requirement to seek support under the Regulations for any future audits of the system. If this was not deemed to be feasible, any future application for support under the Regulations would require more detailed plans in relation to patient notification and dissent mechanisms."]

{"sheet":"A0934","index":101,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number",934]
["Reference","17/CAG/0070"]
["Other Refs"]
["Application Title","2017 Adult Inpatient Survey"]
["Application Summary","This non-research application from Picker Institute Europe, CQC and NHS England set out the purpose of carrying out the 2017 NHS Adult Inpatient Survey, using standardised methodology to build up a national picture of patient experiences. A set of aggregated statistical data was produced which was shared with individual Trusts, CQC, NHS England and the Department of Health and used to monitor and compare the performance of trusts, and to drive improvements.\nThis survey would be the 15th carried out to date. The methodology was well established and had been approved by the CAG via Precedent Set Sub-Committee.\nParticipating trusts identified the sample in line with the inclusion/exclusion criteria, and disclosed names and addresses to approved contractors for the purpose of mailing out the surveys (this data was held in a mailing file along with the unique identifying code which is printed on the survey itself). Demographic information for each potential participant was collected in a separate sample file, linked by the identifying code.\nPicker Institute was commissioned to manage and coordinate the surveys under the title of the Patient Survey Coordination Centre, carrying out checks across the samples submitted by trusts and disseminating aggregated results (identifiable information was not received by the Patient Survey Coordination Centre).\nThis application was escalated from the Precedent Set review to the CAG meeting due to the addition of a new approach to be piloted with up to 10 of the Trusts: - sending SMS reminders to potential participants after the 1st and 3rd mailing of the survey (where the patient had not responded to the survey). As this was a new element where precedent advice had not been set, the advice of the CAG was sought.\nIf the pilot were successful, the applicant intended to request support for a roll-out of this approach as standard across the survey programme, citing reduced costs as the main benefit of text messages as opposed to postal reminders"]
["Applicant Organisation Name","Picker Institute Europe"]
["Contact Name","Carolina Casanas i Comabella"]
["Address","Buxton Court"]
[null,"3 West Way"]
[null,"Oxford"]
["Postcode","OX2 0JB"]
["Telephone"]
["Email","Carolina@PickerEurope.ac.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Access was requested to data from participating trusts in relation to inpatients aged 16 years old or over who were discharged from acute and specialist NHS hospitals in July 2017 having had one overnight stay in hospital (various exclusions were listed in the application including deceased patients and those who had registered their dissent)."]
["Description of confidential patient information used","The mailing file sent to contractors would contain the following information:\n Trust code – included in the unique identifier, below.\n A standardised unique identifier code (application listed full details of how this was constructed)\n Title (Mr, Mrs, Ms, etc.)\n First name\n Surname\n Address Fields\n Postcode (where available)\n Mobile telephone number for those patients included in the pilot, from a total of up to 10 trusts"]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2018-06-26"]
["Notes","Amendment Request (Approved - 7/11/2017)\nThe applicant had decided to use a different provider from the one originally commissioned to undertake the sending of SMS reminders (from Firetext to Healthcare Communications).\nHealthcare Communications proposed to retain the patients’ mobile telephone numbers for original application for 72 hours rather than the 24 hours proposed by Firetext. This was to enable the system to continue to try to send the text if it was not delivered the first time (due to connection problems or the phone being switched off, for example\nThe request, therefore, was for the period of retention of mobile telephone numbers by the provider to be increased to 72 hours.\n\nNotes:\nThe following approved contractors would be used:\n Picker Institute\n Quality Health\n Patient Perspective\n Capita\n Membership Engagement Services\n The SMS provider Firetext\n\nSpecific conditions of support\n1. The findings of the pilot should be reported back to the CAG, when available. The CAG agreed that this report could be provided at the time of the annual review.\n2. Confirmation from the IGT Team at the Health and Social Care Information Centre of suitable security arrangements via Information Governance Toolkit (IGT) submission. IG Toolkit numbers provided for each of the named contractors, confirmed published and reviewed with the exception of Firetext (see below):\nThe applicant advised: ‘The third party providing the SMS reminders for the pilot was changed to Healthcare Communications Ltd. This is because the third party originally proposed (FireText) was not registered with the IGT. The newly appointed third party Healthcare Communications has experience working with several NHS trusts on the Friends and Family Test, which also uses patients’ mobile telephone details, and has a 100% satisfactory IGT score’. The CAG was satisfied with this arrangement and the toolkit confirmed published and reviewed."]

{"sheet":"A0935","index":102,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number",935]
["Reference","17/CAG/0125"]
["Other Refs"]
["Application Title","All-cause mortality within 12 months following Hip Fracture"]
["Application Summary","This service evaluation application from Nuffield Department of Orthopaedics Rheumatology and Musculoskeletal Sciences (NDORMS) at the University of Oxford aimed to investigate the causes of death in patients with hip fracture. The mortality rate was unusually high (up to 30% in the 12 months following hip fracture). In 2013 61,000 patients experienced hip fracture in England, Wales and Northern Ireland therefore a considerable number of patients were affected. The published findings would enable better follow-up care by enabling clinicians to identify patients more likely to die in the 12 months following hip fracture. Potential correlations could be made between demographic trends and causes of death, increasing awareness within the medical community of the likely risks to patients, and facilitating future research on effective follow up and preventative strategies.\n\nThe applicant requested linked data from the National Hip Fracture Database (NHFD) and ONS data held by NHS Digital. Identifiable data would be provided from NHFD to NHS Digital in order to facilitate the linkage and provide pseudonymised data to NDORMS.\n\nA recommendation for class 4 and 6 support was requested to link patient identifiable information from more than one source, to allow access to an authorised user for this purpose."]
["Applicant Organisation Name","Big Health Data Group (BHDG), Nuffield Department of Orthopaedics"]
["Contact Name","Professor Andrew Judge"]
["Address","Rheumatology & Musculoskeletal Science (NDORMS)"]
[null,"Windmill Road\n"]
[null,"Oxford"]
["Postcode","OX3 7LD"]
["Telephone","01865 737837"]
["Email","andrew.judge@ndorms.ox.ac.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Access was requested to data from NHFD in relation to patients over 60 years of age undergoing hip fracture surgery."]
["Description of confidential patient information used","NHS number, date of birth, gender, postcode and unique NHFD identifier to be provided from NHFD to NHS Digital\n\nDate of death and cause of death would be returned to Oxford University for analysis, along with age, gender and clinical data.\n\nThe applicants submitted an appended data dictionary for the NHFD to provide clarification around the data items which would be returned from NHS Digital following data linkage. It was confirmed that the applicants were requesting that a complete, pseudonymised NHFD dataset is transferred to NDORMS with modification of the following data fields:\n- Patient ID number: Removed #1.03\n- Treating clinicians: Removed #1.06, #1.07, #1.08\n- Name: Removed #2.01 and #2.02\n- NHS number: Removed #2.03\n- DOB: Provided as age in years at admission (calculated from DOB and date of admission) #2.04\n- Postcode: to be converted from the postcode to Lower Super Output Area (LSOA) #2.06"]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,null,"Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","University of Oxford"]
["Status","Supported"]
[]
["Next Review Date","2022-08-15"]
["Notes","Amendment (Approved - 7/11/17)\nThe amendment requested additional support to enable NHS Digital to also undertake linkage with the HES dataset. The purpose of this additional linkage is to enable the case ascertainment quality of the NHFD to be determined by searching HES for a number of IC10 and OPCS4 codes which pertain to hip fracture. This will provide the applicants with a representative sample of the hip fracture population. The amendment would also result in limited linkage of those patients registered with the NHFD to both ONS and HES data."]

{"sheet":"A0936","index":103,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number",936]
["Reference","16/CAG/0105"]
["Other Refs"]
["Application Title","Post surgical predictors of chronic pain after total knee replacement"]
["Application Summary","This application from Big Health Data Group, Oxford University set out the purpose of linking data from the National Joint Registry with data from HES and linked PROMs data in order to study patients who have undergone knee replacement surgery, to identify post-operative factors associated with the development and persistence of pain. For the 20% of patients who experience long-term pain after surgery, this will inform future interventions that can either reduce the incidence of this kind of pain or that will provide more effective management for pain.\n\nIdentifiable data will be sent from NJR to HSCIC, for linkage and subsequent pseudonymisation. This data is held by the NJR with express written consent from the patient, recorded as ‘Yes’, ‘No’ or ‘Not recorded’. NJR also has Section 251 support to collect patient data where consent is indicated as ‘Not Recorded’.\n\nAll identifiers will be removed to produce a pseudonymised linked extract of HES/PROMS records, with each record having an associated unique NJR pseudonymised patient identifier. This information will be sent to Oxford University for analysis.\n\nA recommendation for class 1,4 and 6 support was requested for the process of extracting and anonymising the information, To link patient identifiable information obtained from more than one source and to allow access to an authorised user for one or more of the above purposes."]
["Applicant Organisation Name","Big Health Data Group (BHDG), University of Oxford"]
["Contact Name","Professor Andrew Judge"]
["Address","University of Oxford"]
[null,"Windmill Road\n"]
[null,"Oxford"]
["Postcode","OX3 7LD"]
["Telephone","01865 737837"]
["Email","andrew.judge@ndorms.ox.ac.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,"Y","medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,null,"the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Study patients who have undergone knee replacement surgery"]
["Description of confidential patient information used","Access was requested to NHS number, date of birth, gender and postcode, provided by National Joint Registry (NJR)."]
["S251 Class(es)",null,"Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,null,"Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","University of Oxford"]
["Status","Expired"]
[]
["Next Review Date"]
["Notes","All identifiers have been deleted.\n\nAlthough many patients report good outcomes after knee replacement, best quality studies indicate that around 20% of patients experience chronic post-surgical pain, defined as pain persisting three months or longer after surgery. Post-operative risk factors are important because the time after surgery may present an ideal opportunity for targeted intervention to prevent the persistence or worsening of pain. The aim of our study was to identify intra-operative and post-surgical risk factors in the development of chronic knee pain following knee replacement surgery.\n\nWe obtained data on 258,386 patients in the National Joint Registry that had a knee replacement (total or uni-compartmental), with linkage to English (HES) data, and linked PROMS data, between April 2008 and December 2016.\n\n221,354 (85.7%) met the definition of chronic knee pain pre-operatively. Of these patients, 179,699 (81.2%) no longer had chronic pain 6-months after surgery, but 41,655 (18.8%) still had chronic knee pain. 37,032 (14.3%) did not have pre-operative chronic knee pain, and of these patients although 34,985 (94.5%) still had no chronic pain at 6-months, importantly 2047 (5.5%) went on to develop chronic knee pain following surgery.\n\nWe found the following post-operative predictors of chronic pain: (1) mechanical complication of prosthesis; (2) surgical site infection; (3) readmission; (4) reoperation; (5) revision and (6) prolonged length of stay over six days. All post-operative factors with the exception of readmissions and prolonged length of stay had low incidences, meaning these would only be detected in large datasets, but would understandably not be a clinically useful chronic pain marker at a local level. This suggests that the post-operative factors explored in this analysis cannot be reliably used to identify subgroups of patients at risk of chronic pain after knee replacement.\n\nAlthough these risk factors are uncommon, they are available and captured in standard routine data, making it possible to identify such patients from their medical records. Whilst these are not necessarily modifiable risk factors, they allow us to identify high risk patients early, so that we can intervene early, such as chronic pain management strategies or alternative interventions to treat chronic pain.\n\nThe findings have been published as below, and presented at an international conference as part of the wider programme of research. The work has been written up part of the wider NIHR programme final report that is due to be published in the NIHR journal. \n\nKhalid S, Mohammad HR, Gooberman-Hill R, Garriga C, Pinedo-Villanueva R, Arden N, Price A, Wylde V, Peters TJ, Blom A, Judge A. Post-operative determinants of chronic pain after primary knee replacement surgery: Analysis of data on 258,386 patients from the National Joint Registry for England, Wales, Northern Ireland and the Isle of Man (NJR). Osteoarthritis Cartilage Open. 2021;3(1):100139. https://www.sciencedirect.com/science/article/pii/S2665913121000029?via%3Dihub\n\nGooberman-Hill, Bruce J, Wylde V, Judge A, Moore A, Beswick A, Howells N, On behalf of the STAR team. Improving the Post-operative Prediction and Management of Chronic Pain after Total Knee Replacement: The UK STAR Programme. International Association for the Study of Pain conference, Virtual presentation, June 2021.\n"]

{"sheet":"A0937","index":104,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number",937]
["Reference","17/CAG/0121"]
["Other Refs"]
["Application Title","Cancer Patient Experience Survey 2017"]
["Application Summary","This application from Quality Health on behalf of NHS England set out the purpose of administering patient surveys to evaluate services provided to cancer patients in 2017. This would enable comparisons between Trusts, for commissioners, providers and patients (all of whom could access the published results), would allow for monitoring of improvements in services, drive further improvements, and provide NHS England with an up to date overview of cancer patient experience across England.\n\nQuality Health would request a list of eligible patients from participating Trusts, and would mail out surveys to patients after removing duplicates and checking to ensure no surveys were sent to the addresses of deceased patients. Quality Health would then anonymise the data.\n\nA recommendation for class 1, 2, 5 and 6 support was requested for the process of extracting and anonymising the information, to link patient identifiable information obtained from more than one source, for auditing, monitoring and analysing patient care and treatment and to allow access to an authorised user for one or more of the above purposes."]
["Applicant Organisation Name","Quality Health"]
["Contact Name","Mr Daniel Ratchford"]
["Address","Chesterfield Road"]
[null,"Holmewood"]
[null,"Derbyshire"]
["Postcode","S42 5US"]
["Telephone","01246 856263"]
["Email","daniel.ratchford@quality-health.co.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Access was requested to data from NHS Trusts in relation to patients of 16 or over with a confirmed primary diagnosis of cancer discharged from the trust after an inpatient or day care episode, within the specified timeframe"]
["Description of confidential patient information used","Name and full address for the mailing out of surveys,\nNHS number and date of birth to avoid duplication and for validation of data"]
["S251 Class(es)",null,"Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,"Y","Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","NHS England "]
["Status","Expired"]
[]
["Next Review Date","2018-08-29"]
["Notes","Support can be expired as of 17 August 2022.\n\nAll data files for the Cohort have been deleted and relevant database fields for all patients have been overwritten with null values and are no longer accessible to any staff.\n\nSpecific Conditions of Support\n1. Ongoing PPI work to include consideration of feedback from the Quality Health helpline, particularly in relation to patients who were previously unaware that they had been diagnosed with cancer. Progress on this work should be reported back at annual review.\n2. Confirmation from the IGT Team at the Health and Social Care Information Centre of suitable security arrangements via Information Governance Toolkit (IGT) submission. (Quality Health – V14 confirmed by NHS Digital email 24/08/2017)."]

{"sheet":"A0938","index":105,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number",938]
["Reference","17/CAG/0115"]
["Other Refs"]
["Application Title","ECG Diabetic Foot Ulcer (DFU) Pilot"]
["Application Summary","This service evaluation from NHS England set out the purpose of establishing whether routine ECG for patients with diabetic foot ulcer reduced 1-5 year mortality rates in these patients.\n\nThe 5-year mortality rate for the 60,000 diabetic patients who presented every year with foot ulceration was around 50%. To address this, a pilot had been set up by NHS Improving Quality (now part of NHS England), embedding an ECG for all new diabetic foot ulcer (DFU) patients into routine care. This would enable clinical action to be taken should any issues be discovered.\n\nTo assess the effectiveness of the pilot, the applicant would cross reference National Diabetic Food Audit data with ONS mortality data to identify whether patients who received an ECG as part of routine care at the pilot sites had significantly differing 1-5 year mortality rates when compared to patients within the NDFA who received care at other sites. If the use of routine ECG for this cohort was found to significantly reduce 1-5 year mortality rates then this would have the potential to bring about a change in clinical practice across England, ultimately reducing the numbers of people who die within 5 years of developing a DFU.\n\nLinkage would be carried out by NHS Digital, who would receive identifiers from NHS Trusts along with the ECG and NDFA status of the patient. NHS Digital would link this information with mortality status and return the data set to the applicant.\n\nA recommendation for class 4 and 6 support was requested to cover activities as described within the application."]
["Applicant Organisation Name","NHS England"]
["Contact Name","Mr Nicholas Collins\n"]
["Address","5th Floor, Stephenson House"]
[null,"75 Hampstead Road"]
[null,"London"]
["Postcode","NW1 2PL"]
["Telephone","07500-225-639"]
["Email","nicholas.collins@nhs.net"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","All diabetic patients presenting with foot ulceration at participating Trusts."]
["Description of confidential patient information used","Data from participating trusts in relation to diabetic patients presenting with foot ulceration.\n- The NHS number\n- The ECG status of the patient\n- The NDFA status\nData from NHS Digital (via CARMS, Clinical Audit and Registries Management Service) to the applicant:\n- NHS Number\n- NDFA status\n- ECG status\n- ONS Mortality status"]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,null,"Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","NHS England "]
["Status","Supported"]
[]
["Next Review Date","2018-08-31"]
["Notes"]

{"sheet":"A0939","index":106,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","0939"]
["Reference","17/CAG/0152"]
["Other Refs","Replacement of CAG 5-07(c)/2013"]
["Application Title","Barts Health (NICOR) UK Transcatheter Aortic Valve Implantation (TAVI)"]
["Application Summary","This application from Bart’s Health NHS Trust set out the purpose of transferring audit registries in relation to the NICOR UK Transcatheter Aortic Valve Implantation (TAVI), previously held by University College London to Bart’s Health NHS Trust.\n\nThis historic audit application described three national audit datasets; however, it was confirmed that only one of these remained ongoing to be taken forward. This is the UK Transcatheter Aortic Valve Implantation (TAVI) registry – a record of all TAVI procedures performed in the UK since the introduction of the technique in 2007. The dataset included demographic data, indications, procedural details and outcomes up to hospital discharge. Follow up data would be collected at 1 and 3 years.\n\nThe datasets would be analysed with the aim to drive improvements in the quality of care. Findings would be shared with participating Trusts and aggregate analysis reports published.\n\nA recommendation for class 4, 5 and 6 support was requested to cover access by NICOR to identifiable data on patients undergoing the relevant procedures, to track patients across NHS organisations and to link to national datasets such as Hospital Episode Statistics (HES) and ONS mortality data."]
["Applicant Organisation Name","Barts Health NHS Trust"]
["Contact Name","Mr James Chal, NICOR Chief Operating Officer"]
["Address","National Institute for Cardiovascular Outcomes Research (NICOR)"]
[null,"Barts Health NHS Trust"]
[null,"Second Floor, 1 St Martin's Le Grand, London"]
["Postcode","EC1A 4NP"]
["Telephone","0203 765 8539"]
["Email","j.chal@nhs.net"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,"Y","the provision of care and treatment"]
[null,null,"the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","This is the UK Transcatheter Aortic Valve Implantation (TAVI) registry – a record of all TAVI procedures performed in the UK since the introduction of the technique in 2007. The dataset included demographic data, indications, procedural details and outcomes up to hospital discharge. Follow up data would be collected at 1 and 3 years. A recommendation for class 4, 5 and 6 support was requested to cover access by NICOR to identifiable data on patients undergoing the relevant procedures, to track patients across NHS organisations and to link to national datasets such as Hospital Episode Statistics (HES) and ONS mortality data."]
["Description of confidential patient information used","Access was requested to name, NHS number, date of birth, date of death."]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Anita Sanghi, Barts Health (NICOR)"]
["Status","Expired"]
[]
["Next Review Date"]
["Notes","Expired\n\nApplication superseded by new application 22/CAG/0116. Changes to controller as of 24th June 2022\n\n\nSpecific Conditions of Support\n1. All pre-existing conditions of support related to CAG 5-07(c)/2013 remain applicable\n2. The pre-existing annual review cycle remains applicable, with the next annual review to be received 4 weeks before 31/12/2017, and then on an annual basis to this schedule.\n3. Updates around public and patient engagement activities should be provided as part of the standard annual review submission.\n4. Confirmation from the IGT Team at the Health and Social Care Information Centre of suitable security arrangements via Information Governance Toolkit (IGT) submission. (Confirmed - Barts Health reports an assessed satisfactory score at 77% (version 14 (2016-2017)."]

{"sheet":"A0940","index":107,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","0940"]
["Reference","17/CAG/0153"]
["Other Refs","(Previously CAG 10-07(b)/2014)"]
["Application Title","NICOR Commissioning through Evaluation (CtE) Registries/Audits"]
["Application Summary","This application from Bart’s Health NHS Trust set out the purpose of transferring audit registries in relation to the NICOR Commissioning through Evaluation Registries/Audits previously held by University College London to Bart’s Health NHS Trust.\n\nThis application set out the purpose of undertaking three audits for the NHS England Commissioning through Evaluation (CtE) programme. The CtE programme comprises the following registries:\n1. Percutaneous Mitral Valve Repair: a catheter-based device which is used to repair heart valves, providing an alternative to open heart for those patients who are clinically appropriate\n2. Left Atrial Appendage Occlusion: a device used to prevent stroke in patients with atrial fibrillation (irregular and rapid heartbeat)\n3. Patent Foramen Ovale Closure in Adults: a procedure to close a hole, or potential hole, between the upper chambers of the heart, to prevent stroke"]
["Applicant Organisation Name","Barts Health NHS Trust"]
["Contact Name","James Chal, NICOR Chief Operating Officer"]
["Address","National Institute for Cardiovascular Outcomes (NICOR)"]
[null,"Barts Health NHS Trust"]
[null,"Second Floor, 1 St Martin's Le Grand, London"]
["Postcode","EC1A 4NP"]
["Telephone","0203 765 8539"]
["Email","j.chal@nhs.net"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Patients undergoing the procedures: Percutaneous Mitral Valve Repair; Left Atrial Appendage Occlusion; Patent Foramen Ovale Closure in Adults."]
["Description of confidential patient information used","Access was requested to name, postcode, NHS number, date of birth and date of death."]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Anita Sanghi, Barts Health (NICOR)"]
["Status","Expired"]
[]
["Next Review Date"]
["Notes","Expired\n\nApplication superseded by new application 22/CAG/0117. Changes to controller as of 24th June 2022\n\n\nSpecific Conditions of Support\n1. All pre-existing conditions of support related to CAG 10-07(b)/2014 remain applicable.\n2. The pre-existing annual review cycle remains applicable, with the next annual review to be received 4 weeks before 31/08/2018, and then on an annual basis to this schedule.\n3. Updates around public and patient engagement activities should be provided as part of the standard annual review submission.\n4. Confirmation from the IGT Team at the Health and Social Care Information Centre of suitable security arrangements via Information Governance Toolkit (IGT) submission. (Confirmed - Barts Health reports an assessed satisfactory score at 77% (version 14 (2016-2017)."]

{"sheet":"A0941","index":108,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0941"]
["Reference","CAG 6-06(b)/2014"]
["Other Refs"]
["Application Title","Congenital Anomaly Register and Information Service for Wales (CARIS)"]
["Application Summary","This application from Public Health Wales set out the purpose of a systematic collection, registration and publication of population level data of congenital anomalies in Wales. The data would be used to assess patterns of anomalies, possible clusters of anomalies and their causes, antenatal screening and other healthcare interventions and health service provision for affected babies and children."]
["Applicant Organisation Name","Public Health Wales"]
["Contact Name","David Tucker – CARIS Manager"]
["Address","CARIS Office"]
[null,"Singleton Hospital, Sketty Lane,"]
[null,"Swansea"]
["Postcode","SA2 8QA"]
["Telephone","01792 285241"]
["Email","david.tucker2@wales.nhs.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,"Y","medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,null,"the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Confidential patient information from a range of sources was requested in relation to any foetus or baby who had or was suspected of having a congenital anomaly and whose mother was normally resident in Wales at time of birth."]
["Description of confidential patient information used","Data items including mother and baby name, postcode, NHS number, date of birth and date of death and father name were requested."]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,"Y","Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2023-09-12"]
["Notes","04 November 2019: Amendment supported to enable the CARIS dataset to be linked with the following organisational datasets: Cwm Taff Health Board Clinical Portal, Radis (Radiology system) in Swansea Bay Health Board and Cardiff and Vale Health Board Clinical Portal., via weblinks from the Public Health Wales site under the scope of its CPIP assurance. CARIS staff will use items of confidential patient information (NHS Number, sex, date of birth) to facilitate the linkage to enable the CARIS dataset to be completed in relation to reported patients.\n\nAmendment (Approved - 15/09/2017)\nThe applicant submitted the following amendments to the original application:\n1. The addition of Father’s NHS number to the dataset.\n2. Additional linkage with BadgerNet to improve the pickup rates of congenital abnormalities.\n3. CARIS has applied to part of the EUROlinkCAT study – this is a European-wide study (Part of Horizon 2020), using data linkage methods, to look at long-term survival, hospital stays, medications used, education and co-morbidities and mortality of congenital anomalies. The project was approved by the EU in July 2016. The project will start in 2017 and run through until 2020. The applicants clarified that CARIS data will be linked through SAIL, but analysed locally and combined at a European level by an agreed methodology in a similar manner as the previous EUROmediCAT Project.\n\nSpecific Conditions of Support (Final)\n1. Security assurance arrangements:\na. The expectation is for the assessment to reach 91% within one year from final approval to avoid jeopardising the state of future approval. It is understood that the report confirms that a report to the WIGB on the progress made against the outstanding actions against the CPIP assessment will be required in the October 2017 meeting.\nb. There should be full compliance with regards to a mechanism to respect patient objection. The CAG will look specifically at this aspect at time of annual review.\nc. A detailed report at time of annual review showing compliance with all outstanding actions. If there is any possibility that at time of annual review that all aspects have not been achieved, or that an improvement plan exists, this must be flagged in advance with the Advice Team following the report to WIGB in October 2017.\nd. As the Head of IG is named as the lead for the outstanding aspects, to consider that this role be present at time of next consideration.\n2. Continued review of the requirement for the use of confidential patient information and the retention of identifiable data items. This should be reported on at annual review stage."]

{"sheet":"A0942","index":109,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","0942"]
["Reference","CAG 6-06(c)/2014"]
["Other Refs"]
["Application Title","Wales Abdominal Aortic Aneurysm Screening Programme (WAAASP)"]
["Application Summary","This application from Public Health Wales set out the purpose of the Wales Abdominal Aortic Aneurysm Screening Programme (WAAASP), a public health screening programme which aimed to reduce mortality by 50% by 2015.\nA recommendation for class 4, 5 and 6 support was requested to cover access to confidential patient information from the Welsh Demographic Service to Public Health Wales in order to send invitations for screening. Data would be held on the Abdominal Aortic Aneurysm Screening Information System. In addition, data was requested from the Public Health Mortality Files, Patient Episode Database for Wales and the National Vascular Registry in order to determine outcomes within 30 days and 1 year of treatment for all men invited to take part in screening.\nThe application also sought information in relation to patients who had aortic aneurysms not detected by screening from ONS mortality data and various NHS organisations."]
["Applicant Organisation Name","Wales Abdominal Aortic Aneurysm Screening Programme"]
["Contact Name","Dr Rosemary Fox"]
["Address","18 Cathedral Road"]
[null,"Cardiff"]
[]
["Postcode","CF11 9LJ"]
["Telephone"]
["Email","rosemary.fox@wales.nhs.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Patients who had aortic aneurysms' confidential patient information from the Welsh Demographic Service to Public Health Wales as well as those patients not detected by screening from ONS mortality data and various NHS organisations."]
["Description of confidential patient information used","Access was requested to name, postcode, NHS number, date of birth and date of death."]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2022-09-12"]
["Notes","Amendment Request (Approved - 12/09/2017)\nThis amendment requested an extension to the existing support to include additional data flows between Parc Prison and Usk/Prescoed Prison. The extension was requested as this would allow the screening programme to be extended to men currently in prison to ensure equity of healthcare provision.\nThe initial amendment document also includes details around linking with a University of Leicester research programme; however, provisional queries were raised with the applicant and it was been clarified that these requests were outside the scope of CAG and are not to be considered.\n\nSpecific Conditions of Support (Final)\n1. Security assurance arrangements:\na. The expectation is for the assessment to reach 91% within one year from final approval to avoid jeopardising the state of future approval. It is understood that the report confirms that a report to the WIGB on the progress made against the outstanding actions against the CPIP assessment will be required in the October 2017 meeting.\nb. There should be full compliance with regards to a mechanism to respect patient objection. The CAG will look specifically at this aspect at time of annual review.\nc. A detailed report at time of annual review showing compliance with all outstanding actions. If there is any possibility that at time of annual review that all aspects have not been achieved, or that an improvement plan exists, this must be flagged in advance with the Advice Team following the report to WIGB in October 2017.\nd. As the Head of IG is named as the lead for the outstanding aspects, to consider that this role be present at time of next consideration.\n2. Continued review of the requirement for the use of confidential patient information and the retention of identifiable data items. This should be reported on at annual review stage."]

{"sheet":"A0943","index":110,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","0943"]
["Reference","15/CAG/0207"]
["Other Refs","superseded by 21/CAG/0153"]
["Application Title","NHS Cancer Screening Programmes: National Coordination and Quality Assurance"]
["Application Summary","This application from Public Health England set out the purpose of the NHS Cancer Screening Programmes to enable cases of bowel, breast and cervical cancer to identified and treated at the earliest possible stage in order to improve patient outcomes.\n\nThe application indicated some of the data flows involved in the screening programmes supported direct patient care; support under the Regulations was requested by PHE for those components of the programmes (for which it is responsible and accountable to the Secretary of State for Health for as part of its core remit) that depend on the processing of confidential patient information without consent. These include:\n1. the management of patient call and recall to ensure that no eligible patients are missed from screening;\n2. the management of the patient pathway to ensure that a complete record of screening histories is maintained as patients progress through the screening programmes; and\n3. quality assuring screening services to ensure they are effective and safe, and that any incidents are investigated and managed appropriately."]
["Applicant Organisation Name","Public Health England"]
["Contact Name","Anne Mackie, Director of Screening - PHE"]
["Address","Wellington House"]
[null,"133-155 Waterloo Road"]
[null,"London"]
["Postcode","SE1 8UG"]
["Telephone"]
["Email","Anne.Mackie@phe.gov.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","NHS Patient cases of bowel, breast and cervical cancer.\n"]
["Description of confidential patient information used","NHS number, primary care provider code, title, forename, middle name, surname, date of birth, gender, address, post code, PAF key of usual address, reason for removal from GP registration, date of death, telephone number, e-mail address, preferred language and interpreter required."]
["S251 Class(es)",null,"Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Department of Health"]
["Status","Expired"]
[]
["Next Review Date"]
["Notes","Expiry of support 1 October 2021, due to dissolution of PHE. superseded by 21/CAG/0153\n\n25 September 2020 - Amendment conditionally supported to change the data processor for the cervical cancer screening programme from Capita to NHS England via their team in the North of England Commissioning Support Unit. \n\nSpecific conditions of support \n1. Confirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold – Confirmed \n\n• The NHS Digital DSPT 2018/19 review for Public Health England was confirmed as ‘Standards Not Fully Met (Plan Agreed)’ on the NHS Digital DSPT Tracker (checked 18 August 2020). Please note the updated specific condition of support below.\nSupport is conditional upon Public Health England achieving the security assurance action plan as agreed with NHS Digital.  All staff involved in processing information under this application reference should be aware of the precise scope of support and its boundaries and have successfully completed local security awareness training before processing any information under support.\n\n• NHS Digital and Hitachi Consulting have confirmed ‘Standards met’ 2018/19 by check of the NHS Digital DSPT tracker (28 August 2020)\n\n• NHS North of England Commissioning Support Unit has confirmed ‘Standards met’ 2019/20 by check of the NHS Digital DSPT tracker (18 August 2020)\n\n28 August 2020 - Specific conditions of support updated:\nThe following sets out the updated specific conditions of support applied against this application reference.\n\n1. Public Health England (PHE) should achieve the security assurance action plan as agreed with NHS Digital.  All staff involved in processing information under this application reference should be aware of the precise scope of support and its boundaries and have successfully completed local security awareness training before processing any information under support.\n\n03 August 2020 - Amendment to extend the cohort age group of the NHS bowel cancer screening programme, is conditionally supported, subject to compliance with the standard conditions of support. Age CPI needed to access is now 47-74. \n\nSpecific conditions of support \n• The NHS Digital DSPT 2018/19 review for Public Health England was confirmed as ‘Standards Not Fully Met (Plan Agreed)’ on the NHS Digital DSPT Tracker (checked 16 July 2020). \n\nSupport is conditional upon Public Health England achieving the security assurance action plan as agreed with NHS Digital.  All staff involved in processing information under this application reference should be aware of the precise scope of support and its boundaries and have successfully completed local security awareness training before processing any information under support.\n\nSpecific Conditions of Support\n1. Confirmation from the IGT Team at NHS Digital of suitable security arrangements via Information Governance Toolkit (IGT) submission. (Confirmed – Version 14, 2016-17, reviewed satisfactory score of 72%)."]

{"sheet":"A0944","index":111,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number",944]
["Reference","17/CAG/0157"]
["Other Refs"]
["Application Title","The delivery of major trauma care in England - impact and effectiveness following a whole system reorganisation"]
["Application Summary","This application from the Big Health Data Group at the University of Oxford set out the\npurpose of service evaluation to determine the clinical and cost-effectiveness of reorganisation\nof trauma care services into Regional Trauma Networks (RTNs) and Major\nTrauma Centres (MTCs).\nThis request for support under section 251 of the NHS Act 2006 is required to allow\nlinkage of the Trauma Audit and Research Network (TARN) data to Office of National\nStatistics (ONS) and Hospital Episodes Statistics data. Confidential patient information\nwill be released from TARN to NHS Digital, to enable linkage with the ONS and HES\ndatasets. All data provided to the University of Oxford will be psuedonymised data only."]
["Applicant Organisation Name","Big Health Data Group (BHDG)"]
["Contact Name","Professor Andrew Judge"]
["Address","Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Science (NDORMS),"]
[null,"Windmill Road,"]
[null,"Oxford"]
["Postcode","OX3 7LD"]
["Telephone"]
["Email","andrew.judge@ndorms.ox.ac.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Patients sustaining open fracture in England from 1989 to present day. This list will be\nused by NHS Digital, the trusted third party, to link to HES and ONS to generate a dataset\nof outcomes for patients sustaining open fracture in England."]
["Description of confidential patient information used","Identifiable TARN data will be provided to NHS Digital for data linkage.\nTARN will send NHS number, date of birth, gender and postcode as well as a unique\nTARN patient identifier (pseudonymised) for linkage.\nNHS Digital data to be linked for this project are ONS date of and cause of death data\nand the complete HES record.\nThe pseudonymised data set will be returned to the team at the University of Oxford by\nTARN ID, with all other identifiable information removed."]
["S251 Class(es)",null,"Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","University of Oxford"]
["Status","Expired"]
[]
["Next Review Date"]
["Notes","The pseudonymised data was sent to the University of Oxford by secure means, with all identifiable information removed except TARN ID. The data is kept securely in the Secure Data Room which is an access controlled environment that meets the technical and physical measures required for processing sensitive data.\n\nUsing the Trauma Audit and Research Network (TARN) audit data we have analysed trends in incidence of open fractures and the adherence to clinical standards for open fracture care in England. Our work has shown that here has been variable improvement with time in the clinical care standards for patients with severe open fracture of the tibia. The median time to debridement was 13.0 hours; almost two thirds of patients underwent definitive soft tissue coverage within 72 hours between 2016 and 2019. Whilst most open fractures occurred in young men, the incidence increased with age in women to a much greater level than observed in older men.\nWe have examined how timely surgery for patients with severe open tibial fracture varies by day and time of presentation and by type of hospital. Variations in care were observed for timely surgery for severe open tibial fractures with debridement surgery affected by time of presentation and soft tissue coverage affected by day of presentation and type of hospital. The variation is unwarranted and highlights there are opportunities to substantially improve the delivery and quality of care for patients with severe open tibial fracture.\n\nOur work has been published in the following journals as below:\n\nShah, A., Judge, A. & Griffin, X. Incidence and quality of care fr open fractures in England during 2008-2019: a cohort study using data collected by the Trauma Audit and Research Network, 14 Feb 2022, (Accepted/In press) In: The bone & joint journal.\n\nShah, A., Judge, A. & Griffin, X. L. Variation in timely surgery for severe open tibial fractures by time and place of presentation in England during 2012-2019: a cohort study using data collected nationally by the Trauma Audit and Research Network, 14 Oct 2022, (Accepted/In press) In: The bone & joint journal.\n\nAnalysis is ongoing and further public benefits are expected to be realised. Final publication is expected in 2023. \n\nSpecific Conditions of Support\n1. Support extends to England and Wales only.\n2. Patient Notification Mechanism – further work is required to address the following issues. A response should be provided within three months of the date of this letter, together with accompanying documentation, for consideration by a sub-committee of original reviewing Members.\na. Review the drafted patient notification text to make this more accessible to a wider public audience,\nb. The opt-out mechanism available via the TARN website should be more clearly displayed to make this more visible to patients,\nc. Patient Notification materials should be drafted for display in trauma centres to promote the activity. This could be posters and information leaflets as example. The language used should be aimed at a wide public audience.\n3. Confirmation from the IGT Team at NHS Digital of suitable security arrangements via Information Governance Toolkit (IGT) submission. (Confirmed - BHDG at the University of Oxford V14, reviewed satisfactory score 100%, 2017/18 and NHS Digital, V14, reviewed satisfactory score 92%, 2017/18)."]

{"sheet":"A0945","index":112,"n_rows":36,"n_cols":3,"rows_kept":36,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[24,0,30,0],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,2,30,4],[31,1,31,4],[32,1,32,4],[34,1,34,4],[35,1,35,4],[21,1,21,4],[22,1,22,4],[23,1,23,4]]}
[]
[]
["Application Number",945]
["Reference","17/CAG/0150"]
["Other Refs"]
["Application Title","National Perinatal Mortality Review Tool (PMRT)"]
["Application Summary","This application from the National Perinatal Epidemiology Unit at the University of Oxford sets out the purpose of establishing a clinical audit tool, the ‘National Perinatal Mortality Review Tool’ to enable high quality, local, standardised, multi-disciplinary reviews of all late fetal losses, stillbirths, neonatal deaths, all deaths on neonatal units and infant deaths with the review for each individual being used for multiple purposes (e.g. serious incident reviews, Child Death Overview Panels etc.) on the principle of ‘review once, review well’.\nThe PMRT collaboration led by the MBRRACE-UK collaboration has been commissioned to develop and support the implementation of the National Perinatal Mortality Review Tool (PMRT) on behalf of the Department of Health (England) and the Welsh and Scottish Governments. The PMRT will be wholly integrated with the MBRRACE-UK perinatal mortality surveillance data collection in order to minimise the burden on clinical staff and thus maximise its uptake; both systems are concerned with the same group of babies and have the goal of reducing the national perinatal mortality rate.\nLocal reviews should be carried out as part of standard clinical care and staff in Trusts/Health Boards and do not require the consent of parents before a review is undertaken. During the process of using the PMRT to conduct local reviews of care, identifiable and clinical information will be collected and generated. Section 251 support is sought specifically to enable this information to be held without parental consent on the MBRRACE-UK servers. Support was also required to support the applicants to undertake analysis on the improvements made to the perinatal mortality review process following the implementation of the tool.\nUser testing of the PMRT is required with ‘live’ data before all the review questions and data items have been finally defined. For this testing, the applicants will ask NHS staff to use ‘real’ cases, but will be provided with dummy identifiers. This will allow staff to test the review questions and data without disclosing the identity of individuals. Given the extent of clinical details involved in the review, support under the Regulations is requested to cover this user testing phase, as well as wider deployment of the tool, as it cannot be confirmed that the data would be anonymous."]
["Applicant Organisation Name","University of Oxford"]
["Contact Name","Professor Jennifer J Kurinczuk"]
["Address","National Perinatal Epidemiology Unit"]
[null,"Old Road Campus Headington"]
[null,"Oxford"]
["Postcode","OX3 7LF"]
["Telephone"]
["Email","jenny.kurinczuk@npeu.ox.ac.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","All mothers whose pregnancy results in a:\n- Late fetal loss (babies born at 22-23 weeks gestation not showing any signs of life at birth)\n- Stillbirth (all babies born at 24+ weeks gestation not showing any signs of life at birth)\nAll mothers and their babies:\n- Where the baby dies on a neonatal unit and/or before reaching their first birthday (infant deaths)."]
["Description of confidential patient information used","The following items of confidential patient information are required and will be entered into the web-based system by local staff at the Trust/Health Board responsible for the patient care:\nMothers’ details: full name, DOB, ethnicity, NHS number, postcode and clinical information relevant to her care during her pregnancy, labour, birth, postnatal care, bereavement care, follow-up and the causes and circumstances surrounding the death of her baby.\nBabies details: full name, DOB, NHS number, postcode, ethnicity, birth weight, gestational age at birth, sex, place of birth, date of death, place of death, cause of death and clinical information relevant to the care of the baby at birth, on the neonatal unit and any other locations the baby was cared for prior to death."]
["National Data Opt \nOut Status","The Secretary of State for Health and Social Care decision maker, on advice from the CAG, has supported a request to defer the National Data Opt Out. As such, the National Data Opt Out does not need to be applied for this activity"]
["S251 Class(es)",null,"Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","Healthcare Quality Improvement Partnership on behalf of the Department of Health (England) and the Scottish and Welsh governments"]
["Status","Supported"]
[]
["Next Review Date","2022-10-10"]
["Notes","Amendment supported 09 June 2022 to defer applying the National Data Opt-Out in relation to 17/CAG/0150\n\nSpecific conditions of support\n\n1.\tUpdate the poster to provide more specific detail on why the NDO is not applied and how the decision was made.\n\nCondition met July 2022\n\n2.\tProvide an update to the inclusion of information in maternity notes/app, to use of charities and the Royal College of Midwives, as well as consideration of the use of social media by 27 October 2022.\n\n3.\tThis outcome confirms a change to the original conditions of support. The National Data Opt-Out is not to be applied to patients included in the activities specified in 17/CAG/0150. \n\n4.\tA local patient objection mechanism must continue to be used\n\n\n22 March 2022 - Amendment supported\nAmendment suppored to extend the duration of support to 31 September 2022.\n\n17 December 2019 – Amendment supported to extend the duration of support to 31 January 2022. This duration extension reflected the funding extension which had been agreed with the Healthcare Quality Improvement Partnership (HQIP).\n\nSpecific Conditions of Support (Final)\n1. Support extends to England and Wales only.\n2. Patient Notification Materials – work should be undertaken to review and revise the information materials, in order to make the language more accessible to a wider audience. A report should be provided within three months of receipt of this letter around the activity which has been undertaken, together with submission of the revised documentation for consideration. It was recommended that support from an appropriate patient group be sought to support this activity.\n3. Patient, Public and Parent Involvement and Engagement – work in this area should continue as the activity progresses. A report will be required at the time of first annual review around the actual activity which has occurred, together with an updated plan for involvement and engagement for the following year.\n4. Practicable Alternatives – a report should be provided at the time of first annual review around the progress and outputs from the ongoing PARENTS study and how this could be incorporated into the project, to support the move to a fully consented model for the undertaking of perinatal mortality reviews.\n5. Confirmation from the IGT Team at NHS Digital of suitable security arrangements via Information Governance Toolkit (IGT) submission. (Confirmed – University of Oxford, National Perinatal Epidemiology Unit has a published reviewed grade on Version 14 at 97% satisfactory)."]

{"sheet":"A0946","index":113,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","A0946"]
["Reference","17/CAG/0174"]
["Other Refs"]
["Application Title","UTMoST Study"]
["Application Summary","This study from Big Health Data Group at Oxford University, funded by the NIHR with a Health Technology Assessment Programme Grant, set out the purpose of improving information available on the choice between Unicompartmental Knee Replacement (UKR) or Total Knee Replacement (TKR), particularly in relation to risks and benefits (comparative costs and effects). In order to do this an existing dataset from an ongoing RCT (TOPKAT) would be used alongside data relating to patients who were not eligible for the TOPKAT study, in order to validate the results of this trial and to broaden the scope of data collection to include patients with co-morbidities.\nPatients with co-morbidities (‘ASA grade 3 or worse’), who were not eligible for the TOPKAT trial, comprised 17% of those undergoing knee replacement surgery, and their omission was significant given the association between co-morbidities and both post-operative complications and mortality, and subsequent costs associated. Therefore there was public benefit in improving on the TOPKAT study to ensure that results were generalizable to this population as well as improving the validity of the original study by adding follow-up data from a longer period.\nSupport was requested to allow disclosure of data from the NJR to NHS Digital to enable linkage with HES-PROMS data before returning a pseudonymised dataset to Oxford University."]
["Applicant Organisation Name","Big Health Data Group (BHDG)"]
["Contact Name","Professor Prieto Alhambra"]
["Address","Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Science (NDORMS)"]
[null,"Windmill Road"]
[null,"Oxford"]
["Postcode","OX3 7LD"]
["Telephone"]
["Email","daniel.prietoalhambra@ndorms.ox.ac.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","In order to do this an existing dataset from an ongoing RCT (TOPKAT) would be used alongside data relating to patients who were not eligible for the TOPKAT study. Support was requested to allow disclosure of data from the NJR to NHS Digital to enable linkage with HES-PROMS data before returning a pseudonymised dataset to Oxford University."]
["Description of confidential patient information used","Access was requested to:\nNHS number\nDate of birth\nGender\nPostcode\nUnique NJR identifier\n(to be provided to NHS Digital for linkage)\nPseudonymised data (containing NJR identifier) would be transferred to Oxford University"]
["S251 Class(es)",null,"Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,null,"Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","University of Oxford"]
["Status","Expired"]
[]
["Next Review Date","2022-11-07"]
["Notes","April 2022 - Support Expired\nApplicant confirmed in April 2022 that ‘s251’ support can be expired\nAs the data set received from NHS Digital has been securely destroyed.\n\nIn terms of public benefits, \nThe UTMOST study results provide information on the comparative risks, benefit (patient-reported outcomes), and cost of partial and total knee replacement for patients with multiple co- morbid conditions. Benefits of UTMOST findings include:\n- Better inform decision support for patients with co-morbidities undergoing knee replacement;\n- Support evidence-based surgery that surgeons can use to change their practice;\n- Support evidence-based commissioning and care provision\n- Inform on the usefulness of efficient studies using routinely collected (non-randomised) data for the evaluation of surgical alternatives in the NHS to complement randomized studies.\n\n01 March 2021 - Annual Review approved\nUpdated condition of support:\n1. Please provide a plan within two months from the date of this letter, to detail how the applicant plans to achieve the original condition of support of progressing public involvement work, with particular reference to the development of links with suitable charities.\n\nConfirmed - Applicant responded to this condition by email on 3rd March 2021 and the CAG Vice-chair confirmed they were content with responses on 14th March 2021\n\n26 January 2021 - Amendment supported\nThe amendment, to extend the duration of support until 28th February 2022, is supported, subject to compliance with the standard conditions of support.\n\nSpecific conditions of support \n1. Please report back at annual review on the progress of public involvement work, with particular reference to the development of links with suitable charities during the course of the study. \n2. Confirmation from the IGT Team at the Health and Social Care Information Centre of suitable security arrangements via Information Governance Toolkit (IGT) submission. Northgate Public Services (for NJR): v14 confirmed published and reviewed. NHS Digital: v14 confirmed published and reviewed."]

{"sheet":"A0947","index":114,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A0947"]
["Reference","15/CAG/0190"]
["Other Refs","(was 15/CAG/0153)"]
["Application Title","National Study of HIV in Pregnancy and Childhood"]
["Application Summary","It was noted that this submission differed from typical submissions, in that there had been previous discussions with the CAG following the submission at the July 2015 CAG meeting. The outcome dated 23 July 2015 had confirmed the HRA decision that parts of the original protocol relating to the BPSU and flagging aspects had been previously included within reference PIAG/BPSU 2-10 (a)/2005, and that: \n \n• The surveillance aspects of the application were not supported, on the basis that there was an alternative legal basis for the data flows under Regulation 3 of the Health Service (Control of Patient Information) Regulations 2002. \n• The research aspects of the application were deferred; further information had been requested from the applicant as outlined below. \n\nThe applicant had been asked to provide further information focusing solely on the research elements. A covering letter and expanded research protocol to meet this requirement was provided and considered at the meeting on 22 October 2015. This outcome should be read by data controllers in conjunction with the letter dated 23 July 2015.\n\nA recommendation for class 5 and 6 support was requested to achieve the activity specified in the application.\n"]
["Applicant Organisation Name","UCL Great Ormond Street Institute of Child Health"]
["Contact Name","Claire Thorne"]
["Address","Population, Policy and Practice Programme"]
[null,"UCL Great Ormond Street Institute of Child Health,"]
[null,"30 Guilford Street, London "]
["Postcode","WC1N 1EH"]
["Telephone",2079052105]
["Email","Claire.thorne@ucl.ac.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,"Y","medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,null,"the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Data are provided by clinical respondents in maternity units and paediatric clinics."]
["Description of confidential patient information used","Identifiers including date of birth, NHS number and demographic details are provided by respondents and used to identify duplicate reports, match mothers with infants and subsequent pregnancies, and link follow up data to the original reports."]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Expired"]
[]
["Next Review Date","2018-12-03"]
["Notes","Application Expired - Study was deferred twice and never supported.\n\nSpecific conditions of support\n\n1. Provisions of a report detailing direction of travel and progress in ensuring management of dissent for research purposes to be included in next annual review. \n\n2. Confirmation from the IGT Team at the Health and Social Care Information Centre of suitable security arrangements for the bodies processing personal data under this support via Information Governance Toolkit (IGT) submission. \nA reference given in the original application stating the NHSPC had been included in a v12 IG toolkit submission (EE133902FOPHSPPAPPIASG) could not be located. Please ensure the organisation code is provided so the correct toolkit can be referenced. \n"]

{"sheet":"A0948","index":115,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A0948"]
["Reference","17/CAG/0071"]
["Other Refs","(replacement of ECC 1-06(d)/2011)"]
["Application Title","Barts Health (NICOR) National Cardiac Audit Programme (NCAP)"]
["Application Summary","A letter of support had been received from the Healthcare Quality Improvement Partnership (HQIP), who commission these audits, and are specified to be the data controllers for the purposes of the application. This application was received from Bart’s Health NHS Trust. The purpose of the application was to transfer the data processing arrangements from University College London, to Bart’s Health NHS Trust. The letter confirmed that existing UCL staff would undertake a TUPE transfer and HQIP would remain the data controller for the purposes of this application."]
["Applicant Organisation Name","Barts Health (NICOR) National Cardiac Audit Programme (NCAP)"]
["Contact Name","James Chal, NICOR Chief Operating Officer"]
["Address","National Institute for Cardiovascular Outcomes (NICOR)"]
[null,"Barts Health NHS Trust"]
[null,"Second Floor, 1 St Martin's Le Grand, London"]
["Postcode","EC1A 4NP"]
["Telephone","0203 765 8539"]
["Email","j.chal@nhs.net"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,"Y","medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,null,"the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","The patients dealt within these six audits:\n1. Myocardial Ischaemia National Audit Project\n2. Adult Cardiac Surgery Audit\n3. £National Heart Failure Audit\n4. Congenital Heart Disease Audit\n5. Cardiac Rhythm management Audit\n6. Adult cardiac Interventions Audit"]
["Description of confidential patient information used","The following confidential information is required:\nNHS number, postcode, date of birth, date of death, patient's name.\n\nAmendment (30/11/2018) - The following are patient identifiable data items that would be shared with NHS Ambulance Trusts:\n NHS number,  CAD (Computer-Aided Dispatch) number,  Full name,  Date of birth,\n Date of death.\nAmbulance Trusts will only be able to view and export data in relation to patients that they have transported to hospital. Data from the ambulance Trusts and MINAP will be linked by ambulance job number and/or NHS number."]
["S251 Class(es)","Y","Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","HQIP"]
["Status","Expired"]
[]
["Next Review Date"]
["Notes","Expired\n\nApplication superseded by new application 22/CAG/0114. Changes to controller as of 24th June 2022\n\n\n\nAmendment Request (Approved 30/11/2018)\nThis amendment sought to extend support to the flow of data from MINAP to NHS Ambulance Trusts in England in order to enable this linkage. This linkage will enable MINAP to report the following indicators:\n Call to Door times (CtD),\n Patients with initial diagnosis of ‘Definite myocardial infarction’.\n Patients who are direct admissions via the emergency services to hospital.\n Call to Door minutes greater than 0 and less than 1000.\nThis extension to the legal basis would enable:\n NHS Ambulance Trusts to view and export patient information recorded in MINAP database by acute trusts such as time of arrival at hospital, call to door, door to balloon and call to balloon only for patients the acute trust records in MINAP as having been conveyed to hospital by that ambulance Trust.\n NHS Ambulance Trusts to submit information on the pre-hospital care of these patients (already covered in principle by MINAP’s existing s251 approval) as well as obtaining permission to potentially include elements/data of pre-hospital care bundle in the ambulance for heart attack patients prior to arrival in hospital such as assessments undertaken by pre-hospital clinicians.\nThe following are patient identifiable data items that would be shared with NHS Ambulance Trusts:\n NHS number,  CAD (Computer-Aided Dispatch) number,  Full name,  Date of birth,\n Date of death.\nAmbulance Trusts will only be able to view and export data in relation to patients that they have transported to hospital. Data from the ambulance Trusts and MINAP will be linked by ambulance job number and/or NHS number.\n\nAmendment Request (Approved 02/03/18)\nThis amendment was submitted to request explicit support for the flow of data between MINAP and NHS ambulance services. The purpose of the MINAP audit was to provide NHS services with information about their management of patients with acute coronary syndrome. It enabled Ambulance Trusts to access summary reports of the treatment and outcome of patients admitted alive to their hospital with acute coronary syndrome. Trusts are only able to view and export data in relation to patients that they have transported to hospital. Data from the Ambulance Trusts and the MINAP audit are linked by ambulance job number, which is meaningless to all except the local ambulance service which treated the patient. A letter of support was received from HQIP, as data controllers for the audit programme, for the continuation of this data flow.\n\nSpecific conditions of support\n1. All pre-existing conditions of support related to ECC 1-06 (d)/2011 remain applicable\n2. The pre-existing annual review cycle remains applicable, with the next annual review to be received 4 weeks before 07/03/2018, and then on an annual basis to this schedule.\n3. Confirmation from the IGT Team at the Health and Social Care Information Centre of suitable security arrangements via Information Governance Toolkit (IGT) submission. Confirmed"]

{"sheet":"A0949","index":116,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A0494"]
["Reference","17/CAG/0193"]
["Other Refs"]
["Application Title","UKRETS (United Kingdom Registry of Endocrine and Thyroid Surgery)"]
["Application Summary","This application from the British Association of Endocrine and Thyroid Surgeons sets out the purpose of a clinical audit into endocrine and thyroid surgery. The United Kingdom Registry of Endocrine and Thyroid Surgery audit was set up in 2004 to measure the quality of endocrine and thyroid surgery and to use that information to improve the quality of the surgery across the NHS for patients, commissioners and regulators of healthcare professionals. The audit outcomes also provide reassure to patients that the quality of clinical care is being actively monitored and improved. It audit has collected over 80,000 cases since its establishment in 2004.\nMembers of the British Association of Endocrine and Thyroid Surgeons record a number of outcome measures (as well as pre-operative and operative details) for each endocrine surgical operation performed including length of stay, mortality, voice change, hypocalcaemia (for thyroid and parathyroid surgery) and persistent disease (for parathyroid surgery). This data is transferred at the point of entry into a database which is maintained by Dendrite Ltd.\nThe application also stated that data will be requested from the HES dataset via NHS Digital around the number of surgical procedures undertaken; however, this would be requested in anonymised format only and would not involve the processing of confidential patient information to facilitate the data release.\nA recommendation for class 4, 5 and 6 support was requested to cover activities as described within the application."]
["Applicant Organisation Name","British Association of Endocrine and Thyroid Surgeons"]
["Contact Name","Dr Sebastian Aspinall"]
["Address","ASGBI Office"]
[null,"Royal College of Surgeons of England"]
[null,"35-43 Lincoln’s Inn Fields, London"]
["Postcode","WC2A 3PE"]
["Telephone"]
["Email","secretary@baets.org.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,null,"the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","All patients within England and Wales undergoing thyroid, parathyroid, adrenal or endocrine pancreatic surgery. This is approximately 8-9,000 patients per year."]
["Description of confidential patient information used","The following items of confidential patient information will be entered by the direct care team into the web-based registry, maintained by Dendrite:\n NHS number (in England and Wales) – validation and follow-up of patients,\n Date of birth – validation (only available to the clinical care team) and analysis (age at procedure),\n Gender – analysis,\n Date of death (if applicable) – calculate length of stay for analysis\n Date of operation – validation and analysis."]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Expired"]
[]
["Next Review Date","2019-02-21"]
["Notes","10 December 2021 - Applicant confirmed support expired\nThe applicant has confirmed support is no longer required as no items of confidential patient information are retained without consent. Date of death on the UKRETS registry has been removed for all patients in the historical section (2018 and before) and replaced with time in days from operation. Since 2018 applicants have collected information with consent.\n\nRegarding public benefit the applicant confirmed that the UK Register of Endocrine and Thyroid Surgery has produced reports every few years which have allowed surgeons and others to better understand the risks associated with endocrine surgery and the likely initial cure rates for different types of endocrine surgery. The register has the support of the two largest thyroid patient charities, and the latest endocrine GIRFT report recommends surgeons contribute to the register.\n\nSpecific Conditions of Support (Final)\n1. Support is recommended for the ongoing retention of the audit which had been historically collected.\n2. Support under the Regulations would be extended on a time-limited basis whilst work is undertaken to progress to a fully-consented model for inclusion within the audit programme. An update would be required at the time of annual review around the activity which has been undertaken to progress with the consenting model.\n3. An update is required at the time of first annual review around the activity which has been undertaken to improve the case ascertainment which is reported to the audit.\n4. Patient and Public Engagement and Involvement – ongoing work should be undertaken with the relevant charities and patient groups which were referenced with the application as the audit programme continues. A report would be required at the time of first annual review around the activity which had been undertaken here, together with any relevant feedback. If the responses provided from the patient and public involvement and engagement activity were negative, the CAG would take this into account when considering whether support for the activity could continue or whether any additional actions are required.\n5. Patient Notifications – further work should be undertaken to improve the patient information leaflet which supports the audit programme. It is recommended that engagement with a patient group is undertaken to assist this process. An update would be required at the time of first annual review around the activity which has been undertaken in this area, together with a copy of the revised information leaflet for consideration.\n6. Confirmation from the IGT Team at NHS Digital of suitable security arrangements via Information Governance Toolkit (IGT) submission. (Confirmed – Dendrite Ltd. shows a reviewed satisfactory grade on Version 14, 2016/17)"]

{"sheet":"A0950","index":117,"n_rows":36,"n_cols":3,"rows_kept":36,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[24,0,30,0],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,2,30,4],[31,1,31,4],[32,1,32,4],[34,1,34,4],[35,1,35,4],[21,1,21,4],[22,1,22,4],[23,1,23,4]]}
[]
[]
["Application Number","A0950"]
["Reference","17/CAG/0184"]
["Other Refs"]
["Application Title","UK collaborative clinical audit of health care for children and young people with suspected epileptic seizures (Epilepsy12)"]
["Application Summary","This application from the Royal College of Paediatrics and Child Health sets out the purpose of clinical audit into the healthcare provided to children and young people with suspected epileptic seizures. This application is for the third round of the audit which has been commissioned by HQIP from 01 April 2017 to 31 March 2021. The audit will run in England, Wales and Scotland and aims to build on current high levels of engagement established during the previous two rounds to provide a high value audit leading to ongoing significant improvements and equality in clinical outcomes, practice and patient experience.\nThe audit has three main domains:\n1. Service Descriptors – An annual census approach will continue to detail the components of the services that each Health Board/Trust provides to children and young people (CYP) with seizures and epilepsies. This will also be mapped to best practice tariff criteria.\n2. Clinical Performance Indicators – These will continue to be applied to CYP presenting to a paediatric service with a paroxysmal episode or episodes and particularly focus on those with epileptic episodes.\n3. Patient Reported Experience Measures – The audit will capture, via anonymised questionnaires, the experience of both young people and parents on their experience of the care that they have received from the point of their first paediatric assessment for epilepsy and the following 12 month period.\nThe Royal College of Paediatrics and Child Health delivered rounds one and two of the audit between 2009 and 2014; however, the previous rounds of the audit had been delivered without the requirement for support under the Regulations.\nThe methodology of the prospective audit differs from that employed by the historic rounds in that the applicants are proposing linkage via NHS Digital and NHS Wales Informatics Services to enable linkage with HES/PEDW and ONS mortality data.\nA recommendation for class 1, 4, 5 and 6 support was requested to cover the activities as described in the application."]
["Applicant Organisation Name","Royal College of Paediatrics and Child Health"]
["Contact Name","Helen Stacey"]
["Address","5-11 Theobalds Road"]
[null,"London"]
[]
["Postcode","WC1X 8SH"]
["Telephone","020 7092 6168                             "]
["Email","helen.stacey@rcpch.ac.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,null,"the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Cohort\nAll children and young people (aged 0 to 16 years 364 days) under NHS paediatric care with suspected epilepsy with a first paediatric assessment from “day 0” (proposed as 1 April 2018) with ongoing audit of those diagnosed with epilepsy.\nThe data will be provided by participating Trusts and Health Boards and will be cross-referenced with information held by NHS Digital as part of the HES/ONS datasets and NHS Wales Informatics for data within PEDW."]
["Description of confidential patient information used","The following items of confidential patient information are required for the purposes outlined:\n• First name/surname – only viewable by the treating Trust/Health Board – captured to aid local provider patient monitoring and clinical improvement activity,\n• Gender – analysis,\n• Ethnicity – analysis,\n• Date of birth – analysis,\n• Date of death – linkage and analysis,\n• NHS/CHI/ number – validation and linkage,\n• Home postcode – translated into LSOA for analysis,\n• Details of individual patient care – analysis."]
["National Data Opt \nOut Status","The Secretary of State for Health and Social Care decision maker, on advice from the CAG, has supported a request to defer the National Data Opt Out. As such, the National Data Opt Out does not need to be applied for this activity"]
["S251 Class(es)",null,"Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2023-03-05"]
["Notes","Amendment supported 10 January 2023 \nTo defer applying the National Data Opt-Out in relation to 17/CAG/0184\n\nConditions of support; \n\n1.\tThis outcome confirms a change to the original conditions of support. The National Data Opt-Out is not to be applied to patients included in the activities specified in 17/CAG/0184\n\n2.\tA local patient objection mechanism must continue to be used in relation to 17/CAG/0184\n\n\n13 June 2022 - Amendment supported:\nAmendment supported to allow;\n\n• the addition of patient ethnicity to data items,\n• the removal of Rackspace as a data processor, \n• and the change of physical storage location within the RCPCH for storage of Epilepsy12 files used for data processing and analysis – to the Microsoft Cloud in Microsoft UK data centres based in Cardiff, Durham and London with data back up provided at the Microsoft UK South (London) data centre\n\n22 March 2022 - Amendment supported\nAmendment supported to extend the duration of support to 31 March 2025.\n\n06 March 2019 – Amendment supported to allow the joint entry of clinical care information into the epilepsy audit by wider members of a patient’s direct care team across all Trusts involved in the provision of an individual patient’s care.\n\nSpecific Conditions of Support (Final)\n1. Support extends to England and Wales only.\n2. Support is in place for a non-research purpose only to support the audit programme and does not extend to any use of the data collected via this application for research purposes.\n3. Provide a report at the time of first annual review of actual patient and public involvement and engagement activity which has been undertaken. This should explain how children and young people were involved in the project. If the responses given are negative, the CAG will take these into account when considering whether support should continue, or whether further actions are required.\n4. Provide an overview of further engagement work which had been undertaken in relation to patient notification materials to support the audit programme, together with copies of the finalised documentation, at the time of first annual review.\n5. Confirmation from the IGT Team at NHS Digital of suitable security arrangements via Information Governance Toolkit (IGT) submission. (Confirmed - Net Solving Ltd shows a reviewed satisfactory grade at 97% on Version 14, 2016/17. Royal College of Paediatrics and Child Health shows a reviewed satisfactory grade at 82% on Version 14, 2016/17)."]

{"sheet":"A0951","index":118,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A0951"]
["Reference","17/CAG/0030"]
["Other Refs"]
["Application Title","UKSAFE"]
["Application Summary","This application from Big Health Data Group at Oxford University set out the purpose of identifying a cost-effective strategy for follow-up after hip and knee surgery, to focus NHS resources on those patients most at need and reduce clinic visits and tests which did not add benefit.\nHip and knee replacement surgery is now part of mainstream practice. Increasing demand coupled with financial pressures has led to disinvestment in follow-up provided which could lead to complications or disease recurrence going undetected, leading to an increased need for revision surgery and costly rehabilitation.\nUsing data from the National Joint Registry (NJR) linked to NHS Digital Health Episode Statistics (HES)-Patient Reported Outcome Measures (PROMs) data, the applicant aims to:\n1. Determine when patient follow-up should occur and to identify any peak in the mid-late term revision risk.\n2. Identify predictors of mid-late term revision to determine which patients are most likely to require intervention.\nA recommendation for class 1, 4 and 6 support was requested to cover activities described in the application."]
["Applicant Organisation Name","Big Health Data Group at Oxford University"]
["Contact Name","Dr Andrew Judge"]
["Address","Big Health Data Group (BHDG)"]
[null,"Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Science (NDORMS)"]
[null,"Windmill Road, Oxford"]
["Postcode","OX3 7LD"]
["Telephone"]
["Email","Andrew.judge@ndorms.ox.ac.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,null,"the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Access was requested to data from NJR in relation to patients who have undergone joint replacement."]
["Description of confidential patient information used","NHS number, date of birth, gender, postcode and unique NJR patient identifier will be provided to NHS Digital from the NJR.\n\nHES/PROMS linked dataset to be returned to Oxford University, Big Health Data Group – pseudonymised, with unique NJR patient identifier."]
["S251 Class(es)",null,"Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,null,"Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Expired"]
[]
["Next Review Date","2022-02-24"]
["Notes","May 2022 - Support Expired\nApplicant confirmed in May 2022 that all confidential patient information had been deleted, and ‘s251’; support was no longer required.\n \nIn terms of the public benefit, findings have shown that the predictors of revision were different for hips and knees, with the only main consistent finding being age. This suggests that the organization of follow-up services should not be the same for hip and knee operations, as the patients at risk of mid-late revision are not necessarily the same. The findings of the statistical analyses and health economics work were presented at the British Orthopaedic Association (BOA) annual meeting on 12 September 2019, with a separate workshop with stakeholders to draft national consensus and guideline statements for recommendations on patient follow-up after hip and knee replacement surgery.\n\n15 March 2021 - Amendment supported\nAmendment supported to extend the duration of support for one year, until 30 March 2022.\n\nSpecific Conditions of Support\n1. Confirmation from the IGT Team at NHS Digital of suitable security arrangements via Information Governance Toolkit (IGT) submission. Confirmed – reviewed grade satisfactory at 83% on Version 13, 2015-16."]

{"sheet":"A0952","index":119,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A0952"]
["Reference","18/CAG/0042"]
["Other Refs"]
["Application Title","2018 Maternity Survey"]
["Application Summary","This application, submitted by the Picker Institute Europe, CQC and NHS England on behalf of all acute Trusts running eligible maternity services, set out the non-research purpose of carrying out a survey in order to build up a national picture of women’s experiences of maternity care.\nThis application seeks support for the transfer of patient identifiable data from acute Trusts to an approved survey contractor for the purpose of mailing out questionnaires for the 2018 Maternity Survey, which was the sixth iteration of the survey.\nTrusts would provide names and full addresses of women who gave birth at the Trust in January or February 2018 to the contractor to enable them to mail out questionnaires. The questionnaires would be returned voluntarily to the contractor for collation, checking and review before being transferred to the Coordination Centre.\nThis methodology was the same as for previous CQC surveys and had been supported by CAG. In addition, there were some additional aspects which had been introduced for this submission of the survey as follows:\n1. Postcode sector of patients within the sample, together with Trust-held antenatal and postnatal attribution information on these patients, will be transferred from Trusts directly to the Coordination Centre, as opposed to sending this to the survey contractor. This is for the purpose of attributing survey responses to the provider organisation. The primary reason for this is that it had been found in many cases that post-natal information was not available for a couple of months after the birth for which a mother had been sampled, making the ability to include this information in time for the sample checking period difficult. The attribution data does not include any sensitive or clinical information. In addition, there is no benefit in having contractors check attribution information prior to this going to the Coordination Centre and the proposed change enabled a more efficient checking process to be enacted.\n2. Attribution data would be disclosed from the Coordination Centre to the survey contractors, enabling them to provide an extra level of data to participating Trusts. Trusts would benefit as they would potentially receive linked local-level results for antenatal and postnatal services.\n3. Trusts are asked to submit a sample of all eligible women from February 2018. Prior to the 2017 survey, Trusts that did not have a minimum of 300 women in their sample from February were instructed to sample consecutively back into January until they met the minimum threshold. Trusts that had fewer than 300 eligible women across February and January were required to submit all eligible women regardless. However, it was now proposed that Trusts with fewer than 300 eligible patients across February and January could take part in the maternity survey on a voluntary basis.\nA recommendation for class 5 and 6 support was requested to cover activities as described in the application."]
["Applicant Organisation Name","Picker Institute Europe, CQC and NHS England"]
["Contact Name","Ms Jenny King"]
["Address","Picker Institute Europe, Buxton Court"]
[null,"3 West Way"]
[null,"Oxford"]
["Postcode","OX2 0JB"]
["Telephone"]
["Email","jenny.king@pickereurope.ac.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population"," Women, aged over 16 years at the time of delivery, who had a live birth in January or February 2018.\n An estimated 129 Trusts will participate in the survey,\n Trusts are instructed to sample all eligible women in February 2018. If this is fewer than 300 records they are asked to sample back from the last date in January to the beginning of January until they reach 350 records (in order to achieve a sample of 300 post-DBS checks).\n Trusts which do not have 300 eligible women across February and January combined have the option of taking part in the survey."]
["Description of confidential patient information used","Administration of the Maternity Survey required NHS Trusts to share two distinct sets of information with their approved contractor.\nA mailing file, which is used to address questionnaires to the appropriate person, which contains the following information:\n Unique identifier code,\n Full name and title,\n Full address and postcode.\nA sample file which is used to link demographic data to the survey responses for analysis and sample validation. This file will also be used to enable the identification of women who received antenatal and postnatal care directly from the trust. This file contains the following information:\n The unique identifier code (as above),\n Mother’s year of birth,\n Mother’s ethnic group,\n Day of delivery,\n Month of delivery,\n Year of delivery,\n Place of birth: NHS site code,\n Actual delivery place,\n CCG code,\n Mother’s postcode sector.\nSubmission of an attribution file is optional for Trusts. This file would include the sample file fields above and additional information relating to the provision of antenatal care or postnatal community care as follows:\n Antenatal provider information\n Postnatal provider information\n Postcode sectors to which the trust provides maternity services (ONLY if using the postcode method to complete the antenatal and postnatal provider information)."]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2019-03-29"]
["Notes","Specific Conditions of Support (Final)\n1. An interim report is required within three months of support coming into effect around the potential for risk of identification of patients reported by smaller Trusts who were participating in the survey voluntarily. If there is deemed to be a risk of identification, an overview of the mitigating safeguards which have been implemented by Picker Institute Europe should be provided for information purposes.\n2. Monitoring should be undertaken to evaluate whether any benefit realised by participating Trusts from the reporting of local-level information produced from the flow of additional attribution data from the Coordination Centre to the contractors. No formal report is required in relation to this point; however, the findings should inform the submission for the 2019 maternity survey.\n3. Confirmation from the IGT Team at NHS Digital of suitable security arrangements via Information Governance Toolkit (IGT) submission. (Confirmed – Version 14, 2016/17 reviewed satisfactory for the following organisations and respective ODS code (for IGT):\nCAPITA Surveys & Research - 8HW65\nMembership Engagement Services - 8JH55\nPatient Perspective - 8J066\nPicker Institute Europe - 8HV74\nQuality Health - NXT"]

{"sheet":"A0953","index":120,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A0953"]
["Reference","18/CAG/0018"]
["Other Refs"]
["Application Title","Pre-Hospital Emergency Medicine (PHEM) Feedback"]
["Application Summary","This application from the Princess Alexandra Hospital NHS Trust set out the non-research purpose of implementation of a service evaluation system for staff involved in the pre-hospital care of patients. The system would provide staff involved with the pre-hospital care of patients the facility to follow-up on specific cases to facilitate learning, improve clinical judgement, allow an opportunity for reflection, debriefing in particularly difficult or sensitive cases and facilitate improvement in the standard of care provided in the future.\nIn order to request feedback on a specific patient, the member of staff who had been involved with their pre-hospital care, would be required to complete a request. This would be reviewed by a senior member of their service, who would make a judgement on the appropriateness of the request and the potential educational merit. If the senior colleague supported the request, they would then act as mentor for the junior colleague throughout the debriefing process. The request would then be directed to the main applicant at Princess Alexandra Hospital NHS Trust, who would make a determination around whether the data should be released. If the request is approved, the main applicant, or a member of the team, would access patient records in order to extract the pertinent information required to meet the debrief objectives.\nThe proposal does not involve the transfer of standard patient identifiers as linkage would be facilitated via the emergency department number; however, upon receipt at the Princess Alexandra Hospital NHS Trust, this data item becomes identifiable as it will be used to identify the patient and the specific hospital presentation in question. The main applicant, who will initially be the only individual undertaking follow-up, will access the full patient record in order to extract information. The data which would be returned to the pre-hospital treating team would not include any items of confidential patient information; however, the specific patient would be identifiable to the individual staff member who had requested follow-up. The pre-hospital clinicians would also be provided with additional clinical and demographic information about the patient and their onward care, which they would not have access to when fulfilling their usual role."]
["Applicant Organisation Name","Princess Alexandra Hospital NHS Trust"]
["Contact Name","Dr Matthew Snowsill, PHEM Feedback Project Founder and Lead"]
["Address","Emergency Department, North Middlesex University Hospital"]
[null,"Sterling Way"]
[null,"London"]
["Postcode","N18 1QX"]
["Telephone","07751 159 920"]
["Email","matthew.snowsill@nhs.net"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population"," Patients presenting to Princess Alexandra Hospital NHS Trust emergency department via pre-hospital care providers, such as ambulances services, air ambulance trusts and British Association for Immediate Care (BASICs), for whom a pre-hospital clinician has requested follow-up detail post hospital admission.\n The potential number of cases cannot be determined as this is a new initiative; however, it is estimated at the outset that there would be 10 cases per week, across all pre-hospital care providers."]
["Description of confidential patient information used","The pre-hospital care provider would disclose the emergency department number to the Princess Alexandra Hospital NHS Trust, in order to allow follow-up data to be extracted from the patient’s medical record. The applicant would require access to the full medical record in order to extract the specific information which is relevant to the request which has been made from the pre-hospital clinician.\n\nThe following items of data would be provided back to the applying pre-hospital care service, for the purposes of assisting with feedback:\n Emergency Department Number – validation and project identifier,\n Age,\n Gender,\n Relevant features of the clinical history, examination, investigations,\n Hospital management and treatment,\n Diagnoses from the Emergency Department and/or on discharge,\n Condition of the patient and destination on discharge, including death and disability,\n Measurement of time which the patient survived (if subsequently deceased, but not date of death – see advice form).\n\nThis information will be used to provider the debrief session to the relevant clinician to facilitate learning as per the aims of the service evaluation."]
["S251 Class(es)",null,"Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2022-04-16"]
["Notes","19 April 2022 - Amendment supported\nAmendment supported to extend the scope of the application activity to eight additional NHS sites within the scope of the programme, to confirm that Ambulance or Air Ambulance Service Trust email addresses are no longer NHS.net, to check national data opt Out via the MESH system, and to extend the duration of ‘s251’ support until April 2025.\n\n26 November 2019: Amendment supported for the inclusion of both Hospital ID and NHS Number within scope to facilitate sample validation and linkage. The availability of the feedback programme was also extended to wider pre-hospital clinicians, who may have provided intial emergency care to the patient, but did not accompany the patient to the hospital site. \n\nThe scope of support under the Regulations was also extended to ten additional NHS Trusts which will operate the feedback programme as follows: Barts Health NHS Trust, East Suffolk and North Essex Foundation Trust, Mid Essex Hospital Services NHS Trust, Southend University Hospital NHS Foundation Trust, Basildon And Thurrock University Hospitals NHS Foundation Trust, The Princess Alexandra Hospital NHS Trust, West Hertfordshire Hospitals NHS Trust, East Anglian Air Ambulance, Essex Air Ambulance and East of England Ambulance Service NHS Trust. Support is recommended on the basis that the applicant ensures the required security standards are in place at each site prior to any processing of confidential patient information with support under the Regulations. \n\nSpecific Conditions of Support (Final)\n1. Patient and Public Involvement and Engagement – feedback would be required at the time of first annual review around the project evaluation activities which had been undertaken with the patient panel. If the responses given were negative, the CAG will take this into account when considering whether support should continue, or whether further actions are necessary.\n2. Confirmation from the IGT Team at NHS Digital of suitable security arrangements via Information Governance Toolkit (IGT) submission. (Confirmed as satisfactory via direct email from NHS Digital – Princess Alexandra Hospital NHS Trust 01/02/2018, East of England Ambulance Service Trust and Essex and Herts Air Ambulance (report under Essex Air Ambulance) 13/02/2018)."]

{"sheet":"A0954","index":121,"n_rows":36,"n_cols":3,"rows_kept":36,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[24,0,30,0],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,2,30,4],[31,1,31,4],[32,1,32,4],[34,1,34,4],[35,1,35,4],[21,1,21,4],[22,1,22,4],[23,1,23,4]]}
[]
[]
["Application Number","A0954"]
["Reference","18/CAG/0063"]
["Other Refs","(Resubmission of 18/CAG/0017)"]
["Application Title","National Clinical Audit of Rheumatoid and Early Inflammatory Arthritis Clinical Audit"]
["Application Summary","This application from the British Society for Rheumatology (commissioned by HQIP) set out the purpose of the National Clinical Audit of Rheumatoid and Early Inflammatory Arthritis. The audit aims to improve the quality of care for patients with Rheumatoid and early inflammatory arthritis (EIA) in England and Wales. The current contract period is 1 October 2017 – 30 September 2020, with the possibility of a further two year extension.\nEarly diagnosis and treatment is a cornerstone of EIA management and is underpinned by NICE guidelines (CG79). The Healthcare Quality Improvement Partnership (HQIP) has commissioned the British Society for Rheumatology (BSR) to undertake a National clinical audit (NCA) to assess EIA services.\nThe NCA will collect prospective data including:\n Waiting times;\n Time to treatment;\n Provision of education;\n Collection of patient reported outcomes;\n Clinical response.\nThe collected data will be linked with NHS digital data access request service (hospital episode statistics), pending approval from NHS Digital. It will also be linked the patient episode database for Wales (PEDW), pending approval from the NHS Wales Informatics Service. This will enable ascertainment of joint replacements, unplanned hospitalisations, and death. These linkages will be repeated annually.\nThere will also be linkage to the Death Register held by the Office for National Statistics (ONS). The data will provide validated mortality information in England and Wales."]
["Applicant Organisation Name","British Society for Rheumatology (commissioned by HQIP)"]
["Contact Name","Neena Garnavos"]
["Address","British Society for Rheumatology, Bride House"]
[null,"18-20 Bride Lane,"]
[null,"London"]
["Postcode","EC4Y 8EE"]
["Telephone","020 7356 0900"]
["Email","audit@rheumatology.org.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Patients aged 16 years and over in England and Wales who present for the first time in rheumatology outpatient clinics with a suspected diagnosis of early inflammatory arthritis. The audit period is 1 October 2017 through 30 September 2020."]
["Description of confidential patient information used","The following items of confidential patient information will be provided by the treating clinician when registering the patient within the audit:\n Name – sample validation and circulation of PROMS information,\n Date of birth – sample validation, linkage and analysis,\n NHS number – sample validation and linkage,\n Hospital number – sample validation,\n Post code – sample validation, linkage and analysis,\n Email address – circulation of PROMS information,\n Telephone number – to allow telephone contact for PROMS,\n Gender – analysis,\n Ethnicity – analysis,\nThe below additional data items will be provided by NHS Digital via linkage with ONS mortality data:\n Date of death – analysis,\n Cause of death – analysis."]
["National Data Opt \nOut Status","The Secretary of State for Health and Social Care decision maker, on advice from the CAG, has supported a request to defer the National Data Opt Out. As such, the National Data Opt Out does not need to be applied for this activity"]
["S251 Class(es)",null,"Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","HQIP"]
["Status","Supported"]
[]
["Next Review Date","2023-04-17"]
["Notes","Amendment 14 July 2022  to defer applying the National Data Opt-Out in relation to 18/CAG/0063 is conditionally supported for a period of 6 months\n\nSpecific conditions of support\n\n1.Modelling, comparing England with Wales, as no National Data Opt-Out is applied in Wales, to evidence the potential impact of the National Data Opt-Out on the audit is to be carried out. Feedback from this modelling is to be provided within 6 months of the issuing of this outcome letter\n\n2.The patient notification materials need to be revised as follows: \n\na. An explanation on how it was decided that the National Data Opt-Out would not be applied needs to be included.  \n\nb. All  local  opt-out  notification  materials  need to  contain  a  contact  name  and telephone, email and postal contacts. \nCondition 2 met as of 01 September 2022\n\n3.The National Data Opt-Out is not to be applied to patients included in the activities specified in 18/CAG/0063.\n\n4.A  local  patient  objection  mechanism  must  continue  to  be  used  in relation  to18/CAG0063.\n\n\n10 August 2021 - Amendment supported to extend the duration of support until September 2022\n\nAmendment request (Supported 10/12/2018)\nThe amendment is seeking support to widen the linkages undertaken by NHS Digital and NHS Wales Informatics Service with HES and PEDW datasets respectively, in order to provide wider clinical variables for the following analysis:\n Number of outpatient and day case attendances a patient has after symptom onset;\n Number and type of diagnostic imaging investigations undertaken;\n Delay between first appointment, diagnostic imaging request date and diagnostic imaging date.\nAmendment Specific conditions of support\n1. Confirmation from the IGT Team at NHS Digital of suitable security arrangements via Information Governance Toolkit (IGT) submission. (Confirmed - Net Solving Ltd. and NHS Digital have a reviewed satisfactory grade on Version 14.1, 2017/18, NWIS have provided a CPIP (Caldicott: Principles into Practice) report showing a 94% satisfactory assessment rate).\n\nOriginal Specific Conditions of Support (Final)\n1. Support extends to the processing of data for the non-research audit purposes only.\n2. Further work should be undertaken, with involvement from the patient panel, to revise the patient information leaflet to make this more accessible to a wider audience. A report will be required at the time of first annual review of the work which was undertaken in this area, together with the revised document for consideration.\n3. Confirmation from the IGT Team at NHS Digital of suitable security arrangements via Information Governance Toolkit (IGT) submission. (Confirmed - Net Solving Ltd. shows a reviewed grade of satisfactory on Version 14, 2016/17)."]

{"sheet":"A0955","index":122,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","A0955"]
["Reference","18/CAG/0057"]
["Other Refs","(Previously 17/CAG/0045)"]
["Application Title","Hospice-led innovations for end of life care"]
["Application Summary","This application from NHS England and Hospice UK set out the purpose of evaluating the effectiveness of innovations in end of life care. This revised application was resubmitted to replace the activity which was previously supported under application 17/CAG/0045. It was acknowledged that there was a change to data controller and processor arrangements for the project.\nResearch had shown that 80% of patients preferred to die at home, and only 5% in hospital, however the reality was that end of life care was more likely to take place in a hospital setting, which was costly as well as unwelcome for patients. Care models had been introduced at 24 hospices, aimed at reducing hospital-based end-of-life care. These models of care would be evaluated using both quantitative and qualitative methodology; the end result would be a report and set of recommendations for NHS England and end of life care commissioners, and advice for hospices on how to implement the most effective new models.\nThis application specifically related to the use of identifiable information to link patient datasets for quantitative analysis, in order to examine whether rates of hospital-based end-of-life care decreased where the new care models were used.\nThe Hospices involved would transfer identifiable information to NHS Digital, who would link these to the HES and ONS databases. NHS Digital would release a pseudonymised file to McKinsey and Company for analysis.\nA recommendation for class 1, 3, 5 and 6 was requested for the process of extracting and anonymising the information, to link patient identifiable information obtained from more than one source, for auditing, monitoring and analysing patient care and treatment and to allow access to an authorised user for one or more of the above purposes."]
["Applicant Organisation Name","NHS England and Hospice UK"]
["Contact Name","Mr Giles Colclough"]
["Address","McKinsey and Company"]
[null,"1 Jermyn Street"]
[null,"London"]
["Postcode","SW1Y 4UH"]
["Telephone"]
["Email","Giles_Colclough@mckinsey.com"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","The Hospices involved would transfer identifiable information to NHS Digital, who would link these to the HES and ONS databases. NHS Digital would release a pseudonymised file to McKinsey and Company for analysis."]
["Description of confidential patient information used","Access was requested to NHS number, date of birth, gender, postcode."]
["S251 Class(es)",null,"Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,"Y","Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2019-04-20"]
["Notes","Specific Conditions of Support (Final)\n1. All pre-existing conditions of support related to 17/CAG/0045 remain applicable.\n2. The pre-existing annual review cycle remains applicable, with the next annual review to be received 4 weeks before 29/03/2019, and then on an annual basis to this schedule.\n3. Confirmation from the IGT Team at NHS Digital of suitable security arrangements via Information Governance Toolkit (IGT) submission. (Confirmed – NHS Digital sole processor of confidential patient information)."]

{"sheet":"A0956","index":123,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A0956"]
["Reference","18/CAG/0064"]
["Other Refs"]
["Application Title","National Bone and Joint Infection Registry"]
["Application Summary","This application from the Northumbria Healthcare NHS Foundation Trust sets out the purpose the development and establishment of a national registry for Bone and Joint Infections in the United Kingdom, which is intended to be used for audit and service evaluation. Bone and joint infections are a significant cause of morbidity and mortality that affect patients of all ages. Understanding current standards for care and effectiveness of interventions and care pathways is a major challenge for surgeons, physicians, microbiologists and patients. This project seeks to capture data about affected patients and the care they receive for these debilitating and often fatal conditions. Linkage with the HES dataset is proposed via NHS Digital; however, this element is outside of the CAG’s remit as patients will be asked to consent to this element. This will enable robust understanding of the current care pathways, insight into which treatments are most effective and comparisons between different units of the patient outcomes they achieve.\nA recommendation for class 1, 4, 5 and 5 support was requested to cover activities as described within the application."]
["Applicant Organisation Name","Northumbria Healthcare NHS Trust"]
["Contact Name","Mr. Mike Reed"]
["Address","Northumbria Healthcare NHS Trust"]
[]
[]
["Postcode","NE63 9JJ"]
["Telephone"]
["Email","mike.reed@nhs.net"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","All patients aged over 18 who suffer from infection involving native bones and/or joints or related to medical devices in bones or joints within England and Wales.\nData will be provided from individual treating Trusts by entry into a web-based registry."]
["Description of confidential patient information used","The following items of confidential patient information will be requested, together with a wider clinical dataset, for the purposes as detailed:\n Date of Birth – validation and linkage,\n NHS number – validation and linkage,\n Age – analysis,\n Sex – analysis,\n Date of death – analysis,\n Ethnicity – analysis,\n Hospital Unit Identifier – validation and analysis,\n Date of admission – validation and analysis,\n Date and time of discharge – validation and analysis."]
["S251 Class(es)",null,"Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2023-05-10"]
["Notes","Specific Conditions of Support\n1. Patient and Public Involvement and Engagement – submission of a detailed overview of activity planned in this area is required as an interim report within six months of the date of this outcome. Defined activities should be set out within a specific timescale to enable structured feedback to be gathered. (Condition Met 26 March 2019)\n2. Patient Notification Materials – revisions are required to the patient-facing documents, which should be informed by the patient and public involvement and engagement activity. Revised documentation should be submitted for CAG review within six months of the date of this outcome. (Conditions Met 26 March 2019)\na. Patient Information Leaflet – requires revisions to provide a clearer explanation of when patients are included within the registry, and to explain that consent would be sought at a future date around continued participation,\nb. Poster – requires revision to accurately articulate who will have access to confidential patient information when data is entered into the registry and to provide a clearer explanation of the consenting procedure.\n3. Confirmation from the IGT Team at NHS Digital of suitable security arrangements via Information Governance Toolkit (IGT) submission. (Confirmed Dendrite Clinical Systems & Northumbria Healthcare NHS Foundation Trust, Version 14.1, 2017/18, shows a reviewed grade of satisfactory)"]

{"sheet":"A0957","index":124,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","A0957"]
["Reference","17/CAG/0185"]
["Other Refs"]
["Application Title","2018 Community Mental Health Survey"]
["Application Summary","This non-research application from Picker, CQC and NHS England set out the purpose of administering the 2018 Community Mental Health Survey, to gauge patient experience and views of the service they received. A recommendation of support was requested to enable the transfer of patient identifiable data from mental health providers, to an approved survey contractor for the purpose of mailing out questionnaires. The vast majority of trusts involved were expected to opt to use an approved survey contractor, either: Picker, Quality Health, Patient Perspective, CAPITA Surveys & Research or Membership Engagement Services.\nThe end product from the survey would be a set of aggregate statistical data that did not contain patient identifiable information. This statistical dataset is used for a wide variety of purposes to support ongoing improvement in overall patient experience by NHS Trusts and CCGs and by CQC, to inform its regulatory functions.\n\nNHS Patient Survey Programme\nThis survey is part of the NHS Patient Survey Programme, and as such follows the same methodology as other surveys within the programme. The methodology is approved in principle by the CAG, and applications are usually considered via the Precedent Set pathway.\nNew approaches are often piloted within the NHS Patient Survey Programme. The 2017 Adult Inpatient Survey (which is referred to throughout the application) trialled the use of text message reminders to complete the survey, and was escalated to full CAG meeting as there was no precedent for the use of text messages. Support was given at the meeting for this approach.\nBreaches reported for the 2017 Adult Inpatient Survey were considered, as the same methodology and applicant were involved; any changes made to NHS Patient Survey Programme methodology as a result of breaches were considered relevant to this application despite the fact that the breaches occurred in a different survey.\n\nFor the current application (Community Mental Health Survey 2018), the following interventions would be added as part of a pilot:\nPilot Study\nA shorter questionnaire\nAn online survey 􀂱 link to be sent to patients in a text mesage\nSMS (text message) reminders\nNo CQC Flyer\nThe aim was to increase response rates overall and from lesser heard groups."]
["Applicant Organisation Name","Picker"]
["Contact Name","Ms Jenny King"]
["Address","Buxton Court"]
[null,"3 West Way"]
[null,"Oxford"]
["Postcode","OX2 0JB"]
["Telephone"]
["Email","jenny.king@pickereurope.ac.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Access was requested to data from mental health providers in relation to people aged 18 and over who had been in contact with NHS mental health services in the three month period, 1 September to 30 November 2017, and who were receiving specialist care or treatment for a mental health condition, including those who received care under the Care Programme Approach (CPA)"]
["Description of confidential patient information used","The mailing file is used to address questionnaires to the appropriate person, and is sent to the Approved Contractor. It contains:\n􀂃 Trustcode\n􀂃 A standardised unique identifier code, to be constructed as survey identifier, trust code followed by a whole number (consecutive across the sample of 850 service users from each trust), e.g. MH18XXXnnnnn where XXX is the trusts 3 digit trust code and nnnnn is the 5 digit serial number relating to sampled service users\n􀂃 Title (Mr, Mrs, Ms, etc.)\n􀂃 First name\n􀂃 Surname\n􀂃 Address Fields\n􀂃 Postcode\nThe sample data file is used to link demographic data to the survey responses, to aid analysis and to enable checks to be carried out for any errors in how the sample was drawn and is sent to the Coordination Centre. This file contains:\n􀂃 Trustcode\n􀂃 The unique identifier code (as above)\n􀂃 Year of birth\n􀂃 Gender\n􀂃 Ethnic category\n􀂃 Day of last contact\n􀂃 Month of last contact\n􀂃 Year of last contact\n􀂃 CPA status\n􀂃 CCG code\nMental Health Care Cluster Codes\nThe inclusion of mental health care cluster codes in the sample file was a deviation from the previous method, which had been to send this information to the coordination centre separately. This would simplify the process for trusts and avoid errors (previous errors included a Trust sending the care cluster code along with patient identifiers, and mismatching the care cluster code with the patient record, due to having separated it from the sample file).\nThere was precedent for a similar approach to be supported by the CAG in the Adult Inpatient Survey, where ICD-10 codes were included with the sample file.\nPilot study\nAs part of the pilot work, pilot trusts would also be asked to include the following:\n􀁸 Indicator to show whether service users have a mobile phone number or not (main / control sample);\n􀁸 Mobile phone number (for the pilot sample only)"]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,"Y","Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,null,"Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2018-11-23"]
["Notes","Specific conditions of support\n1. Please ensure that instructions to individual trusts go beyond ‘recommending’ that they display patient notifications, making clear that they are requested to ensure patients are aware of the survey and can opt out if they so wish. Please report back on this at annual review stage, including numbers of patients who have opted out.\n2. Confirmation from the IGT Team at the Health and Social Care Information Centre of suitable security arrangements via Information Governance Toolkit (IGT) submission."]

{"sheet":"A0958","index":125,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A0958"]
["Reference","17/CAG/0100"]
["Other Refs"]
["Application Title","London Borough of Tower Hamlets Whole Systems Data\nIntegration Project"]
["Application Summary","Context\nPurpose of Application\nAs one of the most deprived boroughs in England, Tower Hamlets is attempting to efficiently improve overall health outcomes while addressing health inequalities. The intention of this project is to underpin this strategy with evidence identifying the key drivers of health inequalities with respect to health status and service usage. Tower Hamlets already benefits from an integrated care dataset that links data across different settings of care: primary care, community health, mental health, secondary care and adult social care. This was established as part of the Waltham Forest, East London collaborative (WELC) Integrated Care Pioneer Programme in order to map a proposed capitated budgets model based on 14/15 data. The applicants propose to build on this good practice by linking these datasets as well as children’s services data and wider determinants data, which are held and owned by the local authority.\nTo establish a truly integrated and pseudonymised health and social care (H&SC) dataset for the local population which combines information from the London Borough of Tower Hamlets (LBTH), Local Authorities and wider health care sectors so as to:\n Define, inform and implement capitated budget for the Tower Hamlet population.\nA recommendation for class 1, 4, 5 and 6 support was requested to cover activities as described in the application."]
["Applicant Organisation Name","London Borough of Tower Hamlets"]
["Contact Name","Dr Somen Banerjee"]
["Address","Mulberry Place (4th Floor), 5 Clove Crescent"]
[null,"Tower Hamlets"]
[null,"London"]
["Postcode","E14 2BG"]
["Telephone"]
["Email","somen.banerjee@towerhamlets.gov.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Data from the London Borough of Tower Hamlets (LBTH), local authorities, and wider health sectors in relation to the resident population of the London Borough of Tower Hamlets (296,000)"]
["Description of confidential patient information used"," NHS Number,\n Full Name,\n Full Address (including postcode),\n Date of Birth,\n Date of Death,\n Gender,\n GP Code; & Unique Property Reference Number (UPRN) [a unique alphanumeric identifier for every spatial address in Great Britain]."]
["S251 Class(es)",null,"Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2020-07-26"]
["Notes","20 January 2020 – Amendment supported to extend the duration of support until 31 July 2020, to allow the applicants to continue to access the dataset which, though pseudonymised, remains rich enough for patients to be rendered identifiable, to carry out validation and quality assurance work. \n\n11/04/2019: Amendment to extend the duration of support under the Regulations to 31 July 2019 conditionally support.\nConditions of support – response required in 10 working days: \n1. Confirm all confidential patient information used to facilitate activity in zone one of the project has been destroyed.\n2. If so, confirm whether there is a requirement for ongoing support under the Regulations for zone two activities.\n\nAmendment Request (Approved 24/05/2018)\nThis amendment request was submitted to seek approval to extend the duration of support under the Regulations to 31 March 2019.\nA clarification point was also included within the amendment documentation to confirm that the Clinical Effectiveness Group at Queen Mary University of London (CEG QMUL) is acting as the data processor for the project.\nThe applicants also submitted an interim six month progress report for consideration by the CAG, in line with the conditions which were attached to the recommendation of support. This was considered by the Sub-Committee in conjunction with the amendment request.\n\nSpecific Conditions of Support\n1. Support is extended to 31 March 2019.\n2. Further work should be undertaken to improve the lay representation on the project Steering Group. Feedback on the progress achieved is required at annual review.\n3. Further work should be undertaken to improve the project-specific objection mechanism. This should be informed by wider communication plans and additional patient and public involvement and engagement. Feedback on the work undertaken is required at annual review, together with an overview of the improved objection mechanism and how this was operated.\n4. Confirmation of suitable security arrangements via IG Toolkit submission. (Confirmed – Version 14.1, 2017/18, NHS Digital email confirmed 21 May 2018)."]

{"sheet":"A0959","index":126,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","A0959"]
["Reference","18/CAG/0072"]
["Other Refs"]
["Application Title","NHS Improvement Getting It Right First Time (GIRFT) Program"]
["Application Summary","This application from NHS Improvement set out the purpose of service evaluation to determine the specific causes of medical negligence claims with surgical specialities through detailed case analysis. The programme aims to identify poor practice and influence national guidance to address to reduce the number of claims and improve patient care and experience of the NHS.\nThe purpose of the Getting It Right First Time (GIRFT) programme is to determine specific causes of clinical negligence claims against all NHS services from both medical and surgical specialities as well as all areas in which NHS Resolution receive claims in order to improve patient care. The GIRFT programme will also monitor the volume and cost of these claims to drive service improvements. The previous approved programme had looked solely at surgical specialities.\nThe updated GIRFT programme would like to access specific litigation data held by NHS Resolution on its claims management system. This reflects the Secretary of State for Health and Social Care extending the remit of the programme, as part of the Lord Carter recommendations, to include over 34 specialities, both medical and surgical, and the role that both NHS Improvement GIRFT and Model Hospital teams are to play in order to help NHS Resolution and NHS trusts learn from claims."]
["Applicant Organisation Name","NHS Improvement"]
["Contact Name","John Machin"]
["Address","C/O Louise Quayle (P.a. to Professor Tim Briggs)"]
[null,"The Royal National Orthopaedic Hospital"]
[null,"Stanmore & NHS Improvement Brockley Hill Stanmore"]
["Postcode","HA7 4LP"]
["Telephone"]
["Email","john.machin1@nhs.net"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,null,"the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Cohort\n All individuals who have notified NHS Resolution of an intention to make a claim against an NHS Trust since 01/01/2003 to 31/12/2020.\n An accurate sample size cannot be estimated from the outset of the project; however, it is stated that 57,761 claims have been made in the last five years alone."]
["Description of confidential patient information used","The following items of data will be released from NHS Resolution to NHS Improvement:\n Patient age at incident,\n NHS Resolution Claim Reference and Claim ID,\n Sex,\n Description of medical negligence claim including dates of incident, date of case creation (notification), case status and outcome, damages paid, case costs, causes and injury sustained."]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2023-06-18"]
["Notes","Specific Conditions of Support (Final)\n1. Patient and Public Involvement and Engagement – an interim report is required within three months of the date of this letter to provide an update on feedback in this area. This should address the following points:\na. Provide an overview of discussions/activity at the further scheduled meeting with the Patient’s Association,\nb. Confirm the establishment of the volunteer group to support the project and provide an overview of the demographics of the group and the first scheduled meeting date,\nc. Terms of reference for the volunteer group should be provided to explain the role and remit of the group, how regularly meetings would be scheduled and how frequently feedback would be provided by the programme,\nd. The group should be approached to consider the patient notification and dissent materials and be asked to provide comments on their suitability for a wide patient audience. Feedback should be provided together with any documentation which has been revised for review,\ne. If the responses given are negative, the CAG would take this into account when considering whether support can continue or whether further action is required.\n2. Confirmation from the IGT Team at NHS Digital of suitable security arrangements via Information Governance Toolkit (IGT) submission. (Confirmed – NHS Digital’s reviewed grade on Version 14.1, 2017/18 for MONITOR (encompassing NHS Improvement) received via email on 07/06/2018)."]

{"sheet":"A0960","index":127,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","A0960"]
["Reference","18/CAG/0076"]
["Other Refs"]
["Application Title","Audit: evaluation of availability of patient contact details for use in the NHS Patient Survey Programme"]
["Application Summary","This application which was submitted by the Picker Institute, on behalf of the Care Quality Commission, sets out the purpose of audit which aim is to understand the availability and validity of digital contact information, including mobile telephone numbers and email addresses held by NHS organisations on their information systems (most likely PAS) in relation to patients. The audit is being undertaken as part of a wider assessment to understand whether it would be feasible to move data collection for the NHS Patient Survey Programme to a digital methodology.\nThe applicants will be requesting that all organisations which participate in the NHS Patient Survey Programme transfer confidential patient information in relation to their patients within a specific time period to the Coordination Centre, based at Picker Institute Europe, for analysis by Picker Staff. The analysis will enable the CQC to determine whether new methodologies can be employed to facilitate the gathering of patient feedback."]
["Applicant Organisation Name","Picker Institute, on behalf of the Care Quality Commission"]
["Contact Name","Ms Jenny King"]
["Address","Picker Institute, Buxton Court"]
[null,"3 West Way"]
[null,"Oxford"]
["Postcode","OX2 0JB"]
["Telephone"]
["Email","jenny.king@pickereurope.ac.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","This audit involves the retrospective sample of all patients, regardless of what contact information is held, as follows:\n Trusts will be asked to sample all patients who were discharged during October 2018 (for the adult inpatient survey),\n Community mental health services would be asked to sample all service users in contact with the service in May 2018,\n Specialist children’s trusts, we would ask for all children discharged during October 2018,\n There will be a maximum of 2,000 patient per Trust included within the audit.\n\nThe following individuals would be excluded from the audit sample:\n Patients under the age of 16 years old (for the adult inpatient, emergency department and maternity populations only),\n Service users under the age of 18 years old (for the community mental health population only),\n Parents of children and young people for children inpatient and day-case services,\n Patients and service users who were not accessing an NHS based service (ie: include private patients),\n Patients who had specifically indicated that their use of contact details should be for nothing other than their clinical care."]
["Description of confidential patient information used","The following items of confidential patient information will be provided for analysis to be undertaken:\n Unique identifier/ record number: this would be assigned when the sample is compiled,\n Year of birth,\n Gender,\n Ethnicity,\n Telephone number (mobile number only),\n Email address,\n Flag to indicate whether telephone number is for the patient,\n Flag to indicate whether email address is for the patient,\n Date contact information collected (for both contact details separately),\n Date of validation (if applicable) (for both contact details separately),\n Whether consent given for contact information to be used (for both contact details separately)."]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Expired"]
[]
["Next Review Date"]
["Notes","Datafiles containing this information have been deleted by the Survey Coordination Centre (Based at Picker Institute Europe). \nRemaining outputs are aggregated reports, identification of individual records is not possible.  \n\nThe results of the audit activity demonstrated that there was sufficient data capture and quality of mobile phone numbers within trust patient record systems to make implementing a mixed-mode survey feasible, a target of 50% was required and the audit confirmed a 59% coverage. A significant amount of pilot work was then conducted off the back of this audit, testing our new survey methodology (a mix of online and paper questionnaires) during 2019. This has then led to large scale changes being made across the survey programme with the 2020 and 2021 Adult Inpatients Surveys, as well as 2021 and 2022 Maternity Surveys using the mixed mode methodology. The 2022 Maternity Survey this year received 89% of responses digitally and a response rate of 47% compared to 39% in 2019. Both of these measures of success would be unlikely to have been achieved without the initial audit work to provide confidence on mobile phone availability within NHS Trusts.  \n\n22/03/2019 – the amendment to remove the limit of 2000 samples per Trust is fully supported.     \n\nSpecific Conditions of Support (Final)\n1. Confirmation from the IGT Team at NHS Digital of suitable security arrangements via Information Governance Toolkit (IGT) submission (Confirmed – Picker Institute Europe shows a satisfactory reviewed grade on Version 14.1, 2017/18).\n"]

{"sheet":"A0961","index":128,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A0961"]
["Reference","18/CAG/0098"]
["Other Refs"]
["Application Title","2018 NHS Adult Inpatient Survey"]
["Application Summary","This non-research application from Picker Institute Europe, CQC and NHS England set out the purpose of carrying out the 2017 NHS Adult Inpatient Survey, using standardised methodology to build up a national picture of patient experiences. A set of aggregated statistical data is produced which is shared with individual Trusts, CQC, NHS England and the Department of Health and used to monitor and compare the performance of Trusts, and to drive improvements.\nThis survey would be the 16th carried out to date. The methodology is well established and has been approved in principle by the CAG via Precedent Set Sub-Committee. The applicants confirmed that the survey methods are unchanged from the 2017 survey.\nParticipating trusts identify the sample in line with the inclusion/exclusion criteria, and disclose names and addresses to approved contractors for the purpose of mailing out the surveys (this data is held in a mailing file along with the unique identifying code which is printed on the survey itself). Demographic information for each potential participant is collected in a separate sample file, linked by the identifying code.\nPicker Institute is commissioned to manage and coordinate the surveys under the title of the Patient Survey Coordination Centre, carrying out checks across the samples submitted by trusts and disseminating aggregated results (identifiable information is not received by the Patient Survey Coordination Centre).\nAs part of the drive to improve response rates (RR) and possibly reduce response bias, and to explore a move to a mixed mode methodology using online methods within the NPSP, a pilot study is being proposed across 10 Trusts, which would each be asked to provide an additional 1,014 patient, and provide mobile telephone numbers for them, to test the effect of a three separate interventions in the 2018 NHS Inpatient Survey (IP18):\n- Administering the questionnaire online (instead of a postal survey).\n- Sending SMS reminders.\n- Using a shorter questionnaire.\nThe control arm of the pilot will be the main sample. This pilot is aimed at testing the effects of three different methods of invitation which combine postal letters and text messages, and the use of an online questionnaire. Inclusion of mobile phone numbers was approved for last year’s survey via full CAG review – as the proposed pilot does not require the disclosure of any additional items of confidential patient information, promotion to full CAG was not deemed appropriate at this stage. \n\nThe interventions will be piloted as follows: \nIntervention 1:  Mailing 1 (M1) Postal letter with link to online questionnaire; Mailing 2 (M2) Postal reminder with link to online questionnaire; Mailing 3 (M3) Postal letter (no link) and \nhard copy of questionnaire.\nIntervention 2: Mailing 1 (M1) Postal letter with link to online questionnaire, followed by SMS with link; Mailing 2 (M2) Postal reminder with link to online questionnaire, followed by SMS with link; Mailing 3 (M3) Postal letter (no link) and hard copy of questionnaire.\nIntervention 3:  Mailing 1 (M1) Same as main survey, with shorter questionnaire; Mailing 2 (M2) Same as main survey; Mailing 3 (M3) Same as main survey, with shorter questionnaire.\nIt is noted that all pilot interventions will use the shorter version of the questionnaire."]
["Applicant Organisation Name","Picker Institute Europe, CQC and NHS England"]
["Contact Name","Ms Jenny King"]
["Address","Picker Institute Europe, Buxton Court"]
[null,"3 West Way"]
[null,"Oxford"]
["Postcode","OX2 0JB"]
["Telephone"]
["Email","jenny.king@pickereurope.ac.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population"," Inpatients aged 16 years old or over who were discharged from acute and specialist NHS hospitals in July 2018 (and earlier for smaller trusts), having had one overnight stay in hospital.\nExclusions:\n deceased patients,\n children or young persons aged under 16 years at the time of sampling,\n obstetrics/maternity service users, including spontaneous miscarriages,\n patients admitted for planned termination of pregnancy,\n psychiatry patients,\n day cases,\n private patients (non-NHS),\n any patients who are known to be current inpatients patients without a UK postal address,\n any patient known to have requested their details are not used for any purpose other than their clinical care, including those responding to posters displayed on hospital wards referring to the survey (the survey instructions request that all responses to posters are logged and used for this purpose)."]
["Description of confidential patient information used","The mailing file sent to contractors contains the following information:\n A standardised unique identifier code (see application for full details of how this is constructed)\n Title (Mr, Mrs, Ms, etc.)\n First name\n Surname\n Address Fields\n Postcode (where available)\n Mobile telephone number for those patients included in the pilot, from a total of up to 10 Trusts.\nThe sample data file (used to link demographic data to the survey responses, to aid analysis and to enable checks to be carried out for any errors in how the sample was drawn contains:\nThe sample data file (used to link demographic data to the survey responses, to aid analysis and to enable checks to be carried out for any errors in how the sample was drawn contains:\n The unique identifier code,\n Admission/discharge dates,\n Length of stay (this is calculated from the admission and discharge dates),\n Whether admission from Treatment Centre,\n Route of admission,\n NHS Site code on admission and discharge,\n Ethnicity,\n Gender,\n Year of birth,\n Indicator of recorded mobile telephone number (all patients not included in SMS pilots),\n CCG Code: to enable analysis at this level by stakeholders for the production of relevant indicators,\n ICD10 code.\nThe sample file is also shared with the Coordination Centre to enable centralised checks on the appropriateness of samples drawn. For clarity, please note that the Coordination Centre do not receive any names or addresses."]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Expired"]
[]
["Next Review Date","N/A"]
["Notes","Application expired 21/08/2019. Picker Institute Europe confirmed that this application reference is no longer processing confidential patient information without consent. The legal support in place to allow relevant information to be processed without consent is expired.\n\nSpecific conditions of support\n1. Confirmation from the IGT Team at NHS Digital of suitable security arrangements via Information Governance Toolkit (IGT) submission (Confirmed – NHS Digital review of Version 14.1, 2017/18, Capita Business Services Ltd., Membership Engagement Services and Patient Perspectives by email 18 July 2018)."]

{"sheet":"A0962","index":129,"n_rows":36,"n_cols":3,"rows_kept":36,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[24,0,30,0],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,2,30,4],[31,1,31,4],[32,1,32,4],[34,1,34,4],[35,1,35,4],[21,1,21,4],[22,1,22,4],[23,1,23,4]]}
[]
[]
["Application Number","A0962"]
["Reference","18/CAG/0146"]
["Other Refs","New reference for expired PIAG 2-05(j)/2006"]
["Application Title","National Joint Registry (NJR)"]
["Application Summary","Register of patients with hip and knee joint replacements - updated application to show new provider\n\n1. All pre-existing conditions of support related to PIAG 2-05(j)/2006 remain applicable:\n\n•\tThat it is understood that consent is still required but that where consent has not been sought or it is unknown whether consent has been sought, then support under s251 may be utilised to obtain identifiable patient data. Particular care needs to be taken to ensure that dissent is respected and no identifiers are submitted in this circumstance. \n•\tThat where support under s251 has been utilised, once the NHS number has been traced or validated via NHS Digital (previously undertaken by NHS strategic tracing service), name and address are removed and postcode and date of birth reduced.\n•\tThat the Registry continues to demonstrate year on year improvement in consent rates in its annual review.\n•\tThat consideration be given to maintaining valid consent and appropriate data destruction (de-identification) over the longer term.\n•\tThat the CAG be informed of new linkage arrangements with NHS Digital or PEDW.\n•\tThat the possibility of including consent to participation in the Registry on the Consent to Treatment form, should be considered. It would need to be made clear that these are separate consent processes and that refusal to be part of the Registry will not affect the patient’s care or treatment.\n•\tWith respect to Independent Treatment Centres (ITCs), where it is not already the case, that there is a need for commissioners to make it a contractual obligation on ITCs to participate in the Registry and for them to offer participation in the Registry to patients.\n\n2. The pre-existing annual review cycle remains applicable, with the next annual review to be received 4 weeks before 12 November 2019, and then on an annual basis to this schedule.\n3. Confirmation from the IGT Team at the Health and Social Care Information Centre of suitable security arrangements via Information Governance Toolkit (IGT) submission (Confirmed: Northgate Public Services has a satisfactory reviewed score for IGT v14.1 2017-18)"]
["Applicant Organisation Name","Healthcare Quality Improvement Partnership"]
["Contact Name","Chris Boulton, NJR Deputy Director of Operations"]
["Address","27A Harley Place"]
[null,"London"]
[]
["Postcode","W1G 3LZ"]
["Telephone","07945 586072"]
["Email","chris.boulton@njr.org.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","The National Joint Registry collects data on all hip, knee, ankle, elbow and shoulder replacement operations carried out in NHS and independent sector hospitals and treatment centres in England and Wales from 1 April 2003 onwards. The CAG remit extends to those patients whose consent status is unknown within the registry. "]
["Description of confidential patient information used","• Surname\n• Forename\n• Date of Birth\n• Home address including postcode\n• NHS number\n• Gender"]
["National Data Opt \nOut Status","The Secretary of State for Health and Social Care decision maker, on advice from the CAG, has supported a request to defer the National Data Opt Out. As such, the National Data Opt Out does not need to be applied for this activity"]
["S251 Class(es)",null,"Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2023-11-12"]
["Notes","The PIAG application reference PIAG 2-05(j)/2006 was expired 15/08/2018 and is no longer live; no further updates will be made to that Register entry. All activities and amendments previously supported under PIAG 2-05(j)/2006 has been transferred to this reference 18/CAG/0146, and controllers should review only this Register entry.\n\nAmendment supported 09 June 2022 to defer applying the National Data Opt-Out in relation to 18/CAG/0146\n\nSpecific conditions of support\n\n1. The National Data Opt-Out does not apply to the non-research activities specified in 18/CAG/0146.\n\n2. The National Data Opt-Out must be applied in relation to processing for research purposes and specifically in relation to 19/CAG/0182\n\n3. A local patient objection mechanism must continue to be used in relation to 18/CAG/0146\n\n4. Communication and notification – the communications plan presented to CAG is to be followed. Any changes in the communications plan should be notified to the CAG. \n\n\n10 December 2021 - Amendment supported to change the data flow for the linked Hospital Episode Statistics (HES), and Civil Registry (formerly ONS) data so that confidential patient information flows from NEC Software Solutions (UK) Ltd (NECSWS) (on behalf of the National Joint Registry) to NHS Digital for the purposes of data linkage.\n\n18 September 2020 - Amendment conditionally supported to change the data flow for the NHS England Patient Reported Outcomes Measures programme (PROMs) data so that identifiable patient information flows from Northgate Public Services (on behalf of the National Joint Registry) to NHS Digital for the purposes of data linkage.\n\nApplicant responded to the condition as part of the 2020 Annual review. The CAG Chair was content with the level of PPI undertaken and this was confirmed by email on 28 October 2020. \n\nSpecific conditions of support:\n\n1. Further patient and public involvement and engagement is to be carried out on an ongoing basis and reported back on at annual review, including feedback on the updated information leaflet. Annual review is due 12 November 2020.\n\n\n04 November 2013 - Amendment supported to aggregate previous applications relating to NJR under one approval, including continued linkage with HES, PEDW and PROMs datasets.  Revised consent materials were provided to support this.\n\n18 May 2013 - Amendment supported which confirmed that, in line with the original application for support, the continued need for the NJR to undertake outcomes analyses for joint replacement surgery, including risk adjusted mortality rates. In order to undertake these analyses, it was necessary to know a patient’s date of death and the causes of death. As linkage to these ONS data items was not specifically mentioned within the original application the amendment sought to clarify the support provided.\n\n22 October 2012 - Amendment supported for an audit of use of the DePuy Pinnacle acetabular cup, retrospective to 2003, requested by MHRA and Department of Health.             \n\n19 August 2011 - Amendment supported to extend the duration of support to June 2013 and continued linkage with HES/PEDW/PROMS data.\n\n08 November 2010 - Amendment supported to allow the use of HES and PEDW data in order to support an audit of revisions not reported to the NJR. The HES data required would comprise provider codes (5 and 3), local patient identifier, spell start and end dates, consultant code, surgeon date and procedure fields.\n\n09 July 2009 - Amendment supported to extend the duration of support for a period of 2 years until 9 July 2011. The extension provides support for an additional 2 year period, continued linkages with HES, PEDW and PROMS data, and covers the collection of identifiable information where consent has been recorded as 'Don't Know'. Amendment also included access to elbow, shoulder and ankle replacement data.\n\n"]

{"sheet":"A0963","index":130,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","A0963"]
["Reference","18/CAG/0110"]
["Other Refs"]
["Application Title","2018 Urgent and Emergency Care Survey"]
["Application Summary","This application from the Picker Institute Europe set out the purpose of carrying out the 2018 Urgent and Emergency Care Survey, sponsored by the Care Quality Commission. The findings of the survey are used by NHS Trusts and CCGs to facilitate local improvement, by the CQC as part of its regulatory activities and to support other relevant functions and will be shared in a non-identifiable format with NHS England, the Department for Health and Social Care and wider NHS Organisation to gain understanding of patients’ experiences of NHS services and to drive improvements to them.\nThe 2018 survey will be the seventh carried out to date. The title of the survey has been revised for this year’s proposed survey (from the previously titled 2016 Emergency Department Survey) to reflect changes in terminology and increased focus on urgent care as well as emergency care. All emergency department surveys prior to 2016 included patients attending Type 1 services only. The sampling approach was changed in 2016 to include Type 3 services. Broadly, these services are defined as:\n Type 1 - A major, consultant-led A&E department with full resuscitation facilities operating 24 hours a day, seven days a week.\n Type 3 - Other A&E / minor injuries unit / urgent care centre treating minor injuries and illnesses. Can be doctor or nurse-led and accessed without an appointment.\nParticipating Trusts will be asked to begin preparations for the patient sample to be drawn in September 2018. Confidential patient information will be shared with the approved contractors facilitating the survey to enable the standardised to be followed across the full programme of activities.\nSome minor changes to the study methodology are proposed for the 2018 survey as follows:\n A separate survey questionnaire is under development for patients who attended a Type 3 Department (Urgent Care Department),\n The sample size for patients attending a Type 3 Department has been increased from 300 to 420 to enable benchmarking across Trusts. This is in addition to the 950 patient sample for Type 1 Department attendances (Emergency Department), as per the 2016 survey. For Trusts without a Type 3 Department, the sample size for Type 1 Department attendances will remain at 1250, as per the 2016 survey."]
["Applicant Organisation Name","Picker Institute Europe"]
["Contact Name","Ms Jenny King"]
["Address","Buxton Court"]
[null,"3 West Way"]
[null,"Oxford"]
["Postcode","OX2 0JB"]
["Telephone"]
["Email","jenny.king@pickereurope.ac.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population"," People aged 16 and over who attended a Type 1 emergency department in September 2018 or a Type 3 urgent care department in September 2018. Trusts will be instructed to contact the Survey Coordination Centre if they are unable to draw the required sample size from their Type 3 department in which case they will be instructed to also sample back to August 2018.\nThe Sampling Instructions will ask Trusts to exclude:\n deceased patients,\n children or young persons aged under 16 years at the date of their attendance at the emergency department,\n any patients who are known to be current inpatients ,\n planned attendances at outpatient clinics which are run within the Emergency Department (such as fracture clinics),\n patients without a UK postal address,\n patients attending primarily to obtain contraception (e.g. the morning after pill), patients who suffered a miscarriage or another form of abortive pregnancy outcome whilst at the hospital, and patients with a concealed pregnancy*,\n any patient known to have requested their details are not used for any purpose other than their clinical care,\n any patients who were admitted to hospital via Medical or Surgical Admissions Units and therefore have not visited the emergency department,\n For the type 3 sample, any services which are mainly or entirely appointment-based.\n*As per 2016, Trusts will be advised to check ICD-10 codes, or obstetric or gynaecology codes. If the use of these codes will not enable identification of women who should be excluded, the Trust would then be required to check notes on their records to ascertain reason for attendance."]
["Description of confidential patient information used","Administration of the 2018 Urgent and Emergency Care Survey requires NHS trusts to share two distinct sets of information with their approved contractor:\nThe mailing file is used to address questionnaires to the appropriate person. It contains:\n A standardised unique identifier code,\n Title (Mr, Mrs, Ms, etc.),\n First name,\n Surname,\n Address Fields,\n Postcode.\nThe sample file is used to link demographic data to the survey responses, to aid analysis and to enable checks to be carried out for any errors in how the sample was drawn. This file contains:\n The unique identifier code (as above),\n Date and time of attendance,\n NHS Site code,\n Department type (Type 1 or Type 3),\n Ethnicity,\n Gender,\n Year of birth,\n CCG code.\nThe two sets of information listed above will be submitted by participating Trusts to approved contractors as one file. Approved contractors will split the data out and only the sample data will be provided to the Survey Coordination Centre to enable centralised checks on the appropriateness of samples drawn. The Survey Coordination Centre does not receive any names or full addresses."]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,null,"Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor","CQC"]
["Status","Expired"]
[]
["Next Review Date","2020-08-28"]
["Notes","January 2022 - Support expired\nApplicant confirmed support no longer required in January 2022, as all identifers have been deleted. \n\nIn terms of public benefit, the systematically collected quantitative data from urgent and emergency care patient experience surveys are used to monitor the quality of care given to patients, at trust level and nationally, and to support ongoing improvement within urgent and emergency care settings.\n\nSpecific conditions of support (Final)\n1. Confirmation from the IGT Team at NHS Digital of suitable security arrangements via Information Governance Toolkit (IGT) submission (Confirmed – Version 14.1, 2017/18 satisfactory reviewed grade for the following organisations: Picker Institute Europe, Quality Health, Patient Perspective, Capita Business Services Ltd. and Member Engagement Services)."]

{"sheet":"A0964","index":131,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","A0964"]
["Reference","18/CAG/0107"]
["Other Refs"]
["Application Title","National Cancer Patient Experience Survey 2018 (CPES)"]
["Application Summary","This application from NHS England set out the purpose of administering patient surveys to evaluate services provided to cancer patients in 2018. This would enable comparisons between Trusts, for commissioners, providers and patients (all of whom could access the published results), would allow for monitoring of improvements in services, drive further improvements, and provide NHS England with an up to date overview of cancer patient experience across England.\nThe survey methodology and data transfer arrangements remain unchanged since 2011. Quality Health would request a list of eligible patients from participating Trusts, and would mail out surveys to patients after removing duplicates and checking to ensure no surveys were sent to the addresses of deceased patients. Quality Health would then anonymise the data."]
["Applicant Organisation Name","NHS England"]
["Contact Name","Ms Charlotte Houston"]
["Address","Nursing Directorate, NHS England"]
[null,"Quarry House"]
[null,"Leeds"]
["Postcode","LS2 7UE"]
["Telephone"]
["Email","charlotte.houston@nhs.net"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population"," All adult patients (aged 16 and over), with a primary diagnosis of cancer, who have been admitted to hospital as inpatients for cancer related treatment, or who were seen as day case patients for cancer related treatment, and have been discharged between 1st April 2018 and 30th June 2018 will be invited to participate in the survey."]
["Description of confidential patient information used"," Name – survey distribution,\n Address – survey distribution,\n Postcode – survey distribution and analysis (translated to index of multiple deprivation,\n Treating site – survey distribution,\n NHS number – sample validation,\n Date of birth – sample validation and analysis\n Sex – analysis,\n Ethnicity – analysis."]
["S251 Class(es)",null,"Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Expired"]
[]
["Next Review Date","2020-08-29"]
["Notes","Old applications for the National Cancer Patient’s Experience survey: Acute and Specialist trust surveys of inpatients and day cases.\n\nThe currently supported reference is 21/CAG/0084\n\nSpecific conditions of support (Final)\n1. Confirmation from the IGT Team at NHS Digital of suitable security arrangements via Information Governance Toolkit (IGT) submission (Confirmed – Quality Health show a reviewed satisfactory grade on Version 14.1, 2017/18)."]

{"sheet":"A0965","index":132,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","A0965"]
["Reference","18/CAG/0131"]
["Other Refs","(Previously CAG 6-07(d)/2013)"]
["Application Title","Inflammatory Bowel Disease Registry"]
["Application Summary","This audit application from the British Society of Gastroenterology (BSoG) set out the purpose of establishing a national IBD Registry which would feed into national service development planning and fulfil national audit, IBD standards and quality improvement benchmarks.\n\nData sources included HES, ONS, Bowel Cancer audit, cancer registries, IBD Registry patient management system and data collected via a web portal system. Data would be collected by NHS Digital and only pseudonymised data would be disclosed to the British Society of Gastroenterology for analysis purposes.\n\nThere was a transfer of the controller responsibilities in relation to the audit activity for the inflammatory Bowel Disease Registry from the British Society of Gastroenterology (BSG) to the IBD Registry Ltd. A letter of support was received from the British Society of Gastroenterology to support the transfer of controller responsibilities to the newly created IBD Registry Ltd.\nA recommendation for class 4, 5 and 6 support was requested in order to access data, including NHS number, date of birth and postcode in relation to all patients in the UK who had been diagnosed with IBD."]
["Applicant Organisation Name","IBD Registry Limited\n3 St Andrews Place\nRegent's Park\nLondon\nNW1 4LB"]
["Contact Name","Ms Liz Dobson"]
["Address","IBD Registry Limited, 3 St Andrews Place"]
[null,"Regent's Park"]
[null,"London"]
["Postcode","NW1 4LB"]
["Telephone"]
["Email","liz.dobson@ibdregistry.org.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,null,"the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Data in relation to all patients in the UK who had been diagnosed with IBD."]
["Description of confidential patient information used","Access was requested to the following items of confidential patient information:\n NHS Number,\n Date of birth,\n Sex,\n Postcode\n Consultant Code (HES),\n Patient’s Registered/Referring GP Code (HES)."]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2023-05-14"]
["Notes","Amendment supported 17 November 2022 to update the data items collected to include the ‘2022_L dataset’, and to extend the duration of ‘s251’ support until the end of 2027\n\nAmendment supported 05 october 2022 to update the data items collected to include the ‘2021_K dataset’, specifically sex, and IBD audit code\n\n10 December 2021 - Amendment supported to alter the data flows to enable NHS Trusts to upload confidential patient information via a web portal system, direct to the IBD Registry data management platform, hosted at AIMES, instead of to NHS Digital.\n\n09 July 2021 - amendment supported to extend the duration of support until 14 September 2023 to allow the applicant to continue and complete work on a new consent model, launch and rollout that is properly required for the function of the IBD Registry\n\n13 July 2020 - condition placed to give details of progress towards a consented model at the time of the next annual review \n\n01 July 2020 - amendment supported to extend the duration for the study until 14 September 2021\n\n18 November 2019: Amendment supported to enable AIMES Management Services, a named processor within the scope of the application activity, to host the linked data returned from NHS Digital. \n\n29/03/2019 - Amendment supported to allow revisions to the wider clinical data provided in the IBD Registry dataset.\n\nSpecific conditions of support (Final)\n1. All pre-existing conditions of support related to CAG 6-07(d)/2013 remain applicable\n2. The pre-existing annual review cycle remains applicable, with the next annual review to be received 4 weeks before 14/05/2019, and then on an annual basis to this schedule.\n3. Patient and public notification materials should be updated to include clear information around the additional purpose for supply of anonymised aggregated data to commercial companies and provide a mechanism to raise objection to the use of data in this way. Submission of the revised notification materials is required at the time of next annual review.\n4. Confirmation from the IGT Team at NHS Digital of suitable security arrangements via Information Governance Toolkit (IGT) submission (Confirmed – IBD Registry and NHS Digital – reviewed satisfactory grade on V14.1, 2017/18).\n"]

{"sheet":"A0966","index":133,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number",966]
["Reference","18/CAG/0143"]
["Other Refs"]
["Application Title","Associations between frailty and outcomes after knee replacement"]
["Application Summary","This application from the Big Health Data Group at the University of Oxford sets out the purpose of service evaluation which aims determine the burden of frailty among patients undergoing primary knee replacement and any association between the level of frailty and post-operative outcomes following the replacement surgery.\nThe project will routinely collected clinical information for the purpose of the evaluation, using data collected by the National Joint Registry (NJR) linked with HES and ONS information and Patient Reported Outcome Measures (PROMs) data. Confidential patient information will be disclosed from the NJR to NHS Digital in order to facilitate linkage. Analysis will be undertaken by the research team on a pseudonymised dataset only.\nThis application is linked to 18/CAG/0144 as it will make use of the same dataset – separate applications were made to mirror the submissions to the NJR Committee and to ensure that any recommendation of support would extend to the two described purposes. The data flows/linkage will be performed only once.\nA recommendation for class 1, 4, 5 and 6 support was requested to cover activities as described in the application."]
["Applicant Organisation Name","Big Health Data Group at the University of Oxford"]
["Contact Name","Rob Middleton"]
["Address","Big Health Data Group, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS),\nUniversity of Oxford, Botnar Research Centre\nWindmill Road, Oxford\nOX3 7LD"]
[null,"University of Oxford, Botnar Research Centre"]
[null,"Windmill Road, Oxford"]
["Postcode","OX3 7LD"]
["Telephone"]
["Email","rob.middleton@ndorms.ox.ac.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,null,"the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","All adult patients in England and Wales aged 18 years and over recorded as having undergone primary knee replacement within the National Joint Registry, between 2003 to date of linkage with NHS Digital. The NJR currently holds data on 800,477 patients who have undergone primary knew replacement; however, the study sample will be less as patients from Northern Ireland and the Isle of Man will be excluded."]
["Description of confidential patient information used","The following items of confidential patient information will be released from the National Joint Registry database, held by Northgate Information Solution, to NHS Digital to facilitate linkage with HES, ONS and PROMs:\n NHS number,\n Date of birth,\n Sex – also retained for analysis,\n Postcode,\n Ethnicity – for analysis."]
["S251 Class(es)",null,"Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,null,"Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Expired"]
[]
["Next Review Date","2020-09-24"]
["Notes","10 January 2022 - Support Expired\nData has been de-identified.\n\nPublic benefits are not yet clear as the study outcomes have not yet been analysed.\n\nSpecific Conditions of Support (Final)\n1. Study-specific information should be displayed on the National Joint Registry website, together with details of how a patient can raise an objection to the use of their information for the project purposes. Confirmation should be provided at the time of first annual review that this was undertaken.\n2. Confirmation from the IGT Team at NHS Digital of suitable security arrangements via Information Governance Toolkit (IGT) submission (Confirmed – NHS Digital acting as processor, published satisfactory grade on V14.1, 2017/18)."]

{"sheet":"A0967","index":134,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number",967]
["Reference","18/CAG/0144"]
["Other Refs"]
["Application Title","Reconstructive strategy and implant design in knee replacement"]
["Application Summary","This application from the Big Health Data Group at the University of Oxford sets out the purpose of service evaluation which aims determine associations between the choice of surgical reconstructive strategy (use of uni-compartmental knee replacement where possible vs. routine use of total knee replacement in all cases) and health outcomes in patients undergoing primary knee replacement for osteoarthritis. The project will also determine associations between knee replacement designs and health outcomes after knee replacement for osteoarthritis.\nThe project will routinely collected clinical information for the purpose of the evaluation, using data collected by the National Joint Registry (NJR) linked with HES and ONS information and Patient Reported Outcome Measures (PROMs) data. Confidential patient information will be disclosed from the NJR to NHS Digital in order to facilitate linkage. Analysis will be undertaken by the research team on a pseudonymised dataset only.\nThis application is linked to 18/CAG/0143 as it will make use of the same dataset – separate applications were made to mirror the submissions to the NJR Committee and to ensure that any recommendation of support would extend to the two described purposes. The data flows/linkage will be performed only once.\nA recommendation for class 1, 4, 5 and 6 support was requested to cover activities as described in the application."]
["Applicant Organisation Name","Big Health Data Group at the University of Oxford"]
["Contact Name","Rob Middleton"]
["Address","Big Health Data Group, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS),\nUniversity of Oxford, Botnar Research Centre\nWindmill Road, Oxford\nOX3 7LD"]
[null,"University of Oxford, Botnar Research Centre"]
[null,"Windmill Road, Oxford"]
["Postcode","OX3 7LD"]
["Telephone"]
["Email","rob.middleton@ndorms.ox.ac.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,null,"the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","All adult patients in England and Wales aged 18 years and over recorded as having undergone primary knee replacement within the National Joint Registry, between 2003 to date of linkage with NHS Digital. The NJR currently holds data on 800,477 patients who have undergone primary knew replacement; however, the study sample will be less as patients from Northern Ireland and the Isle of Man will be excluded."]
["Description of confidential patient information used","The following items of confidential patient information will be released from the National Joint Registry database, held by Northgate Information Solution, to NHS Digital to facilitate linkage with HES, ONS and PROMs:\n NHS number,\n Date of birth,\n Sex – also retained for analysis,\n Postcode,\n Ethnicity – for analysis."]
["S251 Class(es)",null,"Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Expired"]
[]
["Next Review Date"]
["Notes","Section 251 support was obtained to cover the flow of patient information from the National Joint Registry to NHS Digital, for the purposes of creating the study dataset. Once the pseudo-anonymised study data was supplied by NHS Digital to the study group, the identifiable information used to create the dataset is destroyed by NHS Digital. NHS Digital and the National Joint Registry have their own legal basis for the patient data they hold.\nWhat was supplied to the study group was the pseudo-anonymised dataset. At no point have the study group had access to the identifiable patient information. We cannot access the National Joint Registry or NHS Digital data, and have no way of re-identifying individuals in the study dataset.\n\nThe expectation of public benefit from the activity is to expand on what is known about how different knee replacements influence outcomes following surgery. These address specific areas of interest previously identified by a James Lind Alliance Priority Setting Partnership.\n\nSpecific Conditions of Support (Final)\n1. Study-specific information should be displayed on the National Joint Registry website, together with details of how a patient can raise an objection to the use of their information for the project purposes. Confirmation should be provided at the time of first annual review that this was undertaken.\n2. Confirmation from the IGT Team at NHS Digital of suitable security arrangements via Information Governance Toolkit (IGT) submission (Confirmed – NHS Digital acting as processor, published satisfactory grade on V14.1, 2017/18)."]

{"sheet":"A0968","index":135,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","A0968"]
["Reference","17/CAG/0124"]
["Other Refs"]
["Application Title","National Diabetes Audit (Adults) - Wales"]
["Application Summary","This application seeks to provide an update on the National Diabetes Audit (Adults) (NDA), which has previous Section 251 approval under application ECC 3-04 (r) 2011. NHS Digital NDA has entered a new 3 year agreement (with the possibility to extend to 5 years) with NHS England to deliver the NDA as part of the National Clinical Audit Programme. The audit has been running since 2003 with Wales joining the audit from 2007-08 onwards.\nThis application is for the NDA to continue in the interim in Wales under Section 251 support and along with the collection of data also includes holding, data linkages, analysing and disseminating the historical Welsh NDA data with a change of data controllership from HQIP to NHS Digital whilst we work with the Welsh Assembly Government to develop an exit strategy. The application specifically covers the transfer of data from NWIS to NHS Digital to support the primary care core audit in Wales and the secondary care core audit in Wales which flows from hospitals to NHS Digital and the associated processing and dissemination which follows. This includes linkages to PEDW, ONS mortality and support for the transition audit.\nA recommendation for class 4, 5 and 6 support was requested to cover activity as described in the application."]
["Applicant Organisation Name","NHS Digital (on behalf of HQIP and NHS England)"]
["Contact Name","Chris Dew (Analysis Lead Manager)"]
["Address","7 and 8 Wellington Place"]
[null,"Leeds"]
[null,"West Yorkshire"]
["Postcode","LS1 4AP"]
["Telephone","(0113) 8665687 "]
["Email","chris.dew@nhs.net"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,null,"the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Adult patients with a diagnosis of diabetes within Wales, which was estimated at approximately 200,000 patients."]
["Description of confidential patient information used","The following items of confidential patient identifiable information are collected by NHS Digital for the National Diabetes Audit for the purposes identified:\n NHS number – validation of records and linkage between data sources,\n Date of birth – used in conjunction with postcode and gender to validate NHS number then converted to year of birth and age for analysis,\n Gender – validation and analysis,\n Postcode – validation and converted into LSOA to calculate deprivation for analysis,\n Ethnicity – analysis,\n GP Practice Code – analysis/reporting,\n Date of Diabetes Diagnosis – analysis,\n Date of death – analysis."]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Expired"]
[]
["Next Review Date"]
["Notes","Expiry of support – effective 1 September 2021. \n\nCAG notified that this activity is withdrawn from reliance upon Regulation 5 of the Health Service (Control of Patient Information) Regulations 2002. New legal bases notified to be:\nSection 255(1) of the Health and Social Care Act 2012 (the 2012 Act). Register entry considered and updated September 2021\n\nSpecific Conditions of Support\n1. Exit Strategy – provide a report at first annual review around progress made towards the establishment of an exit strategy from support under the Regulations. Consideration should be given to Section 255 of the Health and Social Care Act 2012 in these deliberations.\n2. Identifiability of Retained Dataset – provide a report at first annual review around the progress which has been made to reduce the identifiability of the data retained for analysis. Consideration should be given to the above suggested point around utilising the same pseudonymisation key each year on NHS Number.\n3. Patient Notifications – provide a report at first annual review around the revisions made to patient information materials. Consideration should be given to the following points:\na. Revision of the language to make content more accessible to all readers,\nb. Within the section entitled ‘How is the information used?’, revise the reference to data being anonymised following linkage.\n4. Confirmation from the IGT Team at NHS Digital of suitable security arrangements via Information Governance Toolkit (IGT) submission. (Confirmed - NHS Digital Version 14 (2016-17) reviewed grade at 92% satisfactory)."]

{"sheet":"A0969","index":136,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","A0969"]
["Reference","CAG 7-04(b)/2014"]
["Other Refs","CAG 5-07(b)/2013"]
["Application Title","UK National Screening Committee Hepatitis B in Pregnancy"]
["Application Summary","This audit application describes a collaborative project between University College London and the Immunisation, Hepatitis and Blood Safety Department at Public Health England (PHE) to look at outcomes for all at-risk infants."]
["Applicant Organisation Name","University College London and the Immunisation, Hepatitis and Blood Safety Department at Public Health England (PHE)"]
["Contact Name","Dr Claire Thorne"]
["Address","Population, Policy and Practice, UCL Institute of Child Health"]
[null,"University College London"]
[null,"30 Guilford Street, London"]
["Postcode","WC1N 1EH"]
["Telephone"]
["Email","Claire.thorne@ucl.ac.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,null,"the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Around 2700 women fell within the low risk category; NHS number would be used to carry out data linkages. Infant date of birth was requested to establish timing of interventions in relation to delivery, and of the infant’s subsequent immunisation schedule."]
["Description of confidential patient information used","Data from NHS Trusts in relation to low risk women (previous application specified collecting this data for high risk women only) including:\n pregnancy outcome, i.e. termination of pregnancy, miscarriage, live birth or stillbirth\n date of pregnancy outcome\n NHS number for live born infants\n receipt of infant vaccination at delivery for live born infants"]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Expired"]
[]
["Next Review Date"]
["Notes","May 2022 - Support Expired:\nApplicant confirmed in May 2022 that all confidential patient information had been deleted from the dataset, and ‘s251’; support was no longer required.\n\nIn terms of the public benefit of the Hepatitis B in Pregnancy Audit, the findings were used to inform the updated (Jan 2021) guidance on the hepatitis B antenatal screening and selective neonatal immunisation pathway in England. You can find the Audit’s contribution and main findings mentioned here: https://www.gov.uk/government/publications/hepatitis-b-antenatal-screening-and-selective-neonatal-immunisation-pathway/guidance-on-the-hepatitis-b-antenatal-screening-and-selective-neonatal-immunisation-pathway--2 There is also a manuscript in draft writing up some of the audit findings – specifically to characterise the population of pregnant women living with HBV infection in England (as this has not been done before on a national basis).\n\n\nAmendment Request (Approved 12/10/2018)\nThe amendment seeks an extension to the duration of support under the Regulations to the end of January 2019, to enable the completion of transfer of confidential patient information collated during the audit to Public Health England.\n\nSpecific conditions of support\n1. Confirmation of suitable security arrangements via IG Toolkit submission for both University College London and Public Health England"]

{"sheet":"A0970","index":137,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","A0970"]
["Reference","18/CAG/0127"]
["Other Refs"]
["Application Title","Child Health Clinical Outcome Review Programme – Long-Term Ventilation"]
["Application Summary","This Healthcare Quality Improvement Partnership commissioned application from the National Confidential Enquiry into Patient Outcome and Death set out the purpose clinical audit which aims to review the quality of the delivery of care of patients receiving, or who have received, long-term ventilation and who range in age from 0-25. The organisation of care and clinical practice will be reviewed to identify potentially remediable factors in the care provided for children and young people. The audit is carried out across the UK, Guernsey, Jersey and the Isle of Man; however, the CAG remit extends only to data generated in England and Wales.\n\nFor the purposes of the audit, long-term ventilation is as ‘ventilation provided every day for three months (including both invasive and non-invasive) where the intention is/was to discharge the patient home on the same level of continuing respiratory support (not home oxygen).\n\nThe audit will follow the standard NCEPOD retrospective questionnaire and case note review methodology on a sample of patients from hospitals, who match the inclusion criteria. Confidential patient information relating to eligible patients will be reported to NCEPOD from participating hospitals to enable a questionnaire to be sent to the clinician(s) involved in the patient’s care, which will be returned with relevant copied extracts of the case notes to NCEPOD to undergo peer review.\n\nParticipating hospitals will be asked to identify all patients who meet the inclusion criteria over the two year period from 01 April 2016 to 31 March 2018. From the information, NCEPOD will sample cases which will include those patients who were newly commenced on long-term ventilation in the two year period, and those patients on the follow-up pathway. A limited number of cases will be randomly sampled for inclusion in the clinical questionnaire and peer review process to ensure hospitals are not overburdened. Sampling will include the following groups:\n A group of patients newly initiated on invasive long-term ventilation (initiations between 1st April 2016 – 31st March 2018) – clinical questionnaire only\n A group of patients who are not admitted to hospital during the study period – clinical questionnaire only\n A group of patients who have an acute admission to hospital during the study period – clinical questionnaire and case note review\n\nFour questionnaires will be used to collect data for this study via a link to an online questionnaire housed on a dedicated NCEPOD server separate to the case identification data – the questionnaires will be linked by a unique NCEPOD case number only:\n Tracheostomy insertion questionnaire: A questionnaire will be sent to the named consultant responsible for undertaking the procedure (new insertions between 1 April 2016 –and 31 March 2018).\n Admission to hospital: A questionnaire will be sent to the named consultant responsible for the patient at the time of admission to hospital (where applicable).\n Ongoing long-term ventilation care: A questionnaire will be sent to the named consultant responsible for initiating and/or providing ongoing long term ventilation (all patients).\n (Main) Community nursing team: A questionnaire will be sent to the team responsible for providing the ongoing care to the patient in the community (all patients where applicable).\n\nThe case note review will focus on those patients who had an acute admission during the study inclusion dates. Where patients were transferred, notes will be requested from both the initial and subsequent admitting hospitals. NCEPOD will request photocopied/scanned copies of the relevant parts of the patient’s notes to allow the peer review to take place and to identify other healthcare providers within the patient care pathway to enable additional questionnaires to be sent."]
["Applicant Organisation Name","Healthcare Quality Improvement Partnership (HQIP) commissioned application from the National Confidential Enquiry into Patient Outcome and Death (NCEPOD)"]
["Contact Name","Marisa Mason"]
["Address","National Confidential Enquiry into Patient Outcome and Death (NCEPOD)"]
[null,"27A Harley Place"]
[null,"London"]
["Postcode","W1G 8LZ"]
["Telephone"]
["Email","mmason@ncepod.org.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Patients from 0 up to their 25th birthday who were receiving, or received, long-term ventilation over a two year period from the 1 April 2016 to 31 March 2018 will be included in the review. It is estimated that 3,000 patients would be identified of which 500 clinician questionnaires would be issued with an aim to receive 250 sets of corresponding notes."]
["Description of confidential patient information used","The following items of confidential patient information are requested for the following purposes:\n NHS Number – sample validation and linkage,\n Hospital Number – sample validation and linkage,\n Date of birth – sample validation and linkage,\n Sex – sample validation and linkage,\n NCEPOD ID – linkage,\n Name – present in case notes; however, not required for the application,\n Postcode – present in case notes; however, not required for the application."]
["S251 Class(es)",null,"Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Expired"]
[]
["Next Review Date"]
["Notes","Support expired 08 July 2021\n\nSpecific conditions of support (Final)\n1. Support extends to data generated in England and Wales only.\n2. Provide feedback at the time of first annual review around the involvement and engagement activities which have been undertaken with patients and their families in relation to the audit. If the responses given are negative, the CAG will take this into account when considering whether support should continue, or whether further actions are necessary.\n3. Confirmation from the IGT Team at NHS Digital of suitable security arrangements via Information Governance Toolkit (IGT) submission (Confirmed – National Confidential Enquiry into Patient Outcome and Death shows a satisfactory reviewed grade on Version 14.1, 2017/18)."]

{"sheet":"A0971","index":138,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[null,null,"Ms Sally Welham"]
[]
["Application Number","A0971"]
["Reference","18/CAG/0147"]
["Other Refs"]
["Application Title","National Adult Community Acquired Pneumonia Audit 2018-19"]
["Application Summary","This application from the British Thoracic Society set out purpose of a national audit programme into community acquired pneumonia in adults. The first British Thoracic Society (BTS) CAP audit took place in 2009/10, with re-audits in 2010/11, 2011/12, 2012/13 and 2014/15. The standards for the audits were derived from the 2009 update to the BTS Guidelines for the management of community acquired pneumonia in adults (the ‘BTS Guidelines’). Over the years, a total of over 120 acute trusts have participated in the audit, involving over 24,000 cases of pneumonia.\nTo date, the CAP audit has not collected confidential patient information so has not required support under the Regulations. Data from the audits have shown a decreasing trend in mortality from CAP associated with improved processes of care. There is however evidence from GP databases and from HES data that variation in care of adults hospitalised with pneumonia exists across the UK. Previous BTS CAP audits have not assessed variation between sites. In contrast, recent national UK audits in both lung cancer and COPD have compared performance between sites to assess for variation in care and outcomes.\nThe aim with the BTS CAP audit 2018/19 is to assess variation in the care of patients hospitalised with pneumonia in the UK and seek explanations for any variation observed. In order to increase the value and data quality of the audit, it is proposed to link the BTS CAP audit data to routinely collected HES and ONS data. The BTS CAP audit dataset is rich in process of care measures whilst the HES dataset is strong in relation to patient baseline parameters and hospital outcome measures, but fails to capture CAP process of care measures. Linkage of these data sources will enable:\n1. Analysis of variation of care according to a wider range of important outcome measures, including mortality, ICU admissions, hospital re-admissions and healthcare costs.\n2. Improved case-mix adjustment of the audit cohort according to underlying co-morbidities and socio-economic parameters.\n3. Health economic analyses.\nThe core aim of the project is to drive improvements in care, particularly in relation to the quality improvement objectives identified in 2014/15, by allowing participants to monitor their progress against these targets. In this round of audit (2018/2019) additional information will be provided on where variation exists in relation to these targets and performance generally, to allow sites to identify where quality improvement initiatives are needed locally.\nA recommendation for class 1, 4, 5 and 6 support was requested to cover activities as described in the application."]
["Applicant Organisation Name","British Thoracic Society"]
["Contact Name","Ms Sally Welham"]
["Address","British Thoracic Society"]
[null,"17 Doughty Street"]
[null,"London"]
["Postcode","WC1N 2PL"]
["Telephone"]
["Email","Sally.Welham@brit-thoracic.org.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","The study population is hospitalised adults (16 years or older) admitted with a clinical radiographic diagnosis of Community Acquired Pneumonia (CAP) from 1 December 2018 to 31 January 2019. 150 Trusts are expected to participate in the audit and will be asked to enter as many cases as possible, with a minimum requirement of 60 cases per Trust. Limited information will be collected on patients who are deemed ineligible for inclusion in the audit; however, these patients are out of scope as confidential patient information will not be requested."]
["Description of confidential patient information used","The following items of confidential patient information will be entered into the audit platform to facilitate linkage with HES and ONS datasets by NHS Digital:\n NHS Number,\n Home Postcode,\n Sex,\n Date of birth,\n Date of death."]
["S251 Class(es)",null,"Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Expired"]
[]
["Next Review Date","2021-10-22"]
["Notes","23 April 2021 - Application support expired:\nApplicant confirmed by email on 23 April 2021 that support was no longer required as they have received the linked dataset from NHS Digital, therefore they no longer require the identifiers to facilitate data linkage. \n• Applicants have confirmed they only hold pseudonymised data\n• Papers have been published and future papers are planned, which will help evaluate and improve care across the UK for Community Acquired Pneumonia, and assist Trusts in making improvements to bring about a  measurable reduction in mortality from CAP and in unwarranted variation in length of hospital stay for CAP\n\n11 June 2020 – Amendment supported: to extend the duration of support by one year until 31 May 2021.\n\nSpecific conditions of support (Final)\n1. Patient and Public Involvement and Engagement strategy should be extended to enable additional activity to be undertaken as the audit progressed. An overview of the actual activity which has been carried out, together with details of the feedback provided, should be provided at the time of first annual review. If the responses given are negative, the CAG will take this into account when considering whether support should continue, or whether further actions are necessary.\n2. Confirmation from the IGT Team at NHS Digital of suitable security arrangements via Information Governance Toolkit (IGT) submission (Confirmed - British Thoracic Society and Westcliff Solutions Ltd have a satisfactory reviewed grade on V14.1, 2017/18)."]

{"sheet":"A0972","index":139,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number",972]
["Reference","17/CAG/0196"]
["Other Refs"]
["Application Title","Understanding local Heart Failure Pathways of Care"]
["Application Summary","This application from Blackpool Teaching Hospitals NHS Foundation Trust set out the purpose of service evaluation to perform an in-depth diagnostic of Heart Failure care delivery by the provider and associated care settings across the Health Economy. This diagnostic will describe and quantify all aspects of the pathway and provide vital data to inform the transformational programme of delivering seamless systems of care for HF patients on the Fylde Coast.\nThe service evaluation has the following aims and objectives:\n To define current practice in triage of patients at the point of hospital discharge, to varying intensity and methods of condition surveillance. In order to support consistent delivery of care in the future.\n To characterise and cost the current provision of HF care and surveillance across the Fylde Coast Health Economy in order to inform new financial and contractual models.\nThis application will allow the applicants to collect vital baseline data from across primary, community and acute care setting that will inform the analytics aspects of the transformational project. It is necessary to integrate some patient-level data in order to understand the individual Heart Failure patient pathway accurately, delivery effective pathway redesign and confirm impact of the changes made."]
["Applicant Organisation Name","Blackpool Teaching Hospitals NHS Foundation Trust"]
["Contact Name","Mr Trevor Morris"]
["Address","1st Floor Office, Off Main Entrance"]
[null,"Whinney Heys Road"]
[null,"Blackpool, Lancashire"]
["Postcode","FY3 8NR"]
["Telephone"]
["Email","trevor.morris2@nhs.net"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","The population of the Fylde Coast health economy (covering Blackpool CCG and Fylde & Wyre CCG) of patients who have been diagnosed with stage C or early stage D (NYHA class II – early IV) Heart Failure either with a primary or secondary Heart Failure diagnosis. This is estimated at 4,732 patients"]
["Description of confidential patient information used","The following items of confidential patient information will be released by Blackpool Teaching Hospitals Acute Informatics Team to the Community Informatics Team and the Midlands and Lancashire CSU for the purposes as described:\n NHS number – validation and linkage,\n Hospital number – validation and linkage,\n Date of birth – for analysis,\n Date of death – for analysis,\n Gender – for analysis,\n Postcode – translated to Lower Super Output Area (LSOA) for analysis."]
["S251 Class(es)",null,"Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Expired"]
[]
["Next Review Date"]
["Notes","No data under section 251 support was ever collected.   Much of the data that the CI was hoping to share across organisational borders is now available without data sharing agreements within these bodies.   Attempts to retrieve GP practice-leval data have provided fruitless.  The searches of the relevant data systems that were possible were too limited to provide sufficient data for the project to continue.\n\nThere stil remains a need to complete the diagnostic to describe and quantify all aspects of the heart failure pathways of care in order to support programme transformation across Lancashire and South Cumbria; however, the CI has continually faced challenges in its set up.   As care governance moves place now, the CI hopes that there may be opportunity to try again in the future.  \n\nSpecific conditions of support\n1. Confirmation from the IGT Team at NHS Digital of suitable security arrangements via\nInformation Governance Toolkit (IGT) submission. (Confirmed - Blackpool Teaching\nHospitals NHS Foundation Trust and Midlands and Lancashire CSU,\nsatisfactory reviewed grade on Version 14.1, 2017/18, confirmed by email\nreceived 05/11/2018)."]

{"sheet":"A0973","index":140,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","A0973"]
["Reference","18/CAG/0150"]
["Other Refs"]
["Application Title","2018 Children and Young People’s Patient Experience Survey"]
["Application Summary","This application submitted by Picker Institute Europe and commissioned by the Care Quality Commission, set out the non-research purpose of facilitation of the 2018 Children and Young People’s Patient Experience Survey. The survey, which will be third carried out to date, forms part of the NHS National Patient Surveys Programme and was last ran in 2016 when it was called Children and Young People’s Inpatient and Day Case Survey (15/CAG/0209).\nTrusts will be asked to conduct the survey with preparations expected to begin in January 2019 and fieldwork expected to start from February 2019. All Trusts will draw a sample of patients according to set criteria, and follow standardised materials and procedures for all stages of the survey. There are some proposed changes to the methodology for the 2018 Children and Young People’s Patient Experience Survey. These changes are in line with applications within the wider NHS National Patient Surveys Programme, which had recently been considered by the CAG in relation to other submissions. The changes are as follows:\n1. The inclusion of relevant Trust email and postal address information, if available, on dissent posters alongside a contact telephone number for patients to contact should they wish not to participate\n2. Dissent posters being available in the ten most commonly spoken languages in England. Trusts can display these optional posters alongside the mandatory English poster to maximise reach for their patient population.\n3. An earlier first reminder letter, sent five working days after the first mailing has been sent."]
["Applicant Organisation Name","Picker Institute Europe"]
["Contact Name","Ms Jenny King"]
["Address","Buxton Court"]
[null,"3 West Way"]
[null,"Oxford"]
["Postcode","OX2 0JB"]
["Telephone"]
["Email","jenny.king@pickereurope.ac.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,null,"the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Patients aged between 14 days and 15 years who were admitted as inpatients, day cases, and emergencies to an acute hospital between 01 November 2018 and 31 December 2018. Trusts will be required to draw a minimum sample of 400 patients, up to a maximum of 1,250. If this is not possible across the sample period, Trusts will be instructed to sample back to 01 October 2018 to achieve the required 400 patients."]
["Description of confidential patient information used","The following two datasets will be shared by the participating Trusts in order to achieve the purposes sets out:\nMailing File – is used to facilitate the circulation of the survey and ensure this is addressed to the appropriate patient:\n Standardised survey identifier,\n Child’s first name and surname,\n Address Fields,\n Postcode.\nThe sample file is being used to link demographic data to the survey responses, to aid analysis and to enable checks to be carried out for any errors in how the sample was drawn. This will contain:\nPage 3 of 9\n Trust code,\n Standardised survey identifier (as above),\n Year of birth,\n Sex,\n Ethnicity,\n Date of admission,\n Date of discharge,\n Length of stay,\n Main speciality on discharge,\n Treatment function code,\n CCG code,\n Treatment centre admission,\n Admission method,\n NHS Site code of admission,\n NHS Site code of discharge."]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Expired"]
[]
["Next Review Date","2020-11-09"]
["Notes","23 December 2021 - Support Expired:\nApplicant confirmed 23 December 2021 support can be expired.\n\nAll data have been pseudonymised.\n\nIn terms of public benefit the systematically collected quantitative data from children and young people’s patient experience surveys are used to monitor the quality of care given to children and young people, at trust level and nationally, and to support ongoing improvement within hospital settings.\n\nSpecific conditions of support (Final)\n1. Confirmation from the IGT Team at NHS Digital of suitable security arrangements via Information Governance Toolkit (IGT) submission (Confirmed – Picker Institute Europe, Quality Health and Patient Perspective all have a published satisfactory reviewed grade on V14.1, 2017/18)."]

{"sheet":"A0974","index":141,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A0974"]
["Reference","18/CAG/0166"]
["Other Refs"]
["Application Title","National Clinical Audit for Specialist Rehabilitation following major Injury (NCASRI) – Transfer of Controllership Arrangements"]
["Application Summary","This application has been submitted by the Trauma Audit and Research Network (TARN) for non-research purposes. The application seeks support under the Regulations for the change of controller of the confidential patient information which was collated under the National Clinical Audit of Specialist Rehabilitation following Major Injury (NCASRI) its physical transfer to TARN.\nThe National Clinical Audit of Specialist Rehabilitation following Major Injury (NCASRI) was commissioned by the Healthcare Quality Improvement Programme (HQIP) on behalf of NHS England to examine current provision of services for patients who have suffered severe injuries. The UK Specialist Rehabilitation Outcomes Colloborative (UKROC) submitted the application on behalf of HQIP. The NCASRI audit application was initially considered by the CAG in September 2016 under application reference 16/CAG/0108. The audit received a final recommendation in January 2017. The audit was completed on 30 June 2018 when its three year National Clinical Audit and Patient Outcomes Programme (NCAPOP) contract ended.\nThe Trauma Audit and Research Network (TARN) is the national clinical audit of trauma care. It is not part of the NCAPOP suite of audits commissioned by HQIP on behalf of NHS England. TARN currently operates with support under the Regulations via application ECC 7-05(g)/2011.\nUKROC is a national clinical database which routinely collects key information about every patient admitted to a specialist rehabilitation unit in England. It is not commissioned by HQIP and processes confidential patient information under direction from NHS England.\nA key component to the National Clinical Audit of Specialist Rehabilitation following Major Injury (NCASRI) was to undertake record level linkages from the TARN and UKROC datasets in order to be able to track individual patients discharged from major trauma centres to identify those that subsequently received specialist rehabilitation."]
["Applicant Organisation Name","Trauma Audit and Research Network (TARN)"]
["Contact Name","Ms Antoinette Edwards"]
["Address","Summerfield House,"]
[null,"Salford Royal Hospital"]
[null,"Salford"]
["Postcode","M5 5AP"]
["Telephone","0161 206 4397"]
["Email","antoinette.edwards@manchester.ac.uk "]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","All patients who were included in the National Clinical Audit of Specialist Rehabilitation following Major Injury, which operated from 01 July 2016 to 30 June 2018."]
["Description of confidential patient information used","The following items of confidential patient information would be transferred within the National Clinical Audit of Specialist Rehabilitation following Major Injury (NCASRI) dataset from UK Specialist Rehabilitation Outcomes Colloborative (UKROC) to Trauma Audit and Research Network (TARN). Information will be retained in an identifiable format to facilitate future linkage:\n NHS number,\n Date of birth,\n Postcode (District Level),\n Date of treatment,\n Date of death."]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2023-11-16"]
["Notes","Amendment supported 22 December 2022 \nTo extend the duration of support for the use of the NCASRI dataset to undertake additional data linkages to the UKROC dataset, until November 2023\n\n09 December 2022 - Annual Review supported, condition of support applied\n1.\tThe retention of confidential patient information as part of the NCARSI database is supported until the next annual review only, and this will be considered on an annual basis. \n\n15 December 2021 - Annual Review supported, condition of support applied:\n1.\tThe retention of confidential patient information as part of the NCARSI database is supported until the next annual review only, and this will be considered on an annual basis. \n\nCondition met 09 December 2022\n\n15 June 2021 - Amendment supported\nSupport provided to use the NCASRI dataset to undertake additional data linkages to the UKROC dataset.\n\n21 December 2020 - Amendment supported\nThe amendment, to allow the retention of the National Clinical Audit of Specialist Rehabilitation (NCASRI) dataset for one year, is conditionally supported, subject to compliance with the standard and specific conditions of support.\n\nSpecific conditions of support (updated)\n\n1. The retention of confidential patient information as part of the NCARSI database is supported until the next annual review only, and this will be considered on an annual basis. \n\n2. Confirmation of suitable security arrangements via IG Toolkit submission. Confirmed -The NHS Digital 2019/20 DSPT review for Trauma Audit and Research Network- was confirmed as ‘Standards Met’ on the NHS Digital DSPT Tracker (checked 16 December 2020)\n\n21 December 2020 - Annual Review approved\nSpecific conditions of support (updated)\nThe following sets out the updated specific conditions of support applied against this application reference.\n1. The retention of confidential patient information as part of the NCASRI database is supported until the next annual review only, and this will be considered on an annual basis. \nConfirmed met on 15 December 2021\n\nAmendment request (Approved 10/12/2018)\nThe amendment requested an extension to the duration of support in place to facilitate the transfer of the National Clinical Audit of Specialist Rehabilitation following Major Injury (NCASRI) from UK Specialist Rehabilitation Outcomes Colloborative (UKROC) to Trauma Audit and Research Network (TARN). Transfer of the dataset would now be completed by 31 March 2019, rather than 30 November 2018 as described in the initial application.\n\nSpecific conditions of support (Final)\n1. Support is extended for a six month period only from the date of the final recommendation. Within this time, an assessment should be undertaken to establish the future purposes of the only going data retention. A report should be provided to the CAG in order to establish an ongoing public interest in the retention of the dataset. This would need to be supported by a duration extension amendment as appropriate.\n2. Support extends to non-research purposes only.\n3. Confirmation from the IGT Team at NHS Digital of suitable security arrangements via Information Governance Toolkit (IGT) submission (Confirmed – Trauma Audit and Research Network, published satisfactory reviewed grade on V14.1, 2017/18)."]

{"sheet":"A0975","index":142,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A0975"]
["Reference","18/CAG/0183"]
["Other Refs"]
["Application Title","2019 Community Mental Health Survey"]
["Application Summary","This non-research application from Picker, CQC and NHS England set out the purpose of administering the 2019 Community Mental Health Survey, to gauge patient experience and views of the service they received. A recommendation of support was requested to enable the transfer of patient identifiable data from mental health providers, to an approved survey contractor for the purpose of mailing out questionnaires. The vast majority of trusts involved were expected to opt to use an approved survey contractor, either: Picker Institute Europe, Quality Health and Patient Perspective.\nAll 56 eligible mental health provider Trusts will be asked to conduct the survey, drawing a sample of service users according to set criteria, and following standardised materials and procedures for all stages of the survey. The aim was to ensure organisations carry out patient surveys in a consistent and systematic way, using a standardised methodology and survey instrument, to build up a national picture of people’s experience.\nThe end product from this survey will be a set of aggregate statistical data that does not contain patient identifiable information. This statistical dataset is used for a wide variety of purposes to support ongoing improvement in overall patient experience by NHS Trusts and CCGs and by CQC, to inform its regulatory functions.\n\nNHS Patient Survey Programme\nThis survey is part of the NHS Patient Survey Programme, and as such follows the same methodology as other surveys within the programme. The methodology is approved in principle by the CAG, and applications are usually considered via the Precedent Set pathway.\nNew approaches are often piloted within the NHS Patient Survey Programme. For the current application (Community Mental Health Survey 2019), the following interventions would be added as part of a pilot:\n Dissent posters being available in the ten most commonly spoken languages in England. Trusts can display these optional posters alongside the mandatory English poster to maximise reach for their service user population.\n The inclusion of relevant Trust email and postal address information, if available, on dissent posters alongside a contact telephone number for service users to contact should they wish not to participate\n An earlier first reminder letter, sent 5 working days after the first mailing has been sent rather than 2 – 3 weeks which was standard practice previously.\n No longer including a CQC flyer within mailing packs to respondents.\n Piloting email augmentation in the survey by including a link to an online questionnaire in the initial postal letter. This would be followed up by a reminder email, which included a link to the online questionnaire. The primary aim of this pilot was to increase response rates overall and from lesser heard groups. A secondary aim of the pilot will be to determine whether a potential move towards a mixed mode (paper and digital) methodology for this survey and the NPSP is possible in future years. The eligibility criteria for the intervention will be different from the main stage survey as email contact is necessary. Therefore service users must have an email address listed to be eligible for sampling. For clarity, please note that the Survey Coordination Centre do not receive any names, postal addresses or email addresses."]
["Applicant Organisation Name","Picker Institute Europe"]
["Contact Name","Ms Jenny King"]
["Address","Buxton Court"]
[null,"3 West Way"]
[null,"Oxford"]
["Postcode","OX2 0JB"]
["Telephone"]
["Email","jenny.king@pickereurope.ac.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Data from mental health providers in relation to people aged 18 and over who had been in contact with NHS mental health services in the three month period, 1 September to 30 November 2018, and who were receiving specialist care or treatment for a mental health condition, including those who receive care under the Care Programme Approach (CPA)."]
["Description of confidential patient information used","The mailing file is used to address questionnaires to the appropriate person, and is sent to the Approved Contractor. It contains:\n Trust code,  A standardised unique identifier code,  Title (Mr, Mrs, Ms, etc.),  First name,  Surname,  Address Fields,  Postcode\n\nThe sample data file is used to link demographic data to the survey responses, to aid analysis and to enable checks to be carried out for any errors in how the sample was drawn and is sent to the Coordination Centre. This file contains:\n Trust code,  The unique identifier code (as above),  Year of birth,  Gender,  Ethnic category,  Day of last contact,  Month of last contact,  Year of last contact,  CPA status,  CCG code,  Mental Health Care Cluster Codes\n\nAs part of the pilot work, between 5-10 Trusts participating in the pilot work will also be asked to include the following:\n Email address for intervention and control pilot sample only."]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,"Y","Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Expired"]
[]
["Next Review Date","2020-11-16"]
["Notes","December 2021 - Support Expired:\nApplicant confirmed that support can be expired, as all data have been pseudonymised.\n\nIn terms of public benefit, the systematically collected quantitative data from community mental health service user experience surveys are used to monitor the quality of care given to service users, at trust level and nationally, and to support ongoing improvement within community mental health care settings.\n\nSpecific conditions of support (Final)\n1. Confirmation from the IGT Team at NHSD Digital of suitable security arrangements via Information Governance Toolkit (IGT) submission (Confirmed – Picker Institute Europe, Quality Health and Patient Perspective all have a published reviewed grade on V14.1, 2017/18)."]

{"sheet":"A0976","index":143,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","A0976"]
["Reference","18/CAG/0149"]
["Other Refs"]
["Application Title","National Ophthalmology Database (NOD) Audit"]
["Application Summary","This application from the Royal College of Ophthalmologists, on behalf of the Healthcare Quality Improvement Partnership (HQIP) set out the medical purpose of clinical audit which consists of consists of a national cataract audit in England and Wales, as well as a feasibility study for the collection of cataract patient reported outcome measures (PROMs).\nThe audit was initially funded for three years from 01/09/2014 to 31/08/2017, during which pseudonymised data only was collected. The audit programme has now been extended for a further two years from 01/09/2017 through to 31/08/2019, during which a change to the methodology is proposed to enable confidential patient information to be collected as part of the audit programme. It is explained that by collecting confidential patient information, the applicants will be able to:\n Check the completeness of extracted data from providers by cross checking patient ID against NHS Digital data for individual cataract operations done by each centre,\n Link patients’ data if collected at different centres and track patients moving between providers for second eyes (R/L) or operations by another provider to deal with complications,\n Match the patient’s postcode to the English and Welsh indices of social deprivation.\nThe Royal College of Ophthalmologists has been commissioned by HQIP to provide the audit. Data processing for the audit has been sub-contracted to Gloucester Hospitals NHS Foundation Trust (GHNHSFT).\nThere is a feasibility element to the project around the collection of PROMs data from patients which will be operated at 5-10 sites who are providing data to the audit."]
["Applicant Organisation Name","Royal College of Ophthalmologists"]
["Contact Name","Professor John Sparrow"]
["Address","NOD Audit Clinical Lead"]
[null,"The Royal College of Ophthalmologists 18 Stephenson Way"]
[null,"London"]
["Postcode","NW1 2HD"]
["Telephone"]
["Email","John.Sparrow@doctors.org.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population"," All adult patients in England and Wales undergoing cataract surgery, between 01/09/2017 to 31/08/2019.\n Sample size is not known; however, 420,000 cataract operations were undertaken across England and Wales in the last audit reporting period (2016/17)."]
["Description of confidential patient information used","The following patient identifiable data will be extracted from the EMR systems and databases of participating centres in England and Wales and transferred to Gloucester Hospitals NHS Foundation Trust (GHNHSFT). This information would also be disclosed to NHS Digital and NHS Wales Informative Service in order to facilitate linkage with wider administrative datasets.\n NHS Number,\n Date of birth,\n Person Gender Current (Sex),\n Ethnic category (where available),\n Post Code of Usual Address – to calculate IMD."]
["S251 Class(es)",null,"Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Expired"]
[]
["Next Review Date","2019-11-21"]
["Notes","Specific conditions of support (Final)\n1. Confirmation from the IGT Team at NHS Digital of suitable security arrangements via Information Governance Toolkit (IGT) submission (Confirmed – Gloucester Hospitals NHS Foundation Trust and Medisoft Limited both have a published satisfactory reviewed grade on Version 14.1, 2017/18)."]

{"sheet":"A0977","index":144,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","A0977"]
["Reference","15/CAG/0166"]
["Other Refs"]
["Application Title","UK Shunt Registry (UKSR)"]
["Application Summary","This application from University of Cambridge set out the purpose of the UK Shunt Registry (UKSR) for hydrocephalus and other disorders of the circulation of cerebrospinal fluid was established in 1994 with the support of MHRA and relevant charities. The current paper-based system held data on over 35,000 patients. The future aims of the Shunt Registry include:\n define the current state-of-the-art in terms of long term management of different groups of patients with disorders of the CSF circulation and related venous disorders [‘hydrocephalus’] using shunts, endoscopic third ventriculostomy, choroid plexectomy and cranial venous stenting in order to inform best practice,\n provide an accurate picture of the use of different types of shunt,\n identify, in collaboration with the UK Shunt Evaluation Laboratory, substandard shunt systems,\n monitor in real time the outcomes of different groups of patients with ‘hydrocephalus’ achieved by type of operative intervention (shunt, endoscopic third ventriculostomy, choroid plexectomy, venous stent), type and manufacturer of implant, hospital and multidisciplinary team, and highlight where these fall below an expected performance in order to allow prompt investigation and to support follow-up action,\n inform patients, carers, clinicians, providers and commissioners of healthcare, regulators, and implant suppliers of the outcomes achieved in surgical interventions for ‘hydrocephalus’,\n provide independent data for a key CQUIN (shunt infection within 30 days of insertion),\n enhance patient awareness of outcomes after surgical interventions for ‘hydrocephalus’ to better inform patient choice and patients’ quality of experience through engagement with patients and patient organisations,\n support evidence-based purchasing of ‘hydrocephalus’ – related implants for healthcare providers to support quality and cost effectiveness,\n support suppliers in the routine post market surveillance of implants and provide information to clinicians, patients, hospital management and the regulatory authorities.\nIn order to meet these aims the UKSR would collect data on all surgical interventions for all groups of patients with disorders of the CSF circulation and related venous disorders in England, Wales, Scotland and Northern Ireland. From 2015 UKSR was in transition to the ORION cloud-based platform (Outcome Registry Intervention and Operation Network) and would seek patient consent for prospective data inclusion, the application specified that this would only take place where local policies required this.\nA recommendation for class 1, 4, 5 and 6 support was requested to allow the disclosure of confidential patient information from Health and Social Care Information Centre (HES and ONS mortality data), Neurosurgical National Audit Programme (NNAP) and local hospitals to University of Cambridge in relation to all surgical interventions for all groups of patients with disorders of the CSF circulation and related venous disorders in England and Wales."]
["Applicant Organisation Name","University of Cambridge"]
["Contact Name","Prof. J D Pickard, Honorary Clinical Director, NIHR Brain Injury MedTech and In-Vitro Diagnostic Co-operative (MIC)  "]
["Address","Orion Medtech Ltd CIC,Heron Suite, Middle Court, Copley Hill Business Park"]
[null,"Cambridge Road"]
[null,"Babraham"]
["Postcode","CB22 3GN "]
["Telephone","01223 942922 "]
["Email","uksr@orion.net "]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,null,"the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Confidential patient information from Health and Social Care Information Centre (HES and ONS mortality data), Neurosurgical National Audit Programme (NNAP) and local hospitals to University of Cambridge in relation to all surgical interventions for all groups of patients with disorders of the CSF circulation and related venous disorders in England and Wales."]
["Description of confidential patient information used","Access was requested to name, postcode, NHS number, date of birth and date of death in the retrospective historical data, collected via a paper based system, in order to carry out linkages with NNAP, HES and ONS mortality data.\nAccess was requested to NHS number, date of birth and date of death only for prospective data from 2015 submitted from Hospitals and linked to NNAP, HES and ONS mortality data."]
["S251 Class(es)",null,"Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2023-06-09"]
["Notes","Specific Conditions of Support\n1. Support for prospective data collection would be provided for a period of one year\nfrom final approval, following this a consent based approach should be adopted in line\nwith other registries and support would be provided where consent was ‘not recorded’\nonly.\n2. Provision of the details of the consent based approach should be provided as soon as\npossible and by annual review stage.\n3. The levels of instances where consent was ‘not recorded’ would continue to be\nmonitored at annual review stage.\n4. In relation to the prospective dataset, where possible linkages should be undertaken\nusing NHS number only, rather than NHS number and date of birth. Complete date of\nbirth should only be accessed where NHS number was not sufficient or available.\n5. The approval relates to those datasets specified within the application only.\n6. Confirmation from the IGT Team at NHS Digital of suitable security arrangements via\nInformation Governance Toolkit (IGT) submission. (Confirmed: Version 13, 2015-16,\nsatisfactory reviewed rating at 94%)."]

{"sheet":"A0978","index":145,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","A0978"]
["Reference","15/CAG/0209"]
["Other Refs"]
["Application Title","2016 Child Inpatient and Day Case Survey"]
["Application Summary","This application from the Care Quality Commission (CQC) set out the purpose of this patient survey/survey evaluation in order to support development of a Children and Young People’s Health Outcomes Strategy. Support was sought to provide a legal basis to support the transfer of patient identifiable data from acute and specialist trusts to a specified ‘approved survey contractor’ for the purpose of mailing out questionnaires for the 2016 children’s survey. The contractors specified are: Picker Institute Europe, Quality Health, Patient Perspective and CAPITA Surveys & Research (registered as Capita Business Services Ltd).\nOne of the principles of the Patient Survey Programme is that by ensuring organisations carry out patient surveys in a consistent and systematic way, using a standardised methodology and survey instrument, it is possible to build up a national picture of people’s experience. With care it is then also possible to compare the performance of different organisations, monitor change over time, and identify variations between different patient groups. This will in turn lead to improvements in overall patient experience. These same principles will apply to the children’s survey in exactly the same way as they do for adults.\nThe end product from this survey will be a set of aggregate statistical data that does not contain patient identifiable information. This statistical dataset is used for a wide variety of purposes to support ongoing improvement in patient experience.\nA recommendation for class 5 and 6 support was requested to achieve the activity specified in the application."]
["Applicant Organisation Name","Care Quality Commission (CQC)"]
["Contact Name","Mr Paul Williamson"]
["Address","Care Quality Commission"]
[null,"151 Buckingham Palace Road"]
[null,"London"]
["Postcode","SW1W 9SZ"]
["Telephone"]
["Email","Paul.williamson@cqc.org.uk "]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population"]
["Description of confidential patient information used","Full details of the scope was set out in the letter dated 05 February 2016, in addition to the advice provided by the CAG on specific aspects. This letter should be read in conjunction with that provisional approval outcome. The remainder of this letter focuses on the responses provided in follow-up."]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2017-07-01"]
["Notes","Specific conditions of support\n1. Confirmation of the final methodology detail once the results of the pilot are known to enable a recommendation of final approval to be made.\nNew approved contractor\nThe response confirmed that at the time of submission the approved contractor framework and the Co-ordination Centre contracts were being reviewed. The response confirmed that the contractors (Picker Institute Europe, Quality Health, Patient Perspective or CAPITA Surveys & Research) have all maintained their ‘approved contractor’ status. Members noted that they must all maintain a satisfactory (as assessed by the HSCIC) level of the Information Governance Toolkit for the duration of this support.\nIt was confirmed that an additional processor, Membership Engagement Services Ltd. (MES), had been engaged by the CQC as an ‘approved contractor’. Members noted that they expected the newly appointed approved contractor to follow the same approach as dictated by the CQC, and must have a satisfactory IG Toolkit submission (as assessed by the HSCIC) for the duration of the approval; specific detail on the arrangements by MES in the response were not assessed by the members as they clarified that they expected the arrangements to be consistent between all parties and subject to the requirements of the Information Governance toolkit. It was noted that MES had a parent company, however, for the purpose of this approval support applies only to MES.\n2. Outstanding aspects pending the pilot (methodology, use of ICD-10 codes, cohort age (currently 0-15 only) to be presented back once known to CAG meeting as described in the application.\nPilot approach – stratified sampling\nThe response confirmed that in relation to the stratified sampling pilot there is a need to alter the sampling approach in order to potentially increase the proportion of responses received from those aged 8-15 years old. The intention is to assess the capability of trusts to draw a disproportionate stratified sample by conducting a pilot. All trusts that would be eligible to participate in the main survey would be required to participate in the pilot, as this would be the first time trusts have been asked to draw a sample in this way as part of the NHS Survey Programme. The response stated that it will benefit the implementation of this survey, but there is a need to test whether it can be conducted accurately and without too much burden on trusts before committing to use of a stratified methodology. It was confirmed that there are no guarantees that a stratified sample will ensure a larger number of trusts will be eligible to receive benchmark reports, due to the dependence on response rates. However every effort is being made by CQC and the Co-ordination Centre to address the factors identified as having the potential to negatively impact response rates.\nFor the purposes of the pilot, there is no requirement for: name, address or postcode. The data requested for the ‘pilot transfer’ will only include the following:\n Trustcode\n A standardised unique identifier code, to be constructed as survey identifier, trust code followed by a whole number\n Month of birth\n Year of birth\n Gender\n Date of admission\n Date of discharge\n Main speciality (of consultant) code on discharge\nThe variables required for the ‘pilot transfer’ represents a significantly reduced version of what was requested on page six of the initial application for the ‘standard transfer for survey’. Only information essential for evaluating whether the pilot had been a success is being requested.\nThis in turn means that the following variables will only be required for the ‘standard transfer for survey’:\n Ethnic group\n Length of stay\n Referring CCG\n Treatment Centre Admission\n Route of admission\n NHS site code of admission\n NHS site code of discharge\n GPPC code\n Treatment function code\nhe response confirmed that no mailings will take place as part of the pilot; the focus is on assessing how capable trusts are at constructing a stratified sample correctly. This means that unlike other pilots recently conducted as part of the NHS Patient Survey Programme (e.g. CAG 10-02(b)/2015) there will be no requirement for pilot sample data to be transferred to a mailing house.\nAge of cohort\nIt was confirmed that for the 2014 Children’s Survey, those aged 16 and 17 will not be included within the sample population. It was confirmed that those aged 0-14 days old will now be excluded from the sample population, this would represent the only change to the cohort age from that which was used within the 2014 iteration of the survey. The reason for this decision is having conducted an evaluation of the 2014 Children’s Survey, it was evident that some trusts had difficulties identifying ‘well-babies’ and removing them from the sample. For example, some trusts included newborns treated for jaundice as a well-baby whilst others did not. CQC will therefore continue to use three different versions of the questionnaire, each of which is bespoke to the needs of the sub-groups: 14 days-7 years old, 8-11 years old and 12-15 years old.\nICD-10 codes\nIt was confirmed that for the 2016 Children’s Survey, ICD-10 codes will not be requested.\nSample period\nIn an attempt to further boost the number of responses received from those aged 8-15 the sampling period in 2016 will primarily be November and December, with some trusts possibly also sampling back into October. The rationale for this shift in sample period is based on analysis of HES data, as these months were revealed to have the highest number of inpatient and day-case discharges amongst those aged 8-15 years old.\nAddition: Community trusts\nThe response also requested approval for the transfer of patient identifiable data from a maximum of three community trusts, as opposed to the acute trusts. It was confirmed that in 2014 no community trusts had participated. There are three community trusts which have a high number of children and young people admissions. As such, in order to fulfil the CQC’s regulatory role, gathering information on patient experiences at these trusts is recommended for 2016, provided that they are able to draw a minimum size sample of 300. The same security arrangements information required of acute and specialist trusts for transferring patient identifiable will be applied to community trusts.\n3. All letters to parent/guardian to be provided on Trust letter headed paper\nConfirmed.\n4. Confirmation that previously expressed objections will be upheld\nConfirmed.\n5. Confirmation from the IGT Team at the Health and Social Care Information Centre of suitable security arrangements for each contractor via Information Governance Toolkit (IGT) submission. A copy of an email dated 27/08/15 from Mr John Hodson was included as part of the submission that confirmed satisfactory security arrangements.\nA reminder was given that while the response was comprehensive, future documentation should be reviewed for relevance and conciseness to avoid ensure only relevant information is presented.\nThe CAG agreed that the minimum criteria under the Regulations appeared to have been met, and noted that the applicant had advised that a number of aspects were undergoing a pilot before final methodology could be confirmed. This information would be submitted to a full CAG meeting before any final approval could be issued and come into effect\nThe CAG therefore advised recommending provisional support to the Secretary of State for Health, subject to satisfactory resolution of and compliance with the specific and standard conditions of support as set out below."]

{"sheet":"A0979","index":146,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","A0979"]
["Reference","CAG 2-06(a)/2014"]
["Other Refs"]
["Application Title","Evaluation of the Nottingham City Alcohol Intensive Case Management Service"]
["Application Summary","This application from Nottingham City Council set out the purpose of evaluating an Intensive Alcohol Case Management and Peer Mentoring service that aimed to reduce the number of emergency department attendances and admissions into hospital relating to alcohol. Three groups would be assessed, those who attended the service and two control groups comprised of those who were eligible to attend the service but did not and those who were identified as high users of A&E.\nA recommendation for class 1, 4, 5 and 6 support was requested to allow the disclosure of data from Nottingham University NHS Trust to Nottinghamshire Health Informatics Service (NHIS) who would link to emergency department admissions data at NHIS using NHS number."]
["Applicant Organisation Name","Nottingham City Council"]
["Contact Name","Dr Jean Robinson"]
["Address","Nottinghamshire County and Nottingham City Council"]
[null,"Loxley House, Station Street"]
[null,"Nottingham"]
["Postcode","NG2 3NG"]
["Telephone"]
["Email","Jean.Robinson@nottinghamcity.gov.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Data from Nottingham University NHS Trust to Nottinghamshire Health Informatics Service (NHIS) who would link to emergency department admissions data at NHIS using NHS number"]
["Description of confidential patient information used","Access was requested to NHS number in order to carry out data linkages only."]
["S251 Class(es)",null,"Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2016-02-02"]
["Notes","Specific conditions of support\n1. Confirmation of suitable security arrangements via IG Toolkit submission. Confirmed 28/01/2015.\n2. Reasonable efforts should be made to inform the cohort in line with the requirements of the Data Protection Act. Please confirm what actions will be taken. Confirmed posters would be displayed at relevant sites.\n3. This does not include support to access data in relation to those patients who had declined to take part previously and those who were not asked due to mental capacity issues."]

{"sheet":"A0980","index":147,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A0980"]
["Reference","17/CAG/0023"]
["Other Refs"]
["Application Title","National Bariatric Surgery Registry (NBSR)"]
["Application Summary","This resubmission from the National Bariatric Surgery Register set out the purpose of recording data on a national scale for patient outcomes after Bariatric Surgery (weight loss surgery). From April 2013 data entry into the NBSR became mandatory for all NHS providers. Currently they are mandated to collect data for 2 years, which is the standard follow up period recommended by NHS for all patients who have undergone bariatric surgery. At every visit to the bariatric team, data are regularly logged into the database, which includes comorbidities associated with bariatric surgery, mobility, weight changes, revision surgery and complications.\nThe data currently recorded was identified by date of birth, local hospital number, date of operation, and gender. However, with moving populations it was stated to be difficult to track the patients for their long term outcomes looking at weight reduction (changes in comorbidities, complication rates, mortality, and revision surgery during this period) as the initial entry was specific to the unit and could not reliably be traced to other units. Support for the additions of name and NHS number was therefore requested\nA recommendation for class 4, 5 and 6 support was requested to cover the relevant activities specified in the application."]
["Applicant Organisation Name","National Bariatric Surgery Register\nName of controller for application: Mr Kamal Mahawar, Consultant Surgeon, Chairman of NBSR "]
["Contact Name","Kerri Smith, BOMSS Secretariat "]
["Address","BOMSS"]
[null,"C/O EBS Davidson Road, Lichfield"]
[null,"Staffordshire"]
["Postcode","WS14 9DZ "]
["Telephone","01543 442 195 "]
["Email","Info@bomss.org "]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,null,"the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Access was requested to data in relation to patient outcomes after Bariatric Surgery\nfrom clinical care teams to the NBSR, and from the NBSR to the care teams."]
["Description of confidential patient information used","The following data would be included: name, date of birth, NHS number, local hospital\nnumber, date of operation and gender."]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2023-04-06"]
["Notes","28 May 2021 - Condition of support added upon annual review\n\nSpecific conditions of support (updated):\nThe following sets out the updated specific conditions of support applied against this application reference.\n\n1. Please feed back to the CAG on further patient and public involvement undertaken and provide an ongoing plan within 6 months. This should include communications with charities, online meetings, and other ways of engaging with patients, using plainer language, and should explore the interesting response regarding NHS number.\nCondition met 10 December 2021\n\n2. Please confirm if an ‘anonymisation request’ is a withdrawal of consent or a refusal of consent, and confirm consent is being sought as intended, within one month from the date of this letter.\nCondition met 10 December 2021\n\n3. Please consider a timescale for the support provided regarding retrospective of collection of NHS number, and provide an update as to when this may take place, within one month from the date of this letter.\nCondition met 10 December 2021\n\n12 November 2020 - Specific conditions of support (updated):\nThe following sets out the updated specific conditions of support applied against this application reference.\n\n1. The Group would like assurance that the NBSR have appropriate systems in place to ensure the next annual review is submitted by 6 April 2021 and conditions are adhered to.\n\n2. The 2021 Annual review should be considered at a full CAG meeting. \n\n3. The applicant is obliged to undertake patient and public involvement (PPI) surrounding the use of confidential patient data without specific consent, for the purposes required in the NBSR, and provide feedback within 6 months from the date of this letter.\n\nConfirmed 28 May 2021 - all 3 conditions of support were met in the 2021 annual review.\n\nSpecific conditions of support\n1. The applicant was advised that the scope of this application now solely concerns\npatients who have already had surgery and are already included on the NBSR and\nfrom whom it is not practicable to seek retrospective consent. Prospectively, consent\nwill be sought.\n\n2. The applicant was asked to clarify the patient information with a paragraph explaining\nthe inclusion of unconsented retrospective data with the opportunity to opt out as set\nout in section ‘2a consent and opt-out’ above.\nThe applicant responded by email on 15 March 2017, providing an updated patient\nleaflet.\nThe additional paragraph was reviewed and approved by the CAG.\n\n3. The applicant was obliged to report back on the existing and future patient and public\ninvolvement undertaken which should be included within the annual review. Annual\nreviews must be provided every 12 months following date of final approval coming\ninto effect. The template is available on the HRA website within the CAG section.\n\n4. Confirmation from the IGT Team at NHS Digital of suitable security arrangements via\nInformation Governance Toolkit (IGT) submission. Toolkit published as\nsatisfactory.\n\n5. The applicant was advised that processing information, without consent, for the\npurpose of research would require an amendment or new application form as the form\nsubmitted was a non-research application.\n\n6. The applicant was advised that an amendment should be provided to cover additional\ndata sources where not clearly specified in the original application."]

{"sheet":"A0981","index":148,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A0981"]
["Reference","17/CAG/0027"]
["Other Refs"]
["Application Title","CQC Maternity Survey"]
["Application Summary","This application, submitted by the Picker Institute Europe, CQC and NHS England on\nbehalf of all acute trusts running eligible maternity services, set out the purpose of\ncarrying out surveys in order to build up a national picture of women’s experiences of\nmaternity care.\nThe information would be shared with individual trusts to use for local improvement\nplanning and share with commissioners, used by the CQC to enable them to assess\ntrusts in England, published on the CQC website so that trusts could compare\nthemselves, and findings for England would be incorporated into the 2017 State of Care\nreport.\nTrusts would provide names and full addresses of women who gave birth at the Trust in\nJanuary or February 2017 to the contractor to enable them to mail out questionnaires.\nThe questionnaires would be returned voluntarily to the contractor for collation, checking\nand review before being transferred to the Coordination Centre.\nThis methodology was the same as for previous CQC surveys and had been supported\nby CAG.\nIn addition, there was a new aspect for this specific survey due to variations in the\nlocation where women received antenatal, birth and postnatal care – these three stages\nof care were not always provided at the same Trust. Information from trusts concerned\nwomen who had given birth at the Trust. The Co-ordination Centre would receive\nadditional information from trusts to enable them to flag women who had received\nantenatal and/or postnatal care at the same Trust.\nA recommendation for class 5 and 6 support was requested for auditing, monitoring\nand analysing patient care and treatment and to allow access to an authorised user\nfor one or more of the above purposes."]
["Applicant Organisation Name","Picker Institute Europe, CQC and NHS England"]
["Contact Name","Mr Chris Graham"]
["Address","Picker Institute Europe"]
[null,"Buxton Court"]
[null,"3 West Way, Oxford"]
["Postcode","OX2 0JB"]
["Telephone"]
["Email","firona.roth@PickerEurope.ac.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Trusts would provide information of women who gave birth at the Trust in January or February 2017."]
["Description of confidential patient information used","Access was requested to name and postcode for the mailing of questionnaires.\nThe sample file containing: unique identifier code, mother’s year of birth, mother’s ethnic\ngroup, day of delivery, month of delivery, year of delivery, actual delivery place, place of\nbirth, NHS site code, CCG code, Postcode sector (optional), and Trust-held provider\ninformation (optional).\nThis information would be used to link demographic data to the survey responses, to aid\nanalysis and to enable checks to be carried out for any errors in how the sample was\ndrawn."]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2018-02-06"]
["Notes","No Specific Conditions of Support"]

{"sheet":"A0982","index":149,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A0982"]
["Reference","17/CAG/0073"]
["Other Refs"]
["Application Title","Application to hold patient identifiable data within the National Head and Neck Cancer Audit (HANA)"]
["Application Summary","This application from Saving Faces and Dendrite sets out the purpose of the continuation\nof the Head and Neck Cancer Audit. The HANA database was commissioned by HQIP to\nassess and improve the quality of services and the outcomes achieved by head and neck\ncancer treatments across the NHS and to provide comparative information to patients,\ncommissioners and regulators of healthcare professionals.\nOn 1st July 2015, Saving Faces – The Facial Surgery Research Foundation (SF) was\ncommissioned by the Healthcare Quality Improvement Partnership (HQIP) on behalf of\nNHS England and the Welsh Government to deliver the National Head and Neck Cancer\nAudit. The audit had previously been delivered for many years by NHS Digital (NHSD)\nwho held the first head and neck database, DAHNO, collecting and storing data from\n2004-2014 relating to more than 54,000 patient records. HQIP supported the flow of this\nhistoric audit data including patient confidential data from NHSD to SF as these data were\nrequired to deliver the audit moving forwards. This was reviewed and approved under the\nhistoric CAG reference 15/CAG/0170.\nIn February 2017, SF published a Clinical Outcomes Publication (COP) on NHS Choices\nand My NHS based on the historical 2012-14 data. More than 23,000 head and neck\ncancer records relating to diagnoses from November 2014 to date, have already been\nuploaded directly to Dendrite Clinical Systems who are the informatics provider and data\nprocessor for this contract. This was reviewed and approved under historic CAG\nreference 15/CAG/0197.\nIn the spring of 2017, the commissioning arrangements for HANA will change and HANA\nwill cease to be part of the National Clinical Audit and Patient Outcomes Programme\n(NCAPOP). SF’s contract with HQIP will end once a new legal basis for holding the data\nhas been established. SF will then take over as the data controller and funder of HANA,\ndelegating Dendrite Clinical Systems Ltd as data processor. HANA will continue as part of\nHQIP's Clinical Outcomes Publication Programme and SF are currently working on the\nnext COP, which will be based on the 2014-16 data. The audit will therefore be retained\non the 2017/18 Quality Accounts list.\nThis application relates to the ongoing retention and processing of both the historical data\nthat have been transferred to Dendrite on behalf of Saving Faces and the data that HANA\nis currently collecting and will continue to collect. SF seeks support to continue the\napplication for the same purpose as previously approved under the HQIP commissioned\naudit programme. Dendrite will hold data securely and will provide Saving Faces with\naggregate or anonymised data for use in the analysis of the following areas:\n Hospital performance – facilities and their timely availability, pastoral aspects of care,\n Clinician performance - surgical skills of surgeons measured to BAHNO standards\nand the current, surgeon-level reporting fields; and for the first time oncologist\nperformance in terms of disease control and complications,\n Long-term treatment outcomes – complications of treatment, disease control and\nsurvival,\n Longitudinal studies tracking treatment and care over many years.\nBuilding on the historic data from 2004, HANA wish to continue to monitor service\nprovision and facilitate processes and outcome improvements covering the whole ‘patient\npathway’. The dataset will be updated approximately once a year to track key processes\nand outcome measures in line with the latest NHS guidelines and clinical group\nsuggestions (e.g. fields that are consistently poorly completed will be assessed for\nremoval, whilst new fields such as robotic surgery may be added). SF are working in\nclose collaboration with the British Association of Head and Neck Oncologists (BAHNO)\nto ensure appropriate clinical leadership and governance. HANA will collect data on preoperative health status and co-morbidity, details of the treatments provided and the\nprincipal healthcare professionals responsible, and the development of any recognised\ncomplications following surgical and non-surgical treatments delivered in NHS hospitals.\nA recommendation for class 1, 4, 5 and 6 support was requested to cover activities as\ndescribed within the application."]
["Applicant Organisation Name","Saving Faces and Dendrite"]
["Contact Name","Professor Iain Hutchinson"]
["Address","Saving Faces – The Facial Surgery Research Foundation"]
[null,"Grove Building, Mile End Hospital"]
[null,"Bancroft Road, London"]
["Postcode","E1 4DG"]
["Telephone"]
["Email","iainhutchison@nhs.net"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","The cohort is all patients with a diagnosis of head and neck cancer in England and\nWales. The historic HANA database which will transfer under this application if supported\ncontains records for over 75,000 patients."]
["Description of confidential patient information used","The following data items are requested for the purposes stated:\n NHS number - used for data linkage to ONS mortality records and to allow patient\ntracking within and across units,\n Date of birth – to allow data to be risk-adjusted by the age of patients when comparing\nunits/trusts. To ensure that the correct patient can be identified and information can\nbe correctly linked. For epidemiological analysis locally & nationally,\n Postcode - to allow data to be risk-adjusted by deprivation when comparing\nunits/trusts and for geographical comparisons,\n Date of treatment – for the assessment of complications including return to theatre\nwithin 30 days and for survival analysis,\n Date of death – to be used in survival analyses and clinical outcomes reporting,\n Cause of death - to be used in survival analyses,\n First name and surname – to be used to verify patient identification in cases where\nNHS numbers are inaccurate. To aid clinicians who are entering patient data via the\nDirect Data Entry (DDE) system during follow-up appointments. To aid clinicians who\nwish to view, check and correct their patients’ records via the DDE.\nData will be uploaded direct from local clinical MDT teams."]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,null,"Class V - audit, monitoring, & analysis of healthcare provision "]
[null,null,"Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2021-04-28"]
["Notes","Specific Conditions of Support\n1. Support is extended to the continued retention of the existing audit database by\nDendrite, as data processors, to support the ongoing audit programme, which will now\nbe led by Saving Faces, as data controller. Support remains in place for the continued\nprospective data collection for the audit programme by the existing data flows only.\nAny proposed data flow outside those which have existing approval was considered\nout of scope and has not been supported.\n2. The extension of support to cover data linkage with NCRAS to augment\nchemotherapy and radiotherapy information is out of scope of this approval; however,\nthe CAG was open to the future submission of an amendment to cover this.\n3. The extension of support to cover additional data linkage with ONS and HES data is\nout of scope of this approval. The CAG required assurance of the value of the existing\ndata source at first annual review before an amendment submission to cover this\nadditional linkage would be accepted.\n4. An extension to the purpose of the project to include research was out of scope of this\napproval. The CAG required assurance of the value of the existing data source at first\nannual review before an amendment submission to cover any extension to purpose\nwould be accepted.\n5. Further information is required to provide assurance in the ongoing value of the audit\nprogramme and current established dataset. This should be submitted no later than\nfour weeks in advance of the submission of the first annual review, to allow sufficient\ntime for consideration by the CAG. This should include:\na. Confirmation of the proportion of head and neck cancers cases submitted for the\naudit against the actual number of cases recorded. Historical information should\nbe provided together with figures for the previous year, to understand the\nimprovements which have been made following engagement with sites,\nb. Clarification of whether clinicians are mandated to submit data for the audits,\n6. Work should continue on moving the audit programme to a fully consented model and\nthe trial of DDE2 data entry system. A report on progress towards achieving this by\n2019 as indicated, together with additional outcomes from the pilot, should be\nprovided at first annual review for consideration by the CAG.\n7. With regards data retained on deceased patient, date of death should be translated\ninto a survival time calculation, with the date identifier being removed from the\ndatabase.\n8. Patient Notifications and Dissent – undertake the following updates providing a report\nback at first annual review that these had been undertaken:\na. Published information required proofreading for accuracy to ensure that\ninformation around the retention of data is accurately reported. Revisions should\nbe made where necessary,\nb. Revise the information around the opt-out process to clearly state that all patient\ninformation would be removed from the audit should a patient lodge an objection,\nc. Update the relevant website sections around the opt-out process for the project,\nd. Include patient notification on the British Association of Head and Neck\nOncologists (BAHNO) website. (Confirmed – Dendrite shows a reported\nreviewed grade at 66% satisfactory on Version 13 (2015/16).\n9. Confirmation from the IGT Team at NHS Digital of suitable security arrangements via\nInformation Governance Toolkit (IGT) submission."]

{"sheet":"A0983","index":150,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A0983"]
["Reference","17/CAG/0130"]
["Other Refs"]
["Application Title","Colonoscopic surveillance for familial risk of colorectal cancer"]
["Application Summary","This non-research application from London North West Healthcare NHS Trust set out the purpose of auditing and monitoring care provided to individuals at increased familial risk of colorectal cancer and developing evidence-based guidelines on the management of familial risk for the NHS.\nIndividuals with a family history of colorectal cancer are at increased risk of developing colorectal cancer. Familial risk of colorectal cancer may be estimated from the number of family members affected and the age at which they were diagnosed. In a small proportion genetic testing may be undertaken to diagnose inherited genetic predispositions.\nThe Family Cancer Clinic at St Mark’s Hospital has over 3000 patients who are undergoing colonoscopic surveillance for an increased familial risk of colorectal cancer and whose clinical, molecular, genetic and family history are recorded on the Bobby Moore database as is the outcome of colonoscopic surveillance including the histopathology of polyps and cancers removed.\nThe applicant wishes to obtain outcome and mortality data from NHS Digital for this cohort in order to assess the effectiveness of their risk assessment methods and of colonoscopy. Complete ascertainment of cancers that develop in individuals who have undergone colonoscopic surveillance ensures that the surveillance protocol is effective and can be changed if there is a new case of cancer.\nIn order to ensure complete ascertainment the applicant wished to flag their patients with NHS Digital in order to provide a list of cancer registrations, deaths and emigrations, in addition to contact details and GP details for patients lost to follow-up. Identifiers would be provided to NHS Digital, who would provide cancer registration data to the Family Cancer Clinic. Staff at the clinic would add any information not already recorded at the clinic, and destroy the dataset by deleting the information.\nA recommendation for class 4 support was requested for auditing, monitoring and analysing patient care and treatment."]
["Applicant Organisation Name","London North West Healthcare NHS Trust"]
["Contact Name","Professor Huw Thomas"]
["Address","Family Cancer Clinic"]
[null,"St Mark’s Hospital"]
[null,"Watford Road, Harrow"]
["Postcode","HA1 3UJ"]
["Telephone"]
["Email","huw.thomas@imperial.ac.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Access was requested to data from NHS Digital in relation to patients undergoing colonoscopic surveillance for an increased risk of colorectal cancer."]
["Description of confidential patient information used","Name, date of birth and NHS number to be supplied to NHS Digital\nNHS Digital would return cancer registration data.\nIn cases where patients were lost to follow up, NHS Digital would return the name, date of birth, address and registered GP for the patient."]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,null,"Class V - audit, monitoring, & analysis of healthcare provision "]
[null,null,"Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Expired"]
[]
["Next Review Date","2022-09-08"]
["Notes","Applicant confirmed in September 2022 that ‘s251’ support can be expired as they no longer retain any confidential patient information that was provided under ‘s251’. \n\n05 July 2021 - amendment supported to remove Queen Mary College, University of London (QMUL) as a data processor, and add Kings College London (KCL) as a data processor, and provide support for the flow of confidential patient information from London North West Healthcare NHS Trust to Kings College London (KCL) for analysis, is supported, subject to compliance with the standard conditions of support.\n\n25 June 2021 - Annual review supported\n\nSpecific conditions of support (updated):\nThe following sets out the updated specific conditions of support applied against this application reference.\n1. Ensure that annual reviews are provided in a timely fashion to avoid jeopardising the status of support. Met as part of 2021 annual review submission\n2. Undertake public and patient engagement work and report back within six months from the date of this letter.\n3. Please confirm with clarity the status of the requested prospective consent since September 2017, within one month from the date of this letter. If an amendment to support is required, please submit an amendment to CAG, considering the justifications for this request, within one month from the date of this letter. Met - confirmed as support not required as data not being requested for any patient post September 2017, as part of 2021 annual review submission\n\nSpecific conditions of support\n1. Confirmation from the IGT Team at the Health and Social Care Information Centre of suitable security arrangements via Information Governance Toolkit (IGT) submission. V14 confirmed published and reviewed as satisfactory."]

{"sheet":"A0984","index":151,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A0984"]
["Reference","19/CAG/0001"]
["Other Refs"]
["Application Title","National Asthma and COPD Audit Programme (NACAP): Paediatric Asthma Clinical Audit"]
["Application Summary","This application submitted by the Royal College of Physicians on behalf of the Healthcare Quality Improvement Partnership (HQIP), sets out the purpose of establishing the Paediatric Asthma Clinical Audit. The audit is commissioned as part of the National Asthma and COPD Audit Programme (NACAP). The wider audit programme also covers Chronic Obstructive Pulmonary Disease (COPD), Adult Asthma, Pulmonary Rehabilitation and primary care. This will be a continuous audit of children and young people admitted to hospital with asthma attacks. \n\nSupport under the Regulations is in place for the Chronic Obstructive Pulmonary Disease (COPD) and Adult Asthma elements of the Audit Programme under reference CAG 8-06(b)/2013. The other activities within the wider audit programme either operate on a consented basis or do not require collection of confidential patient information. \n\nThe overarching aims of the paediatric asthma audit reflect those of the NACAP programme generally, and will be to: identify variability and deficiencies in the care received by children and young people admitted to hospital with asthma attacks, support improvement by providing timely and relevant data/feedback to paediatricians and local hospital teams, and improve the basic standards of care for children and young people admitted to hospital with asthma attacks.\n\nThe application to the CAG will cover the audit in England and Wales. The audit also extends to Scotland; however, a separate application is being made to the Public Benefit and Privacy Panel for this element.  \n"]
["Applicant Organisation Name","The Royal College of Physicians of London (on behalf of HQIP)"]
["Contact Name","Lara Amusan, NACAP Programme Manager / Rachael Andrews, Deputy NACAP Programme Manager / Eloya Imoedemhe, Asthma Project Manager"]
["Address","National Asthma and COPD Audit Programme (NACAP), Audit and Accreditation"]
[null,"The Royal College of Physicians of London"]
[null,"11 St Andrew's Place, Regent's Park, London"]
["Postcode","NW1 4LE"]
["Telephone","020 3075 1526"]
["Email","lara.amusan@rcplondon.ac.uk / rachael.andrews@rcplondon.ac.uk / eloya.imoedemhe@rcplondon.ac.uk "]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","All patients (approximately 30,000 per annum) admitted to hospitals in England and Wales with a primary diagnosis as follows:\n• Patients aged between 1 and 5 years – asthma attack or viral wheeze (which is responsive to salbutamol), \n• Patients aged between 5 and 16 years – asthma attack,\n• Patients aged 17 and 18 years – asthma attack, if treated on paediatric wards only. If treated on adult wards, these patients would be entered into the adult audit. \n"]
["Description of confidential patient information used","• Study ID, \n• NHS number, \n• Date of birth, \n• Postcode, \n• Date, time and cause of death,\n• Sex,\n• Ethnicity. \n"]
["S251 Class(es)",null,"Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2023-03-20"]
["Notes","10 August 2021 - Amendment supported to amend an inclusion criteria for the Paediatric Asthma Clinical Audit to remove secondary diagnosis of asthma, but to include secondary diagnosis of asthma if the patient has a primary diagnosis of wheeze\n\n27 April 2021 - Amendment supported:\nThe amendment, to remove an exclusion criteria regarding wheeze, and to amend the inclusion criteria, including ensuring certain secondary position ICD-10 codes are captured in the inclusion criteria for the Paediatric Asthma Clinical Audit, is supported, subject to compliance with the standard conditions of support.\n\n27 November 2020 – Amendment supported to revise the data flow so that NHS Digital and NWIS send the anonymised, patient-level data directly to Imperial College London, instead of via Crown Informatics.\n\nSpecific conditions of support\n1. Support under this application extends to the non-research audit purposes only. There is no support in place for the processing of information collected within the audit for research purposes. \n2. Confirmation from the IGT Team at NHS Digital of suitable security arrangements via Information Governance Toolkit (IGT) submission – Confirmed:  \n• Crown Informatics, Aimes Management Services and NHS Digital have published satisfactory reviewed grades on Version 14.1, 2017/18, \n• NHS Wales Informatics Service, CPIP Assurance in place. \n"]

{"sheet":"A0985","index":152,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A0985"]
["Reference","19/CAG/0005"]
["Other Refs"]
["Application Title","Outcomes of patients undergoing lower limb vascular procedures in the National Vascular Registry"]
["Application Summary","This application from the North Bristol NHS Trust set out the purpose of undertaking a\nservice evaluation in order to describe the longer term patient outcomes after lower limb\nvascular surgery in England. Clinical and demographics risk factors for poor outcomes will\nalso be investigated. It is intended the findings of the service evaluation would enable\nclinicians and patients to be better informed and to facilitate future research.\nPatients who have undergone lower limb vascular surgery will be identified within the\nNational Vascular Registry (NVR), which is commissioned by the Healthcare Quality\nImprovement Partnership (HQIP) as part of the National Clinical Audit and Patient\nOutcomes Programme (NCAPOP). Patients undergoing elective surgery are included in\nthe NVR via consent. For patients undergoing emergency surgery, support under the\nRegulations is in place via application CAG 5-07(f)/2013 to include these individuals in the\nregistry. The NVR will disclose confidential patient information, together with a studyspecific\nID, to NHS Digital to facilitate linkage with HES and ONS. Wider clinical information\nfrom the NVR will be released to the applicant with the same study-specific ID attached.\nNHS Digital will undertake the wider linkage and release information to the applicant with\nthe study-specific ID attached. The applicant will link the two pseudonymised datasets for\nanalysis.\nA recommendation for class 1, 4 and 6 support was requested to cover activities as\ndescribed in the application."]
["Applicant Organisation Name","North Bristol NHS Trust"]
["Contact Name","Dr Richard Armstrong"]
["Address","North Bristol NHS Trust, Department of Anaesthesia\n"]
[null,"Southmead Hospital"]
[null,"Bristol"]
["Postcode","BS10 5NB"]
["Telephone","0117 9505050\n"]
["Email","rarmstrong1@nhs.net\n"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","All patients recorded in the National Vascular Registry who underwent lower limb vascular\nsurgery from 01/01/2014 to 31/12/2016. The inclusion criteria cover 40,890 procedures;\nhowever, the number of patients may be lower if they have undergone multiple procedures\nduring the inclusion timeframe."]
["Description of confidential patient information used","The following items of confidential patient information will be disclosed from the National\nVascular Registry to NHS Digital to facilitate linkage:\n• NHS Number,\n• Date of Birth,\n• NVR patient ID."]
["S251 Class(es)",null,"Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,null,"Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2020-04-12"]
["Notes","15 July 2020 – Amendment supported to revise the data flow to include the sharing of de-identified data from the National Vascular Registry to the University of Bristol, and then on to North Bristol NHS Trust.\n\nConditions of support:\n1. Project-specific website text to be published on the National Vascular Website within three months of support. \n2. Confirmation from the IGT Team at NHS Digital of suitable security arrangements via Information Governance Toolkit (IGT) submission (Confirmed – NHS Digital (processor) has a published satisfactory reviewed grade on V14.1, 2017/18).\n"]

{"sheet":"A0986","index":153,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A0986"]
["Reference","19/CAG/0055"]
["Other Refs"]
["Application Title","Triage-HF Plus: Cardiac Implantable Electronic Device Remote Monitoring Combined with Telephone Triage to Identify and Manage Worsening Heart Failure"]
["Application Summary","This application from Manchester University NHS Foundation Trust set out the purpose service evaluation which aims to follow-up patients who registered for remote care monitoring via the Medtronic CareLink platform to assess the current care monitoring pathway operated by the Trust and assist in the development of future state care models.\nMedtronic CareLink transmissions from the ambulatory Cardiac Implantable Electronic Device (CIED) population are routinely reviewed as part of standard clinical practice. Advances in heart failure diagnostics mean that it is possible to identify patients at risk of worsening heart failure using information from their implanted device. The Medtronic ‘Heart Failure Risk Score’ (HFRS) uses input from integrated device diagnostics to detect changes in the patient’s key physiological parameters, stratifying patients as low, medium or high-risk of a heart failure event in the next 30 days. Since 2016, the Trust has used HFRS-based alerts for the remote identification of worsening heart failure in CIED patients who are enrolled in the CareLink platform. High-risk HFRS alerts prompt a telephone consultation with the patient, using the information provided by the remote transmission and patient reported symptoms appropriate clinical actions in line with clinical guidelines are instigated. The Trust refers to this as the ‘Triage-HF Plus pathway’.\nThe purpose of the application is to link confidential patient information in relation to the patient cohort enrolled on the care link platform with Hospital Episodes Statistics (HES) and ONS Mortality information held by NHS Digital in order collect 30 and 90 day and 12 month outcome data (elective and non-elective hospital attendance and mortality information) to facilitate evaluation of the Triage-HF Plus Pathway.\nA recommendation for class 1, 4, 5 and 6 support was requested to cover activities as described in the application."]
["Applicant Organisation Name","Manchester University NHS Foundation Trust"]
["Contact Name","Dr. Fozia Z Ahmed"]
["Address","Department of Cardiology"]
[null,"1st Floor, Manchester Royal Infirmary"]
[null,"Manchester University NHS Foundation Trust, Manchester"]
["Postcode","M13 9WL"]
["Telephone","(0)161 276 4271"]
["Email","Fozia.Ahmed@mft.nhs.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","All patients fitted with a Cardiac Implantable Electronic Device under the care of the Manchester University NHS Foundation Trust, who have consented to remote monitoring via the CareLink platform. It is estimated that there are 1,010 patients eligible for inclusion."]
["Description of confidential patient information used","The following items of confidential patient information will be disclosed from Manchester University NHS Foundation Trust to NHS Digital to facilitate linkage with HES and ONS:\n• NHS number,\n• Date of birth,\n• Sex,\n• Postcode"]
["S251 Class(es)",null,"Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2023-05-24"]
["Notes","Conditions of support\n1. Confirmation from the IGT Team at NHS Digital of suitable security arrangements via Information Governance Toolkit (IGT) submission (Confirmed - NHS Digital has a Standards Met grade on the Data Security and Protection Toolkit submission for 2018/19)."]

{"sheet":"A0987","index":154,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A0987"]
["Reference","19/CAG/0051"]
["Other Refs"]
["Application Title","Piloting a new questionnaire to understand patient experiences of liver transplant services"]
["Application Summary","This application from the Picker Institute Europe set out the purpose of undertaking a pilot\nassessment of patient experiences of Liver Transplant Services in England. The aim of the\nstudy is to conduct a pilot survey of adults who have received a liver transplant within the\nlast three years, but more than three months ago, to:\n1. Increase understanding of the views, preferences and experiences of people who\nhave received liver transplants in England and Scotland.\n2. Develop and pilot a national Patient Reported Experience Measure (PREM) as a\ntool for future assessment of patient experience of liver transplant services in\nEngland and Scotland\n3. Gather comparative evidence of patient experience of liver transplant as a basis for\nimproving transplant services across England.\nThe patient cohort will be identified from seven specialist NHS Transplant centres within\nEngland as follows: Royal Free Hospital, King’s College Hospital, University Hospitals\nBirmingham, Cambridge University Hospitals, Leeds Teaching Hospitals and Newcastle\nHospitals. A further site will be located in Edinburgh; however, this is out of scope for the\nCAG application. Participants will be sent a paper questionnaire surveying their\nexperiences of pre-transplant, transplant, and post-transplant care.\nPicker runs and coordinates the NHS Patient Survey Programme (NPSP) under the title of\nthe Survey Coordination Centre. In addition, Picker is an approved NHS contractor. The\npatient experience of Liver transplant services in England survey, will adopt a similar\nmethodology to the NHS Patient Survey Programme (NPSP) – alterations to this\nmethodology will be described below, mainly:\n• Picker will be addressing and mailing out the survey packs to avoid patient\nidentifiable information being shared with sub-contractors.\n• Picker will have access to the mailing data in order to circulate the survey packs,\n• Data files will be password protected and saved on a non-network drive with\nrestricted access to necessary staff,\n• The mailing file will be kept separate to the response file, linked by a unique\nreference, to ensure that survey responses are pseudonymised and there is no risk\nof linkage between the two files.\nA recommendation for class 5, and 6 support was requested to cover activities as described\nin the application."]
["Applicant Organisation Name","Picker Institute Europe"]
["Contact Name","Dr Jenny King"]
["Address","Picker Institute Europe "]
[null,"Buxton Court "]
[null,"3 West Way, Oxford"]
["Postcode","OX2 OJB"]
["Telephone","01865 208118 "]
["Email","Jenny.King@PickerEurope.ac.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Liver transplant patients aged over 18 years who have had a liver transplant between three\nmonths and three years prior to extraction of the patient sample at one of the following\nsites: Royal Free Hospital, King’s College Hospital, University Hospitals Birmingham,\nCambridge University Hospitals, Leeds Teaching Hospitals and Newcastle Hospitals. It is\nestimated that 3,000 patients would be included in the study."]
["Description of confidential patient information used","The following items of confidential patient information are requested in order to facilitate\nthe distribution of the survey and no analysis purposes:\n• Full name and title,\n• Full address and postcode,\n• Date of transplant,\n• Treatment centre code,\n• Study specific ID,\n• Month and year of birth,\n• Sex."]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Expired"]
[]
["Next Review Date","2019-05-24"]
["Notes","Conditions of support:\n1.Confirmation from the IGT Team at NHS Digital of suitable security arrangements via Information Governance Toolkit (IGT) submission (Confirmed: Picker Institute Europe has a satisfactory reviewed grade on V14.1, 2018/18)\n\nThe applicant confirmed that support can be expired as of 27 July 2022. \n\nThe public benefit of the application was use of the results to design a robust mechanism for patients who use liver transplants services to feedback on the care they received. \n"]

{"sheet":"A0988","index":155,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A0988"]
["Reference","18/CAG/0092"]
["Other Refs"]
["Application Title","Prostate brachytherapy survival outcomes supported by death certificate information from NHS Digital"]
["Application Summary","This application from the Royal Surrey County Hospital NHS Foundation Trust set out the purpose of audit which aims to follow-up patients who were treated with a pioneering low dose rate prostate brachytherapy from its introduction to 31/10/2014 who have subsequently died. For the purpose of auditing prostate cancer specific survival outcomes, the applicants require information regarding the cause(s) of death to be provided by NHS Digital. Upon receipt of this information the pseudonymised Brachybase data registry will be updated.\nA recommendation for class 4, 5 and 6 support was requested to cover activities as set out in the application."]
["Applicant Organisation Name","Royal Surrey County Hospital NHS Foundation Trust "]
["Contact Name","Ms Jennifer Uribe"]
["Address","Urology Research Fellow, Royal Surrey County Hospital, Urology Department "]
[null,"Egerton Road "]
[null,"Guilford"]
["Postcode","GU2 7XX"]
["Telephone"]
["Email","Jennifer.uribe@nhs.ne"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"Y","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","All patients who received the low dose rate prostate brachytherapy at the Royal Surrey County Hospital NHS Foundation Trust, prior to 31/10/2014, who are now deceased. The sample size is estimated at 250 patients."]
["Description of confidential patient information used","The following items of confidential patient information will be disclosed to NHS Digital to facilitate linkage with the ONS mortality dataset, in order for cause of death to be supplied:\n• Full name,\n• Date of birth."]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Expired"]
[]
["Next Review Date","2020-06-14"]
["Notes","05 January 2022 - Support Expired:\nData in relation to this approval has been destroyed in accordance with NHSD destruction certificate. \n\nThe public benefits that arose from this work can be assessed from the arising publication.\n\nUribe-Lewis S, Uribe J, Bourke V, Deering C, Higgins D, Mehta S, Mikropoulos C, Otter S, Perna C, Khaksar S, Laing R, Langley S. Long-term survival after low-dose-rate brachytherapy for prostate cancer: the Royal Surrey experience. BJU Int. 2021 Aug 27. doi: 10.1111/bju.15585. Epub ahead of print. PMID: 34448332.\n\nConditions of support:\n1.Confirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. (Confirmed - the NHS Digital has a confirmed ‘Standards Met’ grade on its DSPT submission)."]

{"sheet":"A0989","index":156,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","A0989"]
["Reference","19/CAG/0097"]
["Other Refs"]
["Application Title","2019 NHS Adult Inpatient Survey"]
["Application Summary","This non-research application from the Care Quality Commission set out the purpose of conducting the 2019 NHS Adult Inpatient Survey, using standardised methodology to build up a national picture of patient experiences. The outputs of this survey will be a set of aggregate statistical data that does not contain patient identifiable information.\nThis statistical dataset is used for a wide variety of purposes to support ongoing improvement in overall patient experience. The survey data will be used extensively by NHS trusts and Clinical Commissioning Groups (CCGs) in local improvement. The CQC will use data as part of its regulatory activities, as well as any other relevant functions. Individual level data for respondents will be shared with NHS England and the Department of Health and Social Care, containing sample file information. Individual level data for respondents and non-responders will be shared with NHS England to understand patients’ experiences of NHS services and to drive improvements to them. The Department of Health and NHS England may use the results to generate aggregate indicators at local, regional and national level. These indicators form part of the range of Outcome Frameworks and other publications. The data will also be shared with the Health and Social Care Information Centre, or other organisations, working on behalf of Department of Health or NHS England for the purpose of generating these indicators. NHS Improvement will use the trust level results (scored data) to inform their oversight model for NHS Trusts.\nThe 2019 Inpatient survey will be the sixteenth carried out to date. All trusts will draw a sample of patients according to set criteria and follow standardised materials and procedures for all stages of the survey. The methods for the 2019 survey are unchanged from the 2018 survey. The methodology is well-established and has been supported by CAG in previous years.\nWhen administering the survey, NHS trusts will be advised to employ the service of one of four approved contractors to reduce the cost, burden and risk in the provision of survey data. In doing so, it is expected that the risks to data quality and delay to the timetable are reduced dramatically, as evidenced throughout the application. Some NHS trusts may opt to undertake the mailing of questionnaires themselves, avoiding the need to employ an approved survey contractor.\nA recommendation for class 5 and 6 support was requested to cover access to the relevant unconsented activities as described in the application."]
["Applicant Organisation Name","Care Quality Commission"]
["Contact Name","Ms Tamatha Webster"]
["Address","Care Quality Commission"]
[null,"151 Buckingham Palace Road"]
[null,"London"]
["Postcode","SW1W 9SZ"]
["Telephone",7393754206]
["Email","Tamatha.webster@cqc.org.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"x","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Inpatients aged 16 years old or over who were discharged from acute and specialist NHS hospitals in July 2019 (and earlier for smaller trusts), having had one overnight stay in hospital.\nExclusions:\n• deceased patients\n• children or young persons aged under 16 years at the time of sampling\n• obstetrics/maternity service users, including spontaneous miscarriages\n• patients admitted for planned termination of pregnancy\n• psychiatry patients\n• day cases\n• private patients (non-NHS)\n• any patients who are known to be current inpatients patients without a UK postal address\n• any patient known to have requested their details are not used for any purpose other than their clinical care, including those responding to posters displayed on hospital wards referring to the survey (the survey instructions request that all responses to posters are logged and used for this purpose)."]
["Description of confidential patient information used","Data sources - 148 acute and specialist NHS \nIdentifiers required for linkage purposes: The mailing data is used to address questionnaires to the appropriate person. It contains:\n• Trust code.\n• A standardised unique identifier code, to be constructed as survey identifier, trust code followed by a whole number (consecutive across the sample of 1,250 patients from each trust),\n• Title (Mr, Mrs, Ms, etc.)\n• First name\n• Surname\n• Address Fields\n• Postcode (where available)\nIdentifiers required for analysis purposes\nThe sample data file is used to link demographic data to the survey responses, to aid analysis and to enable checks to be carried out for any errors in how the sample was drawn. This file contains:\n• The unique identifier code (as above)\n• Admission/discharge dates\n• Length of stay (this is calculated from the admission and discharge dates).\n• Whether admission from Treatment Centre\n• Route of admission\n• NHS Site code on admission and discharge\n• Ethnicity\n• Gender\n• Year of birth\n• CCG Code: to enable analysis at this level by stakeholders for the production of relevant indicators\n• ICD-11 code"]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2021-08-12"]
["Notes","Conditions of support:\n1.Confirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. See section below titled ‘security assurance requirements’ for further information. DSPT required for:\n•Picker Institute Europe – confirmed by NHS Digital email on 17 July 2019,\n•Quality Health – confirmed by NHS Digital email on 24 July 2019,\n•Patient Perspective – confirmed by NHS Digital email on 30 July 2019."]

{"sheet":"A0990","index":157,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A0990"]
["Reference","19/CAG/0102"]
["Other Refs"]
["Application Title","2019 NHS Adult Inpatient Survey – Mixed Methods Standalone Pilot"]
["Application Summary","This non-research application from the Care Quality Commission, submitted by Ipsos MORI, set out the purpose of carrying out a pilot study to test mixed methods of distribution of the 2019 NHS Adult Inpatient Survey.\nThe Inpatient Survey is the most established survey within the NHS Patient Survey Programme (NPSP). The NPSP was initiated in 2002 by the Department of Health and is now overseen by the Care Quality Commission (CQC), the independent regulator of health and social care in England. The CQC have commissioned Ipsos MORI to manage and coordinate surveys within the NPSP under the title of the Survey Coordination Centre for mixed survey methods.\nTo date the survey has been conducted using a postal approach but with the increase in use and accessibility of online surveys, the CQC are keen to investigate the potential of moving the NPSP to a mixed method approach, combining a postal approach with an online survey. The pilot study will test the effectiveness of administering the questionnaire with an online option (instead of just postal) and sending SMS invitations and reminders. The pilot study will also include a control sample, which will only receive postal questionnaires, as due to the difference in fieldwork timings it will not be possible to use the 2019 mainstage fieldwork as a control.\nThe following approaches will be made to patients within the pilot:\n\nPilot Group:\nContact - Details\n1 - Letter with URL link for online questionnaire\n1.1 - SMS despatched 3 days later with URL link for online questionnaire\n2 - 1 week after 1, letter with URL\n2.2 - SMS with URL link for online questionnaire despatched 3 days later\n3 - 2 weeks after 2, letter with URL and mail questionnaire\n4 - 2 weeks after 3, letter with URL (50% of the pilot sample will also receive a paper questionnaire as part of this communication while the other 50% will not)\n4.1 - SMS with URL link for online questionnaire 3 days later\n\nThe control group will receive the same number and style of contacts as the current 2019 survey approach:\nContact - Details\n1 - Letter with paper questionnaire\n2 - Reminder with paper questionnaire\n3 - Reminder with paper questionnaire\n\nThe pilot differs to the main survey as it will collect mobile phone numbers for contact and the postcode information will be used for the analysis (e.g. as a deprivation indicator). All patients will be included in the pilot regardless of whether they have a valid mobile phone number as a key analysis point for the pilot is to understand how many Trusts hold this data on their patients.\nInitially 16 trusts will be approached with the aim of 10 trusts being recruited for participation in the pilot. Survey preparations are expected to begin in May and fieldwork in August-October. Pilot trusts will draw a sample of patients according to set criteria and follow standardised materials and procedures for all stages of the survey, aiming to mirror the approach used in the mainstage of the NPSP. Ipsos MORI will conduct the pilot including fieldwork on behalf of all pilot trusts. This will reduce the risks to data quality and ensure that the pilot is completed in a timely manner.\nThe Caldicott Guardian from each trust will be required to sign a sampling checklist in order to minimise the likelihood of mailing details being sent to the Picker Institute (who remain a Coordination Centre for surveys where only paper questionnaires are used). The sampling checklist and declaration should be completed prior to sending the sample files to Ipsos MORI. Ipsos MORI will not open a sample file until a satisfactory sampling checklist has been received.\nThe end product from this survey will be a set of aggregate statistical data that does not contain confidential patient information. This statistical dataset will be primarily used to investigate whether a permanent move to a mixed method research approach is appropriate for the Adult Inpatient survey longer term.\nA recommendation for class 5 and 6 support was requested to cover activities as described in the application."]
["Applicant Organisation Name","Care Quality Commission"]
["Contact Name","Ms Laura Thomas, Research Director"]
["Address","Ipsos MORI"]
[null,"3 Thomas More Square"]
[null,"London"]
["Postcode","E1W 1YW"]
["Telephone","020 3059 4717  "]
["Email","laura.thomas@ipsos.com"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"x","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Inpatients aged 16 years old or over who were discharged from acute and specialist NHS hospitals in June (and earlier for smaller trusts), having had one overnight stay in hospital across 10 participating Trust in England. 1250 patients will be included per Trust from those patients discharged during June 2019. The following exclusion criteria will be applied to the sample:\n• deceased patients,\n• children or young persons aged under 16 years at the time of sampling,\n• obstetrics/maternity service users, including spontaneous miscarriages,\n• patients admitted for planned termination of pregnancy,\n• psychiatry patients,\n• day cases,\n• private patients (non-NHS),\n• any patients who are known to be current inpatients patients without a UK postal address,\n• any patient known to have requested their details are not used for any purpose other than their clinical care, including those responding to posters displayed on hospital wards referring to the survey (the survey instructions request that all responses to posters are logged and used for this purpose)."]
["Description of confidential patient information used","Data sources - 1. Electronic Health records within participating Trusts.\n\nIdentifiers required for linkage purposes:\n1. Trust code\n2. A standardised unique identifier code, to be constructed as survey identifier\n3. Title\n4. First name\n5. Surname\n6. Address Fields\n7. Postcode (where available)\n8. Mobile telephone number\n\nIdentifiers required for analysis purposes:\n1. The unique identifier code (as above)\n2. Admission/discharge dates\n3. Length of stay (this is calculated from the admission and discharge dates)\n4. Whether admission from Treatment Centre\n5. Route of admission\n6. NHS Site code on admission and discharge\n7. Ethnicity\n8. Gender\n9. Year of birth\n10. Deprivation score\n11. ICD-11 code"]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Expired"]
[]
["Next Review Date","2021-08-21"]
["Notes","10 November 2021 - Support expired\nThe applicant confirmed that support was no longer required.\n\nConditions of support:\n1. The use of confidential patient information without consent for the purposes of the survey should be explored as part of the planned patient engagement activity. Feedback on the activity, together with an overview of the views expressed by patients, should be provided for consideration by the CAG at an interim report within six months of the date of this outcome.\nCondition confirmed as met, 02 November 2020.\n\n2. Confirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. See section below titled ‘security assurance requirements’ for further information (Confirmed – Ipsos MORI DSPT submission has a ‘Standards Met’ grade confirmed by NHS Digital email 13 July 2019)."]

{"sheet":"A0991","index":158,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A0991"]
["Reference","19/CAG/0083 "]
["Other Refs"]
["Application Title","National Clinical Audit of Psychosis"]
["Application Summary","This application from the Healthcare Quality Improvements Partnership, set out the purpose of clinical audit which aims to provide those who commission, deliver and use services for people with psychosis with high quality data on the process and outcomes of NHS care. Healthcare Quality Improvements Partnership has commissioned the Royal College of Psychiatrists to undertake the audit on its behalf.\nThe application is also supported by NHS England and NHS Digital and aims to move from a system whereby clinical teams enter pseudonymised information into bespoke online database, to one which is based on secondary analysis of data that Trusts currently submit to NHS Digital as part of the Mental Health Services Data Set (MHSDS).\nThis application is seeking support to enable the Royal College of Psychiatrists (RCPsych) to collect confidential patient information from organisations in England providing Early Intervention Psychosis services in 2019 that will be matched with data from the Mental Health Service Dataset, collected by NHS Digital to establish whether, in future years of the audit, a system can be implemented that will be entirely based on secondary analysis of data already submitted to NHS Digital.\nThe first phase of this plan will involve checking the completeness and validity of data submitted to MHSDS against clinical data submitted directly to the audit team on a random sample of people with psychosis who are receiving care provided by an Early Intervention in Psychosis (EIP) team. The applicant is also seeking support to link information on the quality of care people in the audit receive with data on subsequent use of inpatient and emergency medical services from MHSDS and HES held by NHS Digital.\nA recommendation for class 4, 5 and 6 support was requested to cover activities as described in the application."]
["Applicant Organisation Name","Healthcare Quality Improvements Partnership"]
["Contact Name","Ms Beatrice Tooke, Programme Manager "]
["Address","Royal College of Psychiatrists,"]
[null,"21 Prescot Street,"]
[null,"London"]
["Postcode","E1 8BB"]
["Telephone","0203 701 2602"]
["Email","beatrice.tooke@rcpsych.ac.uk "]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"x","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Patients aged 14 – 65 with First Episode Psychosis (FEP) on the caseload of an Early Intervention Psychosis team for six months or more on the census date: 01/04/2019. A maximum 100 patients per team will be included which will be identified by random sample by NCAP team. Patients will be identified across 154 teams within 57 organisations."]
["Description of confidential patient information used","The following items of confidential patient information are requested:\n• NHS number – for sample validation and linkage,\n• Postcode – for sample validation and linkage,\n• Date of Birth – for sample validation and linkage,\n• Year of birth – analysis,\n• Sex – analysis,\n• Ethnicity – analysis."]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Expired"]
[]
["Next Review Date","2019-08-20"]
["Notes","13 September 2020 - Application expired as change in controllership from solely HQIP to joint controllership between HQIP and NHS England. New application established under reference 20/CAG/0105.\n\nConditions of support:\n1. Support extends to the non-research audit purposes described in the application only. There is no support for any research purposes under this application reference. \n2. Confirmation from the IG Delivery Team at NHS Digital of suitable security arrangements via Data Security and Protection Toolkit (DSPT) submission (Confirmed – NHS Digital and the Royal College of Psychiatrists (12/08/2019) have received ‘Standards Met’ grade)"]

{"sheet":"A0992","index":159,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","A0992"]
["Reference","19/CAG/0137"]
["Other Refs"]
["Application Title","National Cancer Patient Experience Survey 2019"]
["Application Summary","This application from NHS England set out the purpose of administering patient surveys to evaluate services provided to cancer patients in 2019. This would enable comparisons between Trusts, for commissioners, providers and patients (all of whom could access the published results), would allow for monitoring of improvements in services, drive further improvements, and provide NHS England with an up to date overview of cancer patient experience across England.\nThe purpose of collecting and analysing data via this survey is to:\n• Secure continuous improvement by building on the results of previous surveys, enabling local providers and Cancer Alliances to assess their performance improvement with other providers,\n• Enable commissioners to assess local improvements in cancer patient experience,\n• Provide NHS England and NHS Improvement with an up to date overview of cancer patient experience across England,\n• Provide NHS England and NHS Improvement with data on each participating Trust and the areas on which quality improvement needs to be focused,\n• Enable patients to make informed choices about where to go for cancer treatment via publishing the provider level analysis on publicly available websites.\nThe Cancer Patient Experience Survey (CPES) 2019 fieldwork period will begin at the end of September 2019 and there is an aspiration to close fieldwork in January 2020, rather than at the end of March as in previous years, to enable more timely reporting of outputs.\nA recommendation for class 1, 4, 5 and 6 support was requested to cover access to the relevant unconsented activities as described in the application."]
["Applicant Organisation Name","NHS England"]
["Contact Name","Jenny King - Chief Research Officer"]
["Address","Picker Institute Europe, Buxton Court"]
[null,"3 West Way"]
[null,"Oxford "]
["Postcode","OX2 0JB"]
["Telephone","01865 208130"]
["Email","jenny.king@pickereurope.ac.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"x","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","All adult patients (aged 16 and over), with a primary diagnosis of cancer, who have been admitted to hospital as inpatients for cancer related treatment, or who were seen as day case patients for cancer related treatment and were discharged between 1st April 2019 and 30th June 2019 would be included in the survey. This is estimated to cover 125,000 cancer patients.\nData Source - Electronic patient records at participating Trusts in England"]
["Description of confidential patient information used","Identifiers required for linkage purposes:\n1. Name\n2. NHS number\n3. Full address\n4. Sex\n5. Ethnic group\n6. Date of birth\n7. ICD10 code\n8. Admission and discharge dates\n9. Speciality code\n10. Referring CCG\n11. Admission type\n12. Site treated at.\n\nIdentifiers required for analysis purposes\n1. Sex\n2. Age\n3. Ethnic group\n4. ICD10 code\n5. Admission and discharge dates\n6. Speciality code"]
["S251 Class(es)",null,"Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Expired"]
[]
["Next Review Date","2022-09-10"]
["Notes","Old applications for the National Cancer Patient’s Experience survey: Acute and Specialist trust surveys of inpatients and day cases.\n\nThe currently supported reference is 21/CAG/0084\n\nApplicant confirmed in September 2022 that ‘s251’ support can be expired as all confidential patient information has been deleted.\n\nIn terms of public benefit, data from the survey are used to monitor the quality of care given to patients and to support ongoing improvement within cancer care. This data is vitally important to understand not only the wider experience of this patient population but to identify what improvements can be made at trust, cancer alliance and integrated care system level.\n\n02 February 2021 - Amendment supported\nThe amendment, to extend the duration of confidential patient information arrangements until 31 August 2022 to allow a 2020 national Cancer Patient Experience survey to be administered on a voluntary basis, and to include the collection of ICD-11 codes, is supported, subject to compliance with the standard conditions of support.\n\nConditions of support:\n1. Confirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. (Confirmed – Picker Institute Europe (by NHS Digital email 17 July 2019) and Greens Limited (by NHS Digital email dated 01 October 2019) have confirmed ‘Standards Met’ grade on DSPT 2018/19).\n"]

{"sheet":"A0993","index":160,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A0993"]
["Reference","19/CAG/0176"]
["Other Refs"]
["Application Title","All Wales Perinatal Survey (Historic data - 1993 to 2012)"]
["Application Summary","This application from Public Health Wales NHS Trust set out the non-research purpose of preventative medicine which aims to establish longer-term retention arrangements for the historic dataset of the All Wales Perinatal Survey (AWPS), which collected surveillance information on perinatal and infant deaths in Wales from 1993 to 2012.\nThe AWPS was established in 1993 as a continuous surveillance of perinatal and infant mortality. It collected and reported on data on all babies who died in Wales from 20 weeks of pregnancy to one year of age. These data were collected to provide Obstetricians, Paediatricians and parents with robust information about survival and prognosis of pre-term and low birthweight babies and were used to report on population trends in perinatal and infant mortality and investigate variations in rates between service providers.\nThe survey tried to gain full ascertainment of babies that were pre-term, low birthweight involved in transfers, received intensive care, had severe morbidity or died. AWPS collected its own data, and sources of information included: post mortem reports, death certificates, clinic letters, National Community Child Health Database (NCCHD), Patient Episode Database Wales (PEDW), ONS data and Welsh Demographic Service data.\nData collection ceased in December 2012, following which the responsibility for collecting this information was taken over by the MBRRACE-UK surveillance. This arrangement continued until June 2018 when the All Wales Perinatal Survey was ceased.\nThe AWPS dataset is currently held by Cardiff University and is supported under reference ECC 4-15(h)/2009. Funding for the collection and retention of the data held in this dataset by Cardiff University ceased in 2018. This application for support under the Regulations will legitimise the physical transfer of the dataset and acknowledge the change in controllership arrangements for the data to come under the responsibility of Public Health Wales NHS Trust. The onward retention of the dataset by Public Health Wales will enable use of the historic surveillance data to inform understanding long-term trends in perinatal and infant deaths. The ongoing retention will also ensure that clinicians can continue to access the data relating to their own service between 1993 and 2012.\nA recommendation for class 1, 4, 5 and 6 support was requested to cover access to the relevant unconsented activities as described in the application."]
["Applicant Organisation Name","Public Health Wales"]
["Contact Name","Ms. Rosalind Reilly, Consultant in Public Health"]
["Address","Public Health Wales, Floor 5, "]
[null,"2 Capital Quarter, Tyndall Street, "]
[null,"Cardiff "]
["Postcode","CF10 4BZ"]
["Telephone",2921674942]
["Email","Rosalind.reilly@wales.nhs.uk"]
["Medical Purposes","Y","preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,null,"the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Babies who died from 20 weeks gestation to one year of age, born to mothers who were usually resident in Wales, or whose baby died in a Wales between 1993 and 31 December 2012 hospital to include:\n• Spontaneous miscarriage – foetal death before 24 weeks gestation,\n• Therapeutic abortion – therapeutic late foetal deaths before 24 weeks gestation,\n• Still births – late foetal deaths after 24 weeks gestation,\n• Neonatal deaths – death in the first 27 completed days of life,\n• Infant deaths – deaths at ages under 1 year of age."]
["Description of confidential patient information used","Data sources\n1. All Wales Perinatal Survey dataset, Cardiff University\nIdentifiers required for linkage purposes\nThe following details for the infant will be utilised for linkage purposes:\n1. Forename and surname\n2. Date of birth\n3. Date of death\n4. NHS Number\nIdentifiers required for analysis purposes\nThe following details will be retained for the infant’s mother:\n1. Forename and surname\n2. Full address and postcode\n3. Date of birth\n4. Hospital number\n5. NHS Number\n6. Marital status\n7. Country of birth\n8. Ethnicity\n9. Last employment\n10. Employment status\n11. Medical history\nThe following details will be retained for the infant’s father:\n12. Surname\n13. Last employment\n14. Employment status\nThe following details will be retained for the infant:\n15. Forename and surname\n16. Date of birth\n17. Date of death\n18. NHS Number\nAdditional information\nThe proposed linkage is dependent upon the linked application 19/CAG/0177 for the Child Death Review Programme receiving a recommendation of support."]
["S251 Class(es)",null,"Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2023-11-01"]
["Notes","Specific conditions of support:\n1. Provide a copy of the patient-facing website text for review. This should be submitted within two months of the date of this outcome letter and will be considered by a sub-committee of the CAG. Condition met\n2. Support is recommended for a one-year duration on the basis of the information described in the application. The following specific points need to be addressed within the first annual review which will be considered by the full CAG:\na) Provide confirmation that confidential patient information and clinical information has been separated, with a linkage key held to link the datasets.\nb) An assessment of all data items retained in the database should be undertaken to confirm the requirement for ongoing retention. A detailed overview should be provided of the justification for each data item which will be retained in the dataset.\nCondition met\n3. Support extends to non-research purposes only. Any proposed research activity involving the dataset would require the submission of a separate application to the CAG for these purposes.\n4. Confirmation provided from NHS Wales Informatics Service of the ongoing security assurance. Confirmed – NWIS have confirmed the CPIP assurance report for Public Health Wales NHS Trust which has achieved a 96% assurance score."]

{"sheet":"A0994","index":161,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","A0994"]
["Reference","19/CAG/0180"]
["Other Refs"]
["Application Title","CQC 2019/20 Children and Young People’s Patient Experience Survey – Mixed Method Standalone Pilot"]
["Application Summary","This application submitted by Ipsos MORI on behalf of the Care Quality Commission, set\nout the purpose of carrying out a pilot study to test mixed methods of distribution of the\n2019/20 Children and Young People’s Patient Experience Survey (CYP).\nThe National Patient Survey Programme (NPSP) was initiated in 2002 by the then\nDepartment of Health and is now overseen by the Care Quality Commission (CQC), the\nindependent regulator of health and social care in England. The CYP survey was first\ncommissioned in 2014. The CQC have commissioned Ipsos MORI to manage and\ncoordinate surveys within the NPSP under the title of the Survey Coordination Centre for\nmixed survey methods. 39 Trusts will be approached with the aim to recruit between 20-\n25 Trusts to take part in the survey.\n\nThe pilot will be conducted at a different fieldwork period to the mainstage survey, and\nwill involve a different survey method (mixed method and SMS invitations) and revised\nsurvey materials (covering letters and reminders). Due to the differences in approach,\ntimings, materials and Co-ordination Centre a separate application has been submitted\nfor this pilot. The CYP pilot study will also include a control sample, as due to the\ndifference in fieldwork timings it will not be possible to use the 2018/19 CYP mainstage\nfieldwork as a control. The pilot differs to the main survey as it will collect mobile phone\nnumbers for contact and the postcode information will be used for the analysis (e.g. as a\ndeprivation indicator). This follows the precedent set by the 2019 Maternity Survey,\nwhich recently received support to use full postcode for deprivation analysis\n(19/CAG/0021). A similar approach received support under the Regulations for the 2019\nAdult Inpatient Pilot (19/CAG/0102).\n\nThe following approaches will be made to patients within the pilot:\nPilot Group\nContact - Details\n1 - Letter with URL link for online questionnaire\n1.1 - SMS despatched 3 days later with URL link for online questionnaire\n2 1 - week after 1, letter with URL\n2.2 - SMS with URL link for online questionnaire despatched 3 days later\n3 - 2 weeks after 2, letter with URL and mail questionnaire\n4 - 2 weeks after 3, letter with URL (50% of the pilot sample will also receive a paper questionnaire as part of this communication while the other 50% will not)\n4.1 - SMS with URL link for online questionnaire 3 days later\nThe control group will receive the same number and style of contacts as the current 2019 survey approach:\nContact - Details\n1 - Letter with paper questionnaire\n2 - Reminder with paper questionnaire\n3- Reminder with paper questionnaire\n\nIn line with the mainstage survey methodology, the CYP pilot will use three separate questionnaires, with each developed to meet the needs of the target age group. Questionnaires sent to those aged 8-11 and 12-15 will have a short section for the child or young person to complete themselves, and a separate section for their parent or carer to complete. Where a child is aged 0-7, the questionnaire will be completed entirely by their parent or carer.\n\nA recommendation for class 5 and 6 support was requested to cover access to the relevant unconsented activities as described in the application."]
["Applicant Organisation Name","Ipsos MORI on behalf of the Care Quality Commission"]
["Contact Name","Ms Laura Thomas, Research Director"]
["Address","Ipsos MORI"]
[null,"3 Thomas More Square"]
[null,"London"]
["Postcode","E1W 1YW"]
["Telephone","020 3059 4717 "]
["Email","Laura.thomas@ipsos.com "]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"x","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Patients aged between 15 days and 15 years (inclusive) who were discharged from hospital between September-November 2019, across 39 Trusts in England. 25,000 patients will be recruited across the full survey pilot.\nExclusions:\n• Patients who were not admitted (e.g. ward attendees or patients who attended an outpatient appointment, but were not admitted)\n• Deceased patients\n• Persons aged over 16 years at the time of their discharge\n• Babies aged between 0 and 14 days at the time of their discharge\n• New-born babies where the mother was the primary patient (i.e. well babies, treatment function code 424)\n• Patients who were only admitted to a Neonatal Intensive Care Unit (NICU) or a Special Care Baby Unit (SCBU)\n• Obstetrics/maternity service users, including spontaneous miscarriages\n• Patients admitted for planned termination of pregnancy\n• Psychiatry patients, including CAMHS\n• Private patients (non-NHS)\n• NHS patients treated at private hospitals\n• Any patients who are known to be current inpatients\n• Patients without a UK postal address\n• Any patient known to have requested their details are not used for any purpose other than their clinical care, including those responding to posters displayed on hospital wards referring to the survey (the survey instructions request that all responses to posters are logged and used for this purpose, and that trusts also consult dissent logs from previous CYP surveys and exclude patients who asked to be removed from those surveys as well)."]
["Description of confidential patient information used","Data sources\n1. Electronic patient records within acute and specialist Trusts in England\nIdentifiers required for linkage purposes\n1. Trust code\n2. A standardised unique identifier code,\n3. Title (Mr, Mrs, Ms, etc.)\n4. First name or initial\n5. Surname\n6. Address Fields\n7. Postcode (where available)\n8. Mobile telephone number (either childs or parents)\nIdentifiers required for analysis purposes\n1. The unique identifier code (as above)\n2. Admission/discharge dates\n3. Length of stay (this is calculated from the admission and discharge dates).\n4. Main specialty code on discharge\n5. Treatment function code\n6. IC10 or IC11 codes\n7. CCG code\n8. Whether admission from Treatment Centre\n9. Route of admission\n10. NHS Site code on admission and discharge\n11. Ethnicity\n12. Gender\n13. Year and month of birth\n14. Postcode (this will be used to calculate deprivation and then securely deleted)"]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Expired"]
[]
["Next Review Date","2021-11-18"]
["Notes","10 November 2021 - Support expired\nThe applicant confirmed that support was no longer required.\n\nConditions of support: \n1. The feasibility of including an opt-out mechanism within the text message reminders should be explored during this iteration of the survey and used to inform the next submission. \n2. Detailed feedback from the interviews being undertaken as part of the wider user involvement plan for the pilot survey should be provided as part of the next survey iteration. This should include details of how the views expressed had been incorporated into the survey methodology. It is recommended that views are sought as part of this activity around the necessity to include an opt-out mechanism within text message reminders. \n3. Publication of the survey findings should also include feedback on the findings of the piloting of the mixed methods, together with the survey results. \n4. Confirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. Confirmed: Ipsos MORI ‘Standards Met’ confirmed on DSPT 2018/19 by NHS Digital email 13 July 2019.  "]

{"sheet":"A0995","index":162,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","A0995"]
["Reference","19/CAG/0181"]
["Other Refs"]
["Application Title","CQC 2019/20 Maternity Survey – Mixed Methods Standalone Pilot"]
["Application Summary","This application submitted by Ipsos MORI on behalf of the Care Quality Commission, set out the purpose of carrying out a pilot study to test mixed methods of distribution of the 2019/20 Maternity Survey – Mixed Methods Standalone Pilot.\n\nThe National Patient Survey Programme (NPSP) was initiated in 2002 by the then Department of Health and is now overseen by the Care Quality Commission (CQC), the independent regulator of health and social care in England. The Maternity survey was first commissioned in 2007. The CQC have commissioned Ipsos MORI to manage and coordinate surveys within the NPSP under the title of the Survey Coordination Centre for mixed survey methods. 35 Trusts will be approached with the aim to recruit between 20-25 Trusts to take part in the survey.\nThe pilot will be conducted at a different fieldwork period to the mainstage survey, and will involve a different survey method (mixed method and SMS invitations) and revised survey materials (covering letters and reminders). Due to the differences in approach, timings, materials and Co-ordination Centre a separate application has been submitted for this pilot. The maternity pilot study will also include a control sample, as due to the difference in fieldwork timings it will not be possible to use the 2019 or 2020 Maternity mainstage fieldwork as a control. The pilot differs to the main survey as it will collect mobile phone numbers for contact and the postcode information will be used for the analysis (e.g. as a deprivation indicator). This follows the precedent set by the 2019 Maternity Survey, which recently received support to use full postcode for deprivation analysis (19/CAG/0021). A similar approach received support under the Regulations for the 2019 Adult Inpatient Pilot (19/CAG/0102).\n\nThe following approaches will be made to patients within the pilot:\nPilot Group\nContact - Details\n1 - Letter with URL link for online questionnaire\n1.1 - SMS despatched 3 days later with URL link for online questionnaire\n2 - 1 week after 1, letter with URL\n2.2 - SMS with URL link for online questionnaire despatched 3 days later\n3 - 2 weeks after 2, letter with URL and mail questionnaire\n4 - 2 weeks after 3, letter with URL (50% of the pilot sample will also receive a paper questionnaire as part of this communication while the other 50% will not)\n4.1 - SMS with URL link for online questionnaire 3 days later\n\nThe control group will receive the same number and style of contacts as the current 2019 survey approach:\nContact - Details\n1 - Letter with paper questionnaire\n2 - Reminder with paper questionnaire\n3 - Reminder with paper questionnaire\n\nA recommendation for class 5 and 6 support was requested to cover access to the relevant unconsented activities as described in the application."]
["Applicant Organisation Name","Ipsos MORI on behalf of the Care Quality Commission"]
["Contact Name","Ms Laura Thomas, Research Director"]
["Address","Ipsos MORI"]
[null,"3 Thomas More Square"]
[null,"London"]
["Postcode","E1W 1YW"]
["Telephone","020 3059 4717 "]
["Email","Laura.thomas@ipsos.com "]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"x","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Women aged 16 years or over at the time of delivery, who gave birth under the care of an NHS trust (including home births), in October and November 2019.\nExclusions:\n• Women whose baby had died during or since delivery\n• Women who had a stillbirth (including where it occurred during a multiple delivery)\n• Women who were in hospital or whose baby was in hospital at the time the sample was drawn\n• Women who had a concealed pregnancy\n• Women whose baby was taken into care (foster care or adopted)\n• Women who gave birth in a maternity unit managed by another provider or in a private maternity unit or wing\n• Women who died during the birth, or who have died since the birth\n• Women aged under 16 years at the time of their delivery\n• Patients admitted for planned termination of pregnancy\n• Psychiatry patients, including CAMHS\n• Private patients (non-NHS)\n• Any patients who are known to be current inpatients\n• Patients without a UK postal address\n• Any patient known to have requested their details are not used for any purpose other than their clinical care, including those responding to posters displayed on hospital wards referring to the survey (the survey instructions request that all responses to posters are logged and used for this purpose, and that trusts also consult dissent logs from previous Maternity Service surveys and exclude patients who asked to be removed from those surveys as well)."]
["Description of confidential patient information used","Data sources\n1. Electronic patient records within Trusts in England\nIdentifiers required for linkage purposes\n1. Trust code\n2. A standardised unique identifier code,\n3. Title (Mrs, Ms, etc.)\n4. First name\n5. Surname\n6. Address Fields\n7. Postcode (where available)\n8. Mobile telephone number\nIdentifiers required for analysis purposes\n1. The unique identifier code (as above)\n2. Ethnicity\n3. Day of delivery\n4. Month of delivery\n5. Year of delivery\n6. Actual delivery place\n7. NHS Site code\n8. CCG Code\n9. Postcode (used to calculate deprivation and then securely deleted)"]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Expired"]
[]
["Next Review Date","2020-11-18"]
["Notes","10 November 2021 - Support expired\nThe applicant confirmed that support was no longer required. \n\nConditions of support:\n1. The feasibility of including an opt-out mechanism within the text message reminders should be explored during this iteration of the survey and used to inform the next submission. \n2. Detailed feedback from stakeholder consultation undertaken as part of the wider user involvement plan for the pilot survey should be provided as part of the next survey iteration. This should include details of how the views expressed had been incorporated into the survey methodology. \n3. Publication of the survey findings should also include feedback on the findings of the piloting of the mixed methods, together with the survey results. \n4. Confirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. Confirmed: Ipsos MORI ‘Standards Met’ confirmed on DSPT 2018/19 by NHS Digital email 13 July 2019.  "]

{"sheet":"A0996","index":163,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A0996"]
["Reference","19/CAG/0206"]
["Other Refs"]
["Application Title","2020 Community Mental Health Survey"]
["Application Summary","This non-research application from Picker, CQC and NHS England set out the purpose of administering the 2019 Community Mental Health Survey, to gauge patient experience and views of the service they received. A recommendation of support was requested to enable the transfer of patient identifiable data from mental health providers, to an approved survey contractor for the purpose of mailing out questionnaires. The vast majority of trusts involved were expected to opt to use an approved survey contractor, either: Picker Institute Europe, Quality Health and Patient Perspective. \n\nThe 2020 community mental health survey will be the seventeenth iteration of a mental health survey carried out. All 56 eligible mental health provider trusts will be asked to conduct the survey, drawing a sample of service users according to set criteria, and following standardised materials and procedures for all stages of the survey. The aim was to ensure organisations carry out patient surveys in a consistent and systematic way, using a standardised methodology and survey instrument, to build up a national picture of people’s experience. \n\nThe end product from this survey will be a set of aggregate statistical data that does not contain patient identifiable information. This statistical dataset is used for a wide variety of purposes to support ongoing improvement in overall patient experience by NHS Trusts and CCGs and by CQC, to inform its regulatory functions. \n\nNHS Patient Survey Programme\n\nThis survey is part of the NHS Patient Survey Programme, and as such follows the same methodology as other surveys within the programme. The methodology is approved in principle by the CAG, and applications are usually considered via the Precedent Set pathway. \n\nA recommendation for class 1, 4, 5 and 6 support was requested to cover access to the relevant unconsented activities as described in the application."]
["Applicant Organisation Name","Picker, CQC and NHS England "]
["Contact Name","Ms Jenny King, Chief Research Officer"]
["Address","Picker Institute Europe"]
[null,"Buxton Court"]
[null,"3 West Way, Oxford"]
["Postcode","OX2 0B"]
["Telephone","01865 208130"]
["Email","jenny.king@pickereurope.ac.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"x","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Patients aged 18 and over who had been in contact with NHS mental health services in the three-month period from 1 September to 30 November 2019, and who were receiving specialist care or treatment for a mental health condition, including those who receive care under the Care Programme Approach (CPA). "]
["Description of confidential patient information used","Data sources\n1.\tElectronic patient records, Mental Health Trusts in England \nIdentifiers required for linkage purposes\n1.\tTrust code\n2.\tA standardised unique identifier code, \n3.\tTitle (Mr, Mrs, Ms, etc.) \n4.\tFirst name \n5.\tSurname \n6.\tAddress Fields \n7.\tPostcode \nIdentifiers required for analysis purposes\n1.\tTrust code\n2.\tThe unique identifier code (as above)\n3.\tYear of birth \n4.\tGender \n5.\tEthnic category \n6.\tDay of last contact \n7.\tMonth of last contact \n8.\tYear of last contact \n9.\tCPA status \n10.\tCCG code\n11.\tMental Health Care Cluster Codes\n12.\tMobile phone indicator"]
["S251 Class(es)",null,"Specific Support"]
[null,"X","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"X","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"X","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"X","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Expired"]
[]
["Next Review Date"]
["Notes","Applicant confirmed in January 2022 that ‘s251’ support can be expired as all data have been pseudonymised. Names and addresses of the people sent the CMH20 survey have been deleted by the contractor(s) and in house trust who managed the sending out of the questionnaires.\n \nIn terms of public benefit, the systematically collected quantitative data from community mental health service user experience surveys are used to monitor the quality of care given to service users, at trust level and nationally, and to support ongoing improvement within community mental health care settings. \n\nConditions of support:\n\n1.\tContinual achievement of ‘Standards Met’ in relation to the relevant DSPT submission (or any future security assurance changes) for the duration of support. Evidence to be provided (through NHS Digital confirmation they have reviewed and confirmed the DSPT submission as standards met’ for the duration of support, and at time of each annual review. Confirmed: Picker Institute Europe, Quality Health and Patient Perspective all have confirmed ‘Standards Met’ on DSPT 2018/19 (checked on DSPT tracker 23/10/2019)"]

{"sheet":"A0997","index":164,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A0997"]
["Reference","19/CAG/0145"]
["Other Refs","previously CR9/2014"]
["Application Title","Transfusion Medicine Epidemiology Review"]
["Application Summary","This application from the University of Edinburgh set out the non-research purpose of a public health surveillance review to determine whether Creutzfeldt–Jakob is transmissible through blood transfusion. This application has existing support under application reference CR9/2014.\nTransmission of CJD via blood transfusion is an important public health issue, particularly since the advent of variant CJD (vCJD). Three cases of vCJD and one sub-clinical infection have been linked to transfusion transmissions through this study so far.\nThe refreshed application set out the request for revisions to the scope of support which is in place for the activity. Previously, identifiers from all individuals with definite or probable variant CJD eligible to donate blood were notified to the four blood services within the UK to check whether the individual had donated. For other forms of CJD, identifiers were only forwarded from those with a history of blood donation reported by a surrogate witness. This information cannot be directly collected from the patient due to the nature of their illness. The revised protocol standardises the procedure for other forms of CJD to that which is in place for vCJD, so that the blood services are notified of all cases of other forms of CJD. This change is being made as an audit of the accuracy of the history of blood donation found that not all patients who had donated blood were reported as doing so by a surrogate witness. There were potential public health implications in not identifying all cases of patients with CJD who also donated blood.\nThe NCJDRSU will also ascertain whether any of the identified donors or recipients were known to have died from CJD. If so, data from the NCJDRSU unit on cases of CJD/vCJD will be linked to data from the national blood services who provide details of recipients/donors to these CJD/vCJD cases. Details of these recipients/donors are then sent to NHS Digital for flagging.\nSupport was also sought to enable review of the medical records of any flagged donors or recipients who had ‘dementia’ listed as a cause of death on their death certificate, in order to identify those who may have died from CJD or vCJD but were not diagnosed in life. The death certificates will be obtained via NHS Digital, and the Hospital and GP records will be requested via the medical records departments of the hospitals or primary care providers. Copies of the records will be requested and an NCJDRSU clinician will review the records to establish whether the patient could have been suffering from CJD/vCJD according to the established diagnostic criteria for CJD. The notes will then be destroyed.\nData from the NCJDRSU unit on cases of CJD/vCJD is linked to data from the national blood services who provide details of recipients/donors to these CJD/vCJD cases. Details of these recipients/donors are sent to NHS Digital for flagging. This flagging exercise was previously undertaken with the then HSCIC under the class action application."]
["Applicant Organisation Name","University of Edinburgh"]
["Contact Name","Miss Jan Mackenzie\nNational CJD Research and Surveillance Unit, Bryan Matthews\nWestern General Hospital\nEdinburgh"]
["Address","National CJD Research and Surveillance Unit, Bryan Matthews"]
[null,"Western General Hospital"]
[null,"Edinburgh"]
["Postcode","EH4 2XU"]
["Telephone","0131 537 2150"]
["Email","janet.mackenzie1@nhs.scot or jan.mackenzie@ed.ac.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"x","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Individuals included in this cohort are:\na) people who have received blood components from donors who were later identified as suffering from CJD/vCJD,\nb) people whose donated blood components were transfused to persons later identified as suffering from CJD/vCJD.\nPatients have been recruited from 1997 onwards, and recruitment is ongoing. No new cases of vCJD have been identified since 2016.\n392 recipients and 745 donors have been recruited so far."]
["Description of confidential patient information used","Data sources\n1. The National Blood and Transplant Service\n2. The Welsh Blood Service\n3. NHS Digital\n4. GP records\n5. Hospital records\nIdentifiers required for linkage purposes\n1. Name\n2. Date of birth\n3. Sex\n4. Address and postcode at time of blood donation and transfusion\n5. Cause of death\n6. Date of death\nIdentifiers required for analysis purposes\n1. Name\n2. Date of birth\n3. Sex\n4. Address and postcode at time of blood donation and transfusion\n5. Cause of death\n6. Date of death\n7. Type of blood component transfused (red cells, platelets, etc)\n8. Date blood component donated\n9. Date of transfusion\n10. Hospital number\n11. Name of hospital where transfusion took place\n12. Summary reason for transfusion"]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,null,"Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2024-01-17"]
["Notes","Specific conditions of support\n1. Provide a report on the outcome of the advice received from NHS Digital regarding the handling of data belonging to patients who are resident in Wales when submitting the first annual review for the application.\n\nApplicant responded to this as part of the annual review provided in January 2021. The CAG Vice-chair was content with the response provided.\n\n2. Confirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. See section below titled ‘security assurance requirements’ for further information.\n\n(Confirmed: the University of Edinburgh (by NHS Digital email 09 October 2019) and National Blood and Transplant Service (by NHS Digital email 09 January 2020) have confirmed ‘Standards Met’ grade on DSPT 2018/19). "]

{"sheet":"A0998","index":165,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A0998"]
["Reference","19/CAG/0021"]
["Other Refs"]
["Application Title","Maternity Survey 2019"]
["Application Summary","This application from Picker Institute Europe, CQC and NHS England on behalf of all acute Trusts running eligible maternity services, set out the purpose of service evaluation which will be achieved through a patient survey in order to build up a national picture of women’s experiences of maternity care.  This will be the seventh maternity survey carried out to date and forms part of the NHS Patient Survey Programme. Preparations for the survey will begin in March 2019, with fieldwork expected to commence from the end of April 2019. \n\nSupport under the Regulations is sought for the transfer of confidential patient information from participating Trusts to the survey coordination centre to enable the facilitation of the survey invitation process. The survey methodology remains unchanged from that which was supported by the CAG for the 2018 survey; however, some additional variables will be included in the data extract disclosed by Trusts to the coordination centre, including complete patient postcode, to be used for deprivation scoring. 129 Trusts are expected to participate and will be asked to draw a patient sample according to set criteria and use standardised materials and procedures for all stages of the survey. \n"]
["Applicant Organisation Name","Picker Institute Europe"]
["Contact Name","Ms Jenny King"]
["Address","Picker Institute Europe "]
[null,"Buxton Court"]
[null,"3 West Way, Oxford"]
["Postcode","OX2 0JB"]
["Telephone","01865 208130"]
["Email","jenny.king@pickereurope.ac.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"x","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Patients who had a live birth in January or February 2019 and were aged 16 years or over at the time of delivery. Trusts are instructed to sample all eligible service users in February 2019. If this is fewer than 300 records they are asked to sample back from the last date in January to the beginning of January until they reach 350 records (in order to achieve a sample of 300 post-DBS checks). Trusts that do not have 300 eligible service users across February and January combined have the choice whether to participate in the survey. Specific exclusion criteria have been established which will be applied by the Trust prior to drawing the patient sample. "]
["Description of confidential patient information used","1. A mailing file which is used to address questionnaires to the appropriate person. It contains:\n\n•\tA unique identifier, \n•\tTitle,\n•\tFirst name,\n•\tSurname,\n•\tAddress Fields,\n•\tFull postcode.\n\n2. A sample file which is used to link demographic data to the survey responses, to aid analysis and to enable checks to be carried out for any errors in how the sample was drawn. It will also be used to enable the identification of service users who received antenatal and postnatal care directly from the trust. This file contains:\n\n•\tThe unique identifier code (as above),\n•\tSex,\n•\tMother’s year of birth,\n•\tMother’s ethnic group,\n•\tDelivery date (DD/MM/YY),\n•\tTime of delivery (for multiple births, this will be the time that the last baby is born),\n•\tNumber of babies born at delivery,\n•\tPlace of birth: NHS site code,\n•\tActual delivery place,\n•\tCCG code, \n•\tMother’s full postcode.  \n\n3. An attribution file which includes the sample file fields above and additional information relating to the provision of antenatal care or postnatal community care as follows:\n\n•\tAntenatal provider information,\n•\tPostnatal provider information,\n•\tPostcode sectors to which the Trust provides maternity services (ONLY if using the postcode method to complete the antenatal and postnatal provider information).\n\nFor clarity, please note that the Survey Coordination Centre does not receive any names or full addresses."]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"X","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"X","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Expired"]
[]
["Next Review Date","2021-03-15"]
["Notes","March 2022 - Support Expired\nApplicant confirmed March 2022 that support could be expired. All data have been pseudonymised. Names and addresses of the people sent the Maternity 2019 survey have been deleted by the contractor(s) and the four in house trusts who managed the sending out of the questionnaires. \n\nIn terms of public benefit, the \nsurvey data are used extensively by NHS trusts in their own improvement initiatives and CQC use it as part of their regulatory activities. NHS England and NHS Improvement use the results to understand experiences of maternity services, and may use the results to generate indicators at local, regional and national level. \n\n\nSpecific conditions of support (Final) \n1.\tConfirmation from the IGT Team at NHS Digital of suitable security arrangements via Information Governance Toolkit (IGT) submission (Confirmed - Picker Institute Europe, Quality Health and Patient Perspective – all have a published satisfactory reviewed grade on V14.1, 2017/18)."]

{"sheet":"A0999","index":166,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","A0999"]
["Reference","20/CAG/0016"]
["Other Refs"]
["Application Title","2020 Maternity Survey"]
["Application Summary","This application from the Care Quality Commission set out the purpose of service evaluation which will be achieved through a patient survey in order to build up a national picture of women’s experiences of maternity care.  \n\nSupport under Section 251 and its Regulations is sought for the transfer of confidential patient information from participating Trusts to the Survey Co-ordination Centre for Existing Methods (SCCEM), to enable the facilitation of the survey invitation process. The methodology for the 2020 survey is unchanged from the 2019 survey. The applicants received support under Section 251 in 2019 to allow the transfer of full postcodes or sample members and trust-held antenatal and postnatal attribution information on sample members from trusts directly to the Survey Co-ordination Centre for Existing Methods. Support was also given for the sharing of this data with approved contractors by the SCCEM, which enabled them to provide an extra level of data insight to trusts. \n\nThis will be the eighth maternity survey carried out to date and forms part of the NHS Patient Survey Programme (NPSP). Preparations for the survey will begin in March 2020, with fieldwork expected to commence from the end of April 2020. 126 trusts are expected to be involved. All trusts will draw a sample of patients according to set criteria and follow standardised materials and procedures for all stages of the survey. The current model for the NPSP is a devolved model where participating trusts can either undertake the implementation of the survey themselves or they can appoint one of the approved contractors from the CQC framework. The flow of data and what is processed will vary depending on whether a trust undertakes the survey themselves or not. If a Trust undertakes the survey themselves, the SCCEM is the main centre for assisting and supporting the trusts. SCCEM will issue sampling materials for a trust to use to draw their sample correctly, send the sample for deceased checks and how to submit an anonymised file for checking. For trusts using an approved contractor, the SCCEM will also remain as the main centre for assisting trusts, however the main liaison will happen between the SCCEM and the approved contractor. The applicants anticipate that most trusts will opt to use an approved contractor."]
["Applicant Organisation Name","Care Quality Commission"]
["Contact Name","Tamatha Webster"]
["Address","151 Buckingham Palace Road  "]
[null,"London "]
[]
["Postcode","SW1W 9SZ "]
["Telephone"," 03000 616161"]
["Email"," Tamatha.Webster@cqc.org.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"x","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Service users who had a live birth in January or February 2020, and were aged 16 years and over at the time of delivery. Trusts are instructed to sample all eligible service users in February 2020. If this is fewer than 300 records they are asked to sample back from the last date in January to the beginning of January or until they reach 350 records (in order to achieve a sample of 300 post-DBS checks)."]
["Description of confidential patient information used","Data Sources \n\n1.\t126 participating trusts \n\nIdentifiers required for linkage purposes \n\n1.\tA unique identifier code\n2.\tTitle\n3.\tFirst name\n4.\tSurname\n5.\tAddress fields\n6.\tFull postcode  \n\nIdentifiers required for analysis purposes A sample file is used to link demographic data to the survey responses, to aid analysis and to enable checks to be carried out for any errors in how the sample was drawn. It will also be used to enable the identification of service users who received antenatal and postnatal care directly from the trust. This file contains:\n\n1.\tA unique identifier code \n2.\tGender\n3.\tMother’s year of birth\n4.\tMother’s ethnic group\n5.\tDay of delivery\n6.\tMonth of delivery\n7.\tYear of delivery\n8.\tTime of delivery (for multiple births, this will be the time that the last baby is born)\n9.\tNumber of babies born at delivery\n10.\tPlace of birth: NHS site code\n11.\tActual delivery place\n12.\tCCG code\n13.\tMother’s full postcode (or postcode sector if approval for the additional element is not granted)\n\n\n\nAn attribution file which includes the sample file fields above and additional information relating to the provision of antenatal care or postnatal community care as follows:\n\n•\tAntenatal provider information\n•\tPostnatal provider information\n•\tFull postcodes to which the trust provides maternity services (ONLY if using the postcode method to complete the antenatal and postnatal provider information).\n\nSubmission of an attribution file is optional for trusts though the majority of trusts choose to submit this information (in 2019, 118 out of 126 trusts chose to do so)."]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"X","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"X","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Expired"]
[]
["Next Review Date"]
["Notes","28 March 2022 - Support Expired\nThe applicant confirmed 28 March 2022 that support could be expired for the Maternity Survey 2020. The survey received ‘section 251’ support but was then cancelled by CQC before trusts were required to draw their patient samples. No data was transferred to the Survey Coordination Centre.\n\n23 June 2020 – Applicant confirmed that the 2020 survey was cancelled and that support was no longer required.\n\nSpecific conditions of support \n\nThe following sets out the provisional specific conditions of support. These may change in the final outcome letter depending on the responses to queries. \n\n\n1.\tConfirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. See section below titled ‘security assurance requirements’ for further information. (Confirmed: Patient Perspective (by NHS Digital email 30 July 2019), Picker Institute Europe (by NHS Digital email 17 July 2019) and Quality Health (by NHS Digital email dated 23 July 2019) have confirmed ‘Standards Met’ grade on DSPT 2018/19). "]

{"sheet":"A1000","index":167,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","A1000"]
["Reference","20/CAG/0067 (previously 16/CAG/0056)"]
["Other Refs"]
["Application Title","Learning Disability Mortality Review (LeDeR) programme"]
["Application Summary","This application from NHS England set out the purpose of the Learning Disability Mortality Review (LeDeR) Programme as a service improvement initiative. \n\nThe aim of the programme was to drive improvement in the quality of service delivery for people with learning disabilities (LD) and help to reduce premature mortality and health inequalities in this population. The remit of the LeDeR Programme was primarily to support local agencies to review deaths of people with learning disabilities and to use the learning gained to make improvements in the delivery of care. The LeDeR programme will develop and roll out a standardised process for reviews to support this local delivery, and provide strategic support for its implementation. In doing so, it will be building on the well-established practice in health and social care of conducting mortality reviews as a means of improving patient care.\n\nThe anonymised mortality case reviews will be collated and evaluated by the programme team to ensure that learning is being embedded in practice. This will be reported on annually. Reports on the findings of this work will be disseminated to regulators, policy makers, commissioners, service providers, practitioners and patient and family groups with the aim of supporting changes that improve the quality and safety of care for people with learning disabilities.\n\nThis submission was to change the data controller only from HQIP to NHS England, and supercedes a previous application (16/CAG/0056)"]
["Applicant Organisation Name","NHS England and NHS Improvement"]
["Contact Name","Tom Cahill, National Director, Learning Disability and Autism, NHS England"]
["Address","NHS England and NHS Improvement"]
[null,"Skipton House"]
[null,"80 London Road, London"]
["Postcode","SE1 6LH"]
["Telephone"]
["Email","tom.cahill1@nhs.net"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"x","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","People with learning disabilities who have died"]
["Description of confidential patient information used"," Relating to people with learning disabilities: name of deceased person, date of birth, date of death, gender, NHS number, first 2 digits of postcode, ethnicity, gender, information about the circumstances leading to the death of the individual, including the person's medical history, details of diagnoses and treatments, contacts with services, the care and support that they have received prior to death, and their cause of death.\n Relating to the person’s next of kin/family: name of relative/next of kin, address, and relationship to the deceased."]
["S251 Class(es)",null,"Specific Support"]
[null,"x","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"x","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"x","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"x","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2023-05-12"]
["Notes","02 August 2022 - Amendment supported to extend the cohort to include all cases reported from 01 January 2019 onwards and to allow staff from both the North of England Commissioning Support Unit and the South, Central and West Commissioning Support Unit to access LeDeR data for the purpose of auditing the quality of reviews\n\n03 November 2021 - Amendment supported to remove University of Bristol as a data processor with its remaining functions transferring to Kings College London and University of Central Lancashire (UCLAN)\n\n03 November 2021 - Amendment supported to include people with autism who have died in the LeDeR\n\n14 July 2021 - amendment supported to remove University of Bristol as a data processor with its functions transferring to NHS South Central and West Commissioning Support Unit (part of NHS England and NHS Improvement)\n\n25 September 2020 - Amendment supported to LeDeR to disclose the NHS numbers and dates of birth of patients with learning disabilities and a diagnosis of cancer to Public Health England (PHE)/ PHE will then link the patients to those on the National Cancer Registry and return the linked dataset to LeDeR.\n\nSpecific conditions of support\nThe following sets out the specific conditions of support. \n\n1. The legal status of the controller. Our understanding is that the controller is NHS England until evidenced otherwise. However, we are aware there are steps to become the entity NHS England and Improvement. In terms of clarifying the correct legal status so support can be given to entities that exist, please confirm the current legal name of the data controller. Condition met\n\n2. We would welcome clarity on the data flows surrounding linking in to other existing reviews. It is noted the LeDeR Process Flowchart (V4.1), submitted with the current application, refers to the local reviewer checking to see if the individual is subject to any other existing review process and, if so, they will link into this existing review. This data flow (which presumably involves the use of confidential patient information) is not apparent in the initial 16/CAG/0056 application. It was present in the flowchart submitted with an amendment in September 2019, but no mention of this was made as part of the amendment. Please clarify this data flow and the processors involved. Condition met\n\n3. Confirmation provided from the IG Delivery Team at NHS Digital to the CAG that the\nrelevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the\n‘Standards Met’ threshold. NHS England (Controller), University of Bristol\n(Processor), North of England CSU (Processor), South Central and West\nCommissioning Support Unit (Processor). Confirmed via DSPT tracker,\nchecked 04 May 2020."]

{"sheet":"A1001","index":168,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A1001"]
["Reference","20/CAG/0011"]
["Other Refs"]
["Application Title","An exploratory descriptive analysis of the 5-year survivorship of total ankle replacements compared with equivalent rates in administrative datasets with further adjusting for co-varieties"]
["Application Summary","This application from the Royal Devon and Exeter NHS Foundation Trust set out the purpose of a service evaluation to determine the 5-year survivorship of total ankle replacements.\n\nOver 650 total ankle replacements (TAR) are recorded in the National Joint Registry each year. There have been varying results reported with these implants, and considerable research is ongoing in assessing long term outcomes of these replacements and comparing total ankle replacements with ankle arthrodesis. A previous systematic review on long term outcomes of ankle replacements found that TAR had a positive impact on patients’ lives, but was unable to make strong conclusions as previous studies have been small and of poor quality. \n\nThis service evaluation aims to determine the failure rate of ankle replacements. A failure is determined as revision, arthrodesis or amputation.  This will enable further information to be to be given to patients in the consenting process, and inform surgeons of the likely outcomes for these patients. It will also determine risk factors for ankle replacement failures.\n\nThe NJR will disclose confidential patient information to NHSD to facilitate linkage with HES/ONS. The linked, anonymised dataset will be returned to the applicant for analysis."]
["Applicant Organisation Name","Royal Devon and Exeter NHS Foundation Trust "]
["Contact Name","Dr Toby Jennison"]
["Address","Barrack Rd"]
[null,"Exeter "]
[]
["Postcode","EX2 5DW"]
["Telephone"]
["Email","Toby.jennison@nhs.net"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"x","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Patients who underwent ankle replacement surgery in the UK that are recorded on the NJR between 01/01/2010 and 31/12/2018.\n\nThe applicants estimate that 5,500 patients will be included."]
["Description of confidential patient information used","Data sources\n\n1.\tNational Joint Registry\n2.\tHES/ONS data held by NHS Digital\n\nIdentifiers required for linkage purposes\n\n1.\tIndividual anonymised number\n2.\tAge\n3.\tSex\n4.\tDate of admission\n5.\tIndication for primary procedure, previous infection, previous fracture, previous surgery, ankle ROM, associated procedure, side\n6.\tASA grade:\n7.\tImplant data/ brand / manufacturer:\n8.\tRevision codes\n9.\tBelow knee amputation\n10.\tSite code for the ankle joint combined with fusion codes \n11.\t30 day and 1-year mortality\n\nIdentifiers required for analysis purposes\n\n1.\tIndividual anonymised number\n2.\tAge\n3.\tSex"]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"x","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"x","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"x","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Expired"]
[]
["Next Review Date"]
["Notes","Applicant confirmed support expired 28 October 2021.\n\nApplicant confirms that all the data has been pseudonymised. All original identifiers are no longer being processed.\n\nThe public benefits from this work are currently in progress. The benefits that will arise are providing detailed information on the survival of ankle replacements. This will ensure that ankle replacements are only performed in those patients that we know have a high chance of success\n\nSpecific conditions of support\n\n1.\tFurther patient and public involvement and engagement needs to be carried out. Feedback from this is to be provided in the first annual review for the project.\n\n2.\tConfirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. See section below titled ‘security assurance requirements’ for further information. It was confirmed that the relevant DSPT submission related only to NHS Digital. "]

{"sheet":"A1002","index":169,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","A1002"]
["Reference","20/CAG/0043"]
["Other Refs"]
["Application Title","Adult social care free text analysis"]
["Application Summary","This application from London Borough of Islington Council set out the purpose of the management of health and social care services which aims to inform the management of health and social care services and provision of care locally.\n\nLondon Borough of Islington Council and NHS Islington CCG would like to combine datasets from GP practices in Islington, hospital admissions and adult social care, with “free text” data from adult social care records (e.g. assessment forms) to inform the management of health and social care services and provision of care locally. Examples of uses includes (but not limited to) informing the design and implementation of local integrated care systems, and well as providing reasons for delayed transfers of care so service provision can be redesigned to reduce this.\nAdult Social Care data containing NHS number, as well as other identifiers contained in free text information, will be transferred to NEL CSU. NEL CSU will pseudonymise the free text information. The pseudonymised dataset will be transferred to London School of Economics for structuring. Finally, GP data (held by NEL CSU) and secondary care data (held by NHS Digital) will be linked by NHS number to provide a final pseudonymised dataset for analysis."]
["Applicant Organisation Name","London Borough of Islington"]
["Contact Name","Mahnaz Shaukat"]
["Address","Head of Health and Care Intelligence, London Borough of Islington"]
[null,"222 Upper Street, 4th Floor, Public Health"]
[null,"London"]
["Postcode","N1 1XR"]
["Telephone","0207 527 3860"]
["Email","mahnaz.shaukat@islington.gov.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"x","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","People aged 65 and over, using adult social care services in Islington. Those with HIV will be removed from the dataset."]
["Description of confidential patient information used","Data sources\n1. London Borough of Islington Council\n2. NHS Digital\n3. NEL CSU\n\nIdentifiers required for linkage purposes\n1. NHS Number\n\nIdentifiers required for analysis purposes\n1. Identifiers (e.g. names, addresses) contained within free text information provided by London Borough of Islington Council. This will be held temporarily by NEL CSU whilst they strip the information from identifiers during pseudonymisation."]
["S251 Class(es)",null,"Specific Support"]
[null,"x","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"x","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,null,"Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"x","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2022-07-12"]
["Notes","Specific conditions of support\n\n1. Provide the CAG a copy of the patient information materials once it has been subject to review by the communications team.\n\n19 October 2020 - the applicant responded to the condition of support by sending the CAG an updated patient information leaflet. The CAG were happy with this response and this was confirmed by email on 3 November 2020.\n\n2. Continual achievement of ‘Standards Met’ in relation to the relevant DSPT submission (or any future security assurance changes) for the duration of support. Evidence to be provided (through NHS Digital confirmation they have reviewed and confirmed the DSPT submission as standards met’ for the duration of support, and at time of each annual review. The NHS Digital DSPT reviews for NEL CSU, London Borough of Islington and Islington CCG were confirmed as ‘Standards Met’ on the NHS DSPT Tracker (checked 12 July 2020)."]

{"sheet":"A1003","index":170,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","A1003"]
["Reference","20/CAG/0025"]
["Other Refs"]
["Application Title","SUPER (Southampton cardiac surgery Unit Performance Evaluation and Review Project)"]
["Application Summary","This application from the University Hospital Southampton NHS Foundation Trust set out the purpose of an evaluation of survival rates following cardiac surgery at Southampton General Hospital in order to improve performance and service provision in the Southampton cardiothoracic surgery unit. \n\nThis project involving unconsented processing will allow an updated and accurate analysis of mortality rates following cardiac surgery and identify any patterns in this cohort. The long-term survival data of patients after cardiac surgery will be considered for different surgical procedures in order to develop benchmarks and assess performance in the form of a local audit, in order to improve future performance and patient-related outcomes. Reflection on these findings will be translated into better management and improved service provision.\n\nThe applicants sought support for the disclosure of confidential patient information from University Hospital Southampton NHS Foundation Trust to NHS Digital for linkage to their survival database. The dataset disclosed from University Hospital Southampton NHS Foundation Trust to NHS Digital will contain confidential patient information for all living and deceased patients within the cohort. NHS Digital will return confidential patient information only for deceased patients."]
["Applicant Organisation Name","University Hospital Southampton NHS Foundation Trust"]
["Contact Name","Dr Suvitesh Luthra FRCS(CTh), Consultant Cardiac Surgeon"]
["Address","Division of Cardiac Surgery"]
[null,"Southampton General Hospital"]
[null,"Tremona Road, Southampton"]
["Postcode","SO16 6YD"]
["Telephone","023 8077 7222"]
["Email","suvitesh.luthra@nhs.net"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"x","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","All patients undergoing cardiac surgery at Southampton General Hospital between 01/01/2000 and 01/07/2019. The applicants estimate that 21,200 patients will be included."]
["Description of confidential patient information used","Data sources\n1. Mortality data held by NHS Digital\n\nIdentifiers required for linkage purposes\n1. Name\n2. Date of birth\n3. Hospital number\n4. NHS number\n\nIdentifiers required for analysis purposes\n1. Date of death"]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"x","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"x","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"x","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2022-08-03"]
["Notes","Specific conditions of support \n\n1. Confirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. See section below titled ‘security assurance requirements’ for further information. (Confirmed: University Hospital Southampton NHS Foundation Trust (by NHS Digital email dated 29 November 2019) and NHS Digital (by NHS Digital email dated 10 June 2019) have confirmed ‘Standards Met’ grade on DSPT 2018/19)."]

{"sheet":"A1004","index":171,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A1004"]
["Reference","20/CAG/0093"]
["Other Refs"]
["Application Title","2020 Urgent and Emergency Care Survey"]
["Application Summary","This application from the Care Quality Commission set out the purpose of conducting a national survey of patients aged 16 years and over who attended a Type 1 emergency department in September 2020 or a Type 3 urgent care department in September 2020. \n\nThe NHS Patient Survey Programme (NPSP) was initiated in 2002 by the Department of Health and Social Care and is now overseen by the Care Quality Commission (CQC), the independent regulator of health and social care in England. The CQC have commissioned the Survey Coordination Centre for Existing Methods (SCCEM) at Picker to manage and coordinate the survey programme under the title of the SCCEM. The 2020 Urgent and Emergency Care Survey will be the eighth carried out to date. All eligible trusts will be asked to conduct the survey with preparations expected to begin in September 2020 and fieldwork expected to start from November 2020. All trusts will draw a sample of patients according to set criteria, and follow standardised materials and procedures for all stages of the survey. An overview of the survey methodology, and a copy of the Survey Handbook and Sampling Instructions from 2018, were provided with the application.  \n\nThe methodology for the 2020 survey is unchanged from the 2018 survey. Two separate questionnaires will be created; one for patients attending a Type 1 department and another for patients attending Type 3. For trusts with only Type 1 departments, the sample size will remain at 1250. Trusts who have both departments will have a sample size of 950 for Type 1 and 420 for Type 3. In administering the survey, NHS Trusts will be advised to employ the service of one of the approved contractors to reduce the cost, burden and risk in the provision of survey data. As in 2018, and across all surveys in the NPSP, NHS Trusts will submit a sampling checklist and declaration for trust Caldicott Guardians to sign, to minimise the likelihood of complete mailing details being sent to the SCCEM in error. The sampling checklist and declaration should be completed by the trust prior to sending the combined mailing and sample file to the approved contractor, and then by the approved contractor when sending the sample data only. The complete mailing data will be removed, except for the full postcode, which will be sent to the SCCEM as part of the sample file. Both the approved contractors and the SCCEM will not open a sample file until a satisfactory sample declaration form has been received. The end product from this survey will be a set of aggregate statistical data that does not contain patient identifiable information. The statistical data outputs will be provided at both national and at trust level. This statistical dataset is used for a wide variety of purposes, with the ultimate aim of supporting the improvement of patient experience in England. "]
["Applicant Organisation Name","Care Quality Commission"]
["Contact Name","Ms Jenny King"]
["Address","Buxton Court"]
[null,"3 West Way"]
[null,"Oxford"]
["Postcode","OX2 0JB"]
["Telephone","07493 868 951"]
["Email","jenny.king@pickereurope.ac.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"x","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","People aged 16 and over who attended a Type 1 emergency department in September 2020 or a Type 3 urgent care department in September 2020. The applicants anticipate that 127 trusts will be involved. \n\nTrusts will be instructed to contact the SCCEM if they are unable to draw the required sample size from their Type 3 department in which case they will be instructed to also sample back to August 2020.\n\nThe Sampling Instructions will ask trusts to exclude: \n\n-\tdeceased patients \n-\tchildren or young persons aged under 16 years at the date of their attendance at the emergency department\n-\tany patients who are known to be current inpatients \n-\tplanned attendances at outpatient clinics which are run within the Emergency Department (such as fracture clinics)\n-\tpatients without a UK postal address\n-\tpatients attending primarily to obtain contraception (e.g. the morning after pill), patients who suffered a miscarriage or another form of abortive pregnancy outcome whilst at the hospital, and patients with a concealed pregnancy* \n-\tany patient known to have requested their details are not used for any purpose other than their clinical care \n-\tany patients who were admitted to hospital via Medical or Surgical Admissions Units and therefore have not visited the emergency department \n-\tAny attendances at Walk-in Centre’s\n-\tAny attendances at Type 3 departments not wholly managed by the sampling trust. "]
["Description of confidential patient information used","Data sources\n1. Electronic patient records held at the 127 participating trusts\n\nIdentifiers required for linkage purposes\nAdministration of the 2020 Urgent and Emergency Care Survey requires NHS trusts to share two distinct sets of information with their approved contractor:\n\n1. The mailing file is used to address questionnaires to the appropriate person. It contains:\n A standardised unique identifier code, to be constructed as survey identifier, trust code followed by a whole number (consecutive across the sample of patients from each trust), e.g. UEC20XXXNNNN where XXX is the trusts 3 digit trust code and NNNN is the 4 digit serial number relating to sampled patients. \n Title (Mr, Mrs, Ms, etc.) \n First name \n Surname \n Address Fields \n Full Postcode \n\nIdentifiers required for analysis purposes\n1. The sample file is used to link demographic data to the survey responses, to aid analysis and to enable checks to be carried out for any errors in how the sample was drawn. This file contains:\n The unique identifier code (as above)\n NHS Trust code\n Date and time of attendance\n NHS Site code \n Department type (Type 1 or Type 3)\n Ethnicity \n Gender\n Year of birth\n CCG code\n Patients full postcode \n Mobile phone indicator"]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"x","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"x","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2022-08-28"]
["Notes","Specific conditions of support:\n1. Confirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. See section below titled ‘security assurance requirements’ for further information.\n\n(Confirmed: Patient Perspective Ltd (by check of the NHS Digital DSPT tracker on 25 August 2020), Picker Institute Europe (by NHS Digital email dated 17 July 2019) and Quality Health Ltd (by NHS Digital email dated 23 July 2019) have confirmed ‘Standards Met’ grade on DSPT 2018/19). "]

{"sheet":"A1005","index":172,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A1005"]
["Reference","20/CAG/0105"]
["Other Refs","Previous CAG ref: 19/CAG/0083"]
["Application Title","National Clinical Audit of Psychosis"]
["Application Summary","This application from the Healthcare Quality Improvements Partnership and NHS England, set out the purpose of clinical audit which aims to provide those who commission, deliver and use services for people with psychosis with high quality data on the process and outcomes of NHS care. Healthcare Quality Improvements Partnership has commissioned the Royal College of Psychiatrists to undertake the audit on its behalf.\n\nThe application is also supported by NHS Digital and aims to move from a system whereby clinical teams enter pseudonymised information into bespoke online database, to one which is based on secondary analysis of data that Trusts currently submit to NHS Digital as part of the Mental Health Services Data Set (MHSDS).\n\nThis application is seeking support to enable the Royal College of Psychiatrists (RCPsych) to collect confidential patient information from organisations in England providing Early Intervention Psychosis services in 2019 that will be matched with data from the Mental Health Service Dataset, collected by NHS Digital to establish whether, in future years of the audit, a system can be implemented that will be entirely based on secondary analysis of data already submitted to NHS Digital.\n\nThe first phase of this plan will involve checking the completeness and validity of data submitted to MHSDS against clinical data submitted directly to the audit team on a random sample of people with psychosis who are receiving care provided by an Early Intervention in Psychosis (EIP) team. The applicant is also seeking support to link information on the quality of care people in the audit receive with data on subsequent use of inpatient and emergency medical services from MHSDS and HES held by NHS Digital.\nA recommendation for class 4, 5 and 6 support was requested to cover activities as described in the application."]
["Applicant Organisation Name","Healthcare Quality Improvement Partnership (HQIP) and NHS England "]
["Contact Name","Aimee Morris, Programme Manager            "]
["Address","Royal College of Psychiatrists"]
[null,"21 Prescot Street"]
[null,"London"]
["Postcode","E1 8BB"]
["Telephone","0208 618 4268"]
["Email","ncap@rcpsych.ac.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"x","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Patients aged 14 – 65 with First Episode Psychosis (FEP) on the caseload of an Early Intervention Psychosis team for six months or more on the census date: 01/04/2019. A maximum 100 patients per team will be included which will be identified by random sample by NCAP team. Patients will be identified across 154 teams within 57 organisations."]
["Description of confidential patient information used","The following items of confidential patient information are requested:\n• NHS number – for sample validation and linkage,\n• Postcode – for sample validation and linkage,\n• Date of Birth – for sample validation and linkage,\n• Year of birth – analysis,\n• Sex – analysis,\n• Ethnicity – analysis."]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"x","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"x","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"x","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2023-08-20"]
["Notes","Specific conditions of support\n\n1. Confirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. (Confirmed – NHS Digital and the Royal College of Psychiatrists (12/08/2019) have received ‘Standards Met’ grade for 18/19)."]

{"sheet":"A1006","index":173,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A1006"]
["Reference","20/CAG/0085"]
["Other Refs"]
["Application Title","2020 NHS Adult Inpatient Main Stage Survey – Mixed Methods"]
["Application Summary","This non-research application submitted by Ipsos MORI on behalf of the Care Quality Commission, sets out the purpose of conducting the 2020 NHS Adult Inpatient Survey. \n\nThe Adult Inpatient Survey is the most established survey within the NHS Patient Survey Programme (NPSP). The NPSP was initiated in 2002 by the then Department of Health, and is now overseen by the Care Quality Commission (CQC), the independent regulator of health and social care in England. The 2020 Adult Inpatient survey will be the eighteenth carried out to date, and the first mainstage to be completed using a mixed method approach, following a pilot of the approach during 2019. \n\nFollowing a pilot in the 2019 survey, the survey will use a mixed methods approach for conducting the surveys. Trusts will collect information of all eligible patients and, following suitability checks, will share confidential patient information with the coordination centre (IPSOS MORI) and one of three approved contractors (Patient Perspective, Quality Health or Picker Institute Europe). The contractors will distribute questionnaires to patients using the approach detailed below, as successfully piloted:\n\nContact 1 - Postal letter inviting the patient to take part online\nContact 1.1 - SMS reminder timed to arrive with the initial letter including a link to the survey\nContact 2 - Postal reminder inviting the patient to take part online\nContact 2.2 - SMS reminder timed to arrive with the second letter including a link to the survey\nContact 3 - Postal reminder along with a paper questionnaire\n\nWhilst the survey remains similar to previous years, COVID status has been added to the data requested for analysis so the applicants can distinguish between these patients for reporting purposes.\n"]
["Applicant Organisation Name","Ipsos MORI"]
["Contact Name","Laura Thomas"]
["Address","Ipsos MORI"]
[null,"3 Thomas More Square"]
[null,"London"]
["Postcode","E1W 1YW"]
["Telephone","020 3059 4717"]
["Email","laura.thomas@ipsos.com"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"x","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Inpatients aged 16 years old or over who were discharged from acute and specialist NHS hospitals in November (and earlier for smaller trusts), having had at least one overnight stay in hospital. \n\nExclusions: \n• deceased patients \n• children or young persons aged under 16 years at the time of sampling \n• obstetrics/maternity service users, including spontaneous miscarriages  \n• patients admitted for planned termination of pregnancy \n• psychiatry patients  \n• day cases \n• private patients (non-NHS) \n• any patients who are known to be current inpatients patients\n• patients without a UK postal address or patients whose address was unusable because it was incomplete\n• any patient known to have requested their details are not used for any purpose other than their clinical care, including those responding to posters displayed on hospital wards referring to the survey (the survey instructions request that all responses to posters are logged and used for this purpose)."]
["Description of confidential patient information used","Data sources\n1. Electronic patient records within acute and specialist Trusts in England\n\nIdentifiers required for linkage purposes\n1. Title\n2. Initials or first name\n3. Surname\n4. Address Fields including postcode\n5. Mobile phone number\n6. Patient unique identifier\n\nIdentifiers required for analysis purposes\n1. Trust code\n2. Patient unique identifier\n3. Postcode\n4. Year of Birth\n5. Gender\n6. Ethnic Category\n7. Mobile phone indicator\n8. Day of the month of admission\n9. Month of admission\n10. Year of admission\n11. Day of the month of discharge\n12. Month of discharge\n13. Year of discharge\n14. Length of stay\n15. Treatment Function Code\n16. ICD-10 or ICD-11 (Chapter Code)\n17. Covid-19 diagnosis (derived from ICD-10 codes U07.1 COVID-19, virus identified and U07.2 COVID-19, virus not identified)\n18. Treated as a suspected or confirmed covid-19 case\n19.\tCCG code\n20.\tTreatment Centre Admission\n21.\tAdmission Method\n22.\tHospital Site Code on Admission\n23.\tHospital Site Code on Discharge"]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,null,"Class V - audit, monitoring, & analysis of healthcare provision "]
[null,null,"Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Expired"]
[]
["Next Review Date","2022-09-22"]
["Notes","March 2022 - Support Expired\nApplicant confirmed March 2022 that ‘s251’ support can be expired, as sample data has been pseudonymised by the CCMM and personal data (postcode) deleted. Mailing data (name, address, postcode and mobile number) has been deleted by each of the contractors and the relevant in-house trusts for each survey. \n\nIn terms of public benefit, reports can be viewed here: \nInpatients: https://nhssurveys.org/surveys/survey/02-adults-inpatients/year/2020/\n\nAnd a summary of findings for each survey is also available from the CQC website:\nInpatients: https://www.cqc.org.uk/publications/surveys/adult-inpatient-survey-2020\n\nSpecific conditions of support:\n\n1. Continual achievement of ‘Standards Met’ in relation to the relevant DSPT submission (or any future security assurance changes) for the duration of support. Evidence to be provided (through NHS Digital confirmation they have reviewed and confirmed the DSPT submission as standards met’ for the duration of support, and at time of each annual review. \nThe NHS Digital DSPT submission for Ipsos MORI, Patient Perspective, Quality Health and Picker Institute Europe were confirmed as ‘Standards Met’ by NHS Digital by check of DSPT tracker (03 August 2020)"]

{"sheet":"A1007","index":174,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A1007"]
["Reference","20/CAG/0102"]
["Other Refs"]
["Application Title","National Haemophilia Database (NHD)"]
["Application Summary","This application from United Kingdom Haemophilia Doctors Organisation set out the purpose of the management of health and social care services to enable reporting of outcomes regarding Haemophilia.\n\nThe UK National Haemophilia Database (NHD) is a long running national database that was established in 1968. Whilst the database maybe used for direct clinical care, it is also used extensively for national audit purposes. The database has a long history of working with national bodies to further patient care by assisting continuity of care and monitoring safety through the provision of accurate data, and this information informs and shapes national policy. \n\nNational Haemophilia centres provide confidential information to the NHD through an encrypted transfer. Haemtrak data (an application in which patients input medication usage etc) is also transferred to the NHD in an encrypted format. However, it is noted that the existing held database has historically not had a proper legal basis under the common law duty of confidentiality for transfer confidential patient information and subsequent processing. As such, the applicants request support for the continued prospective holding and processing of existing data in the NHD, and well as the continued collection of prospective data from Haemophilia Centres.\n\nAdditionally, the applicants also request support to transfer confidential patient information to NHS Digital to enable linkage to mortality data, which will contribute to safety (provision of care and treatment), cost reduction (management of health and social care services), improved knowledge and therefore care (provision of care and treatment), and provision of a firmer evidence base to inform public policy (Serve the wider public interest)."]
["Applicant Organisation Name","United Kingdom Haemophilia Doctors Organisation"]
["Contact Name","Professor Charles Hay"]
["Address","UKHCDO Ltd."]
[null,"City View House, Union Street"]
[null,"Ardwick, Manchester"]
["Postcode","M12 4JD"]
["Telephone","0161 277 7924 "]
["Email","Charles.Hay@mft.nhs.uk "]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"x","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","All patients with a bleeding disorder in England and Wales"]
["Description of confidential patient information used","Data sources\n1. Haemophila Centres\n2. Haemtrak Application\n3. NHS Digital\n\nIdentifiers required for linkage purposes\n1. NHS Number\n2. Name\n3. Date of birth\n\nIdentifiers required for analysis purposes\n1. Gender\n2. Postcode\n3. Ethnicity\n4. Date of Death"]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"x","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"x","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"x","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2023-09-30"]
["Notes","Specific conditions of support\n\n1. Provide, within six months of the final support letter, updated patient notification materials that have undergone review by a patient group.\n   a. These materials should include a central telephone and email address for patients to opt out of their use of data.\n\n2. Confirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. See section below titled ‘security assurance requirements’ for further information. The NHS Digital DSPT review for Manchester University NHS Foundation Trust was confirmed as ‘Qualified Assurance – Trust has not achieved 95% staff undertaking security awareness training’ on the NHS Digital DSPT Tracker (checked 14 August 2020). All staff at Manchester University NHS Foundation Trust that are involved in processing information under this application reference should have successfully completed local security awareness training before processing any information under support.\n\nThe NHS Digital DSPT review for the National Haemophilia was confirmed as ‘standards met’ (by email from NHS Digital 18 September 2020)."]

{"sheet":"A1008","index":175,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","A1008"]
["Reference","20/CAG/0139"]
["Other Refs"]
["Application Title","2021 NHS Maternity Survey – Mixed Methods"]
["Application Summary","This non-research application submitted by Ipsos MORI on behalf of the Care Quality Commission, sets out the purpose of conducting the 2021 NHS Maternity Survey. \n\nThe Maternity Survey started in 2007 and falls within the NHS Patient Survey Programme (NPSP). The NPSP was initiated in 2002 by the then Department of Health, and is now overseen by the Care Quality Commission (CQC), the independent regulator of health and social care in England. \n\nThe 2021 Maternity Survey will be the eighth carried out to date, although this will be the first time that the maternity survey will be completed using a mixed method approach, following a successful pilot of the approach during 2019/20.\n\nTrusts will collect information of all eligible patients and, following suitability checks, will share confidential patient information with the coordination centre (IPSOS MORI) and once of three approved contractors (Patient Perspective, Quality Health or Picker Institute Europe). The contractors will distribute questionnaires to patients using the approach detailed below, as successfully piloted:\n\n1 - Postal: Invitation letter inviting the patient to take part online, Multi-language sheet\n                Days from first mailing - 1\n1.1 - SMS: SMS reminder (if phone number available), including a link to the survey\t\n                Days from first mailing - 4\n2 - Postal: Reminder letter, Multilanguage sheet\n                Days from first mailing - 15\n2.1 - SMS: SMS reminder (if phone number available), including a link to the survey\t\n                Days from first mailing - 18\n3 - Postal: Reminder letter, Paper questionnaire, Freepost return envelope, Multi-language sheet\n                Days from first mailing - 29\n4 - Postal: Reminder letter, Multilanguage sheet\n                Days from first mailing - 43\n4.1 - SMS: SMS reminder (if phone number available)\n                Days from first mailing - 46\n\nAhead of each reminder mailing, it will be necessary to remove all respondents who have completed the survey already, and to conduct a DBS or local check on the full sample. If anyone has requested to be opted out of further reminders, they should also be removed at these timepoints.\n\nPlease also note that whilst the survey remains similar to previous years, the applicants have added in COVID status to the data requested for analysis so they can distinguish between these for reporting purposes."]
["Applicant Organisation Name","Care Quality Commission"]
["Contact Name","Stacey Smith"]
["Address","Patient Services, Intelligence & Digital"]
[null,"Care Quality Commission"]
[null,"Temple Quay House, 2 The Square, Bristol"]
["Postcode","BS1 6PN"]
["Telephone","0789 151 9090"]
["Email","Stacey.Smith@cqc.org.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"x","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","ALL maternity service users aged 16 and over at the time of delivery who had a live birth between 1 February and 28 February 2021. (and earlier for smaller trusts), \n\nExclusions: \n• Mothers who were under 16 years of age at the time of delivery.\n• Mothers who had one or more stillbirths.\n• Mothers whose baby has died since delivery \n• Mothers who have died during, or since, delivery.\n• Mothers who were in hospital, or whose baby was in hospital, at the time of drawing the sample.\n• Where possible, mothers who had a concealed pregnancy.\n• Where possible, mothers whose baby was taken into care or adopted.\n• Mothers who delivered in a private maternity unit or wing.\n• Mothers who delivered in a maternity unit managed by another provider \n• Mothers without a UK postal address (but do not exclude if addresses are incomplete but still useable, e.g. no postcode).\n• Mothers who have requested that their details are not used for any purpose other than their clinical care, including requests made following sight of survey pre-publicity; This does not include the National Data Opt-out Programme."]
["Description of confidential patient information used","Data sources\n1. Electronic patient records within all eligible Trusts in England (120-130 trusts)\n\nIdentifiers required for contact purposes\n1. Title\n2. Initials or first name\n3. Surname\n4. Address Fields including postcode\n5. Mobile phone number\n6. Patient unique identifier\n\nIdentifiers required for analysis purposes\n1. Patient unique identifier\n2. Postcode\n3. Mother’s year of birth\n4. Mother’s gender\n5. Time of delivery\n6. Number of babies born at delivery \n7. Day of delivery\n8. Month of delivery\n9. Year of delivery\n10. Maternity Care Setting (Actual Place of Birth)\n11. Actual delivery place\n12. Mother’s ethnic group\n13. Trust code\n14. NHS Site code (of birth)\n15. CCG code\n16. Mobile phone indicator\n17. Whether or not mother received antenatal and/or postnatal care from the trust\n18. Covid-19 diagnosis during labour and birth (derived from ICD-10 codes U07.1 COVID-19, virus identified and U07.2 COVID-19, virus not identified)\n19. Treated as a suspected or confirmed covid-19 case"]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"x","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"x","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Expired"]
[]
["Next Review Date","2022-11-24"]
["Notes","March 2022 - Support Expired\nApplicant confirmed March 2022 that ‘s251’ support can be expired, as sample data has been pseudonymised by the CCMM and personal data (postcode) deleted. Mailing data (name, address, postcode and mobile number) has been deleted by each of the contractors and the relevant in-house trusts for each survey. \n\nIn terms of public benefit, reports can be viewed here: \nMaternity: https://nhssurveys.org/surveys/survey/04-maternity/year/2021/\n\nAnd a summary of findings for each survey is also available from the CQC website:\nhttps://www.cqc.org.uk/publications/surveys/maternity-survey-2021\n\n24 November 2020 - Application supported\nThe application, to allow the disclosure of confidential patient information from NHS trusts to one of three approved contractors for the purpose of sending out questionnaires for the 2021 Maternity Survey, and for disclosure of postcode to IPSOS MORI for analysis purposes, is fully supported, subject to compliance with the standard conditions of support.\n\nConditions of support:\n\n1. Continual achievement of ‘Standards Met’ in relation to the relevant DSPT submission (or any future security assurance changes) for the duration of support. Evidence to be provided (through NHS Digital confirmation they have reviewed and confirmed the DSPT submission as standards met’ for the duration of support, and at time of each annual review. \n\nConfirmed: The NHS Digital 2018/19 DSPT submission for Ipsos MORI, Patient Perspective, Quality Health and Picker Institute Europe were confirmed as ‘Standards Met’ by NHS Digital by check of DSPT tracker (17 November 2020). The 2019/20 DSPT submissions have not yet been reviewed by NHS Digital, but the applicant has requested that these be reviewed. "]

{"sheet":"A1009","index":176,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A1009"]
["Reference","20/CAG/0111"]
["Other Refs"]
["Application Title","Under 16 Cancer Patient Experience Survey 2020-2023"]
["Application Summary","This application from NHS England and NHS Improvement and Picker Institute Europe (Picker) set out the purpose of a patient survey to collect patient experience data for patients aged under 16 years of age with a diagnosis of cancer. \n\nThe National Cancer Patient Experience Survey (CPES), commissioned and managed by NHS England and NHS Improvement, is one of the ways that patient experience data for cancer patients in England is captured. The results of these surveys are used to help commissioners, providers and national policy makers to identify priority areas of improvement for services. However, as recognised in the Achieving World Class Cancer Outcomes: A Strategy for England 2015-2020, January 2015, NHS Independent Cancer Taskforce, the CPES is not appropriate for use with children with cancer. This Strategy recommended that NHS England and NHS Improvement “should develop a methodology to collect data on patient experience for under 16s”. This commitment to improvement was recently restated in the NHS Long Term Plan, January 2019, NHS England. This application supports NHS England and NHS Improvement to fulfil the Cancer Strategy recommendation and Long-Term Plan objectives. NHS England and NHS Improvement has commissioned Picker Europe Ltd.to develop and carry out the Under 16 Cancer Patient Experience Survey over the period 2020-2023. \n\nThe applicants are seeking support to collect and use confidential patient information for patients under 16 years of age diagnosed with cancer and other tumours in order to conduct the Under 16 Cancer Patient Experience Survey between 2020 and 2023. Confidential patient information will be disclosed from NHS Principal Treatment Centres (PTCs), delivering children’s cancer care and treatment in England, to Picker Europe Ltd. Picker will also liaise with PTCs so that patient questionnaires are sent to recipients on the letter-headed paper for the appropriate trust. The survey materials will be addressed to parents of children who have received care. The first wave of data collection is due to take place in the autumn of 2020 and repeated on an annual basis thereafter. Support is sought for the first three years of the survey. \n\nOnce Picker receives the patient information from the PTCs, most of the checking and mailing processes are automated (in-house) with access limited to approved individuals in accordance with their Information Security Management System. \n\nOther details are needed to verify survey responses, check eligibility to take part or to provide data that patients could not be expected to supply. These details (e.g. age and coding of cancer diagnosis ICD10 codes) will be used to check the accuracy of the sample data, and to compare different groups’ experiences of acute cancer care at the reporting stage, where numbers allow. \n\nAs hospitals do not routinely collect email and/or mobile phone numbers for patients, for the first 1-2 survey waves, the applicants intend to approach patients by post using a paper-based survey, with the option for respondents to complete the survey online, should they prefer. However, in response to advances in digital communications, for future waves the applicants intend to explore a mixed-method approach in instances where email and/or mobile phone numbers are available, e.g. an initial approach by email, or survey reminders sent by SMS. Support is therefore requested for email and/or telephone number to be collected to further explore the digital potential for the survey. The patient name and address will be needed to send out postal surveys to recipients, and the email address and mobile phone number of the parent(s)/carer(s) (where available) will be needed to explore whether a mixed-mode approach could be used in future waves of data collection. "]
["Applicant Organisation Name","NHS England and NHS Improvement & Picker Institute Europe"]
["Contact Name","Peter Williamson, Insight and Feedback Manager"]
["Address","NHS England and NHS Improvement"]
[null,"Skipton House"]
[null,"London"]
["Postcode","SE1 6LH"]
["Telephone","07900 715 209"]
["Email","peter.williamson7@nhs.net"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"x","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","All children aged under 16 at the time of their care, with a confirmed primary diagnosis of cancer or a non-malignant brain, other central nervous system or intracranial tumour, who are aware of their diagnosis and have received NHS care and/or treatment for their cancer or tumour within a recent twelve-month period. This will include: \n\n• Admitted patients who did not stay overnight (e.g. emergency admissions and planned day cases) \n• Admitted patients who did stay overnight \n• An ICD-10 code of C00 – C97, D32 - D33, D35.2 - D35.4, D42 - D43, D44.3 - D44.5, D48, D76.1. \n\nThe applicants estimate that this will include between 1,000 and 10,000 patients per year.\n"]
["Description of confidential patient information used","Data sources\n1. NHS Principal Treatment Centres (PTCs)\n\nIdentifiers required for linkage purposes\n1. Patient name\n2. Address\n3. Sex\n4. Ethnic group\n5. Date of birth\n6. ICD10 code\n7. Discharge date\n8. Specialty code\n9. NHS number\n10. Site code\n11. Trust code\n12. Patient classification\n13. Parent email address and mobile phone number will be collected, where available. \n\nIdentifiers required for analysis purposes\nNo identifiers are required for analysis purposes"]
["S251 Class(es)",null,"Specific Support"]
[null,"x","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"x","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"x","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"x","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2023-11-20"]
["Notes","03 November 2021 – amendment supported to include the ICD-O-3 4 and the ICD-O-3 morphology code, to give participating trusts the option to use an online sampling checker platform and to send the survey type, trust name and site name to Greens Ltd.\n\n12 December 2020 - Amendment supported\nAmendment supported to allow the collection of patient’s ICD-11 codes, in addition to ICD-10 codes, from participating NHS trusts.\n\nSpecific conditions of support:\n\n1. Confirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. See section below titled ‘security assurance requirements’ for further information. \n\n(Confirmed – Picker Institute Europe has a confirmed ‘Standards Met’ grade on DSPT submission 2018/19 by check of the NHS Digital email dated 17 July 2019) "]

{"sheet":"A1010","index":177,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A1010"]
["Reference","20/CAG/0155"]
["Other Refs"]
["Application Title","Community Mental Health Survey 2021"]
["Application Summary","This non-research application from Picker, on behalf of the Care Quality Commission, set out the purpose of administering the 2021 Community Mental Health Survey.\n \nThe community mental health Survey falls within the NHS Patient Survey Programme (NPSP). The NPSP was initiated in 2002 by the then Department of Health, and is now overseen by the Care Quality Commission (CQC), the independent regulator of health and social care in England. \n\nThe 2021 community mental health Survey will be the eighteenth carried out to date. All 55 eligible mental health provider trusts will be asked to conduct the survey, drawing a sample of service users according to set criteria, and following standardised materials and procedures for all stages of the survey. \n\nThe 2021 methodology is broadly unchanged from the 2020 survey. However, due to the impact of Covid-19, the eligibility criteria for drawing the sample has been amended to include not only face to face contact but also contact via video conferencing or telephone. Applicants are also seeking support to disclose additional variables to the Survey Coordination Centre for Existing Methods’ (SSCEM); postcode (to map LSOA) – this is in line with other supported surveys. The reason for this addition is to allow the SCCEM and the CQC to conduct sub-group analysis to understand the link between deprivation and quality of community mental health services at the local level. This information will enable researchers, governmental bodies, service users and providers of services to better understand the quality of service in their local area.  Applicants are also additionally collecting email address indicator (similar to the mobile phone indicator supported in 2020), and mode of contact, in line with the changes to eligibility criteria. There are no other changes to the survey, specifically Covid-19 status is not being collected in this instance. \n\nTrusts will collect information of all eligible patients and, following suitability checks, will share confidential patient information with the coordination centre (Picker Institute Europe under the title ‘Survey Coordination Centre for Existing Methods’ (SSCEM)) and once of three approved contractors (Patient Perspective, Quality Health or Picker Institute Europe). "]
["Applicant Organisation Name","Picker Institute & Care Quality Commission"]
["Contact Name","Tamatha Webster, CQC Survey Manager"]
["Address","151 Buckingham Palace Road"]
[null,"London"]
[]
["Postcode","SW1W 9SZ"]
["Telephone","03000 616 161"]
["Email","Tamatha.Webster@cqc.org.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"x","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Patients aged 18 and over who had been in contact with NHS mental health services in the three-month period from 1 September 2020 to 30 November 2020, and who were receiving specialist care or treatment for a mental health condition, including those who receive care under the Care Programme Approach (CPA)\n\n‘Contact’ in the 2021 survey is defined as face-to-face, via video-conference (e.g. using Attend Anywhere, MS Teams, Zoom, etc.) or telephone call \n\nHowever: Service users who only had telephone appointments during the sampling period are eligible to be included in the sample if they would otherwise have had at least one face-to-face appointment if it were not for the COVID-19 pandemic. Do not include service users who would have only ever had telephone appointments regardless of the COVID-19 pandemic.\n\n1250 service users from each Trust.\n"]
["Description of confidential patient information used","Data sources\n1. Electronic patient records, Mental Health Trusts in England\n\nIdentifiers required for linkage purposes\n1. Trust code\n2. A standardised unique identifier code, \n3. Title (Mr, Mrs, Ms, etc.) \n4. First name \n5. Surname \n6. Address Fields \n7. Postcode \n\nIdentifiers required for analysis purposes\n1. Trust code\n2. The unique identifier code (as above)\n3. Year of birth \n4. Postcode\n5. Gender \n6. Ethnic category \n7. Day of last contact \n8. Month of last contact \n9. Year of last contact \n10. CPA status \n11. CCG code\n12. Mental Health Care Cluster Codes\n13. Mobile phone indicator\n14. Email address indicator\n15. Mode of contact"]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"x","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"x","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2022-11-30"]
["Notes","14 January 2021 - Amendment supported\nThe amendment, to include in the sample all service users who received care and treatment by telephone, regardless of whether this was a replacement for face to face contact, is supported, subject to compliance with the standard conditions of support.\n\nSpecific conditions of support \n\n1. Continual achievement of ‘Standards Met’ in relation to the relevant DSPT submission (or any future security assurance changes) for the duration of support. Evidence to be provided (through NHS Digital confirmation they have reviewed and confirmed the DSPT submission as standards met’ for the duration of support, and at time of each annual review. \n\nConfirmed: The NHS Digital 2018/19 DSPT submission for Patient Perspective, Quality Health and Picker Institute Europe were confirmed as ‘Standards Met’ by NHS Digital by check of DSPT tracker (24 November 2020). The 2019/20 DSPT submissions have not yet been reviewed by NHS Digital, but the applicant has requested that these be reviewed. "]

{"sheet":"A1011","index":178,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","A1011"]
["Reference","20/CAG/0145"]
["Other Refs"]
["Application Title","2020 Children and Young People’s Patient Experience Survey"]
["Application Summary","This application submitted by Picker Institute Europe and commissioned by the Care Quality Commission, set out the non-research purpose of facilitation of the 2020 Children and Young People’s Patient Experience Survey. The survey, which will be fifth carried out to date, forms part of the NHS National Patient Surveys Programme and was last run in 2018 (CAG reference 18/CAG/0150).\n\nThe applicants are seeking support for the transfer of patient identifiable data from acute trusts, to an approved survey contractor for the purpose of mailing out questionnaires for the 2020 Children and Young People’s Survey. The applicants expect that the vast majority of the trusts involved will opt to use an approved survey contractor, either: Picker, Quality Health or Patient Perspective. In 2018, 125 of 129 trusts chose to use a contactor.\n\nThe methodology for the 2020 survey is largely unchanged from the 2018 survey. In 2018, the applicants received support to send three separate, age-dependent, self-completion questionnaires to patient’s home addresses. One questionnaire is for the parents/carers of children aged 0-7 year’s old, one for children and young people aged 8-11 years old and their parents/carers, and one for young people aged 12-15 years old and their parents/ carers. The sampling methodology is also unchanged from the 2018 survey. The sample for the survey is a disproportionate stratification model with a total sample size per participating NHS Trust in England of 1250 patients. The total sample size is comprised of a target sample size for each age group: 450 patients within the 0-7 year-old category, 400 patients within the 8-11 year-old category and 400 patients within the 12-15 year-old category. All eligible trusts will be asked to conduct the survey with preparations expected to begin in October 2020 and fieldwork expected to start from February 2021. All trusts will draw a sample of patients according to set criteria and will follow standardised materials and procedures for all stages of the survey. An overview of the survey methodology, the Survey Handbook and Sampling Instructions were provided with the application. \n\nThe applicants seek to collect additional sample variables as part of the data submitted by NHS trusts to the Survey Coordination Centre for Existing Methods (SCCEM). These variables are:\n\n• Full postcode information for each patient in the sample from a trust – to enable the SCCEM to map case level postcodes to the Lower Layer Super Output Areas (LSOA) deprivation indices in order to examine links between deprivation and patients’ experience of hospital care. \n• A flag to indicate whether there is a mobile phone number recorded for the patient’s parent or carer – to assist in the planned transition from a purely paper-based approach to a mixed mode design where respondents will have the option of providing their feedback through a paper questionnaire or online.\n• Covid-19 diagnosis – to aid in assessing the impact that Covid-19 has had on services. \n• Treated as a suspected or confirmed covid-19 case - to aid in assessing the impact that Covid-19 has had on services. "]
["Applicant Organisation Name","Picker Institute Europe & Care Quality Commission"]
["Contact Name","Tamatha Webster"]
["Address","2nd Floor"]
[null,"2 Redman Place"]
[null,"Stratford, London"]
["Postcode","E20 1JQ"]
["Telephone","07493 868 951"]
["Email","Tamatha.Webster@cqc.org.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"x","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Children and young people aged between 14 days and 15 years who were admitted as inpatients, day-cases and emergencies to an acute hospital between 01 November and 31 December 2020. \n\nTrusts will be required to draw a disproportionate stratified sample of patients who were admitted and discharged during this time period. The maximum sample size for the survey is 1250 patients. If a trust is unable to draw a minimum sample size of 400 patients they must contact the SCCEM directly and will be instructed to also sample back to 01 October 2020."]
["Description of confidential patient information used","Data sources\n1. Each participating NHS trust in England providing hospital services (inpatient and day case) to children and young people \n\nIdentifiers required for linkage purposes\n1. The mailing file is used to address questionnaires to the appropriate person. It contains:\n\n A standardised unique identifier code, to be constructed as survey identifier, trust code followed by a whole number (consecutive across the sample of patients from each trust), e.g. CYP20XXXNNNN where XXX is the trusts 3 digit trust code and NNNN is the 4 digit serial number relating to sampled patients. \n Child/ young person’s first name \n Child/ young person’s surname \n Address Fields \n Full Postcode \n\nIdentifiers required for analysis purposes\n\n1.\tThe sample file is used to link demographic data to the survey responses, to aid analysis and to enable checks to be carried out for any errors in how the sample was drawn. This file contains:\n\n Trustcode\n The unique identifier code (as above)\n Year of birth\n Gender\n Ethnicity\n Date of admission\n Date of discharge\n Length of stay\n Main speciality on discharge\n Treatment function code\n CCG code\n Treatment centre admission\n Admission method\n NHS site code of admission\n NHS site code of discharge\n Patients full postcode\n Parents or carers mobile phone indicator \n Covid-19 diagnosis (derived from ICD-10 codes U07.1 COVID-19, virus identified and U07.2 COVID-19, virus not identified. Note: some trusts may have upgraded to using ICD-11 codes. If that is the case, those trusts would create this variable from using ICD-11 RA01.0 COVID-19, virus identified and RA01.1 COVID-19, virus not identified)\n Treated as a suspected or confirmed covid-19 case\n\nThe two sets of information listed above will be submitted by trusts to approved contractors as one file. Approved contractors will split the data out and only the sample data will be provided to the SCCEM to enable centralised checks on the appropriateness of samples drawn. \n\nSome trusts may experience delays in clinical coding needed for the COVID-19 specific sample variables. Consequently, if a trust is not able to provide the COVD-19 specific variables as part of their sample file submission, the applicants will request that these trusts submit the COVD-19 related variables as part of a separate attribution file to be sent directly to the SCCEM during fieldwork.  This file would contain:\n\n NHS Trust code\n Patient Record Number (PRN)- the unique identifier code for each sampled patient\n Covid-19 diagnosis (derived from ICD-10 codes U07.1 COVID-19, virus identified and U07.2 COVID-19, virus not identified. Note: some trusts may have upgraded to using ICD-11 codes. If that is the case, those trusts would create this variable from using ICD-11 RA01.0 COVID-19, virus identified and RA01.1 COVID-19, virus not identified)\n Treated as a suspected or confirmed covid-19 case\n\nThe file would be transferred to the SCCEM directly using the file transfer secure site. It would be matched into the final survey response file to aid analysis"]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"x","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"x","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2022-12-04"]
["Notes","12 January 2021 - Amendment supported\nThe amendment, to allow the sampling period to be extended to between 1st November 2020 and 31st January 2021 and the inclusion of patients’ month and year of birth in the sample file, is fully supported, subject to compliance with the standard conditions of support.\n\n04 December 2020 - Support issued\nConditions of support:\n\n1. Provide the final versions of the questionnaires and patient-facing documents for review before they are sent to patients.  \n\n2. Confirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. See section below titled ‘security assurance requirements’ for further information. (Confirmed: Patient Perspective, Picker Institute Europe and Quality Health (by check of the NHS Digital DSPT tracker on 19 November 2020) have confirmed ‘Standards Met’ grade on DSPT 2018/19). "]

{"sheet":"A1012","index":179,"n_rows":36,"n_cols":3,"rows_kept":36,"cut":false,"hidden":false,"merged":[[31,1,31,4],[32,1,32,4],[34,1,34,4],[35,1,35,4],[21,1,21,4],[22,1,22,4],[23,1,23,4],[24,0,30,0],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,2,30,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A1012"]
["Reference","21/CAG/0007"]
["Other Refs"]
["Application Title","National Neonatal Audit Programme (NNAP) data flow"]
["Application Summary","This application from the Royal College of Paediatrics and Child Health (RCPCH) sets out the purpose of an audit programme, to assess whether babies admitted to neonatal units in England and Wales receive consistent high-quality care and to identify areas for service and quality improvement in relation to the delivery and outcomes of neonatal care.\n\nThe National Neonatal Audit Programme (NNAP) was established in 2006 and has, until now, been delivered by the RCPCH and is commissioned to do so by the Healthcare Quality Improvement Partnership (HQIP) as part of the National Clinical Audit and Patient Outcomes Programme (NCAPOP). The NNAP assesses whether babies admitted to neonatal units in England and Wales receive consistent high-quality care and identifies areas for service and quality improvement in relation to the delivery and outcomes of neonatal care as measured by adherence to a set of agreed professional guidelines and standards. Currently, for the 1 April 2017 to 31 March 2021 NNAP contract period, neonatal units use identical (BadgerNet) software to route clinical data via Clevermed Ltd into the National Neonatal Research Database (NNRD) dataset maintained at Imperial College by the Neonatal Data Analysis Unit (NDAU), (CAG reference: ECC 8-05(f) 2010).  NNAP data is a sub-set of the wider NNRD and the NDAU processes NNAP data on behalf of the RCPCH to whom it provides quarterly and annual aggregated and anonymised reports.\n\nThe NNAP is not run or delivered by the National Neonatal Research Database (NNRD), as the Neonatal Data Analysis Unit (NDAU) within Imperial College is sub-contracted by the RCPCH to undertake data analysis for the NNAP and it does this by processing NNAP-related data within the NNRD using the legal basis given under CAG reference ECC 8-05(f)2010. The applicants are now seeking support under Regulation 5 of the COPI Regulations for the NNAP, so that NNAP will have its own support and will no longer come under ECC 8-05(f)2010.\n\nParticipating Neonatal units will input confidential patient information into the BadgerNet system on all babies admitted to all NHS neonatal units in England and Wales associated with a delivery unit, including special care units (SCUs), local neonatal units (LNUs) and neonatal intensive care units (NICUs). Data entered into BadgerNet is stored on servers within the Clevermed Microsoft Azure environment, accessible only via the HSCN NHS Network. A dedicated NNAP SQL Server Database will be created by Clevermed within its Azure environment for the sole purpose of hosting the national NNAP dataset extracted from the live BadgerNet system.  Data for each neonatal care episode will be added to the dedicated NNAP SQL Server Database thirty days after the date of the baby’s discharge from neonatal care. After this date any changes by users to that raw BadgerNet record will be synchronised to the dedicated NNAP database so that it always reflects the current raw BadgerNet care record.  The NNAP Database within the Clevermed Azure environment can then be synchronised to a “mirror” instance of a NNAP SQL Server Database located on an entirely separate RCPCH Azure hosting infrastructure. Appropriately trained and approved RCPCH-based NNAP project staff will be able to work with data within the NNAP database within the RCPCH Azure environment only and produce monthly, quarterly or whole-year analysis and reporting.  A pseudonymised version of the NNAP data will be created within the RCPCH Azure environment and it is this pseudonymised version of the data that the NNAP project team will work with. The applicant confirmed that confidential patient information is put into the BadgerNet system by participating trusts as part of routine care and input into BadgerNet is outside the scope of the s251 support sought."]
["Applicant Organisation Name","Royal College of Paediatrics and Child Health"]
["Contact Name","Rachel Winch, National Neonatal Audit Programme Manager"]
["Address","Royal College of Paediatrics and Child Health"]
[null,"5-11 Theobalds Road"]
[null,"London"]
["Postcode","WC1X 8SH"]
["Telephone","0203 861 1910"]
["Email","Rachel.winch@rcpch.ac.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"x","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","The following inclusion criteria apply to all NNAP measures:\n• Babies who were admitted for neonatal care\n• Babies who had care provided by an NNAP-registered NHS neonatal unit\n• Babies whose parents or carers have not opted them out of secondary use of their data"]
["Description of confidential patient information used","Data sources\n1. Confidential patient information entered by participating neonatal units into BadgerNet\n\nIdentifiers required for linkage purposes\n1. NHS Number of baby\n2. NHS number of mother\n\nIdentifiers required for analysis purposes\n1. Date and time of baby’s admission\n2. Date of time of baby’s discharge\n3. Date and time of baby’s birth\n4. Baby’s date of death\n5. Mother’s date of birth\n6. Mother’s ethnicity\n7. Gender of baby\n8. Postcode of mother’s usual address"]
["National Data Opt \nOut Status","The Secretary of State for Health and Social Care decision maker, on advice from the CAG, has supported a request to defer the National Data Opt Out. As such, the National Data Opt Out does not need to be applied for this activity"]
["S251 Class(es)",null,"Specific Support"]
[null,"x","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"x","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"x","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2023-03-01"]
["Notes","Amendment supported 21 December 2022 \nTo defer applying the National Data Opt-Out in relation to 21/CAG/0007\n\nSpecific conditions of support:\n1.\tThe patient notification materials need to be revised as follows:\n\na.\tA layered approach is to be adopted, making simple, easy-read versions available, with more detailed information to be provided on request. \n\nb.\tTelephone and email contacts need to be provided. \n\n2.\tThe National Data Opt-Out is not to be applied to patients included in the activities specified in 21/CAG/0007. \n\n3.\tA local patient objection mechanism must continue to be used in relation to 21/CAG/0007.\n\n10 March 2022 - Amendment supported \nAmendment supported to extend the duration of support until 31 March 2025 and to revise the inclusion criteria to include babies admitted within the NNAP reporting calendar year, instead of including babies discharged within the calendar year.\n\n10 August 2021 - Amendment supported to allow BadgerNet ID to be collected and processed by RCPCH for the purposes of this audit, and to support the flow of data including BadgerNet ID from RCPCH to individual Trusts\n\nConditions of support:\n1. Confirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. See section below titled ‘security assurance requirements’ for further information. \n\n• Confirmed: Royal College of Paediatrics and Child Health (by check of the NHS Digital DSPT tracker on 26 January 2021) has a confirmed ‘Standards Met’ grade on DSPT 2019/20) \n\n• Confirmed: CleverMed Ltd (by check of the NHS Digital DSPT tracker on 19 February 2021) has a confirmed ‘Standards Met’ grade on DSPT 2019/20) "]

{"sheet":"A1013","index":180,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","A1013"]
["Reference","21/CAG/0028"]
["Other Refs"]
["Application Title","Motor Neuron Disease Register for England, Wales and Northern Ireland"]
["Application Summary","This non-research application from Kings College London (KCL), set out the purpose of creating a register that will act as a central resource of information about all people with a diagnosis of Motor Neuron Disease (MND) as confirmed by a consultant neurologist in England, Wales and Northern Ireland, to enable the calculation of incidence and prevalence of MND in England, Wales and Northern Ireland. Confidential patient information will also be linked with clinical data from national datasets. This non-research application is for the purpose of improving care planning, looking at regional differences, and enabling the applicants to provide answers associated with the NICE MND Audit.  There is also a separate research application (21/CAG/0009).\n\nMotor neuron disease (MND, ALS) is a terminal disease resulting in progressive paralysis and leading to respiratory failure around 2–5 years after symptom onset. Research shows that the overall number of people diagnosed with MND in the UK is expected to increase significantly. Across the UK there are five regional population registers for MND. Current estimates suggest there are 5,000 people living with MND in the UK at any one time, but whether this is the true figure and how people with MND are geographically distributed is not known. Having a national MND Register for patients living in England, Wales and Northern Ireland will enable calculation of the incidence and prevalence of the disease across these three regions, improve care provision, examine regional differences in survival, and reveal clusters. A national register will also allow the correct modelling of epidemiological variables, for example, the development of a mathematical model of MND. Such models can inform future studies, drug discovery and knowledge of pathogenesis of the disease. \n\nThe MND Register for England, Wales and Northern Ireland has been established to provide the international research community with a resource to understand the epidemiology of MND in the UK, and to further knowledge of causative and disease modifying factors in the disease. It has been funded through a healthcare research grant provided by the MND Association. The MND Register received REC approval in 2015, and has been recruiting patients from England, Wales and Northern Ireland for 5 years using a consented model. Applicants have recruited 1,802 patients across 32 centres in England and Wales which includes complete data capture from six recruiting centres only, and a rate of 38% ascertainment. The current consented register is used for the described non-research purposes.\n\nApplicants have found it difficult to meet the primary objective of obtaining the incidence and prevalence of MND across England, Wales and Northern Ireland as data has been incomplete. Applicants are therefore proposing to change to an opt-out registry to ensure complete ascertainment, and are seeking support under Regulation 5 to enable the prospective recording of all patients with MND across England and Wales. Northern Ireland Is not covered by regulation 5 support. Support is also being sought to collect data retrospectively for patients dating back to June 2015, however, the applicant has confirmed that anyone who previously declined will not be added, and their dissent will be respected. \n\nApplicants will collect confidential patient information regarding every person with MND in England and Wales, including name in order to prevent double counting, and disclose NHS Number, Date of Birth, Gender, Full Postcode and Unique study identifier to NHS Digital and NWIS annually for the purposes of linkage with data from Hospital Episode Statistics (HES), and Office of National Statistics (ONS) mortality data (held at NHS Digital), and also to Patient Episode Database for Wales (PEDW) data held at NHS Wales Informatics Service (NWIS). The register is currently consented, however, the consent taken does not cover the proposed linkages with HES and ONS data. Therefore Regulation 5 support is requested to link identifiers from the previously consented patients to these datasets, and also to link data about every patient added to the register under Regulation 5 support, either prospectively or retrospectively. Clinical and identifiable data will be sent to the study team at KCL every 6 months from clinicians and other providers. Each participant will be assigned a unique study identifier by the direct care team, at the time of data collection and this will be used throughout the involvement of the project. \n\nIdentifiers will be held in a separate database to clinical information and this will be linked through the unique study identifier. No identifiable data will be used as part of analysis for non-research purposes. The following fields will never be shared: Full name, date of birth, NHS number, full postcode, exact dates for example date of birth or date of death. If the year of birth is required for risk factor analysis, then this will be provided. "]
["Applicant Organisation Name","Kings College London (KCL)"]
["Contact Name","Professor Ammar Al-Chalabi, Consultant Neurologist and Head of Basic and Clinical Neuroscience"]
["Address","Maurice Wohl Clinical Neuroscience Institute"]
[null,"Kings College London, Department of Basic and Clinical Neuroscience"]
[null,"5 Cutcombe Road, Camberwell, London"]
["Postcode","SE5 9RX"]
["Telephone","0207 848 5192"]
["Email","ammar.al-chalabi@kcl.ac.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"x","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Data will be collected from patients living in England, Wales, and Northern Ireland over the age of sixteen with a diagnosis of Motor Neuron Disease (MND) as confirmed by a consultant neurologist.\n\nThis collection will be retrospective dating back to June 2015, and prospective.\n\nNote: CAG support only extends to patients in England and Wales, and will not override the dissent of anybody who previously declined."]
["Description of confidential patient information used","Data sources\n1. NHS Digital - HES Admitted Patient Care, Outpatients, and ONS Mortality datasets\n2. NHS Wales Informatics Service, Patient Episode Database for Wales (PEDW).\n3. Clinical notes of MND patients in England and Wales held at various:\n    • NHS Providers\n    • Independent Sector Providers \n    • Voluntary & Third Sector Providers\n\nIdentifiers required for linkage purposes\n1. NHS Number\n2. DOB, \n3. Gender \n4. Full Postcode\n5. Unique study identifier\n\nIdentifiers retained in KCL database\n1. Date of Birth\n2. Gender\n3. Postcode\n4. NHS number\n5. Name (First name and surname) – to prevent double counting\n6. Full date of death \n7. Ethnicity \n8. Date of diagnosis \n9. Unique Study identifier\n\nPatient identifiable information will be held in a separate database to clinical information and this will be linked through a unique study identifier\n\nThese identifiers will be held within the database but not released; any dates required will be modified before releasing.\n\nIdentifiers required for analysis purposes\n1. Date of birth (modified for release to year of birth)\n2. Date of death (modified for release)\n3. Gender\n4. Ethnicity\n5. Date of diagnosis (modified for release)\n6. Unique study identifier \n\nOther clinical data as described in the application\n\nData released for analysis can be considered anonymous\n\nAdditional information\nAnnual extracts from HES – identifiers are sent each time to NHS Digital/NWIS from KCL, and not retained by NHS Digital/NWIS"]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"x","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"x","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"x","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2022-04-14"]
["Notes","The application to allow;\n\n• The disclosure of confidential patient information prospectively for every Motor Neurone Disease (MND) patient over 16 in England and Wales, and retrospectively dating back to June 2015, from various healthcare providers to Kings College London (KCL), in order to create an MND register for non-research purposes) (However, support is not in place to override any patient who has previously dissented from the MND Register),\n\n• Disclosure of confidential patient information from the MND register at KCL to NHS Digital and NHS Wales Informatics Service (NWIS) for the purposes of linkage with Hospital Episode Statistics (HES), and Office of National Statistics (ONS) mortality data (held at NHS Digital), and also to Patient Episode Database for Wales (PEDW) outcomes; This support is regarding approximately 1,802 consented patients who have previously consented to be on the register, but not specifically consented for their data to be linked, and also for any patients who are added to the MND register under Regulation 5 support, and for the flow of data from NHS Digital and NWIS back to KCL, as date of death is part of this dataset and can be considered identifiable, \n\n• KCL to hold identifiers in the MND register indefinitely, \n\nis conditionally supported, subject to compliance with the standard and specific conditions of support.\n\nConditions of support:\n1. As applicants are planning to consult with patients on an ongoing basis, any feedback regarding these ongoing conversations with patients should be provided to the CAG at the time of the first annual review.\n\n2. Support is in place for five years from the date of the final outcome letter. Further support is to be sought after this time\n\n3. Support is not in place for those people who previously dissented to be part of the MND register when the consented model was in place.\n\n4. Support is only in place for England and Wales, and does not extend to Northern Ireland.\n\n5. Confirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. See section below titled ‘security assurance requirements’ for further information.\n\nConfirmed: \nThe NHS Digital 19/20 DSPT review for Kings College London (HQ) EE133874 was confirmed as ‘Standards Met’ on the NHS Digital DSPT Tracker (checked 08 February 2021).\n\nThe NHS Digital 2019/20 DSPT equivalent was confirmed as ‘Standards Met’ on the NHS Digital DSPT Tracker (checked 08 February 2021).\n\nA CPiP has been received for NHS Wales Informatics Service (NWIS). \n\nAs there are additionally 5 or more organisations who will be processing confidential patient information without consent as part of this application, the Confidentiality Advice Team (CAT) team will not check these individually. It is the responsibility of the applicant to ensure these are in place. "]

{"sheet":"A1014","index":181,"n_rows":36,"n_cols":3,"rows_kept":36,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A1014"]
["Reference","20/CAG/0130"]
["Other Refs"]
["Application Title","Yorkshire and Humber Care Record (YHCR) Population Health Management (PHM) for non-research purposes"]
["Application Summary","This application from Humber Teaching NHS Foundation Trust set out the purpose of creating a Population Health Management Solution, which will allow organisations in the Yorkshire and Humber Region to request and receive data for non-research purposes, as part of the Local Health and Care Record Exemplar (LHCRE) Programme.\n\nPopulation Health Management is a technique for local health and care partnerships to use data to design new models of proactive care and deliver improvements in direct care resulting in a positive impact upon health and wellbeing of patients. This will take advantage of digital technologies and data analytics that can be used to prevent avoidable delays in diagnosis, unnecessary repeat tests and reduce clinical uncertainty that can slow down the speed at which people are able to begin to receive the treatment and care they need. The main aims of this work are to \n\n• Improving the physical and mental health outcomes and wellbeing of people, whilst reducing health inequalities within and across the Yorkshire and Humber region. \n• The reduction of re-occurrence of ill-health, including addressing wider determinants of health, and requires working with communities and partner agencies.\n• Addressing the wider determinants of health to early intervention, primary, secondary and tertiary disease prevention.\n\nSupport is requested for the transfer of confidential patient information from participating organisations in the Yorkshire and Humber region to Humber Teaching Hospitals NHS Foundation Trust. The NHS number of patients will then be collated and sent to the NHS Digital’s National De Identify / Re-Identify service, who will return a pseudonym. This will be applied to the data to render it pseudonymous prior to the person requesting access to view the data for analysis on the Humber Teaching Hospitals NHS Foundation Trust system."]
["Applicant Organisation Name","Humber Teaching NHS Foundation Trust"]
["Contact Name","Johnny Chagger"]
["Address","Humber Teaching NHS Foundation Trust"]
[null,"Willerby Hill, Beverley Road"]
[null,"Willerby, East Riding of Yorkshire"]
["Postcode","HU10 6ED"]
["Telephone","07590 914 439"]
["Email","johnny.chagger@nhs.net"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"x","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","All patients and service users irrespective of age or characteristics from organisations in the Yorkshire and Humber area who have not opted out via the national data opt-out.\n\nThe applicants anticipate that 5.5 million service users will be included once fully deployed"]
["Description of confidential patient information used","Data sources\n1. Humber Teaching Hospitals NHS Foundation Trust\n2. Rotherham, Doncaster and South Humber NHS Foundation Trust \n3. Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust \n\nIdentifiers required for linkage purposes\n1. NHS number\n2. Postcode\n\nIdentifiers required for analysis purposes\n1. LSOA or postcode to be able to do geographical analysis and link to deprivation but will not identify individual households.\n\nAdditional information\nNo medical images nor free text information will be included in the clinical data provided."]
["S251 Class(es)",null,"Specific Support"]
[null,"x","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,null,"Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"x","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2022-04-12"]
["Notes","02 November 2022 -  amendment supported to remove the NHS Digital De-identify/Re-identify service and replace it with the Interweave Exchange\n\n12 April 2021 - Application supported\n\nConditions of support:\n\n1. Support is provided for the medical purpose of the non-research activity of the management of health and social care only and does not extend to medical research. \n\n2. In the annual review submissions: \n\n    a. The patient notification materials are to be reviewed as part of the continuing patient and public involvement and any changes or updates are to be reported at annual reviews. \n\n    b. the numbers of patients who opt-out are to be reported at annual reviews. \n\t\n3. This support applies only to Humber Teaching Hospitals NHS Foundation Trust, Rotherham, Doncaster and South Humber NHS Foundation Trust and Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust in the first instance. Where further organisations are in a position to undertake this work an amendment should be submitted to extend this support to these organisations. \n\n4. Confirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold.\n\nConfirmed:-\nThe NHS Digital DSPT submission for Humber Teaching NHS Foundation Trust (18/19), Rotherham, Doncaster and South Humber NHS Foundation Trust (19/20) and Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust (18/19) was confirmed as ‘Standards Met’ by NHS Digital (by check of DSPT tracker on 18 October 2020). "]
[null,"  "]

{"sheet":"A1015","index":182,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","A1015"]
["Reference","21/CAG/0047"]
["Other Refs"]
["Application Title","Neonatal Intensive Care Data to be provided to the National Pregnancy in Diabetes Audit (part of the National Diabetes Audit NDA"]
["Application Summary","This application from NHS Digital set out the purpose of a non-research application seeking to link the National Pregnancy in Diabetes (NPID) audit dataset to the National Neonatal Research (NNRD) database in order to improve data collection and to better look at outcomes for babies who are born to a diabetic mother. \n\nThe applicants are seeking support to link the NPID dataset to neonatal data in order to improve the collection and to better look at outcomes for babies who are born to a diabetic mother. The applicants will investigate whether the outcomes of women with pre-existing diabetes and their babies are different to the general population and will also examine if there is a higher instance of admissions to neonatal intensive care and if these admissions are for longer periods. The findings can then be used to inform changes to the diabetes service for women of childbearing age. Under the work package deliverables set by NHS England and after discussion with the NPID specialist advisory group, it was decided that information on neonatal length of stay and outcomes is required in order to see the full patient journey. The applicants opted to link to the NNRD as the required information is already collected for this database and, by using this existing information, the burden on NPID participants will be eased as will not need to enter any further data. The NNRD has existing support under CAG reference ECC 8-05(f)2010 to enable routinely collected patient identifiable data to be populated on this research database and for onward disclosure of confidential patient information to researchers. Researchers applying to access data from the NNRD must apply via the Neonatal Data Analysis Unit Data Steering Board.\n\nThe NPID audit is part of the National Diabetes audit undertaken by NHS Digital and is directed under s254 of the Health and Social Care Act by NHS England. The applicants will disclose a list of NHS numbers and patient dates of birth from the NPID at NHS Digital to Imperial College London for linkage to NNRD. Imperial College London will match the patients to their records and return a linked dataset, containing patient outcomes, to NHS Digital. All patients in Wales are recruited on a consented basis. Until 31 December 2017, when NHS England directed NHS Digital to undertake the audit under s254, patients in England were recruited on a consented basis. Support is therefore only sought for the processing of confidential patient information for patients in England included in the NPID from 01 January 2018 onwards."]
["Applicant Organisation Name","NHS Digital"]
["Contact Name","Carla Howgate"]
["Address","7 and 8 Wellington Place"]
[null,"Leeds"]
[null,"West Yorkshire"]
["Postcode","LS1 4AP"]
["Telephone","07710 517 376"]
["Email","carla.howgate@nhs.net"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"x","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","All pregnant women in England with pre-existing diabetes that have been entered into the NPID audit since 01 January 2018. \n\nThe babies of women in the cohort who were admitted to neonatal care after birth. "]
["Description of confidential patient information used","Data sources\n1. The National Pregnancy in Diabetes dataset at NHS Digital\n2. The Nation Neonatal Research Database at Imperial College London\n\nIdentifiers required for linkage purposes\n1. Mother’s NHS Number \n2. Mother’s Date of birth \n3. Mother’s Postcode – unit level\n\nIdentifiers required for analysis purposes\n1. Mother’s NHS number\n2. Mother’s DOB\n3. Baby’s NHS number\n4. Baby’s DOB \n\nAdditional information\nPatients in Wales and the Isle of Man, as well as English patients recruited prior to 31 December 2017, are outside the scope of the Regulation 5 support sought. "]
["S251 Class(es)",null,"Specific Support"]
[null,"x","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"x","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"x","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2023-05-07"]
["Notes","07 May 2021 - Application Supported\n\nConditions of support:\n1. Within 6 months of the issuing of the supported outcome the applicants are to provide revised website information. Condition met 15 November 2021. \n\n2. In the first annual review the applicants are to provide the following:\n\n- a. Further patient and public involvement is to be carried out, with a larger group of patient representatives, and feedback provided to the CAG.\n\n- b. Revised patient notification materials are to be provided. Telephone, email and postal contacts need to be provided on all notification materials, including the website information.\n\n- c. Confirm the approximate number of patients who would come under the scope of the Regulation 5 support, e.g. those included on the NPID since 01 January 2018.\nCondition met as part of first annual review\n\n3. Within 4 years of the issuing of the supported outcome, provide an update on the move of the NNRD to NHS Digital and confirm when this will take place. Condition pending\n\n4. This project is to be included on the Imperial College London website, in the area where current projects using the NNRD as listed. Condition met as part of first annual review\n\n5. Confirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. See section below titled ‘security assurance requirements’ for further information. \n\nConfirmed: The NHS Digital 2019/20 DSPT reviews for NHS Digital and Imperial College London – Faculty of Medicine – Neonatal Data Analysis Unit were confirmed as ‘Standards Met’ on the NHS Digital DSPT Tracker (checked 16 April 2021)."]

{"sheet":"A1016","index":183,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","A1016"]
["Reference","21/CAG/0032"]
["Other Refs"]
["Application Title","Non-statutory Medical Examiner System – second phase"]
["Application Summary","This application from NHS England and NHS Improvement set out the purpose of the implementation of the National Medical Examiner system in England.\n\nThe National Medical Examiner system forms part of the NHS Patient Safety Strategy in England and is an important component of improving patient safety. Medical examiners provide independent scrutiny of causes of death and the care before death, and to facilitate feedback from the bereaved. The Government’s proposals for medical examiners, and for a new rigorous, unified system of death certification for both burials and cremations in England and Wales, is part of the response to several independent inquiries into deaths, including the Shipman Inquiry, the Francis Inquiry into Mid Staffordshire, the Morecambe Bay Inquiry and the Gosport Inquiry.  This application has been made to implement the system in England only. Primary legislation is expected to put the system on a statutory footing from April 2022. The applicants seek to establish a legal basis for the disclosures of confidential patient information made to medical examiners employed by host trusts before the statutory system becomes operational.\n\nThe programme is comprised of two phases. The first phase, which involved setting up medical examiner offices within NHS trusts and NHS foundation trusts, is already underway. Medical examiners are senior doctors employed by Host Trusts, to provide independent scrutiny of non-coronial deaths, and are operating in larger NHS trusts and NHS foundation trusts across England (“Host Trusts”), reviewing deaths that occur in their organisation. Medical examiners and medical examiner officers currently access Trust patient records undertake this review.\n\nThis application concerns the next phase of the programme, where the medical examiner offices will provide independent scrutiny of non-coronial deaths which occur in settings outside the Host Trust (for example, at home or in the care of other health providers, such as hospices and private hospitals). This will require medical examiners to access the records of deceased individuals held outside Host Trusts by different healthcare providers. The wide range of patient record systems utilised by providers means that local arrangements to enable independent scrutiny to take place will vary.  Medical examiner scrutiny will take place in the brief window before the death must be registered (5 days) and has three elements; discussion with the doctor completing the medical certificates of cause of death; giving the bereaved an opportunity to ask questions about the causes of death and raise any concerns; and a proportionate review of the patient record. \n\nThe medical examiners will require access to confidential patient information for deceased patients who were cared for by other providers. These healthcare providers, such as GPs, independent healthcare providers, and NHS Trusts and NHS foundation trusts which do not host a medical examiner office, will share medical records of deceased patients (with medical examiners and medical examiner officers, or provide equivalent access to review such records, for example through electronic patient record systems. Medical examiners will carry out a proportionate review of the records of these deceased patients, as part of their independent scrutiny. They will also contact the next of kin identified in the patient record to ask if they have questions about the causes of death or concerns about care before death. After the medical examiner has completed their work, the patient record will remain with or be returned to the original healthcare provider. Medical examiner offices will retain records of their scrutiny, including patient identifiable data, and these records will be maintained in line with the information governance and data security policies of their NHS Trust or NHS foundation trust. Where medical examiners identify points for learning or improvement, medical examiners will indicate these for further investigation through established clinical governance and quality processes, such as mortality reviews. "]
["Applicant Organisation Name","NHS England and NHS Improvement"]
["Contact Name","Mr Nick Day, Policy and Programme Lead"]
["Address","Medical Examiner System"]
[null,"Skipton House"]
[null,"80 London Road, London"]
["Postcode","SE1 6LH"]
["Telephone","07500 066 544"]
["Email","nickday@nhs.net"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"x","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","All deaths which occur in England that are not referred to a coroner and occur outside the host Trust of a medical examiner (approximately 240,000 per annum) "]
["Description of confidential patient information used","Data sources\n1. Electronic and paper records held at healthcare providers outside host Trusts of the medical examiner. For example, GPs, independent healthcare providers (e.g. hospices and private hospitals), and NHS Trusts and NHS foundation trusts which do not host a medical examiner office\n\nIdentifiers required for linkage purposes\n1. Name \n2. Date of birth \n3. Date of death \n4. Place of death \n5. NHS number \n6. Contact details of next of kin, likely to include name and telephone number, and in some cases, address and/or email address \n\nIdentifiers required for analysis purposes\n1. Name \n2. Date of birth \n3. Date of death \n4. Place of death \n5. NHS number \n6. Contact details of next of kin, likely to include name and telephone number, and in some cases, address and/or email address "]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"x","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"x","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2022-05-10"]
["Notes","21 February 2022 - Amendment supported:\nAmendment supported to extend the duration of support until 31 March 2023.\n\n\n10 May 2021 - Application supported\n\nSpecific conditions of support:\n\n1. Confirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. See section below titled ‘security assurance requirements’ for further information. \n\nConfirmed:-\nDue to the number of organisations involved it is the responsibility of NHS England and NHS Improvement, as controller, to ensure that Trusts hosting the medical examiners meet the minimum required standard in complying with DSPTs, and take remedial action if they become aware of any that fall below this, or where any concerns are raised about a Trust.\n"]

{"sheet":"A1017","index":184,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A1017"]
["Reference","21/CAG/0084"]
["Other Refs"]
["Application Title","National Cancer Patient experience survey 2021 (NCPES)"]
["Application Summary","This application from Picker Institute Europe on behalf of NHS England and NHS Improvement set out the purpose of administering patient surveys to evaluate services provided to cancer patients in 2021. This will enable comparisons between Trusts, for commissioners, providers and patients (all of whom can access the published results), allow for monitoring of improvements in services, drive further improvements, and provide NHS England with an up to date overview of cancer patient experience across England. \n\nThe Cancer Patient Experience Survey (CPES) 2021 fieldwork period will begin at the end of October 2021 and is due to close in January 2022. Survey findings will be published in March 2022. \n\nThe 2021 survey will replicate the methodology used in previous iterations of the survey. Picker Institute Europe works with Greens Limited to mail initial questionnaires and then reminders (as required) to eligible participants following the above checks using name and address. The survey will be conducted by post, with two reminders (to non-responders only) as is the case with other national patient surveys. A standard questionnaire, covering letter and up to two reminder letters will be used. Patients will also be sent a link to complete the survey online should they prefer to do so. \n\nAlthough the methodology is the same as previous surveys, the questionnaire is slightly altered, to allow for the pandemic, and to allow further inclusivity. Information on gender identity alongside sex will be collected, however this is self reported in the questionnaire rather than disclosed to Picker from Trusts. ICD 11 code will also be collected alongside ICD 10 code."]
["Applicant Organisation Name","Picker Institute Europe (on behalf of NHS England & NHS Improvement)"]
["Contact Name","Nikki Gambles, Insight & Feedback Manager"]
["Address","NHD England and NHS Improvement"]
[null,"Leeds Quarry House"]
[null,"Quarry Hill, Leeds"]
["Postcode","LS2 7UA"]
["Telephone","07527 696 885"]
["Email","Nikki.gambles@nhs.net"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"x","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","approximately 125,000 patients\n\nAll adult patients (aged 16 and over), with a confirmed diagnosis of cancer, who have been admitted to hospital as inpatients for cancer related treatment, or who were seen as day case patients for cancer related treatment, and have been discharged between 1st April 2021 and 30th June 2021 will be included in the survey."]
["Description of confidential patient information used","Data sources\n1. Acute and specialist NHS Trusts in England that provide adult cancer services.\n\nIdentifiers required to be disclosed to Picker\nIdentifiers disclosed by the Trusts:\n1. Trust Code\n2. Anonymised reference number for each record (applied by Trust)\n3. Name \n4. NHS number\n5. Full address\n6. Sex\n7. Ethnic group\n8. Date of birth\n9. ICD10 code\n10. ICD11 code \n11. Admission and discharge dates\n12. Speciality code\n13. Referring CCG\n14. Admission type\n15. Site treated at\n\nIdentifiers required for analysis purposes\n1. Postcode – (modified for analysis)\n2. Anonymised reference number for each record (applied by Trust)\n3. ICD10 code\n4. ICD11 code \n5. Speciality code\n6. Ethnic group\n7. Age\n8. Self reported sex (from questionnaire response)\n9. Self reported gender  (from questionnaire response)"]
["S251 Class(es)",null,"Specific Support"]
[null,"x","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"x","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"x","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"x","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2023-06-17"]
["Notes","17 June 2021 - Application supported\n\nConditions of support:\n1. Please confirm if support is required for confidential patient information to be disclosed from Picker to NHS Digital in order to undertake ‘deceased checks’, within one month from the date of this letter. \n\nConfirmed 23 June 2021 - The applicant confirmed by email that support is not required for this element; Picker has its own access to the NHS spine to conduct deceased checks in-house. Therefore, no confidential patient information needs to be passed between Picker and NHS Digital as part of this process. The Members were content with this response, and the condition has been met- confirmed to the applicant by email on 23 June 2021.\n\n2. Confirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold.\n\nConfirmed:- \nThe NHS Digital 19/20 DSPT reviews for Picker Institute Europe and Greens Ltd were confirmed as ‘Standards Met’ on the NHS Digital DSPT Tracker (checked 15 June 2021)"]

{"sheet":"A1018","index":185,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","A1018"]
["Reference","20/CAG/0151"]
["Other Refs"]
["Application Title","NHS Digital and BAD: Dermatology Intervention Service and Clinical Registries"]
["Application Summary","This application from the British Association of Dermatologists set out the purpose of creating a national audit of the NICE Service Guidance on the organisation and delivery of dermatology healthcare services, which will provide the national NHS dermatology service with clinical outcomes for benchmarking by individual consultants, their trusts, Clinical Commissioning Groups and patients in England.\n\nThe dermatology specialty is largely outpatient-based, and diagnostic data is not routinely collected to identify patients’ skin disease and co-morbidities. Trusts also have historically under recorded outpatient procedural data. This has made it difficult to undertake qualitative and quantitative data analysis to audit and benchmark services. The applicants will create a national audit intended to address these deficiencies and support quality improvement activities, local clinical audit processes and to deliver improved, measurable patient care. The data will also be used to help dermatology departments to achieve some of the areas for improvement identified in the It Right First Time (GIRFT) programme.\n\nThe applicants seek support to allow the disclose of confidential patient information from participating NHS trusts to NHS Digital. The confidential patient information will be entered into the NHS Digital Clinical Audit Platform (CAP) system by staff at participating NHS trusts in England. An extract of identifiable and sensitive data will be taken for statistical analysis by NHS Digital, and reports created of de-identified aggregate data. Reports with identifiable data will be made available within CAP for individual organisations to access their own results for local audit. There will be no linkage to other datasets. The data collection is prospective and will be undertaken on a yearly basis to provide the comparative analysis needed to inform on patient demographics, skin disease rates and efficacy of treatments."]
["Applicant Organisation Name","British Association of Dermatologists"]
["Contact Name","Ms Tania von Hospenthal"]
["Address","The British Association of Dermatologists, Wilan House"]
[null,"4 Fitzroy Square"]
[null,"London"]
["Postcode","W1T 5HQ"]
["Telephone"]
["Email","tania@bad.org.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"x","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","All (child and adult) dermatology patients receiving phototherapy treatment and/or cutaneous allergy testing, seen in outpatient secondary care departments and tertiary dermatology centres in NHS trusts in England.  \n\nApproximately 600,000 attendances for dermatological treatment occurred in 2019. "]
["Description of confidential patient information used","Data sources\n1. Clinical data for eligible patients at participating trusts, input into the NHS Digital Clinical Audit Platform (CAP) system.\n\nIdentifiers required for linkage purposes\n1. NHS Number\n2. Date of birth\n3. Postcode – district level\n4. Sex\n5. Ethnicity\n6. Consultant GMC code\n\nIdentifiers required for analysis purposes\n1. NHS Number\n2. Date of birth\n3. Postcode – district level\n4. Sex\n5. Ethnicity"]
["S251 Class(es)",null,"Specific Support"]
[null,"x","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"x","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"x","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2023-06-21"]
["Notes","21 June 2021 - Application supported\n\nSpecific conditions of support:\n1. At the first annual review, provide a report on further patient and public involvement undertaken by the applicants.\nApplicant has submitted first annual review, but has not undertaken any patient and public involvement. The Condition has therefore been applied to the second annual review expected in 2023. \n\n2. Confirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. \n\nConfirmed:- The NHS Digital 19/20 DSPT review for NHS Digital was confirmed as ‘Standards Met’ on the NHS Digital DSPT Tracker (21 June 2021)"]

{"sheet":"A1019","index":186,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","A1019"]
["Reference","21/CAG/0085"]
["Other Refs"]
["Application Title","The Child Health Clinical Outcome Review Programme (CH-CORP)"]
["Application Summary","This Healthcare Quality Improvement Partnership (HQIP) commissioned non-research application from the National Confidential Enquiry into Patient Outcome and Death (NCEPOD) set out the purpose of undertaking a rolling programme of topics under the Child Health Clinical Outcome Review Programme (CH-CORP) core methodology, which aims to review the organisation of, and clinical care provided to children and young people up to their 25th birthday, by undertaking confidential reviews of case notes. Previous related applications for specific studies in this area include 15/CAG/0210 and 18/CAG/0127, however this application falls under a new contract with HQIP and it has been set up in a rolling manner so applicants apply a core methodology but start a new topic each year, as is undertaken as part of the Medical and Surgical Clinical Outcome Review Programme (PIAG 4-08(b)/2003), where CAG have supported the core method and applicants submit an amendment with a new protocol for each new study started. The application activities are carried out across England, Wales, Northern Ireland, Guernsey, Jersey and the Isle of Man; however, the CAG remit extends only to data generated in England and Wales.\n\nThis application is for the Child Health Clinical Outcome Review Programme (CH-CORP) core methodology, to allow NCEPOD to run confidential enquiries to improve the quality of care for future young people. Although aiming to identify areas for improvement, NCEPOD will also highlight examples of good practise, and provide tools to help providers make changes and monitor the impact they are having. The recommendations made by NCEPOD over the last 30 years have had considerable impact on healthcare.\n\nThis application is additionally for their first proposed study; ‘Transition from child to adult services study’. The purpose of this study is to explore the barriers and facilitators in the process of the transition of young people with complex chronic conditions from child to adult health services. There is evidence that for many young people with complex conditions and their families, this can be an apprehensive time as it is often associated with a dislocation of care and a deterioration in health and wellbeing.\n\nApplicants plan to use standard NCEPOD retrospective questionnaire and case note review methodology on a sample of patients from various healthcare providers, who match the inclusion criteria for a specific study. Confidential patient information relating to all eligible patients will be reported to NCEPOD from participating healthcare providers via a patient identification spreadsheet. This data is entered onto the NCEPOD database, and a pseudonym applied unique NCEPOD number. From this, the data will be sampled for those to be included in the study. The patient identifiable data for those not included in the study are kept until all sampling is done, just in case re-sampling is required, and then removed from the database at the earliest possible opportunity as it is not needed.\n\nThe clinician(s) involved in the patient’s care are then notified that they need to complete a questionnaire, and return copied extracts of the case notes, to undergo peer review. The NHS number and date of birth alongside the NCEPOD number is used to enable clinicians to identify the correct patients, and the questionnaire is returned back pseudonymously via the online questionnaire system, using only the NCEPOD number. Depending on the study, case notes will be requested from all relevant healthcare services. If a young person is identified and tracked across a number of care settings, case notes will be requested from all organisations. Case notes are returned in an identifiable format, and upon receipt at NCEPOD, patient identifiers are removed by the NCEPOD team as soon as possible after receipt but no later than two months, if not already done so. Care providers are encouraged where possible to remove patient identifiable data, however the applicants understand this does represent an additional burden to the direct care team.\n\nA multidisciplinary group of clinical case reviewers will be recruited to assess the case notes and questionnaires and provide their opinion on what went well and what did not go well during the care under review. NCEPOD staff will ensure there is a mix of specialties at each meeting from across the UK. Note that all patient identifiable data are removed from case notes before being seen by case reviewers. The set of case notes is only identified by the ‘NCEPOD number’ allocated to the case."]
["Applicant Organisation Name","National Confidential Enquiry into Patient Outcome and Death (NCEPOD) "]
["Contact Name","Dr Marisa Mason"]
["Address","Ground Floor Abbey House "]
[null,"74-76 St John Street "]
[null,"London"]
["Postcode","EC1M 4DZ "]
["Telephone",2072519060]
["Email","mmason@ncepod.org.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"x","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Cohort\n\nIn general, patients from birth up to their 25th birthday will be eligible for inclusion. However, the inclusion criteria will be specific for each topic and will be highlighted in the amendment form when each study protocol is submitted. \n\nSupport is also in place for those who are deceased. \n\n"]
["Description of confidential patient information used","Data sources\n\nCase notes from all organisations that provide care to patients aged 0-24 years, such as, but not limited to; secondary/tertiary care, community care. primary care, mental healthcare, independent healthcare or hospices \n\nIdentifiers initially collected for all patients\n\nThis could include but are not limited to the below;\n\n1.\tNHS number \n2.\tHospital number \n3.\tDate of birth \n4.\tSex \n5.\tDiagnosis and/or procedure code \n6.\tDate of admission \n7.\tSource of admission \n8.\tDate of discharge/death \n9.\tAdditional healthcare organisations \n10.\tPotentially partial postcode if an aspect of a study was very focused on deprivation \n\nIdentifiers required for linkage between organisations purposes (sampled patients)\n\nThis information will be used to notify the clinician who needs to complete a questionnaire, or the local contact at the healthcare provider who will send/scan copied case note extracts to NCEPOD. \n\n•\tNHS number \n•\tHospital number \n•\tDate of birth \n•\tSex\n•\tDate of admission – where applicable \n•\tDate of discharge – where applicable \n•\tNCEPOD number – for future pseudonymisation where possible \n•\tNCEPOD ‘site identification – for future pseudonymisation where possible \n\nIdentifiers required for analysis purposes\n\nFor the clinical questionnaires and case reviewer data – no identifiers are needed as all data are linked by the NCEPOD number only. Note that NHS number is removed."]
["S251 Class(es)",null,"Specific Support"]
[null,"X","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"X","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"X","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"X","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2023-07-13"]
["Notes","19 July 2022 – amendment supported to add the first topic for the 2022 NCEPOD reviews, Testicular Torsion\n\n07 June 2022 - Amendment supported:\nAmendment supported to extend the duration of ‘s251’ support for the ‘Transition from child to adult services study’ sub-study until September 2023, and to use hard copy questionnaires for this sub-study if required.\n\n13 July 2021 - Application Supported\nThe application, \n\n1.\tto support a core methodology of data collection for The Child Health Clinical Outcome Review Programme (CH-CORP); of disclosing confidential patient information regarding all eligible cases from participating healthcare providers to the National Confidential Enquiry into Patient Outcome and Death (NCEPOD), selecting a sample, and using confidential patient information to follow-up with clinicians involved in the patients care by way of questionnaire (completed online in pseudonymised format), and to disclose relevant copies of extracts from the patient’s case notes from treating clinicians to NCEPOD,\n\n2.\tand also for the described core methodology to be used to undertake the ‘Transition from child to adult services study’, \n\nis conditionally supported, subject to compliance with the standard and specific conditions of support.\n\nConditions of support:\n\n1.\tSupport extends to data generated in England and Wales only. \n\n2.\tPlease re-visit the methods of disclosing confidential patient information to explore if there are more secure alternatives available and provide feedback at annual review.\n\nCondition met as part of first annual review\n\n3.\tPlease update the general NCEPOD poster to explain what NCEPOD is and provide an updated version to CAG within one month from the date of this letter. \n\nCondition met 11 August 2021\n\n4.\tPlease provide some more detail on whether different approaches will be considered for different sub-studies, specifically regarding age appropriate patient notification, how you will differentiate between parent/carer and children notifications, and a statement regarding the policy that will be followed regarding any conflicting opt-out requests (from a parent/carer and their child), within one month from the date of this letter.\n\nCondition met 11 August 2021\n\n5.\tPlease revise the transition notification materials to ensure the poster explains what NCEPOD is, ensure there is no suggestion of research activity, and re-consider the language used to ensure they are written in plain English, and provide updated versions to CAG within one month from the date of this letter. \n\nCondition met 11 August 2021\n\n6.\tPlease provide any detail regarding turnover of the eight permanent lay representatives, within one month from the date of this letter.\n\nCondition met 11 August 2021\n\n7.\tPlease provide any further patient and public involvement feedback surrounding the use of confidential patient information without consent, that is noted as expected for both the core methodology and the transition sub-study, when it is available. \n\nCondition met 19 May 2022\n\n8.\tConfirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. See section below titled ‘security assurance requirements’ for further information. Confirmed: \n\nThe NHS Digital 2019/20 DSPT review for National Confidential Enquiry into Patient Outcome and Death (NCEPOD) was confirmed as ‘Standards Met’ on the NHS Digital DSPT Tracker (checked 5 July 2021)\n\nDue to the number of participating care providers involved it is the responsibility of NCEPOD on behalf of HQIP, as controller, to ensure that all organisations disclosing confidential patient information to NCEPOD meet the minimum required standard in complying with DSPTs, and take remedial action if they become aware of any that fall below this, or where any concerns are raised about a care provider. These will not be individually checked by the CAT team due to the number of organisations involved."]

{"sheet":"A1020","index":187,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A1020"]
["Reference","21/CAG/0074"]
["Other Refs"]
["Application Title","CQC 2021 Community Mental Health Survey - Mixed Methods stand alone pilot"]
["Application Summary","This non-research application submitted by Ipsos MORI on behalf of the Care Quality Commission, set out the purpose of administering the 2021 Community Mental Health Survey - Mixed Methods stand alone pilot. The community mental health mainstage survey has previously been conducted using a postal approach. However, this pilot study will test the effectiveness of a mixed methods approach, offering the questionnaire online (in addition to a postal survey), and sending SMS reminders (in addition to postal reminders).\n\nThe community mental health Survey falls within the NHS Patient Survey Programme (NPSP). The NPSP was initiated in 2002 by the then Department of Health, and is now overseen by the Care Quality Commission (CQC), the independent regulator of health and social care in England. \n\nIpsos MORI will select 21 Trusts for inclusion in the pilot with the aim of 20 trusts completing it. Trusts will collect information of all eligible patients and, following suitability checks, will share confidential patient information with the coordination centre (IPSOS MORI). The sample for each trust will be split into a “control” group and an “intervention” group. The “control” group will receive the survey as they would for the current Community Mental Health Survey design (a paper questionnaire only). Those in the “intervention” group will receive a different mailing strategy designed to encourage them to take part online – this will also include SMS messages. A postal questionnaire will be available to all patients. All fieldwork will be conducted by the Coordination Centre for Mixed Methods (based at Ipsos MORI).  This differs to the main survey where NHS trusts may opt to undertake the mailing of questionnaires themselves or to employ an approved survey contractor to administer the survey on their behalf.\n\nIPSOS MORI will distribute questionnaires to patients using the approach detailed below;\n\nThe intervention group will receive;\nContact 1:      Letter + URL link for online questionnaire\nContact 2:      SMS despatched 7 days later +URL link for online questionnaire\nContact 3:     Contact 1 +2wks, 50% letter +URL, 50% letter +URL +paper questionnaire\nContact 4:      SMS despatched 7 days later +URL link for online questionnaire \nContact 5:      Contact 3 +2wks, letter with paper questionnaire (no URL)\n\nThe control group will receive the same number and style of contacts as the 2021 Community Mental Health Survey approach:\nContact 1:         Letter with paper questionnaire\nContact 2:         1 week after contact 1, reminder letter\nContact 3:         2 weeks after contact 2, reminder letter with paper questionnaire\n\nAhead of each reminder, it will be necessary to remove all respondents who have completed the survey already, and to conduct a DBS or local check on the full sample. If anyone has requested to be opted out of further reminders, they should also be removed at these timepoints."]
["Applicant Organisation Name","Ipsos MORI"]
["Contact Name","Laura Thomas"]
["Address","Ipsos MORI"]
[null,"3 Thomas More Square"]
[null,"London"]
["Postcode","E1W 1YW"]
["Telephone","0203 059 4717"]
["Email","laura.thomas@ipsos.com"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"x","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Patients aged 18 and over who had been in contact with NHS mental health services in the three-month period from 1st May 2021– 31st July 2021, and who were receiving specialist care or treatment for a mental health condition, including those who receive care under the Care Programme Approach (CPA)\n•\tWho were seen by someone face-to-face at the trust or via video conference (e.g. using Attend Anywhere, MS Teams, Zoom etc) or telephone call between 1st May and 31st July 2021 (the sample period); AND \n•\thad at least one other contact (face-to-face, video conference, phone or email) either before, during or after the sampling period \n760 service users from 20 Trusts. (a total of 14,000)"]
["Description of confidential patient information used","Data sources\n\n1.\tElectronic patient records, Mental Health Trusts in England\n\nIdentifiers required for contact purposes\n\n1.\tTrust code\n2.\tA standardised unique identifier code, \n3.\tTitle (Mr, Mrs, Ms, etc.) \n4.\tFirst name \n5.\tSurname \n6.\tAddress Fields \n7.\tPostcode \n8.\tMobile phone number where available \n\nIdentifiers required for analysis purposes\n\n1.\tTrust code\n2.\tThe unique identifier code (as above)\n3.\tYear of birth \n4.\tPostcode\n5.\tGender \n6.\tEthnic category \n7.\tDay of last contact \n8.\tMonth of last contact \n9.\tYear of last contact \n10.\tCPA status \n11.\tCCG code\n12.\tMental Health Care Cluster Codes\n13.\tMode of contact since 1st March 2020\n14.\tPostcode (mapped to Lower Layer Super Output Areas to allow analysis by deprivation and region, then securely deleted)"]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"X","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"X","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2023-08-10"]
["Notes","Conditions of support:\n\n1.\tConfirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. See section below titled ‘security assurance requirements’ for further information. Confirmed: \n\n\nThe NHS Digital 20/21 DSPT review for Ipsos MORI was confirmed as ‘Standards Met’ (by email to the CAG inbox 4 August 2021)."]

{"sheet":"A1021","index":188,"n_rows":36,"n_cols":3,"rows_kept":36,"cut":false,"hidden":false,"merged":[[31,1,31,4],[32,1,32,4],[34,1,34,4],[35,1,35,4],[21,1,21,4],[22,1,22,4],[23,1,23,4],[24,0,30,0],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,2,30,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A01021"]
["Reference","21/CAG/0090"]
["Other Refs","superseded PIAG 4-07 (c)/ 2002"]
["Application Title","Paediatric Intensive Care Audit Network (Non research application)"]
["Application Summary","This non-research application from University of Leeds (on behalf of Healthcare Quality Improvement Partnership (HQIP), NHS England & Improvement (NHSE&I) and University of Leicester), set out the purpose of collecting data on all infants, children and young people accepted for referral, transported or admitted to designated paediatric intensive care units (PICUs) in the UK, to establish PICANet - the national clinical audit of the Paediatric Intensive Care services. PICANet is part of the National Clinical Audit and Patient Outcomes Programme (NCAPOP).\n\nThe commissioning body for data collected from English NHS PICUs and transport teams is HQIP. They are data controller for this part of the dataset alongside NHSE&I. The University of Leeds is data controller for all other personal data alongside University of Leicester. The database is held at the University of Leeds. PICANet is a collaboration between the Universities of Leeds and Leicester, both of whom are considered data processors. \n\nPICANet currently has ‘s251’ support under application reference PIAG 4-07 (c)/ 2002. This non-research application has been submitted alongside a research application (21/CAG/0098), in order to split out the research and non-research functions of PICANet into separate applications, and to refresh the support required, as the original application was supported in 2002. PIAG 4-07 (c)/ 2002 will be expired and replaced with 21/CAG/0090 and 21/CAG/0098. \n\nThe aim of PICANet is to audit the quality of care delivered against the Paediatric Intensive Care Society (PICS) standards and key quality metrics adopted by the Care Quality Commission (CQC), including the whole patient pathway from the initial referral to paediatric intensive care, specialist transport and inpatient care. Data is also used to support healthcare planning and undertake service evaluations. Audit data is used continuously to develop anonymised outputs, including an annual report on data.gov and PICANet websites, CQC reports, and published papers. \n\nData collection started in 2002 and is currently ongoing under PIAG 4-07 (c)/ 2002.  Data is collected from PICUs and Specialist Paediatric Critical Care Transport Services throughout the UK and Republic of Ireland via a secure web based application, however this ‘s251’ application only covers English and Welsh data. Confidential patient information is collected to allow identification of multiple admissions, referrals, and transports for the same individual. Data is also collected regarding demographics, referral, transport and admission details, diagnosis, interventions received and outcomes. Customised data collections are occasionally undertaken, which collect additional clinical data items specific to an area of care or in response to local or national policy requirements. However, no additional identifiers are required to support these customised data collections. Current customised data collections include NET-PACK 3, Renal Summary, Renal Daily and COVID-19/PIMS-TS.\n\nIdentifiable patient data collected as part of PICANet dataset is stored at the University of Leeds on the Secure Electronic Environment for Data (SEED) system. Identifiers are retained in the same database as clinical data but are stored in a separate table using column-level AES-256 encryption. During Summer 2021, the SEED architecture is being replaced by a new system called LASER. Patient identifiable data will be stored in a secured project area on the LASER platform.\n\nData requests from third parties that are outside scope of the purposes of this application will be requested to submit a separate ‘s251’ application. PICANet has a Clinical Advisory Group (CAG), whose members review requests for access to PICANet data to ensure feasibility, prevent duplication of service evaluation and audit, and to encourage collaboration. "]
["Applicant Organisation Name","University of Leeds"]
["Contact Name","Professor Richard Feltbower, "]
["Address","Level 11 LIDA Reception"]
[null,"Worsley Building"]
[null,"Clarendon Way, University of Leeds"]
["Postcode","LS2 9JT"]
["Telephone","0113 343 4841"]
["Email","r.g.feltbower@leeds.ac.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"x","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","All infants, children and young people accepted for referral, transported or admitted to designated paediatric intensive care units (PICUs) providing paediatric Level 3 Critical Care (as defined by the Royal College of Paediatrics and Child Health) in the UK and Republic of Ireland. (‘s251’ support covers England and Wales only).\n\nThere are on average around 20,000 new admissions per year in total, approximating 16,500  for England and Wales. (relevant to ‘s251’ support)\n\nData collection started in 2002 and is ongoing."]
["Description of confidential patient information used","Data sources\n\nMedical records from the below sources;\n1.\tEnglish NHS Paediatric Intensive Care Units (PICU)s\n2.\tEnglish private/non-NHS PICU\n3.\tWelsh NHS PICU \n4.\tEnglish NHS Transport teams \n5.\tWelsh NHS Transport teams\n\nIdentifiers collected in PICANet database\n\nName\nAddress\nPostcode (unit level)\nNHS number\nCase note number/Hospital number\nGP registration\nDate of birth\nDate and time of death\nSex\nEthnicity \n\nIdentifiers required for linkage purposes within PICANet database \n\nNHS number \nCase note number/Hospital number\nPostcode (with address used to validate postcode)\nName\nDate of Birth\nSex\n\nIdentifiers required for analysis purposes\n\nIdentifiers required for analysis within PICANet \n1.\tDate of birth\n2.\tPostcode\n3.\tDate of death\n4.\tSex\n5.\tEthnicity\n\nNo identifiers released to external third parties for analysis. "]
["National Data Opt \nOut Status","The Secretary of State for Health and Social Care decision maker, on advice from the CAG, has supported a request to defer the National Data Opt Out. As such, the National Data Opt Out does not need to be applied for this activity"]
["S251 Class(es)",null,"Specific Support"]
[null,"X","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"X","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"X","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"X","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2023-08-10"]
["Notes","Amendment supported 17 November 2022 \nTo allow ‘level 2’ additional data collection, regarding children admitted to all designated Level 2 paediatric critical care ‘PCC’ units in England, including confidential patient information, and additional clinical data items specific for level 2 care\n\nAmendment supported 22 July to defer applying the National Data Opt-Out in relation to 21/CAG/0090\n\nSpecific conditions of support \n\n1.\tThis outcome confirms a change to the original conditions of support. The National Data Opt-Out is not to be applied to patients included in the activities specified in 21/CAG/0090.\n\n2.\tA local patient objection mechanism must continue to be used in relation to 21/CAG/0090. \n\n3.\tPlease provide updated patient notification materials, which make a clear distinction between the application of the NDO for research and non-research. These should be provided within 3 months from the date of this letter.\n\nCondition met 17 August 2022\n\n4.\tPlease provide any feedback of planned discussions with patients and the public, surrounding the non-application of the National Data Opt-Out, when it is available.\n\n\n22 June 2022 - Amendment supported:\nAmendment supported to allow a ‘pilot level 2’ additional data collection, regarding children admitted to 7 participating level 2 paediatric critical care ‘PCC’ units, including confidential patient information, and additional clinical data items specific for level 2 care.\n\nConditions of support:\n\n1.\tSupport for PIAG 4-07 (c)/ 2002 is expired from the date of this letter.\n\n2.\tSupport extends to data collected in England and Wales only.\n\n3.\tSupport is provided for five years, at which time point a duration amendment is required.\n\n4.\tPlease provide justification as to why GP registration is required, and feedback to the Confidentiality Advisory Group within three months from the date of this letter. \nCAG confirmed condition met 10 December 2021\n\n5.\tPlease review the privacy notice in line with the advice given in the text of this letter, and provide an updated version to the Confidentiality Advisory Group within three months from the date of this letter.\nCondition met 15 December 2021\n\n6.\tPlease provide a description of the communications and processes used surrounding the opt out process, specifically regarding the data that remains in PICANet, within three months from the date of this letter.\nCondition met 15 December 2021\n\n7.\tPlease provide a Patient and Public Involvement plan to the Confidentiality Advisory Group within three months from the date of this letter.\nCAG confirmed condition met 10 December 2021\n\n8.\tPlease consider lay representation on the PICANet Clinical Advisory Group.\nCAG confirmed condition met 10 December 2021\n\n9.\tConfirmation provided from the IG Delivery Team at NHS Digital to the Confidentiality Advisory Group that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. See section below titled ‘security assurance requirements’ for further information. Confirmed: \n\nThe NHS Digital 19/20 DSPT reviews for University of Leeds - Secure Electronic Environment for Data (SEED) (8E218 – SEED) and University of Leicester College of Life Sciences (EE133832-CMBSP) were confirmed as ‘Standards Met’ on the NHS Digital DSPT Tracker (checked 26 July 2021)\n\nThe NHS Digital 20/21 DSPT review for University of Leeds - LASER (8KM29) was confirmed as ‘Standards Met’ on the NHS Digital DSPT Tracker (checked 26 July 2021) - will be required once migration from SEED to LASER is complete later this year.\n\nDue to the number of participating PICUs/transport providers involved it is the responsibility of the applicant, as controller, to ensure that all organisations processing confidential patient information meet the minimum required standard in complying with DSPTs (or CPiPs for Wales), and take remedial action if they become aware of any that fall below this, or where any concerns are raised about a care provider. These will not be individually checked by the CAT team due to the number of organisations involved."]

{"sheet":"A1022","index":189,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A1022"]
["Reference","21/CAG/0105"]
["Other Refs"]
["Application Title","Adherence to oral anticoagulants and statins"]
["Application Summary","This application from the Leeds Teaching Hospitals NHS Foundation Trust set out the purpose of a service evaluation to investigate the real-world rates of non-adherence to direct oral anticoagulants (DOACs) and statins, and to improve the awareness of healthcare professionals on adherence across Leeds.\nAtrial Fibrillation (AF) is the most common adult arrhythmia. One of its major complications is ischemic stroke and, therefore, individuals who are at risk are prescribed an anticoagulant. Evidence shows that oral anticoagulants (OACs) reduce the risk of stroke by over 70%, however non-adherence to these effective therapies can translate to an increased risk of treatment failure, hospitalisations and early mortality. Direct oral anticoagulants (DOACs), which include dabigatran, rivaroxaban and edoxaban, are the most commonly prescribed OACs. According to the 2021 NICE Guidelines, DOACs are the treatment of choice for patients with AF. DOACs have many advantages over warfarin, however, as they do not require routine therapeutic monitoring, the chances of detecting non-adherence is reduced. Previous studies have shown that non-adherence to DOACs was associated with an increased risk for combined all-cause mortality and stroke. Various studies report different levels of self-reported non-adherence to OACs, but it seems to be prevalent and common among patients with atrial fibrillation. One study showed that only 55% of patients reported high level of adherence to OAC. The applicants will calculate the rates of medication adherence/non-adherence using individual repeat prescription data extracted from the two primary care patient records systems, SystmOne and Egton Medical Information Systems (EMIS). Currently, a general estimate of adherence is automatically calculated within the medical records systems, however data are not extractable from the systems. The applicants therefore need to extract confidential patient information, and then calculate the rate externally for each individual patient, to acquire objective information on real-world adherence patterns.\nConfidential patient information from GP records, collected as part of routine care and services provided by the practice, will be accessed and extracted by the LTHT Pharmacist, and transferred to Leeds Teaching Hospitals NHS Foundation Trust. Access to primary care systems will be granted by GP Practices on a temporary basis for the extraction. A search has been designed by the Leeds Clinical Commissioning Group (CCG) to identify all potential patients who currently have a repeat prescription for a DOAC or a statin for at least 6 months prior to the date of data extraction and who have not objected to the project or opted-out. The LTHT Pharmacist will pseudonymise the data using OpenPseudonymiser, to ensure that patients cannot be re-identified. The pseudonymised dataset will then be used for analysis."]
["Applicant Organisation Name","Leeds Teaching Hospitals NHS Trust,"]
["Contact Name","Dr Emmanouela Kampouraki"]
["Address","Medicines Management and Pharmacy Services and Cardiology Department,"]
[null,"Great George Street,"]
[null,"Leeds  "]
["Postcode","LS1 3EX"]
["Telephone","07542425375 (WFH) / 0113 3926856"]
["Email"," emmanouela.kampouraki1@nhs.net"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"X","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","The applicants estimate that 7,979 patients who are receiving a DOAC for treatment of AF, and 55,404 patients treated with statins for high cholesterol. Only patients who started treatment with a DOAC or statin within six months of the data of the extraction will be included.\nThe final sample size will only be calculated during the searches performed by CCG staff when extracting the data.\nThe applicants anticipate that a maximum of 63,383 patients will be included, however they note that the actual sample size will be lower."]
["Description of confidential patient information used","Data sources:\n\n1. Electronic patient data from participating GP practices\n\nIdentifiers required for linkage purposes:\n\nThe applicants advised that no identifiers were required for linkage.\n\nIdentifiers required for analysis purposes:\n\n1. Strategic report patient ID\n2. Lower Layer Super Output area"]
["S251 Class(es)",null,"Specific Support"]
[null,"X","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"X","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"X","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2022-09-06"]
["Notes","Specific conditions of support \n\n1. Patient and public involvement needs to be conducted specifically around the use of confidential patient information without consent as proposed in this application. Feedback is to be provided to the CAG. Condition met 17 December 2021.\n\n2. A sentence directing patients to the Patient Information Leaflet needs to be included in the poster. Email, telephone and postal contacts for the study team, for patients who wish to dissent or who have questions, also need to be included in the poster and information leaflet. \nCondition met 17 December 2021.\n\n3. The patient information materials need to be revised for simplicity and clarity, and revised materials submitted to the CAG. \nCondition met 17 December 2021.\n\n4. The CAG agreed that there needs to be a gap of 6 weeks between the publication of patient information materials and the beginning of the data extraction, to allow patients sufficient time to register dissent. \nCondition met 17 December 2021.\n\n5. Responses to the above four conditions need to be provided within three months of the issuing of this outcome letter. \nCondition met 17 December 2021.\n\n6. Confirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. See section below titled ‘security assurance requirements’ for further information. \n\nDue to the number of participating sites where confidential patient information will be accessed, individual DSPT submissions are not required for the purpose of the application. Support is recommended on the basis that the applicant ensures the required security standards are in place at each site prior to any processing of confidential patient information with support under the Regulations."]

{"sheet":"A1023","index":190,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A1023"]
["Reference","21/CAG/0107"]
["Other Refs"]
["Application Title","Wales Cancer Network – hosted by Public Health Wales NHS Trust"]
["Application Summary","This application from Public Health Wales NHS Trust set out the purpose of a patient survey to measure patients’ experiences of cancer care in Wales and to compare the results against two previous surveys.\nThe Wales Cancer Network (WCN), Macmillan Cancer Support (MCS) and Digital Health and Care Wales (DHCW) will work with NHS Health Boards and Velindre Cancer Centre in Wales. The survey results will be used to support Macmillan Cancer Support, the Welsh Government and Wales Cancers Networks aims of improving the quality and standard of cancer care across Wales.\nThe survey has been run twice previously, in 2013 and 2016. The methodology is largely consistent with the previous surveys, however in this survey, data from all participating Health Boards and Velindre Cancer Centre will be submitted to DHCW and then transferred centrally from DHCW to Quality Health. Support under s251 is needed for the disclosure of confidential patient information from DHCW to Quality Health, so that Quality Health can extract the sample group and send out the surveys and reminders. Data will be processed on secure SQL servers and made available for analysis. Access to the data is managed by DHCW Data Warehouse team using NHS and SQL Server Security protocols.\nOnce the activity data has been extracted, the latest demographic data and fact of death will be incorporated from the data held in the national Patient Demographic Service at DCHW before being sent via the NHS Wales’ Secure File Sharing Portal to Quality Health. Quality Health will then check and deduplicate the data set. 24 hours before each survey or reminder is sent, DHCW will run a death check using the national Patient Demographic Service and will send a list of deceased patients to Quality Health via the NHS Wales Secure File Sharing Portal. Quality Health will remove these patients from the mailing list before the send-out."]
["Applicant Organisation Name","Quality Health"]
["Contact Name","Emma Moore"]
["Address","Quality Health, Unit 1, Holmewood Business Park,"]
[null,"Chesterfield Road,"]
[null,"Holmewood, Chesterfield, Derbyshire"]
["Postcode","S42 5US"]
["Telephone","07425 622958"]
["Email","emma.moore@quality-health.co.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"X","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Adult inpatients and day case patients, with a histologically confirmed primary diagnosis of cancer, who were admitted to an acute or specialist NHS Hospital in Wales between 1 January 2020 and 31 December 2020.\nApproximately 11,000 patients will be included."]
["Description of confidential patient information used","Data sources:\n\n1. Participating NHS Health Boards in Wales\n2. Patient Demographic Service data held by Digital Health and Care Wales (DHCW)\n\nIdentifiers required for linkage purposes:\n\n1. NHS Number\n2. Name\n3. Full address and postcode\n4. Sex\n5. Ethnic Group\n6. Year of birth\n\nIdentifiers required for analysis purposes:\n\n1. Full address and postcode\n2. Sex\n3. Ethnic Group\n4. Year of birth"]
["S251 Class(es)",null,"Specific Support"]
[null,"X","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"X","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,null,"Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"X","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2022-09-06"]
["Notes","Specific conditions of support\n\n1. Provide confirmation that the specific issue of the processing of confidential patient information as proposed in the application had been discussed, alongside written feedback from the activities undertaken.\n2. Confirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. See section below titled ‘security assurance requirements’ for further information. Confirmed:\nThe NHS Digital 2020/21 DSPT review for Quality Health Ltd was confirmed as ‘Standards Met’ on the NHS Digital DSPT Tracker.\nThe CPIP Out-turn report for 2021/22 for Digital Health and Care Wales is confirmed."]

{"sheet":"A1024","index":191,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A1024"]
["Reference","21/CAG/0116"]
["Other Refs"]
["Application Title","United Kingdom COVID and Gynaecological Cancers Study (UKCOGS)"]
["Application Summary","This application from the Queen Mary University London and Barts Health NHS Trust\nJoint Research Office set out the purpose of an audit that seeks to evaluate the MDT\ndecision making process for gynaecological cancer patient outcomes across the UK.\n50 sites across the UK will participate in the audit. Individual sites will input\npseudonymised data into a central REDCap database. The sites are responsible for\nmaintaining a record of audit-specific patient IDs and their corresponding NHS numbers.\nThe participating sites will be able to see data for their patients, while the audit team will\nonly be able to access pseudonymised data from all sites. At the end of the enrolment\nperiod, which will run between March 2020 and March 2021, each site will disclose their\nlist of project specific IDs and the corresponding NHS numbers and dates of birth to the\naudit team at Barts Cancer Centre at Queen Mary University London. The audit team will\nthen disclose the patient NHS numbers and dates of birth to Public Health England for\nlinkage to the National Cancer Registration and Analysis Service (NCRAS) and Hospital\nEpisode Statistics (HES) datasets. A linked dataset will then be sent to the audit team at\nBarts Cancer Centre. A pseudonymised dataset will be used for analysis. The applicants\nalso seek to undertake long-term follow up of patients in order to analyse long-term\noutcomes. Annual linkages to the NCRAS and HES datasets will be undertaken, and\npatients NHS numbers and dates of birth will be retained by the audit team for 5 years to\nfacilitate this follow up."]
["Applicant Organisation Name","Queen Mary University London and Barts Health NHS Trust\nJoint Research Office"]
["Contact Name","Professor Ranjit Manchanda"]
["Address","UKCOGS Lead"]
[null,"Charterhouse Square"]
[null,"London"]
["Postcode","EC1M 5PZ"]
["Telephone","07562 077837"]
["Email","BCC-UKCOGS@qmul.ac.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"X","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Patients discussed at Gynaecological cancer MDTs between\nMarch 2020 and March 2021, who have a diagnosis or\ndifferential diagnosis, or suspected diagnosis, or\ngynaecological cancer."]
["Description of confidential patient information used","Data sources:\n\n1. Participating NHS Trusts\n2. NCRAS and HES datasets at Public Health England\n\nIdentifiers required for linkage purposes:\n\n1. NHS number\n2. Date of birth\n\nIdentifiers required for analysis:\n\nNo items of confidential patient information will be retained for\nanalysis.\n\n"]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"X","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"X","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"X","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2022-09-06"]
["Notes","Specific conditions of support \n\n1. Clarify the list of hospitals in England and Wales who are involved in the study. Condition met 08 October 2021.\n\n2. The patient-facing website needs to clearly explain that confidential patient information will be used for data linkage. Condition met 08 October 2021.\n\n3. Confirm that it had been made clear to the patient and public involvement groups who reviewed the application that confidential patient information would be used to undertake the linkages. Condition met 08 October 2021.\n\n4. Responses need to be provided to the above three points within three months of the issuing of this outcome letter. Condition met 08 October 2021.\n\n5. Confirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. See section below titled ‘security assurance requirements’ for further information. \n\nDue to the number of participating sites where confidential patient information will be accessed, individual DSPT submissions are not required for the purpose of the application. Support is recommended on the basis that the applicant ensures the required security standards are in place at each site prior to any processing of confidential patient information with support under the Regulations."]

{"sheet":"A1025","index":192,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","A1025"]
["Reference","19/CAG/0134"]
["Other Refs"]
["Application Title","Welsh residents treated in England – use of Secondary Uses Services (SUS) Dataset for Wales Health Boards and Trusts"]
["Application Summary","Background to application\n\nMembers identified that NWIS had previously submitted applications to the two CAG predecessor bodies; the NIGB ECC and to PIAG.  Both times it has been advised that the activities were too broadly described to fall within the scope of Regulation 5 of the COPI Regulations, and that it would be more appropriate for specific legislation to be established that would place the activities of NWIS on a secure legal footing. Members also noted that NHS Wales Informatics Services (NWIS) had previously submitted an application to the CAG in 2014 (CAG 8-02(d)/2014) to cover the processing of PEDW data and undertake further pseudonymisation activities. This was provisionally supported at the time subject to security arrangements and information to be provided on how patients would be informed. Responses were not provided to this provisional support and the application support did not come into effect. \n\nNHS Digital reviewed their legal basis for disseminating SUS data to NWIS and halted the dataflow until this clarity was in place. Following stakeholder discussions, NHS Digital agreed to resume the data flow as the direct and indirect care purposes could not be differentiated sufficiently to enable separation of the dataflow, and it was agreed that due to this complexity, halting the dataflow would harm patient care. This temporary resumption of the dataflow was given on the premise that NWIS would seek ‘section 251 support’ to provide NHS Digital with a secure legal basis to transfer relevant information to NWIS to avoid a breach of the common law duty of confidentiality.   \n\n\n\nPurpose of application\n\nThis application from NHS Wales Informatics Services set out the purpose of non-research, designed for the purpose of healthcare planning, verification, validation, commissioning services and tariff reimbursement by the originating Data Controllers.\n\nThis application was received from NHS Wales Informatics Service (NWIS); NWIS is hosted by Velindre University NHS Trust and is subject to their governance arrangements and policies. \n\nThe application set out two distinct elements for which support was requested:\n\n1.\tPurpose 1: Where NWIS is acting in a contractual processor capacity on behalf of the seven Health Boards in Wales who are controllers of the relevant information. \n\na.\tThese seven Health Boards were listed as 1. Abertawe Bro Morgannwg University Health Board 2. Aneurin Bevan Health Board 3. Betsi Cadwaladr University Health Board 4. Cardiff and Vale University Health Board 5. Cwm Taf University Health Board 6. Hywel Dda Health Board, and 7. Powys Teaching Health Board.\n \nb.\tSupport requested for NWIS to receive specified identifiable Secondary Uses Service (SUS) information on Welsh residents treated in England from NHS Digital. NWIS to subsequently disseminate identifiable information back to the originating seven Health Boards.\n\nc.\tSUS information received from NHS Digital is transferred by NWIS to the Health Boards for the purpose of validation, commissioning and management of health care. \n\nd.\tThis dataflow also fulfils the purpose of direct care. It was confirmed that processing for the purpose of direct care was out of scope of the application due to the restriction placed within section 251(6) of the NHS Act 2006. \n\n\n2.\tPurpose 2: Where NWIS is acting as a controller of the information for the purpose of pseudonymisation, and is determining the purposes and manner by which and to whom information will be disclosed.   \n\na.\tSupport requested for NWIS to receive specified identifiable Secondary Uses Service (SUS) information on Welsh residents treated in England from NHS Digital. (This is the same dataset required for purpose 1). \n\nb.\tThis identifiable information will be processed by NWIS for the purpose of pseudonymisation, prior to collation with other Welsh-resident population data. \n\nc.\tThis de-identified information will be used to assist in performance management of the NHS (including clinical practitioners), including clinical performance and quality of care generally. Other purposes include supporting the management and planning of health services centrally and locally; for general medical research and statistical functions (following approval by the appropriate parties); supply of data to other outside bodies; to identify public health issues; to monitor improvements in public health; to develop, monitor and evaluate government policies, and otherwise support the work of the NHS Department of the Welsh Government. Other purposes include contributing to the production of Welsh Government publications such as Health Statistics Wales, Digest of Welsh Statistic and Wales in Figures. Further purposes include assessing the effective delivery of care, to determine fair access to health care, to improve the patient/carer experience, to examine health outcomes for the public, Welsh Government and parliamentary accountability; and to develop potential further uses."]
["Applicant Organisation Name","NHS Wales Informatics Services"]
["Contact Name","Darren Lloyd"]
["Address","NHS Wales Informatics Services"]
[null,"Ty Glan y Afon"]
[null,"21 Cowbridge Rd East, Cardiff"]
["Postcode","CF11 9AD"]
["Telephone","02920500500"]
["Email","Darren.Lloyd@wales.nhs.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"X","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","All Welsh residents who received treatment by the NHS within England"]
["Description of confidential patient information used","Data sources:\n\n1.\tSecondary Use Service (SUS) data held by NHS Digital\n2.\tElectronic patient records held at the below Health Boards and NHS Trusts:\na.\tAneurin Bevan\nb.\tCardiff & Vale\nc.\tCwm Taf Morgannwg\nd.\tBetsi Cadwaladr\ne.\tHywel Dda\nf.\tPowys\ng.\tSwansea Bay\n\nIdentifiers required for linkage purposes:\n\n1.\tLocal Patient Identifier\n2.\tNHS Number\n3.\tPatient Name\n4.\tPatient Usual Address\n5.\tDate of birth\n6.\tGender\n7.\tPostcode – unit level\n\nIdentifiers required for analysis purposes:\n\n1.\tLocal Patient Identifier\n2.\tNHS Number\n3.\tPatient Name\n4.\tPatient Usual Address\n5.\tDate of birth\n6.\tGender\n7.\tPostcode – unit level\n\nAdditional information:\n\nThe total list of patient identifiers required was too long to be included in this letter. The complete list was provided in additional documentation. \n\nIn response to the COVID-19 pandemic, the applicants also seek support to collect the below:\n\n• 65PW - Coronavirus contact\n• A795 - Coronavirus infection\n• 1JX - Suspected Coronavirus infection\n• Acute respiratory infections (Read codes not yet defined)\n• Lower respiratory tract infections (Read codes not yet defined)"]
["S251 Class(es)",null,"Specific Support"]
[null,"X","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"X","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"X","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"X","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Expired"]
[]
["Next Review Date"]
["Notes","CAG notified that this activity is withdrawn from reliance upon Regulation 5 of the Health Service (Control of Patient Information) Regulations 2002. New legal bases notified to be: The Digital Health and Care Wales (Establishment and Membership) Order 2020 and The Digital Health and Care Wales Directions 2021. Register entry considered and updated September 2021. \n\nSpecific conditions of support\n\n1.\tThe flows of identifiable, de-identified and pseudonymised data need to be provided. \n\n2.\tA patient notification and dissent mechanism needs to be created. The notification materials and information on the dissent mechanism need to be provided to the CAG for review.  \n\n3.\tPatient and public involvement and engagement needs to be carried out, including discussion of the specific issue on the uses of confidential patient information without consent as required for the purposes described in the application. \n\n4.\tConfirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. See section below titled ‘security assurance requirements’ for further information. Caldicott: Principles into Practice (CPiP) assurance was provided for NWIS."]

{"sheet":"A1026","index":193,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A1026"]
["Reference","CAG 8-02(d)/2014"]
["Other Refs"]
["Application Title","Patient Episode Database Wales"]
["Application Summary","This application from NHS Wales Informatics Service detailed the definitive statistical database on NHS hospital activity in Wales, the Secondary Care National Database for Wales (SCNDW), which is used to support the NHS Wales Department and the Health Statistics Division of the Welsh Government, other Government functions and organisations in NHS Wales. A number of key purposes were set out within the application form."]
["Applicant Organisation Name","Health Solution Wales "]
["Contact Name","Darren Lloyd "]
["Address","12th Floor, Brunel House "]
[null,"2 Fitzalan Road "]
[null,"Cardiff "]
["Postcode","CF24 0HA "]
["Telephone"]
["Email","Darren.Lloyd@wales.nhs.uk "]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"X","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population"]
["Description of confidential patient information used","Access was requested to NHS Number, Name, Date of Birth, Gender, Address and Postcode."]
["S251 Class(es)",null,"Specific Support"]
[null,"X","Class I - making the person less readily identifiable "]
[null,"X","Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"X","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"X","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"X","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Expired"]
[]
["Next Review Date"]
["Notes","CAG notified that this activity is withdrawn from reliance upon Regulation 5 of the Health Service (Control of Patient Information) Regulations 2002. New legal bases notified to be: The Digital Health and Care Wales (Establishment and Membership) Order 2020 and The Digital Health and Care Wales Directions 2021. Register entry considered and updated September 2021\n\nSpecific conditions of support\n\n1.\tAn exit strategy via Regulations should be pursued and significant progress should be made within 12 months. A report on progress made should be submitted with the annual review report.\n2.\tConfirmation of suitable security arrangements. This would need to be confirmed following the establishment of a MoU between DH and NWIS if C-PIP was to be relied upon, or via the completion of the IG Toolkit.\n3.\tFair processing information should be amended to include information in relation to how a patient can register an objection to processing by NWIS and this should be respected."]

{"sheet":"A1027","index":194,"n_rows":36,"n_cols":3,"rows_kept":36,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[24,0,30,0],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,2,30,4],[31,1,31,4],[32,1,32,4],[34,1,34,4],[35,1,35,4],[21,1,21,4],[22,1,22,4],[23,1,23,4]]}
[]
[]
["Application Number","A1027"]
["Reference","21/CAG/0136"]
["Other Refs","Previously ECC 5-05(e)/2012"]
["Application Title","National Drug & Alcohol Treatment Monitoring System (NDTMS) & Criminal Justice Intervention Teams (CJIT)  [replacing and extending National Drug Treatment Monitoring System collection ECC 5-05(e)/2012]"]
["Application Summary","This non-research audit application from Public Health England (PHE), on behalf of the Office for Health Improvement and Disparities (OHID) within the Department for Health and Social Care (DHSC) set out the purpose of continued processing of confidential patient information within The National Drug Treatment Monitoring System (NDTMS). The NDTMS collects information with the consent of the users of drug and alcohol treatment services across England to assess the need for services and to support the commissioning, planning and provision of effective treatment services and interventions. \n\n‘Section 251’ Support was previously provided in 2012 (ECC 5-05(e)/2012 - National Drug Treatment Monitoring System (NDTMS)) for data collected by the National Treatment Agency (NTA) pre-PHE formation in 2013 to be processed by PHE, as the consent provided pre-2013 was not sufficient. There is also a consented cohort from 2013-2021. Whilst PHE currently hold the data, the controller is the Department for Health and Social Care (DHSC) which was reflected in the 2012 application. However this was not reflected in the consent forms and information sheets, which includes the statement “All data matching is conducted by PHE and at no point is any identifiable information about service users passed onto other government departments”. The NDTMS dataset is going to move to DHSC on 01 October. The consent between 2013 – 2021 has been deemed to not cover NDTMS moving to DHSC. This application therefore covers both the pre-2013 cohort (ECC 5-05(e)/2012 will be expired), and the 2013-2021 cohort. The applicants have also requested support for newly consented patients between 1 October 2021 and April 2022, in order to ensure the consent materials are updated appropriately.  \n\nIt is important that an ongoing legal basis is provided for DHSC to access the NDTMS dataset, as outputs inform the ongoing monitoring and quality improvement of drug and alcohol treatment services, interventions and policies at local and national levels. All routine and annual reporting takes place using pseudonymised datasets.\n\nA recommendation for Class 1, 4, 5 & 6 support was requested to cover access to the relevant unconsented activities as described in the application."]
["Applicant Organisation Name","The Office of Health Improvement and Disparities, Department of Health and Social Care"]
["Contact Name","Rosanna O’Connor - Director, Addictions & Inclusion"]
["Address","The Office of Health Improvement and Disparities, Department of Health and Social Care\n\n"]
[null,"39 Victoria Street"]
[null,"London"]
["Postcode","SW1H 0EU"]
["Telephone","0203 682 0501 or 07776 250 724"]
["Email","rosanna.oconnor@dhsc.gov.uk "]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"X","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","All individuals being treated for drug and alcohol misuse (requiring support and / or interventions for their drug or alcohol use and this need meets the clinical or operational threshold as defined by the service and setting)\n\nPeople of all ages are included\n\n1.\t2005/2006 - 31 March 2013; National Drug Treatment Monitoring System consented cohort (approximately 965,000 individuals)\n\n2.\t1 April 2013- 30 September 2021; National Drug Treatment Monitoring System consented cohort (approximately 886,000 individuals)\n\n3.\t30 September 2021 – 6 April 2022 National Drug Treatment Monitoring System consented cohort (applicant would expect around ~58,000 individuals)"]
["Description of confidential patient information used","Data Sources:\nAround 1,000 drug and alcohol treatment services in England (and additionally one Welsh prison) contribute to:\n\n•\tNDTMS data including NDTMS core dataset, and DIRWEB data collected by Home Office (DIR / DIP programmes) in early version of what would become the CJIT collection, collected by NTA (pre 2013)\n\n•\tNDTMS data including NDTMS core dataset, CJIT dataset and IPS dataset as collected by PHE (2013-30Sept2021), and the same collected at DHSC up to 6April2022.  \n\n•\tNDTMS data including NDTMS core dataset, CJIT dataset and IPS dataset as collected by DHSC from 1 October 2021 to 6April2022.  \n\nThese datasets are currently held at PHE, and will be retained at UK Health Security Agency (UKHSA) after 1 October 2021, with DHSC as data controller.\n\nLinkage with HES (NHS Digital) and other datasets from Department for Work & Pensions (benefits claims records) and Ministry of Justice (Police National Computer records) are not currently in scope for CAG support.\n\nIdentifiers collected  and required for linkage /de-duplication:\n1.\tPatient initials - linkage & deduplication\n2.\tDate of Birth - linkage & deduplication\n3.\tSex - linkage & deduplication\n4.\tTreatment clinic represented by a unique NDTMS agency code - deduplication \n5.\tnational prison (NOMS) ID number unique to the individual - used for linkage once\n6.\tLocal authority - linkage & deduplication\n7.\tFirst part of postcode – deduplication/ used for linkage once\n8.\tEthnicity – deduplication/ used for linkage once\n9.\tGP practice code – deduplication/ used for linkage once\n\nIPS data collection does not appear to be in scope.\n\nIdentifiers required for analysis purposes:\n1.\tPatient initials\n2.\tdate of birth, \n3.\tpartial postcode of residence, \n4.\ttreatment clinic and/or national prison (NOMS) ID number unique to the individual), \n5.\tEthnicity\n6.\tSex\n7.\tLocal authority\n\nThe date of birth is not modified for regular analysis, nor are treatment provider (clinic) ID and prison ID as these are required for reporting to provider level. For specific projects requiring pseudonymised data, applicants remove date of birth to be replaced by age (or age band), remove initials, and apply k-3 anonymity, which could be considered pseudonymous for these external analyses. \n"]
["National Data Opt \nOut Status","The Secretary of State for Health and Social Care decision maker, on advice from the CAG, has supported a request to defer the National Data Opt Out. As such, the National Data Opt Out does not need to be applied for this activity"]
["S251 Class(es)",null,"Specific Support"]
[null,"X","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"X","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"X","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"X","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2023-10-01"]
["Notes","28 March 2022 - Amendment Supported\nAmendment supported to extend the end date of ‘s251’ support for the post PHE dissolution National Drug Treatment Monitoring System consented cohort, from 6 April 2022, to 1st October 2022.\n\nConditions of support:\n\n1.\tPlease provide a patient notification describing the change in data controller, clearly indicating the differences between pre 2013, 2103-2021, and 2021-2022. This notification should be displayed on the NDTMS website, and in clinics. This is required to be provided to CAG as soon as possible, preferably prior to 1 October 2021, and should also provide a mechanism for patients to object to this processing. \nCondition met 10 December 2021\n\n2.\tProvide a clearer data flow diagram, which clarifies legal bases, which flows are confidential patient information, and clearly define the organisations involved, both now and in the future. Provide this to the CAG within 3 months from the date of this letter. Condition met 03 November 2022\n\n3.\tPlease clarify the scope of Regulation 5 support requested regarding linkages with HES, MoJ, and DWP datasets, for the pre 2013 cohort, the 2013-2021 cohort, and the 2021-2022 cohort, within 3 months from the date of this letter. Condition met 03 November 2022 (no Regulation 5 support requested for any linkages)\n\n4.\tPlease provide the updated information sheets and consent forms, ensuring linkages are clearly described, and they are as ‘futureproofed’ as possible. These should be provided to CAG as soon as possible, although noting this is planned for December.\nCondition met 12 August 2022\n\n5.\tPlease consider if the confidential patient information regarding deceased people can begin to be deleted, and inform CAG within 3 months from the date of this letter. \nCondition met 18 August 2022\n\n6.\tPlease undertake patient and public involvement activities with patients representative of the cohort. The acceptability of the change in data controller without having an updated consent process should be discussed, and the opinion of the public should be provided to CAG. The new consent materials, and the notification should also be discussed. Please provide an update within 3 months from the date of this letter.\nCondition met 18 August 2022\n\n7.\tThe support commences on the 1st October 2021 when PHE is replaced by the Office for Health Improvement and Disparities (OHID) within DHSC.\n\n8.\tThis support supersedes ECC 5-05 (e)/2012.\n\n9.\tSupport provided for 5 years in the first instance, and will require an amendment at this point to continue support.\n\n10.\tConfirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. See section below titled ‘security assurance requirements’ for further information. Confirmed: The NHS Digital 20/21 DSPT reviews for PHE, and NDEC at the University of Manchester were confirmed as ‘Standards Met’ on the NHS Digital DSPT Tracker (checked 27 September 2021). UKHSA will supersede PHE when security assurances are in place, however application can be supported using PHE DSPT until UKHSA DSPT is in place. "]

{"sheet":"A1028","index":195,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","A1028"]
["Reference","21/CAG/0153 "]
["Other Refs","previously 15/CAG/0207"]
["Application Title","NHS Cancer Screening Programmes: National Coordination and Quality Assurance"]
["Application Summary","This submitted information represented a new application in relation to an existing activity under application reference 15/CAG/0207. In the original application, Public Health England (PHE) are the data controller. This new application represents a change in controllership only, to NHS England, due to the dissolution of PHE. The intention is to replace 15/CAG/0207 with this new application once support is in place.\n\nThe NHS Cancer Screening Programmes run by Public Health England (PHE) enable cases of bowel, breast and cervical cancer to be identified and treated at the earliest possible stage in order to improve patient outcomes. There is currently support under the Regulations to enable PHE to process confidential patient information for those components of the programmes (for which it is responsible and accountable to the Secretary of State for Health for as part of its core remit) that depend on the processing of confidential patient information without consent. \n\nPublic Health England has been dissolved. The applicant has informed CAG that the screening functions previously held within Public Health England have been transferred to NHS England. The data processing required to undertake these functions will now be under the interim controllership of NHS England until a formal arrangement is established. This amendment is in advance of a refreshed application to CAG, which the CAG are to expect once the transition is complete and final arrangements for data processing are agreed, which could be around September 2022.\n\nIt was noted that no other changes to people, purposes, data and flows were flagged to the CAG by the applicant.\n\nThe Chair therefore agreed that the minimum criteria under the Regulations appeared to have been met, and therefore advised recommending support to the Secretary of State for Health and Social Care, subject to compliance with the specific and standard conditions of support as set out below. "]
["Applicant Organisation Name","NHS England"]
["Contact Name","Ming Tang"]
["Address","NHS England, Quarry House, Leeds\t\t\t\n"]
[]
[]
["Postcode","LS2 7UE"]
["Telephone"]
["Email","ming.tang@nhs.net"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"X","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","NHS Patient cases of bowel, breast and cervical cancer."]
["Description of confidential patient information used","NHS number, primary care provider code, title, forename, middle name, surname, date of birth, gender, address, post code, PAF key of usual address, reason for removal from GP registration, date of death, telephone number, e-mail address, preferred language and interpreter required."]
["S251 Class(es)",null,"Specific Support"]
[null,"X","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"X","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"X","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"X","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2023-07-06"]
["Notes","Conditions of support:\n\n1.\tThe support commences on the 1st October 2021.\n\n2.\tThis support supersedes 15/CAG/0207.\n\n3.\tThe date of annual review is retained from 15/CAG/0207.\n\n4.\tConfirmation from the IGT Team at NHS Digital of suitable security arrangements via Information Governance Toolkit (IGT) submission. Confirmed:\n\n•\tThe NHS Digital 2020/21 DSPT reviews for NHS Digital, Hitachi Consulting, NHS North of England Commissioning Support Unit and Public Health England were confirmed as ‘Standards Met’ on the NHS Digital DSPT Tracker (checked 27 September 2021). \n\n•\tPHE DSPT is sufficient until UKHSA have a DSPT in place."]

{"sheet":"A1029","index":196,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","A1029"]
["Reference","21/CAG/0154 "]
["Other Refs","previously ECC 3-04 (o) 2011"]
["Application Title","NHS Abdominal Aortic Aneurysm Screening Programme (NAAASP)"]
["Application Summary","This submitted information represented a new application in relation to an existing activity under application reference ECC 3-04 (o) 2011. In the original application, Public Health England (PHE) are the data controller. This new application represents a change in controllership only, to NHS England, due to the dissolution of PHE. The intention is to replace ECC 3-04 (o) 2011 with this new application once support is in place.\n\nAs part of ECC 3-04 (o) 2011, Public Health England has support to allow confidential patient information to be processed by PHE, NHS Digital and Northgate Public Services to support the Abdominal Aortic Aneurysm Screening Programme activities. Northgate Public Services are now called NEC Software Solutions UK Ltd, and their sub-processor Visbion Ltd also process confidential patient information, contained in patient scans in the form of DICOM images. \n\nPublic Health England has been dissolved. The applicant has informed CAG that the screening functions previously held within Public Health England have been transferred to NHS England. The data processing required to undertake these functions will now be under the interim controllership of NHS England until a formal arrangement is established. This amendment is in advance of a refreshed application to CAG, which the CAG are to expect once the transition is complete and final arrangements for data processing are agreed, which could be around September 2022.\n\nIt was noted that no other changes to people, purposes, data and flows were flagged to the CAG by the applicant.\n\nThe Chair therefore agreed that the minimum criteria under the Regulations appeared to have been met, and therefore advised recommending support to the Secretary of State for Health and Social Care, subject to compliance with the specific and standard conditions of support as set out below. "]
["Applicant Organisation Name","NHS England"]
["Contact Name","Ming Tang"]
["Address","NHS England, Quarry House, Leeds\t\t\t\n"]
[]
[]
["Postcode","LS2 7UE"]
["Telephone"]
["Email","ming.tang@nhs.net"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"X","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","All men in their 65th year registered with a GP in England"]
["Description of confidential patient information used","Section 251 support was requested to enable legitimate access to NHS number, Name, Date of Birth, Date of Death, Address and Postcode, Registered GP Practice."]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"X","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"X","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2023-11-15"]
["Notes","\nConditions of support:\n\n1.\tThe support commences on the 1st October 2021.\n\n2.\tThis support supersedes ECC 3-04 (o) 2011.\n\n3.\tThe date of annual review is retained from ECC 3-04 (o) 2011.\n\n4.\tConfirmation from the IGT Team at NHS Digital of suitable security arrangements via Information Governance Toolkit (IGT) submission. Confirmed:\n\n•\tThe NHS Digital 2020/21 DSPT reviews for NHS Digital, NEC Software Solutions UK Ltd (formerly Northgate Public Services (NWY), Visbion Ltd (8HN22) and Public Health England were confirmed as ‘Standards Met’ on the NHS Digital DSPT Tracker (checked 29 September 2021). \n\n•\tPHE DSPT is sufficient until UKHSA have a DSPT in place."]

{"sheet":"A1030","index":197,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","A1030"]
["Reference","19/CAG/0177"]
["Other Refs"]
["Application Title","The Child Death Review Programme"]
["Application Summary","This application from Public Health Wales NHS Trust set out the non-research medical purpose of the ongoing operation of the Child Death Review Programme (CDRP) for Wales. The programme was started as a pilot project in 2009 and became established and an integrated part of core activity within Public Health Wales NHS Trust (PHW) in April 2014. The aim of the programme is to learn from common factors contributing to child deaths in order to reduce preventable child deaths in Wales.\n\nThe objectives of the programme are to:\n•\tascertain and collate data on child deaths in Wales and deaths of children who are normally resident in Wales,\n•\tundertake surveillance of child deaths including the identification of and description of patterns and causes of child death, including any trends,\n•\tidentify modifiable factors that may be contributing to child deaths in Wales,\n•\tidentify opportunities for prevention of future child deaths,\n•\tshare the findings to inform action."]
["Applicant Organisation Name","Public Health Wales "]
["Contact Name","Rosalind Reilly"]
["Address","Public Health Wales"]
[null,"Level 5, Number 2 Capital Quarter"]
[null,"Tyndall Street, Cardiff"]
["Postcode","CF10 4BZ"]
["Telephone","02921 674942 / 07968622126"]
["Email","Rosalind.reilly@wales.nhs.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"X","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","•\tDeath of any a live born child that occurs after 1 October 2009 and before the child’s 18th birthday and where the child is either normally resident in Wales or dies within Wales.  \n•\tIt also includes where an incident which led to the child’s death in Wales irrespective of place of normal residence; and children who are under local authority care and placed outside of Wales; or those who may temporarily reside outside of Wales for healthcare or education purposes. \n•\tStillbirths and terminations of pregnancy are excluded. "]
["Description of confidential patient information used","Data sources\n\n1.\tPatient Episodes Database (PEDW), NHS Wales Informatics Service\n2.\tWelsh Cancer Surveillance Unit (WCISU), Public Health Wales,\n3.\tCongenital Anomaly Register and Information Service (CARIS), Public Health Wales\n4.\tMothers & Babies: Reducing Risk through Audits and Confidential Enquiries across the UK (MBRRACE-UK), University of Oxford\n5.\tAll Wales Perinatal Survey, Public Health Wales\n6.\tOffice for National Statistics (ONS) via NHS Wales Informatics Service (NWIS)\n7.\tWelsh Demographic Service (WDS), NHS Wales Informatics Service (NWIS)\n\nIdentifiers required for linkage purposes\n\n1.\tChild’s forename and surname, \n2.\tDate of birth, \n3.\tDate of death, \n4.\tFull address and postcode,\n5.\tNHS number. \n\nIdentifiers required for analysis purposes\n\nDeceased child’s details\n1.\tSex\n2.\tDate of birth\n3.\tTime of birth\n4.\tTreating hospital\n5.\tTreating clinician(s)\n6.\tDate and time of death\n7.\tPlace of event that led to death (home, hospital or other)\n8.\tAddress of event if hospital or other"]
["S251 Class(es)",null,"Specific Support"]
[null,"X","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"X","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"X","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"X","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2023-10-05"]
["Notes","Conditions of support\n\n1. Support extends to non-research purposes only. Any wider use of the data retained or collected under this application for research purposes would require submission of a separate application. \n\n2. Feedback is required at the time of first annual review from the patient and public involvement and engagement activity which has been carried out against the plan. \n\n3. Confirmation provided from NHS Wales Informatics Service of the ongoing security assurance. Confirmed – NWIS have confirmed the CPIP assurance report for Public Health Wales NHS Trust which has achieved a 96% assurance score. "]

{"sheet":"A1031","index":198,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","A1031"]
["Reference","21/CAG/0147"]
["Other Refs"]
["Application Title","2021 NHS Adult Inpatient Main Stage Survey – Mixed Methods"]
["Application Summary","This non-research application submitted by Ipsos MORI on behalf of the Care Quality Commission, sets out the purpose of conducting the 2021 NHS Adult Inpatient Survey. \n\nThe Adult Inpatient Survey is the most established survey within the NHS Patient Survey Programme (NPSP). The NPSP was initiated in 2002 by the then Department of Health, and is now overseen by the Care Quality Commission (CQC), the independent regulator of health and social care in England. The 2021 Adult Inpatient survey will be the nineteenth carried out to date, and the second mainstage to be completed using a mixed method approach, following a pilot of the approach during 2019 and the first mainstage during 2021. The NHS Patient Survey programme is used to help the CQC understand what patients think of the NHS healthcare services they use. The results from the Adult Inpatient Survey will help to assess NHS performance and the CQC will use the findings for regulatory activities such as monitoring ongoing compliance and reviews. Trusts will also use the findings to monitor performance, and to drive improvements and initiatives at a local level. \n\nAll eligible trusts (137) will be asked to conduct the survey, with preparations expected to begin in the autumn of 2021 and fieldwork expected to start from January 2022. All trusts will draw a sample of patients according to set criteria, and follow standardised materials and procedures for all stages of the survey.\n\nThe 2021 Adult Inpatient Survey will be managed and coordinated by Ipsos MORI in their role as the Coordination Centre for Mixed Methods.  The survey will follow the same mixed method approach as the 2020 Adult Inpatient Survey, which was developed and tested during the 2019 Adult Inpatient Pilot Study, and completed in 2021 with a response rate of 45.9%, which is consistent with other surveys in the NPSP. The applicants anticipate that the vast majority of trusts involved will opt to use an approved survey contractor, either Picker, Quality Health, Patient Perspective, to facilitate the sending of surveys. \n\n\n\tMode of contact\nContact 1\tPostal letter inviting the patient to take part online\nContact 1.1\tThree days later an SMS reminder will be sent, including a direct link to the online survey\nContact 2\tIn week 2, a reminder letter will be sent to non-responders\nContact 2.2\tThree days later an SMS reminder will be sent, including a direct link to the online survey\nContact 3\tFinal, postal reminder sent, along with a paper questionnaire\n\nA recommendation for class 5 and 6 support was requested to cover access to the relevant unconsented activities as described in the application."]
["Applicant Organisation Name","Ipsos MORI on behalf of the Care Quality Commission"]
["Contact Name","Laura Thomas, Research Director "]
["Address","Ipsos MORI, 3 Thomas More Square, London\n"]
[]
[]
["Postcode","E1W 1YW"]
["Telephone","0203 059 4717"]
["Email","Laura.thomas@ipsos.com"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"X","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Inpatients aged 16 years old or over who were discharged from acute and specialist NHS hospitals in November (and earlier for smaller trusts), having had at least one overnight stay in hospital. \n\nA list of reasons for exclusion, such as deceased patients and those under 16 years of age at the time of sampling, was included in the application. "]
["Description of confidential patient information used","Data sources:\n1.\tElectronic patient records with acute and specialist trusts in England.\n\nIdentifiers required for contact purposes:\n1.\tTitle\n2.\tInitials or first name\n3.\tSurname\n4.\tAddress fields including postcode\n5.\tMobile phone number\n6.\tPatient unique identifier\n\nIdentifiers required for anlaysis purposes:\n1.\tUnique identifier (a three-digit Trust code and 4 digital serial number related to sampled patient)\n2.\tPostcode\n3.\tTrust code\n4.\tYear of birth\n5.\tGender\n6.\tEthnic category\n7.\tDate of admission\n8.\tDate of discharge\n9.\tLength of Stay\n10.\tTreatment Function Code\n11.\tICD-10 Chapter Code \n12.\tTreated as a suspected or confirmed covid-19 case\n13.\tCCG code\n14.\tTreatment Centre Admission\n15.\tAdmission method\n16.\tNHS Site code-Admitted\n17.\tNHS Site code-Discharged\n18.\tDischarge Pathway "]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"X","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"X","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2023-11-08"]
["Notes","Application supported 08 November 2021. Conditions of support:\n\n1.\tPatient and public involvement around the specific issue of processing of confidential patient information without consent needs to be conducted and fed-back to the CAG at the first annual review. \n\nCondition met 29 November 2022\n\n2.\tMore work should be done with participating Trusts to encourage effective notification, and an account of this should be fed back at Annual Review.\n\nCondition met 09 December 2022 and will be followed up as part of application 22/CAG/0152\n\n3.\tConfirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. See section below titled ‘security assurance requirements’ for further information Confirmed: \n\nThe NHS Digital 2020/21 DSPT review for Ipsos Mori, Quality Health Ltd and the Picker Institute Europe were confirmed as ‘Standards Met’ on the NHS Digital DSPT Tracker (checked 30 September 2021).\n\nThe NHS Digital 2020/21 DSPT review for Patient Perspective was confirmed as ‘Standards Met’ by email to the CAG inbox on 8 November 2021.\n\n"]

{"sheet":"A1032","index":199,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A1032"]
["Reference","21/CAG/0174"]
["Other Refs"]
["Application Title","CQC 2022 Urgent and Emergency Care Survey – Mixed Methods Standalone Pilot"]
["Application Summary","This application from the Care Quality Commission set out the purpose of conducting a national survey of patients aged 16 and above on the day of their attendance who attended a Type 1, and patients who have attended a Type 3 if applicable, department within a participating trust between 01 February and 28 February 2022. \n\nThe NHS Patient Survey Programme (NPSP) was initiated in 2002 by the then Department of Health, with the Urgent and Emergency Care Survey first established in 2003. The NPSP is now overseen by the Care Quality Commission (CQC), the independent regulator of health and social care in England. To date, the mainstage survey has been conducted using a postal approach. However, to improve accessibility to the survey, address falling response rates and reduce non-response bias, the CQC are moving the NHS Patient Survey Programme (NPSP) towards a mixed mode methodology using online methods alongside the traditional postal approach. The CQC have commissioned Ipsos MORI to manage and coordinate surveys within the NPSP under the title of the Coordination Centre for Mixed Methods. Ipsos MORI was selected by the CQC to work with them to redevelop the NPSP, with a view to moving the programme to a mixed methods approach (online and postal). The pilot study will test the effectiveness of offering the questionnaire online, instead of a postal survey, and sending SMS reminders in addition to postal reminders. The pilot of mixed methods will be conducted in a different fieldwork period and involve a different survey method to the mainstage survey. Therefore, a separate application has been submitted for this pilot. This pilot will also include a control sample, who will receive paper questionnaires only, in order to assess the feasibility of changing the methodology. \n\nIpsos MORI will select 12 trusts for inclusion in the pilot, with the aim of 10 trusts completing the pilot in full. As 50 urgent and emergency care providers were initially approached to gather interest in participation and more than 12 trusts expressed an interest in participation, a selection of trusts was made on criteria agreed with the CQC to ensure a diverse group of trusts participate. Survey preparations are expected to begin in January 2022 and fieldwork in April to July 2022. Trusts taking part in the online survey pilot will each provide a random sample of patients to Ipsos Mori (as Coordination Centre for Mixed Methods). Ipsos MORI will distribute the URL links for the online surveys via mailings and SMS messages. Ipsos MORI will also send out paper copies of the questionnaires to the control sample. "]
["Applicant Organisation Name","Care Quality Commission"]
["Contact Name","Laura Thomas"]
["Address","Ipsos MORI"]
[null,"3 Thomas More Square"]
[null,"London"]
["Postcode","E1W 1YW"]
["Telephone","0203 059 4717"]
["Email","laura.thomas@ipsos.com"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"x","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Patients (aged 16 and above on the day of their attendance) who attended a Type 1 (and patients who have attended a Type 3 if applicable) department within a participating trust between 1st February 00:00 and 28th February 2022 23:59."]
["Description of confidential patient information used","Data sources:\n1. Confidential patient information provided by 12 participating NHS Trusts. \n\nIdentifiers required for linkage purposes:\n1. Trustcode\n2. A standardised unique identifier code taking the following format: JNNNNXXX where J is the survey code, NNNN is the 4-digit number, e.g. 0001, 0002 etc and XXX is the trust’s 3-digit trust code.\n3. Title (Mr, Mrs, Ms, etc.) \n4. First name \n5. Surname \n6. Address Fields \n7. Postcode \n8. Mobile number (where available)\n\nIdentifiers required for analysis purposes:\n1. Trustcode\n2. The unique identifier code (as above)\n3. Year of birth \n4. Gender \n5. Ethnic category \n6. Department type\n7. Day of attendance \n8. Month of attendance\n9. Year of attendance\n10. Time of attendance\n11. NHS site code (the five-character NHS trust side code of the site the patient attended)\n12. CCG code\n13. Mobile phone indicator (to denote whether a mobile number was included) \n14. Postcode (mapped to Lower Layer Super Output Areas to allow analysis by deprivation and region, then securely deleted)\n\n\n"]
["S251 Class(es)",null,"Specific Support"]
[null,"X","Class I - making the person less readily identifiable "]
[null,"X","Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"X","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,null,"Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"X","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2022-12-14"]
["Notes","Specific conditions of support \n1. Confirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. See section below titled ‘security assurance requirements’ for further information. \n\nConfirmed:- \nThe NHS Digital 2020/21 DSPT review for Ipsos MORI was confirmed as ‘Standards Met’ on the NHS Digital DSPT Tracker (04 August 2021)"]

{"sheet":"A1033","index":200,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","A1033"]
["Reference","21/CAG/0181"]
["Other Refs"]
["Application Title","Community Mental Health 2022 Survey"]
["Application Summary","This application from the Care Quality Commission set out the purpose of administering the 2022 Community Mental Health Survey, to gauge patient experience and views of the service they received. \n\nThe Community Mental Health Survey is one of the more established surveys within the NHS Patient Survey Programme (NPSP). The NPSP was initiated in 2002 by the Department of Health and is now overseen by the Care Quality Commission (CQC), the independent regulator of health and social care in England. The CQC have commissioned Picker to manage and coordinate the survey programme under the title of the Survey Coordination Centre for Existing Methods (SSCEM). \n\nThe 2022 Community Mental Health Survey will be the nineteenth mental health survey carried out to date. All 53 eligible mental health provider trusts will be asked to conduct the survey, with preparations beginning in early December 2021 and fieldwork scheduled to start from February 2022. All trusts will draw a sample of service users according to set criteria and will follow standardised materials and procedures for all stages of the survey. A copy of the survey handbook and sampling instruction manual from 2021 was provided with the application. Due to changes in care and treatment as a result of the Covid-19 pandemic, the sampling criteria for the 2021 survey was expanded to include patients who received care remotely, such as via video-conference or telephone, as well patients who received face-to-face treatment. The 2022 survey will also use this amended sampling criteria, as NHS Community Mental Health Trusts have been consulted and confirmed that changes to service provisions made during the pandemic remain in place.  \n\nIn administering the survey, NHS trusts will be advised to employ the service of one of the approved contractors to reduce the cost, burden and risk in the provision of survey data. In doing so, it is expected that the risks to data quality and delay to the timetable are reduced dramatically, as evidenced throughout this application. From previous studies, the applicants anticipate that most of the participating trusts will use an approved survey contractor, either Quality Health or Patent Perspective. Trusts will submit a single file to their Approved Contractor, which will contain both mailing data, such as patients’ names and addresses, and sample information, such as the year of birth, ethnicity and gender of patients. The Approved Contractor will then send the surveys out and patients’ participation would proceed on a consented basis.\n\nTrusts may opt to undertake the survey themselves. In this event, the SCCEM (Picker) will provide trusts with the sampling materials and the process to be followed. This is outside the scope of support, as participating trusts will only process confidential patient information which they have an existing legal basis to process.  At no point will the SCCEM receive mailing information for the service users in the sample file, apart from service user postcode."]
["Applicant Organisation Name","Care Quality Commission"]
["Contact Name","Jenny King,  Chief research officer "]
["Address","Picker Suite 6, Fountain House"]
[null,"1200 Parkway Court"]
[null,"John Smith Drive, Oxford "]
["Postcode","OX4 2JY           "]
["Telephone","07493 868951"]
["Email","Jenny.King@PickerEurope.ac.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"x","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Patients aged 18 and over at the time of drawing the sample who received specialist care or treatment for a mental health condition, including those who received care under the Care Programme Approach.  Patients may have been seen face-to-face at the trust, via video-conference, or by telephone call between 1st September and 30th November 2021 (the sampling period), and will have had at least one other contact, either before, during or after the sampling period.\n\n1250 patients in each trust will be included. "]
["Description of confidential patient information used","Data sources\n1. Confidential patient information provided by 53 participating community mental health provider trusts.  \n\nIdentifiers required to address questionnaires to the appropriate person. It contains:\n1. Trustcode\n2. A standardised unique identifier code, to be constructed as survey identifier, trust code followed by a whole number (consecutive across the sample of 1250 service users from each trust), e.g. MH22XXXnnnnn where XXX is the trusts 3 digit trust code and nnnnn is the 5 digit serial number relating to sampled service users \n3. Title (Mr, Mrs, Ms, etc.) \n4. First name \n5. Surname \n6. Address Fields \n7. Postcode \n\nIdentifiers required to link demographic data to the survey responses, to aid analysis and to enable checks to be carried out for any errors in how the sample was drawn\n1. Trustcode\n2. The unique identifier code (as above)\n3. Year of birth \n4. Service users full postcode \n5. Gender \n6. Ethnic category \n7. Day of last contact \n8. Month of last contact \n9. Year of last contact \n10. CPA status \n11. CCG code\n12.\tMental Health Care Cluster Codes\n13.\tMobile phone indicator\n14.\tEmail address indicator\n15.\tMode of contact"]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"X","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"X","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2023-12-20"]
["Notes","20 December 2021 - Application supported\n\nSpecific conditions of support:\n\n1.\tConfirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. See section below titled ‘security assurance requirements’ for further information. \n\nConfirmed:-\nThe NHS Digital 2020/21 DSPT reviews for Patient Perspective, Quality Health (IQVIA Group) and Picker Europe were confirmed as ‘Standards Met’ on the NHS Digital DSPT Tracker (checked 14 December 2021)."]

{"sheet":"A1034","index":201,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A1034"]
["Reference","22/CAG/0016"]
["Other Refs"]
["Application Title","2022 NHS Maternity Survey - Mixed Methods"]
["Application Summary","This non-research application submitted by Ipsos MORI on behalf of the Care Quality Commission, sets out the purpose of conducting the 2022 NHS Maternity Survey. \n\nThe Maternity Survey started in 2007 and falls within the NHS Patient Survey Programme (NPSP). The NPSP was initiated in 2002 by the then Department of Health, and is now overseen by the Care Quality Commission (CQC), the independent regulator of health and social care in England. The 2022 Maternity Survey will be the ninth carried out to date, and the second using a mixed method approach.\n\nTrusts will collect information of all eligible patients and, following suitability checks, will share confidential patient information with the coordination centre (IPSOS MORI) and one of three approved contractors (Patient Perspective, Quality Health or Picker Institute Europe). The contractors will distribute questionnaires to patients using the approach detailed below:\n\nContact\tType\t-Content of contact\tDays from first mailing\n1\tPostal\tInvitation letter inviting the patient to take part online, Multi-language sheet \t1\n1.1\tSMS\tSMS reminder (if phone number available), including a link to the survey\t4\n2\tPostal\tReminder letter, Multilanguage sheet\t15\n2.1\tSMS\tSMS reminder (if phone number available), including a link to the survey\t18\n3\tPostal\tReminder letter, Paper questionnaire, Freepost return envelope, Multi-language sheet\t29\n4\tPostal\tReminder letter, Multilanguage sheet\t43\n4.1\tSMS\tSMS reminder (if phone number available)\t46\n\n\nAhead of each reminder mailing, it will be necessary to remove all respondents who have completed the survey already, and to conduct a DBS or local check on the full sample. If anyone has requested to be opted out of further reminders, they should also be removed at these timepoints.\n\nWhilst the survey remains similar to previous years, and as in 2021, the applicants have added in COVID status to the data requested for analysis so they can distinguish between these for reporting purposes."]
["Applicant Organisation Name","Ipsos MORI on behalf of the Care Quality Commission"]
["Contact Name","Ms Laura Thomas, Research Director"]
["Address","Ipsos MORI"]
[null,"3 Thomas More Square"]
[null,"London"]
["Postcode","E1W 1YW"]
["Telephone","0203 059 4717"]
["Email","Laura.thomas@ipsos.com"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"x","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","This non-research application submitted by Ipsos MORI on behalf of the Care Quality Commission, sets out the purpose of conducting the 2022 NHS Maternity Survey. \n\nThe Maternity Survey started in 2007 and falls within the NHS Patient Survey Programme (NPSP). The NPSP was initiated in 2002 by the then Department of Health, and is now overseen by the Care Quality Commission (CQC), the independent regulator of health and social care in England. The 2022 Maternity Survey will be the ninth carried out to date, and the second using a mixed method approach.\n\nTrusts will collect information of all eligible patients and, following suitability checks, will share confidential patient information with the coordination centre (IPSOS MORI) and one of three approved contractors (Patient Perspective, Quality Health or Picker Institute Europe). The contractors will distribute questionnaires to patients using the approach detailed below:\nContact\tType\t-\tContent of contact\t-\tDays from first mailing\n1 - Postal\tInvitation letter inviting the patient to take part online, Multi-language sheet \t1\n1.1\tSMS\tSMS reminder (if phone number available), including a link to the survey\t4\n2\tPostal\tReminder letter, Multilanguage sheet\t15\n2.1\tSMS\tSMS reminder (if phone number available), including a link to the survey\t18\n3\tPostal\tReminder letter, Paper questionnaire, Freepost return envelope, Multi-language sheet\t29\n4\tPostal\tReminder letter, Multilanguage sheet\t43\n4.1\tSMS\tSMS reminder (if phone number available)\t46\n\n\nAhead of each reminder mailing, it will be necessary to remove all respondents who have completed the survey already, and to conduct a DBS or local check on the full sample. If anyone has requested to be opted out of further reminders, they should also be removed at these timepoints.\n\nWhilst the survey remains similar to previous years, and as in 2021, the applicants have added in COVID status to the data requested for analysis so they can distinguish between these for reporting purposes."]
["Description of confidential patient information used","This non-research application submitted by Ipsos MORI on behalf of the Care Quality Commission, sets out the purpose of conducting the 2022 NHS Maternity Survey. \n\nThe Maternity Survey started in 2007 and falls within the NHS Patient Survey Programme (NPSP). The NPSP was initiated in 2002 by the then Department of Health, and is now overseen by the Care Quality Commission (CQC), the independent regulator of health and social care in England. The 2022 Maternity Survey will be the ninth carried out to date, and the second using a mixed method approach.\n\nTrusts will collect information of all eligible patients and, following suitability checks, will share confidential patient information with the coordination centre (IPSOS MORI) and one of three approved contractors (Patient Perspective, Quality Health or Picker Institute Europe). The contractors will distribute questionnaires to patients using the approach detailed below:\n\nContact\tType\t-\tContent of contact\t-\tDays from first mailing\n1. Postal - Invitation letter inviting the patient to take part online, Multi-language sheet - 1\n1.1. SMS - SMS reminder (if phone number available), including a link to the survey - 4\n2. Postal - Reminder letter, Multilanguage sheet - 15\n2.1. SMS - SMS reminder (if phone number available), including a link to the survey\t - 18\n3. Postal - Reminder letter, Paper questionnaire, Freepost return envelope, Multi-language sheet - 29\n4. Postal - Reminder letter, Multilanguage sheet - 43\n5. SMS - SMS reminder (if phone number available) - 46\n\nAhead of each reminder mailing, it will be necessary to remove all respondents who have completed the survey already, and to conduct a DBS or local check on the full sample. If anyone has requested to be opted out of further reminders, they should also be removed at these timepoints.\n\nWhilst the survey remains similar to previous years, and as in 2021, the applicants have added in COVID status to the data requested for analysis so they can distinguish between these for reporting purposes."]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"X","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"X","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2022-02-07"]
["Notes","Conditions of support:\n\n1. Confirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. See section below titled ‘security assurance requirements’ for further information. \n\nConfirmed:-\nThe NHS Digital 20/21 DSPT reviews for Ipsos MORI, Patient Perspective, Quality Health Limited, and Picker Institute Europe were confirmed as ‘Standards Met’ on the NHS Digital DSPT Tracker (checked 27 January 2022)"]

{"sheet":"A1035","index":202,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A1035"]
["Reference","20/CAG/0116"]
["Other Refs"]
["Application Title","Quality and Outcomes in Oral and Maxillofacial Surgery (QOMS)"]
["Application Summary","This application from Saving Faces set out the purpose of undertaking a series of audits to collect data indicative of effectiveness or quality of care. \n\nOral and Maxillofacial Surgery (OMFS) is a unique surgical speciality, covering a wide range of conditions of the head and neck. This includes neoplasm, trauma, congenital malformations, diseases of the salivary glands. Due to the complexity of this speciality, the diversity of its practice and lack of, or limited, consensus on, appropriate metrics and benchmarks, systemic data collection indicative of effectiveness or quality of care is lacking in OMFS. This was highlighted in the 2018 OMFS Getting It Right First Time (GIRFT) report. In response to this report, the British Association of Oral and Maxillofacial Surgeons (BOAMS) has initiated the Quality and Outcomes in Oral and Maxillofacial Surgery (QOMS) project in order to undertake a series of audits to measure performance and quality of care at hospital, regional and national levels, assess disparities and encourage quality improvement. \n\nIn this application, support is sought for QOMS to undertake a programme of sub-specialty clinical audits under the QOMS umbrella. QOMS will also create registries, but support for these will be sought in a separate application. The audits will cover the following areas of OMFS practice: oral and dentoalveolar surgery, oncology & reconstruction, orthognathic, non-melanoma skin cancers, and trauma surgeries. The audits have already been developed and piloted using anonymous or consented data. The applicants are now extending the programme to include the processing of confidential patient information without consent. QOMS will collect data on pre-operative health status, details of the surgery performed, the principle healthcare professional responsible, and the development of recognised complications and outcomes. Clinical data will be collected and entered at hospital level by designated NHS staff at participating Trusts. The data will then be transferred via REDCap to the Barts Cancer Care (BCC) Safe Haven Environment, where the data will be checked for completeness and errors by the Designated Data Manager (DDM). The DDM will be the only member of the QOMS team who has access to confidential patient information. The DDM will prepare anonymised datasets to be used in analysis. The applicants advised that all UK NHS Trusts and Health Boards with an Oral and Maxillofacial Unit will be eligible to take part. This application sought support for the processing of confidential patient information generated within England and Wales, and appropriate support will be sought for the processing of information generated within Scotland and Northern Ireland. "]
["Applicant Organisation Name","Saving Faces"]
["Contact Name","Mr Fabien Puglia"]
["Address","Royal College of Surgeons of England"]
[null,"35/43 Lincoln's Inn Fields"]
[null,"London"]
["Postcode","WC2A 3PE"]
["Telephone","0207 405 8074"]
["Email","office@baoms.org.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"x","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","All patients undergoing the selected OMFS procedures for the selected conditions in an NHS hospital within England and Wales.\n\nQOMS will be comprised of a series of audits, each with their own specific populations. "]
["Description of confidential patient information used","Data sources\n1. All Trusts in England and Wales which have an Oral and Maxillofacial Unit. \n\nIdentifiers required for linkage purposes\n1. NHS number \n2. Hospital number\n3. Sex\n4. Date of birth\n\nIdentifiers required for analysis purposes\n1. Sex\n2. Age \n3. Postcode"]
["S251 Class(es)",null,"Specific Support"]
[null,"x","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"x","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"x","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"x","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2023-12-03"]
["Notes","19 April 2022 - Amendment supported\nAmendment supported to expand data capture to not only include NHS providers but also independent healthcare providers.\n\n11 February 2022 – Amendment supported\nAmendment supported to allow the inclusion of data items related to patients who undergo Sentinel Lymph Node Biopsy (SLNB). The SLNB data will be collected as an extension of the QOMS registry as part of the current data collection cycle (2021-2024).\n\n03 December 2020 - Support issued\n\nConditions of support:\n\n1. Feedback from the further public and patient involvement carried out will need to be submitted to the CAG within 6 months of support being issued, and further feedback given in annual reports to the CAG. \nConfirmed - conditions met, 15 March 2021\n\n2. Confirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. See section below titled ‘security assurance requirements’ for further information.\n\nConfirmed – Barts CR-UK Centre, Queen Mary University of London has a confirmed ‘Standards Met’ grade on DSPT submission 2018/19 by NHS Digital email dated 03 March 2020). \n\nDue to the number of participating sites where confidential patient information will be accessed, individual DSPT submissions are not required for the purpose of the application. Support is recommended on the basis that the applicant ensures the required security standards are in place at each site prior to any processing of confidential patient information with support under the Regulations."]

{"sheet":"A1036","index":203,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A1036"]
["Reference","22/CAG/0014"]
["Other Refs","Supersedes ECC 7-05(g)/2011 and PIAG 3-04(e)/2006"]
["Application Title","The Trauma Audit & Research Network (TARN)"]
["Application Summary","This non-research application submitted by Trauma Audit and Research Network (TARN), based at The University of Manchester, sets out the purpose of auditing trauma care in England, Wales, NI and Ireland, for the purposes of monitoring standards of care, providing accurate outcome analysis, and facilitating improvements for the treatment of trauma patients. This CAG application is only relevant for English and Welsh data.\n\nTraumatic injury is a global burden and largely contributes to death and disability across the UK. TARN aims to facilitate the development and improvement of trauma services, thereby reducing the associated burden of death and disability. \n\nTARN was initially established in 1990. As support was initially recommended many years ago, and there have been many amendments to this support, CAG requested that a new application was made. This refreshed application for TARN will supersede both ECC 7-05(g)/2011 and PIAG 3-04 (e) 2006, as all the processes covered by the ECC and PIAG applications are included in this refreshed application. \n\nTARN have existing ‘s251’ support to collect confidential patient information from participating Trusts, and retain patient NHS numbers and dates of birth to support specific activities as a national clinical audit in England and Wales.  The specific activities that require these identifiers include;\n•\tproviding participating Trusts with case mix standardised outcome analysis and comparisons of care for clinicians, NHS governance and commissioners to drive improvements, \n•\tlinkage with HES and PEDW trauma data for validation and to assist with data completeness across hospitals, \n•\tlinkage with PROMS data, \n•\tOutcome prediction modelling that require data linkage with ONS to obtain true 30 day patient outcomes. \n•\tTARN also provides data for specific Welsh projects that link with SAIL data, but this is not disclosed back to TARN.\n\nTARN also supports the implementation of the Best Practice Tariff, however any data flows regarding this do not require ‘s251’ support, as these are undertaken with NHS England Directions as the legal basis."]
["Applicant Organisation Name","Trauma Audit and Research Network (TARN)"]
["Contact Name","Antoinette Edwards, Executive Director "]
["Address","Trauma Audit and Research Network (TARN)"]
[null,"Summerfield House, 544 Eccles New Road"]
[null,"Salford Royal NHS Foundation Trust, Salford"]
["Postcode","M5 5AP"]
["Telephone","0161 206 4397"]
["Email","antoinette.edwards@manchester.ac.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"x","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Trauma patients attending Major Trauma receiving Hospitals in England and Wales\n\n1)Trauma patients: Irrespective of age  \n\n2) Who fulfil one of the following length of stay criteria: \n• In hospital for >3 overnight stays \n• Admitted to a Critical care area (regardless of LOS) \n• Transferred out for specialist care or repatriation (total LOS >3 overnight stays)\n• Transferred in for specialist care or repatriation* (total LOS >3 overnight stays) \n• Deaths (including deaths in ED, even if COD is medical) 3. AND whose isolated injuries meet one of the following criteria>>).\n\n3) And whose injuries fulfil the following criteria:\n• All head, complicated facial, spinal, organ or vessel injuries\n• Any open limb injury or any 2 limb fractures &/or dislocations.\n\nIrrespective of the length of stay criteria, patients with the following injuries are excluded:\n• Isolated femoral neck or single pubic rami fractures aged 65 years or greater\n• Simple skin injuries including uncomplicated penetrating injuries\n• Closed unilateral limb fractures"]
["Description of confidential patient information used","Data sources:\n1.\t218 participating hospitals – those in England and Wales are in scope for ‘s251’ ,Northern Ireland and Ireland are out of scope for ‘s251’. \n2.\tHES and ONS (NHS Digital)\n3.\tMajor trauma PROMS (quality health)\n4.\tPatient Episode Database for Wales (PEDW) (DHCW)\n\nSAIL and SUS data are not disclosed back to the applicant, and are not data sources for the TARN application. \n\nIdentifiers required to be collected by participating Trusts and disclosed to TARN, and retained by TARN:\nDirect identifiers collected:\n1. NHS number \n2. Date of Birth \n\nAdditional data collected: \n3. Age\n4. Sex\n5. Incidence postcode\n6. Partial patient postcode (first part and first digit of second part)\n\n(Patient Name and Full patient postcode are encrypted at source and only the submitting hospitals can view this data)\n\nIdentifiers required for linkage purposes:\nFor linkage by TARN to HES, ONS, PROMS, PEDW;\n1. NHS number \n2. Date of Birth \n\nProvided to DHCW for linkage with SAIL:\n1. NHS number\n2. Date of birth\n3. Sex\n\nProvided to CSU for linkage with SUS (with NHS Directions as legal basis):\n1. NHS number\n2. Date of Birth\n3. Partial postcode\n4. Encrypted name\n\nIdentifiers required for analysis purposes:\nDirect identifiers required:\n1. NHS number \n2. Date of Birth \n\nAdditional data required: \n3. Age\n4. Sex\n5. Incidence postcode\n6. Partial patient postcode (first part and first digit of second part)"]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"X","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"X","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"X","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2023-02-21"]
["Notes","Amendment supported 22 December 2022 \nTo include an additional purpose to the TARN application, of linkage of TARN data with STATS-19 data, by providing partial postcode to the Department for TransportAmendment supported 22 December 2022\n\nTo allow MDSAS Limited (Medical Data Solutions and Services) to process confidential patient information for the purposes of maintaining and monitoring the current TARN data collection system21 February 2022 - Application supported\n\nConditions of support:\n\n1. ECC 7-05(g)/2011 and PIAG 3-04 (e) 2006 will be expired from the date of this letter, and superseded by 22/CAG/0014. Please note new annual review date.\n\n2. Support is provided for 5 years in the first instance. A duration amendment will be required at that time to extend support.\n\n3. Please provided clear justification as to why NHS number is required to be retained for 3 years, and why date of birth is required to be retained indefinitely. Please provide a response to CAG within three months from the date of this letter. Condition met June 2022\n\n4. Please ensure the flyer is more visible on the TARN website. Please provide a response to CAG within three months from the date of this letter. Condition met June 2022\n\n5. Please confirm if the flyer provided is also displayed in clinical areas in Trusts or is this available on the website only? Please provide a response to CAG within three months from the date of this letter. Condition met June 2022\n\n6. Please make the changes as described in this letter to the notification flyer and provide an updated version to the CAG within three months form the date of this letter. This includes;\na. Making it clearer how to opt out on the flyer\nb. Explain who the cohort are on the flyer\nc. Include a phone number alongside the email address on the flyer\nd. Ensure the role of CAG is more accurately described\nCondition met June 2022\n\n7. Please undertake further patient and public involvement, as described in this letter, and provide a progress report to the CAG within three months form the date of this letter. This includes;\na. Ensuring 20 or more people are consulted\nb. Ensure the use of confidential patient information without consent is discussed\nc. Ensure the patient notification flyer, privacy notice and any other potential methods are discussed\nCondition not yet met, 6 further months allowed from 21 June 2022\n\n8. Confirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. See section below titled ‘security assurance requirements’ for further information. \n\nConfirmed:-\nThe NHS Digital 20/21 DSPT reviews for The Trauma Audit & Research Network (J160), University of Manchester (re data safe haven storage of HES and ONS data), NHS Digital, and Quality Health were confirmed as ‘Standards Met’ on the NHS Digital DSPT Tracker (checked 18 February 2022)\n\nDepartment of Health and Care Wales (DHCW) has a Caldicott Principles into Practice (CPiP) Out-turn report with a score of 97.5%, and improvement plan for 20/21 provided 9th June 2021.\n\nDue to the number of participating care providers involved it is the responsibility of TARN, as controller, to ensure that all organisations disclosing confidential patient information to TARN meet the minimum required standard in complying with DSPTs, and take remedial action if they become aware of any that fall below this, or where any concerns are raised about a care provider. These will not be individually checked by the CAT team due to the number of organisations involved.\n"]

{"sheet":"A1037","index":204,"n_rows":36,"n_cols":3,"rows_kept":36,"cut":false,"hidden":false,"merged":[[31,1,31,4],[32,1,32,4],[34,1,34,4],[35,1,35,4],[21,1,21,4],[22,1,22,4],[23,1,23,4],[24,0,30,0],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,2,30,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A1037"]
["Reference","21/CAG/0150"]
["Other Refs","Resubmission of 21/CAG/0019"]
["Application Title","Biliary Atresia Registry (England and Wales)"]
["Application Summary","This non-research application from Kings College Hospital NHS Foundation Trust (KCH) set out the purpose of creating a registry of all infants with biliary atresia (BA) in England and Wales from Jan 1999 onwards. The purpose of the registry is to monitor the outcome of the clinical management of BA. Prior to 1999, management in the UK was decentralised. Outcome surveys had shown that only the larger centres treating more than 5 cases per year had acceptable results, so it was mandated that the care of such infants was to be centralised and managed only at three large national centres in London, Birmingham and Leeds. Since centralisation, there has been a dramatic improvement in national outcome. \n\nThis registry has been in existence since 1999 when the Department of Health mandated that a record be kept of all infants in England and Wales with BA. However, it has been operating without a legal basis under common law, and this application is therefore to provide a legal basis under common law to retain the database which has been created retrospectively, and to provide a legal basis for the data collection prospectively. NHS England are supportive of this registry being controlled by KCH moving forwards, under ‘s251’, as there does not appear to be any current NHS Directions mandating the data collection. \n\nBiliary atresia is a rare, potentially life-threatening, condition of newborns characterised by persisting jaundice and the development of liver fibrosis and cirrhosis. It requires early identification and prompt surgical management to try and forestall liver failure. The registry is required to continue to provide regular, consistent and transparent monitoring of the outcomes of all infants with BA, in order to continue to improve outcomes of infants and children with this disease.\n\nData is collected by the direct care team in individual centres, and name is removed. At the end of each year, confidential patient information including hospital ID number, date of birth, gender and NHS number, alongside a pseudo-Identifier and clinical information about each new patient treated in the centre for BA is transferred via a password-protected spreadsheet using NHS emails, to the central database (in KCH), together with a yearly record of outcome of all infants previously registered. These annual updates of patient management and outcome for previously registered children are then linked to baseline measures via the hospital ID. Data are stored on password-protected hospital server at KCH and only accessible by Mark Davenport, and a nominated deputy."]
["Applicant Organisation Name","Kings College Hospital NHS Foundation Trust (KCH)"]
["Contact Name","Professor Mark Davenport, Consultant Paediatric Surgery and National Lead for Biliary Atresia "]
["Address","Dept. Paediatric Surgery"]
[null,"Kings College Hospital"]
[null,"Denmark Hill, London"]
["Postcode","SE5 9RS"]
["Telephone","020 3299 9000"]
["Email","mark.davenport@nhs.net"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"x","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","All infants diagnosed with biliary atresia and managed in one of the three national centres, from January 1999 onwards\n\nApproximately 850 infants, and more prospectively. "]
["Description of confidential patient information used","Data sources:\nMedical records at the three national centres;\n• Kings College Hospital, London\n• Birmingham Women's and Children's Hospital\n• Leeds Children's Hospital\n\nIdentifiers required for linkage purposes (for annual follow up):\n1. Hospital ID\n\nIdentifiers retained in registry:\n1. Hospital ID – to allow linkage\n2. NHS number – as suggested by CAG in 21/CAG/0019 (to ensure future linkage is possible if required)\n3. Date of Birth – to allow linkage and for analysis\n4. Maternal Postcode – for analysis\n5. Gender – to allow linkage and for analysis \n6. Ethnicity – for analysis\n7. Date of surgical (Kasai) intervention – for analysis\n8. Clearance of jaundice – Primary outcome measure\n9. Associated anomalies – for analysis\n10. Type of BA – for analysis\n11. Need for and date of transplant – for analysis\n12. Date of death – for analysis\n\nIdentifiers required for analysis purposes:\n1. Maternal postcode (at time of childs birth) \n2. Ethnicity, \n3. Associated congenital anomalies, \n4. Type of biliary atresia, \n5. Date of surgical (Kasai) intervention\n6. Date of liver transplant\n7. Date of death\n8. Date of birth \n9. Gender\n\nAdditional information:\nAn update of patient management and outcomes for all previously registered children is also sent annually to KCH.\n\nThese annual outcomes will cease once a child turns 16, but their previously collected data will remain in the registry"]
["National Data Opt \nOut Status","The Secretary of State for Health and Social Care decision maker, on advice from the CAG, has supported a request to defer the National Data Opt Out. As such, the National Data Opt Out does not need to be applied for this activity"]
["S251 Class(es)",null,"Specific Support"]
[null,"X","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"X","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"X","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"X","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2022-02-23"]
["Notes","23 February 2022 - Application supported\n\nConditions of support:\n\n1. Support will be provided for 5 years in the first instance. A duration amendment will be required at this time to ensure continuing ‘s251’ support.\n\n2. Please provide updated patient notification for both parents and children turning 16, as described above. These notification materials should be returned to CAG within 3 months from the date of this letter, and should include;\n\na) The poster should be updated to ensure it is clear that the mothers postcode will be collected and retained for analysis indefinitely. \nb) Develop a poster notification for those turning 16, ensuring it is age appropriate\nc) Ensure the above documents are discussed with a patient and public involvement group – (this is part of condition 3 and can be provided at annual review).\n\nConditions met 20 September 2022\n\n3. Further Patient and Public Involvement and Engagement is required to be undertaken. This should better describe the activities, and not refer to the information being processed as anonymous or pseudonymous. Children should be asked for their opinions if possible. Feedback should be provided to CAG at annual review, and is specifically requested to focus on;\n\na) The acceptability of this use of confidential patient information without consent;\nb) Their opinions on the level of confidential patient information retained; \nc) Feedback surrounding newly developed notification materials; \n\n4. Confirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. See section below titled ‘security assurance requirements’ for further information. \n\nConfirmed:- \nThe NHS Digital 20/21 DSPT reviews for King’s College Hospital NHS Foundation Trust and Birmingham Women's and Children's NHS Foundation Trust and Leeds Teaching Hospitals NHS Trust were confirmed as ‘Standards Met’ on the NHS Digital DSPT Tracker (checked 25 November 2021)."]

{"sheet":"A1038","index":205,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A1038"]
["Reference","22/CAG/0015"]
["Other Refs"]
["Application Title","REDCap registry for the UK highly specialised national service for Bardet-Biedl syndrome"]
["Application Summary","This application from University College London set out the purpose of creating a registry to aid in the NHS delivery of highly specialised services for Bardet-Biedl syndrome (BBS).\n\nApproximately 620 people in the UK have a diagnosis of BBS. Bardet Biedl Syndrome is a rare genetic disorder with highly variable symptoms which may include retinal degeneration, obesity, reduced kidney function, polydactyly (extra digits of the hands or feet) among many other features. Around 190 of those affected are under 18 years of age. The national Bardet-Biedl Syndrome service was commissioned by NHS England Highly Specialised Services in 2010, with a view to improving the diagnosis of BBS, gaining a better understanding of the natural history, preventing and treating secondary sequalae and to ensure that the BBS community are in the best position to access novel therapies as they are developed. Clinicians from the four national commissioned BBS service centres have collaborated with BBS UK, the support group for patients with BBS, to develop a REDCap based registry. This registry will be used to audit, review and update the management of BBS locally and nationally.  The applicants also intend to make the registry available for research purposes, in order to develop knowledge of the natural history of BBS and to create novel therapies. \n\nData managers at the four nationally commissioned BBS services centres will manually enter confidential patient information into the REDCap registry. The REDCap registry will be held within the University College London data safe haven and data will be processed by a central data manager. Clinicians directly involved in the clinical care of BBS patients may apply for read-only access to the database via the BBS access committee. "]
["Applicant Organisation Name","University College London"]
["Contact Name","Dr Elizabeth Forsythe"]
["Address","UCL Great Ormond Street Institute of Child Health"]
[null,"30 Guilford Street"]
[null,"London"]
["Postcode","WC1N 1EH"]
["Telephone","07974 265 654"]
["Email","Elizabeth.forsythe@ucl.ac.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"x","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Patients in England with a diagnosis of Bardet-Biedl syndrome and attending a BBS clinic from 12th of May 2010 onwards."]
["Description of confidential patient information used","Data sources:\n1. Patient records held at:\na. Great Ormond Street Hospital for Children NHS Foundation Trust, \nb. Guy’s and St Thomas’ NHS Foundation Trust, \nc. University Hospitals Birmingham NHS Foundation Trust \nd. Birmingham Women’s and Children’s NHS Foundation Trust.\n\nIdentifiers required for linkage purposes:\n1. Patient name\n2. Date of birth\n3. Gender\n4. Ethnicity\n\nIdentifiers required for analysis purposes:\n1. Patient name\n2. Date of birth\n3. Gender\n4. Ethnicity"]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"X","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"X","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2023-02-25"]
["Notes","25 February 2022 - Application supported\n\nConditions of support:\n\n1. Consider whether seeking consent prospectively from patients is possible, so that support under s251 is only required for patients included retrospectively\n\n2. Consider whether patients NHS numbers should be included.  \n\n3. Clarify whether the applicants hold email addresses for all patients and what would happen if they did not, e.g. will information about the registry be posted to patients. \n\n4. Clarify whether information about the registry will be included in the twice-yearly magazine for the foreseeable future. \n\n5. Explain how patients included in the registry as children will be informed about the study when they reach adulthood. \n\n6. The patient facing information needs to be written in plain English. \n\n7. The finalised version of the leaflet needs to be provided, rather than the text alone.  \n\n8. Provide clarification on the number of people involved in the patient and public involvement group. \n\n9. Further patient and public involvement needs to be caried out, including review of the patient notification materials to ensure the language used is suitable. \n\n10. Feedback from the above needs to be provided within 6 months of the issuing of the conditional outcome letter. \n\n11. Confirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. See section below titled ‘security assurance requirements’ for further information. \n\nConfirmed:-\nThe NHS Digital 2020/21 DSPT reviews for University College London, Great Ormond Street Hospital for Children NHS Foundation Trust, Guy’s and St Thomas’ Hospital NHS Foundation Trust, University Hospitals Birmingham NHS Foundation Trust and  Birmingham Women’s and Children’s NHS Foundation Trust, were confirmed as ‘Standards Met’ on the NHS Digital DSPT Tracker (checked 14 February 2022)."]

{"sheet":"A1039","index":206,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A1039"]
["Reference","22/CAG/0007"]
["Other Refs"]
["Application Title","Prison healthcare, focusing on natural and other non-natural deaths"]
["Application Summary","This application from NCEPOD set out the purpose of a confidential enquiry to review the clinical healthcare provided to prisoners. \n\nThe House of Commons Health and Social Care Committee report, ‘Prison Health’ which was published in 2018, reported that the Government was failing in its duty of care towards people detained in English prisons. The Select Committee recommended that the National Prison Healthcare Board worked with stakeholders to agree a definition of equivalent care and indicators to measure health inequalities between those in prison and the general population. The application has been commissioned by the Health Foundation, supported by NHS England, to review of the healthcare provided to prisoners who died in prison. The information collected will be used to highlight where care and organisation of care could be improved. \n\nThe standard NCEPOD methodology will be followed. A retrospective peer review of clinical notes will be undertaken and those involved in prisoners care will be asked to complete a questionnaire to provide their views on the care they could provide.  \n\nThe Prisons and Probation Ombudsman (PPO) produce Fatal Incident reports for any prisoner who dies. The Fatal Incident reports will be accessed to identify relevant patients. These reports are in the public domain, therefore this is outside the scope of support. However, as these reviews are undertaken to varying levels of detail dependent on the nature of the death the applicants will undertake more detailed reviews, which will include review of the care provided over the previous 12 months, to assess the healthcare provided as well as the death. Information for identified patients will be linked to prison healthcare and primary care records at SystemOne, and hospital case notes if the prisoner was admitted to hospital. NHS commissioned independent clinical reviews, provided by NHS England/Health Inspectorate Wales, and coroners inquest reports will also be accessed, if available. For the in-depth peer review, extracts of case notes from hospitals and SystmOne will be scanned and sent to NCEPOD via an nhs.net email address. Questionnaires will be sent to the clinician involved in the care of the prisoner and confidential patient information is required to send this questionnaire. The data collected will be aggregated before publication and confidential patient information is only required to link data at the collection phase."]
["Applicant Organisation Name","NCEPOD"]
["Contact Name","Dr Neil Smith"]
["Address","Ground Floor Abbey House"]
[null,"74-76 St John Street"]
[null,"London"]
["Postcode","EC1M 4DZ"]
["Telephone","0207 2519 060"]
["Email","nsmith@ncepod.org.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"X","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","All prisoners aged 18 years and over who died between 01 January 2018 and 31 December 2020, of natural causes or other non-natural deaths. Deaths where the cause was suicide or homicide will be excluded. "]
["Description of confidential patient information used","Data sources\n1. Fatal Incident Reports, created by the Prisons and Probation Ombudsman\n2. Records of the NHS clinical review associated to the Fatal Incident Report\n3. Coroner’s inquest reports\n4. SystmOne notes for the 12 months leading up to the death – held by Primary Care Support England\n5. Patient records at the treating hospital for any acute admissions and outpatient appointments in the 12 months leading up to the death\n\nIdentifiers required for linkage purposes\n1. Name\n2. Sex\n3. Age\n4. Date of birth\n5. NHS number\n6. Date of death\n7. Prison name\n8. Hospital name\n9. NHS number\n10. Hospital number \n11. Prisoner number\n12. Date of admission – where applicable\n13. Date of discharge – where applicable\n\nIdentifiers required for analysis purposes\n1. Name\n2. Sex\n3. Date of birth\n4. Prison number\n5. Hospital number\n6. NHS number\n7. Date of death\n8. Prison name\n9. Hospital name\n10. Date of admission\n11. Date of discharge"]
["S251 Class(es)",null,"Specific Support"]
[null,"X","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"X","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"X","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"X","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2023-03-22"]
["Notes","22 March 2022 - Application Supported\nConditions of support:\n\n1. Confirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. See section below titled ‘security assurance requirements’ for further information.\n\nConfirmed:-\nThe NHS Digital 2020/21 DSPT reviews for NCEPOD, The Health Foundation and Primary Care Support England/The Phoenix Partnership were confirmed as ‘Standards Met’ on the NHS Digital DSPT Tracker (checked 26 January 2022)."]

{"sheet":"A1040","index":207,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","A1040"]
["Reference","21/CAG/0094"]
["Other Refs"]
["Application Title","Time limited access for NHS Digital to undertake record linkage of East Anglian Air Ambulance patients to HES and ECDS"]
["Application Summary","This non-research application from East Anglian Air Ambulance (EAAA) sets out the medical purpose which aims to link routinely collected clinical data regarding patients treated by East Anglian Air Ambulance to hospital held NHS data to audit and evaluate the care provided by the air ambulance in relation to the complete patient pathway and patient outcomes. This application is for support to link information regarding the 2020 cohort of patients, and an amendment will be submitted should the applicant wish to undertake linkages of further cohorts. \n\nEast Anglian Air Ambulance are a key provider of pre-hospital emergency care within East Anglia, attending the most critically ill patients within the region. Alongside regular audit that is undertaken using in house data, this application requests to link this with centrally held NHS data to audit and evaluate the care provided by the air ambulance in relation to the complete patient pathway and patient outcomes. This gives opportunity for improved clinical excellence, gives learning opportunity for clinical staff and, ultimately, can lead to improved care for future patients (members of the public) of the air ambulance. The intention is to also share outcomes with other air ambulances and NHS partners, so that this project can potentially be of wider regional and national benefit in terms of using data to maximise patient benefit. \n\nSome examples of expected outcomes:\n• Accuracy of Dispatch and of Diagnosis:  To identify the proportion of patients whose condition is correctly categorised: 1) At tasking 2) At scene based on working diagnosis. \n• Survival: Proportion of people who survive to discharge. \n• Decision making: To consider accuracy of conveyance (e.g. where patients are soon transferred onwards to another hospital) or unnecessary conveyance (patients who had no additional investigations or treatments at hospital which need to be provided in a hospital setting)\n• Special cases or rarer conditions - analysis of patient record to look at the whole patient pathway and consider any learning opportunities. \n• Impact of pre-existing comorbidities on pre-hospital care. These are recorded as associated diagnoses on the hospital record, but are often not well known about or not recorded during emergency care.\n\nEAAA will provide NHS Digital with identifiers of eligible patients. Whilst these may be more than usual these are the minimum necessary to ensure linkage given the EAAA do not record NHS numbers as standard practice. This has been discussed and agreed with NHS Digital. NHS Digital will link to the requested datasets and return the data in pseudonymised form, where it will be linked to currently held clinical data for the purposes described.  "]
["Applicant Organisation Name","East Anglian Air Ambulance (EAAA)"]
["Contact Name","Kate Lachowycz, Research & Development Lead"]
["Address","East Anglian Air Ambulance"]
[null,"Helimed House, Hangar 14"]
[null,"Gambling Close, Norwich"]
["Postcode","NR6 6EG"]
["Telephone","07984 074 523"]
["Email","Kate.Lachowycz@eaaa.org.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"X","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","All patients treated by East Anglian Air Ambulance, (excluding those who die before admission to hospital) in 2020. \n\nThese patients are either taken by air ambulance to hospital, ‘ground escorted’ by EAAA to hospital, whereby EAAA crew accompanies the patient in a road ambulance, or treated by EAAA at scene and then taken to hospital by road ambulance with the normal ambulance crew. \n\nThis initial phase will test linkage on the 2020 cohort (1384 patients) to test feasibility and usage of date before expanding to further years of data collection, however amendments will be submitted to CAG for support for further cohorts. "]
["Description of confidential patient information used","Data sources\nNHS Digital datasets\n1. Hospital Episode Statistics (HES): Admitted patient care\n2. Hospital Episode Statistics (HES): Critical care\n3. Emergency care data set (ECDS)\n\nIdentifiers required for linkage purposes\n1. Full name (first name and surname)\n2. Date of birth\n3. NHS number\n4. Age\n5. Home address, including postcode\n6. Gender\n7. Date of admission\n8. Hospital of admission\n\nIdentifiers required for analysis purposes\nNone\n\nAdditional information\nNote that the data will be linked to EAAA data through a code, but EAAA will not attempt to reidentify patients through this."]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"X","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"X","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"X","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2022-05-03"]
["Notes","03 May 2022 - Application Supported\nThe application, to allow East Anglian Air Ambulance to disclose confidential patient information to NHS Digital, in order to undertake linkage with Hospital Episode Statistics (HES): Admitted patient care and Critical care datasets, and to Emergency care data set (ECDS), in order for NHS digital to provide a pseudonymous dataset back to the applicant, is fully supported\n\nConditions of support:\n1. Confirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. See section below titled ‘security assurance requirements’ for further information. \n\nConfirmed:-\nThe NHS Digital 20/21 DSPT reviews for NHS Digital and East Anglian Air Ambulance are confirmed as ‘standards met’ on the NHS Digital DSPT Tracker (Checked 03 May 2022)."]

{"sheet":"A1041","index":208,"n_rows":36,"n_cols":3,"rows_kept":36,"cut":false,"hidden":false,"merged":[[31,1,31,4],[32,1,32,4],[34,1,34,4],[35,1,35,4],[21,1,21,4],[22,1,22,4],[23,1,23,4],[24,0,30,0],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,2,30,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A1041"]
["Reference","22/CAG/0087"]
["Other Refs"]
["Application Title","Epidemiology and Outcome from Out of Hospital Cardiac Arrest (Non-research application)"]
["Application Summary","This application from the University of Warwick set out the purpose of a non-research application, aiming to collect and summarise data about people who experienced Out of Hospital Cardiac Arrests to be used to produce summary data for quality improvement work with ambulance services, charities and NHS England. A separate research application has also been submitted, under reference 22/CAG/0072.\n\nThe OCHAO application has been supported since 2013 as a research database, under reference ECC 8-04 (c)/2013). As part of CAT review it was identified that OCHAO also has substantial use for non-research purposes, something that was not originally supported. As such, CAT requested this application to form a legal basis for non-research use. In November 2021, the applicants submitted an amendment seeking support to include an additional data linkage from NHS Digital, to collect long-term outcome data from NHS Digital, and to increase the frequency of data collection from ambulance services from annual to continuous. The applicants noted that, from May 2021, ambulance services had recorded a new outcome variable, 30-day survival, under the general COPI notice, issued under Regulation 3(4) of the COPI Regulations. The applicants sought to continue receiving this data after the COPI Notice expired. 30-day survival would replace survival to discharge as the main outcome variable. A new application was requested, due to the change in main outcome variable from survival to discharge to 30-day survival, the changes made with the COPI Notice as the legal basis, and the age of the application. As part of CAT review, it was identified that OCHAO also has substantial use for non-research purposes, something that was not originally supported. As such, CAT requested this application to form a legal basis for non-research use.\n\nAn estimated 60,000 people have an out of hospital cardiac arrest (OHCA) each year in the UK. Resuscitation is not attempted in around 60% of cases and attempted resuscitation by ambulance services occurs in less than 50% of cases. Where resuscitation is attempted, there is significant variability between ambulance services in rates of the return of spontaneous circulation (ROSC) at hospital handover and survival to hospital discharge. The average survival rate is 7% and if this could be increased to the best reported survival rate of 12%, then it is estimated that an additional 1000 lives could be saved each year. Improving survival to levels seen in the best performing health systems, e.g. 21% as is seen in Seattle, US, could save an estimated 4800 lives annually.\n\nThe audit teams at participating ambulance services will collect data from patient report forms, ambulance 999 call records, ambulance clinical records and ambulance vehicle tracking systems. The ambulance services will also collect patient outcome data from other NHS providers or systems, such as the Summary Care Record (SCR) at NHS Digital, or directly from NSH Trusts. The OHCAO project has an additional agreement in place with NHS Digital to collect additional variables relating to long-term survival and cause of death. This includes date of death, place of death and cause of death.\n\nThe research database is used as a data source for a variety of research projects. External collaborators wishing to access OHCAO data must complete and send in a data sharing request application form outlining their research project and the OHCAO data variables they require. Following an initial informal review by the OHCAO project team the application is sent to the OHCAO Academic Committee for a formal peer review. Data released to external researchers will be anonymised (unless they have their own ‘s251’ support)."]
["Applicant Organisation Name","University of Warwick"]
["Contact Name","Professor Gavin Perkins, Director Warwick Clinical Trials Unit"]
["Address","Warwick Medical School"]
[null,"University of Warwick"]
[null,"Gibbet Hill Road, Coventry"]
["Postcode","CV4 7AL"]
["Telephone","0247 6150 479"]
["Email","G.D.Perkins@warwick.ac.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"X","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Patients who experienced an OHCA, who were attended by or on behalf of an NHS Ambulance Service and where resuscitation was attempted. \n\nPatients who experienced an OHCA during inter-hospital transfer or on acute NHS hospital trust premises, or where there is clear evidence of death defined by the Joint Royal College Ambulance Liaison Committee (JRCALC) Recognition of Life Extinct (ROLE) criteria, will be excluded. \n\nThe OHCAO registry receives data for approximately 30,000 cases each year.\nTo date the registry holds 255,877 cases.\nTotal cases by the end of the current funding period (2018 to 2023) will be approx. 300,000."]
["Description of confidential patient information used","Data sources\n1. Participating NHS ambulance services will provide data obtained from patient report forms, ambulance 999 call records, ambulance clinical records and ambulance vehicle tracking systems, and patient outcome data obtained from the Summary Care Record (SCR) at NHS Digital or through direct contact with acute NHS Trusts (which is part of their usual clinical process).\n\n2. NHS Digital \na. demographics data, \nb. Civil Registration Mortality data (ONS)\n\nAs part of additional queries, linkage with ICNARC mentioned, and linkage to antecedants to OHCA held by NHS D mentioned, but these studies are not yet in place, and we should expect an amendment about each. \n\nIdentifiers required for linkage purposes\n1. Name\n2. NHS number\n3. Date of birth\n4. Date of death\n5. Postcode – unit level\n\nIdentifiers required to be retained in the OHCA database\n1. Name\n2. Date of birth\n3. Date of death\n4. Postcode – unit level\n5. Gender\n\nAdditional information\nTwo patient identifiers (date of birth and date of death) will be held in the same table as the clinical data. A secondary table will hold the remaining identifiers (surname, forename, NHS number and home postcode). "]
["National Data Opt \nOut Status","The Secretary of State for Health and Social Care decision maker, on advice from the CAG, has supported a request to defer the National Data Opt Out. As such, the National Data Opt Out does not need to be applied for this activity"]
["S251 Class(es)",null,"Specific Support"]
[null,"X","Class I - making the person less readily identifiable "]
[null,"X","Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"X","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"X","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"X","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2023-06-15"]
["Notes","Amendment supported 29 July 2022 to defer applying the National Data Opt-Out in relation to 22/CAG/0087\n\nSpecific conditions of support \n\n1.\tThis outcome confirms a change to the original conditions of support. The National Data Opt-Out is not to be applied to patients included in the activities specified in 22/CAG/0087.\n\n2.\tA local patient objection mechanism must continue to be used in relation to 22/CAG/0087. \n\n3.\tPlease provide a poster to inform the relevant cohort about OHCAO and that the NDO will not be applied. This should be developed with PPI input, and should be provided within 3 months from the date of this letter.\n\nCondition met 18 November 2022\n\n4.\tPlease provide feedback of further discussions with patients and the public, surrounding the non-application of the National Data Opt-Out, within 3 months from the date of this letter.\n\nCondition met 18 November 2022\n\n15 June 2022 - Application Supported\n\nConditions of support:\n\n1. Further efforts need to be made to publicise the study;\na. The website information needs to be provided for review. The information needs to explain the research and non-research activities taking place and include a link to the Privacy Notice.\nb. The Privacy Notice needs to be written using lay appropriate language. The explanation of the CAG and its role also needs to be revised as follows, “The Confidentiality Advisory Group have recommended that support under Regulation 5 of the Health Service (control of patient information) Regulations 2002 (‘section 251 support’) is given for the processing of confidential patient information.”\n\n2. Provide further details on why confidential patient information needs to be retained long term and whether an alternative, such as NHS Digital retaining confidential patient information and/or a data linkage key, so that the applicants hold anonymised data only, could be used.\n\n3. Provide further information on how an anonymised dataset could be done and an anticipated time frame for the creation of this.\n\n4. Details on how requests by other researchers to access the data will be handled needs to be provided. This needs to include information on the application process and how it would be determined whether a project was research or non-research.\n\n5. Confirm that the CAG will be kept updated on the development of work with NHS Digital to make the OHCAO registry data available within NHS Digital’s Trusted Research Environment and that amendments will be submitted, as needed.\n\n6. Confirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. See section below titled ‘security assurance requirements’ for further information. \n\nConfirmed:-\nThe NHS Digital 2020/21 DSPT reviews for University of Warwick Clinical Trials Unit and NHS Digital were confirmed as ‘Standards Met’ on the NHS Digital DSPT Tracker (checked 26 May 2022).\n\nDue to the number of participating ambulance services, where confidential patient information will be accessed, individual DSPT submissions are not required for the purpose of the application. Support is recommended on the basis that the applicant ensures the required security standards are in place at each site prior to any processing of confidential patient information with support under the Regulations."]

{"sheet":"A1042","index":209,"n_rows":35,"n_cols":5,"rows_kept":35,"cut":false,"hidden":false,"merged":[[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","A1042"]
["Reference","22/CAG/0100"]
["Other Refs"," "]
["Application Title","National Cancer Patient Experience Survey 2022-2024 "]
["Application Summary","This application from NHS England and Picker Institute Europe set out the purpose of administering patient surveys to evaluate services provided to cancer patients in 2022-2024. \n\n \n\nThe applicants seek to work with NHS trusts to collect and use data for approximately 125,000 cancer patients to carry out the Cancer Patient Experience Surveys for 2022, 2023 and 2024. The applicants also seek to collect email and mobile telephone numbers for the first time, in order to explore the digital potential for the survey. Survey fieldwork will be conducted annually. The survey methodology, data transfer arrangements and consent issues are the same as previous iterations of the study. The questionnaire, developed with engagement from a variety of stakeholders including patients in 2021, will be used unchanged for 2022.\n\n \n\nThe results of the survey will be used to enable comparisons between Trusts, for commissioners, providers and patients (all of whom could access the published results), would allow for monitoring of improvements in services, drive further improvements, and provide NHS England with an up-to-date overview of cancer patient experience across England. \n\n \n\nEach participating NHS trusts will extract confidential patient information required for the survey and disclose this to Picker Institute Europe. Picker Institute Europe then check that patients are still living and that the sampling guidance has been followed. Picker Institute Europe and Greens Ltd then mail the initial questionnaires and reminders, if required, to participants. Patient participation then proceeds on a consented basis. "]
["Applicant Organisation Name","NHS England and Picker Institute Europe"]
["Contact Name","Ms Nikki Gambles "]
["Address","7E56, Quarry House,  "]
[null,"Quarry Hill,  "]
[null,"Leeds"]
["Postcode","LS2 7UE "]
["Telephone","07527696885"]
["Email","nikki.gambles@nhs.net"]
["Medical Purposes"," ","preventative medicine"]
[null," ","medical diagnosis"]
[null," ","medical research, approved by a research ethics committee"]
[null," ","the provision of care and treatment"]
[null,"X","the management of health and social care services"]
[null," ","informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","All adult patients (aged 16 and over), with a primary diagnosis of cancer, who have been admitted to hospital as inpatients for cancer related treatment, or who were seen as day case patients for cancer related treatment, and have been discharged between 1st April and 30th June of the survey year will be included in the survey (for example the 2022 survey will include those discharged between 1st April 2022 and 30th June 2022) "]
["Description of confidential patient information used","Data sources:\n\nElectronic patient records at participating Trusts in England\n\nIdentifiers required for linkage purposes :\n\nDate of birth\n\nNHS number\n\nName\n\nSex\n\nAddress\n\nPostcode – unit level\n\nEmail address\n\nMobile telephone number\n\nSite treated at\n\nTreating NHS trust\n\nIdentifiers required for analysis purposes:\n\nPostcode\n\nICD 10/11 code\n\nMain speciality code"]
["S251 Class(es)"," ","Specific Support"]
[null,"X","Class I - making the person less readily identifiable "]
[null," ","Class II - present or past geographical locations of patients "]
[null," ","Class III - to identify and contact patients to obtain consent"]
[null,"X","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"X","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"X","Class VI - granting of access to data for purposes I-V"]
["Sponsor"," "]
["Status","Supported"]
[" "," "," "," "," "]
["Next Review Date","2023-07-20"]
["Notes","Specific conditions of support :\n\nThe first three conditions below need to be reported back on within 3 months of the issuing of this outcome letter: \n\n1. Confirm whether patients mobile telephone numbers and email addresses need to be collected, or if the trusts could instead record whether or not the items of information were available.\n\n2. The National Data Opt-Out exemption needs to be explained in the patient notification materials. This needs to include an explanation that the exemption had not been granted by CAG, but via policy consideration. A link to the information around the exemption on the NHS Digital website, 7. Policy considerations for specific organisations or purposes - NHS Digital also needs to be included on the patient notification materials.\n\n3. Further patient and public involvement needs to be carried out, including discussion of the collection of patient mobile telephone numbers and email addresses.\n\n4. Confirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. See section below titled ‘security assurance requirements’ for further information. Confirmed:\n\nThe NHS Digital 2020/21 DSPT review for NHS England & NHS Improvement, Picker Institute Europe and Greens Ltd were confirmed as ‘Standards Met’ on the NHS Digital DSPT Tracker (checked 14 July 2022). "]

{"sheet":"A1043","index":210,"n_rows":36,"n_cols":3,"rows_kept":36,"cut":false,"hidden":false,"merged":[[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[24,0,30,0],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,2,30,4],[31,1,31,4],[32,1,32,4],[34,1,34,4],[35,1,35,4],[21,1,21,4],[22,1,22,4],[23,1,23,4]]}
[]
[]
["Application Number","A1043"]
["Reference","22/CAG/0114"]
["Other Refs","17/CAG/0071"]
["Application Title","NHS England (NICOR) National Cardiac Audit Programme (NCAP)"]
["Application Summary","The amendment, to transfer activities supported under reference 17/CAG/0071 (including subsequent amendments) via a new non-research application is supported, subject to compliance with the with the pre-existing standard and specific conditions and the conditions of support outlined below\n\nThis submitted information represented a new application in relation to an existing activity under application reference 17/CAG/0071. The applicant states that in the current application, HQIP has been the joint data controller for NCAP data with NHS England & NHS Improvement (NHSE/I) for the English data and the Welsh Government (WG) / Data Health and Care Wales (DHCW) for the Welsh data respectively. The data processor has been Barts Health NHS Trust (NICOR). This new application represents a change in controllership to NHSE/I for English data, and DHCW for Welsh data. This new application also represents a change in data processor to NHS Arden and Greater East Midland Commissioning Support Unit (Arden & GEM). The intention is to replace 17/CAG/0071 with this new application.\n"]
["Applicant Organisation Name","NHS England & NHS Improvement"]
["Contact Name","Professor Nick Linker"]
["Address","Skipton House, 80 London Road, London \n\n"]
[]
[]
["Postcode","SE1 6LH"]
["Telephone","01642 282412"]
["Email","nick.linker@nhs.net"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"X","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","The patients within these six audits:\n1. Myocardial Ischaemia National Audit Project\n2. Adult Cardiac Surgery Audit\n3. National Heart Failure Audit\n4. Congenital Heart Disease Audit\n5. Cardiac Rhythm management Audit\n6. Adult cardiac Interventions Audit"]
["Description of confidential patient information used","The following confidential information is required:\nNHS number, postcode, date of birth, date of death, patient's name.\n\nAmendment (30/11/2018) - The following are patient identifiable data items that would be shared with NHS Ambulance Trusts:\n NHS number,  CAD (Computer-Aided Dispatch) number,  Full name,  Date of birth,\n Date of death.\nAmbulance Trusts will only be able to view and export data in relation to patients that they have transported to hospital. Data from the ambulance Trusts and MINAP will be linked by ambulance job number and/or NHS number."]
["National Data Opt \nOut Status","The Secretary of State for Health and Social Care decision maker, on advice from the CAG, has supported a request to defer the National Data Opt Out. As such, the National Data Opt Out does not need to be applied for this activity"]
["S251 Class(es)",null,"Specific Support"]
[null,"Y","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2023-03-07"]
["Notes","Amendment supported 26 July to defer applying the National Data Opt-Out in relation to 22/CAG/0114 (Prev 17/CAG/0071)\n\nSpecific conditions of support \n\n1.\tThis outcome confirms a change to the original conditions of support. The National Data Opt-Out is not to be applied to patients included in the activities specified in\n22/CAG/0114 (prev 17/CAG/0071)\n\n2.\tThe National Data Opt-Out must be applied in relation to processing for research purposes, specifically in relation to 22/CAG/0118 (Prev 17/CAG/0078)\n\n3.\tA local patient objection mechanism must continue to be used in relation to 22/CAG/0114 (Prev 17/CAG/0071)\n\n4.\tThe applicant is requested to submit full refreshed applications in relation to 22/CAG/0114 (17/CAG/0071) and 22/CAG/0018 (17/CAG/0078) to ensure to scope of support is clear regarding research and non-research activity. This should be submitted in lieu of the next due annual review.\n\n5.\tPlease provide evidence of discussions with patients and the public, surrounding the non-application of the National Data Opt-Out, within 3 months from the date of this letter\n\n6.\tPlease provide the updated communications plan regarding Communications Notice to Patients, section 5.5, as per the advice in this letter, as soon as possible to avoid any incorrect versions of text being uploaded to websites. Condition met 26 July 2022\n\n\nConditions of support:\n\n1.\tThis support supersedes 17/CAG/0071\n\n2.\tThe date of annual review is retained from 17/CAG/0071.\n\n3.\tAs per the NDO exemption outcome letter dated 01 July 2022, the applicant is requested to submit full refreshed applications in relation to 17/CAG/0071 (now 22/CAG/0014) and 17/CAG/0078 (now 22/CAG/0018) to ensure to scope of support is clear regarding research and non-research activity. This should be submitted in lieu of the next due annual review.\n4.\tConfirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. Confirmed:\n\nThe NHS Digital 2021/22 DSPT reviews for NHS Arden and Greater East Midland Commissioning Support Unit (Arden & GEM) & Redcentric (Harrogate) were confirmed as ‘Standards Met’ on the NHS DSPT Tracker (checked 18 July 2022)\n"]

{"sheet":"A1044","index":211,"n_rows":36,"n_cols":3,"rows_kept":36,"cut":false,"hidden":false,"merged":[[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[24,0,30,0],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,2,30,4],[31,1,31,4],[32,1,32,4],[34,1,34,4],[35,1,35,4],[21,1,21,4],[22,1,22,4],[23,1,23,4]]}
[]
[]
["Application Number","A1044"]
["Reference","22/CAG/0116"]
["Other Refs","17/CAG/0152"]
["Application Title","NHS England (NICOR): UK Transcatheter Aortic Valve Implantation (TAVI)"]
["Application Summary","The amendment, to transfer activities supported under reference 17/CAG/0152 (including subsequent amendments) via a new non-research application is supported, subject to compliance with the with the pre-existing standard and specific conditions and the conditions of support outlined below\n\nThis submitted information represented a new application in relation to an existing activity under application reference 17/CAG/0152. The applicant states that in the current application, HQIP has been the joint data controller for TAVI data with NHS England & NHS Improvement (NHSE/I) for the English data and the Welsh Government (WG) / Data Health and Care Wales (DHCW) for the Welsh data respectively. The data processor has been Barts Health NHS Trust (NICOR). This new application represents a change in controllership to NHSE/I for English data, and DHCW for Welsh data. This new application also represents a change in data processor to NHS Arden and Greater East Midland Commissioning Support Unit (Arden & GEM). The intention is to replace 17/CAG/0152 with this new application.\n"]
["Applicant Organisation Name","NHS England & NHS Improvement"]
["Contact Name","Professor Nick Linker"]
["Address","Skipton House, 80 London Road, London \n\n"]
[]
[]
["Postcode","SE1 6LH"]
["Telephone","01642 282412"]
["Email","nick.linker@nhs.net"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"X","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","This is the UK Transcatheter Aortic Valve Implantation (TAVI) registry – a record of all TAVI procedures performed in the UK since the introduction of the technique in 2007. The dataset included demographic data, indications, procedural details and outcomes up to hospital discharge. Follow up data would be collected at 1 and 3 years. A recommendation for class 4, 5 and 6 support was requested to cover access by NICOR to identifiable data on patients undergoing the relevant procedures, to track patients across NHS organisations and to link to national datasets such as Hospital Episode Statistics (HES) and ONS mortality data."]
["Description of confidential patient information used","Access was requested to name, NHS number, date of birth, date of death, postcode, local patient identifier."]
["National Data Opt \nOut Status","The Secretary of State for Health and Social Care decision maker, on advice from the CAG, has supported a request to defer the National Data Opt Out. As such, the National Data Opt Out does not need to be applied for this activity"]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2023-12-31"]
["Notes","Amendment supported 26 July to defer applying the National Data Opt-Out in relation to 22/CAG/0116 (Prev 17/CAG/0152)\n\nSpecific conditions of support \n\n1.\tThis outcome confirms a change to the original conditions of support. The National Data Opt-Out is not to be applied to patients included in the activities specified in\n22/CAG/0116 (prev 17/CAG/0152).\n\n2.\tA local patient objection mechanism must continue to be used in relation to 22/CAG/0116 (prev 17/CAG/0152).\n\n3.\tPlease provide evidence of discussions with patients and the public, surrounding the non-application of the National Data Opt-Out, within 3 months from the date of this letter.\n\n4.\tPlease provide the updated communications plan regarding Communications Notice to Patients, section 5.5, as per the advice in this letter, as soon as possible to avoid any incorrect versions of text being uploaded to websites. Condition met 26 July 2022\n\nConditions of support:\n\n1.\tThis support supersedes 17/CAG/0152.\n\n2.\tThe date of annual review is retained from 17/CAG/0152.\n\n3.\tConfirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. Confirmed:\n\nThe NHS Digital 2021/22 DSPT reviews for NHS Arden and Greater East Midland Commissioning Support Unit (Arden & GEM) & Redcentric (Harrogate) were confirmed as ‘Standards Met’ on the NHS DSPT Tracker (checked 18 July 2022)\n"]

{"sheet":"A1045","index":212,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","A1045"]
["Reference","22/CAG/0117 "]
["Other Refs","17/CAG/0153"]
["Application Title","NICOR Commissioning through Evaluation Registries/Audits: \n• Percutaneous Mitral Valve Repair,\n• Left Atrial Appendage Occlusion and \n• Patent Foramen Ovale Closure in Adults\n"]
["Application Summary","The amendment, to transfer activities supported under reference 17/CAG/0153 (including subsequent amendments) via a new non-research application is supported, subject to compliance with the with the pre-existing standard and specific conditions and the conditions of support outlined below\n\nThis submitted information represented a new application in relation to an existing activity under application reference 17/CAG/0153. The applicant states that in the current application, Barts Health NHS Trust (NICOR) has been the data controller and processor. This new application represents a change in controllership to NHS England & NHS Improvement (NHSE/I). This new application also represents a change in data processor to NHS Arden and Greater East Midland Commissioning Support Unit (Arden & GEM). The intention is to replace 17/CAG/0153 with this new application.\n"]
["Applicant Organisation Name","NHS England & NHS Improvement"]
["Contact Name","Professor Nick Linker"]
["Address","Skipton House, 80 London Road, London \n\n"]
[]
[]
["Postcode","SE1 6LH"]
["Telephone","01642 282412"]
["Email","nick.linker@nhs.net"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"X","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Patients undergoing the procedures: Percutaneous Mitral Valve Repair; Left Atrial Appendage Occlusion; Patent Foramen Ovale Closure in Adults."]
["Description of confidential patient information used","Access was requested to name, postcode, NHS number, date of birth and date of death."]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"Y","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"Y","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"Y","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2023-08-31"]
["Notes","Amendment supported 16 January \nTo re-instate the registries; Percutaneous Mitral Valve Repair, Left Atrial Appendage Occlusion and Patent Foramen Ovale Closure in Adults, including both the previously archived data, and beginning a new data collection prospectively\n\nConditions of support:\n\n1.\tThis support supersedes 17/CAG/0153.\n\n2.\tThe date of annual review is retained from 17/CAG/0153.\n\n3.\tConfirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. Confirmed:\n\nThe NHS Digital 2021/22 DSPT reviews for NHS Arden and Greater East Midland Commissioning Support Unit (Arden & GEM) & Redcentric (Harrogate) were confirmed as ‘Standards Met’ on the NHS DSPT Tracker (checked 18 July 2022)\n"]

{"sheet":"A1046","index":213,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A1046"]
["Reference","22/CAG/0107"]
["Other Refs"]
["Application Title","The 2022 Urgent and Emergency Care Survey"]
["Application Summary","This non-research application submitted by Picker Institute Europe, (on behalf of the Care Quality Commission), sets out the purpose of conducting the 2022 Urgent and Emergency Care Survey.\n\nThe 2022 Urgent and Emergency Care Survey will be the ninth carried out to date, and falls within the NHS Patient Survey Programme (NPSP). The NPSP was initiated in 2002 by the then Department of Health, and is now overseen by the Care Quality Commission (CQC), the independent regulator of health and social care in England. The CQC have commissioned the Survey Coordination Centre for Existing Methods (SCCEM) at Picker to manage and coordinate the survey programme under the title of the SCCEM. All eligible trusts will be asked to conduct the survey with preparations expected to begin in September 2022 and fieldwork expected to start from November 2022. All trusts will draw a sample of patients according to set criteria, and follow standardised materials and procedures for all stages of the survey.\n\nThe methodology for the 2022 survey is unchanged from the 2020 survey. The Same Day Emergency Care (SDEC) indicator will no longer be requested for the 2022 survey. The SCCEM will use an online sample checking platform for the 2022 survey.\n\nNHS Trusts will submit the combined mailing and sample file to the approved contractor. The complete mailing data will then be removed, except for the full postcode, which will be sent to the SCCEM as part of the sample file. Both the approved contractors and the SCCEM will not open a sample file until a satisfactory sample declaration form has been received. Any outputs provided will be anonymous. This statistical dataset is used for a wide variety of purposes, with the ultimate aim of supporting the improvement of patient experience in England."]
["Applicant Organisation Name","Picker Institute Europe"]
["Contact Name","Tamantha Webster"]
["Address","151 Buckingham Palace Road"]
[null,"London"]
[]
["Postcode","SW1W 9SZ"]
["Telephone","03000 616161"]
["Email","Tamatha.Webster@cqc.org.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"X","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","People aged 16 and over who attended a Type 1 emergency department in September 2022 or a Type 3 urgent care department in September 2022. Trusts can sample back to August 2022 if required to fulfil sample. For trusts with only Type 1 departments, the sample size will remain at 1250. Trusts who have both departments will have a sample size of 950 for Type 1 and 420 for Type 3.\n\nThe applicants anticipate that 126 trusts will be involved. \n\nThe Sampling Instructions will ask trusts to exclude:\n\n - deceased patients\n- children or young persons aged under 16 years at the date of their attendance at the emergency department \n- any patients who are known to be current inpatients \n- planned attendances at outpatient clinics which are run within the Emergency Department (such as fracture clinics) \n- patients without a UK postal address \n- patients attending primarily to obtain contraception (e.g. the morning after pill), patients who suffered a miscarriage or another form of abortive pregnancy outcome whilst at the hospital, and patients with a concealed pregnancy* \n- any patient known to have requested their details are not used for any purpose other than their clinical care \n- any patients who were admitted to hospital via Medical or Surgical Admissions Units and therefore have not visited the emergency department \n- Any attendances at Walk-in Centre’s \n- Any attendances at Type 3 departments not wholly managed by the sampling trust. \n- Patients who attended or were streamed to a separate Same Day Emergency Care unit (i.e. not the A&E department or Urgent Treatment Centre).\n\n"]
["Description of confidential patient information used","Data sources\n\n1. Electronic patient records within all eligible Trusts in England (126 trusts)1. Electronic patient records within all eligible Trusts in England (126 trusts).\n\nIdentifiers required for contact purposes\n\n1. A standardised unique identifier code, to be constructed as survey identifier, trust code followed by a whole number (consecutive across the sample of patients from each trust), e.g. UEC22XXXNNNN where XXX is the trusts 3 digit trust code and NNNN is the 4 digit serial number relating to sampled patients. \n2. Title (Mr, Mrs, Ms, etc.) \n3. First name \n4. Surname \n5. Address Fields \n6. Full Postcode\n\nIdentifiers required for analysis purposes\n\n1. The unique identifier code (as above) \n2. NHS Trust code \n3. Date and time of attendance \n4. NHS Site code \n5. Department type (Type 1 or Type 3) \n6. Ethnicity \n7. Gender \n8. Year of birth \n9. CCG code \n10. Patients full postcode – to use to map to deprivation index\n11. Mobile phone indicator"]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"X","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"X","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2023-08-02"]
["Notes","14 September 2022 – amendment supported \n\nTo increase the sample size of the cohort from 420 type 3 patients (1370 total), to 580 type 3 patients (1530 total), in Trusts that have type 1 & type 3 department\n\nAmendment supported 14th September 2022 \n\nTo increase the sample size of the cohort from 420 type 3 patients (1370 total), to 580 type 3 patients (1530 total), in Trusts that have type 1 & type 3 departments\n\nConditions of support:\n\n1.\tConfirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. See section below titled ‘security assurance requirements’ for further information. Confirmed: \n\nThe NHS Digital 21/22 DSPT reviews for Patient Perspective Ltd, Picker Institute Europe and Quality Health Ltd were confirmed as ‘Standards Met’ on the NHS Digital DSPT Tracker (checked 27 July 2022)\n"]

{"sheet":"A1047","index":214,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A1047"]
["Reference","22/CAG/0084"]
["Other Refs"]
["Application Title","Warrington Health and Wellbeing Survey 2022"]
["Application Summary","This  application  from  Warrington  Borough  Council(WBC) set  out  the  non-research service  evaluation  purpose  of establishing  a  patient  health  and  wellbeing  survey  in  the region.  The  application  will  undertake  a comprehensive,  large  scale  survey  ofadultresidents  in  Warrington  to  update  the  information  currently  held  from  previous  locallifestyle  surveys. The  surveyneeds  to  collect  information  on  a  wide  range  of  topics including;  perceptions  of  health  status,  emotional  wellbeing,  social  connectedness  and resilience,  long-term  and  recent  morbidity,  disability,  health  risk  behaviour,  use of services,  social  circumstances,  and  neighbourhood  issues.Impact  of  the  Covid-19 pandemic will be an additional topic in this survey.\n\nHistorically   the   survey   facilitation   team had   been   based   within   the   public   health department of the local Trust and had been able to facilitate the survey distribution locally without  the  requirement  to  seek  support  under  the  Regulations.  Due  to  revision  of  local services,  the  survey  distribution team  was  now  hosted  by  the  Warrington  Borough Council,  which  has  led  to  the changes  in  the  survey  methodology.‘s251’support  is requested  in  order  fora  third  party  mailout  company  contracted  bythe  council,  who  are not  considered  direct  care  team,to facilitate the  invitation  of  individualsin  the  area,  in order for them to consent into the survey. NHS Digital will supply the third partymail out company  with  confidential  patient  information about  the cohort. The  council themselveswillnever have access to any confidential patient information.\n\nOutcomes of the survey will be used for the following purposes:\n\n•Inform Warrington’s Health&  Wellbeing  Strategy,  Joint  Strategic NeedsAssessment and underpinning strategies for council and partner organisations. \n\n•Assist  in  health  needs  assessment,  by  providing  up-to-date  data  on  morbidity  and health and wellbeing status,\n\n•Assist  in  the  commissioning  and  targeting  of  resources  by  highlighting  areas/groups experiencing health inequalities,\n\n•Provide  information  for  monitoring  health  change  and  the  impact  of  local  prevention and  health  programmes,  by  repeating  salient  aspects  of  previous  surveys  where possible and practical."]
["Applicant Organisation Name","Warrington Borough Council"]
["Contact Name","Ms Frances Mann"]
["Address","East Annexe"]
[null,"Town Hall"]
[null,"Sankey St, Warrington"]
["Postcode","WA1 1UH"]
["Telephone","01925 443067"]
["Email","fmann@warrington.gov.uk"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"X","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","18+  adults  living  in  Warrington  and/or  registeredwith  a Warrington GP (excludingprisons).\n\nApproximately 34,000patients will be invited to participate, to aim to get 6,800 responses. \n\n‘s251’support  also  requested  for  potentialboost  sample, approximate numberswill   not   be   known   until   survey   is underway. "]
["Description of confidential patient information used","Data sources\n\n1.NHSDigital\n a)Primary Care Registration System\n\nIdentifiers required for thepurposesof sendingsurveyinvitations\n\n1.Name –title, forename and surname\n\n2.Address –house name/number, street, post town, postcode\n\n3.Sex\n\n4.GP practice code\n\n5.Date of birth\n\n6.Unique ID\n\nIdentifiers required for analysis purposes\n\n1.Age\n\n2.GP Practice code\n\n3.Sex \n\n4.Postcode–modified to LSOA/OA levelby NHS DigitalThe  final   dataset  tobe  retainedfor   analysis   will   be   in pseudonymised  form  only,  with  no  way  for  applicants  to  re-identify\n\nAdditional information\n\n3rd party  to  hold  a  look-up  list  which  matches  unique  ID  to patient  name  and  address  to  allow  for  respondent  opt-out after completing the questionnaireIf required, (if certain groups are underrepresented) WBCtocontact NHS Digital torequesta boost sample of additional patients to be sent aletterinviting them to participate in the survey."]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"X","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"X","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2023-09-29"]
["Notes","The application, to allow the disclosure of confidential patient information from NHS Digital to Direct Data Analysis, a third party mailout company, in order for them to facilitate sample validation and survey distribution is fully supported, subject to compliance with the standard conditions of support.\n\nConditions of support:\n\n1.\tConfirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. See section below titled ‘security assurance requirements’ for further information. Confirmed: \n\nThe NHS Digital 21/22 DSPT reviews for NHS Digital, Direct Data Analysis, and Central Mailing Services were confirmed as ‘Standards Met’ on the NHS Digital DSPT Tracker\n\n"]

{"sheet":"A1048","index":215,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","A1048"]
["Reference","22/CAG/0128 "]
["Other Refs"]
["Application Title","Stroke Patient Reported Experience Measures (PREMS) "]
["Application Summary","This   non-research   application   submitted   by The Stroke   Association,as   joint   data controllers with NHS England, sets out the purpose of conducting the 2022 Stroke Patient Reported Experience Measures (PREMS) Survey.\n\nThe  purpose  of  the  Stroke  PREMS  survey  isto  undertake  a  national  survey  which captures  the  patient  experience  of  stroke  care,  andto  use  the  survey  findings  to  inform quality  improvement  activity  at  local, regional,and  national  level –in  line  with the NHS’s statutory  responsibility  for  qualityimprovement. No  such  patient  experience  toolor  data existsat a national level, and yet this is part of the Stroke Long Term Plan ambitions for England. The survey will support nationally recognised aims of:\n\n•Improving  the  quality  andstandard  of  stroke  care  and  rehabilitation  across England.\n\n•Supporting   a   shift   in   focus   towards   measuring   patient   reported experience measures.\n\n•Placing  the  experience  of  people  affected  by  Stroke  at  the  heart  of  Stroke services.\n\n•Ensuring  that  Stroke  patient  experience measurement  becomes a  regular  feature and  key  driver for  improving  and  learning  from  patients  to  improve  the  services experienced by them.\n\nThere  are  approximately  80,000  strokes  per  year. Some  patients will  require  inpatient stroke  rehabilitation,  but for  the  majority  of  patients,rehabilitationwill  take place  in  the community. The intentionis to use the patient-reported data to better understand patients experiences  across  the entire  stroke  pathway, from emergencyadmissions,  acute stroke unit stay, community or inpatient rehabilitationand life after stroke services. \n\nThe outcome aims to enable further improvementsto improve the experience, and hopefully outcomes, for stroke survivors. ‘s251’ support is requested to allow Trusts  to  disclose  confidential  patient informationto Quality Health  for  the  purposes  of  undertaking  a  postal questionnairesurvey. Quality Health  will  contact  patients  by  post. Patients  will  be  sent  a  survey  pack  initially.  This  will include  the  survey  itself,  cover  letter  and  language  leaflet.  A first  reminder  will  be  sent 5weeks  after  the  survey  to  non-responders  only.  A  second  reminder  and  another  copy  of the  survey  will  be  sent  4  weeks  later  to  non-responders  only.If  patientsopt-out  of  the survey they will not receive further lettersor communication. Questionnairesare sent back to QualityHealth,  and  this  is  taken  as  implied  consent  to  take  part.  Quality  Healthundertake analyses, and provide anonymous outputs to the Stroke Association."]
["Applicant Organisation Name","Stroke Association"]
["Contact Name","Juliet Bouverie,OBE"]
["Address","Stroke Association House,"]
[null,"240 City Road"]
[null,"London"]
["Postcode","EC1V 2PR"]
["Telephone","07515 596919  & DL: 0151 604 7285"]
["Email","Juliet.Bouverie@stroke.org.uk & deborah.lowe4@nhs.net "]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"X","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Adult stroke survivors(aged 18+)who have experienced a confirmed Stroke and were admitted to an NHS England stroke service within the last 4-8 months Maximum estimated number of patients contacted; 27,712"]
["Description of confidential patient information used","Identifiers required forpatient invitation purposes\n\n1.NHS number, \n\n2.Name, \n\n3.Address including postcode, \n\n4.Sex, \n\n5.Ethnicity, \n\n6.Date of birth, \n\n7.ICD10 code, \n\n8.Date of stroke, \n\n9.Specialty code, \n\n10.Treating NHS Trust, \n\n11.NHS Trust of residence orcommissioning board.\n\nIdentifiers required for analysis purposes\n\n1.Date of birth–modified to age\n\n2.Ethnicity \n\n3.Gender This   would   be   effectively   anonymous,   and   additionally analysis undertaken with consent as the legal basis"]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"X","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"X","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2023-09-29"]
["Notes","The application, to allow the disclosure of confidential patient information from NHS trusts to Quality Health for the purpose of sending out questionnaires for the 2022 Stroke Patient Reported Experience Measures (PREMS) Survey, is fully supported, subject to compliance with the standard conditions of support.\n\n\nConditions of support:\n\n1.\tConfirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. See section below titled ‘security assurance requirements’ for further information. Confirmed: \n\nThe NHS Digital 21/22 DSPT review for Quality Health was confirmed as ‘Standards Met’ on the NHS Digital DSPT Tracker (checked 08 September 2022)\n"]

{"sheet":"A1049","index":216,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A1049"]
["Reference","22/CAG/0115 "]
["Other Refs"]
["Application Title","Evaluation of ocular and systemic outcomes after treatment of ocular melanoma and other ocular tumours"]
["Application Summary","This   non-research   application   submitted   by Liverpool University Hospitals NHSFoundation Trustsets out the purpose of obtaining death notification data aboutpatients with  ocular  cancers treated  at the  Trust,  in  order  toaudit  local  treatment  outcomes, prognosis and mortality from the disease or other causes. The data will also be used for service  evaluation  such  as  ongoing  Liverpool  Uveal  Melanoma  Prognosticator  Online (LUMPO)  refinement  and  validation,  as  well  as  understanding  the  timing  and  nature  of metastatic  disease  to  enable  clarification  of  screening  practices. Further  collaborative projects with other ocular oncology centres as well as medical oncologistsmay happen in the  future,  butany  amendments  to  the  purposes  of  this  study  will  be confirmedvia amendment, or new application to CAG.\n\nParticipants  records  were previously ‘flagged’  with  the  ONS,  undera  study  referenceMR572,whichis no longer running.ONS, and more recently, NHS Digital,notified Royal Liverpool  University  Hospitals  NHS  Foundation  Trust of participants’ deaths (date and cause) and cancer events when they occurred.This has been completedfor patients prior to September2018.\n\nTheapplicant now requires ‘s251’ in order to progress this activityfor patients post September 2018.The  most  common  primary  intraocular malignancy  is  uveal melanoma, with  an  incidence of  about  7  per  million  per  year.  The  chances  of  dying  of  metastaticdisease  within  ten years increase with large tumour size, epithelioid cell type, and old age, ranging from 5% -70%. Liverpool Ocular Oncology Servicewas designateda supra-regional centre in April 1997. As a specialised service there is a need to evaluateocular and systemic outcomes after  treatment  of  ocular  melanoma  and  other  ocular  tumoursas  part  of  this  service evaluation.In  addition, service  evaluation  reports  in  parallel  to  new  revised  uveal melanoma  guidelines  will  be  produced  to  enable  improvements in  patient  care. Regular meetings are also held with patient support groups such as Ocumel to enable such groups to better understand treatment options and outcomes.\n\nIn  this  application,  the  applicant  at Liverpool University Hospitals NHSFoundation Trustwill send confidential patient information to NHS Digital for all patients with ocularcancers, who have beentreated at Liverpool University Hospitals NHS Trust after September 2018. This  would  be  for approximately250-300  patients  a  year,  and theapplicant  would  sent these extracts twice a year. NHS Digitalwould then flag these individuals, and sendback linked  mortality data  once  a  month, for any  deceased  patients.  The  applicant  will  deleteconfidential  patient  information  received 12  months  after receiving  it  for  each  individual, however ‘s251’  support  will  be  required  in  an ongoing  fashion  for futureflagging  and linkages."]
["Applicant Organisation Name","Liverpool University Hospitals NHS Foundation Trust"]
["Contact Name","Professor Heinrich Heimann"]
["Address","Liverpool University Hospitals NHS Foundation Trust "]
[null,"Prescot Street "]
[null,"Liverpool "]
["Postcode","L7 8XP"]
["Telephone","0151 7063973"]
["Email","heinrich.heimann1@nhs.net"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"X","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Patients  with ocularcancers,  who have  beentreated  at Liverpool  University  Hospitals  NHSTrust  after  September 2018\n\nApproximately 250-300 patientsper year would be flaggedto NHS Digital who would link the dataand return only deceased patientinformation."]
["Description of confidential patient information used","Data sources\n\n1.Clinical databases at Liverpool Trust\n\n2.NHS Digital;ONS Mortality Dataset\n\nIdentifiers required for linkage purposes\n\n1.NHS number \n\n2.Date of Birth\n\nApplicant  has nowconfirmedminimum  required with  NHS Digital, and this is provided in separate correspondencefrom NHS D.\n\nIdentifiers required for analysis purposes\n\n1.Date of death \n\n2.Cause of death \n\n(not directly identifiable)(confirmed as part of further queries via email)\n\nAdditional information\n\nNHS   Digital   provide   linked   outcome   data   back   to the applicant monthly, for only deceased patients.\n\nApplicant  willprovide  an  update  of the cohort for  flagging to NHS Digitaltwiceannually, in an ongoing fashion. "]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"X","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"X","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"X","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2023-11-07"]
["Notes","The application, to allow the disclosure of confidential patient information from Liverpool University Hospitals NHS Foundation Trust to NHS Digital, for the purposes of flagging the patient to allow linkage to mortality outcomes, and for the flow of confidential patient information back to the applicant, is conditionally supported, subject to compliance with the standard and specific conditions of support.\n\nConditions of support:\n\n1.\t‘s251’ support provided for five years in the first instance. An amendment will be required at that time to extend the duration of ‘s251’ support if required.\n\n2.\tConfirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. See section below titled ‘security assurance requirements’ for further information. Confirmed:\n\nThe NHS Digital 21/22 DSPT reviews for Liverpool University Hospitals NHS Foundation Trust and NHS Digital were confirmed as ‘Standards Met’ on the NHS Digital DSPT Tracker (checked 31 August 2022)\n"]

{"sheet":"A1050","index":217,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A1050"]
["Reference","22/CAG/0152 "]
["Other Refs"]
["Application Title","2022 NHS Adult Inpatient Main Stage Survey –Mixed Methods"]
["Application Summary","This non-research application submitted by Ipsos MORI on behalf of the Care Quality Commission, sets out the purpose of conducting the 2022 NHS Adult Inpatient Survey. \n\nThe Adult Inpatient Survey started in 2002 and falls within the NHS Patient Survey Programme (NPSP). The NPSP was initiated in 2002 by the then Department of Health, and is now overseen by the Care Quality Commission (CQC), the independent regulator of health and social care in England.\n\n The 2022 Adult Inpatient survey will be the twentieth carried out to date, and the third mainstage to be completed using a mixed method approach.\n\nAll eligible trusts (134) will be asked to conduct the survey, with preparations expected to begin in the autumn of 2022 and fieldwork expected to start from January 2023. Trusts will collect information of all eligible patients and, following suitability checks, will share confidential patient information with the coordination centre (IPSOS MORI) and one of three approved contractors (Patient Perspective, Quality Health or Picker Institute Europe). \n\nAhead of each reminder mailing, it will be necessary to remove all respondents who have completed the survey already, and to conduct a DBS or local check on the full sample. If anyone has requested to be opted out of further reminders, they should also be removed at these timepoints."]
["Applicant Organisation Name","Care Quality Commission"]
["Contact Name","Laura Thomas"]
["Address","Ipsos UK"]
[null,"3 Thomas More Square"]
[null,"London"]
["Postcode","E1W 1YW"]
["Telephone","0203 059 4717"]
["Email","laura.thomas@ipsos.com"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"X","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","Inpatients  aged  16  years  old  or  over  who  were  discharged from  acute  and  specialist  NHS  hospitals  in  November  (and earlier  for  smaller  trusts),  having  had  at  least  one  overnight stay in hospital. \n\nA list of reasons for exclusion, such as deceased patients and those  under  16  years  of  age  at  the  time  of  sampling,  was included in the application. "]
["Description of confidential patient information used","Data sources\n\n1.Electronic patient records with acute and specialist trusts in England (134).\n\nIdentifiers required for contact purposes\n\n1.Name\n2.Address fields including postcode\n3.Mobile phone number\n4.Patient unique identifier\n\nIdentifiers required for analysis purposes\n\n1.Unique  identifier  (a  three  digit  Trust  code  and  4  digital serial number related to sampled patient)\n2.Postcode\n3.Trust code\n4.Year of birth\n5.Gender\n6.Ethnic category\n7.Date of admission\n8.Date of discharge\n9.Length of Stay\n10.Treatment Function Code\n11.ICD-10 Chapter Code \n12.Treatment Centre Admission\n13.Admission method\n14.NHS Site code-Admitted\n15.NHS Site code-Discharged\n16.‘Decided to admit’ date\n\nAdditional information\n\nTrusts may also choose to collect additional sample variables outside of those detailed in the Survey Handbook. This can be valuable to trusts in enabling them to make greater use of their survey locally to target quality improvements.\n\nSample and mailing data will be submitted by trusts to approved contractors in a single file. The file which contains both mailing and sample information will be split into separate files by the contractor before submitting only the sample informationto the Coordination Centre for checking and approval.\n\nPlease note that the Survey Coordination Centre does notreceive any names or full addresses"]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,"X","Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"X","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2023-11-11"]
["Notes","The application, to allow the disclosure of confidential patient information from NHS Trusts to one of three approved contractors for the purpose of sending out questionnaires for the 2022 Adult Inpatient Survey, and for disclosure of postcode to IPSOS MORI for analysis purposes, is conditionally supported, subject to compliance with the standard and specific conditions of support\n\nConditions of support:\n\n1.\tThe applicant is encouraged to develop further patient notification methods, and report back on doing so within 6 months from the date of this letter. \n\n2.\tPlease advise CAG if instructions ‘to share information about the survey on social media and Trust websites’ has been incorporated into the publicity instruction documentation provided to Trusts, and if not, why not, within one month from the date of this letter.\n\nCondition met 13 December 2022\n\n3.\tConfirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. See section below titled ‘security assurance requirements’ for further information. Confirmed: \n\nThe NHS Digital 21/22 DSPT reviews for Ipsos MORI, Patient Perspective, Quality Health Limited, and Picker Institute Europe were confirmed as ‘Standards Met’ on the NHS Digital DSPT Tracker (checked 03 November 2022)"]

{"sheet":"A1051","index":218,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4]]}
[]
[]
["Application Number","A1051"]
["Reference","22/CAG/0101"]
["Other Refs"]
["Application Title","Nottingham and Nottinghamshire ICB S251 non-research purposes "]
["Application Summary","This  non-research  application  from  Nottingham  and  Nottinghamshire  ICB  set  out  the purpose of using patient and population data to enable better use of a Population Health Management  solution,  with  the  aim  of  providing  health  and  social care teams  with analytical products and tools to support service planning.\n\nThe Integrated Care System (ICS) Population Health Management programme forms part of a larger initiative that the ICS is undertaking to transform data to intelligence. In recent years,the  quality  and  volume  of  data  held  for  individual  patients  has  greatly  increased. Regulations  and  guidance  are  in  place  to  protect  privacy  and  confidentiality.  However, these  rules  can  impact  on  the  use  of data  to  meet  the  national  population  healthmanagement  agenda.  Recent  Planning  Guidance  has  emphasised  Population  Health Intelligence and insights, with the aim of using data to inform and design models of care to deliver tailored and at scale improvementsof the health and wellbeing of the population.\n\nConfidential  patient  information  will  be  extracted  by  the  ICBs  Data  Management  Team from  the  GPRCC  (GP  Repository  for  Clinical  Care).  The  dataset  will  be  saved  to  a restricted  area  within  Nottingham  and  Nottinghamshire  ICB.  This  is  outside  the  scope  ofsupport and already occurs to create the GPRCC.\n\nPatient  NHS  numbers  will  be  pseudonymised  by  replacing  the  NHS  numbers  with  a common  pseudonym,  which  willbe  used  to  link  the  dataset  to  other  local  and  national health  care  data.  However,  the  dataset  will  also  contain  patients  date  of  birth  and postcode,  and  therefore  contains  confidential  patient  information.  Support  is  required  for the  data  linkage of  the GPRCC  data  tolocal  and  national dataset,  held  byNHS  Digital,and  the  retention  of  the  identifiable  datasetwithin  Nottingham  and  Nottinghamshire  ICB. Support is also required to share the datasets, containing confidential patient information, withPopulation Health Management (PHE) analysts.\n\nAdditionally,  the  applicants  clarified  that they  propose  to  facilitate  linkage  between  data originating  from  the  GPRCC  and  data  originating  from  NHS  Digital,  by  sharing  with  the Data     Services     for     Commissioners     Regional     Offices(DSCRO)     a     bespoke pseudonymisation key (sometimes referred to as a SALT).This would enable the DSCRO to  return  a  simple  mapping  table  of  the  PHM  pseudonym  of  NHS  numbers  held  in  the GPRCC   to   the   pseudonyms   of   NHS   numbers   already   applied   to   the   national commissioning data, excluding patients who have opted out.\n\nThe  applicants noted  thatsupport  under  Regulation  5  of  the  COPI  Regulations  was sought  for  2  years  initially  as  there  may  be  changes  in  statute  law  to  allow  Health  and Care  organisations  to  process  confidential  patient  information. If  these  changes  do  not occur within the next 2 years, an extension to support will be sought"]
["Applicant Organisation Name","Nottingham and Nottinghamshire Integrated Care Board (ICB)"]
["Contact Name","Maria Principe"]
["Address","Sir John Robinson House"]
[null,"Sir John Robinson Way"]
[null,"Arnold, Nottingham"]
["Postcode","NG5 6DA"]
["Telephone",7970875779]
["Email","maria.principe@nhs.net "]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"X","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","All patients who use or have used a Nottingham and Nottinghamshire Integrated Care System (ICS) based provider. This will include:  \n\n1. Patients who are registered with a GP practice in Nottingham and Nottinghamshire \n\n2. Patients/Citizens who have used any local providers \n\n3. Patients/Citizen who reside from outside of Nottingham and Nottinghamshire.  \n\n4. Patients/Citizens who have been registered but subsequently left the area or died, irrespective of age or characteristics. "]
["Description of confidential patient information used","Data sources\n\n1.GPRCC (GP  Repository  for  Clinical  Care),  held  at Nottingham    and    Nottinghamshire   Integrated    Care Board (ICB)\n\n2.National Datasets, held by NHS Digital:\na.Primary care  (SystmOne,  EMISWeb) –Read  codes, medications, referrals \nb.Community  data  (CityCare,  PICS  and  Nottinghamshire Healthcare Trust (CHP) \nc.Mental Health data (community and inpatient) \nd.Acute data (admissions, ED attendance) \ne.Adult Social Care (City and County Councils) \nf.Out-of-Hours Care (NEMS, DHU 111 and EMAS) \ng.Secondary  Uses  Service  (SUS)  ·  CHSDS  CommunityHealth Services \nh.MHD –Mental Health Datasets i.National IAPT Patient datasets \nj.MSDS Maternity Service Data Set\n\nIdentifiers required for linkage purposes\n\n1.NHS Number\n2.Date of birth\n3.Postcode\n\nIdentifiers required for analysis purposes\n\n1.Age  \n2.Date of birth \n3.Postcode  \n4.Lower Super Output Area,  \n5.Ethnicity\n6.Gender"]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,"X","Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,null,"Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"X","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2023-11-17"]
["Notes","Conditions of support:\n\n1. Ongoing patient and public involvement is to be carried out and reported back on at annual reviews. \n\n2. Confirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. Confirmed: The NHS Digital 2021/22 DSPT reviews for Nottingham and Nottinghamshire Integrated Care Board (ICB) and NHS Digital were confirmed as ‘Standards Met’ on the NHS Digital DSPT Tracker (checked 31 August 2022)\n"]

{"sheet":"A1052","index":219,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[7,1,7,4],[8,1,8,4],[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[13,1,13,4],[12,1,12,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number","A1052"]
["Reference","22/CAG/0137"]
["Other Refs"]
["Application Title","West Yorkshire ICB S251 non-research purposes"]
["Application Summary","This non-research application West Yorkshire Integrated Care Board (ICB) from set out the purpose of using patient data to enable a whole system approach to supporting the reduction of health inequalities and improvement of efficiency of the health and care offered.\n\nThe main aims of the Population Health Management solution will be to improve the mental and physical health outcomes and wellbeing of patients, the reduction of health inequalities, reducing the re-occurrence of ill-health and use of Artificial Intelligence to risk stratify and target individual and communities at risk of deteriorating health. \n\nThe North of England Commissioning Support Unit (NECS) will extract primary care data from all GP practices in the West Yorkshire area. Once the datasets are received by NECS, a common pseudonym will be applied. Data from the Commissioning Datasets, held by NHS Digital, will be sent from NHS Digital to NECS, using the same common pseudonym to allow NECS to link the datasets. The pseudonymised dataset will then be stored at a data warehouse within West Yorkshire ICB for analysis. Pseudonymised data will also flow back to the GP practices, this data will be limited to the practices own patients. Patient NHS numbers will be held by NECS for re-identification purposes only."]
["Applicant Organisation Name","West Yorkshire Integrated Care Board (ICB)"]
["Contact Name","Mrs Natalie Tolson "]
["Address","West Yorkshire Integrated Care Board "]
[null,"White Rose Hose, West Parade \n"]
[null,"Wakefield "]
["Postcode","WF1 1LT"]
["Telephone"]
["Email","Natalie.tolson@nhs.net"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,"X","the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population","All active patients in the West Yorkshire area. The applicants anticipate that 2.6 million patients will be included."]
["Description of confidential patient information used","Data sources\n\n1. GP practice data \n\n2. Commissioning Datasets held by NHS Digital\n\nIdentifiers required for linkage purposes\n\n1. NHS Number\n\nIdentifiers required for analysis purposes\n\n1. NHS Number The applicants confirmed that the NHS Number would not be used for analysis, but would be retained for re-identification purposes."]
["S251 Class(es)",null,"Specific Support"]
[null,"X","Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,null,"Class V - audit, monitoring, & analysis of healthcare provision "]
[null,"X","Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status","Supported"]
[]
["Next Review Date","2023-12-07"]
["Notes","Conditions of support:\n\n1. Confirmation provided from the IG Delivery Team at NHS Digital to the CAG that the relevant Data Security and Protection Toolkit (DSPT) submission(s) has achieved the ‘Standards Met’ threshold. See section below titled ‘security assurance requirements’ for further information. Confirmed: NHS Digital 2021/22 DSPT review for NHS Digital and The North of England Commissioning Support Unit (NECS were confirmed as ‘Standards Met’ on the NHS Digital DSPT Tracker (07/12/2022) Due to the number of participating GP practices where confidential patient information will be accessed, individual DSPT submissions are not required for the purpose of the application. Support is recommended on the basis that the applicant ensures the required security standards are in place at each site prior to any processing of confidential patient information with support under the Regulations.\n\n"]

{"sheet":"TEMPLATE","index":220,"n_rows":35,"n_cols":3,"rows_kept":35,"cut":false,"hidden":false,"merged":[[2,1,2,4],[3,1,3,4],[4,1,4,4],[5,1,5,4],[6,1,6,4],[7,1,7,4],[8,1,8,4],[9,0,11,0],[9,1,9,4],[10,1,10,4],[11,1,11,4],[12,1,12,4],[13,1,13,4],[14,1,14,4],[15,0,20,0],[15,2,15,4],[16,2,16,4],[17,2,17,4],[18,2,18,4],[19,2,19,4],[20,2,20,4],[23,0,29,0],[23,2,23,4],[24,2,24,4],[25,2,25,4],[26,2,26,4],[27,2,27,4],[28,2,28,4],[29,2,29,4],[30,1,30,4],[31,1,31,4],[33,1,33,4],[34,1,34,4],[21,1,21,4],[22,1,22,4]]}
[]
[]
["Application Number"]
["Reference"]
["Other Refs"]
["Application Title"]
["Application Summary"]
["Applicant Organisation Name"]
["Contact Name"]
["Address"]
[]
[]
["Postcode"]
["Telephone"]
["Email"]
["Medical Purposes",null,"preventative medicine"]
[null,null,"medical diagnosis"]
[null,null,"medical research, approved by a research ethics committee"]
[null,null,"the provision of care and treatment"]
[null,null,"the management of health and social care services"]
[null,null,"informing individuals about their physical or mental health or condition, the diagnosis of their condition or their care and treatment"]
["Cohort/Population"]
["Description of confidential patient information used"]
["S251 Class(es)",null,"Specific Support"]
[null,null,"Class I - making the person less readily identifiable "]
[null,null,"Class II - present or past geographical locations of patients "]
[null,null,"Class III - to identify and contact patients to obtain consent"]
[null,null,"Class IV - linking multiple sources;validating quality and completeness; avoiding error"]
[null,null,"Class V - audit, monitoring, & analysis of healthcare provision "]
[null,null,"Class VI - granting of access to data for purposes I-V"]
["Sponsor"]
["Status"]
[]
["Next Review Date"]
["Notes"]